Entry_ID	Molecule_name	Molecule_ID	Target_RNA_name	Source_organism	Disease_involved	Target_RNA_ID	Ka(M-1)	Ki(M)	Kd(M)	IC50(M)	EC50(M)	T50(M)	CD50(M)	PDB_ID	Modeled_complex	Reference_DOI	Reference_PMID	Title	Authors_list	Journal_name	Volume	Page_number	Year	Ligand_concentration	RNA_concentration	pH	Temperature	Ions_present	Experimental_method	Data_source	SMILES	IUPAC_name	PubChem_CID	LogP	MW	HBA	HBD	NRB	TPSA	Benzene_count	QED	SAS	Heavy_atom_count	Target_RNA_sequence	Sequence_source	RNA_type	RNA_subclass	RNA_sequence_length	Target_region	Secondary_structure	Ka_lower	Ka_upper	Ki_lower	Ki_upper	Kd_lower	Kd_upper	IC50_lower	IC50_upper	EC50_lower	EC50_upper
1	Spermine	Target_lig_0	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0	8.50E-06	0	0	0	0	1EVV	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C(CCNCCCN)CNCCCN	N,N'-bis(3-aminopropyl)butane-1,4-diamine	1103	-0.356599999999998	202.215746832	4	4	11	76.1	0	0.34528060577149	2.17853122035495	14	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	8.50E-06	8.50E-06	0	0	0	0
2	Ethidium bromide	Target_lig_6	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.6	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.6	0.6	0	0	0	0	0	0
3	Methidiumpropyl-EDTA(MPE)	Target_lig_2	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	1000000	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	-	-	7.6	37	0.1M Na+	Fluorescence titrations, Competitive experiments	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	1000000	1000000	0	0	0	0	0	0	0	0
4	Hygromycin_B	Target_lig_3	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.000267	0	0	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N	4-[3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6'-(1-amino-2-hydroxyethyl)-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol	3659	-7.2706	527.232638244	16	11	6	272.06	0	0.152994487643804	6.04885226343299	36	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.000267	0.000267	0	0	0	0	0	0
5	Neomycin	Target_lig_4	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.000342	0	0	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.000342	0.000342	0	0	0	0	0	0
6	Paromomycin_mol_mol	Target_lig_1116	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.002	0	0	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.002	0.002	0	0	0	0	0	0
7	Tobramycin	Target_lig_540	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.008	0	0	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.008	0.008	0	0	0	0	0	0
8	Kanamycin A	Target_lig_7	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.005	0	0	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.005	0.005	0	0	0	0	0	0
9	KANAMYCIN B	Target_lig_8	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.0112	0	0	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.0112	0.0112	0	0	0	0	0	0
10	ribostamycin	Target_lig_9	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.0233	0	0	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	5066	-6.6523	454.227493288	14	10	6	262.38	0	0.178778081939411	4.96778075738293	31	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.0233	0.0233	0	0	0	0	0	0
11	sisomicin	Target_lig_10	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.00044	0	0	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.00044	0.00044	0	0	0	0	0	0
12	5_episisomicin	Target_lig_1244	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	2.50E-06	0	0	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	2.50E-06	2.50E-06	0	0	0	0	0	0
13	Lividomycin	Target_lig_11	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.018	0	0	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(CC(C(O2)CO)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)OC5C(C(C(C(O5)CO)O)O)O)O)N)O)O)N	2-[5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-4-hydroxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	3940	-10.0083	761.35420992	23	15	12	406.24	0	0.087736447103846	5.92634264032295	52	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.018	0.018	0	0	0	0	0	0
14	tetra_methylpyridyl_porphyrine	Target_lig_12	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	73	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN1C=CC(=C2C3=CC=C([N-]3)C(=C4C=CN(C=C4)C)C5=CC=C([N-]5)C(=C6C=CN(C=C6)C)C7=CC=C([N-]7)C(=C8C=CN(C=C8)C)C9=CC=C2[N-]9)C=C1.[Ni]	nickel;5,10,15,20-tetrakis(1-methylpyridin-4-ylidene)porphyrin-21,22,23,24-tetraide	3316441	6.92510000000001	734.24383037164	4	0	0	69.36	4	0.158971767415998	7.15861701160679	53	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	73	73	0	0	0	0	0	0
15	tetra_methylpyridyl_porphyrine_Cu complex	Target_lig_13	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	1.7	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN1C=CC(=C2C3=CC=C([N-]3)C(=C4C=CN(C=C4)C)C5=CC=C([N-]5)C(=C6C=CN(C=C6)C)C7=CC=C([N-]7)C(=C8C=CN(C=C8)C)C9=CC=C2[N-]9)C=C1.[Cu]	copper;5,10,15,20-tetrakis(1-methylpyridin-4-ylidene)porphyrin-21,22,23,24-tetraide	3292428	6.92510000000001	739.23808497164	4	0	0	69.36	4	0.15871071691542	7.16626497540769	53	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	1.7	1.7	0	0	0	0	0	0
16	tetra_methylpyridyl_porphyrine_Zn complex	Target_lig_14	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	230	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN1C=CC(=C2C3=NC(=C(C4=NC(=C(C5=CC=C([N-]5)C(=C6C=CC2=N6)C7=CC=[N+](C=C7)C)C8=CC=[N+](C=C8)C)C=C4)C9=CC=[N+](C=C9)C)C=C3)C=C1.[Zn+2]	zinc;5,10,15-tris(1-methylpyridin-1-ium-4-yl)-20-(1-methylpyridin-4-ylidene)porphyrin-22-ide	5489106	5.36030000000001	740.23324103236	4	0	3	66.06	4	0.209917311224031	6.57694372049346	53	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	230	230	0	0	0	0	0	0
17	Berberine_mol	Target_lig_15	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.115	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.115	0.115	0	0	0	0	0	0
18	Palmataine	Target_lig_16	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.105	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.105	0.105	0	0	0	0	0	0
19	Coralyne	Target_lig_17	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.67	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.67	0.67	0	0	0	0	0	0
20	Sanguinarine	Target_lig_18	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.1	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C[N+]1=C2C(=C3C=CC4=C(C3=C1)OCO4)C=CC5=CC6=C(C=C52)OCO6	24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene	5154	3.4281	332.09173434809	4	0	0	40.8	4	0.365369910827105	2.89850674553215	25	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.1	0.1	0	0	0	0	0	0
21	Aristololactam_Beta_D_glucoside	Target_lig_19	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0.01	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=CC=CC2=C3C4=C(C=C21)N(C(=O)C4=CC5=C3OCO5)C6C(C(C(C(O6)CO)O)O)O	14-methoxy-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-10-azapentacyclo[9.7.1.02,6.08,19.013,18]nonadeca-1(18),2(6),7,11(19),12,14,16-heptaen-9-one	53462738	0.490399999999999	455.121631252	9	4	3	138.15	3	0.415812076480599	4.136728384639	33	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.01	0.01	0	0	0	0	0	0
22	Ethidium bromide	Target_lig_6	RNA duplex (polyApolyU)	Synthetic	-	Target_2	0	(1.0±0.2)X1E-12	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	8.00E-13	1.20E-12	0	0	0	0	0	0
23	Ethidium bromide	Target_lig_6	RNA duplex (polyApolyU)	Synthetic	-	Target_2	0	(0.6±0.2)X1E-12	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	4.00E-13	8.00E-13	0	0	0	0	0	0
24	Berenil	Target_lig_20	RNA duplex (polyApolyU)	Synthetic	-	Target_2	0	12	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=O)NCC(=O)O.C1=CC(=CC=C1C(=N)N)NN=NC2=CC=C(C=C2)C(=N)N	2-acetamidoacetic acid;4-[2-(4-carbamimidoylphenyl)iminohydrazinyl]benzenecarboximidamide	65060	1.57264	398.181486564	6	7	7	202.89	2	0.159384466089287	2.6432732954258	29	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	12	12	0	0	0	0	0	0
25	Berenil	Target_lig_20	RNA duplex (polyApolyU)	Synthetic	-	Target_2	0	4.8	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=O)NCC(=O)O.C1=CC(=CC=C1C(=N)N)NN=NC2=CC=C(C=C2)C(=N)N	2-acetamidoacetic acid;4-[2-(4-carbamimidoylphenyl)iminohydrazinyl]benzenecarboximidamide	65060	1.57264	398.181486564	6	7	7	202.89	2	0.159384466089287	2.6432732954258	29	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	4.8	4.8	0	0	0	0	0	0
26	Berenil	Target_lig_20	RNA duplex (polyApolyU)	Synthetic	-	Target_2	0	1.4	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=O)NCC(=O)O.C1=CC(=CC=C1C(=N)N)NN=NC2=CC=C(C=C2)C(=N)N	2-acetamidoacetic acid;4-[2-(4-carbamimidoylphenyl)iminohydrazinyl]benzenecarboximidamide	65060	1.57264	398.181486564	6	7	7	202.89	2	0.159384466089287	2.6432732954258	29	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	1.4	1.4	0	0	0	0	0	0
27	Berenil	Target_lig_20	RNA duplex (polyApolyU)	Synthetic	-	Target_2	0	0.44	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=O)NCC(=O)O.C1=CC(=CC=C1C(=N)N)NN=NC2=CC=C(C=C2)C(=N)N	2-acetamidoacetic acid;4-[2-(4-carbamimidoylphenyl)iminohydrazinyl]benzenecarboximidamide	65060	1.57264	398.181486564	6	7	7	202.89	2	0.159384466089287	2.6432732954258	29	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.44	0.44	0	0	0	0	0	0
28	Berenil	Target_lig_20	RNA duplex (polyApolyU)	Synthetic	-	Target_2	0	0.076	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=O)NCC(=O)O.C1=CC(=CC=C1C(=N)N)NN=NC2=CC=C(C=C2)C(=N)N	2-acetamidoacetic acid;4-[2-(4-carbamimidoylphenyl)iminohydrazinyl]benzenecarboximidamide	65060	1.57264	398.181486564	6	7	7	202.89	2	0.159384466089287	2.6432732954258	29	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.076	0.076	0	0	0	0	0	0
29	Dapi	Target_lig_21	RNA duplex (polyApolyU)	Synthetic	-	Target_2	0	6.4	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=CC(=CC=C1C2=CC3=C(N2)C=C(C=C3)C(=N)N)C(=N)N	2-(4-carbamimidoylphenyl)-1H-indole-6-carboximidamide	2954	2.40304	277.13274548	2	5	3	115.53	3	0.373396336397623	2.27030046528223	21	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	6.4	6.4	0	0	0	0	0	0
30	MPE-Zn(II)	Target_lig_22	RNA duplex (polyApolyU)	Synthetic	-	Target_2	6e-07±2e-07	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	-	-	7.6	23	50mM NaCl	Fluorescence titrations, Competitive experiments	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	4.00E-07	8.00E-07	0	0	0	0	0	0	0	0
31	MPE-Zn(II)	Target_lig_22	RNA duplex (polyApolyU)	Synthetic	-	Target_2	3.5e-07±2e-07	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	-	-	7.6	23	100mM NaCl	Fluorescence titrations, Competitive experiments	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	1.50E-07	5.50E-07	0	0	0	0	0	0	0	0
32	MPE-Zn(II)	Target_lig_22	RNA duplex (polyApolyU)	Synthetic	-	Target_2	1.3e-07±5e-08	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	-	-	7.6	23	200mM NaCl	Fluorescence titrations, Competitive experiments	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	8.00E-08	1.80E-07	0	0	0	0	0	0	0	0
33	MPE-Zn(II)	Target_lig_22	RNA duplex (polyApolyU)	Synthetic	-	Target_2	1.6e-07±5e-08	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	-	-	7.6	37	100mM NaCl	Fluorescence titrations, Competitive experiments	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	1.10E-07	2.10E-07	0	0	0	0	0	0	0	0
34	MPE-Fe(II)	Target_lig_23	RNA duplex (polyApolyU)	Synthetic	-	Target_2	6e-07±3e-07	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	-	-	7.6	23	50mM NaCl	Fluorescence titrations, Competitive experiments	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	3.00E-07	9.00E-07	0	0	0	0	0	0	0	0
35	Phenylquinoline_derivative_1	Target_lig_24	RNA duplex (polyApolyU)	Synthetic	-	Target_2	0	0.907	0	0	0	0	0	-	-	10.1002/bip.360340108	7509202	The interaction of substituted 2-phenylquinoline intercalators with poly(A).poly(U): classical and threading intercalation modes with RNA.	Zhao M, Janda L, Nguyen J, Strekowski L, Wilson WD	Biopolymers	34	61-73	1994	-	1x10-4 M	6.25	-	0.1M NaCl	Viscometry, pKa, Spectrophotometry, Binding, Tm and Kinetic methods	SMMRNA	CN(C)CCNC1=CC(=NC2=CC=CC=C21)C3=CC=CC=C3	N',N'-dimethyl-N-(2-phenylquinolin-4-yl)ethane-1,2-diamine	453048	3.8753	291.173547672	3	1	5	28.16	3	0.773072562413847	1.85236903026368	22	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.907	0.907	0	0	0	0	0	0
36	Phenylquinoline_derivative_2	Target_lig_25	RNA duplex (polyApolyU)	Synthetic	-	Target_2	0	0.059	0	0	0	0	0	-	-	10.1002/bip.360340108	7509202	The interaction of substituted 2-phenylquinoline intercalators with poly(A).poly(U): classical and threading intercalation modes with RNA.	Zhao M, Janda L, Nguyen J, Strekowski L, Wilson WD	Biopolymers	34	61-73	1994	-	1x10-4 M	6.25	-	0.1M NaCl	Viscometry, pKa, Spectrophotometry, Binding, Tm and Kinetic methods	SMMRNA	c1(c(c(c(cc1)c1nc2c(cccc2)cc1)N1CCN(CC1)C)N1CCN(CC1)C)N1CCN(CC1)C	-	-	3.1572	499.342344312	7	0	4	32.33	3	0.545341554540629	2.66647130359406	37	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.059	0.059	0	0	0	0	0	0
37	Phenylquinoline_derivative_3	Target_lig_26	RNA duplex (polyApolyU)	Synthetic	-	Target_2	0	0.0029	0	0	0	0	0	-	-	10.1002/bip.360340108	7509202	The interaction of substituted 2-phenylquinoline intercalators with poly(A).poly(U): classical and threading intercalation modes with RNA.	Zhao M, Janda L, Nguyen J, Strekowski L, Wilson WD	Biopolymers	34	61-73	1994	-	1x10-4 M	6.25	-	0.1M NaCl	Viscometry, pKa, Spectrophotometry, Binding, Tm and Kinetic methods	SMMRNA	c1(c(c(c(cc1)c1nc2c(cccc2)c(c1)NCCN(C)C)N1CCN(CC1)C)N1CCN(CC1)C)N1CCN(CC1)C	-	-	3.1307	585.426742632	9	1	8	47.6	3	0.429841267726575	2.93200813347648	43	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.0029	0.0029	0	0	0	0	0	0
38	Ethidium bromide	Target_lig_6	E.Coli 16S rRNA	Escherichia coli	Bacterial growth and infection	Target_3	0	4 - 20	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	4	20	0	0	0	0	0	0
39	Cibacron blue	Target_lig_27	RNA_APTAMER_CB_42	Synthetic	-	Target_4	0	0	0.0001	0	0	0	0	-	-	10.1038/346818a0	1697402	In vitro selection of RNA molecules that bind specific ligands.	Ellington AD, Szostak JW	Nature	346	818-22	1990	10mM	30ug	7.6	37	1mM MgCl2	In vitro selection with PCR and transcription	SMMRNA	C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6S(=O)(=O)O)Cl)S(=O)(=O)O)S(=O)(=O)O)N	1-amino-4-[4-[[4-chloro-6-(2-sulfoanilino)-1,3,5-triazin-2-yl]amino]-3-sulfoanilino]-9,10-dioxoanthracene-2-sulfonic acid	172469	3.8535	773.00714514	15	7	9	298.03	5	0.081022974261585	3.2770277972283	51	GGGAGAATTCCCGCGGCAGAAGCCCACCTGGCTTTGAACTCTATGTTATTGGGTGGGGGAAACTTAAGAAAACTACCACCCTTCAACATTACCGCCCTTCAGCCTGCCAGCGCCCTGCAGCCCGGGAAGCTT	https://www.nature.com/articles/346818a0	RNA aptamer	-	132	-	Internal Loop	0	0	0	0	0.0001	0.0001	0	0	0	0
40	Reactive Blue 4	Target_lig_28	RNA_APTAMER_B4_25	Synthetic	-	Target_5	0	0	0.0006	0	0	0	0	-	-	10.1038/346818a0	1697402	In vitro selection of RNA molecules that bind specific ligands.	Ellington AD, Szostak JW	Nature	346	818-22	1990	2mM	30ug	7.6	37	1mM MgCl2	In vitro selection with PCR and transcription	SMMRNA	C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)S(=O)(=O)O)NC5=NC(=NC(=N5)Cl)Cl)S(=O)(=O)O)N	1-amino-4-[3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-sulfoanilino]-9,10-dioxoanthracene-2-sulfonic acid	25863	3.5166	635.969158768	12	5	6	231.63	4	0.132480746054139	3.02848387943335	41	GGGAGAAUUCCCGCGGCGUUGGCCCAGGAUAAUAGGACGAAAUCCGAAAAAUCCGUACCCAACAUGAACCCCCCAGCGCUCACACGGACGCCCCAUUACGGCUAACCGAACGCCUGCAGCCCGGGAAGCUU	https://www.nature.com/articles/346818a0	RNA aptamer	-	131	-	Internal Loop	0	0	0	0	0.0006	0.0006	0	0	0	0
41	MPE-Fe(II)	Target_lig_23	RNA HAIRPIN_1_BULGELESS	Synthetic	-	Target_7	4.6e-07±1.5e-07	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGCUCGAUUUUUCGAGCC	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Hairpin	-	18	-	Stem-Loop	3.10E-07	6.10E-07	0	0	0	0	0	0	0	0
42	MPE-Fe(II)	Target_lig_23	RNA HAIRPIN_2	Synthetic	-	Target_8	6e-07±2e-07	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGCUCGAUUUUUCUGAGCC	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Hairpin	-	19	-	Stem-Loop with Bulge	4.00E-07	8.00E-07	0	0	0	0	0	0	0	0
43	MPE-Fe(II)	Target_lig_23	RNA HAIRPIN_3	Synthetic	-	Target_9	2.4999999999999998e-06±8e-07	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGCUCGAUUUUUCGCAGCC	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Hairpin	-	19	-	Stem-Loop with Bulge	1.70E-06	3.30E-06	0	0	0	0	0	0	0	0
44	MPE-Fe(II)	Target_lig_23	RNA HAIRPIN_4	Synthetic	-	Target_10	2.1e-06±5e-07	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGCUCGAUUUUUCGACGCC	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Hairpin	-	19	-	Stem-Loop with Bulge	1.60E-06	2.60E-06	0	0	0	0	0	0	0	0
45	MPE-Fe(II)	Target_lig_23	RNA HAIRPIN_5	Synthetic	-	Target_11	5e-07±2e-07	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGCUCGAUUUUUCGAGUCC	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Hairpin	-	19	-	Stem-Loop with Bulge	3.00E-07	7.00E-07	0	0	0	0	0	0	0	0
46	MPE-Fe(II)	Target_lig_23	RNA HAIRPIN_6	Synthetic	-	Target_12	6.3e-07±1.5e-07	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGCUACGAUUUUUCGAGCC	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Hairpin	-	19	-	Stem-Loop with Bulge	4.80E-07	7.80E-07	0	0	0	0	0	0	0	0
47	MPE-Fe(II)	Target_lig_23	RNA HAIRPIN_BULGE A	Synthetic	-	Target_13	4.2999999999999995e-06±1.3e-06	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGGUCUCGAGUUUUCGAAGACCC	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Hairpin	-	23	-	Stem-Loop with Bulge	3.00E-06	5.59E-06	0	0	0	0	0	0	0	0
48	MPE-Fe(II)	Target_lig_23	RNA HAIRPIN_BULGE U	Synthetic	-	Target_14	3.7999999999999996e-06±1.6e-06	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGGUCUCGAGUUUUCGUAGACCC	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Hairpin	-	23	-	Stem-Loop with Bulge	2.20E-06	5.40E-06	0	0	0	0	0	0	0	0
49	MPE-Fe(II)	Target_lig_23	RNA_OTHER_ HAIRPIN _BULGELESS	Synthetic	-	Target_15	3e-07±3e-08	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGGUCUCGAGUUUUCGAGACCC	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Hairpin	-	22	-	Stem-Loop	2.70E-07	3.30E-07	0	0	0	0	0	0	0	0
50	MPE-Fe(II)	Target_lig_23	HRV2	Synthetic	-	Target_16	3.35e-06±8e-07	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	AAGCUUGAGUCUCGUAGAGGGGGGUAGAAUGGAAUACCGGUGGCAAGGCGGCCCCCUGGACGAAGACUGAU	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Viral RNA	Plasmid sequence	71	-	Stem-Loop	2.55E-06	4.15E-06	0	0	0	0	0	0	0	0
51	MPE-Fe(II)	Target_lig_23	HRV4	Synthetic	-	Target_17	4.1999999999999995e-07±1.5e-07	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	AAGCUUGAGUCUCGUAGAGGGGGGUAGAAUGGAAUACCGGUGGCAAGGCGGCCCCCUGGACGAGACUGAU	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Viral RNA	Plasmid sequence	70	-	Stem-Loop	2.70E-07	5.69E-07	0	0	0	0	0	0	0	0
52	MPE-Fe(II)	Target_lig_23	HRV6	Synthetic	-	Target_18	4.2999999999999995e-06±8e-07	0	0	0	0	0	0	-	-	10.1021/bi00430a069	2655698	Effects of single-base bulges on intercalator binding to small RNA and DNA hairpins and a ribosomal RNA fragment.	White SA, Draper DE	Biochemistry	28	1892-7	1989	2-10 uM	<0.03 uM	7.6	37	100mM NaCl	Gel electrophoresis and titrations	SMMRNA	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	AAGCUUGAGUCUCGUAGAGGGGGGUAGAAUGGAAUACCGGUGGCAAGGCGGCCCCCUGGACGUAGACUGAU	https://pubs.acs.org/doi/pdf/10.1021/bi00430a069	Viral RNA	Plasmid sequence	71	-	Stem-Loop	3.50E-06	5.09E-06	0	0	0	0	0	0	0	0
53	Ethidium bromide	Target_lig_6	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	2x1E5	0	0	0	0	0	0	-	-	10.1093/nar/13.21.7741	2415923	Self-catalyzed cyclization of the intervening sequence RNA of Tetrahymena: inhibition by intercalating dyes.	Tanner NK, Cech TR	Nucleic Acids Res	13	7741-58	1985	1-2 uM	0.5 - 2.0 nM	7.5	37	200 mM NaCl, 5 mM MgCl2	Gel electrophoresis, autoradiogram and kinetic studies	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	200000	200000	0	0	0	0	0	0	0	0
54	L_arginine	Target_lig_29	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	4e-06±3e-07	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	10mM Mg2+	Gel autoradiogram	SMMRNA	C(C[C@@H](C(=O)O)N)CN=C(N)N	(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid	6322	-1.5481	174.111675688	3	4	5	127.72	0	0.227783103512755	2.73494438418824	12	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	3.70E-06	4.30E-06	0	0	0	0	0	0
55	D_arginine	Target_lig_30	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	8.4e-06±4e-07	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	10mM Mg2+	Gel autoradiogram	SMMRNA	C(C[C@H](C(=O)O)N)CN=C(N)N	(2R)-2-amino-5-(diaminomethylideneamino)pentanoic acid	71070	-1.5481	174.111675688	3	4	5	127.72	0	0.227783103512755	2.73494438418824	12	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	8.00E-06	8.80E-06	0	0	0	0	0	0
56	L- L_lysine	Target_lig_31	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	4.6e-05±6e-06	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	10mM Mg2+	Gel autoradiogram	SMMRNA	C(CCN)C[C@@H](C(=O)O)N	(2S)-2,6-diaminohexanoic acid	5962	-0.472699999999999	146.105527688	3	3	5	89.34	0	0.457177158496557	2.47366829558304	10	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	4.00E-05	5.20E-05	0	0	0	0	0	0
57	Guanidine-acetic acid	Target_lig_32	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	4.8e-05±1.3e-05	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	10mM Mg2+	Gel autoradiogram	SMMRNA	CC(=O)O.C(=N)(N)N	acetic acid;guanidine	2724684	-1.07053	119.069476528	2	4	0	113.19	0	0.239924140391728	2.18018909954569	8	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	3.50E-05	6.10E-05	0	0	0	0	0	0
58	agmatine	Target_lig_33	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	1.1e-06±2e-07	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	10mM Mg2+	Gel autoradiogram	SMMRNA	C(CCN=C(N)N)CN	2-(4-aminobutyl)guanidine	199	-1.0013	130.121846448	2	3	4	90.42	0	0.258790226994927	2.34508569953325	9	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	9.00E-07	1.30E-06	0	0	0	0	0	0
59	l_arginine_methyl ester	Target_lig_34	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	3.1e-06±6e-07	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	10mM Mg2+	Gel autoradiogram	SMMRNA	COC(=O)[C@H](CCCN=C(N)N)N	methyl (2S)-2-amino-5-(diaminomethylideneamino)pentanoate	92932	-1.4597	188.127325752	4	3	5	116.72	0	0.210847491192031	2.76321069423135	13	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	2.50E-06	3.70E-06	0	0	0	0	0	0
60	l-arginine_ethyl ester	Target_lig_35	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	2.8e-06±1.4e-06	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	10mM Mg2+	Gel autoradiogram	SMMRNA	CCOC(=O)[C@H](CCCN=C(N)N)N	ethyl (2S)-2-amino-5-(diaminomethylideneamino)pentanoate	439495	-1.0696	202.142975816	4	3	6	116.72	0	0.219318423440529	2.72680569403354	14	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	1.40E-06	4.20E-06	0	0	0	0	0	0
61	L-arginine amide	Target_lig_36	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	7e-07±1e-07	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	10mM Mg2+	Gel autoradiogram	SMMRNA	C(C[C@@H](C(=O)N)N)CN=C(N)N	(2S)-2-amino-5-(diaminomethylideneamino)pentanamide	447555	-2.1474	173.1276601	3	4	5	133.51	0	0.214101954315832	2.90139748592521	12	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	6.00E-07	8.00E-07	0	0	0	0	0	0
62	L-argininyl -L-Leucine	Target_lig_37	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	1.4e-05±4e-06	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	10mM Mg2+	Gel autoradiogram	SMMRNA	CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N	(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid	152914	-1.0172	287.19573966	4	5	9	156.82	0	0.20743903411186	2.96848161553582	20	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	1.00E-05	1.80E-05	0	0	0	0	0	0
63	L-alpha -OH -Arginine	Target_lig_38	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	2.2e-06±5e-07	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	10mM Mg2+	Gel autoradiogram	SMMRNA	C(C[C@H](C(=O)O)O)CN=C(N)N	(2R)-5-(diaminomethylideneamino)-2-hydroxypentanoic acid	92172231	-1.5145	175.095691276	3	4	5	121.93	0	0.229596815421878	2.88815877624779	12	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	1.70E-06	2.70E-06	0	0	0	0	0	0
64	L-Leucyl -L-Arginine	Target_lig_1245	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	8.999999999999999e-05±3.9999999999999996e-05	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	10mM Mg2+	Gel autoradiogram	SMMRNA	CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N	(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid	152914	-1.0172	287.19573966	4	5	9	156.82	0	0.20743903411186	2.96848161553582	20	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	5.00E-05	0.00013	0	0	0	0	0	0
65	UREA	Target_lig_39	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	>0.2	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(=O)(N)N	urea	1176	-0.9762	60.032362748	1	2	0	69.11	0	0.370507351403538	1.9319076618526	4	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.2	0.2	0	0	0	0	0	0
66	L-ORNITHINE	Target_lig_40	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	>0.2	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(C[C@@H](C(=O)O)N)CN	(2S)-2,5-diaminopentanoic acid	6262	-0.862799999999999	132.089877624	3	3	4	89.34	0	0.463886112009811	2.56480599453288	9	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.2	0.2	0	0	0	0	0	0
67	L-Canavanine	Target_lig_41	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.097±0.01	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(CON=C(N)N)[C@@H](C(=O)O)N	(2S)-2-amino-4-(diaminomethylideneamino)oxybutanoic acid	439202	-2.0066	176.090940244	4	4	5	136.95	0	0.165229510161694	3.21541038915102	12	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.087	0.107	0	0	0	0	0	0
68	L-citrulline	Target_lig_42	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.15±0.08	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(C[C@@H](C(=O)O)N)CNC(=O)N	(2S)-2-amino-5-(carbamoylamino)pentanoic acid	9750	-1.1532	175.095691276	3	4	5	118.44	0	0.394159185213804	2.56017019063985	12	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.07	0.23	0	0	0	0	0	0
69	Guanidinium	Target_lig_43	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.19±0.07	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(=[NH2+])(N)N	diaminomethylideneazanium	32838	-2.9811	60.05562361209	0	3	0	77.63	0	0.205907838321391	4.51556535416029	4	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.12	0.26	0	0	0	0	0	0
70	Methyl Guanidinium	Target_lig_44	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.14±0.06	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C[NH+]=C(N)N	diaminomethylidene(methyl)azanium	7311729	-3.0298	74.07127367609	0	3	0	66.01	0	0.211245361941422	5.08152208858207	5	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.08	0.2	0	0	0	0	0	0
71	Ethyl Guanidinium	Target_lig_45	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.14±0.02	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	CC[NH+]=C(N)N	diaminomethylidene(ethyl)azanium	6999068	-2.6397	88.08692374009	0	3	1	66.01	0	0.242173968134329	5.12432131751693	6	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.12	0.16	0	0	0	0	0	0
72	Guanidinic Formic acid	Target_lig_46	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.07±0.008	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(=NC(=O)O)(N)N	diaminomethylidenecarbamic acid	15590749	-1.0622	103.0381764	1	3	0	101.7	0	0.268305080783536	2.91298829240643	7	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.062	0.078	0	0	0	0	0	0
73	Guanyl-Urea	Target_lig_47	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.011±0.001	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(=NC(=O)N)(N)N	diaminomethylideneurea	8859	-1.6615	102.054160812	1	3	0	107.49	0	0.251346077525288	2.90260367702182	7	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.01	0.012	0	0	0	0	0	0
74	2-Guanidinio Succinic Acid	Target_lig_48	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	>0.2	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(C(C(=O)O)N=C(N)N)C(=O)O	2-(diaminomethylideneamino)butanedioic acid	97856	-1.8123	175.059305768	3	4	4	139	0	0.292996888494678	3.17768617078874	12	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.2	0.2	0	0	0	0	0	0
75	creatine	Target_lig_49	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.24±0.07	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	CN(CC(=O)O)C(=N)N	2-[carbamimidoyl(methyl)amino]acetic acid	586	-1.10373	131.069476528	2	3	2	90.41	0	0.327362746224278	2.59397765757521	9	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.17	0.31	0	0	0	0	0	0
76	creatinine	Target_lig_50	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.4±0.14	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	CN1CC(=O)N=C1N	2-amino-3-methyl-4H-imidazol-5-one	588	-1.2269	113.058911844	3	1	0	58.69	0	0.4277648474316	3.1511325061391	8	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.26	0.54	0	0	0	0	0	0
77	3-guanidinic propionic acid	Target_lig_51	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.17±0.06	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(CN=C(N)N)C(=O)O	3-(diaminomethylideneamino)propanoic acid	67701	-1.2655	131.069476528	2	3	3	101.7	0	0.328156922180581	2.39719590020215	9	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.11	0.23	0	0	0	0	0	0
78	4-guanidinic butyric acid	Target_lig_52	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.06±0.02	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(CC(=O)O)CN=C(N)N	4-(diaminomethylideneamino)butanoic acid	500	-0.875399999999999	145.085126592	2	3	4	101.7	0	0.271483960184782	2.20582617140924	10	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.04	0.08	0	0	0	0	0	0
79	5-guanidinic valeric acid	Target_lig_53	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.08±0.02	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(CCN=C(N)N)CC(=O)O	5-(diaminomethylideneamino)pentanoic acid	160464	-0.485299999999999	159.100776656	2	3	5	101.7	0	0.286064854531538	2.11915152993118	11	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.06	0.1	0	0	0	0	0	0
80	6-guanidinic caproic acid	Target_lig_54	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	>0.25	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(CCC(=O)O)CCN=C(N)N	6-(diaminomethylideneamino)hexanoic acid	81176	-0.095199999999999	173.11642672	2	3	6	101.7	0	0.296415331180589	2.08687088833091	12	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.25	0.25	0	0	0	0	0	0
81	L-2-Amino-3-guanidinic propionic acid	Target_lig_55	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.06±0.01	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C([C@@H](C(=O)O)N)N=C(N)N	(2S)-2-amino-3-(diaminomethylideneamino)propanoic acid	160635	-2.3283	146.08037556	3	4	3	127.72	0	0.262087052467954	3.20065059144103	10	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.05	0.07	0	0	0	0	0	0
82	L-2-Amino-4-guanidinic butyric acid	Target_lig_56	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.05±0.014	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(CN=C(N)N)C(C(=O)O)N	2-amino-4-(diaminomethylideneamino)butanoic acid	435719	-1.9382	160.096025624	3	4	4	127.72	0	0.280820379855036	2.96697703359022	11	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.036	0.064	0	0	0	0	0	0
83	L-homoarginine	Target_lig_57	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.028±0.008	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(CCN=C(N)N)C[C@@H](C(=O)O)N	(2S)-2-amino-6-(diaminomethylideneamino)hexanoic acid	9085	-1.158	188.127325752	3	4	6	127.72	0	0.237357288408479	2.74634282092818	13	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.02	0.036	0	0	0	0	0	0
84	L-2-Hydroxy-5-Guanidic valericacid	Target_lig_58	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.0022±0.0005	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	C(C[C@H](C(=O)O)O)CN=C(N)N	(2R)-5-(diaminomethylideneamino)-2-hydroxypentanoic acid	92172231	-1.5145	175.095691276	3	4	5	121.93	0	0.229596815421878	2.88815877624779	12	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.0017	0.0027	0	0	0	0	0	0
85	N_Benzoyl-L-Arginine Ethyl Ester	Target_lig_59	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.055±0.02	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	CCOC(=O)[C@H](CCCN=C(N)N)NC(=O)C1=CC=CC=C1	ethyl (2S)-2-benzamido-5-(diaminomethylideneamino)pentanoate	123880	0.401700000000002	306.169190564	4	3	8	119.8	1	0.277827257152572	2.41595959330158	22	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.035	0.075	0	0	0	0	0	0
86	N-Acetyl-L-arginine	Target_lig_60	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	0.1±0.05	0	0	0	0	0	-	-	10.1021/bi00429a010	2653441	Specificity of arginine binding by the Tetrahymena intron.	Yarus M	Biochemistry	28	980-8	1989	0-25 mM	0.1-0.3 uM	8	37	6mM MgCl2	Gel autoradiogram	SMMRNA	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O	(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoic acid	67427	-1.3707	216.122240372	3	4	6	130.8	0	0.246968951820986	2.597492994457	15	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	0.05	0.15	0	0	0	0	0	0
87	deoxy Guanosine	Target_lig_61	Tetrahymena Group I intron	Tetrahymena thermophila	Bacterial growth and infection	Target_23	0	0.0011±0.0004	0	0	0	0	0	-	-	10.1021/bi00364a001	3639741	Ribozyme inhibitors: deoxyguanosine and dideoxyguanosine are competitive inhibitors of self-splicing of the Tetrahymena ribosomal ribonucleic acid precursor.	Bass BL, Cech TR	Biochemistry	25	4473-7	1986	0.25 uM	-	6.8-7.0	30	7mM MgCl2	Gel autoradiogram	SMMRNA	C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(NC3=O)N)CO)O	2-amino-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one	135398592	-1.6575	267.096753896	8	4	2	139.28	2	0.510372838268684	3.67445189232985	19	GACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGACGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGGAGACUGUUGAUAUGGAUGCAGUUCACAGACUAAAUGUCGGUCGGGGAAGAUGUAUUCUUCUCAUAAGAUAUAGUCGGACCUCUCCCGAAAGGGAGUUGGAGUACUCG	https://www.rcsb.org/structure/1GRZ	mRNA	Group I intron	247	-	-	0	0	0.0007	0.0015	0	0	0	0	0	0
88	dideoxy Guanosine	Target_lig_62	Tetrahymena Group I intron	Tetrahymena thermophila	Bacterial growth and infection	Target_23	0	0.0054±0.0019	0	0	0	0	0	-	-	10.1021/bi00364a001	3639741	Ribozyme inhibitors: deoxyguanosine and dideoxyguanosine are competitive inhibitors of self-splicing of the Tetrahymena ribosomal ribonucleic acid precursor.	Bass BL, Cech TR	Biochemistry	25	4473-7	1986	0.25 uM	-	6.8-7.0	30	8mM MgCl2	Gel autoradiogram	SMMRNA	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2N=C(NC3=O)N	2-amino-9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one	135463029	-0.6283	251.101839276	7	3	2	119.05	2	0.653547826778999	3.56880503659923	18	GACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGACGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGGAGACUGUUGAUAUGGAUGCAGUUCACAGACUAAAUGUCGGUCGGGGAAGAUGUAUUCUUCUCAUAAGAUAUAGUCGGACCUCUCCCGAAAGGGAGUUGGAGUACUCG	https://www.rcsb.org/structure/1GRZ	mRNA	Group I intron	247	-	-	0	0	0.0035	0.0073	0	0	0	0	0	0
89	Streptomycin	Target_lig_63	Tetrahymena Group I intron	Tetrahymena thermophila	Bacterial growth and infection	Target_23	0	0	0	0.005	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	0,4,10,25 uM	1,5,10 uM	7.5	30	8mM Mg2+	Gel electrophoresis and titrations	SMMRNA	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	GACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGACGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGGAGACUGUUGAUAUGGAUGCAGUUCACAGACUAAAUGUCGGUCGGGGAAGAUGUAUUCUUCUCAUAAGAUAUAGUCGGACCUCUCCCGAAAGGGAGUUGGAGUACUCG	https://www.rcsb.org/structure/1GRZ	mRNA	Group I intron	247	-	-	0	0	0	0	0	0	0.005	0.005	0	0
90	Argininamide	Target_lig_64	argininamide_TAR_complex	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	0.0018	0	0	0	1AJU	-	10.1093/nar/gkf541	12364603	The bulge region of HIV-1 TAR RNA binds metal ions in solution.	Olejniczak M, Gdaniec Z, Fischer A, Grabarkiewicz T, Bielecki L, Adamiak RW	Nucleic Acids Res	30	4241-9	2002	-	0.1-0.2 mM	8.5	37	40mM NaCl	F19-NMR spectroscopy and gel electrophoresis	SMMRNA	C(CC(C(=O)N)N)CN=C(N)N	2-amino-5-(diaminomethylideneamino)pentanamide	2234	-2.1474	173.1276601	3	4	5	133.51	0	0.214101954315832	2.90139748592521	12	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	0.0018	0.0018	0	0
91	ATP	Target_lig_65	RNA_Aptamer	Synthetic	-	Target_6	0	0	4.00E-06	0	0	0	0	-	-	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1369402	8756406	Solution structure of an ATP-binding RNA aptamer reveals a novel fold.	Dieckmann T, Suzuki E, Nakamura GK, Feigon J	RNA	2	628-40	1996	-	0.5-1.6 mM	6	-	100mM NaCl	NMR spectroscopy	SMMRNA	C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N	[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate	238	-1.629	506.995745462	14	7	8	279.13	2	0.19742203378388	4.41361201850629	31	GGGAAGGGAAGAAACUGCGGCUUCGGCCGGCUUCCC	http://www.smmrna.org/	RNA aptamer	-	36	-	UUCG Tetraloop	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
92	AMP	Target_lig_66	RNA_Aptamer	Synthetic	-	Target_6	0	0	1x1E-8 - 1x1E-13	0	0	0	0	1RAW	-	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1369402	8756406	Solution structure of an ATP-binding RNA aptamer reveals a novel fold.	Dieckmann T, Suzuki E, Nakamura GK, Feigon J	RNA	2	628-40	1996	-	0.5-1.6 mM	6	-	100mM NaCl	NMR spectroscopy	SMMRNA	C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)O)O)O)N	[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate	224	-1.863	347.063084418	10	5	4	186.07	2	0.39017854457244	3.80488944930722	23	GGGAAGGGAAGAAACUGCGGCUUCGGCCGGCUUCCC	http://www.smmrna.org/	RNA aptamer	-	36	-	UUCG Tetraloop	0	0	0	0	1.00E-08	1.00E-13	0	0	0	0
93	FAD	Target_lig_67	35 nucleotide RNA	Synthetic	-	Target_26	0	0	2.30E-05	0	0	0	0	-	-	10.1021/ja00109a008	11539282	RNA aptamers that bind flavin and nicotinamide redox cofactors.	Lauhon CT, Szostak JW	J Am Chem Soc	117	1246-57	1995	0.3 mM	-	7.5	-	5-20mM Mg2+	NMR spectroscopy, fluorescence binding measurements, column binding assays and gel filtration	SMMRNA	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)O	[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate	703	-2.42396	785.157134616	21	9	13	362.93	3	0.044260635935885	5.27373773778347	53	GGCGUGUAGGAUAUGCUUCGGCAGAAGGACACGCC	10.1093/nar/gki992	RNA aptamer	-	35	-	Stem-Loop	0	0	0	0	2.30E-05	2.30E-05	0	0	0	0
94	FMN	Target_lig_68	35 nucleotide RNA	Synthetic	-	Target_26	0	0	5.00E-07	0	0	0	0	1FMN	-	10.1021/ja00109a008	11539282	RNA aptamers that bind flavin and nicotinamide redox cofactors.	Lauhon CT, Szostak JW	J Am Chem Soc	117	1246-57	1995	0.3 mM	-	7.5	-	5-20mM Mg2+	NMR spectroscopy, fluorescence binding measurements, column binding assays and gel filtration	SMMRNA	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)O)O)O)O	[5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate	710	-1.60656	456.104614882	10	6	7	208.09	1	0.176020349335941	4.02831596221591	31	GGCGUGUAGGAUAUGCUUCGGCAGAAGGACACGCC	10.1093/nar/gki992	RNA aptamer	-	35	-	Stem-Loop	0	0	0	0	5.00E-07	5.00E-07	0	0	0	0
95	ADENOSINE	Target_lig_69	35 nucleotide RNA	Synthetic	-	Target_26	0	0	0.004	0	0	0	0	-	-	10.1021/ja00109a008	11539282	RNA aptamers that bind flavin and nicotinamide redox cofactors.	Lauhon CT, Szostak JW	J Am Chem Soc	117	1246-57	1995	0.3 mM	-	7.5	-	5-20mM Mg2+	NMR spectroscopy, fluorescence binding measurements, column binding assays and gel filtration	SMMRNA	C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N	2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol	191	-1.98	267.096753896	9	4	2	139.54	2	0.490519867679223	3.53130958813491	19	GGCGUGUAGGAUAUGCUUCGGCAGAAGGACACGCC	10.1093/nar/gki992	RNA aptamer	-	35	-	Stem-Loop	0	0	0	0	0.004	0.004	0	0	0	0
96	riboflavin	Target_lig_70	Riboflavin binding RNA aptamer	Synthetic	-	Target_29	0	0	01/05/25	0	0	0	0	-	-	10.1021/ja00109a008	11539282	RNA aptamers that bind flavin and nicotinamide redox cofactors.	Lauhon CT, Szostak JW	J Am Chem Soc	117	1246-57	1995	0.3 mM	-	7.5	-	5-20mM Mg2+	NMR spectroscopy, fluorescence binding measurements, column binding assays and gel filtration	SMMRNA	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O	7,8-dimethyl-10-(2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4-dione	1072	-1.72356	376.13828436	9	5	5	161.56	1	0.328412159456043	3.79050028070519	27	GGAACGAGGGAUGGAGGAGGAGUCGUUCC	10.1021/ja00109a008	RNA aptamer	-	29	-	Stem-Loop	0	0	0	0	1	5	0	0	0	0
97	NMN	Target_lig_71	NMN binding RNA aptamer	Synthetic	-	Target_30	0	0	2.4999999999999998e-06±5e-07	0	0	0	0	-	-	10.1021/ja00109a008	11539282	RNA aptamers that bind flavin and nicotinamide redox cofactors.	Lauhon CT, Szostak JW	J Am Chem Soc	117	1246-57	1995	0.3 mM	-	7.5	-	5-20mM Mg2+	NMR spectroscopy, fluorescence binding measurements, column binding assays and gel filtration	SMMRNA	C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)[O-])O)O)C(=O)N	[5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate	4661174	-2.8305	334.05660207	7	4	5	166.25	1	0.330084574972052	4.5702430806645	22	GGAACCCAACUAGGCGUUUGAGGGGAUUCGGCCACGGUAACAACCCCUC	http://www.smmrna.org/	RNA aptamer	-	49	-	Stem-Loop	0	0	0	0	2.00E-06	3.00E-06	0	0	0	0
98	cyanocobalamine	Target_lig_72	cyanocobalamin 35 nt RNA aptamer	Synthetic	-	Target_31	0	0	8.699999999999998e-08±1.8999999999999998e-08	0	0	0	0	1ET4	-	10.1021/bi00170a016	7508262	In vitro selection of RNA aptamers specific for cyanocobalamin.	Lorsch JR, Szostak JW	Biochemistry	33	973-82	1994	1mM	10uM	7.4	-	1 M LiCl or 1 M NaCl plus 5 mM MgCl2	Affinity column binding and purification	SMMRNA	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;cyanide	184933	3.40921000000001	1354.567400126	20	9	26	488.71	2	0.048125213524287	8.35176404036808	93	CGGGUGCGCAUAACCACCUCAGUGCGAGCAA	http://www.smmrna.org/	RNA aptamer	-	31	-	Pseudoknot	0	0	0	0	6.80E-08	1.06E-07	0	0	0	0
99	cobinamide dicyanide	Target_lig_73	cyanocobalamin 35 nt RNA aptamer	Synthetic	-	Target_31	0	0	1.9699999999999998e-05±8.7e-06	0	0	0	0	-	-	10.1021/bi00170a016	7508262	In vitro selection of RNA aptamers specific for cyanocobalamin.	Lorsch JR, Szostak JW	Biochemistry	33	973-82	1994	0.23 uM	10uM	7.4	-	1 M LiCl or 1 M NaCl plus 5 mM MgCl2	Affinity column binding and purification	SMMRNA	C/C/1=C/2\[C@@]([C@@H](C(=N2)/C=C\3/C([C@@H](C(=N3)/C(=C\4/[C@]([C@H](C([N-]4)[C@]5([C@@]([C@@H](C1=N5)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)(C)CCC(=O)NCC(C)O)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N.[C-]#N.[C-]#N.[Co]	cobalt;3-[(1R,2S,3S,5Z,7S,8S,10Z,13S,15Z,17R,18R)-2,7,18-tris(2-amino-2-oxoethyl)-3,13-bis(3-amino-3-oxopropyl)-17-[3-(2-hydroxypropylamino)-3-oxopropyl]-1,2,5,7,12,12,15,17-octamethyl-8,13,18,19-tetrahydro-3H-corrin-24-id-8-yl]propanamide;dicyanide	6450878	2.71034000000001	1041.49752200373	13	8	20	406.63	0	0.082438012108535	7.31201252608937	72	CGGGUGCGCAUAACCACCUCAGUGCGAGCAA	http://www.smmrna.org/	RNA aptamer	-	31	-	Pseudoknot	0	0	0	0	1.10E-05	2.84E-05	0	0	0	0
100	tetracyclin	Target_lig_74	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.50E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54685734	-0.370999999999999	444.153265728	9	6	2	181.62	1	0.33151896393022	4.2536794077623	32	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.50E-06	3.50E-06	0	0	0	0
101	Spectinomycin	Target_lig_75	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.60E-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O	8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one	2021	-2.9256	332.158351108	9	5	2	129.51	0	0.360820282325169	5.12987922706813	23	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.60E-07	2.60E-07	0	0	0	0
102	Paromomycin_mol_mol	Target_lig_1116	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.20E-05	0	0	0	0	1J7T	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.20E-05	1.20E-05	0	0	0	0
103	gentamicin_mol_c1a	Target_lig_76	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.70E-06	0	0	0	0	2ET3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.70E-06	1.70E-06	0	0	0	0
104	kanamycin	Target_lig_7	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.1 uM - 0.15	0	0	0	0	2ESI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-07	1.50E-07	0	0	0	0
105	Edeine_mol	Target_lig_325	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	8.00E-06	0	0	0	-	-	10.1016/S1097-2765(04)00002-4	14731399	Dissecting the ribosomal inhibition mechanisms of edeine and pactamycin: the universally conserved residues G693 and C795 regulate P-site RNA binding.	Dinos G, Wilson DN, Teraoka Y, Szaflarski W, Fucini P, Kalpaxis D, Nierhaus KH	Mol Cell	13	113-24	2004	0-200 uM	0.5 uM	7.6	37	4.5mM Magnesium acetate and 150 mM ammonium acetate	Coupled transcription-translation assay	SMMRNA	C1=CC(=CC=C1C(CC(=O)NCC(C(=O)NC(CN)C(=O)NC(CCCC(C(CC(=O)NCC(=O)NCCCNCCCCN)O)N)C(=O)O)O)N)O	6-amino-2-[[3-amino-2-[[3-[[3-amino-3-(4-hydroxyphenyl)propanoyl]amino]-2-hydroxypropanoyl]amino]propanoyl]amino]-9-[[2-[3-(4-aminobutylamino)propylamino]-2-oxoethyl]amino]-7-hydroxy-9-oxononanoic acid	379085	-4.52830000000001	754.433738056	14	14	28	359.6	1	0.035842878592344	4.63937491785627	53	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	8.00E-06	8.00E-06	0	0
106	Pactamycin	Target_lig_77	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	3.00E-06	0	0	0	-	-	10.1016/S1097-2765(04)00002-4	14731399	Dissecting the ribosomal inhibition mechanisms of edeine and pactamycin: the universally conserved residues G693 and C795 regulate P-site RNA binding.	Dinos G, Wilson DN, Teraoka Y, Szaflarski W, Fucini P, Kalpaxis D, Nierhaus KH	Mol Cell	13	113-24	2004	0-200 uM	0.5 uM	7.6	37	4.5mM Magnesium acetate and 150 mM ammonium acetate	Coupled transcription-translation assay	SMMRNA	CC1=C(C(=CC=C1)O)C(=O)OCC2(C(C(C(C2(C)O)(C(C)O)NC(=O)N(C)C)N)NC3=CC=CC(=C3)C(=O)C)O	[5-(3-acetylanilino)-4-amino-3-(dimethylcarbamoylamino)-1,2-dihydroxy-3-(1-hydroxyethyl)-2-methylcyclopentyl]methyl 2-hydroxy-6-methylbenzoate	413861	0.754520000000001	558.268964176	10	7	8	194.68	2	0.179480744226426	4.68901329104993	40	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	3.00E-06	3.00E-06	0	0
107	Kasugamycin	Target_lig_78	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.50E-05	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1C(CC(C(O1)OC2C(C(C(C(C2O)O)O)O)O)N)N=C(C(=O)O)N	2-amino-2-[5-amino-2-methyl-6-(2,3,4,5,6-pentahydroxycyclohexyl)oxyoxan-3-yl]iminoacetic acid	265071	-4.53769999999999	379.15907938	10	8	3	221.31	0	0.172165560366347	4.8447582581896	26	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.50E-05	1.50E-05	0	0	0	0
108	apramycin	Target_lig_79	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.06 uM - 0.1	0	0	0	0	2M4Q	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O	5-amino-2-[[7-amino-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4-diol	439519	-6.94930000000001	539.280257132	16	11	6	283.64	0	0.149405525228447	5.52548579783966	37	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.00E-08	1.00E-07	0	0	0	0
109	Neamine	Target_lig_80	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	5.00E-07	0	0	0	0	2ET8	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol	413349	-5.11559999999999	322.185234552	10	8	3	203.46	0	0.247960739843155	4.62440978066844	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	5.00E-07	5.00E-07	0	0	0	0
110	1H-1,3-benzodiazol-2-amine	Target_lig_81	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00023	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	C1=CC=C2C(=C1)NC(=N2)N	1H-benzimidazol-2-amine	13624	1.1451	133.063997224	2	2	0	54.7	2	0.565899971243582	1.89285663458002	10	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00023	0.00023	0	0	0	0
111	5,6-dimethyl-1H-1,3-benzodiazole	Target_lig_82	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00081	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=CC2=C(C=C1C)N=CN2	5,6-dimethyl-1H-benzimidazole	675	2.17974	146.08439832	1	1	0	28.68	2	0.605927945947549	2.18283706086299	11	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00081	0.00081	0	0	0	0
112	4,6-dimethyl-1H-1,3-benzodiazol-2-amine	Target_lig_83	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00026	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=CC(=C2C(=C1)NC(=N2)N)C	4,6-dimethyl-1H-benzimidazol-2-amine	19017773	1.76194	161.095297352	2	2	0	54.7	2	0.618200200195238	2.28914995301623	12	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00026	0.00026	0	0	0	0
113	4-methylquinolin-2-amine	Target_lig_84	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	9.00E-05	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=CC(=NC2=CC=CC=C12)N	4-methylquinolin-2-amine	231935	2.12542	158.08439832	2	1	0	38.91	2	0.637451564728004	1.80823613154358	12	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	9.00E-05	9.00E-05	0	0	0	0
114	5,6-dimethyl-1H-1,3-benzodiazol-2-amine	Target_lig_85	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00022	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=CC2=C(C=C1C)N=C(N2)N	5,6-dimethyl-1H-benzimidazol-2-amine	93125	1.76194	161.095297352	2	2	0	54.7	2	0.618200200195239	2.21361289007917	12	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00022	0.00022	0	0	0	0
115	6,7-dimethyl-1H-1,3-benzodiazol-2-amine	Target_lig_86	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00016	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=C(C2=C(C=C1)NC(=N2)N)C	4,5-dimethyl-1H-benzimidazol-2-amine	19017763	1.76194	161.095297352	2	2	0	54.7	2	0.618200200195238	2.26308981315609	12	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00016	0.00016	0	0	0	0
116	dimethylamino_methylquinolinyl_pyridinyl_acetamide	Target_lig_87	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.80E-05	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=CC(=NC2=C1C=CC(=C2)NC(=O)CC3=CC=NC=C3)N(C)C	N-[2-(dimethylamino)-4-methylquinolin-7-yl]-2-pyridin-4-ylacetamide	85830272	3.18542	320.16371126	4	1	4	58.12	3	0.801912965839993	2.18761447819816	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.80E-05	1.80E-05	0	0	0	0
117	dimethylamino_quinolinyl_pyridinyl_acetamide	Target_lig_88	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	9e-06±5e-06	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CN(C)C1=NC2=CC=CC=C2C(=C1)NC(=O)CC3=CC=C(C=C3)O	N-[2-(dimethylamino)quinolin-4-yl]-2-(4-hydroxyphenyl)acetamide	85830273	3.1876	321.147726848	4	2	4	65.46	3	0.774383790581708	2.04383031530223	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	4.00E-06	1.40E-05	0	0	0	0
118	N,4-dimethylquinolin-2-amine	Target_lig_89	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.00E-05	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=CC2=C(C=C1)C(=CC(=N2)N)C	4,7-dimethylquinolin-2-amine	84618300	2.43384	172.100048384	2	1	0	38.91	2	0.66246421157387	1.9953205192396	13	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.00E-05	6.00E-05	0	0	0	0
119	N,N,4-trimethylquinolin-2-amine	Target_lig_90	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00017	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=C(C2=C(C=C1)C(=CC(=N2)N)C)C	4,7,8-trimethylquinolin-2-amine	84618597	2.74226	186.115698448	2	1	0	38.91	2	0.686692788204906	2.14197086909295	14	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00017	0.00017	0	0	0	0
120	N,N-dimethylquinolin-2-amine	Target_lig_91	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00099	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CN(C)C1=NC2=CC=CC=C2C=C1	N,N-dimethylquinolin-2-amine	588801	2.3008	172.100048384	2	0	1	16.13	2	0.655791349878834	1.80710918867826	13	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00099	0.00099	0	0	0	0
121	methylpyridine_der_1	Target_lig_92	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0006	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=C(N=CC=C1)NCCN	N'-(3-methylpyridin-2-yl)ethane-1,2-diamine	12818865	0.76062	151.110947416	3	2	3	50.94	1	0.670228290457975	2.07585988964711	11	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0006	0.0006	0	0	0	0
122	methylpyridine_der_2	Target_lig_93	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3e-06±1e-06	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=CC(=NC=C1)NCCN	N'-(4-methylpyridin-2-yl)ethane-1,2-diamine	10034794	0.76062	151.110947416	3	2	3	50.94	1	0.670228290457975	2.11146237103668	11	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.00E-06	4.00E-06	0	0	0	0
123	methylpyridine_der_3	Target_lig_94	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2e-05±1.2e-05	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=CC(=NC=C1)NCCCN	N'-(4-methylpyridin-2-yl)propane-1,3-diamine	14397357	1.15072	165.12659748	3	2	4	50.94	1	0.65793703736238	2.06191395959788	12	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	8.00E-06	3.20E-05	0	0	0	0
124	methylpyridine_der_4	Target_lig_95	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.2e-05±8e-06	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=CN=C(C=C1)NCCN	N'-(5-methylpyridin-2-yl)ethane-1,2-diamine	13224296	0.76062	151.110947416	3	2	3	50.94	1	0.670228290457975	2.08190306582576	11	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.40E-05	3.00E-05	0	0	0	0
125	methylpyridine_der_5	Target_lig_96	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.01	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	C1=CC(=NC=C1[N+](=O)[O-])NCCN	N'-(5-nitropyridin-2-yl)ethane-1,2-diamine	122425	0.3604	182.08037556	5	2	4	94.08	1	0.517531478896062	2.2443628269319	13	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.01	0.01	0	0	0	0
126	methylpyridine_der_6	Target_lig_97	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000105	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=NC(=CC=C1)NCCN	N'-(6-methylpyridin-2-yl)ethane-1,2-diamine	22118602	0.76062	151.110947416	3	2	3	50.94	1	0.670228290457975	2.07769115515579	11	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000105	0.000105	0	0	0	0
127	methylpyridine_der_7	Target_lig_98	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.80E-05	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	C1=CC=NC(=C1)NCCN	N'-pyridin-2-ylethane-1,2-diamine	410428	0.4522	137.095297352	3	2	3	50.94	1	0.635680696273363	1.9699271916092	10	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.80E-05	6.80E-05	0	0	0	0
128	2-N,2-N,4-trimethylquinoline-2,7-diamine	Target_lig_99	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.50E-05	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=CC(=NC2=C1C=CC(=C2)N)N(C)C	2-N,2-N,4-trimethylquinoline-2,7-diamine	326802	2.19142	201.12659748	3	1	1	42.15	2	0.719040523742236	2.22288208690898	15	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.50E-05	3.50E-05	0	0	0	0
129	2-N,2-N-dimethylquinoline-2,4-diamine	Target_lig_100	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.00E-05	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CN(C)C1=NC2=CC=CC=C2C(=C1)N	2-N,2-N-dimethylquinoline-2,4-diamine	646689	1.883	187.110947416	3	1	1	42.15	2	0.740823837317023	2.09802614782232	14	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.00E-05	6.00E-05	0	0	0	0
130	N-methylquinolin-2-amine	Target_lig_101	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00049	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CNC1=NC2=CC=CC=C2C=C1	N-methylquinolin-2-amine	12548157	2.2765	158.08439832	2	1	1	24.92	2	0.688266922088801	1.72964617679245	12	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00049	0.00049	0	0	0	0
131	quinolin-2-amine	Target_lig_84	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00318	0	0	0	0	-	-	10.1021/ja021354o	12683814	Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA.	Yu L, Oost TK, Schkeryantz JM, Yang J, Janowick D, Fesik SW	J Am Chem Soc	125	4444-50	2003	0.5 mM	50 uM	6.5	35	20mM Sodium phosphate	1D NMR spectra (Jump-return method)	SMMRNA	CC1=CC(=NC2=CC=CC=C12)N	4-methylquinolin-2-amine	231935	2.12542	158.08439832	2	1	0	38.91	2	0.637451564728004	1.80823613154358	12	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00318	0.00318	0	0	0	0
132	1,3-bis(piperidin-1-ylmethyl)imidazolidine-2-thione	Target_lig_103	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000109	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	C1CCN(CC1)CN2CCN(C2=S)CN3CCCCC3	1,3-bis(piperidin-1-ylmethyl)imidazolidine-2-thione	272041	1.7757	296.203467896	3	0	4	12.96	0	0.73129576555343	2.65829676018935	20	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000109	0.000109	0	0	0	0
133	1,4-bis((1H-indol-3-yl)methyl)piperazine	Target_lig_104	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000216	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	C1CN(CCN1CC2=CNC3=CC=CC=C32)CC4=CNC5=CC=CC=C54	3-[[4-(1H-indol-3-ylmethyl)piperazin-1-yl]methyl]-1H-indole	412865	3.967	344.200096768	2	2	4	38.06	4	0.587860328940284	2.04791232970035	26	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000216	0.000216	0	0	0	0
134	2-((2,2,6,6-tetramethylpiperidin-4-ylamino)methyl)phenol	Target_lig_105	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000206	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CC1(CC(CC(N1)(C)C)NCC2=CC=CC=C2O)C	2-[[(2,2,6,6-tetramethylpiperidin-4-yl)amino]methyl]phenol	566707	2.791	262.204513452	3	3	3	44.29	1	0.784607172968446	2.4299743873115	19	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000206	0.000206	0	0	0	0
135	2-(hydroxymethyl)-5-(5-phenyl-4-(quinolin-3-yl)-1H-imidazol-2-yl)phenol	Target_lig_106	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000111	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	OCC1=C=C=C(c2nc(C3=C=NC4=C(C=C=C=C4)C3)c(C3=C=C=C=C=C3)[nH]2)C=C1O	-	-	3.5296	385.085126592	4	3	4	81.5	1	0.693830482302703	6.51299536140952	30	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000111	0.000111	0	0	0	0
136	2-nitro-5-(piperazin-1-yl)-N-(2-(o-tolyloxy)ethyl)aniline	Target_lig_107	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000204	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CC1=CC=CC=C1OCCNC2=C(C=CC(=C2)N3CCNCC3)[N+](=O)[O-]	N-[2-(2-methylphenoxy)ethyl]-2-nitro-5-piperazin-1-ylaniline	3142696	2.80372	356.184840628	6	2	7	79.67	2	0.451121441032644	2.23619133561751	26	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000204	0.000204	0	0	0	0
137	3-(1H-benzo[d]imidazol-2-yl)-6-ethyl-7-hydroxy-8-(morpholinomethyl)-4H-chromen-4-one	Target_lig_108	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000251	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CCC1=CC2=C(C(=C1O)CN3CCOCC3)OC=C(C2=O)C4=NC5=CC=CC=C5N4	3-(1H-benzimidazol-2-yl)-6-ethyl-7-hydroxy-8-(morpholin-4-ylmethyl)chromen-4-one	1130510	3.4365	405.168856216	6	2	4	91.59	4	0.540481882231765	2.69028782584164	30	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000251	0.000251	0	0	0	0
138	3-(3-(4-methylpiperazin-1-yl)propyl)-3H-pyrimido[5,4-b]indol-4(5H)-one	Target_lig_109	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000426	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CN1CCN(CC1)CCCN2C=NC3=C(C2=O)NC4=CC=CC=C43	3-[3-(4-methylpiperazin-1-yl)propyl]-5H-pyrimido[5,4-b]indol-4-one	933200	1.5153	325.190260356	5	1	4	57.16	3	0.79001127950121	2.272414782012	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000426	0.000426	0	0	0	0
139	3-(azepan-1-ylmethyl)-2-methylquinolin-4-ol	Target_lig_110	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000401	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CC1=C(C(=O)C2=CC=CC=C2N1)CN3CCCCCC3	3-(azepan-1-ylmethyl)-2-methyl-1H-quinolin-4-one	728816	3.21252	270.173213324	2	1	2	36.1	2	0.909293464344128	1.97380041077605	20	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000401	0.000401	0	0	0	0
140	3-methyl-7-(2-(piperidin-1-yl)ethyl)-1H-purine-2,6(3H,7H)-dione	Target_lig_111	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000212	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CN1C2=C(C(=O)NC1=O)N(C=N2)CCN3CCCCC3	3-methyl-7-(2-piperidin-1-ylethyl)purine-2,6-dione	659131	-0.090800000000001	277.153874848	6	1	3	75.92	2	0.850424185640029	2.37798543101897	20	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000212	0.000212	0	0	0	0
141	4-(4,5-bis(azepan-1-ylmethyl)-1H-1,2,3-triazol-1-yl)-1,2,5-oxadiazol-3-amine	Target_lig_112	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000291	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	C1CCCN(CC1)CC2=C(N(N=N2)C3=NON=C3N)CN4CCCCCC4	4-[4,5-bis(azepan-1-ylmethyl)triazol-1-yl]-1,2,5-oxadiazol-3-amine	1915272	1.9845	374.25425758	9	1	5	102.13	2	0.8474967925648	2.6889040387611	27	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000291	0.000291	0	0	0	0
142	4-(4-chlorophenyl)-N-(2-(pyrrolidin-1-yl)ethyl)phthalazin-1-amine	Target_lig_113	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000146	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	C1CCN(C1)CCNC2=NN=C(C3=CC=CC=C32)C4=CC=C(C=C4)Cl	4-(4-chlorophenyl)-N-(2-pyrrolidin-1-ylethyl)phthalazin-1-amine	1069155	4.4579	352.145474352	4	1	5	41.05	3	0.735746459275507	2.06306163118704	25	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000146	0.000146	0	0	0	0
143	4,6-bis(piperidin-1-ylmethyl)-2-p-tolylpyridin-3-ol	Target_lig_114	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000143	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CC1=CC=C(C=C1)C2=C(C(=CC(=N2)CN3CCCCC3)CN4CCCCC4)O	2-(4-methylphenyl)-4,6-bis(piperidin-1-ylmethyl)pyridin-3-ol	1068918	4.73442000000001	379.262362676	4	1	5	39.6	2	0.814835886283426	2.30501486173583	28	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000143	0.000143	0	0	0	0
144	4-hydroxy-2-oxo-N-(3-(piperidin-1-yl)propyl)-1,2-dihydroquinoline-3-carboxamide	Target_lig_115	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000242	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	C1CCN(CC1)CCCNC(=O)C2=C(C3=CC=CC=C3NC2=O)O	4-hydroxy-2-oxo-N-(3-piperidin-1-ylpropyl)-1H-quinoline-3-carboxamide	54685835	1.8395	329.173941596	4	3	5	85.43	2	0.730804336043832	2.10287427556193	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000242	0.000242	0	0	0	0
145	6-methyl-3-((4-methyl-1,4-diazepan-1-yl)methyl)-4H-chromen-4-one	Target_lig_116	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000184	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CC1=CC2=C(C=C1)OC=C(C2=O)CN3CCCN(CC3)C	6-methyl-3-[(4-methyl-1,4-diazepan-1-yl)methyl]chromen-4-one	24015721	2.23892	286.168127944	4	0	2	36.69	2	0.848182834703496	2.19127823581679	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000184	0.000184	0	0	0	0
146	7-(2-(azocan-1-yl)ethyl)-3-methyl-1H-purine-2,6(3H,7H)-dione	Target_lig_117	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000283	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	N1(CCCCCCC1)CCN1C=NC=2N(C(NC(C12)=O)=O)C	-	-	0.6894	305.185174976	6	1	3	75.92	2	0.905002265322259	2.36253874180214	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000283	0.000283	0	0	0	0
147	7-benzyl-3-methyl-8-(piperazin-1-yl)-1H-purine-2,6(3H,7H)-dione	Target_lig_1111	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000246	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	C(C1=CC=CC=C1)N1C(=NC=2N(C(NC(C12)=O)=O)C)N1CCNCC1	7-benzyl-3-methyl-8-(piperazin-1-yl)-1H-purine-2,6(3H,7H)-dione	679638	0.8	340.4	2	5	3	82.5	0	0	0	25	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000246	0.000246	0	0	0	0
148	8-bromo-3-(2-(piperazin-1-yl)ethyl)-3H-pyrimido[5,4-b]indol-4(5H)-one	Target_lig_118	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000264	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	C1CN(CCN1)CCN2C=NC3=C(C2=O)NC4=C3C=C(C=C4)Br	8-bromo-3-(2-piperazin-1-ylethyl)-5H-pyrimido[5,4-b]indol-4-one	1917662	1.5455	375.069472296	5	2	3	65.95	3	0.728153370201612	2.52786399800254	23	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000264	0.000264	0	0	0	0
149	8-methyl-3-(2-(pyrrolidin-1-yl)ethyl)-3H-pyrimido[5,4-b]indol-4(5H)-one	Target_lig_119	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000341	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CC1=CC2=C(C=C1)NC3=C2N=CN(C3=O)CCN4CCCC4	8-methyl-3-(2-pyrrolidin-1-ylethyl)-5H-pyrimido[5,4-b]indol-4-one	920188	2.28202	296.16371126	4	1	3	53.92	3	0.806520378175612	2.28836278026368	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000341	0.000341	0	0	0	0
150	biphenyl_derivative	Target_lig_120	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	5.30E-05	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	N=C(N)CCCOC1=C=C=C=C=C1C1=C=C=C=C=C1	-	-	2.16767	246.07931294	2	2	6	59.1	0	0.326399945470127	6.26774209037766	19	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	5.30E-05	5.30E-05	0	0	0	0
151	N-(2-morpholinoethyl)-1-(naphthalen-1-ylmethyl)piperidine-4-carboxamide	Target_lig_121	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000233	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	C1CN(CCC1C(=O)NCCN2CCOCC2)CC3=CC=CC4=CC=CC=C43	N-(2-morpholin-4-ylethyl)-1-(naphthalen-1-ylmethyl)piperidine-4-carboxamide	30137413	2.5002	381.241627232	4	1	6	44.81	2	0.835131383222162	2.01429447700743	28	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000233	0.000233	0	0	0	0
152	N-(4-bromo-3-methylphenyl)-3-(4-ethylpiperazin-1-yl)propanamide	Target_lig_122	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000419	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CCN1CCN(CC1)CCC(=O)NC2=CC(=C(C=C2)Br)C	N-(4-bromo-3-methylphenyl)-3-(4-ethylpiperazin-1-yl)propanamide	1149597	2.72362	353.110274488	3	1	5	35.58	1	0.883314471400437	1.90113384207493	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000419	0.000419	0	0	0	0
153	N1-(3,7-dimethoxynaphthalen-1-yl)pentane-1,4-diamine	Target_lig_123	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000206	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	COC=1C=C(C2=CC(=CC=C2C1)OC)NCCCC(C)N	-	-	3.3963	288.183778008	4	2	7	56.51	2	0.766728716990872	2.54138163268139	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000206	0.000206	0	0	0	0
154	benzodiazolyl_methyl_sulfanylmethanimidamide	Target_lig_124	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000175	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	N=C(N)SCc1nc2C=C=C=Cc2n1CCC1=C=C=C=C=C1	-	-	2.75427	304.078267384	4	2	5	67.69	1	0.506874546081754	5.79081878987907	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000175	0.000175	0	0	0	0
155	7-hydroxy-3-(2-methoxyphenyl)-8-(piperidin-1-ylmethyl)-4H-chromen-4-one	Target_lig_125	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000395	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	COC1=CC=CC=C1C2=COC3=C(C2=O)C=CC(=C3CN4CCCCC4)O	7-hydroxy-3-(2-methoxyphenyl)-8-(piperidin-1-ylmethyl)chromen-4-one	5438997	4.1601	365.162708216	5	1	4	62.91	3	0.752109266446769	2.29657566598003	27	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000395	0.000395	0	0	0	0
156	tetraene_mol	Target_lig_126	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.50E-05	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CC(=O)C1=CCC2C1(CC=C3C2CCC4=CC(=O)C=CC43C)C	17-acetyl-10,13-dimethyl-6,7,8,12,14,15-hexahydrocyclopenta[a]phenanthren-3-one	14605222	4.3397	308.177630008	2	0	1	34.14	0	0.675281675489474	4.37392011551601	23	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.50E-05	3.50E-05	0	0	0	0
157	5E1bromophenyl52piperazin1	Target_lig_127	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000137	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	O=C1NC(=O)N(C2=C=C=C(Br)C=C2)C(=O)/C/1=C/NCCN1CCNCC1	-	-	-0.07	419.059301536	6	3	5	93.78	0	0.249696000439726	3.86178894892312	26	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000137	0.000137	0	0	0	0
158	6-chloro-3-((4-methyl-1,4-diazepan-1-yl)methyl)-4H-chromen-4-one	Target_lig_128	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000156	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CN1CCCN(CC1)CC2=COC3=C(C2=O)C=C(C=C3)Cl	6-chloro-3-[(4-methyl-1,4-diazepan-1-yl)methyl]chromen-4-one	23769929	2.5839	306.113505528	4	0	2	36.69	2	0.854368018841299	2.20637054350909	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000156	0.000156	0	0	0	0
159	dihydroquinoline-3-carboxamide_derivative	Target_lig_129	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000222	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	O=C(NCCN1CCCCC1)c1c(O)c2C=C=C=Cc2[nH]c1=O	-	-	1.0902	313.142641468	4	3	4	85.43	1	0.737718437379539	3.56690061213467	23	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000222	0.000222	0	0	0	0
160	N-(isochroman-1-ylmethyl)-3-(piperidin-1-yl)propan-1-amine	Target_lig_130	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.80E-05	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	C1CCN(CC1)CCCNCC2C3=CC=CC=C3CCO2	N-(3,4-dihydro-1H-isochromen-1-ylmethyl)-3-piperidin-1-ylpropan-1-amine	659151	2.766	288.220163516	3	1	6	24.5	1	0.81471352784568	2.66476647157131	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.80E-05	1.80E-05	0	0	0	0
161	N1-isopropyl-N2-(2-(4-(4-methylbenzoyl)piperazin-1-yl)ethyl)oxalamide	Target_lig_131	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000308	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CC1=CC=C(C=C1)C(=O)N2CCN(CC2)CCNC(=O)C(=O)NC(C)C	N-[2-[4-(4-methylbenzoyl)piperazin-1-yl]ethyl]-N'-propan-2-yloxamide	1940137	0.393620000000001	360.216140756	4	2	5	81.75	1	0.744731388644908	1.99029679715597	26	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000308	0.000308	0	0	0	0
162	1-(4-chlorobenzyl)-N-(2-morpholinoethyl)piperidine-4-carboxamide	Target_lig_132	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00025	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	C1CN(CCC1C(=O)NCCN2CCOCC2)CC3=CC=C(C=C3)Cl	1-[(4-chlorophenyl)methyl]-N-(2-morpholin-4-ylethyl)piperidine-4-carboxamide	25250022	2.0004	365.187004816	4	1	6	44.81	1	0.837122440975059	1.91611087790478	25	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00025	0.00025	0	0	0	0
163	1-(2,4-dimethoxybenzyl)-4-methyl-1,4-diazepane	Target_lig_133	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.10E-05	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	CN1CCCN(CC1)CC2=C(C=C(C=C2)OC)OC	1-[(2,4-dimethoxyphenyl)methyl]-4-methyl-1,4-diazepane	763014	1.8413	264.183778008	4	0	4	24.94	1	0.828279994043191	1.81336689224247	19	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.10E-05	3.10E-05	0	0	0	0
164	DIONE_DERIVATIVE	Target_lig_134	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	5.00E-05	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	Cn1c2nc(N/N=C\3/C4=C(C=C=C=C4)NC3=O)n(CC3=C=C=C(Cl)C=C3)c2c(=O)[nH]c1=O	-	-	0.828	445.069014924	8	3	4	126.17	2	0.474383427952835	4.83579673816939	32	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	5.00E-05	5.00E-05	0	0	0	0
165	4-hydroxy-2-oxo-N-(3-(piperidin-1-yl)propyl)-1,2,3,4,5,6,7,8-octahydroquinoline-3-carboxamide	Target_lig_135	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.70E-05	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	OC1C(C(NC=2CCCCC12)=O)C(=O)NCCCN1CCCCC1	-	-	0.913599999999999	335.220891788	4	3	5	81.67	0	0.515275420850031	3.45720805299985	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.70E-05	1.70E-05	0	0	0	0
166	pyran-3,4-diol_derivative	Target_lig_136	A-site 16S rRNA_E_coli (1)	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.23E-05	0	0	0	0	-	-	10.1016/j.bmc.2003.12.023	14980606	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.	Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R	Bioorg Med Chem	12	935-47	2004	500 uM	30 nM	7.5	-	50mM Kcl	FRET assay	SMMRNA	NC[C@H]1O[C@H](O[C@H]2[C@H](CO)O[C@H](O[C@H]3[C@H]([C@H](N)C[C@H]([C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3N)N)O)[C@H]2O)[C@@H](N)[C@H](O)[C@@H]1O	-	-	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.23E-05	1.23E-05	0	0	0	0
167	Neomycin	Target_lig_4	16S rRNA_neomycin	Escherichia coli	Bacterial growth and infection	Target_96	0	0	6.00E-08	0	0	0	0	2ET4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GCACCGGCUAACUCCGUGCCAGCAGCGCGGUAAUACGGAGGGUGC	http://www.smmrna.org/	Ribosomal	-	45	-	-	0	0	0	0	6.00E-08	6.00E-08	0	0	0	0
168	Paromomycin_mol_mol	Target_lig_1116	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.0001	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.0001	0.0001	0	0
169	gentamicin_mol_c1a	Target_lig_76	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	1.00E-06	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	1.00E-06	1.00E-06	0	0
170	apramycin	Target_lig_79	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.0002	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O	5-amino-2-[[7-amino-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4-diol	439519	-6.94930000000001	539.280257132	16	11	6	283.64	0	0.149405525228447	5.52548579783966	37	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.0002	0.0002	0	0
171	Neamine	Target_lig_80	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.0002	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol	413349	-5.11559999999999	322.185234552	10	8	3	203.46	0	0.247960739843155	4.62440978066844	22	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.0002	0.0002	0	0
172	gentamicin_mol_c2	Target_lig_137	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	1.00E-06	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)N	2-[4,6-diamino-3-[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	588785	-3.58819999999999	463.300598652	12	8	6	213.72	0	0.191846628918506	5.29105565941732	32	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	1.00E-06	1.00E-06	0	0
173	gentamicin_mol_c1	Target_lig_76	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	1.00E-06	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	1.00E-06	1.00E-06	0	0
174	gentamicin_mol_B	Target_lig_139	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	1.00E-05	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CN)O)O)O)N)N)O	2-(aminomethyl)-6-[4,6-diamino-3-[3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	37569	-6.0015	482.258793416	14	10	6	248.39	0	0.169222144372969	5.16306268381088	33	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	1.00E-05	1.00E-05	0	0
175	Geneticin	Target_lig_140	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.001	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O	2-[4,6-diamino-3-[3-amino-4,5-dihydroxy-6-(1-hydroxyethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	354578	-5.613	496.27444348	14	10	6	248.39	0	0.164623849535594	5.36827337610045	34	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.001	0.001	0	0
176	Tobramycin	Target_lig_540	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	5.00E-07	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	5.00E-07	5.00E-07	0	0
177	Kanamycin A	Target_lig_7	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.005	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.005	0.005	0	0
178	KANAMYCIN B	Target_lig_8	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	1.00E-05	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	1.00E-05	1.00E-05	0	0
179	Kanamycin C	Target_lig_141	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.005	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CO)O)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	16785	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.08347133606856	33	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.005	0.005	0	0
180	ribostamycin	Target_lig_9	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.001	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	5066	-6.6523	454.227493288	14	10	6	262.38	0	0.178778081939411	4.96778075738293	31	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.001	0.001	0	0
181	Neomycin_B	Target_lig_1246	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	5.00E-07	0	0	0	-	-	10.1038/353368a0	1922343	Antibiotic inhibition of group I ribozyme function.	von Ahsen U, Davies J, Schroeder R	Nature	353	368-70	1991	-	-	7.5	42	60mM MgCl2	Incubation and gel purification assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	5.00E-07	5.00E-07	0	0
182	Garamine	Target_lig_142	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.0002	0	0	0	-	-	10.1016/0022-2836(92)91043-O	1518063	Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics.	von Ahsen U, Davies J, Schroeder R	J Mol Biol	226	935-41	1992	-	-	7.5	-	5mM MgCl2	Gel autoradiogram	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)O)N)N)O	2-(4,6-diamino-2,3-dihydroxycyclohexyl)oxy-5-methyl-4-(methylamino)oxane-3,5-diol	14699894	-3.79209999999999	321.189985584	9	7	3	163.45	0	0.276084112890395	4.72641115559525	22	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.0002	0.0002	0	0
183	gentamicin_mol_c	Target_lig_76	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	1.00E-06	0	0	0	-	-	10.1016/0022-2836(92)91043-O	1518063	Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics.	von Ahsen U, Davies J, Schroeder R	J Mol Biol	226	935-41	1992	-	-	7.5	-	5mM MgCl2	Gel autoradiogram	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	1.00E-06	1.00E-06	0	0
184	2_phospho_gentamicin_mol	Target_lig_143	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.0001	0	0	0	-	-	10.1016/0022-2836(92)91043-O	1518063	Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics.	von Ahsen U, Davies J, Schroeder R	J Mol Biol	226	935-41	1992	-	-	7.5	-	5mM MgCl2	Gel autoradiogram	SMMRNA	O([C@@H]1[C@H](O)[C@H](O[C@H]2O[C@@H](CC[C@@H]2N)[C@H](NC)C)[C@@H](N)C[C@@H]1N)[C@H]1OC[C@](O)([C@@H](NC)[C@H]1OP(=O)(=O)O)C	-	-	-3.03999999999999	557.282579238	14	8	9	243.1	0	0.131355383114133	5.99014485416019	37	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.0001	0.0001	0	0
185	sisomicin	Target_lig_10	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	5.00E-05	0	0	0	-	-	10.1016/0022-2836(92)91043-O	1518063	Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics.	von Ahsen U, Davies J, Schroeder R	J Mol Biol	226	935-41	1992	-	-	7.5	-	5mM MgCl2	Gel autoradiogram	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	5.00E-05	5.00E-05	0	0
186	5_episisomicin	Target_lig_1244	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	5.00E-07	0	0	0	-	-	10.1016/0022-2836(92)91043-O	1518063	Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics.	von Ahsen U, Davies J, Schroeder R	J Mol Biol	226	935-41	1992	0.5-50 uM	-	7.5	-	5mM MgCl2	Gel autoradiogram	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	5.00E-07	5.00E-07	0	0
187	dihydro_sisomicin	Target_lig_144	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.0001	0	0	0	-	-	10.1016/0022-2836(92)91043-O	1518063	Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics.	von Ahsen U, Davies J, Schroeder R	J Mol Biol	226	935-41	1992	-	-	7.5	-	5mM MgCl2	Gel autoradiogram	SMMRNA	O([C@@H]1[C@@H](O)[C@@H](O[C@H]2O[C@@H](CC[C@H]2N)CN)[C@@H](N)C[C@H]1N)[C@H]1OC[C@](O)([C@H](NC)[C@H]1O)C	-	-	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411332	5.16899065295033	31	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.0001	0.0001	0	0
188	1_N_Acetyl_sisomicin	Target_lig_145	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.0001	0	0	0	-	-	10.1016/0022-2836(92)91043-O	1518063	Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics.	von Ahsen U, Davies J, Schroeder R	J Mol Biol	226	935-41	1992	-	-	7.5	-	5mM MgCl2	Gel autoradiogram	SMMRNA	O([C@@H]1[C@@H](O)[C@@H](O[C@H]2O[C@@H](CC[C@H]2N)CN)[C@@H](N)C[C@H]1NC(=O)C)[C@H]1OC[C@](O)([C@H](NC)[C@H]1O)C	-	-	-3.7993	491.295513272	12	8	7	216.8	0	0.171945038173101	5.15904596819235	34	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.0001	0.0001	0	0
189	Lividomycin	Target_lig_11	T4 phage derived td intron	Tetrahymena thermophila	Bacterial growth and infection	Target_116	0	0	0	0.0005	0	0	0	-	-	10.1016/0022-2836(92)91043-O	1518063	Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics.	von Ahsen U, Davies J, Schroeder R	J Mol Biol	226	935-41	1992	-	-	7.5	-	5mM MgCl2	Gel autoradiogram	SMMRNA	C1C(C(C(C(C1N)OC2C(CC(C(O2)CO)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)OC5C(C(C(C(O5)CO)O)O)O)O)N)O)O)N	2-[5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-4-hydroxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	3940	-10.0083	761.35420992	23	15	12	406.24	0	0.087736447103846	5.92634264032295	52	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.0005	0.0005	0	0
190	Streptomycin	Target_lig_63	td wildtype group IA2	Tetrahymena thermophila	Bacterial growth and infection	Target_117	0	0	0	0.005	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	20 mM	-	7.5	37	8mM MgCl2	Gel autoradiogram	SMMRNA	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.005	0.005	0	0
191	myomycin	Target_lig_146	td wildtype group IA2	Tetrahymena thermophila	Bacterial growth and infection	Target_117	0	0	0	0.01	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	20 mM	-	7.5	37	8mM MgCl2	Gel autoradiogram	SMMRNA	C(CC(CC(=O)NCCCC(CC(=O)NC(=NC1C(C(OC(C1O)OC2C(C(C(C(C2O)OC(=O)N)O)OC(=O)N)O)CO)O)N)N)N)CN	[3-[4-[[amino-[[3-amino-6-(3,6-diaminohexanoylamino)hexanoyl]amino]methylidene]amino]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-carbamoyloxy-2,4,6-trihydroxycyclohexyl] carbamate	3040806	-7.29570000000001	725.355547312	18	14	17	419.12	0	0.037595361874912	5.44538350358129	50	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.01	0.01	0	0
192	Streptomycin	Target_lig_63	Tetrahymena_rRNA_ICI	Tetrahymena thermophila	Bacterial growth and infection	Target_24	0	0	0	0.002	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	20 mM	-	7.5	37	8mM MgCl2	Gel autoradiogram	SMMRNA	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	CUUCUAAAUAGCAAUAUUUACCUUUGGAGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGACGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUGCAGUUCACAGACUAAAUGUCGGUCGGGGAAGAUGUAUUCUUCUCAUAAGAUAUAGUCGGACCUCUCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUUGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGU	https://www.rcsb.org/structure/6WLS	Ribosomal	Group I intron	413	-	-	0	0	0	0	0	0	0.002	0.002	0	0
193	Streptomycin	Target_lig_63	td-mutant U870	Tetrahymena thermophila	Bacterial growth and infection	Target_118	0	0	0	0.0004	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	20 mM	-	7.5	37	8mM MgCl2	Gel autoradiogram	SMMRNA	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAAUGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	10.1021/bi00227a018	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.0004	0.0004	0	0
194	myomycin	Target_lig_146	td-mutant U870	Tetrahymena thermophila	Bacterial growth and infection	Target_118	0	0	0	0.01	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	20 mM	-	7.5	37	8mM MgCl2	Gel autoradiogram	SMMRNA	C(CC(CC(=O)NCCCC(CC(=O)NC(=NC1C(C(OC(C1O)OC2C(C(C(C(C2O)OC(=O)N)O)OC(=O)N)O)CO)O)N)N)N)CN	[3-[4-[[amino-[[3-amino-6-(3,6-diaminohexanoylamino)hexanoyl]amino]methylidene]amino]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-carbamoyloxy-2,4,6-trihydroxycyclohexyl] carbamate	3040806	-7.29570000000001	725.355547312	18	14	17	419.12	0	0.037595361874912	5.44538350358129	50	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAAUGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	10.1021/bi00227a018	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.01	0.01	0	0
195	Streptomycin	Target_lig_63	td truncated at PVU II	Tetrahymena thermophila	Bacterial growth and infection	Target_119	0	0	0	0.001	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	20 mM	-	7.5	37	8mM MgCl2	Gel autoradiogram	SMMRNA	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAACGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329428/	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.001	0.001	0	0
196	Paromomycin_mol_mol	Target_lig_1116	decoding region 16SrRNA	Escherichia coli	Bacterial growth and infection	Target_97	0	0	1.85e-06±3.2e-07	0	0	0	0	2O3W	-	10.1021/bi962095g	9020774	Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.	Wang Y, Hamasaki K, Rando RR	Biochemistry	36	768-79	1997	-	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2,	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	1543	-	-	0	0	0	0	1.53E-06	2.17E-06	0	0	0	0
197	Tobramycin	Target_lig_540	decoding region 16SrRNA	Escherichia coli	Bacterial growth and infection	Target_97	0	0	1.69e-06±1.6e-07	0	0	0	0	-	-	10.1021/bi962095g	9020774	Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.	Wang Y, Hamasaki K, Rando RR	Biochemistry	36	768-79	1997	-	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2,	Fluorescence anisotropy and intensity measurements	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	1543	-	-	0	0	0	0	1.53E-06	1.85E-06	0	0	0	0
198	KANAMYCIN B	Target_lig_8	decoding region 16SrRNA	Escherichia coli	Bacterial growth and infection	Target_97	0	0	2.14e-06±2.9e-07	0	0	0	0	-	-	10.1021/bi962095g	9020774	Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.	Wang Y, Hamasaki K, Rando RR	Biochemistry	36	768-79	1997	-	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2,	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	1543	-	-	0	0	0	0	1.85E-06	2.43E-06	0	0	0	0
199	Neomycin_B	Target_lig_1246	decoding region 16SrRNA	Escherichia coli	Bacterial growth and infection	Target_97	0	0	1.32e-07±2.2999999999999998e-08	0	0	0	0	-	-	10.1021/bi962095g	9020774	Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.	Wang Y, Hamasaki K, Rando RR	Biochemistry	36	768-79	1997	-	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2,	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	1543	-	-	0	0	0	0	1.09E-07	1.55E-07	0	0	0	0
200	gentamicin_mol_c	Target_lig_76	decoding region 16SrRNA	Escherichia coli	Bacterial growth and infection	Target_97	0	0	1.84e-06±3.8999999999999997e-07	0	0	0	0	-	-	10.1021/bi962095g	9020774	Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.	Wang Y, Hamasaki K, Rando RR	Biochemistry	36	768-79	1997	-	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2,	Fluorescence anisotropy and intensity measurements	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	1543	-	-	0	0	0	0	1.45E-06	2.23E-06	0	0	0	0
201	CRP	Target_lig_147	decoding region 16SrRNA	Escherichia coli	Bacterial growth and infection	Target_97	0	0	1.65e-07±3.1e-08	0	0	0	0	-	-	10.1021/bi962095g	9020774	Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.	Wang Y, Hamasaki K, Rando RR	Biochemistry	36	768-79	1997	-	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2,	Fluorescence anisotropy and intensity measurements	SMMRNA	CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC3C(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C4CCCN4C(=O)C(CCCCN)N	1-[2-[[2-[[5-amino-2-[[1-(2,6-diaminohexanoyl)pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid	22146496	-0.000699999999992	767.433009784	9	8	20	276.14	2	0.083550176470666	4.39770138518893	55	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	1543	-	-	0	0	0	0	1.34E-07	1.96E-07	0	0	0	0
202	Neomycin	Target_lig_4	Hammerhead 16	Synthetic	Bacterial growth and infection	Target_115	0	0	0	1.50E-06	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GCGAUGACCUGAUGAGGCCGAAAGGCCGAAACGUUCCCGGGAACGUCGUCGUCGC	http://www.smmrna.org/	Ribozyme	Group I ribozyme	55	-	-	0	0	0	0	0	0	1.50E-06	1.50E-06	0	0
203	Paromomycin_mol_mol	Target_lig_1116	Hammerhead 16	Synthetic	Bacterial growth and infection	Target_115	0	0	0	0.00014	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GCGAUGACCUGAUGAGGCCGAAAGGCCGAAACGUUCCCGGGAACGUCGUCGUCGC	http://www.smmrna.org/	Ribozyme	Group I ribozyme	55	-	-	0	0	0	0	0	0	0.00014	0.00014	0	0
204	neocarzinostatin	Target_lig_148	RNA_Str_HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	1.40E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1C(C(C(C(O1)OC2C3CC#CC4C(O4)(C#CC3=CC2OC(=O)C5=C(C=CC6=C5C=C(C=C6C)OC)O)C7COC(=O)O7)NC)O)O	[11-[4,5-dihydroxy-6-methyl-3-(methylamino)oxan-2-yl]oxy-4-(2-oxo-1,3-dioxolan-4-yl)-5-oxatricyclo[8.3.0.04,6]tridec-1(13)-en-2,7-diyn-12-yl] 2-hydroxy-7-methoxy-5-methylnaphthalene-1-carboxylate	76632185	1.46732	661.21592556	13	4	7	174.77	2	0.191003180515107	6.57336699874626	48	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	1.40E-05	1.40E-05	0	0	0	0
205	Neocarzinostatin_chromophore_derivative_1	Target_lig_149	RNA_Str_HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	1.40E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cc(cc1C)OC)[C@@]1(C(=O)C=C2)C(=O)O[C@@H]2[C@H]1c1c([C@@H]2O[C@H]2[C@@H]([C@@H]([C@H]([C@H](O2)C)O)O)NC)cc2c(c1)[C@](C=C2)([C@H]1OC(=O)OC1)O	-	-	1.42222	661.21592556	13	4	5	179.31	2	0.26738260316774	6.33596268186911	48	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	1.40E-05	1.40E-05	0	0	0	0
206	Neocarzinostatin_chromophore_derivative_2	Target_lig_150	RNA_Str_HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	1.40E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cccc1)[C@]1(C(=O)C=C2)[C@@H](O[C@@H]2[C@@H]1c1c(C2=O)cc2c(c1)cccc2)O[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)CO)O)O)N	-	-	1.1614	529.173666824	9	4	3	148.54	3	0.392223613095501	5.34806308393096	39	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	1.40E-05	1.40E-05	0	0	0	0
207	Neocarzinostatin_chromophore_derivative_3	Target_lig_151	RNA_Str_HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	1.30E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cccc1)[C@]1([C@@H](C=C2)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)CO)O)O)N)C(=O)O[C@H]2[C@@H]1c1c(C2=O)cc2c(c1)cccc2	-	-	1.1614	529.173666824	9	4	3	148.54	3	0.366909642437388	5.32842898829686	39	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	1.30E-05	1.30E-05	0	0	0	0
208	Neocarzinostatin_chromophore_derivative_5	Target_lig_152	RNA_Str_HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	8.00E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cc(cc1)OC)[C@@]1(C(=O)C=C2)C=C[C@@H]2[C@@H]1c1c([C@H]2O[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)C)O)O)NC)cc2c(c1)cccc2	-	-	3.7778	539.230787776	7	3	4	97.25	3	0.434466412262569	5.39426082967241	40	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	8.00E-06	8.00E-06	0	0	0	0
209	Neocarzinostatin_chromophore_derivative_6	Target_lig_153	RNA_Str_HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	9.00E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cc(cc1)OC)[C@@]1(C(=O)C=C2)C=C[C@H]2[C@H]1c1c([C@@H]2O[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)C)O)O)NC)cc2c(c1)cccc2	-	-	3.7778	539.230787776	7	3	4	97.25	3	0.434466412262569	5.39426082967241	40	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	9.00E-06	9.00E-06	0	0	0	0
210	Theophylline	Target_lig_154	TCT8-4 RNA Aptamer	Synthetic	-	Target_32	0	0	3.2e-07±1.3e-07	0	0	0	0	1EHT	-	10.1126/science.7510417	7510417	High-resolution molecular discrimination by RNA.	Jenison RD, Gill SC, Pardi A, Polisky B	Science	263	1425-9	1994	-	-	-	-	-	Competitive binding experiments SELEX	SMMRNA	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione	2153	-1.0397	180.064725496	5	1	0	72.68	2	0.562472235782798	2.54357777198685	13	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	http://www.smmrna.org/	RNA aptamer	-	42	-	Stem-Loop	0	0	0	0	1.90E-07	4.50E-07	0	0	0	0
211	caffeine	Target_lig_155	TCT8-4 RNA Aptamer	Synthetic	-	Target_32	0	0	0.0034999999999999996±0.0015	0	0	0	0	-	-	10.1126/science.7510417	7510417	High-resolution molecular discrimination by RNA.	Jenison RD, Gill SC, Pardi A, Polisky B	Science	263	1425-9	1994	-	-	-	-	-	Competitive binding experiments SELEX	SMMRNA	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	1,3,7-trimethylpurine-2,6-dione	2519	-1.0293	194.08037556	6	0	0	61.82	2	0.538462826237222	2.29798245679401	14	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	http://www.smmrna.org/	RNA aptamer	-	42	-	Stem-Loop	0	0	0	0	0.002	0.005	0	0	0	0
212	1_methylxanthine	Target_lig_156	TCT8-4 RNA Aptamer	Synthetic	-	Target_32	0	0	9e-06±3e-07	0	0	0	0	-	-	10.1126/science.7510417	7510417	High-resolution molecular discrimination by RNA.	Jenison RD, Gill SC, Pardi A, Polisky B	Science	263	1425-9	1994	-	-	-	-	-	Competitive binding experiments SELEX	SMMRNA	CN1C(=O)C2=C(NC1=O)N=CN2	1-methyl-3,7-dihydropurine-2,6-dione	80220	-1.0501	166.049075432	4	2	0	83.54	2	0.523395385532382	2.78350799497427	12	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	http://www.smmrna.org/	RNA aptamer	-	42	-	Stem-Loop	0	0	0	0	8.70E-06	9.30E-06	0	0	0	0
213	1,3-dimethyluric acid	Target_lig_157	TCT8-4 RNA Aptamer	Synthetic	-	Target_32	0	0	>0.001	0	0	0	0	-	-	10.1126/science.7510417	7510417	High-resolution molecular discrimination by RNA.	Jenison RD, Gill SC, Pardi A, Polisky B	Science	263	1425-9	1994	-	-	-	-	-	Competitive binding experiments SELEX	SMMRNA	CN1C2=C(C(=O)N(C1=O)C)NC(=O)N2	1,3-dimethyl-7,9-dihydropurine-2,6,8-trione	70346	-1.7464	196.059640116	5	2	0	92.65	2	0.52312189980637	2.77590303891459	14	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	http://www.smmrna.org/	RNA aptamer	-	42	-	Stem-Loop	0	0	0	0	0.001	0.001	0	0	0	0
214	3,7-dimethylxanthine	Target_lig_158	TCT8-4 RNA Aptamer	Synthetic	-	Target_32	0	0	>0.0005	0	0	0	0	-	-	10.1126/science.7510417	7510417	High-resolution molecular discrimination by RNA.	Jenison RD, Gill SC, Pardi A, Polisky B	Science	263	1425-9	1994	-	-	-	-	-	Competitive binding experiments SELEX	SMMRNA	CN1C=NC2=C1C(=O)NC(=O)N2C	3,7-dimethylpurine-2,6-dione	5429	-1.0397	180.064725496	5	1	0	72.68	2	0.562472235782798	2.47175183792091	13	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	http://www.smmrna.org/	RNA aptamer	-	42	-	Stem-Loop	0	0	0	0	0.0005	0.0005	0	0	0	0
215	3-methylxanthine	Target_lig_159	TCT8-4 RNA Aptamer	Synthetic	-	Target_32	0	0	2e-06±7e-07	0	0	0	0	-	-	10.1126/science.7510417	7510417	High-resolution molecular discrimination by RNA.	Jenison RD, Gill SC, Pardi A, Polisky B	Science	263	1425-9	1994	-	-	-	-	-	Competitive binding experiments SELEX	SMMRNA	CN1C2=C(C(=O)NC1=O)NC=N2	3-methyl-7H-purine-2,6-dione	70639	-1.0501	166.049075432	4	2	0	83.54	2	0.523395385532382	2.68262407889035	12	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	http://www.smmrna.org/	RNA aptamer	-	42	-	Stem-Loop	0	0	0	0	1.30E-06	2.70E-06	0	0	0	0
216	7-methylxanthine	Target_lig_160	TCT8-4 RNA Aptamer	Synthetic	-	Target_32	0	0	>0.0005	0	0	0	0	-	-	10.1126/science.7510417	7510417	High-resolution molecular discrimination by RNA.	Jenison RD, Gill SC, Pardi A, Polisky B	Science	263	1425-9	1994	-	-	-	-	-	Competitive binding experiments SELEX	SMMRNA	CN1C=NC2=C1C(=O)NC(=O)N2	7-methyl-3H-purine-2,6-dione	68374	-1.0501	166.049075432	4	2	0	83.54	2	0.523395385532382	2.78385624672252	12	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	http://www.smmrna.org/	RNA aptamer	-	42	-	Stem-Loop	0	0	0	0	0.0005	0.0005	0	0	0	0
217	CP-theophylline	Target_lig_161	TCT8-4 RNA Aptamer	Synthetic	-	Target_32	0	0	9.3e-07±2e-07	0	0	0	0	-	-	10.1126/science.7510417	7510417	High-resolution molecular discrimination by RNA.	Jenison RD, Gill SC, Pardi A, Polisky B	Science	263	1425-9	1994	-	-	-	-	-	Competitive binding experiments SELEX	SMMRNA	CN1C2=C(C(=O)N(C1=O)CCC(=O)O)NC=N2	3-(3-methyl-2,6-dioxo-7H-purin-1-yl)propanoic acid	20474649	-1.102	238.0702048	6	2	3	109.98	2	0.704671900894722	2.51422812030209	17	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	http://www.smmrna.org/	RNA aptamer	-	42	-	Stem-Loop	0	0	0	0	7.30E-07	1.13E-06	0	0	0	0
218	Hypoxanthine	Target_lig_162	TCT8-4 RNA Aptamer	Synthetic	-	Target_32	0	0	4.9e-05±9.999999999999999e-06	0	0	0	0	-	-	10.1126/science.7510417	7510417	High-resolution molecular discrimination by RNA.	Jenison RD, Gill SC, Pardi A, Polisky B	Science	263	1425-9	1994	-	-	-	-	-	Competitive binding experiments SELEX	SMMRNA	C1=NC2=C(N1)C(=O)N=CN2	3,7-dihydropurin-6-one	790	-0.3538	136.038510748	3	2	0	74.43	2	0.519236856563892	2.99952241707339	10	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	http://www.smmrna.org/	RNA aptamer	-	42	-	Stem-Loop	0	0	0	0	3.90E-05	5.90E-05	0	0	0	0
219	xanthine	Target_lig_156	TCT8-4 RNA Aptamer	Synthetic	-	Target_32	0	0	8.5e-06±4e-07	0	0	0	0	-	-	10.1126/science.7510417	7510417	High-resolution molecular discrimination by RNA.	Jenison RD, Gill SC, Pardi A, Polisky B	Science	263	1425-9	1994	-	-	-	-	-	Competitive binding experiments SELEX	SMMRNA	CN1C(=O)C2=C(NC1=O)N=CN2	1-methyl-3,7-dihydropurine-2,6-dione	80220	-1.0501	166.049075432	4	2	0	83.54	2	0.523395385532382	2.78350799497427	12	AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA	http://www.smmrna.org/	RNA aptamer	-	42	-	Stem-Loop	0	0	0	0	8.10E-06	8.90E-06	0	0	0	0
220	bis(phenanthroline)(9,10-phenanthrenequinone diimine)Rhodium(III)	Target_lig_164	BIV TAR RNA	Bovine immunodeficiency virus	Acquired immunodeficiency syndrome (AIDS)	Target_21	0	2.2±0.3x1E6 M	0	0	0	0	0	-	-	10.1016/S0968-0896(97)00049-7	9222507	Targeting the Tat-binding site of bovine immunodeficiency virus TAR RNA with a shape-selective rhodium complex.	Lim AC, Barton JK	Bioorg Med Chem	51	131-6	1997	5 nM - 50 uM	0.1-1000 uM	7	-	-	Photocleavage and gel autoradiogram	SMMRNA	C1C=C=Cc2c1c1c(cccc1)c1=N[Rh]34(N=c21)(N1=CC=Cc2ccc5C=CC=N3c5c12)N1=CC=Cc2ccc3C=CC=N4c3c12	-	-	0	0	0	0	0	0	0	0	0	0	GGCUCGUGUAGCUCAUUAGCUCCGAGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	28	-	Apical Loop	0	0	1900000	2500000	0	0	0	0	0	0
221	Adenine	Target_lig_165	ADENINE RIBOSWITCH	Synthetic	Bacterial growth and infection	Target_69	0	0	4e-07±4e-08	0	0	0	0	-	-	10.1021/ja063645t	17076468	Modified pyrimidines specifically bind the purine riboswitch.	Gilbert SD, Mediatore SJ, Batey RT	J Am Chem Soc	128	14214-5	2006	-	-	7.5	30	100 mM KCl, 10 mM MgCl2	Isothermal Titration Calorimetry (ITC)	SMMRNA	C1=NC2=NC=NC(=C2N1)N	7H-purin-6-amine	190	-0.0649	135.05449516	4	2	0	80.48	2	0.529675929378058	2.66020570619806	10	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGAUUAUGUCC	https://www.rcsb.org/structure/2G9C	Riboswitch	Riboswitch	67	-	-	0	0	0	0	3.60E-07	4.40E-07	0	0	0	0
222	2-aminopurine	Target_lig_166	ADENINE RIBOSWITCH	Synthetic	Bacterial growth and infection	Target_69	0	0	0.25 uM - 3	0	0	0	0	-	-	10.1021/ja063645t	17076468	Modified pyrimidines specifically bind the purine riboswitch.	Gilbert SD, Mediatore SJ, Batey RT	J Am Chem Soc	128	14214-5	2006	-	-	7.5	30	100 mM KCl, 10 mM MgCl2	Isothermal Titration Calorimetry (ITC)	SMMRNA	C1=C2C(=NC(=N1)N)N=CN2	7H-purin-2-amine	9955	-0.0649	135.05449516	4	2	0	80.48	2	0.529675929378059	2.69120676720602	10	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGAUUAUGUCC	https://www.rcsb.org/structure/2G9C	Riboswitch	Riboswitch	67	-	-	0	0	0	0	2.50E-07	3.00E-06	0	0	0	0
223	2,4,6-triaminopyrimidine	Target_lig_167	ADENINE RIBOSWITCH	Synthetic	Bacterial growth and infection	Target_69	0	0	1.9999999999999998e-05±3e-06	0	0	0	0	2G9C	-	10.1021/ja063645t	17076468	Modified pyrimidines specifically bind the purine riboswitch.	Gilbert SD, Mediatore SJ, Batey RT	J Am Chem Soc	128	14214-5	2006	-	-	7.5	30	100 mM KCl, 10 mM MgCl2	Isothermal Titration Calorimetry (ITC)	SMMRNA	C1=C(N=C(N=C1N)N)N	pyrimidine-2,4,6-triamine	13863	-0.7768	125.070145224	5	3	0	103.84	1	0.421754100457696	2.59910493030248	9	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGAUUAUGUCC	https://www.rcsb.org/structure/2G9C	Riboswitch	Riboswitch	67	-	-	0	0	0	0	1.70E-05	2.30E-05	0	0	0	0
224	2,6- diaminopurine	Target_lig_168	ADENINE RIBOSWITCH	Synthetic	Bacterial growth and infection	Target_69	0	0	2e-08±6e-09	0	0	0	0	-	-	10.1021/ja063645t	17076468	Modified pyrimidines specifically bind the purine riboswitch.	Gilbert SD, Mediatore SJ, Batey RT	J Am Chem Soc	128	14214-5	2006	-	-	7.5	30	100 mM KCl, 10 mM MgCl2	Isothermal Titration Calorimetry (ITC)	SMMRNA	C1=NC2=NC(=NC(=C2N1)N)N	7H-purine-2,6-diamine	30976	-0.4827	150.065394192	5	3	0	106.5	2	0.469730963770893	2.7153646042873	11	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGAUUAUGUCC	https://www.rcsb.org/structure/2G9C	Riboswitch	Riboswitch	67	-	-	0	0	0	0	1.40E-08	2.60E-08	0	0	0	0
225	2,4-diaminopurine	Target_lig_169	ADENINE RIBOSWITCH	Synthetic	Bacterial growth and infection	Target_69	0	0	4.00E-09	0	0	0	0	-	-	10.1021/ja063645t	17076468	Modified pyrimidines specifically bind the purine riboswitch.	Gilbert SD, Mediatore SJ, Batey RT	J Am Chem Soc	128	14214-5	2006	-	-	7.5	30	100 mM KCl, 10 mM MgCl2	Isothermal Titration Calorimetry (ITC)	SMMRNA	C1=NC(=NC2(C1=NC=N2)N)N	purine-2,4-diamine	18410141	-1.5191	150.065394192	6	2	0	101.48	0	0.437744580227719	5.22227908959872	11	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGAUUAUGUCC	https://www.rcsb.org/structure/2G9C	Riboswitch	Riboswitch	67	-	-	0	0	0	0	4.00E-09	4.00E-09	0	0	0	0
226	Neomycin	Target_lig_4	A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.00E-08	0	0	0	0	2ET4	-	10.4155/fmc.09.149	21426048	Strategies for the design of RNA-binding small molecules.	Aboul-ela F	Future Med Chem	2	93-119	2010	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.00E-08	6.00E-08	0	0	0	0
227	apramycin	Target_lig_79	A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	60 nM - 100	0	0	0	0	2M4Q	-	10.4155/fmc.09.149	21426048	Strategies for the design of RNA-binding small molecules.	Aboul-ela F	Future Med Chem	2	93-119	2010	-	-	-	-	-	-	SMMRNA	CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O	5-amino-2-[[7-amino-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4-diol	439519	-6.94930000000001	539.280257132	16	11	6	283.64	0	0.149405525228447	5.52548579783966	37	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.00E-08	1.00E-07	0	0	0	0
228	quinolinediamine_trimethyl_der	Target_lig_170	A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.50E-05	0	0	0	0	-	-	10.4155/fmc.09.149	21426048	Strategies for the design of RNA-binding small molecules.	Aboul-ela F	Future Med Chem	2	93-119	2010	-	-	-	-	-	-	SMMRNA	CC1=CC(=NC2=C1C=CC(=C2)N)N(C)C	2-N,2-N,4-trimethylquinoline-2,7-diamine	326802	2.19142	201.12659748	3	1	1	42.15	2	0.719040523742236	2.22288208690898	15	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.50E-05	3.50E-05	0	0	0	0
229	3-quinolinecarboxamide	Target_lig_171	A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.70E-05	0	0	0	0	-	-	10.4155/fmc.09.149	21426048	Strategies for the design of RNA-binding small molecules.	Aboul-ela F	Future Med Chem	2	93-119	2010	-	-	-	-	-	-	SMMRNA	C1=CC=C2C(=C1)C=C(C=N2)C(=O)N	quinoline-3-carboxamide	15561101	1.3337	172.063662876	2	1	1	55.98	2	0.705092678670038	1.70129089345997	13	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.70E-05	1.70E-05	0	0	0	0
230	4-pyridineacetamide, N- [2- (dimethylamino)-4-methyl-7-quinolinyl]	Target_lig_172	A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.80E-05	0	0	0	0	-	-	10.4155/fmc.09.149	21426048	Strategies for the design of RNA-binding small molecules.	Aboul-ela F	Future Med Chem	2	93-119	2010	-	-	-	-	-	-	SMMRNA	CC1=CC(=NC2=C1C=CC(=C2)NC(=O)CC3=CC=NC=C3)N(C)C	N-[2-(dimethylamino)-4-methylquinolin-7-yl]-2-pyridin-4-ylacetamide	85830272	3.18542	320.16371126	4	1	4	58.12	3	0.801912965839993	2.18761447819816	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.80E-05	1.80E-05	0	0	0	0
231	deoxy_adenosylcobalamin	Target_lig_173	Riboswitch	-	Bacterial growth and infection	Target_70	0	0	3.00E-07	0	0	0	0	-	-	10.1016/S1074-5521(02)00224-7	12323379	Genetic control by a metabolite binding mRNA.	Nahvi A, Sudarsan N, Ebert MS, Zou X, Brown KL, Breaker RR	Chem Biol	9	1043	2002	-	20 nM	7.5	23	200mM NaCl	Equilibrium dialysis	SMMRNA	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[CH2-]C1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O.[Co+3]	2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate	3648667	2.17463	1578.65834037	27	12	27	584.23	4	0.030056279874545	8.75079122991079	109	GCCGGUCCUGUGAGUUAAUAGGGAAUCCAGUGCGAAUCUGGAGCUGACGCGCAGCGGUAAGGAAAGGUGCGAUGAUUGCGUUAUGCGGACACUGCCAUUCGGUGGGAAGUCAUCAUCUCUUAGUAUCUUAGAUACCCCUCCAAGCCCGAAGACCUGCCGGCCAACGUCGCAUCUGGUUCUCAUCAUCGCGUAAUAUUGAUGA	https://pubmed.ncbi.nlm.nih.gov/12323379/	Riboswitch	Riboswitch	202	-	-	0	0	0	0	3.00E-07	3.00E-07	0	0	0	0
232	Cethromycin	Target_lig_174	U2609_Ecoli_ribosome	Escherichia coli	Bacterial growth and infection	Target_99	0	0	1.30E-09	0	0	0	0	1NWX	-	10.1128/JB.183.23.6898-6907.2001	11698379	Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.	Garza-Ramos G, Xiong L, Zhong P, Mankin A	J Bacteriol	183	6898-907	2001	2-200 nM	23 pM	7.2	37	10 mM NH4Cl, 4 mM MgCl2, and 100 mM Kcl	RNA footprinting assay	SMMRNA	CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OCC=CC4=CC5=CC=CC=C5N=C4)C)C)NC(=O)O2)C	8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-9-(3-quinolin-3-ylprop-2-enoxy)-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone	4470571	5.1097	765.420045088	12	2	8	162.82	2	0.270366261541423	5.98419080233129	55	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	1.30E-09	1.30E-09	0	0	0	0
233	sisomicin	Target_lig_10	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	6.4e-06±2.7e-06	7.3e-07±2.4e-07	0	0	0	0	-	-	10.1038/nchembio.596	21706033	Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble.	Stelzer AC, Frank AT, Kratz JD, Swanson MD, Gonzalez-Hernandez MJ, Lee J, Andricioaei I, Markovitz DM, Al-Hashimi HM	Nat Chem Biol	7	553-9	2011	-	-	-	-	-	-	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	3.70E-06	9.10E-06	4.90E-07	9.70E-07	0	0	0	0
234	Amikacin	Target_lig_175	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	1.6199999999999997e-05±9.6e-06	1.5399999999999999e-06±2.9e-07	0	0	0	0	-	-	10.1038/nchembio.596	21706033	Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble.	Stelzer AC, Frank AT, Kratz JD, Swanson MD, Gonzalez-Hernandez MJ, Lee J, Andricioaei I, Markovitz DM, Al-Hashimi HM	Nat Chem Biol	7	553-9	2011	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	6.60E-06	2.58E-05	1.25E-06	1.83E-06	0	0	0	0
235	Acetylpromazine	Target_lig_176	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.00027	0	0	0	0	-	-	10.1021/ja0398870	15053636	NMR-based characterization of phenothiazines as a RNA binding scaffold.	Mayer M, James TL	J Am Chem Soc	126	4453-60	2004	-	-	-	-	-	-	SMMRNA	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	6077	4.4436	326.145284324	4	0	5	23.55	2	0.757792051694743	2.19866048303301	23	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.00027	0.00027	0	0	0	0
236	CMC1_dioxo-hexahydro-nitro-cyclopentaquinoxaline	Target_lig_177	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	1.3e-06±1e-07	0	0	0	-	-	10.1021/bi981308u	9760258	Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.	Mei HY, Cui M, Heldsinger A, Lemrow SM, Loo JA, Sannes-Lowery KA, Sharmeen L, Czarnik AW	Biochemistry	37	14204-12	1998	-	-	7.4	37	9mM MgCl2	Recombinant DNA technology and ELISA	SMMRNA	c12c(cc3c([nH]c(=O)c(=O)[nH]3)c2C[C@H](C1)c1[nH]nnn1)N(=O)O	-	-	0	0	0	0	0	0	0	0	0	0	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	1.20E-06	1.40E-06	0	0
237	CMC2_tetraaminoquinozaline	Target_lig_178	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	9.999999999999999e-06±1e-06	0	0	0	-	-	10.1021/bi981308u	9760258	Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.	Mei HY, Cui M, Heldsinger A, Lemrow SM, Loo JA, Sannes-Lowery KA, Sharmeen L, Czarnik AW	Biochemistry	37	14204-12	1998	-	-	7.4	37	9mM MgCl2	Recombinant DNA technology and ELISA	SMMRNA	Nc1nc(N)nc2C=C=C(N)[C@@H](N)c12	-	-	-0.8909	190.09669432	6	4	0	129.86	1	0.392445843079469	4.70723831248194	14	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	9.00E-06	1.10E-05	0	0
238	CMC3_Hoechst33258	Target_lig_179	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.00E-05	0	0	0	0	-	-	10.1021/bi981308u	9760258	Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.	Mei HY, Cui M, Heldsinger A, Lemrow SM, Loo JA, Sannes-Lowery KA, Sharmeen L, Czarnik AW	Biochemistry	37	14204-12	1998	-	-	7.4	37	9mM MgCl2	Recombinant DNA technology and ELISA	SMMRNA	CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC(=C(C(=C6)O)O)O	5-[6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazol-2-yl]benzene-1,2,3-triol	135507274	3.6418	456.190988628	7	5	3	124.53	5	0.262584823982756	2.70071217562553	34	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
239	CMC3-2_Hoechst33258	Target_lig_180	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.00E-05	0	0	0	0	-	-	10.1021/bi981308u	9760258	Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.	Mei HY, Cui M, Heldsinger A, Lemrow SM, Loo JA, Sannes-Lowery KA, Sharmeen L, Czarnik AW	Biochemistry	37	14204-12	1998	-	-	7.4	37	9mM MgCl2	Recombinant DNA technology and ELISA	SMMRNA	CN1CCN(CC1)C1=C=C=c2c(=C1)[nH]c(n2)C1=C=C=c2c(=C1)nc([nH]2)C1=C=C=C(C=C1)O	-	-	-0.845999999999997	418.154209196	5	3	3	84.07	2	0.566212763109292	5.67928416465453	32	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
240	Quinacridone	Target_lig_181	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.00E-06	0	0	0	0	-	-	10.1016/S1074-5521(02)00106-0	11880033	Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.	Lind KE, Du Z, Fujinaga K, Peterlin BM, James TL	Chem Biol	9	185-93	2002	-	-	-	-	-	-	SMMRNA	C1=CC=C2C(=C1)C(=O)C3=CC4=C(C=C3N2)C(=O)C5=CC=CC=C5N4	5,12-dihydroquinolino[2,3-b]acridine-7,14-dione	13976	3.676	312.089877624	2	2	0	65.72	5	0.428400761390138	2.1237862462939	24	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
241	Mitoxantrone	Target_lig_182	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	7.1e-07±3.2e-07	5.4999999999999996e-08±2.1e-08	0	0	0	0	-	-	10.1038/nchembio.596	21706033	Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble.	Stelzer AC, Frank AT, Kratz JD, Swanson MD, Gonzalez-Hernandez MJ, Lee J, Andricioaei I, Markovitz DM, Al-Hashimi HM	Nat Chem Biol	7	553-9	2011	-	-	-	-	-	-	SMMRNA	C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO	1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione	4212	-0.1392	444.200884616	10	8	12	163.18	2	0.139316778047515	2.81447110510123	32	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	3.90E-07	1.03E-06	3.40E-08	7.60E-08	0	0	0	0
242	Rbt203	Target_lig_183	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	2.00E-06	0	0	0	0	1UUD	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	SMMRNA	COC1=CC(=C(C=C1)OCCN=C(N)N)CNCCCCN=C(N)N	2-[2-[2-[[4-(diaminomethylideneamino)butylamino]methyl]-4-methoxyphenoxy]ethyl]guanidine	448945	-0.509399999999997	351.238273168	5	5	12	159.29	1	0.192511066913818	2.48548442298983	25	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
243	Rbt417	Target_lig_184	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.48E-07	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	SMMRNA	C1=CC=C2C(=C1)C=C(S2)C3=CC(=C(C=C3)OCCN=C(N)N)CNCCCCN=C(N)N	2-[2-[4-(1-benzothiophen-2-yl)-2-[[4-(diaminomethylideneamino)butylamino]methyl]phenoxy]ethyl]guanidine	516511	2.3637	453.231079612	5	5	12	150.06	3	0.161343210788234	2.70393264540597	32	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.48E-07	1.48E-07	0	0	0	0
244	Rbt418	Target_lig_185	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.61E-07	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	SMMRNA	C1=CC=C2C(=C1)C=C(O2)C3=CC(=C(C=C3)OCCN=C(N)N)CNCCCCN=C(N)N	2-[2-[4-(1-benzofuran-2-yl)-2-[[4-(diaminomethylideneamino)butylamino]methyl]phenoxy]ethyl]guanidine	516510	1.8952	437.253923232	5	5	12	163.2	3	0.163994098039968	2.66458398319861	32	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.61E-07	1.61E-07	0	0	0	0
245	Rbt428	Target_lig_186	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.25E-07	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	SMMRNA	C1=CC=C2C(=C1)C=C(S2)C3=CC(=C(C=C3)OCCCN)CNCCCCN=C(N)N	2-[4-[[2-(3-aminopropoxy)-5-(1-benzothiophen-2-yl)phenyl]methylamino]butyl]guanidine	516512	3.4391	425.224931612	5	4	12	111.68	3	0.201735181719116	2.52854405926339	30	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.25E-07	1.25E-07	0	0	0	0
246	Rbt550	Target_lig_187	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	5.00E-08	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	SMMRNA	C1CN(CCN1)CCNCC2=C(C=CC(=C2)C3=CC4=C(C=C3)NC=C4)OCCCN	3-[4-(1H-indol-5-yl)-2-[(2-piperazin-1-ylethylamino)methyl]phenoxy]propan-1-amine	448939	2.5573	407.268510676	5	4	10	78.34	3	0.388678028960903	2.52288008286784	30	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	5.00E-08	5.00E-08	0	0	0	0
247	Thiethylperazine	Target_lig_188	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	>0.00027	0	0	0	0	-	-	10.1021/ja0398870	15053636	NMR-based characterization of phenothiazines as a RNA binding scaffold.	Mayer M, James TL	J Am Chem Soc	126	4453-60	2004	-	-	-	-	-	-	SMMRNA	CCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C	2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine	5440	5.03880000000001	399.180289928	5	0	6	9.72	2	0.627821954333259	2.43261729582049	27	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.00027	0.00027	0	0	0	0
248	Trifluoperazine	Target_lig_189	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.00027	0	0	0	0	-	-	10.1021/ja0398870	15053636	NMR-based characterization of phenothiazines as a RNA binding scaffold.	Mayer M, James TL	J Am Chem Soc	126	4453-60	2004	-	-	-	-	-	-	SMMRNA	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F	10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine	5566	4.9456	407.164303428	4	0	4	9.72	2	0.709478258096045	2.35159927543189	28	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.00027	0.00027	0	0	0	0
249	Usnic acid	Target_lig_190	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.00E-06	0	0	0	0	-	-	10.1016/S1074-5521(02)00106-0	11880033	Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.	Lind KE, Du Z, Fujinaga K, Peterlin BM, James TL	Chem Biol	9	185-93	2002	-	-	-	-	-	-	SMMRNA	CC1=C(C(=C2C(=C1O)C3(C(=CC(=O)C(C3=O)C(=O)C)O2)C)C(=O)C)O	2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3-dione	5646	1.49982	344.089602852	7	2	2	117.97	1	0.616312686805643	4.24826480780032	25	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
250	Wm5	Target_lig_191	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.90E-08	0	0	0	0	-	-	10.1128/aac.47.3.889-896.2003	12604517	New anti-human immunodeficiency virus type 1 6-aminoquinolones: mechanism of action.	Parolin C, Gatto B, Vecchio CD, Pecere T, Tramontano E, Cecchetti V, Fravolini A, Masiero S, Palumbo M, Palù G	Antimicrob Agents Chemother	47	889-96	2003	-	-	7	25	20mM NaCl	Fluorescence spectroscopy	SMMRNA	CN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C4=CC=CC=N4)N)C(=O)O	6-amino-1-methyl-4-oxo-7-(4-pyridin-2-ylpiperazin-1-yl)quinoline-3-carboxylic acid	481127	1.5405	379.164439532	7	2	3	104.69	3	0.66523382216156	2.4080708358019	28	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.90E-08	1.90E-08	0	0	0	0
251	Xanthinol	Target_lig_192	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.00E-06	0	0	0	0	-	-	10.1016/S1074-5521(02)00106-0	11880033	Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.	Lind KE, Du Z, Fujinaga K, Peterlin BM, James TL	Chem Biol	9	185-93	2002	-	-	-	-	-	-	SMMRNA	CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CN(C)CCO)O	7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione	9913	-2.2813	311.159354152	9	2	6	105.52	2	0.622496811035115	3.10444572406439	22	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
252	Yohimbine	Target_lig_193	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.00E-06	0	0	0	0	-	-	10.1016/S1074-5521(02)00106-0	11880033	Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.	Lind KE, Du Z, Fujinaga K, Peterlin BM, James TL	Chem Biol	9	185-93	2002	-	-	-	-	-	-	SMMRNA	COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O	methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	2866	2.6471	354.194342692	4	2	1	65.56	2	0.772957405745492	3.87459645153332	26	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
253	netilmicin	Target_lig_194	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	1.4099999999999999e-05±8.3e-06	1.35e-06±3.5e-07	0	0	0	0	-	-	10.1038/nchembio.596	21706033	Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble.	Stelzer AC, Frank AT, Kratz JD, Swanson MD, Gonzalez-Hernandez MJ, Lee J, Andricioaei I, Markovitz DM, Al-Hashimi HM	Nat Chem Biol	7	553-9	2011	-	-	-	-	-	-	SMMRNA	CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N	2-[4-amino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	4460	-3.20069999999999	475.300598652	12	8	8	199.73	0	0.175035370530913	5.30603969377175	33	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	5.80E-06	2.24E-05	1.00E-06	1.70E-06	0	0	0	0
254	hydroxymethyl_piperidinyl_propyl_phenothiazinyl_ethanone	Target_lig_195	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.00018	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	c1c(ccc2Sc3ccccc3N(c12)CCCN1CCC[C@H](C1)CO)C(=O)C	-	-	4.58630000000001	396.187149136	5	1	6	43.78	2	0.723880522933596	2.81784223951365	28	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.00018	0.00018	0	0	0	0
255	methoxypiperidin_butyl_der	Target_lig_196	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.00014	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CO[C@H]1CCCN(C1)CCCCN1c2cc(ccc2Sc2c1cccc2)C(=O)C	-	-	5.38290000000001	410.2027992	5	0	7	32.78	2	0.451802764841982	2.86142513529773	29	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.00014	0.00014	0	0	0	0
256	dimethylamino_propyl_phenothiazinyl_ethanone	Target_lig_197	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.00027	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	6077	4.4436	326.145284324	4	0	5	23.55	2	0.757792051694743	2.19866048303301	23	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.00027	0.00027	0	0	0	0
257	3-(2-methoxy-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine	Target_lig_198	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1000 uM - 5000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC	3-(2-methoxyphenothiazin-10-yl)-N,N-dimethylpropan-1-amine	18847	4.2496	314.145284324	4	0	5	15.71	2	0.819247768443118	2.13184423630764	22	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.001	0.005	0	0	0	0
258	3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine	Target_lig_199	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	100 uM - 1000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl	3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine	2726	4.8944	318.095747288	3	0	4	6.48	2	0.791805341329135	2.1401928512014	21	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.0001	0.001	0	0	0	0
259	3-(3,7-dimethyl-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine	Target_lig_200	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.005	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CC=1C=CC=2N(C3=CC=C(C=C3SC2C1)C)CCCN(C)C	-	-	4.85784000000001	312.166019768	3	0	4	6.48	2	0.795978145343256	2.25555214130586	22	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.005	0.005	0	0	0	0
260	3-(4-methoxy-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine	Target_lig_201	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1000 uM - 5000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	COC1=CC=CC=2N(C3=CC=CC=C3SC12)CCCN(C)C	-	-	4.2496	314.145284324	4	0	5	15.71	2	0.819247768443118	2.30431676378016	22	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.001	0.005	0	0	0	0
261	dimethylamino_propyl_phenothiazin_der_2	Target_lig_202	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1000 uM - 5000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)O	10-[3-(dimethylamino)propyl]phenothiazin-2-ol	77525	3.9466	300.12963426	4	1	4	26.71	2	0.92476619619011	2.24347592812448	21	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.001	0.005	0	0	0	0
262	10-(3-(dimethylamino)propyl)-10H-phenothiazin-4-ol	Target_lig_203	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1000 uM - 5000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CN(CCCN1C2=CC=CC=C2SC=2C(=CC=CC12)O)C	-	-	3.9466	300.12963426	4	1	4	26.71	2	0.92476619619011	2.3972928512014	21	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.001	0.005	0	0	0	0
263	N,N-dimethyl-3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propan-1-amine	Target_lig_204	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	100 uM - 1000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F	N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine	5568	5.2598	352.122104268	3	0	4	6.48	2	0.741024745079045	2.28726104738841	24	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.0001	0.001	0	0	0	0
264	N,N-dimethyl-3-(3-methyl-10H-phenothiazin-10-yl)propan-1-amine	Target_lig_205	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1000 uM - 5000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CN(CCCN1C2=CC=CC=C2SC=2C=C(C=CC12)C)C	-	-	4.54942	298.150369704	3	0	4	6.48	2	0.817402822412871	2.14311208197063	21	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.001	0.005	0	0	0	0
265	N,N-dimethyl-3-(10H-phenothiazin-10-yl)propan-1-amine	Target_lig_206	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.005	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31	N,N-dimethyl-3-phenothiazin-10-ylpropan-1-amine	4926	4.241	284.13471964	3	0	4	6.48	2	0.828858048675116	2.02521499963547	20	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.005	0.005	0	0	0	0
266	[3-(2-chloro-10H-phenothiazin-10	Target_lig_207	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	100 uM - 1000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl	3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine	2726	4.8944	318.095747288	3	0	4	6.48	2	0.791805341329135	2.1401928512014	21	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.0001	0.001	0	0	0	0
267	hydroxymethyl_piperidinyl_propyl	Target_lig_195	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	100 uM - 1000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	c1c(ccc2Sc3ccccc3N(c12)CCCN1CCC[C@H](C1)CO)C(=O)C	-	-	4.58630000000001	396.187149136	5	1	6	43.78	2	0.723880522933596	2.81784223951365	28	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.0001	0.001	0	0	0	0
268	hydroxymethyl_piperidinyl_butyl	Target_lig_208	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	100 uM - 1000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	c1c(ccc2Sc3ccccc3N(c12)CCCCN1CCC[C@H](C1)CO)C(=O)C	-	-	4.97640000000001	410.2027992	5	1	7	43.78	2	0.515289350735087	2.83341304738564	29	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.0001	0.001	0	0	0	0
269	hydroxymethyl_piperidinyl_pentyl	Target_lig_209	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1000 uM - 5000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	c1c(ccc2Sc3ccccc3N(c12)CCCCCN1CCC[C@H](C1)CO)C(=O)C	-	-	5.36650000000001	424.218449264	5	1	8	43.78	2	0.456033188591812	2.85029381453288	30	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.001	0.005	0	0	0	0
270	3_phenothiazine_analog_1	Target_lig_210	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1000 uM - 5000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	c1c(ccc2Sc3ccccc3N(c12)CCCNCN(CO)CO)C(=O)C	-	-	2.6307	387.16166266	7	3	9	76.04	2	0.346866964488485	2.86808320459527	27	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.001	0.005	0	0	0	0
271	3_phenothiazine_analog_2	Target_lig_211	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.005	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	c1c(ccc2Sc3ccccc3N(c12)CCCN[C@H](CCSC)O)C(=O)C	-	-	4.5431	402.143570072	6	2	9	52.57	2	0.364750655892135	3.06826100078935	27	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.005	0.005	0	0	0	0
272	3_phenothiazine_analog_3	Target_lig_212	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	100 uM - 1000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	C1=CC=C2C(=C1)N(C3=C(S2)C=CC(=C3)Cl)CCCNCCO	2-[3-(2-chlorophenothiazin-10-yl)propylamino]ethanol	59122031	3.9147	334.090661908	4	2	6	35.5	2	0.784969906157474	2.24267047257137	22	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.0001	0.001	0	0	0	0
273	2-chloro-10-pyrrolidin_phenothiazine_der	Target_lig_213	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	100 uM - 1000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	c1cccc2Sc3ccc(cc3N(c12)CCCNCCCCC)Cl	-	-	6.1126	360.14269748	3	1	8	15.27	2	0.571258390562332	2.18296665014386	24	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.0001	0.001	0	0	0	0
274	2-chloro-10-methylpyrrolidin_phenothiazine_der	Target_lig_214	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.005	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	c1cccc2Sc3ccc(cc3N(c12)CCN1CCCC1)Cl	-	-	5.0385	330.095747288	3	0	3	6.48	2	0.778208184986988	2.12376596073705	22	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.005	0.005	0	0	0	0
275	2-chloro-10-[2-(2-methylpyrrolidin-1-yl)ethyl]_phenothiazine_der	Target_lig_215	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.005	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	c1cccc2Sc3ccc(cc3N(c12)CCN1CCC[C@@H]1C)Cl	-	-	5.427	344.111397352	3	0	3	6.48	2	0.732907762762687	2.71972435939262	23	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.005	0.005	0	0	0	0
276	chloro_piperidine_propyl_der	Target_lig_216	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	100 uM - 1000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	C1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	2-chloro-10-(3-piperidin-1-ylpropyl)phenothiazine	59122032	5.81870000000001	358.127047416	3	0	4	6.48	2	0.67958593611186	2.13721720268991	24	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.0001	0.001	0	0	0	0
277	chloro_methylpiperazinyl_propyl_phenothiazine_der	Target_lig_217	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1000 uM - 5000	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine	4917	4.5802	373.137946448	4	0	4	9.72	2	0.775124662295156	2.20663732679835	25	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.001	0.005	0	0	0	0
278	choro_imidazole_phenothiazine_der	Target_lig_218	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.005	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	c1cccc2Sc3ccc(cc3N(c12)CCn1cncc1)Cl	-	-	4.8394	327.059696128	4	0	3	21.06	3	0.686543752808915	2.34207294298557	22	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.005	0.005	0	0	0	0
279	benzyl_phenothiazin_der	Target_lig_219	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.005	0	0	0	0	-	-	10.1016/j.chembiol.2006.07.009	16984889	Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.	Mayer M, Lang PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL	Chem Biol	13	993-1000	2006	250-500 uM	25-50 uM	-	15	-	STD NMR experiments and differential line broadening of proton resonances	SMMRNA	C1=CC=C(C=C1)CNCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	N-benzyl-2-(2-chlorophenothiazin-10-yl)ethanamine	23593635	5.7325	366.095747288	3	1	5	15.27	3	0.580065059867591	2.05410466653007	25	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.005	0.005	0	0	0	0
280	Butirosin	Target_lig_220	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	1.38e-05±5.299999999999999e-06	4.78e-06±5.3e-07	0	0	0	0	-	-	10.1038/nchembio.596	21706033	Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble.	Stelzer AC, Frank AT, Kratz JD, Swanson MD, Gonzalez-Hernandez MJ, Lee J, Andricioaei I, Markovitz DM, Al-Hashimi HM	Nat Chem Biol	7	553-9	2011	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1NC(=O)C(CCN)O)O)OC2C(C(C(O2)CO)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	4-amino-N-[5-amino-4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-hydroxycyclohexyl]-2-hydroxybutanamide	2485	-7.78510000000001	555.275171752	16	12	10	311.71	0	0.118983994095138	5.19812698359593	38	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	8.50E-06	1.91E-05	4.25E-06	5.31E-06	0	0	0	0
281	N_N_dimethyl_amiloride	Target_lig_221	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0.000169±9.8e-05	0.00012185±5.065e-05	0	0	0	0	-	-	10.1038/nchembio.596	21706033	Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble.	Stelzer AC, Frank AT, Kratz JD, Swanson MD, Gonzalez-Hernandez MJ, Lee J, Andricioaei I, Markovitz DM, Al-Hashimi HM	Nat Chem Biol	7	553-9	2011	-	-	-	-	-	-	SMMRNA	CN(C)C1=NC(=C(N=C1Cl)C(=O)N=C(N)N)N	3-amino-6-chloro-N-(diaminomethylidene)-5-(dimethylamino)pyrazine-2-carboxamide	1793	-0.808199999999999	257.079185684	5	3	2	136.51	1	0.465437155389687	2.99750609233007	17	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	7.10E-05	0.000267	7.12E-05	0.0001725	0	0	0	0
282	Amikacin	Target_lig_175	A-site for Amikacin	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.05 uM - 0.06	0	0	0	0	4P20	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	5.00E-08	6.00E-08	0	0	0	0
283	Anisomycin	Target_lig_222	Ribosome (PTC)	Escherichia coli	Bacterial growth and infection	Target_99	0	0	1.00E-07	0	0	0	0	1K73	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=O)OC1C(CNC1CC2=CC=C(C=C2)OC)O	[4-hydroxy-2-[(4-methoxyphenyl)methyl]pyrrolidin-3-yl] acetate	2199	0.502099999999999	265.131408088	5	2	4	67.79	1	0.776086959605928	3.24414478057369	19	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
284	Azithromycin	Target_lig_223	Ribosome (PTC)	Escherichia coli	Bacterial growth and infection	Target_99	0	0	0.002 uM - 0.0056	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O	11-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one	2269	1.90070000000001	748.508525744	14	5	7	180.08	0	0.238475441191226	6.13284897579343	52	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	2.00E-09	5.60E-09	0	0	0	0
285	B-12	Target_lig_224	RNA hairpin loop	Synthetic	-	Target_120	0	0	2.50E-05	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@@H]1([C@H]([C@H](O)[C@H]([C@@H](C1)N)O)OCCCc1cn(nn1)Cc1cccc(Cn2cc(nn2)CCCO[C@H]2[C@@H](C[C@@H]([C@@H](O)[C@H]2O)N)N)c1)N	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.0391964179211	46	CGCGCGUGUGCGCG	http://www.smmrna.org/	Hairpin	-	14	-	Stem-Loop	0	0	0	0	2.50E-05	2.50E-05	0	0	0	0
286	Benzimidazole13ibis	Target_lig_225	HCV IRES Domain II	Hepatitis C virus	Hepatitis C	Target_66	0	0	7.20E-07	0	0	0	0	-	-	10.1021/jm050815o	16279767	SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.	Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ, Swayze EE, Griffey RH	J Med Chem	48	7099-102	2005	0.25-25 uM	2.5, 5 uM	-	-	100 mM ammonium acetate	Mass spectrometry screening	SMMRNA	c1c2OC[C@@H](Cc2c2c(c1)N=C1[C@H]2C[C@@H](CN1)CN(C)C)CN(C)C	-	-	2.0976	342.24196158	5	1	4	40.1	1	0.909648875567406	4.46144069329163	25	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	7.20E-07	7.20E-07	0	0	0	0
287	Benzimidazole3ibis	Target_lig_226	HCV IRES Domain II	Hepatitis C virus	Hepatitis C	Target_66	0	0	1.70E-05	0	0	0	0	-	-	10.1021/jm050815o	16279767	SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.	Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ, Swayze EE, Griffey RH	J Med Chem	48	7099-102	2005	0.25-25 uM	2.5, 5 uM	-	-	100 mM ammonium acetate	Mass spectrometry screening	SMMRNA	CN(C)CCCN1C2=C(C=CC(=C2)OCCCN(C)C)N=C1N	6-[3-(dimethylamino)propoxy]-1-[3-(dimethylamino)propyl]benzimidazol-2-amine	10471212	1.9007	319.237210548	6	1	9	59.55	2	0.715460264693856	2.3094330422046	23	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	1.70E-05	1.70E-05	0	0	0	0
288	biotin_molecule	Target_lig_227	Biotin aptamer	Synthetic	-	Target_33	0	0	5.703e-06±2e-07	0	0	0	0	1F27	-	10.1021/bi981371j	9772167	Functional requirements for specific ligand recognition by a biotin-binding RNA pseudoknot.	Wilson C, Nix J, Szostak J	Biochemistry	37	14410-9	1998	5 mM	-	-	Room temp.	-	Competitive elution gel assay	SMMRNA	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2	5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid	253	0.7968	244.088163372	3	3	5	78.43	0	0.493478115192196	3.64435461718705	16	GGAACACUAUCCGAUGGCACCGACCAUAGGCUCGGGUUGCCAGAGGUUCCACACUUUCAUCGAAAAGCCUAUGCUAGGCAAUGACAUGGACUCCUUGGUCAUUAGGAUCG	https://pubs.acs.org/doi/pdf/10.1021/bi981371j	RNA aptamer	-	110	-	Pseudoknot	0	0	0	0	5.50E-06	5.90E-06	0	0	0	0
289	Chloramphenicol	Target_lig_228	50S subunit	Escherichia coli	Bacterial growth and infection	Target_100	0	0	2.00E-06	0	0	0	0	-	-	10.1111/j.1432-1033.1977.tb11423.x	323016	Synergistic interaction of the streptogramins with the ribosome.	Contreras A, Vázquez D	Eur J Biochem	74	549-51	1977	0.16-3.4 uM	-	-	-	-	Chromatography	SMMRNA	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide	298	0.909	322.012326844	5	3	6	112.7	1	0.409070928047897	3.12962708276815	20	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
290	Streptogramin_B	Target_lig_229	50S subunit	Escherichia coli	Bacterial growth and infection	Target_100	0	0	5.90E-08	0	0	0	0	-	-	10.1111/j.1432-1033.1977.tb11423.x	323016	Synergistic interaction of the streptogramins with the ribosome.	Contreras A, Vázquez D	Eur J Biochem	74	549-51	1977	0.16-3.4 uM	-	-	-	-	Chromatography	SMMRNA	CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3CCC(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CC6=CC=C(C=C6)N(C)C)C	N-[(3S,6S,12R,15S,16R,19S,22S)-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide	11136668	1.27000000000001	866.396289928	12	4	7	227.96	3	0.24650832039913	5.53123088833318	63	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	5.90E-08	5.90E-08	0	0	0	0
291	Spectinomycin	Target_lig_75	Small subunit	Escherichia coli	Bacterial growth and infection	Target_101	0	0	2.60E-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O	8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one	2021	-2.9256	332.158351108	9	5	2	129.51	0	0.360820282325169	5.12987922706813	23	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	7OE1	Ribosomal	-	1543	-	-	0	0	0	0	2.60E-07	2.60E-07	0	0	0	0
292	Minocycline	Target_lig_230	Small subunit	Escherichia coli	Bacterial growth and infection	Target_101	0	0	1.00E-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C	4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	54687237	0.030000000000002	457.184900204	9	5	3	164.63	1	0.393816301697774	4.10221648906762	33	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	7OE1	Ribosomal	-	1543	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
293	Tigecycline_mol	Target_lig_231	Small subunit	Escherichia coli	Bacterial growth and infection	Target_101	0	0	1.00E-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C	9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	54681041	0.356600000000003	585.279863208	11	7	6	205.76	1	0.179169911251612	4.36160749664511	42	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	7OE1	Ribosomal	-	1543	-	-	0	0	0	0	1.00E-08	1.00E-08	0	0	0	0
294	Clarithromycin	Target_lig_232	PTC	Escherichia coli	Bacterial growth and infection	Target_99	0	0	6.20E-09	0	0	0	0	-	-	10.1128/aac.19.2.260	6751216	Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogs.	Högenauer G, Ruf C	Antimicrob Agents Chemother	19	260-5	1981	20 uM	4.8 uM	-	40	200 mM Ammonium chloride	Equilibrium dialysis	SMMRNA	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O	6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione	4663848	2.4397	747.476891268	14	4	8	182.91	0	0.265829428081599	6.11618166810112	52	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	6.20E-09	6.20E-09	0	0	0	0
295	Eryrthromycin	Target_lig_233	PTC	Escherichia coli	Bacterial growth and infection	Target_99	0	0	9.90E-07	0	0	0	0	-	-	10.1128/aac.19.2.260	6751216	Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogs.	Högenauer G, Ruf C	Antimicrob Agents Chemother	19	260-5	1981	20 uM	4.8 uM	-	40	200 mM Ammonium chloride	Equilibrium dialysis	SMMRNA	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione	3255	1.7856	733.461241204	14	5	7	193.91	0	0.237872505983735	6.08831082805574	51	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	9.90E-07	9.90E-07	0	0	0	0
296	Pristinamycin IIA	Target_lig_234	PTC	Escherichia coli	Bacterial growth and infection	Target_99	0	0	1.40E-07	0	0	0	0	-	-	10.1128/aac.19.2.260	6751216	Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogs.	Högenauer G, Ruf C	Antimicrob Agents Chemother	19	260-5	1981	20 uM	4.8 uM	-	40	200 mM Ammonium chloride	Equilibrium dialysis	SMMRNA	CC1C=CC(=O)NCC=CC(=CC(CC(=O)CC2=NC(=CO2)C(=O)N3CCC=C3C(=O)OC1C(C)C)O)C	21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone	5674	2.6594	525.24750046	8	2	1	139.04	1	0.533767667593495	5.99691109277322	38	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	1.40E-07	1.40E-07	0	0	0	0
297	Quinupristin	Target_lig_235	PTC	Escherichia coli	Bacterial growth and infection	Target_99	0	0	3.20E-07	0	0	0	0	-	-	10.1128/aac.19.2.260	6751216	Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogs.	Högenauer G, Ruf C	Antimicrob Agents Chemother	19	260-5	1981	20 uM	4.8 uM	-	40	200 mM Ammonium chloride	Equilibrium dialysis	SMMRNA	CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C	N-[25-(1-azabicyclo[2.2.2]octan-3-ylsulfanylmethyl)-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide	71338	2.32350000000001	1021.473160344	14	4	10	231.2	3	0.213901638924351	6.88618709143459	73	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	3.20E-07	3.20E-07	0	0	0	0
298	Tiamulin	Target_lig_236	PTC	Escherichia coli	Bacterial growth and infection	Target_99	0	0	1.49E-07	0	0	0	0	-	-	10.1128/aac.19.2.260	6751216	Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogs.	Högenauer G, Ruf C	Antimicrob Agents Chemother	19	260-5	1981	20 uM	4.8 uM	-	40	200 mM Ammonium chloride	Equilibrium dialysis	SMMRNA	CCN(CC)CCSCC(=O)OC1CC(C(C(C23CCC(C1(C2C(=O)CC3)C)C)C)O)(C)C=C	(4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl) 2-[2-(diethylamino)ethylsulfanyl]acetate	4517617	4.96790000000001	493.322579984	6	1	9	66.84	0	0.277945511326359	5.51137155517158	34	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	1.49E-07	1.49E-07	0	0	0	0
299	Valnemulin	Target_lig_237	PTC	Escherichia coli	Bacterial growth and infection	Target_99	0	0	5.00E-12	0	0	0	0	-	-	10.1128/aac.19.2.260	6751216	Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogs.	Högenauer G, Ruf C	Antimicrob Agents Chemother	19	260-5	1981	20 uM	4.8 uM	-	40	200 mM Ammonium chloride	Equilibrium dialysis	SMMRNA	CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC(C)(C)CNC(=O)C(C(C)C)N)C	(4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl) 2-[1-[(2-amino-3-methylbutanoyl)amino]-2-methylpropan-2-yl]sulfanylacetate	21706784	4.5042	564.359693764	7	3	9	118.72	0	0.27860165101001	5.84151584191295	39	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	5.00E-12	5.00E-12	0	0	0	0
300	CMC3-1_Hoechst33258	Target_lig_238	tRNA	Saccharomyces cereviseae	-	Target_1	0	0	1.48e-05±9e-07	0	0	0	0	-	-	10.1039/A608106A	-	Unique binding site for bis-benzimidazoles on transfer RNA	Ebrahimi SES, Wilton AN, Douglas KT	ChemComm	4	385-386	1997	-	-	7.8	25	0.1 m sodium phosphate buffer	Fluorescence quenching	SMMRNA	CN1CCN(CC1)C1=C=C=c2c(=C1)[nH]c(n2)C1=C=C=c2c(=C1)nc([nH]2)C1=C=C(C(=C=C1)OC)OC	-	-	-0.783499999999997	462.180423944	6	2	5	82.3	2	0.567662760905767	5.69251406278933	35	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	1.39E-05	1.57E-05	0	0	0	0
301	Delfinidin	Target_lig_239	tRNA	Saccharomyces cereviseae	-	Target_1	(9.47±0.70)x1E4	0	0	0	0	0	0	-	-	10.1007/s12013-007-0037-2	17873337	An overview of DNA and RNA bindings to antioxidant flavonoids.	Kanakis CD, Tarantilis PA, Polissiou MG, Diamantoglou S, Tajmir-Riahi HA	Cell Biochem Biophys	49	29-36	2007	0.005 - 0.3 mM	0.25 mM	7.3	5	Tris/Hcl buffer	FTIR spectroscopy	SMMRNA	C1=C(C=C(C(=C1O)[O-])O)C2=C(C=C3C(=CC(=O)C=C3O2)O)O	4-(3,5-dihydroxy-7-oxochromen-2-yl)-2,6-dihydroxyphenolate	25203213	1.3076	301.03537620791	7	4	1	134.19	1	0.531904073861187	3.50591104949445	22	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	87700	101700	0	0	0	0	0	0	0	0
302	Protoporphyrin IX	Target_lig_240	tRNA	Saccharomyces cereviseae	-	Target_1	0	0	1.3800000000000002e-07±1.7e-08	0	0	0	0	-	-	10.1016/j.bbaexp.2005.06.003	16005529	Porphyrins and porphines bind strongly and specifically to tRNA, precursor tRNA and to M1 RNA and inhibit the ribonuclease P ribozyme reaction.	Hori Y, Rogert MC, Tanaka T, Kikuchi Y, Bichenkova EV, Wilton AN, Gbaj A, Douglas KT	Biochim Biophys Acta	1730	47-55	2005	10 nM	-	7.6	20	100mM NH4Cl, 60 mM MgCl2	Fluorescence emission spectrum	SMMRNA	CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C=C	3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid	4971	7.80864000000001	562.258005568	4	4	8	131.96	3	0.221357118080438	5.52452355148132	42	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	1.21E-07	1.55E-07	0	0	0	0
303	Kirromycin	Target_lig_241	tRNA	Saccharomyces cereviseae	-	Target_1	0	0	4.00E-09	0	0	0	0	-	-	10.1038/nsmb831	15448679	tRNA selection and kinetic proofreading in translation.	Blanchard SC, Gonzalez RL, Kim HD, Chu S, Puglisi JD	Nat Struct Mol Biol	11	1008-14	2004	-	7.5 nM	7.5	25	100 mM KCl, 5 mM NH4OAc, 0.5 mM Ca(OAc)2, 15 mM Mg(OAc)2	FRET	SMMRNA	CCC(C(=O)NCC=CC=C(C)C(C(C)C1C(C(C(O1)C=CC=CC=C(C)C(=O)C2=C(C=CNC2=O)O)O)O)OC)C3(C(C(C(C(O3)C=CC=CC)(C)C)O)O)O	N-[7-[3,4-dihydroxy-5-[7-(4-hydroxy-2-oxo-1H-pyridin-3-yl)-6-methyl-7-oxohepta-1,3,5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]-2-(2,3,4-trihydroxy-5,5-dimethyl-6-penta-1,3-dienyloxan-2-yl)butanamide	135452736	3.0748	796.41462536	12	8	17	228.1	1	0.064687130384566	6.34120505301918	57	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	4.00E-09	4.00E-09	0	0	0	0
304	CMC4_Hoechst33258	Target_lig_242	Yeast tRNA	Saccharomyces cereviseae	-	Target_1	0	0	0.598 uM - 0.044	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=CC(=CC=C1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)N=C(N5)C6=CC=C(C=C6)O)O	4-[6-[2-(4-hydroxyphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazol-2-yl]phenol	449494	5.85140000000001	418.142975816	4	4	3	97.82	6	0.289661655068449	2.22706600988456	32	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	5.98E-07	4.40E-08	0	0	0	0
305	CMC6_diphenylfuran	Target_lig_243	HIV-1 RRE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	5.00E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(C)N=C(C1=CC=CC(=C1)C2=CC=C(O2)C3=CC(=CC=C3)C(=NC(C)C)N)N	N'-propan-2-yl-3-[5-[3-(N'-propan-2-ylcarbamimidoyl)phenyl]furan-2-yl]benzenecarboximidamide	460176	4.841	388.226311516	3	2	6	89.9	3	0.467479900039455	2.67171962237593	29	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	5.00E-06	5.00E-06	0	0	0	0
306	CMC7_diphenylfuran	Target_lig_244	HIV-1 RRE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	1.00E-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN(C)CCN=C(C1=CC=CC(=C1)C2=CC=C(O2)C3=CC(=CC=C3)C(=NCCN(C)C)N)N	N'-[2-(dimethylamino)ethyl]-3-[5-[3-[N'-[2-(dimethylamino)ethyl]carbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide	485808	3.1474	446.279409708	5	2	10	96.38	3	0.368385220515765	2.83430903547256	33	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
307	CMC8_diphenylfuran	Target_lig_245	HIV-1 RRE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	1.60E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN(C)CCCN=C(C1=CC=CC(=C1)C2=CC=C(O2)C3=CC(=CC=C3)C(=NCCCN(C)C)N)N	N'-[3-(dimethylamino)propyl]-3-[5-[3-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide	485809	3.9276	474.310709836	5	2	12	96.38	3	0.235550990585172	2.81837000684527	35	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	1.60E-06	1.60E-06	0	0	0	0
308	DB340	Target_lig_246	HIV-1 RRE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	1.1×1E7	0	0	0	0	0	0	-	-	10.1021/bi002338b	11170440	A heterocyclic inhibitor of the REV-RRE complex binds to RRE as a dimer.	Li K, Davis TM, Bailly C, Kumar A, Boykin DW, Wilson WD	Biochemistry	40	1150-8	2001	25 nM - 10 uM	100 uM	7	5	10 mM sodium phosphate, 0.1 mM NaCl	Fluorescence spectroscopy and SPR	SMMRNA	CN(C)CCCN=C(C1=CC=C(C=C1)C2=CC=C(O2)C3=NC4=C(N3)C=C(C=C4)C(=NCCCN(C)C)N)N	N'-[3-(dimethylamino)propyl]-2-[5-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]furan-2-yl]-3H-benzimidazole-5-carboximidamide	460172	3.8039	514.316857836	6	3	12	125.06	4	0.15000822757931	2.99943212073298	38	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	11000000	11000000	0	0	0	0	0	0	0	0
309	Ethidium bromide	Target_lig_6	Bulge_A_RNA	Synthetic	-	Target_121	0	0	3.30E-06	0	0	0	0	-	-	10.1093/nar/15.10.4049	2438651	Single base bulges in small RNA hairpins enhance ethidium binding and promote an allosteric transition.	White SA, Draper DE	Nucleic Acids Res	15	4049-64	1987	1 uM	10-8 - 10-9 M	7.6	37	0.1 M NaCl	Photocleavage and gel autoradiogram	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	GGGUCUCGAGUUUUCGAAGACCC	http://www.smmrna.org/	Bulge	-	23	-	Stem-Loop with Bulge	0	0	0	0	3.30E-06	3.30E-06	0	0	0	0
310	Evernimicin	Target_lig_247	Bacterial 23S rRNA hairpins 82 and 91	Escherichia coli	Bacterial growth and infection	Target_102	0	0	10 uM - 50	0	0	0	0	-	-	10.1073/pnas.071527498	11259679	A novel site of antibiotic action in the ribosome: interaction of evernimicin with the large ribosomal subunit.	Belova L, Tenson T, Xiong L, McNicholas PM, Mankin AS	Proc Natl Acad Sci U S A	98	3726-31	2001	10, 50 uM	200 nM	7.2	37	80 mM potassium cacodylate, 20 mM MgCl2/100 mM NH4Cl	Footprinting assay	SMMRNA	CC1C(C(CC(O1)OC2C(OC3(CC2O)OC4C(OC(C(C4(O3)C)O)OC5C(C(OC(C5OC)C)OC6C(OC(C(C6O)OC)OC7C(C8C(CO7)OC9(O8)C1C(C(CO9)OC(=O)C2=C(C=C(C=C2C)O)O)OCO1)O)COC)O)C)C)OC1CC(C(C(O1)C)OC)(C)[N+](=O)[O-])OC(=O)C1=C(C(=C(C(=C1OC)Cl)O)Cl)C	[6-[6-[2-[6-[7-(2,4-dihydroxy-6-methylbenzoyl)oxy-7'-hydroxyspiro[3a,6,7,7a-tetrahydro-[1,3]dioxolo[4,5-c]pyran-4,2'-4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran]-6'-yl]oxy-4-hydroxy-5-methoxy-2-(methoxymethyl)oxan-3-yl]oxy-3-hydroxy-5-methoxy-6-methyloxan-4-yl]oxy-4',7-dihydroxy-2',4,7a-trimethylspiro[3a,4,6,7-tetrahydro-[1,3]dioxolo[4,5-c]pyran-2,6'-oxane]-3'-yl]oxy-4-(5-methoxy-4,6-dimethyl-4-nitrooxan-2-yl)oxy-2-methyloxan-3-yl] 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate	22563662	1.26214000000001	1629.506563024	38	8	21	479.1	2	0.049532072531575	8.30707001920609	111	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCAUCCCGACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACUGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACUAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGCAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCUU	https://www.rcsb.org/structure/3J9Z	Ribosomal, Hairpin	-	2904	-	Stem-Loop	0	0	0	0	1.00E-05	5.00E-05	0	0	0	0
311	FMN	Target_lig_68	FMN aptamer	Synthetic	-	Target_34	0	0	5.00E-09	0	0	0	0	1FMN	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)O)O)O)O	[5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate	710	-1.60656	456.104614882	10	6	7	208.09	1	0.176020349335941	4.02831596221591	31	GGCGUGUAGGAUAUGCUUCGGCAGAAGGACACGCC	http://www.smmrna.org/	RNA aptamer	-	35	-	Stem-Loop	0	0	0	0	5.00E-09	5.00E-09	0	0	0	0
312	Geneticin	Target_lig_140	Eubacterial A-site _sec str of A-site from E.coli 16S rRNA	Escherichia coli	Bacterial growth and infection	Target_3	0	0.5	0	0	0	0	0	1MWL	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O	2-[4,6-diamino-3-[3-amino-4,5-dihydroxy-6-(1-hydroxyethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	354578	-5.613	496.27444348	14	10	6	248.39	0	0.164623849535594	5.36827337610045	34	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0.5	0.5	0	0	0	0	0	0
313	Paromomycin_mol_mol	Target_lig_1116	Bacterial A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.20E-05	0	0	0	0	1J7T	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.20E-05	1.20E-05	0	0	0	0
314	gentamicin_mol_c1a	Target_lig_76	Bacterial A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.70E-06	0	0	0	0	2ET3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.70E-06	1.70E-06	0	0	0	0
315	Adenine	Target_lig_165	Guanine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	4.69E-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=NC2=NC=NC(=C2N1)N	7H-purin-6-amine	190	-0.0649	135.05449516	4	2	0	80.48	2	0.529675929378058	2.66020570619806	10	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	4.69E-07	4.69E-07	0	0	0	0
316	Hypoxanthine	Target_lig_162	Guanine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	5.00E-08	0	0	0	0	4FE5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=NC2=C(N1)C(=O)N=CN2	3,7-dihydropurin-6-one	790	-0.3538	136.038510748	3	2	0	74.43	2	0.519236856563892	2.99952241707339	10	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	5.00E-08	5.00E-08	0	0	0	0
317	GUANINE	Target_lig_248	Guanine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	5.00E-09	0	0	0	0	6UBU	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=NC2=C(N1)C(=O)NC(=N2)N	2-amino-1,7-dihydropurin-6-one	135398634	-0.7716	151.04940978	4	3	0	100.45	2	0.459751267779177	2.92465591942378	11	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	5.00E-09	5.00E-09	0	0	0	0
318	2,4-diaminopurine	Target_lig_169	Guanine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	1.70E-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=NC(=NC2(C1=NC=N2)N)N	purine-2,4-diamine	18410141	-1.5191	150.065394192	6	2	0	101.48	0	0.437744580227719	5.22227908959872	11	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	1.70E-08	1.70E-08	0	0	0	0
319	2-AMINO-N6-HYDROXYADENINE	Target_lig_249	Guanine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	2.00E-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=NC2=C(N1)C(=NC(=N2)N)NO	N-(2-amino-7H-purin-6-yl)hydroxylamine	101513	-0.2638	166.060308812	6	4	1	112.74	2	0.433798094830407	3.03256192339879	12	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	2.00E-08	2.00E-08	0	0	0	0
320	2,5,6-TRIAMINO-PYRIMIDINE-4-ONE	Target_lig_250	Guanine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	1.00E-07	0	0	0	0	-	-	10.1371/journal.ppat.1000865	20421948	Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways.	Mulhbacher J, Brouillette E, Allard M, Fortier LC, Malouin F, Lafontaine DA	PLoS Pathog	6	e1000865	2010	1-10 uM	-	8.5	25	20 mM MgCl2 and 100 mM KCl	In-line probing assays	SMMRNA	C1(=C(N=C(NC1=O)N)N)N	2,4,5-triamino-1H-pyrimidin-6-one	135406869	-1.4835	141.065059844	5	4	0	123.81	1	0.350338786569491	2.98342617140924	10	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
321	Tobramycin	Target_lig_540	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.08 uM - 0.12	0	0	0	0	1LC4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	8.00E-08	1.20E-07	0	0	0	0
322	Kanamycin A	Target_lig_7	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.1 uM - 0.15	0	0	0	0	2ESI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-07	1.50E-07	0	0	0	0
323	ribostamycin	Target_lig_9	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.70E-06	0	0	0	0	2ET5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	5066	-6.6523	454.227493288	14	10	6	262.38	0	0.178778081939411	4.96778075738293	31	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.70E-06	1.70E-06	0	0	0	0
324	Lividomycin A	Target_lig_1247	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.80E-08	0	0	0	0	2ESJ	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(CC(C(O2)CO)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)OC5C(C(C(C(O5)CO)O)O)O)O)N)O)O)N	2-[5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-4-hydroxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	3940	-10.0083	761.35420992	23	15	12	406.24	0	0.087736447103846	5.92634264032295	52	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.80E-08	2.80E-08	0	0	0	0
325	Phenyl ether paromomycin derivative 1	Target_lig_251	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.80E-06	0	0	0	0	3S4P	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	[C@@H]1([C@H]([C@@H]([C@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@H]([C@H]([C@@H]1OCCc1ccccc1)O[C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)N)O)O)N)CO)N)O)O	-	-	-6.63720000000001	705.343251312	19	12	12	336.32	1	0.096104825191663	5.63260898282166	49	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.80E-06	3.80E-06	0	0	0	0
326	Aminoglycoside derivative 1	Target_lig_252	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@@H]1CO)O[C@H]1[C@@H]([C@@H]([C@@H](C[C@@H]1N)N)O)O[C@@H]1OC[C@@H]([C@H]1OCCNc1cnccc1)O[C@@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-5.66200000000001	689.359570072	19	11	13	320.78	1	0.085959622039993	5.70824222681789	48	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.00E-07	6.00E-07	0	0	0	0
327	Aminoglycoside derivative 2	Target_lig_253	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	9.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@@H]([C@@H](O[C@H]1CO)O[C@@H]1[C@H]([C@@H]([C@H](C[C@H]1N)N)O)O[C@H]1OC[C@@H]([C@@H]1OCCNCc1ncccc1)O[C@@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-5.98430000000001	703.375220136	19	11	14	320.78	1	0.080329096002063	5.69968651320387	49	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	9.00E-07	9.00E-07	0	0	0	0
328	Aminoglycoside derivative 3	Target_lig_254	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	4.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@@H]([C@H]([C@@H](O[C@H]1CO)O[C@H]1[C@@H]([C@@H]([C@H](C[C@@H]1N)N)O)O[C@@H]1OC[C@H]([C@@H]1OCCNCCCN)O[C@H]1[C@@H]([C@H](C[C@H](O1)CN)O)N)N)O)O	-	-	-7.23070000000002	669.3908702	19	12	15	333.91	0	0.07202164951772	5.73891751604941	46	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	4.00E-07	4.00E-07	0	0	0	0
329	Aminoglycoside derivative 4	Target_lig_255	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	7.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@@H]1CO)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@@H]1OC[C@@H]([C@H]1OCCNCCN)O[C@@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-7.62080000000002	655.375220136	19	12	14	333.91	0	0.077271955168213	5.74441027146949	45	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	7.00E-07	7.00E-07	0	0	0	0
330	Aminoglycoside derivative 6	Target_lig_256	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@@H]([C@H](C[C@@H]1N)N)O)O[C@H]1OC[C@H]([C@@H]1OCCN)O[C@H]1[C@@H]([C@H](C[C@H](O1)CN)O)N)N)O)O	-	-	-7.21040000000002	612.333020976	18	11	11	321.88	0	0.103133084478588	5.70415182273031	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.00E-07	3.00E-07	0	0	0	0
331	Aminoglycoside derivative 7	Target_lig_257	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	9.20E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@@H](O[C@H]1CO)O[C@@H]1[C@@H]([C@@H]([C@H](C[C@H]1N)N)O)O[C@@H]1OC[C@@H]([C@H]1OCCNCCNCCN)O[C@@H]1[C@@H]([C@H](C[C@H](O1)CN)O)N)N)O)O	-	-	-8.03120000000003	698.417419296	20	13	17	345.94	0	0.062700211345703	5.80534815812147	48	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	9.20E-06	9.20E-06	0	0	0	0
332	Aminoglycoside derivative 8	Target_lig_258	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.30E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@@H]([C@H](C[C@H]1N)N)O)O[C@@H]1OC[C@H]([C@@H]1OCCNCCN1CCNCC1)O[C@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-7.67430000000003	724.43306936	20	12	15	323.16	0	0.069780609701508	5.80185341484061	50	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.30E-06	1.30E-06	0	0	0	0
333	Aminoglycoside derivative 9	Target_lig_259	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CO)O[C@H]1[C@@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@@H]1OC[C@H]([C@H]1OCCNC1CCNCC1)O[C@H]1[C@@H]([C@H](C[C@H](O1)CN)O)N)N)O)O	-	-	-6.82750000000002	695.406520264	19	12	13	319.92	0	0.079646050891113	5.80168826585349	48	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
334	Aminoglycoside derivative 10	Target_lig_260	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@H]([C@@H]([C@H](O[C@@H]1CO)O[C@H]1[C@@H]([C@@H]([C@H](C[C@@H]1N)N)O)O[C@H]1OC[C@H]([C@@H]1OCCNC[C@H]1CNCCC1)O[C@@H]1[C@@H]([C@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-6.57990000000002	709.422170328	19	12	14	319.92	0	0.074586270642862	5.86195039998934	49	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.00E-07	3.00E-07	0	0	0	0
335	Aminoglycoside derivative 12	Target_lig_261	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@@H]1OC[C@@H]([C@H]1OCCNc1ccnc2c1cccc2)O[C@@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-4.5088	739.375220136	19	11	13	320.78	2	0.086230689329786	5.71198894900184	52	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
336	Aminoglycoside derivative 13	Target_lig_262	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CO)O[C@@H]1[C@H]([C@@H]([C@H](C[C@H]1N)N)O)O[C@H]1OC[C@H]([C@@H]1OCCNC1CCCCC1)O[C@H]1[C@@H]([C@H](C[C@H](O1)CN)O)N)N)O)O	-	-	-5.24680000000001	694.411271296	18	11	13	307.89	0	0.080239691056273	5.70070330603718	48	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
337	Aminoglycoside derivative 14	Target_lig_263	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@@H]([C@@H](C[C@@H]1N)N)O)O[C@H]1OC[C@@H]([C@H]1OCCNCCc1cnccc1)O[C@@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-5.94180000000001	717.3908702	19	11	15	320.78	1	0.075232470017945	5.72051418407138	50	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.00E-07	2.00E-07	0	0	0	0
338	Aminoglycoside derivative 15	Target_lig_264	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CO)O[C@H]1[C@@H]([C@@H]([C@@H](C[C@H]1N)N)O)O[C@H]1OC[C@@H]([C@H]1OCCNCCc1ccccc1)O[C@@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-5.33680000000001	716.395621232	18	11	15	307.89	1	0.075509224932721	5.6228177005549	50	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
339	Aminoglycoside derivative 16	Target_lig_265	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@@H]([C@H]([C@@H](O[C@H]1CO)O[C@H]1[C@@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@@H]1OC[C@@H]([C@H]1OCCNCc1ccccc1)O[C@@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-5.37930000000001	702.379971168	18	11	14	307.89	1	0.080619926649718	5.59909976418646	49	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
340	Aminoglycoside derivative 17	Target_lig_266	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@@H](O[C@H]1CO)O[C@H]1[C@@H]([C@@H]([C@H](C[C@H]1N)N)O)O[C@@H]1OC[C@H]([C@H]1OCCNc1cccc(c1)O)O[C@@H]1[C@@H]([C@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-5.3514	704.359235724	19	12	13	328.12	1	0.085264826532801	5.70456005169843	49	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.00E-07	6.00E-07	0	0	0	0
341	Aminoglycoside derivative 18	Target_lig_267	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@@H]([C@H]([C@H](C[C@@H]1N)N)O)O[C@@H]1OC[C@H]([C@H]1OCCNCc1cnc(cc1)N)O[C@@H]1[C@@H]([C@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-6.40210000000002	718.386119168	20	12	14	346.8	1	0.079550022678968	5.77055390657909	50	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
342	Aminoglycoside derivative 19	Target_lig_268	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.00E-08	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H]([C@@H](C[C@H]1N)N)O)O[C@H]1OC[C@@H]([C@H]1OCCNCc1ccnc(c1)N)O[C@H]1[C@H]([C@@H](C[C@H](O1)CN)O)N)N)O)O	-	-	-6.40210000000002	718.386119168	20	12	14	346.8	1	0.079550022678968	5.78472778593714	50	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.00E-08	2.00E-08	0	0	0	0
343	Aminoglycoside derivative 20	Target_lig_269	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	5.00E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@@H](O[C@H]1CO)O[C@@H]1[C@H]([C@@H]([C@H](C[C@@H]1N)N)O)O[C@H]1OC[C@@H]([C@@H]1OCCNc1ncccc1)O[C@@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-5.66200000000001	689.359570072	19	11	13	320.78	1	0.085959622039993	5.6948879214218	48	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	5.00E-06	5.00E-06	0	0	0	0
344	Aminoglycoside derivative 21	Target_lig_270	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.50E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@H]1CO)O[C@H]1[C@@H]([C@H]([C@@H](C[C@H]1N)N)O)O[C@@H]1OC[C@@H]([C@H]1OCCNCCC(C)(C)C)O[C@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-5.14330000000001	696.42692136	18	11	14	307.89	0	0.07565133956869	5.7923052131195	48	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.50E-06	2.50E-06	0	0	0	0
345	Aminoglycoside derivative 22	Target_lig_271	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.00E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CO)O[C@@H]1[C@H]([C@H]([C@@H](C[C@H]1N)N)O)O[C@H]1OC[C@H]([C@@H]1OCCNCCCc1ccccc1)O[C@@H]1[C@@H]([C@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-4.94670000000001	730.411271296	18	11	16	307.89	1	0.070995254269188	5.63982536173698	51	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
346	Aminoglycoside derivative 24	Target_lig_272	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	7.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@@H](O[C@H]1CO)O[C@@H]1[C@H]([C@@H]([C@@H](C[C@H]1N)N)O)O[C@H]1OC[C@@H]([C@H]1OCCNCCCCc1ccccc1)O[C@H]1[C@@H]([C@H](C[C@H](O1)CN)O)N)N)O)O	-	-	-4.55660000000001	744.42692136	18	11	17	307.89	1	0.066925634250462	5.65114079304821	52	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	7.00E-07	7.00E-07	0	0	0	0
347	Aminoglycoside derivative 25	Target_lig_273	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	9.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CO)O[C@@H]1[C@H]([C@H]([C@@H](C[C@H]1N)N)O)O[C@@H]1OC[C@@H]([C@@H]1OCCNCCc1ccc(cc1)c1ccccc1)O[C@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	-	-	-3.6698	792.42692136	18	11	16	307.89	2	0.07299359174674	5.65684547815925	56	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	9.00E-07	9.00E-07	0	0	0	0
348	Aminoglycoside derivative 33	Target_lig_274	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	7.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CO)O[C@H]1[C@@H]([C@@H]([C@H](C[C@H]1N)N)O)O[C@@H]1OC[C@@H]([C@H]1OCCN)O[C@@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)NCCc1cc2c(cc1)cccc2)N)O)O	-	-	-4.18360000000001	766.411271296	18	11	15	307.89	2	0.081910266378424	5.73370925396758	54	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	7.00E-07	7.00E-07	0	0	0	0
349	Perazidoparomomycin derivative 1	Target_lig_275	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@H]([C@H]([C@@H](O[C@H]1CN(C)C)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@@H]([C@@H]1O)O[C@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-7.57720000000001	627.332686628	18	11	10	304.31	0	0.107094431196466	5.59824829524757	43	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.00E-07	6.00E-07	0	0	0	0
350	Perazidoparomomycin derivative 2	Target_lig_276	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.60E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@H]([C@H]([C@H](O[C@@H]1CNCCCN)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-8.20040000000002	656.359235724	19	13	13	339.12	0	0.081805790935864	5.64026801890309	45	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.60E-06	1.60E-06	0	0	0	0
351	Perazidoparomomycin derivative 3	Target_lig_277	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.60E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@H]1CCN1CCOCC1)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-7.41650000000002	683.358901376	19	11	11	313.54	0	0.096310792301451	5.60474318786277	47	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.60E-06	3.60E-06	0	0	0	0
352	Perazidoparomomycin derivative 4	Target_lig_278	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.00E-08	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@H]([C@H]([C@H](O[C@H]1CNNC(=O)OC(C)(C)C)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-7.10950000000001	714.364715028	20	13	11	351.43	0	0.088387180949588	5.77021329876939	49	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-08	1.00E-08	0	0	0	0
353	Perazidoparomomycin derivative 5	Target_lig_279	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	4.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@H](O[C@H]1CNC)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-7.91940000000002	613.317036564	18	12	10	313.1	0	0.108761001924381	5.59125589946898	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	4.00E-07	4.00E-07	0	0	0	0
354	Perazidoparomomycin derivative 6	Target_lig_280	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.30E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@H]([C@H]([C@H](O[C@@H]1CNCCCCN)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-7.81030000000002	670.374885788	19	13	14	339.12	0	0.076279366823402	5.63662745771109	46	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.30E-06	6.30E-06	0	0	0	0
355	Perazidoparomomycin derivative 8	Target_lig_281	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.20E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@@H]([C@H]([C@H](O[C@@H]1CNCC(C)C)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-6.89320000000001	655.363986756	18	12	12	313.1	0	0.092890444764436	5.61716227043324	45	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.20E-06	1.20E-06	0	0	0	0
356	Perazidoparomomycin derivative 9	Target_lig_282	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@H]1CNN)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-8.67550000000002	614.312285532	19	13	10	339.12	0	0.080155069346729	5.68797249865926	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.00E-07	6.00E-07	0	0	0	0
357	Perazidoparomomycin derivative 10	Target_lig_283	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	5.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@H](O[C@@H]1CNCCc1ccccc1)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@@H]([C@@H]1O)O[C@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-6.30650000000001	703.363986756	18	12	13	313.1	1	0.085014935087397	5.5254542387118	49	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	5.00E-07	5.00E-07	0	0	0	0
358	Perazidoparomomycin derivative 11	Target_lig_284	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.20E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@H]1CN(CCc1ccccc1)C)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@@H]([C@H]1O)O[C@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-5.96430000000001	717.37963682	18	11	13	304.31	1	0.09048324016888	5.5647756106227	50	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.20E-06	2.20E-06	0	0	0	0
359	Perazidoparomomycin derivative 12	Target_lig_285	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.40E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@H]([C@@H]([C@H](O[C@@H]1CNCCCc1ccccc1)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-5.91640000000001	717.37963682	18	12	14	313.1	1	0.079727067711873	5.54387914278025	50	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.40E-06	1.40E-06	0	0	0	0
360	Perazidoparomomycin derivative 13	Target_lig_286	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	4.80E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@H](O[C@@H]1CNCCc1ccc(cc1)C1CCCCC1)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@@H]([C@@H]1O)O[C@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-4.2588	785.442237076	18	12	14	313.1	1	0.079491403408778	5.67174865196197	55	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	4.80E-06	4.80E-06	0	0	0	0
361	Perazidoparomomycin derivative 14	Target_lig_287	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	8.00E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@H]1CNCCc1c(cccc1)OC)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-6.29790000000001	733.37455144	19	12	14	322.33	1	0.079121623143356	5.59486015982888	51	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	8.00E-06	8.00E-06	0	0	0	0
362	Perazidoparomomycin derivative 15	Target_lig_288	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0014	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@H](O[C@H]1CNCCc1ccc(cc1)F)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@@H]([C@@H]1O)O[C@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-6.16740000000001	721.354564944	18	12	13	313.1	1	0.084327966885633	5.57114985811434	50	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0014	0.0014	0	0	0	0
363	Perazidoparomomycin derivative 16	Target_lig_289	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0023	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@H](O[C@@H]1CN[C@@H](Cc1ccccc1)C)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-5.91800000000001	717.37963682	18	12	13	313.1	1	0.0903650531225	5.62014459861741	50	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0023	0.0023	0	0	0	0
364	Perazidoparomomycin derivative 17	Target_lig_290	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0029	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@H](O[C@@H]1CNCCc1ccc(cc1)C(F)(F)F)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@@H]([C@@H]1O)O[C@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-5.2877	771.351371384	18	12	13	313.1	1	0.083371277127249	5.66482447438129	53	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0029	0.0029	0	0	0	0
365	Perazidoparomomycin derivative 18	Target_lig_291	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0062	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@H]([C@H]([C@H](O[C@@H]1CNCCc1ccc(cc1)OC)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-6.29790000000001	733.37455144	19	12	14	322.33	1	0.079121623143356	5.56274395688289	51	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0062	0.0062	0	0	0	0
366	Perazidoparomomycin derivative 19	Target_lig_292	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0129	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@H](O[C@@H]1CN1C[C@H]2[C@H](C1)CCCC2)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@@H]([C@@H]1O)O[C@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-6.01680000000001	707.395286884	18	11	10	304.31	0	0.100664353090172	5.77913648892453	49	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0129	0.0129	0	0	0	0
367	Perazidoparomomycin derivative 20	Target_lig_293	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0163	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@H]1CN[C@@H]([C@@H](c1ccccc1)O)C)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-6.42710000000001	733.37455144	19	13	13	333.33	1	0.089604670776672	5.75298715037637	51	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0163	0.0163	0	0	0	0
368	Perazidoparomomycin derivative 21	Target_lig_294	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0202	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@H](O[C@H]1CNCCc1cc(ccc1)C(F)(F)F)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@@H]([C@@H]1O)O[C@H]1CO[C@@H]([C@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-5.2877	771.351371384	18	12	13	313.1	1	0.083371277127249	5.68109991204707	53	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0202	0.0202	0	0	0	0
369	Perazidoparomomycin derivative 22	Target_lig_295	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.00E-07	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@H](O[C@@H]1CNCCc1cc(ccc1)OC)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@@H]([C@@H]1O)O[C@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-6.29790000000001	733.37455144	19	12	14	322.33	1	0.079121623143356	5.58831416964884	51	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
370	Perazidoparomomycin derivative 23	Target_lig_296	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.001	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@@H]1CCN1C[C@@H]2[C@H](C1)CCCC2)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-5.62670000000001	721.410936948	18	11	11	304.31	0	0.094738010008209	5.79055018087671	50	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
371	Perazidoparomomycin derivative 26	Target_lig_297	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	5.20E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@H]([C@H]([C@H](O[C@@H]1CNCC[C@H]1CCCNC1)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@@H]([C@@H]1O)O[C@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-7.15950000000001	710.406185916	19	13	13	325.13	0	0.078954881665525	5.78639101147928	49	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	5.20E-06	5.20E-06	0	0	0	0
372	Perazidoparomomycin derivative 27	Target_lig_298	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.60E-06	0	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@H]([C@H]([C@H](O[C@@H]1CNCC[C@H]1NCCCC1)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	-	-	-7.01700000000001	710.406185916	19	13	13	325.13	0	0.07896423135766	5.80262562686389	49	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.60E-06	3.60E-06	0	0	0	0
373	Benzoyl paromomycin derivative	Target_lig_299	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.90E-06	4.00E-07	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](C[C@@H]1CO)O[C@@H]1[C@@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@@H]1O[C@@H]([C@H]([C@H]1OCCN(CCc1ccccc1)C(=O)c1ccccc1)O[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)N)O)O)N)CO)N)O)O	-	-	-4.8312	850.432400664	19	12	16	347.4	2	0.075359167139885	5.90361150833462	60	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.90E-06	3.90E-06	4.00E-07	4.00E-07	0	0
374	Acetyl parmomycin derivative	Target_lig_300	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.50E-06	4.00E-07	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@@H](C[C@@H]1CO)O[C@@H]1[C@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@H]1O[C@H]([C@H]([C@@H]1OCCN(CCc1ccccc1)C(=O)C)O[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)N)O)O)N)CO)N)O)O	-	-	-6.12510000000001	788.4167506	19	12	15	347.4	1	0.078648267162328	5.93567318797905	55	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.50E-06	1.50E-06	4.00E-07	4.00E-07	0	0
375	Ether paromomycin derivative 1	Target_lig_1112	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	9.00E-07	1.00E-07	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@@H]([C@H]([C@@H](C[C@@H]1CO)O[C@@H]1[C@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@H]1O[C@H]([C@H]([C@@H]1OCCN(CCc1ccccc1)C(=O)C)O[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)N)O)O)N)CO)N)O)O	-	-	0	0	0	0	0	0	0	0	0	0	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	9.00E-07	9.00E-07	1.00E-07	1.00E-07	0	0
376	Ether paromomycin derivative 3	Target_lig_301	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.70E-06	3.00E-07	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@@H]1([C@H]([C@H]([C@@H](C[C@H]1CO)O[C@H]1[C@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@@H]1O[C@@H]([C@H]([C@@H]1OC[C@@H](O)c1ccccc1)O[C@H]1[C@H]([C@@H]([C@H]([C@H](O1)N)O)O)N)CO)N)O)O	-	-	-6.48270000000001	719.358901376	19	13	12	347.32	1	0.09544939362235	5.89570043839108	50	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.70E-06	2.70E-06	3.00E-07	3.00E-07	0	0
377	Ether paromomycin derivative 4	Target_lig_302	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.90E-05	2.00E-07	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@@H]([C@H]([C@@H](C[C@H]1CO)O[C@@H]1[C@@H]([C@H]([C@@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@@H]([C@@H]1OCCN)O)CO)N)O)O	-	-	-5.9721	496.27444348	14	10	9	262.38	0	0.142416635696286	5.28351096282119	34	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.90E-05	1.90E-05	2.00E-07	2.00E-07	0	0
378	Ether paromomycin derivative 5	Target_lig_303	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	9.20E-06	1.00E-07	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@H]([C@@H](C[C@@H]1CO)O[C@H]1[C@@H]([C@@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@H]([C@H]1OCCNCN)O)CO)N)O)O	-	-	-6.42500000000001	525.300992576	15	11	11	274.41	0	0.088334620222162	5.39952365653883	36	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	9.20E-06	9.20E-06	1.00E-07	1.00E-07	0	0
379	Ethyl paromomycin derivative 2	Target_lig_304	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	4.10E-06	3.00E-07	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@@H]([C@H]([C@H](C[C@@H]1CO)O[C@H]1[C@@H]([C@@H]([C@H](C[C@H]1N)N)O)O[C@@H]1O[C@@H]([C@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)CN)O)O)N)COCN(C)C)N)O)O	-	-	-7.65470000000002	670.374885788	19	12	12	330.33	0	0.085750084311365	5.88128265010448	46	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	4.10E-06	4.10E-06	3.00E-07	3.00E-07	0	0
380	Deoxy fluoro paromomycin	Target_lig_305	Bacterial ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.10E-06	3.00E-07	0	0	0	-	-	https://patents.google.com/patent/US20110166334	-	Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents	Swayze EE, Hanessian S, Szychowski J, Adhikari SS, Pachamuthu K, Wang X, Migawa MT, Griffey RH	-	-	-	2012	0.25 - 25 uM	0.1 uM	7.5	-	100 mM ammonium acetate buffer	Mass spectrometry screening	SMMRNA	[C@H]1([C@H]([C@@H]([C@@H](C[C@H]1CO)O[C@@H]1[C@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@@H]1O[C@@H]([C@H]([C@H]1O)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CN)O)O)N)COF)N)O)O	-	-	-7.28930000000001	631.307614752	18	12	10	327.09	0	0.106448593414224	5.84871760039139	43	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.10E-06	1.10E-06	3.00E-07	3.00E-07	0	0
381	KANAMYCIN B	Target_lig_8	A-site for Kanamycin B	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.06 uM - 0.1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.00E-08	1.00E-07	0	0	0	0
382	Kasugamycin	Target_lig_78	Bacterial 70S ribosome	Escherichia coli	Bacterial growth and infection	Target_99	0	0	1.50E-05	0	0	0	0	-	-	10.1038/nsmb1150	16998486	Structural analysis of kasugamycin inhibition of translation.	Schuwirth BS, Day JM, Hau CW, Janssen GR, Dahlberg AE, Cate JH, Vila-Sanjurjo A	Nat Struct Mol Biol	13	879-86	2006	0.5 mM	-	7.4	-	60 mM NH4Cl, 10 mM magnesium acetate	Toeprinting analysis	SMMRNA	CC1C(CC(C(O1)OC2C(C(C(C(C2O)O)O)O)O)N)N=C(C(=O)O)N	2-amino-2-[5-amino-2-methyl-6-(2,3,4,5,6-pentahydroxycyclohexyl)oxyoxan-3-yl]iminoacetic acid	265071	-4.53769999999999	379.15907938	10	8	3	221.31	0	0.172165560366347	4.8447582581896	26	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	1.50E-05	1.50E-05	0	0	0	0
383	Sparsomycin	Target_lig_306	Bacterial 70S ribosome	Escherichia coli	Bacterial growth and infection	Target_99	0	0	4.00E-06	0	0	0	0	-	-	10.1073/pnas.96.16.9003	10430885	Direct crosslinking of the antitumor antibiotic sparsomycin, and its derivatives, to A2602 in the peptidyl transferase center of 23S-like rRNA within ribosome-tRNA complexes.	Porse BT, Kirillov SV, Awayez MJ, Ottenheijm HC, Garrett RA	Proc Natl Acad Sci U S A	96	9003-8	1999	200 nM - 150 uM	20-150 nM	7.5	37	50 mM NH4Cl, and 10 mM MgCl2	Gel autoradiogram	SMMRNA	CC1=C(C(=O)NC(=O)N1)C=CC(=O)NC(CO)CS(=O)CSC	N-[1-hydroxy-3-(methylsulfanylmethylsulfinyl)propan-2-yl]-3-(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)prop-2-enamide	14967	-1.06888	361.076612708	6	4	8	132.12	1	0.436064068045395	4.13107838372711	23	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
384	Linezolid	Target_lig_307	Bacterial ribosome	Escherichia coli	Bacterial growth and infection	Target_99	0	0	4.00E-05	0	0	0	0	7S1H	-	10.5012/bkcs.2006.27.10.1664	-	Enhanced Binding Affinity of Neomycin-Chloramphenicol (or Linezolid) Conjugates to A-Site Model of 16S Ribosomal RNA	Kwon M, Kim H, Lee J, Yu J	Bull Korean Chem Soc	27	1664-1666	2006	-	-	-	20	-	Fluorescence anisotropy and intensity measurements	SMMRNA	CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F	N-[[3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	3929	1.1236	337.14378434	5	1	4	71.11	1	0.891597388751196	2.75916822785055	24	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	4.00E-05	4.00E-05	0	0	0	0
385	Malachite green	Target_lig_308	Aptamer	Synthetic	-	Target_6	0	0	5.00E-08	0	0	0	0	1Q8N	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3.[Cl-]	[4-[[4-(dimethylamino)phenyl]-phenylmethylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium;chloride	11294	1.3976	364.17062648	1	0	3	6.25	2	0.746116805912024	2.76799679715597	26	GGGAAGGGAAGAAACUGCGGCUUCGGCCGGCUUCCC	http://www.smmrna.org/	RNA aptamer	-	36	-	UUCG Tetraloop	0	0	0	0	5.00E-08	5.00E-08	0	0	0	0
386	Micrococcin	Target_lig_309	L11 binding BD RNA	Thermotoga maritima	Bacterial growth and infection	Target_122	0	0	8.00E-08	3e-07±1e-08	0	0	0	-	-	10.1016/S1074-5521(03)00173-X	12954336	Structural basis for contrasting activities of ribosome binding thiazole antibiotics.	Lentzen G, Klinck R, Matassova N, Aboul-ela F, Murchie AI	Chem Biol	10	769-78	2003	-	0-0.032 uM	-	37	-	In vitro translation assay	SMMRNA	CC=C1C2=NC(=CS2)C(=O)NC(C3=NC(=CS3)C(=O)NC(C4=NC(=CS4)C5=C(C=CC(=N5)C6=NC(=CS6)C7=NC(=CS7)C(=O)NC(=CC)C(=O)NCC(C)O)C8=NC(=CS8)C(=O)NC(C(=O)N1)C(C)O)C(C)O)C(C)C	2-[2-[26-ethylidene-12,29-bis(1-hydroxyethyl)-14,21,28,31-tetraoxo-19-propan-2-yl-10,17,24,34-tetrathia-6,13,20,27,30,35,36,37,38-nonazahexacyclo[30.2.1.18,11.115,18.122,25.02,7]octatriaconta-1(35),2(7),3,5,8,11(38),15,18(37),22,25(36),32-undecaen-5-yl]-1,3-thiazol-4-yl]-N-[1-(2-hydroxypropylamino)-1-oxobut-2-en-2-yl]-1,3-thiazole-4-carboxamide	3051328	5.56800000000001	1143.210046148	22	9	10	325.52	7	0.07563128833718	7.73325114757081	76	GCUGGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAGUGCGUAACAGCUCACCAGC	https://www.rcsb.org/structure/1MMS	Ribosomal, RNA aptamer	-	58	-	Four-way junction	0	0	0	0	8.00E-08	8.00E-08	2.90E-07	3.10E-07	0	0
387	Nosiheptide	Target_lig_310	L11 binding BD RNA	Thermotoga maritima	Bacterial growth and infection	Target_122	0	0	5.00E-06	2.3e-07±6e-08	0	0	0	-	-	10.1016/S1074-5521(03)00173-X	12954336	Structural basis for contrasting activities of ribosome binding thiazole antibiotics.	Lentzen G, Klinck R, Matassova N, Aboul-ela F, Murchie AI	Chem Biol	10	769-78	2003	-	0-0.032 uM	-	37	-	In vitro translation assay	SMMRNA	CC=C1C2=NC(=CS2)C(=O)NC3CC(C(=O)OCC4=C5C(=C(C(=O)SCC(C6=NC(=CS6)C7=NC(=C(C=C7C8=NC(=CS8)C(=O)NC(C(=O)N1)C(C)O)O)C9=NC(=CS9)C(=O)NC(=C)C(=O)N)NC(=O)C1=CSC3=N1)NC5=CC=C4)C)O	N-(3-amino-3-oxoprop-1-en-2-yl)-2-[21-ethylidene-9,30-dihydroxy-18-(1-hydroxyethyl)-40-methyl-16,19,26,31,42,46-hexaoxo-32-oxa-3,13,23,43,49-pentathia-7,17,20,27,45,51,52,53,54,55-decazanonacyclo[26.16.6.12,5.112,15.122,25.138,41.147,50.06,11.034,39]pentapentaconta-2(55),4,6,8,10,12(54),14,22(53),24,34(39),35,37,40,47,50-pentadecaen-8-yl]-1,3-thiazole-4-carboxamide	16130051	4.88262	1221.147839816	24	10	5	385.78	8	0.081019251046761	6.76723324605011	82	GCUGGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAGUGCGUAACAGCUCACCAGC	https://www.rcsb.org/structure/1MMS	Ribosomal, RNA aptamer	-	58	-	Four-way junction	0	0	0	0	5.00E-06	5.00E-06	1.70E-07	2.90E-07	0	0
388	Pactamycin	Target_lig_77	30S ribosomal subunit for pactamycin	Escherichia coli	Bacterial growth and infection	Target_101	0	0	0	3.00E-06	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C(C(=CC=C1)O)C(=O)OCC2(C(C(C(C2(C)O)(C(C)O)NC(=O)N(C)C)N)NC3=CC=CC(=C3)C(=O)C)O	[5-(3-acetylanilino)-4-amino-3-(dimethylcarbamoylamino)-1,2-dihydroxy-3-(1-hydroxyethyl)-2-methylcyclopentyl]methyl 2-hydroxy-6-methylbenzoate	413861	0.754520000000001	558.268964176	10	7	8	194.68	2	0.179480744226426	4.68901329104993	40	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	7OE1	Ribosomal	-	1543	-	-	0	0	0	0	0	0	3.00E-06	3.00E-06	0	0
389	Paromamine	Target_lig_311	Human A-site	Homo sapiens	Bacterial growth and infection	Target_103	0	0	0.0001	0	0	0	0	-	-	10.1002/cbic.200300689	12964164	Piperidine glycosides targeting the ribosomal decoding site.	Simonsen KB, Ayida BK, Vourloumis D, Winters GC, Takahashi M, Shandrick S, Zhao Q, Hermann T	Chembiochem	4	886-90	2003	-	-	-	-	-	Coupled transcription-translation assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)O)O)N	5-amino-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxy-2-(hydroxymethyl)oxane-3,4-diol	4475106	-5.08199999999999	323.16925014	10	8	3	197.67	0	0.248455706426994	4.52530951541645	22	UACCUGGUUGAUCCUGCCAGUAGCAUAUGCUUGUCUCAAAGAUUAAGCCAUGCAUGUCUAAGUACGCACGGCCGGUACAGUGAAACUGCGAAUGGCUCAUUAAAUCAGUUAUGGUUCCUUUGGUCGCUCGCUCCUCUCCCACUUGGAUAACUGUGGUAAUUCUAGAGCUAAUACAUGCCGACGGGCGCUGACCCCCUUCGCGGGGGGGAUGCGUGCAUUUAUCAGAUCAAAACCAACCCGGUCAGCCCCUCUCCGGCCCCGGCCGGGGGGCGGGCGCCGGCGGCUUUGGUGACUCUAGAUAACCUCGGGCCGAUCGCACGCCCCCCGUGGCGGCGACGACCCAUUCGAACGUCUGCCCUAUCAACUUUCGAUGGUAGUCGCCGUGCCUACCAUGGUGACCACGGGUGACGGGGAAUCAGGGUUCGAUUCCGGAGAGGGAGCCUGAGAAACGGCUACCACAUCCAAGGAAGGCAGCAGGCGCGCAAAUUACCCACUCCCGACCCGGGGAGGUAGUGACGAAAAAUAACAAUACAGGACUCUUUCGAGGCCCUGUAAUUGGAAUGAGUCCACUUUAAAUCCUUCCGCGAGGAUCCAUUGGAGGGCAAGUCUGGUGCCAGCAGCCGCGGUAAUUCCAGCUCCAAUAGCGUAUAUUAAAGUUGCUGCAGUUAAAAAGCUCGUAGUUGGAUCUUGGGAGCGGGCGGGCGGUCCGCCGCGAGGCGAGCCACCGCCCGUCCCCGCCCCUUGCCUCUCGGCGCCCCCUCGAUGCUCUUAGCUGAGUGUCCCGCGGGGCCCGAAGCAUUUACUUUGAAAAAAUUAGAGUGUUCAAAGCAGGCCCGAGCCGCCUGGAUACCGCAGCUAGGAAUAAUGGAAUAGGACCGCGGUUCUAUUUUGUUGGUUUUCGGAACUGAGGCCAUGAUUAAGAGGGACGGCCGGGGGCAUUCGUAUUGCGCCGCUAGAGGUGAAAUUCUUGGACCGGCGCAAGACGGACCAGAGCGAAAGCAUUUGCCAAGAAUGUUUUCAUUAAUCAAGAACGAAAGUCGGAGGUUCGAAGACGAUCAGAUACCGUCGUAGUUCCGACCAUAAACGAUGCCGACUGGCGAUGCGGCGGCGUUAUUCCCAUGACCCGCCGGGCAGCUUCCGGGAAACCAAAGUCUUUGGGUUCCGGGGGGAGUAUGGUUGCAAAGCUGAAACUUAAAGGAAUUGACGGAAGGGCACCACCAGGAGUGGAGCCUGCGGCUUAAUUUGACUCAACACGGGAAACCUCACCCGGCCCGGACACGGACAGGAUUGACAGAUUGAUAGCUCUUUCUCGAUUCCGUGGGUGGUGGUGCAUGGCCGUUCUUAGUUGGUGGAGCGAUUUGUCUGGUUAAUUCCGAUAACGAACGAGACUCUGGCAUGCUAACUAGUUACGCGACCCCCGAGCGGUCGGCGUCCCCCAACUUCUUAGAGGGACAAGUGGCGUUCAGCCACCCGAGAUUGAGCAAUAACAGGUCUGUGAUGCCCUUAGAUGUCCGGGGCUGCACGCGCGCUACACUGACUGGCUCAGCGUGUGCCUACCCUACGCCGGCAGGCGCGGGUAACCCGUUGAACCCCAUUCGUGAUGGGGAUCGGGGAUUGCAAUUAUUCCCCAUGAACGAGGAAUUCCCAGUAAGUGCGGGUCAUAAGCUUGCGUUGAUUAAGUCCCUGCCCUUUGUACACACCGCCCGUCGCUACUACCGAUUGGAUGGUUUAGUGAGGCCCUCGGAUCGGCCCCGCCGGGGUCGGCCCACGGCCCUGGCGGAGCGCUGAGAAGACGGUCGAACUUGACUAUCUAGAGGAAGUAAAAGUCGUAACAAGGUUUCCGUAGGUGAACCUGCGGAAGGAUCAUUA	6Y0G	Ribosomal	A-site for tRNA	1870	-	-	0	0	0	0	0.0001	0.0001	0	0	0	0
390	Puromycin	Target_lig_312	50S A-site for puromycin	Escherichia coli	Bacterial growth and infection	Target_100	0	0	0.00048	0	0	0	0	1FG0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)NC(=O)C(CC4=CC=C(C=C4)OC)N)O	2-amino-N-[5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide	4984	-0.793699999999997	471.223017028	11	4	8	160.88	3	0.327503745325444	3.9387461435615	34	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	0.00048	0.00048	0	0	0	0
391	Retapamulin	Target_lig_313	large ribosomal subunit from Deinococcus radiodurans	Escherichia coli	Bacterial growth and infection	Target_100	0	0	2e-09±5.000000000000001e-11	0	0	0	0	2OGO	-	10.1073/pnas.0700041104	17360517	Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity.	Davidovich C, Bashan A, Auerbach-Nevo T, Yaggie RD, Gontarek RR, Yonath A	Proc Natl Acad Sci U S A	104	4291-6	2007	-	-	-	-	-	Radioligand displacement assay	SMMRNA	CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CC5CCC(C4)N5C)C	(4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl) 2-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)sulfanyl]acetate	73046449	5.25130000000001	517.322579984	6	1	5	66.84	0	0.39682626540964	6.13278936484694	36	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	1.95E-09	2.05E-09	0	0	0	0
392	S-adenosyl methionine	Target_lig_314	S_Adenosyl_methionine_riboswitch	Thermoanaerobacter tengcongensis	Bacterial growth and infection	Target_71	0	0	1.00E-08	0	0	0	0	2GIS	-	10.1038/nsb967	12910260	An mRNA structure that controls gene expression by binding S-adenosylmethionine.	Winkler WC, Nahvi A, Sudarsan N, Barrick JE, Breaker RR	Nat Struct Biol	10	701-7	2003	100nM	1nM	8.3	25	20 mM MgCl2, 100  mM  KCl	In-line probing assays	SMMRNA	C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O	2-amino-4-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylsulfonio]butanoate	5136	-3.2569	398.137238804	11	4	7	185.46	2	0.344969936201303	4.7565494434378	27	GGCUUAUCAAGAGAGGUGGAGGGACUGGCCCGAUGAAACCCGGCAACCAGAAAUGGUGCCAAUUCCUGCAGCGGAAACGUUGAAAGAUGAGCCA	https://www.rcsb.org/structure/2GIS	Riboswitch	Riboswitch	94	-	-	0	0	0	0	1.00E-08	1.00E-08	0	0	0	0
393	sisomicin	Target_lig_10	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	2.60E-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	2.60E-07	2.60E-07	0	0	0	0
394	Spiramycin A	Target_lig_315	50S exit tunnel for SPIRAMYCIN A	Escherichia coli	Bacterial growth and infection	Target_100	0	0	1.80E-06	0	0	0	0	1KD1	-	10.1021/bi00091a014	8399209	Interaction between the antibiotic spiramycin and a ribosomal complex active in peptide bond formation.	Dinos G, Synetos D, Coutsogeorgopoulos C	Biochemistry	32	10638-47	1993	2mM	-	7.2	25	100 mM NH4C1, 10 mM MgCl2	Gel chromatography	SMMRNA	CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C	2-[6-[5-(4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde	5266	2.32510000000001	842.514005048	16	4	11	195.38	0	0.174749327593629	6.70942456425475	59	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	1.80E-06	1.80E-06	0	0	0	0
395	T4-MPyP (Tetrakismethylpiridiniumylporphine)	Target_lig_316	E.Coli tRNA Val	Escherichia coli	Bacterial growth and infection	Target_105	0	0	1.21E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	2, 4,8, 16, 32 nM	-	7.6	37	100 mM NH4Cl, 60mM MgCl2	Spectrofluorimetry	SMMRNA	CN1C=CC(=C2C3=NC(=C(C4=NC(=C(C5=CC=C([N-]5)C(=C6C=CC2=N6)C7=CC=[N+](C=C7)C)C8=CC=[N+](C=C8)C)C=C4)C9=CC=[N+](C=C9)C)C=C3)C=C1	5,10,15-tris(1-methylpyridin-1-ium-4-yl)-20-(1-methylpyridin-4-ylidene)porphyrin-22-ide	101068503	5.36280000000001	676.30519599218	4	0	3	66.06	4	0.27453893908777	6.49893281822592	52	GGGUGAUUAGCUCAGCUGGGAGAGCACCUCCCUUACAAGGAGGGGGUCGGCGGUUCGAUCCCGUCAUCACCCACCA	http://www.smmrna.org/	tRNA	-	76	-	Cloverleaf	0	0	0	0	1.21E-06	1.21E-06	0	0	0	0
396	Telithromycin	Target_lig_317	Large subunit (TELITHROMYCIN)	Escherichia coli	Bacterial growth and infection	Target_100	0	0	1.30E-09	0	0	0	0	1P9X	-	10.1128/JB.185.14.4276-4279.2003	12837804	Structural insight into the antibiotic action of telithromycin against resistant mutants.	Berisio R, Harms J, Schluenzen F, Zarivach R, Hansen HA, Fucini P, Yonath A	J Bacteriol	185	4276-9	2003	-	-	-	-	-	-	SMMRNA	CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C	8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone	21881641	4.92920000000001	811.47314328	14	1	11	171.85	2	0.184283434829262	6.03700146103189	58	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	1.30E-09	1.30E-09	0	0	0	0
397	tetracyclin	Target_lig_74	Small subunit tetracycline	Escherichia coli	Bacterial growth and infection	Target_101	0	0	3.50E-06	0	0	0	0	1I97	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	9-50 mM	0.8-6.0 uM	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Isothermal Titration Calorimetry (ITC)	SMMRNA	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54685734	-0.370999999999999	444.153265728	9	6	2	181.62	1	0.33151896393022	4.2536794077623	32	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	7OE1	Ribosomal	-	1543	-	-	0	0	0	0	3.50E-06	3.50E-06	0	0	0	0
398	Thiamine_Pyrophosphate(TPP)	Target_lig_318	thiamine_BOX_Riboswitch	Escherichia coli	Bacterial growth and infection	Target_72	0	0	6.00E-07	0	0	0	0	2GDI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)OP(=O)(O)[O-]	[2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethoxy-hydroxyphosphoryl] hydrogen phosphate	5431	0.20974	424.037143176	9	3	8	171.8	2	0.392748623002051	4.47021276522935	26	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	https://www.rcsb.org/structure/2GDI	Riboswitch	Riboswitch	80	-	-	0	0	0	0	6.00E-07	6.00E-07	0	0	0	0
399	Thiostrepton	Target_lig_319	L11 BD RNA	Thermotoga maritima	Bacterial growth and infection	Target_122	0	0	1.3e-06±3e-07	1e-07±1e-08	0	0	0	-	-	10.1016/S1074-5521(03)00173-X	12954336	Structural basis for contrasting activities of ribosome binding thiazole antibiotics.	Lentzen G, Klinck R, Matassova N, Aboul-ela F, Murchie AI	Chem Biol	10	769-78	2003	1-2 uM	1 mM	7.5	37	70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2	Coupled transcription-translation assay	SMMRNA	CCC(C)C1C(=O)NC(C(=O)NC(=C)C(=O)NC(C(=O)NC23CCC(=NC2C4=CSC(=N4)C(C(OC(=O)C5=NC6=C(C=CC(C6O)N1)C(=C5)C(C)O)C)NC(=O)C7=CSC(=N7)C(NC(=O)C8CSC(=N8)C(=CC)NC(=O)C(NC(=O)C9=CSC3=N9)C(C)O)C(C)(C(C)O)O)C1=NC(=CS1)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)C)C	N-[3-[(3-amino-3-oxoprop-1-en-2-yl)amino]-3-oxoprop-1-en-2-yl]-2-[37-butan-2-yl-18-(2,3-dihydroxybutan-2-yl)-11-ethylidene-59-hydroxy-8,31-bis(1-hydroxyethyl)-26,40,46-trimethyl-43-methylidene-6,9,16,23,28,38,41,44,47-nonaoxo-27-oxa-3,13,20,56-tetrathia-7,10,17,24,36,39,42,45,48,52,58,61,62,63,64-pentadecazanonacyclo[23.23.9.329,35.12,5.112,15.119,22.154,57.01,53.032,60]tetrahexaconta-2(64),4,12(63),19(62),21,29(61),30,32(60),33,51,54,57-dodecaen-51-yl]-1,3-thiazole-4-carboxamide	16129995	0.773900000000009	1663.49235188	31	17	12	562.74	5	0.060585200124882	8.94101862922376	114	GCUGGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAGUGCGUAACAGCUCACCAGC	https://www.rcsb.org/structure/1MMS	Ribosomal, RNA aptamer	-	58	-	Four-way junction	0	0	0	0	1.00E-06	1.60E-06	9.00E-08	1.10E-07	0	0
400	Tylosin	Target_lig_320	Exit tunnel for TYLOSIN	Escherichia coli	Bacterial growth and infection	Target_100	0	0	2.7500000000000002e-09±5.400000000000001e-10	0	0	0	0	1K9M	-	10.1074/jbc.M708371200	18079110	Stepwise binding of tylosin and erythromycin to Escherichia coli ribosomes, characterized by kinetic and footprinting analysis.	Petropoulos AD, Kouvela EC, Dinos GP, Kalpaxis DL	J Biol Chem	283	4756-65	2008	4 uM	100 nM	7.2	25	4.5 mM Mg(CH3COO)2, 150 mM NH4Cl	Footprinting assay	SMMRNA	CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC	2-[6-[5-(4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde	5062352	1.83350000000001	915.519150004	18	5	13	238.67	0	0.130887261974031	6.85125631597821	64	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	2.21E-09	3.29E-09	0	0	0	0
401	Clindamycin	Target_lig_324	50S ribosome (CLINDAMYCIN)	Escherichia coli	Bacterial growth and infection	Target_100	0	0	8.00E-06	0	0	0	0	4V7V	-	10.1093/nar/20.18.4717	1383931	Interaction of the antibiotics clindamycin and lincomycin with Escherichia coli 23S ribosomal RNA.	Douthwaite S	Nucleic Acids Res	20	4717-20	1992	0.1-1000 uM	6 pmol	7.2	37	20 mM-MgCl2, 100mM-NH4Cl	Footprinting assay	SMMRNA	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl	N-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide	2786	0.389500000000002	424.179870836	7	4	7	102.26	0	0.438273016979582	4.74343750029956	27	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	8.00E-06	8.00E-06	0	0	0	0
402	Edeine_mol	Target_lig_325	30S (EDIENE)	Escherichia coli	Bacterial growth and infection	Target_101	0	0	0	8.00E-06	0	0	0	1I95	-	10.1016/s1097-2765(04)00002-4	14731399	Dissecting the ribosomal inhibition mechanisms of edeine and pactamycin: the universally conserved residues G693 and C795 regulate P-site RNA binding.	Dinos G, Wilson DN, Teraoka Y, Szaflarski W, Fucini P, Kalpaxis D, Nierhaus KH	Mol Cell	13	113-24	2004	-	0.3 uM	7.6	30	4.5 mM magnesium acetate, 150 mM ammonium acetate	Coupled transcription-translation assay	SMMRNA	C1=CC(=CC=C1C(CC(=O)NCC(C(=O)NC(CN)C(=O)NC(CCCC(C(CC(=O)NCC(=O)NCCCNCCCCN)O)N)C(=O)O)O)N)O	6-amino-2-[[3-amino-2-[[3-[[3-amino-3-(4-hydroxyphenyl)propanoyl]amino]-2-hydroxypropanoyl]amino]propanoyl]amino]-9-[[2-[3-(4-aminobutylamino)propylamino]-2-oxoethyl]amino]-7-hydroxy-9-oxononanoic acid	379085	-4.52830000000001	754.433738056	14	14	28	359.6	1	0.035842878592344	4.63937491785627	53	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	7OE1	Ribosomal	-	1543	-	-	0	0	0	0	0	0	8.00E-06	8.00E-06	0	0
403	Virginiamycin M	Target_lig_1113	50S ribosome (Virginiamycin M)	Escherichia coli	Bacterial growth and infection	Target_100	0	0	1.8×1E-8	0	0	0	0	6PC5	-	10.1016/j.cell.2005.02.005	15851032	Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.	Tu D, Blaha G, Moore PB, Steitz TA	Cell	121	257-70	2005	-	-	-	-	-	-	SMMRNA	CC1C=CC(=O)NCC=CC(=CC(CC(=O)CC2=NC(=CO2)C(=O)N3CCC=C3C(=O)OC1C(C)C)O)C	(10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone	5459319	2.5	525.6	2	8	1	139	0	0	0	38	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	1.80E-08	1.80E-08	0	0	0	0
404	Linezolid	Target_lig_307	23SrRNA	Escherichia coli	Bacterial growth and infection	Target_104	0	5.04e-06±1.1699999999999998e-06	1.00E-06	0	0	0	0	3DLL	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	SMMRNA	CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F	N-[[3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	3929	1.1236	337.14378434	5	1	4	71.11	1	0.891597388751196	2.75916822785055	24	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCAUCCCGACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACUGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACUAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGCAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCUU	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	2904	-	-	0	0	3.87E-06	6.21E-06	1.00E-06	1.00E-06	0	0	0	0
405	LINEZOLID_DERIVATIVE_1	Target_lig_326	23SrRNA	Escherichia coli	Bacterial growth and infection	Target_104	0	0	0.000195	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	SMMRNA	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)C(=O)CO)F	N-[[(5S)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)piperazin-1-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	73214	-0.0721	394.165248056	6	2	5	102.42	1	0.724863067860134	2.88106682859977	28	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCAUCCCGACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACUGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACUAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGCAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCUU	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	2904	-	-	0	0	0	0	0.000195	0.000195	0	0	0	0
406	LINEZOLID_DERIVATIVE_2	Target_lig_327	23SrRNA	Escherichia coli	Bacterial growth and infection	Target_104	0	0	0.000761	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	SMMRNA	CC(=O)NC[C@@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)C(=O)CO)F	N-[[(5R)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)piperazin-1-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	12016333	-0.0721	394.165248056	6	2	5	102.42	1	0.724863067860134	2.88106682859977	28	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCAUCCCGACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACUGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACUAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGCAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCUU	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	2904	-	-	0	0	0	0	0.000761	0.000761	0	0	0	0
407	LINEZOLID_DERIVATIVE_3	Target_lig_328	23SrRNA	Escherichia coli	Bacterial growth and infection	Target_104	0	0	9.40E-05	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	SMMRNA	CC(=S)NC[C@@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCS(=O)CC3)F	N-[[(5R)-3-[3-fluoro-4-(1-oxo-1,4-thiazinan-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]ethanethioamide	101158576	1.6565	385.09301172	5	1	4	61.88	1	0.795729633207047	3.38009035105205	25	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCAUCCCGACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACUGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACUAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGCAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCUU	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	2904	-	-	0	0	0	0	9.40E-05	9.40E-05	0	0	0	0
408	LINEZOLID_DERIVATIVE_4	Target_lig_329	23SrRNA	Escherichia coli	Bacterial growth and infection	Target_104	0	0	0.000474	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	SMMRNA	CC(=S)NC[C@@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCS(=O)CC3)F	N-[[(5R)-3-[3-fluoro-4-(1-oxo-1,4-thiazinan-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]ethanethioamide	101158576	1.6565	385.09301172	5	1	4	61.88	1	0.795729633207047	3.38009035105205	25	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCAUCCCGACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACUGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACUAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGCAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCUU	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	2904	-	-	0	0	0	0	0.000474	0.000474	0	0	0	0
409	radezolid	Target_lig_330	Ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	<2e-08	0	0	0	6WQQ	-	10.1128/AAC.01193-07	18663023	R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.	Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F	Antimicrob Agents Chemother	52	3550-7	2008	0.1 - 1 mM	50-200 nM	7.8	37	10 mM MgOAc, 60 mM NH4Cl	Competitive binding experiments	SMMRNA	CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)CNCC4=NNN=C4)F	N-[[3-[3-fluoro-4-[4-[(2H-triazol-4-ylmethylamino)methyl]phenyl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	22274119	2.3619	438.181566816	6	3	8	112.24	3	0.497844423315673	3.10617635177683	32	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	2.00E-08	2.00E-08	0	0
410	Adenine	Target_lig_165	B_subtilis_pbuE _Adenine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_73	0	0	5.81E-07	0	0	0	0	-	-	10.1021/bi051008u	16201765	The kinetics of ligand binding by an adenine-sensing riboswitch.	Wickiser JK, Cheah MT, Breaker RR, Crothers DM	Biochemistry	44	13404-14	2005	50 nM	-	7.5	25	100 mM KCl, and 2 mM MgCl2	Fluorescence-based binding and displacement assays	SMMRNA	C1=NC2=NC=NC(=C2N1)N	7H-purin-6-amine	190	-0.0649	135.05449516	4	2	0	80.48	2	0.529675929378058	2.66020570619806	10	GGAAUAAUUGUAUAACCUCAAUAAUAUGGUUUGAGGGUGUCUACCAGGAACCGUAAAAUCCUGAUUACAA	10.1021/bi051008u	Riboswitch	Riboswitch	70	-	-	0	0	0	0	5.81E-07	5.81E-07	0	0	0	0
411	Hypoxanthine	Target_lig_162	B.subtilis xpt-pbuX guanine binding domain of guanine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	2.99e-06±1.8999999999999998e-07	0	0	0	0	4FE5	-	10.1038/nature03037	15549109	Structure of a natural guanine-responsive riboswitch complexed with the metabolite hypoxanthine.	Batey RT, Gilbert SD, Montange RK	Nature	432	411-5	2004	-	-	-	-	1mM MgCl2	-	SMMRNA	C1=NC2=C(N1)C(=O)N=CN2	3,7-dihydropurin-6-one	790	-0.3538	136.038510748	3	2	0	74.43	2	0.519236856563892	2.99952241707339	10	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	2.80E-06	3.18E-06	0	0	0	0
412	FMN	Target_lig_68	FMN RIBOSWITCH APTAMER	Synthetic	Bacterial growth and infection	Target_36	0	0	1.2e-09±3e-10	0	0	0	0	1FMN	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	SMMRNA	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)O)O)O)O	[5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate	710	-1.60656	456.104614882	10	6	7	208.09	1	0.176020349335941	4.02831596221591	31	GGCGUGUAGGAUAUGCUUCGGCAGAAGGACACGCC	https://www.rcsb.org/structure/1FMN	RNA aptamer, Riboswitch	Riboswitch	35	-	-	0	0	0	0	9.00E-10	1.50E-09	0	0	0	0
413	preQ1 (7-Aminomethyl-7-deazaguanine)	Target_lig_331	PreQ1_riboswitch_Fusobacterium	Faecalibacterium prausnitzii	Bacterial growth and infection	Target_75	0	0	2.8300000000000003e-07±5.5e-08	0	0	0	0	4RZD	-	10.1073/pnas.0914925107	20534493	Folding of a transcriptionally acting preQ1 riboswitch.	Rieder U, Kreutz C, Micura R	Proc Natl Acad Sci U S A	107	10804-9	2010	-	0.5 uM	7	25	100 mM KCl, 2 mM MgCl2	Fluorescence spectroscopy	SMMRNA	C1=C(C2=C(N1)N=C(NC2=O)N)CN	2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one	135398563	-0.7079	179.080709908	4	4	1	113.58	2	0.462740545711741	2.99718975000883	13	AGUAGAUGUGCUAGCAAAACAUCUUUAAAAAACUAGACUUGGGGUGCAAGUCCCCUUUUUUAUUGCUUAAAUUU	https://www.pnas.org/content/pnas/107/24/10804.full.pdf	Riboswitch	Riboswitch	74	-	-	0	0	0	0	2.28E-07	3.38E-07	0	0	0	0
414	Thiamine_Pyrophosphate(TPP)	Target_lig_318	TPP RIBOSWITCH APTAMER	Synthetic	Bacterial growth and infection	Target_37	0	0	4.95E-07	0	0	0	0	2GDI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)OP(=O)(O)[O-]	[2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethoxy-hydroxyphosphoryl] hydrogen phosphate	5431	0.20974	424.037143176	9	3	8	171.8	2	0.392748623002051	4.47021276522935	26	GGUAACCACUAGGGGUGUCCUUCAUAAGGGCUGAGAUAAAAGUGUGACUUUUAGACCCUCAUAACUUGAACAGGUUCAGACCUGCGUAGGGAAGUGGAGC	10.1016/j.chembiol.2005.10.007	RNA aptamer, Riboswitch	Riboswitch	100	-	-	0	0	0	0	4.95E-07	4.95E-07	0	0	0	0
415	SAM	Target_lig_1248	S_Adenosyl_methionine	Thermoanaerobacter tengcongensis	Bacterial growth and infection	Target_71	0	0	1.35e-06±1.5e-07	0	0	0	0	2GIS	-	10.1261/rna.1852310	20106958	Idiosyncratically tuned switching behavior of riboswitch aptamer domains revealed by comparative small-angle X-ray scattering analysis.	Baird NJ, Ferré-D'Amaré AR	RNA	16	598-609	2010	200 uM	20 uM	7.5	37	1mM Mg2+	Isothermal Titration Calorimetry (ITC)	SMMRNA	C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O	2-amino-4-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylsulfonio]butanoate	5136	-3.2569	398.137238804	11	4	7	185.46	2	0.344969936201303	4.7565494434378	27	GGCUUAUCAAGAGAGGUGGAGGGACUGGCCCGAUGAAACCCGGCAACCAGAAAUGGUGCCAAUUCCUGCAGCGGAAACGUUGAAAGAUGAGCCA	https://www.rcsb.org/structure/2GIS	Riboswitch	Riboswitch	94	-	-	0	0	0	0	1.20E-06	1.50E-06	0	0	0	0
416	lysine	Target_lig_31	LYSINE RIBOSWITCH APTAMER	Synthetic	Bacterial growth and infection	Target_38	0	0	1.8e-06±4e-07	0	0	0	0	3D0U	-	10.1261/rna.1852310	20106958	Idiosyncratically tuned switching behavior of riboswitch aptamer domains revealed by comparative small-angle X-ray scattering analysis.	Baird NJ, Ferré-D'Amaré AR	RNA	16	598-609	2010	980 uM	25 uM	7.5	37	10 mM Mg2+	Isothermal Titration Calorimetry (ITC)	SMMRNA	C(CCN)C[C@@H](C(=O)O)N	(2S)-2,6-diaminohexanoic acid	5962	-0.472699999999999	146.105527688	3	3	5	89.34	0	0.457177158496557	2.47366829558304	10	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUGUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	http://www.genesdev.org/cgi/doi/10.1101/ gad.1140003	RNA aptamer, Riboswitch	Riboswitch	239	-	-	0	0	0	0	1.40E-06	2.20E-06	0	0	0	0
417	tetracyclin	Target_lig_74	Tetracycline in vitro aptamer	Synthetic	Bacterial growth and infection	Target_39	0	0	8.00E-10	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	9-50 uM	0.8-6 uM	7.5	25	100 mM NaCl, 10 mM MgCl2	Isothermal Titration Calorimetry (ITC)	SMMRNA	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54685734	-0.370999999999999	444.153265728	9	6	2	181.62	1	0.33151896393022	4.2536794077623	32	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACACCUAGGCUC	http://www.smmrna.org/	RNA aptamer	-	70	-	Internal Loop	0	0	0	0	8.00E-10	8.00E-10	0	0	0	0
418	guanosine	Target_lig_61	Tetrahymena group I ribozyme	Tetrahymena thermophila	Bacterial growth and infection	Target_25	0	0	0.00011	0	0	0	0	-	-	10.1073/pnas.252749799	12591943	Extraordinarily slow binding of guanosine to the Tetrahymena group I ribozyme: implications for RNA preorganization and function.	Karbstein K, Herschlag D	Proc Natl Acad Sci U S A	100	2300-5	2003	0-10 uM	50-200 nM	-	-	-	Kinetic studies	SMMRNA	C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(NC3=O)N)CO)O	2-amino-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one	135398592	-1.6575	267.096753896	8	4	2	139.28	2	0.510372838268684	3.67445189232985	19	GGAGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGACGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUGCAGUUCACAGACUAAAUGUCGGUCGGGGAAGAUGUAUUCUUCUCAUAAGAUAUAGUCGGACCUCUCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUUGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGU	https://www.rcsb.org/structure/6WLS	Ribozyme	Group I ribozyme	388	-	-	0	0	0	0	0.00011	0.00011	0	0	0	0
419	SB-280080	Target_lig_334	50S SB 280080	Escherichia coli	Bacterial growth and infection	Target_100	0	0	7.500000000000001e-09±1.4e-09	0	0	0	0	2OGN	-	10.1073/pnas.0700041104	17360517	Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity.	Davidovich C, Bashan A, Auerbach-Nevo T, Yaggie RD, Gontarek RR, Yonath A	Proc Natl Acad Sci U S A	104	4291-6	2007	-	-	-	-	-	Radioligand displacement assay	SMMRNA	CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCNCC4)C	-	-	4.3781	477.291279856	6	2	5	75.63	0	0.452154844866245	5.61234691665122	33	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	6.10E-09	8.90E-09	0	0	0	0
420	SB-571519	Target_lig_335	50S SB571519	Escherichia coli	Bacterial growth and infection	Target_100	0	0	1.11e-08±3.2000000000000005e-09	0	0	0	0	2OGM	-	10.1073/pnas.0700041104	17360517	Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity.	Davidovich C, Bashan A, Auerbach-Nevo T, Yaggie RD, Gontarek RR, Yonath A	Proc Natl Acad Sci U S A	104	4291-6	2007	-	-	-	-	-	Radioligand displacement assay	SMMRNA	[C@@H]1(C[C@]([C@@H]([C@@H]([C@]23[C@@H]([C@]1([C@@H](CC3)C)C)C(=O)[C@H](C2)O)C)O)(C)C=C)OC(=O)NC(=O)c1ccc(nn1)N	-	-	2.2593	500.263484872	9	4	3	164.73	1	0.455508216623644	5.82271183645817	36	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	7.90E-09	1.43E-08	0	0	0	0
421	Ethidium bromide	Target_lig_6	ss_PolyA	Synthetic	-	Target_40	0	0.046	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.046	0.046	0	0	0	0	0	0
422	Dapi	Target_lig_21	ss_PolyA	Synthetic	-	Target_40	0	0.811	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=CC(=CC=C1C2=CC3=C(N2)C=C(C=C3)C(=N)N)C(=N)N	2-(4-carbamimidoylphenyl)-1H-indole-6-carboximidamide	2954	2.40304	277.13274548	2	5	3	115.53	3	0.373396336397623	2.27030046528223	21	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.811	0.811	0	0	0	0	0	0
423	Proflavin	Target_lig_336	ss_PolyA	Synthetic	-	Target_40	0	0.0045	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N	acridine-3,6-diamine	7099	2.5524	209.095297352	3	2	0	64.93	3	0.441447262692883	2.05911636832492	16	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.0045	0.0045	0	0	0	0	0	0
424	Proflavin	Target_lig_336	ss_PolyA	Synthetic	-	Target_40	0	1.3	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N	acridine-3,6-diamine	7099	2.5524	209.095297352	3	2	0	64.93	3	0.441447262692883	2.05911636832492	16	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	1.3	1.3	0	0	0	0	0	0
425	acridine orange	Target_lig_337	ss_PolyA	Synthetic	-	Target_40	0	5	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N(C)C	3-N,3-N,6-N,6-N-tetramethylacridine-3,6-diamine	62344	3.52	265.157897608	3	0	2	19.37	3	0.660864401147856	2.16285480638045	20	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	5	5	0	0	0	0	0	0
426	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	62	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	62	62	0	0	0	0	0	0
427	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	1.15	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	1.15	1.15	0	0	0	0	0	0
428	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	65	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	65	65	0	0	0	0	0	0
429	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	1.17	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	1.17	1.17	0	0	0	0	0	0
430	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	1.9	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	1.9	1.9	0	0	0	0	0	0
431	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	1.6	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	1.6	1.6	0	0	0	0	0	0
432	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	0.35	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.35	0.35	0	0	0	0	0	0
433	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	0.15	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.15	0.15	0	0	0	0	0	0
434	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	0.05	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.05	0.05	0	0	0	0	0	0
435	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	1.2	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	1.2	1.2	0	0	0	0	0	0
436	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	2	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	2	2	0	0	0	0	0	0
437	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	2.8	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	2.8	2.8	0	0	0	0	0	0
438	Berberine_mol	Target_lig_15	ss_PolyA	Synthetic	-	Target_40	0	0.979	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.979	0.979	0	0	0	0	0	0
439	Coralyne	Target_lig_17	ss_PolyA	Synthetic	-	Target_40	0	1.8	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	1.8	1.8	0	0	0	0	0	0
440	Sanguinarine	Target_lig_18	ss_PolyA	Synthetic	-	Target_40	0	4.6	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C[N+]1=C2C(=C3C=CC4=C(C3=C1)OCO4)C=CC5=CC6=C(C=C52)OCO6	24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene	5154	3.4281	332.09173434809	4	0	0	40.8	4	0.365369910827105	2.89850674553215	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	4.6	4.6	0	0	0	0	0	0
441	PROFLAVIN_PLATINUM_DERIVATIVE	Target_lig_338	ss_PolyA	Synthetic	-	Target_40	0	0.0029	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c1c2c(nc3c1ccc(c3)NCC[Pt]1(Cl)[N](CC[N]1(C)C)(C)C)cc(cc2)NCC[Pt]1(Cl)[N](C)(C)CC[N]1(C)C	-	-	0	0	0	0	0	0	0	0	0	0	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.0029	0.0029	0	0	0	0	0	0
442	Methylene Blue	Target_lig_339	ss_PolyA	Synthetic	-	Target_40	0	2.57	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-]	[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride	6099	-0.497099999999999	319.090996256	3	0	1	19.14	1	0.444985459041416	2.8944168997844	21	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	2.57	2.57	0	0	0	0	0	0
443	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	0.836	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.836	0.836	0	0	0	0	0	0
444	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	1.4	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	1.4	1.4	0	0	0	0	0	0
445	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	0.64	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.64	0.64	0	0	0	0	0	0
446	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	0.44	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.44	0.44	0	0	0	0	0	0
447	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	0.26	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.26	0.26	0	0	0	0	0	0
448	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	1.2	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	1.2	1.2	0	0	0	0	0	0
449	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	0.69	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.69	0.69	0	0	0	0	0	0
450	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	2.15	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	2.15	2.15	0	0	0	0	0	0
451	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	0.45	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.45	0.45	0	0	0	0	0	0
452	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	0.32	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.32	0.32	0	0	0	0	0	0
453	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	0.4	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.4	0.4	0	0	0	0	0	0
454	palmatine_mol	Target_lig_1249	ss_PolyA	Synthetic	-	Target_40	0	0.2	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.2	0.2	0	0	0	0	0	0
455	Quinacrine	Target_lig_340	ss_PolyA	Synthetic	-	Target_40	0	0.139	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC	4-N-(6-chloro-2-methoxyacridin-9-yl)-1-N,1-N-diethylpentane-1,4-diamine	237	5.97240000000001	399.20774026	4	1	9	37.39	3	0.449383143228503	2.78182531860052	28	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.139	0.139	0	0	0	0	0	0
456	hoechst	Target_lig_179	ss_PolyA	Synthetic	-	Target_40	0	2.22	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC(=C(C(=C6)O)O)O	5-[6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazol-2-yl]benzene-1,2,3-triol	135507274	3.6418	456.190988628	7	5	3	124.53	5	0.262584823982756	2.70071217562553	34	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	2.22	2.22	0	0	0	0	0	0
457	Ellipticine	Target_lig_342	ss_PolyA	Synthetic	-	Target_40	0	0	4.60E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=CN=CC2=C(C3=C1NC4=CC=CC=C43)C	5,11-dimethyl-6H-pyrido[4,3-b]carbazole	3213	4.48614	246.115698448	1	1	0	28.68	4	0.486410161758902	2.29466376869934	19	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0	0	4.60E-06	4.60E-06	0	0	0	0
458	Azacyanine 3	Target_lig_343	ss_PolyA	Synthetic	-	Target_40	0	0.38	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN1C2=CC=CC=C2N3C1=NC4=[N+](C5=CC=CC=C5N4C3)C	10,14-dimethyl-1,3,12,14-tetraza-10-azoniapentacyclo[11.7.0.03,11.04,9.015,20]icosa-4,6,8,10,12,15,17,19-octaene	404658	2.3808	290.14002193209	4	0	0	27.65	3	0.594568906776402	3.23127503987906	22	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.38	0.38	0	0	0	0	0	0
459	Azacyanine 5	Target_lig_344	ss_PolyA	Synthetic	-	Target_40	0	0.25	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=CC2=C(C=C1)N3C[N+]4=C(N=C3S2)SC5=C4C=CC(=C5)OC	7,17-dimethoxy-10,14-dithia-3,12-diaza-1-azoniapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),4(9),5,7,11,15(20),16,18-octaene	404662	3.7769	356.05219510809	6	0	2	37.94	3	0.655192232626063	3.26349676003397	24	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.25	0.25	0	0	0	0	0	0
460	Berberine_mol	Target_lig_15	t-RNA(type XX) E.coli strain W	Escherichia coli	Bacterial growth and infection	Target_107	0	10.5	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25			tRNA	-	0	-	Cloverleaf	0	0	10.5	10.5	0	0	0	0	0	0
461	Berberine_mol	Target_lig_15	t-RNA(type XX) E.coli strain W	Escherichia coli	Bacterial growth and infection	Target_107	0	0.87	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25			tRNA	-	0	-	Cloverleaf	0	0	0.87	0.87	0	0	0	0	0	0
462	Berberine_mol	Target_lig_15	t-RNA(type XX) E.coli strain W	Escherichia coli	Bacterial growth and infection	Target_107	0	11	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25			tRNA	-	0	-	Cloverleaf	0	0	11	11	0	0	0	0	0	0
463	Berberine_mol	Target_lig_15	t-RNA(type XX) E.coli strain W	Escherichia coli	Bacterial growth and infection	Target_107	0	0.875	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25			tRNA	-	0	-	Cloverleaf	0	0	0.875	0.875	0	0	0	0	0	0
464	Coralyne	Target_lig_17	double stranded poly(A)	Synthetic	-	Target_45	0	0.657	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.657	0.657	0	0	0	0	0	0
465	Sanguinarine	Target_lig_18	double stranded poly(A)	Synthetic	-	Target_45	0	0.071	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C[N+]1=C2C(=C3C=CC4=C(C3=C1)OCO4)C=CC5=CC6=C(C=C52)OCO6	24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene	5154	3.4281	332.09173434809	4	0	0	40.8	4	0.365369910827105	2.89850674553215	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.071	0.071	0	0	0	0	0	0
466	Sanguinarine	Target_lig_18	double stranded poly(A)	Synthetic	-	Target_45	0	0.0308	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C[N+]1=C2C(=C3C=CC4=C(C3=C1)OCO4)C=CC5=CC6=C(C=C52)OCO6	24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene	5154	3.4281	332.09173434809	4	0	0	40.8	4	0.365369910827105	2.89850674553215	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.0308	0.0308	0	0	0	0	0	0
467	Sanguinarine	Target_lig_18	double stranded poly(A)	Synthetic	-	Target_45	0	0.022	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C[N+]1=C2C(=C3C=CC4=C(C3=C1)OCO4)C=CC5=CC6=C(C=C52)OCO6	24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene	5154	3.4281	332.09173434809	4	0	0	40.8	4	0.365369910827105	2.89850674553215	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.022	0.022	0	0	0	0	0	0
468	Methylene Blue	Target_lig_339	double stranded poly(A)	Synthetic	-	Target_45	0	0.17	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-]	[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride	6099	-0.497099999999999	319.090996256	3	0	1	19.14	1	0.444985459041416	2.8944168997844	21	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.17	0.17	0	0	0	0	0	0
469	Coralyne	Target_lig_17	Poly (G)	Synthetic	-	Target_46	0	0.271	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.271	0.271	0	0	0	0	0	0
470	Coralyne	Target_lig_17	Poly (G)	Synthetic	-	Target_46	0	0.232	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.232	0.232	0	0	0	0	0	0
471	Coralyne	Target_lig_17	Poly (G)	Synthetic	-	Target_46	0	0.15	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.15	0.15	0	0	0	0	0	0
472	Coralyne	Target_lig_17	Poly (G)	Synthetic	-	Target_46	0	2.045	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	2.045	2.045	0	0	0	0	0	0
473	Coralyne	Target_lig_17	Poly (G)	Synthetic	-	Target_46	0	0.149	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.149	0.149	0	0	0	0	0	0
474	Coralyne	Target_lig_17	Poly (I)	Synthetic	-	Target_47	0	0.197	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.197	0.197	0	0	0	0	0	0
475	Coralyne	Target_lig_17	Poly (I)	Synthetic	-	Target_47	0	0.148	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.148	0.148	0	0	0	0	0	0
476	Coralyne	Target_lig_17	Poly (I)	Synthetic	-	Target_47	0	0.15	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.15	0.15	0	0	0	0	0	0
477	Coralyne	Target_lig_17	Poly (I)	Synthetic	-	Target_47	0	1.503	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	1.503	1.503	0	0	0	0	0	0
478	Coralyne	Target_lig_17	Poly (I)	Synthetic	-	Target_47	0	0.041	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.041	0.041	0	0	0	0	0	0
479	Coralyne	Target_lig_17	Poly (U)	Synthetic	-	Target_48	0	0.00117	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.00117	0.00117	0	0	0	0	0	0
480	Coralyne	Target_lig_17	Poly (U)	Synthetic	-	Target_48	0	0.0065	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.0065	0.0065	0	0	0	0	0	0
481	Coralyne	Target_lig_17	Poly (C)	Synthetic	-	Target_49	0	0.00068	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.00068	0.00068	0	0	0	0	0	0
482	Coralyne	Target_lig_17	Poly (C)	Synthetic	-	Target_49	0	0.0028	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.0028	0.0028	0	0	0	0	0	0
483	palmatine_mol	Target_lig_1249	ss poly(A)	Synthetic	-	Target_40	0	0.64	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.64	0.64	0	0	0	0	0	0
484	palmatine_mol	Target_lig_1249	Bakers Yeast-tRNA	Saccharomyces cereviseae	-	Target_1	0	0.051	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0.051	0.051	0	0	0	0	0	0
485	Ethidium bromide	Target_lig_6	ss poly(rG)	Synthetic	-	Target_41	0	0.285	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.285	0.285	0	0	0	0	0	0
486	Ethidium bromide	Target_lig_6	ss poly(rG)	Synthetic	-	Target_41	0	0.245	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.245	0.245	0	0	0	0	0	0
487	Ethidium bromide	Target_lig_6	ss poly(rG)	Synthetic	-	Target_41	0	0.511	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.511	0.511	0	0	0	0	0	0
488	Berberine_mol_chloride_salt Chloride	Target_lig_1250	ss poly(rG)	Synthetic	-	Target_41	0	0.264	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.264	0.264	0	0	0	0	0	0
489	Berberine_mol_chloride_salt Chloride	Target_lig_1250	ss poly(rG)	Synthetic	-	Target_41	0	0.227	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.227	0.227	0	0	0	0	0	0
490	Berberine_mol_chloride_salt Chloride	Target_lig_1250	ss poly(rG)	Synthetic	-	Target_41	0	0.455	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.455	0.455	0	0	0	0	0	0
491	palmatine chloride new	Target_lig_345	ss poly(rG)	Synthetic	-	Target_41	0	0.23	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.23	0.23	0	0	0	0	0	0
492	palmatine chloride new	Target_lig_345	ss poly(rG)	Synthetic	-	Target_41	0	0.19	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.19	0.19	0	0	0	0	0	0
493	palmatine chloride new	Target_lig_345	ss poly(rG)	Synthetic	-	Target_41	0	0.36	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.36	0.36	0	0	0	0	0	0
494	Ethidium bromide	Target_lig_6	ss poly(rI)	Synthetic	-	Target_42	0	0.21	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.21	0.21	0	0	0	0	0	0
495	Ethidium bromide	Target_lig_6	ss poly(rI)	Synthetic	-	Target_42	0	0.154	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.154	0.154	0	0	0	0	0	0
496	Ethidium bromide	Target_lig_6	ss poly(rI)	Synthetic	-	Target_42	0	0.325	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.325	0.325	0	0	0	0	0	0
497	Berberine_mol_chloride_salt Chloride	Target_lig_1250	ss poly(rI)	Synthetic	-	Target_42	0	0.181	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.181	0.181	0	0	0	0	0	0
498	Berberine_mol_chloride_salt Chloride	Target_lig_1250	ss poly(rI)	Synthetic	-	Target_42	0	0.14	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.14	0.14	0	0	0	0	0	0
499	Berberine_mol_chloride_salt Chloride	Target_lig_1250	ss poly(rI)	Synthetic	-	Target_42	0	0.215	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.215	0.215	0	0	0	0	0	0
500	palmatine chloride new	Target_lig_345	ss poly(rI)	Synthetic	-	Target_42	0	0.179	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.179	0.179	0	0	0	0	0	0
501	palmatine chloride new	Target_lig_345	ss poly(rI)	Synthetic	-	Target_42	0	0.119	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.119	0.119	0	0	0	0	0	0
502	palmatine chloride new	Target_lig_345	ss poly(rI)	Synthetic	-	Target_42	0	0.19	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.19	0.19	0	0	0	0	0	0
503	Ethidium bromide	Target_lig_6	ss poly(rU)	Synthetic	-	Target_43	0	0.00086	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.00086	0.00086	0	0	0	0	0	0
504	Berberine_mol_chloride_salt Chloride	Target_lig_1250	ss poly(rU)	Synthetic	-	Target_43	0	0.00179	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.00179	0.00179	0	0	0	0	0	0
505	palmatine chloride new	Target_lig_345	ss poly(rU)	Synthetic	-	Target_43	0	0.0201	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.0201	0.0201	0	0	0	0	0	0
506	Ethidium bromide	Target_lig_6	ss poly(rC)	Synthetic	-	Target_44	0	0.00059	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.00059	0.00059	0	0	0	0	0	0
507	Berberine_mol_chloride_salt Chloride	Target_lig_1250	ss poly(rC)	Synthetic	-	Target_44	0	0.00033	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.00033	0.00033	0	0	0	0	0	0
508	palmatine chloride new	Target_lig_345	ss poly(rC)	Synthetic	-	Target_44	0	0.00074	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.00074	0.00074	0	0	0	0	0	0
509	Berberine_mol	Target_lig_15	POLY(AU)	Synthetic	-	Target_50	0	0.0224	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0224	0.0224	0	0	0	0	0	0
510	Berberine_mol	Target_lig_15	POLY(AU)	Synthetic	-	Target_50	0	0.0213	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0213	0.0213	0	0	0	0	0	0
511	Berberine_mol	Target_lig_15	POLY(AU)	Synthetic	-	Target_50	0	0.84	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.84	0.84	0	0	0	0	0	0
512	Berberine_mol	Target_lig_15	POLY(AU)	Synthetic	-	Target_50	0	1	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	1	1	0	0	0	0	0	0
513	Berberine_mol	Target_lig_15	POLY(AU)	Synthetic	-	Target_50	0	1.6	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	1.6	1.6	0	0	0	0	0	0
514	Berberine_mol	Target_lig_15	POLY(AU)	Synthetic	-	Target_50	0	0.81	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.81	0.81	0	0	0	0	0	0
515	Berberine_mol	Target_lig_15	POLY(AU)	Synthetic	-	Target_50	0	0.09	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.09	0.09	0	0	0	0	0	0
516	Coralyne	Target_lig_17	POLY(AU)	Synthetic	-	Target_50	0	0.0886	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0886	0.0886	0	0	0	0	0	0
517	Coralyne	Target_lig_17	POLY(AU)	Synthetic	-	Target_50	0	0.068	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.068	0.068	0	0	0	0	0	0
518	Coralyne	Target_lig_17	POLY(AU)	Synthetic	-	Target_50	0	2.73	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	2.73	2.73	0	0	0	0	0	0
519	Coralyne	Target_lig_17	POLY(AU)	Synthetic	-	Target_50	0	4.39	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	4.39	4.39	0	0	0	0	0	0
520	Coralyne	Target_lig_17	POLY(AU)	Synthetic	-	Target_50	0	4.84	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	4.84	4.84	0	0	0	0	0	0
521	Coralyne	Target_lig_17	POLY(AU)	Synthetic	-	Target_50	0	3.02	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	3.02	3.02	0	0	0	0	0	0
522	Coralyne	Target_lig_17	POLY(AU)	Synthetic	-	Target_50	0	1.18	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	1.18	1.18	0	0	0	0	0	0
523	palmatine_mol	Target_lig_1249	POLY(AU)	Synthetic	-	Target_50	0	0.0412	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0412	0.0412	0	0	0	0	0	0
524	palmatine_mol	Target_lig_1249	POLY(AU)	Synthetic	-	Target_50	0	0.0368	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0368	0.0368	0	0	0	0	0	0
525	palmatine_mol	Target_lig_1249	POLY(AU)	Synthetic	-	Target_50	0	1.44	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	1.44	1.44	0	0	0	0	0	0
526	palmatine_mol	Target_lig_1249	POLY(AU)	Synthetic	-	Target_50	0	1.64	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	1.64	1.64	0	0	0	0	0	0
527	palmatine_mol	Target_lig_1249	POLY(AU)	Synthetic	-	Target_50	0	2.48	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	2.48	2.48	0	0	0	0	0	0
528	palmatine_mol	Target_lig_1249	POLY(AU)	Synthetic	-	Target_50	0	1.23	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	1.23	1.23	0	0	0	0	0	0
529	palmatine_mol	Target_lig_1249	POLY(AU)	Synthetic	-	Target_50	0	0.56	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.56	0.56	0	0	0	0	0	0
530	Berberine_mol	Target_lig_15	POLY(IC)	Synthetic	-	Target_51	0	0.57	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.57	0.57	0	0	0	0	0	0
531	Berberine_mol	Target_lig_15	POLY(IC)	Synthetic	-	Target_51	0	0.61	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.61	0.61	0	0	0	0	0	0
532	Berberine_mol	Target_lig_15	POLY(IC)	Synthetic	-	Target_51	0	0.95	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.95	0.95	0	0	0	0	0	0
533	Berberine_mol	Target_lig_15	POLY(IC)	Synthetic	-	Target_51	0	0.61	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.61	0.61	0	0	0	0	0	0
534	Berberine_mol	Target_lig_15	POLY(IC)	Synthetic	-	Target_51	0	0.06	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.06	0.06	0	0	0	0	0	0
535	Berberine_mol	Target_lig_15	POLY(IC)	Synthetic	-	Target_51	0	0.0142	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0142	0.0142	0	0	0	0	0	0
536	Berberine_mol	Target_lig_15	POLY(IC)	Synthetic	-	Target_51	0	0.0101	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0101	0.0101	0	0	0	0	0	0
537	Coralyne	Target_lig_17	POLY(IC)	Synthetic	-	Target_51	0	0.84	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.84	0.84	0	0	0	0	0	0
538	Coralyne	Target_lig_17	POLY(IC)	Synthetic	-	Target_51	0	2.27	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	2.27	2.27	0	0	0	0	0	0
539	Coralyne	Target_lig_17	POLY(IC)	Synthetic	-	Target_51	0	2.69	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	2.69	2.69	0	0	0	0	0	0
540	Coralyne	Target_lig_17	POLY(IC)	Synthetic	-	Target_51	0	1.17	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	1.17	1.17	0	0	0	0	0	0
541	Coralyne	Target_lig_17	POLY(IC)	Synthetic	-	Target_51	0	0.95	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.95	0.95	0	0	0	0	0	0
542	Coralyne	Target_lig_17	POLY(IC)	Synthetic	-	Target_51	0	0.0562	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0562	0.0562	0	0	0	0	0	0
543	Coralyne	Target_lig_17	POLY(IC)	Synthetic	-	Target_51	0	0.0469	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0469	0.0469	0	0	0	0	0	0
544	palmatine_mol	Target_lig_1249	POLY(IC)	Synthetic	-	Target_51	0	0.75	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.75	0.75	0	0	0	0	0	0
545	palmatine_mol	Target_lig_1249	POLY(IC)	Synthetic	-	Target_51	0	1.13	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	1.13	1.13	0	0	0	0	0	0
546	palmatine_mol	Target_lig_1249	POLY(IC)	Synthetic	-	Target_51	0	1.84	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	1.84	1.84	0	0	0	0	0	0
547	palmatine_mol	Target_lig_1249	POLY(IC)	Synthetic	-	Target_51	0	0.94	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.94	0.94	0	0	0	0	0	0
548	palmatine_mol	Target_lig_1249	POLY(IC)	Synthetic	-	Target_51	0	0.07	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.07	0.07	0	0	0	0	0	0
549	palmatine_mol	Target_lig_1249	POLY(IC)	Synthetic	-	Target_51	0	0.035	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.035	0.035	0	0	0	0	0	0
550	palmatine_mol	Target_lig_1249	POLY(IC)	Synthetic	-	Target_51	0	0.0296	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0296	0.0296	0	0	0	0	0	0
551	Berberine_mol	Target_lig_15	poly(C) and poly(G)	Synthetic	-	Target_52	0	0.00014	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.00014	0.00014	0	0	0	0	0	0
552	Berberine_mol	Target_lig_15	poly(C) and poly(G)	Synthetic	-	Target_52	0	0.00016	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.00016	0.00016	0	0	0	0	0	0
553	Coralyne	Target_lig_17	poly(C) and poly(G)	Synthetic	-	Target_52	0	1.76	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	1.76	1.76	0	0	0	0	0	0
554	Coralyne	Target_lig_17	poly(C) and poly(G)	Synthetic	-	Target_52	0	0.87	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.87	0.87	0	0	0	0	0	0
555	Coralyne	Target_lig_17	poly(C) and poly(G)	Synthetic	-	Target_52	0	0.08	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.08	0.08	0	0	0	0	0	0
556	Coralyne	Target_lig_17	poly(C) and poly(G)	Synthetic	-	Target_52	0	0.0172	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0172	0.0172	0	0	0	0	0	0
557	Coralyne	Target_lig_17	poly(C) and poly(G)	Synthetic	-	Target_52	0	0.0145	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0145	0.0145	0	0	0	0	0	0
558	palmatine_mol	Target_lig_1249	poly(C) and poly(G)	Synthetic	-	Target_52	0	1.3	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	1.3	1.3	0	0	0	0	0	0
559	palmatine_mol	Target_lig_1249	poly(C) and poly(G)	Synthetic	-	Target_52	0	0.78	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.78	0.78	0	0	0	0	0	0
560	palmatine_mol	Target_lig_1249	poly(C) and poly(G)	Synthetic	-	Target_52	0	0.06	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.06	0.06	0	0	0	0	0	0
561	palmatine_mol	Target_lig_1249	poly(C) and poly(G)	Synthetic	-	Target_52	0	0.017	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.017	0.017	0	0	0	0	0	0
562	palmatine_mol	Target_lig_1249	poly(C) and poly(G)	Synthetic	-	Target_52	0	0.0168	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	-	0	0	0.0168	0.0168	0	0	0	0	0	0
563	Ethidium bromide	Target_lig_6	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.138	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.138	0.138	0	0	0	0	0	0
564	Ethidium bromide	Target_lig_6	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.12	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.12	0.12	0	0	0	0	0	0
565	Ethidium bromide	Target_lig_6	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.132	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.132	0.132	0	0	0	0	0	0
566	Berberine_mol	Target_lig_15	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.115	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.115	0.115	0	0	0	0	0	0
567	Berberine_mol	Target_lig_15	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.095	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.095	0.095	0	0	0	0	0	0
568	Berberine_mol	Target_lig_15	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.129	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.129	0.129	0	0	0	0	0	0
569	Coralyne	Target_lig_17	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	1.106	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	1.106	1.106	0	0	0	0	0	0
570	Coralyne	Target_lig_17	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.787	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.787	0.787	0	0	0	0	0	0
571	Coralyne	Target_lig_17	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.131	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.131	0.131	0	0	0	0	0	0
572	Coralyne	Target_lig_17	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.00213	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.00213	0.00213	0	0	0	0	0	0
573	Coralyne	Target_lig_17	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.00198	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.00198	0.00198	0	0	0	0	0	0
574	Coralyne	Target_lig_17	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.0028	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.0028	0.0028	0	0	0	0	0	0
575	palmatine_mol	Target_lig_1249	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.105	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.105	0.105	0	0	0	0	0	0
576	palmatine_mol	Target_lig_1249	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.09	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.09	0.09	0	0	0	0	0	0
577	palmatine_mol	Target_lig_1249	ANTICODON LOOP	Saccharomyces cereviseae	-	Target_108	0	0.126	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26			tRNA	Anticodon loop of tRNA	0	-	Cloverleaf	0	0	0.126	0.126	0	0	0	0	0	0
578	Berberine_mol	Target_lig_15	poly(U) and Poly(A)	Synthetic	-	Target_2	0	0.16	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.16	0.16	0	0	0	0	0	0
579	Berberine_mol	Target_lig_15	poly(U) and Poly(A)	Synthetic	-	Target_2	0	0.28	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.28	0.28	0	0	0	0	0	0
580	Coralyne	Target_lig_17	poly(U) and Poly(A)	Synthetic	-	Target_2	0	4	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	4	4	0	0	0	0	0	0
581	Coralyne	Target_lig_17	poly(U) and Poly(A)	Synthetic	-	Target_2	0	6.72	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1=C2C=C(C(=CC2=CC3=[N+]1C=CC4=CC(=C(C=C43)OC)OC)OC)OC	2,3,10,11-tetramethoxy-8-methylisoquinolino[2,1-b]isoquinolin-7-ium	23307	4.07452	364.15433460409	4	0	4	41.02	4	0.310886816419356	2.58308426143316	27	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	6.72	6.72	0	0	0	0	0	0
582	palmatine_mol	Target_lig_1249	poly(U) and Poly(A)	Synthetic	-	Target_2	0	0.8	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.8	0.8	0	0	0	0	0	0
583	palmatine_mol	Target_lig_1249	poly(U) and Poly(A)	Synthetic	-	Target_2	0	0.72	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC	2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium	19009	3.3848	352.15433460409	4	0	4	40.8	3	0.675154532390906	2.62010703624121	26	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0.72	0.72	0	0	0	0	0	0
584	Ethidium bromide	Target_lig_6	A Form of poly(rC)	Synthetic	-	Target_53	0	0.12	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	7	20	10 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.12	0.12	0	0	0	0	0	0
585	Ethidium bromide	Target_lig_6	A Form of poly(rC)	Synthetic	-	Target_53	0	0.11	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	7	20	11 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.11	0.11	0	0	0	0	0	0
586	Berberine_mol	Target_lig_15	A Form of poly(rC)	Synthetic	-	Target_53	0	0.008	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	7	20	12 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.008	0.008	0	0	0	0	0	0
587	Methylene Blue	Target_lig_339	A Form of poly(rC)	Synthetic	-	Target_53	0	0.1	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	7	20	13 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-]	[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride	6099	-0.497099999999999	319.090996256	3	0	1	19.14	1	0.444985459041416	2.8944168997844	21	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.1	0.1	0	0	0	0	0	0
588	Methylene Blue	Target_lig_339	A Form of poly(rC)	Synthetic	-	Target_53	0	0.09	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	7	20	14 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-]	[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride	6099	-0.497099999999999	319.090996256	3	0	1	19.14	1	0.444985459041416	2.8944168997844	21	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.09	0.09	0	0	0	0	0	0
589	Ethidium bromide	Target_lig_6	Protonated form of poly(rC)	Synthetic	-	Target_54	0	0.05	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	4.3	20	15 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.05	0.05	0	0	0	0	0	0
590	Ethidium bromide	Target_lig_6	Protonated form of poly(rC)	Synthetic	-	Target_54	0	0.032	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	4.3	20	16 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.032	0.032	0	0	0	0	0	0
591	Berberine_mol	Target_lig_15	Protonated form of poly(rC)	Synthetic	-	Target_54	0	0.12	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	4.3	20	17 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.12	0.12	0	0	0	0	0	0
592	Berberine_mol	Target_lig_15	Protonated form of poly(rC)	Synthetic	-	Target_54	0	0.2	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	4.3	20	18 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC	16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene	2353	3.0963	336.12303447609	4	0	2	40.8	3	0.674490556794137	2.787109824164	25	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.2	0.2	0	0	0	0	0	0
593	Methylene Blue	Target_lig_339	Protonated form of poly(rC)	Synthetic	-	Target_54	0	0.7	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	4.3	20	19 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-]	[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride	6099	-0.497099999999999	319.090996256	3	0	1	19.14	1	0.444985459041416	2.8944168997844	21	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.7	0.7	0	0	0	0	0	0
594	Methylene Blue	Target_lig_339	Protonated form of poly(rC)	Synthetic	-	Target_54	0	0.52	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	4.3	20	20 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-]	[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride	6099	-0.497099999999999	319.090996256	3	0	1	19.14	1	0.444985459041416	2.8944168997844	21	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.52	0.52	0	0	0	0	0	0
595	Distamycin A	Target_lig_346	Protonated form of poly(rC)	Synthetic	-	Target_54	0	0.28	0	0	0	0	0	-	-	10.1016/j.bmc.2005.09.007	16202606	The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.	Sinha R, Islam MM, Bhadra K, Kumar GS, Banerjee A, Maiti M	Bioorg Med Chem	14	800-14	2006	-	-	4.3	20	21 mM citrate-phosphate buffer	Absorption and fluorescence spectroscopy	SMMRNA	CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NC3=CN(C(=C3)C(=O)NC4=CN(C(=C4)C(=O)NC5=CN(C(=C5)C(=O)NCCC(=N)N)C)C)C)C)NC=O	N-[5-[[5-[[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-4-formamido-1-methylpyrrole-2-carboxamide	161892	2.01247	725.314625968	12	8	14	249.12	5	0.048005278239347	3.4723399152529	53	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC	https://www.cytivalifesciences.com/en/us/shop/molecular-biology/cloning/polynucleotides/poly-a-p-05725	RNA aptamer	-	200	-	-	0	0	0.28	0.28	0	0	0	0	0	0
596	Paromomycin_mol_mol	Target_lig_1116	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.30E-07	0	0	0	0	1J7T	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.30E-07	1.30E-07	0	0	0	0
597	Neamine	Target_lig_80	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0039	0	0	0	0	2ET8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol	413349	-5.11559999999999	322.185234552	10	8	3	203.46	0	0.247960739843155	4.62440978066844	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0039	0.0039	0	0	0	0
598	Tobramycin	Target_lig_540	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1 uM - 2	0	0	0	0	1LC4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-06	2.00E-06	0	0	0	0
599	Kanamycin A	Target_lig_7	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.00E-06	0	0	0	0	2ESI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
600	Neomycin B	Target_lig_1251	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1 uM - 2	0	0	0	0	2ET4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-06	2.00E-06	0	0	0	0
601	radezolid	Target_lig_330	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	2.00E-08	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)CNCC4=NNN=C4)F	N-[[3-[3-fluoro-4-[4-[(2H-triazol-4-ylmethylamino)methyl]phenyl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	22274119	2.3619	438.181566816	6	3	8	112.24	3	0.497844423315673	3.10617635177683	32	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	2.00E-08	2.00E-08	0	0	0	0	0	0
602	Spiro-compound_1	Target_lig_347	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	7.40E-05	0	0	0	-	-	10.1016/j.bmcl.2010.10.001	29137205	Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.	Ayeleso TB, Matumba MG, Mukwevho E	Molecules	22		2017	500 nM - 1 mM	1nM - 1mM	6.8	37	30 mM Sodium cacodylate buffer	RNA fluorescence and coupled in-vitro transcription-translation assay	SMMRNA	C1[C@@H]([C@H](C[C@@]2(O1)[C@H](C[C@H]([C@@H]([C@H]2O)O)N)N)O)O	-	-	-3.3526	248.13722174	7	6	0	142.19	0	0.262769002831054	5.47735578859491	17	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	7.40E-05	7.40E-05	0	0
603	Spiro-compound_2	Target_lig_348	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	6.90E-06	0	0	0	-	-	10.1016/j.bmcl.2010.10.001	29137205	Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.	Ayeleso TB, Matumba MG, Mukwevho E	Molecules	22		2017	500 nM - 1 mM	1nM - 1mM	6.8	37	30 mM Sodium cacodylate buffer	RNA fluorescence and coupled in-vitro transcription-translation assay	SMMRNA	C1[C@H]([C@@H](C[C@@]2(O1)[C@H](C[C@H]([C@@H]([C@H]2O)O)NC(=O)[C@H](CCN)O)N)O)O	-	-	-4.48539999999999	349.184900204	9	8	4	191.52	0	0.246965784947732	5.43126612836383	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	6.90E-06	6.90E-06	0	0
604	Spiro-compound_3	Target_lig_349	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	1.20E-05	0	0	0	-	-	10.1016/j.bmcl.2010.10.001	29137205	Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.	Ayeleso TB, Matumba MG, Mukwevho E	Molecules	22		2017	500 nM - 1 mM	1nM - 1mM	6.8	37	30 mM Sodium cacodylate buffer	RNA fluorescence and coupled in-vitro transcription-translation assay	SMMRNA	C1[C@@H]([C@@H](C[C@]2(O1)[C@H](C[C@H]([C@@H]([C@H]2O)O)NC(=O)[C@H](CCCCN)N)N)O)O	-	-	-3.73879999999999	376.232184744	9	8	6	197.31	0	0.214645426451952	5.25706966136494	26	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	1.20E-05	1.20E-05	0	0
605	Spiro-ether_compound_1	Target_lig_350	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	2.0000000000000003e-10±9e-11	0	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	SMMRNA	C(O)c1cn(nn1)C[C@@H]1CC[C@]2(O1)[C@H](C[C@H]([C@@H]([C@H]2O)O)N)N	-	-	-2.5317	313.175004216	9	5	3	152.67	1	0.409283543854222	5.21395814050921	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	1.10E-10	2.90E-10	0	0
606	Spiro-ether_compound_2	Target_lig_351	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	2.5e-09±8.000000000000001e-10	0	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	SMMRNA	C(c1cn(nn1)C[C@@H]1CC[C@]2(O1)[C@H](C[C@H]([C@@H]([C@H]2O)O)N)N)OCc1ccccc1	-	-	-0.307199999999996	403.221954408	9	4	6	141.67	2	0.514703689409718	4.84670095980045	29	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	1.70E-09	3.30E-09	0	0
607	Bifunctional_aminoglycoside_derivative_1	Target_lig_353	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	8.00E-07	0	0	0	0	-	-	10.1021/ja000575w	-	Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes	Sucheck SJ, Wong AL, Koeller KM, Boehr DD, Draker K, Sears P, Wright GD, Wong C	J Am Chem Soc	122	5230-5231	2000	-	-	7.8	21	15 mM MgSO4	SPR spectroscopy	SMMRNA	[C@H]1([C@@H]([C@@H]([C@@H](O[C@@H]1CN)O[C@@H]1[C@@H]([C@@H]([C@@H](C[C@@H]1N)N)O)OCC(=O)NCCCCCNC(=O)CO[C@@H]1[C@@H]([C@H](C[C@@H]([C@H]1O)N)N)O[C@H]1[C@H]([C@H]([C@H]([C@@H](O1)CN)O)O)N)N)O)O	-	-	-9.76630000000002	826.475996792	22	16	18	443.12	0	0.057042402720279	5.87815637075893	57	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	8.00E-07	8.00E-07	0	0	0	0
608	Bifunctional_aminoglycoside_derivative_2	Target_lig_354	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	4.00E-08	0	0	0	0	-	-	10.1021/ja000575w	-	Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes	Sucheck SJ, Wong AL, Koeller KM, Boehr DD, Draker K, Sears P, Wright GD, Wong C	J Am Chem Soc	122	5230-5231	2000	-	-	7.8	21	15 mM MgSO4	SPR spectroscopy	SMMRNA	[C@H]1([C@@H]([C@@H]([C@@H](O[C@H]1CN)O[C@H]1[C@H]([C@H]([C@H](C[C@@H]1N)N)O)OC[C@@H](CN(CCCCN(C[C@@H](CO[C@H]1[C@@H]([C@H](C[C@H]([C@@H]1O)N)N)O[C@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)CN)O)O)N)O)C)C)O)N)O)O	-	-	-9.80340000000002	872.554247112	24	16	21	431.86	0	0.047615260931395	6.19046277986171	60	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	4.00E-08	4.00E-08	0	0	0	0
609	Bifunctional_aminoglycoside_derivative_3	Target_lig_355	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.10E-05	0	0	0	0	-	-	10.1021/ja000575w	-	Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes	Sucheck SJ, Wong AL, Koeller KM, Boehr DD, Draker K, Sears P, Wright GD, Wong C	J Am Chem Soc	122	5230-5231	2000	-	-	7.8	21	15 mM MgSO4	SPR spectroscopy	SMMRNA	[C@@H]1([C@H]([C@H]([C@@H](O[C@@H]1CN)OC[C@@H](CN(CCCCCCN(C)C[C@H](CO[C@@H]1O[C@H]([C@@H]([C@@H]([C@H]1N)O)O)CN)O)C)O)N)O)O	-	-	-5.36920000000001	612.405791992	16	10	19	268.86	0	0.060984336812913	5.13307976571623	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.10E-05	1.10E-05	0	0	0	0
610	Bifunctional_aminoglycoside_derivative_4	Target_lig_356	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.10E-05	0	0	0	0	-	-	10.1021/ja000575w	-	Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes	Sucheck SJ, Wong AL, Koeller KM, Boehr DD, Draker K, Sears P, Wright GD, Wong C	J Am Chem Soc	122	5230-5231	2000	-	-	7.8	21	15 mM MgSO4	SPR spectroscopy	SMMRNA	[C@@H]1([C@H]([C@H]([C@@H]([C@@H](C1)N)OC[C@@H](CN(CCCCCCN(C)C[C@@H](CO[C@@H]1[C@@H](C[C@H]([C@@H]([C@H]1O)O)N)N)O)C)O)O)O)N	-	-	-4.5372	580.415962752	14	10	17	250.4	0	0.072788362356786	5.10629746110933	40	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.10E-05	2.10E-05	0	0	0	0
611	Bifunctional_aminoglycoside_derivative_5	Target_lig_357	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	5.20E-05	0	0	0	0	-	-	10.1021/ja000575w	-	Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes	Sucheck SJ, Wong AL, Koeller KM, Boehr DD, Draker K, Sears P, Wright GD, Wong C	J Am Chem Soc	122	5230-5231	2000	-	-	7.8	21	15 mM MgSO4	SPR spectroscopy	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CO)OC[C@@H](CN(CCCCCCN(C)C[C@H](CO[C@@H]1O[C@H]([C@@H]([C@@H]([C@H]1N)O)O)CO)O)C)O)N)O)O	-	-	-5.302	614.373823168	16	10	19	257.28	0	0.060940294824083	5.03224089931947	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	5.20E-05	5.20E-05	0	0	0	0
612	Bifunctional_aminoglycoside_derivative_6	Target_lig_358	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.90E-05	0	0	0	0	-	-	10.1021/ja000575w	-	Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes	Sucheck SJ, Wong AL, Koeller KM, Boehr DD, Draker K, Sears P, Wright GD, Wong C	J Am Chem Soc	122	5230-5231	2000	-	-	7.8	21	15 mM MgSO4	SPR spectroscopy	SMMRNA	[C@H]1([C@H]([C@@H]([C@H]([C@@H](C1)N)OC[C@@H](CN(CCCCCCN(C)C[C@H](CO[C@@H]1O[C@@H]([C@H]([C@H]([C@H]1N)O)O)CO)O)C)O)O)O)N	-	-	-4.9196	597.39489296	15	10	18	253.84	0	0.066439972524628	5.08456552732597	41	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.90E-05	3.90E-05	0	0	0	0
613	Bifunctional_aminoglycoside_derivative_7	Target_lig_359	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.20E-05	0	0	0	0	-	-	10.1021/ja000575w	-	Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes	Sucheck SJ, Wong AL, Koeller KM, Boehr DD, Draker K, Sears P, Wright GD, Wong C	J Am Chem Soc	122	5230-5231	2000	-	-	7.8	21	15 mM MgSO4	SPR spectroscopy	SMMRNA	[C@H]1([C@H]([C@@H]([C@H]([C@@H](C1)N)OC[C@@H](CN(CCCCCCN(C)C[C@H](CO[C@@H]1O[C@H]([C@@H]([C@@H]([C@H]1N)O)O)CN)O)C)O)O)O)N	-	-	-4.9532	596.410877372	15	10	18	259.63	0	0.06645742075047	5.13634764790809	41	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.20E-05	3.20E-05	0	0	0	0
614	Neamine derivative_1	Target_lig_360	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0012±2e-06	0	0	0	0	-	-	10.1021/ja011695m	11916405	Design of novel antibiotics that bind to the ribosomal acyltransfer site.	Haddad J, Kotra LP, Llano-Sotelo B, Kim C, Azucena EF Jr, Liu M, Vakulenko SB, Chow CS, Mobashery S	J Am Chem Soc	124	3229-37	2002	-	1 uM	7.4	37	150 mM NaCl, 3 mM Na2EDTA	Fluorescence intensity measurements and Kinetic studies	SMMRNA	[C@H]1([C@H]([C@@H]([C@@H](O[C@@H]1CN)O[C@@H]1[C@@H]([C@H]([C@@H](C[C@@H]1N)NC(=O)[C@@H](CCN)O)OCCNCCN)O)N)O)O	-	-	-6.67580000000001	509.317311336	14	11	13	279.84	0	0.102931633521554	4.99451902695244	35	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001198	0.001202	0	0	0	0
615	Neamine derivative_2	Target_lig_361	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	5.9e-06±1.3e-06	0	0	0	0	-	-	10.1021/ja011695m	11916405	Design of novel antibiotics that bind to the ribosomal acyltransfer site.	Haddad J, Kotra LP, Llano-Sotelo B, Kim C, Azucena EF Jr, Liu M, Vakulenko SB, Chow CS, Mobashery S	J Am Chem Soc	124	3229-37	2002	-	1 uM	7.4	37	150 mM NaCl, 3 mM Na2EDTA	Fluorescence intensity measurements and Kinetic studies	SMMRNA	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)OCCNCCCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)N	(2S)-4-amino-N-[(1R,2S,3R,4R,5S)-5-amino-4-[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-2-[2-(3-aminopropylamino)ethoxy]-3-hydroxycyclohexyl]-2-hydroxybutanamide	10142905	-6.28570000000001	523.3329614	14	11	14	279.84	0	0.094462279941492	4.98110586772705	36	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	4.60E-06	7.20E-06	0	0	0	0
616	Neamine derivative_3	Target_lig_362	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.9e-06±1e-07	0	0	0	0	-	-	10.1021/ja011695m	11916405	Design of novel antibiotics that bind to the ribosomal acyltransfer site.	Haddad J, Kotra LP, Llano-Sotelo B, Kim C, Azucena EF Jr, Liu M, Vakulenko SB, Chow CS, Mobashery S	J Am Chem Soc	124	3229-37	2002	-	1 uM	7.4	37	150 mM NaCl, 3 mM Na2EDTA	Fluorescence intensity measurements and Kinetic studies	SMMRNA	[C@H]1([C@H]([C@@H]([C@@H](O[C@@H]1CN)O[C@H]1[C@H]([C@@H]([C@H](C[C@H]1N)NC(=O)[C@@H](CCN)O)OCCNCCCCN)O)N)O)O	-	-	-5.89560000000001	537.348611464	14	11	15	279.84	0	0.08676749135003	4.96922627083035	37	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.80E-06	4.00E-06	0	0	0	0
617	Neamine derivative_4	Target_lig_363	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.6e-06±3e-07	0	0	0	0	-	-	10.1021/ja011695m	11916405	Design of novel antibiotics that bind to the ribosomal acyltransfer site.	Haddad J, Kotra LP, Llano-Sotelo B, Kim C, Azucena EF Jr, Liu M, Vakulenko SB, Chow CS, Mobashery S	J Am Chem Soc	124	3229-37	2002	-	1 uM	7.4	37	150 mM NaCl, 3 mM Na2EDTA	Fluorescence intensity measurements and Kinetic studies	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@H]1CN)O[C@@H]1[C@@H]([C@H]([C@@H](C[C@H]1N)N)OCCNCCCN)O)N)O)O	-	-	-5.1529	422.285282936	12	9	10	230.51	0	0.150398859955546	4.74573327429143	29	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.30E-06	1.90E-06	0	0	0	0
618	Neamine derivative_5	Target_lig_364	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.1e-05±2e-06	0	0	0	0	-	-	10.1021/ja011695m	11916405	Design of novel antibiotics that bind to the ribosomal acyltransfer site.	Haddad J, Kotra LP, Llano-Sotelo B, Kim C, Azucena EF Jr, Liu M, Vakulenko SB, Chow CS, Mobashery S	J Am Chem Soc	124	3229-37	2002	-	1 uM	7.4	37	150 mM NaCl, 3 mM Na2EDTA	Fluorescence intensity measurements and Kinetic studies	SMMRNA	[C@H]1([C@@H]([C@H]([C@H](O[C@@H]1CN)O[C@@H]1[C@@H]([C@@H]([C@H](C[C@H]1N)NC(=O)[C@H](CCN)O)OCCN(CCCN)C(=O)[C@H](CCN)O)O)N)O)O	-	-	-7.33700000000002	624.380639864	16	12	17	334.37	0	0.071442267148926	5.31582747351492	43	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	9.00E-06	1.30E-05	0	0	0	0
619	Neamine derivative_6	Target_lig_365	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.4e-05±8e-06	0	0	0	0	-	-	10.1021/ja011695m	11916405	Design of novel antibiotics that bind to the ribosomal acyltransfer site.	Haddad J, Kotra LP, Llano-Sotelo B, Kim C, Azucena EF Jr, Liu M, Vakulenko SB, Chow CS, Mobashery S	J Am Chem Soc	124	3229-37	2002	-	1 uM	7.4	37	150 mM NaCl, 3 mM Na2EDTA	Fluorescence intensity measurements and Kinetic studies	SMMRNA	[C@H]1([C@H]([C@@H]([C@@H](O[C@H]1CN)O[C@@H]1[C@@H]([C@H]([C@@H](C[C@@H]1N)NC(=O)Cc1ccc(cc1)N)OCCNCCCCN)O)N)O)O	-	-	-3.7804	569.353696844	13	10	14	259.61	1	0.076253504732478	4.7284957758219	40	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.60E-05	3.20E-05	0	0	0	0
620	Neamine derivative_7	Target_lig_366	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.4e-05±6e-06	0	0	0	0	-	-	10.1021/ja011695m	11916405	Design of novel antibiotics that bind to the ribosomal acyltransfer site.	Haddad J, Kotra LP, Llano-Sotelo B, Kim C, Azucena EF Jr, Liu M, Vakulenko SB, Chow CS, Mobashery S	J Am Chem Soc	124	3229-37	2002	-	1 uM	7.4	37	150 mM NaCl, 3 mM Na2EDTA	Fluorescence intensity measurements and Kinetic studies	SMMRNA	[C@H]1([C@H]([C@@H]([C@@H](O[C@@H]1CN)O[C@H]1[C@H]([C@H]([C@@H](C[C@H]1N)NC(=O)Cc1cccc(c1)N)OCCNCCCCN)O)N)O)O	-	-	-3.7804	569.353696844	13	10	14	259.61	1	0.076253504732478	4.75569910222522	40	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.80E-05	3.00E-05	0	0	0	0
621	Neamine mimic_1	Target_lig_367	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	4.90E-05	0	0	0	0	-	-	10.1002/cbic.200400105	15368574	Disaccharide mimetics of the aminoglycoside antibiotic neamine.	Venot A, Swayze EE, Griffey RH, Boons GJ	Chembiochem	5	1228-36	2004	0.75, 2.5, 7.5, 25 uM	0.5 uM	-	-	-	ESI–FT-ICR mass spectra	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CO)O[C@H]1[C@@H]([C@H](O[C@H]([C@@H]1N)OC)CN)O)N)O)O	-	-	-4.84389999999999	353.179814824	11	7	5	195.9	0	0.250190891094437	4.63278205074756	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	4.90E-05	4.90E-05	0	0	0	0
622	Neamine mimic_2	Target_lig_368	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.70E-05	0	0	0	0	-	-	10.1002/cbic.200400105	15368574	Disaccharide mimetics of the aminoglycoside antibiotic neamine.	Venot A, Swayze EE, Griffey RH, Boons GJ	Chembiochem	5	1228-36	2004	0.75, 2.5, 7.5, 25 uM	0.5 uM	-	-	-	ESI–FT-ICR mass spectra	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@@H]1CN)O[C@@H]1[C@H]([C@@H](O[C@@H]([C@H]1N)OC)CN)O)N)O)O	-	-	-4.87749999999999	352.195799236	11	7	5	201.69	0	0.249821890170851	4.72259166613218	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.70E-05	3.70E-05	0	0	0	0
623	Neamine mimic_3	Target_lig_369	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	4.00E-05	0	0	0	0	-	-	10.1002/cbic.200400105	15368574	Disaccharide mimetics of the aminoglycoside antibiotic neamine.	Venot A, Swayze EE, Griffey RH, Boons GJ	Chembiochem	5	1228-36	2004	0.75, 2.5, 7.5, 25 uM	0.5 uM	-	-	-	ESI–FT-ICR mass spectra	SMMRNA	[C@@H]1([C@H]([C@H]([C@H](O[C@@H]1CN)O[C@H]1[C@H]([C@@H]([C@H](O[C@H]1CO)OC)N)O)N)O)O	-	-	-4.84389999999999	353.179814824	11	7	5	195.9	0	0.250190891094437	4.62170512767064	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	4.00E-05	4.00E-05	0	0	0	0
624	Neamine mimic_4	Target_lig_370	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.60E-05	0	0	0	0	-	-	10.1002/cbic.200400105	15368574	Disaccharide mimetics of the aminoglycoside antibiotic neamine.	Venot A, Swayze EE, Griffey RH, Boons GJ	Chembiochem	5	1228-36	2004	0.75, 2.5, 7.5, 25 uM	0.5 uM	-	-	-	ESI–FT-ICR mass spectra	SMMRNA	[C@@H]1([C@@H]([C@@H]([C@H](O[C@@H]1CO)O[C@H]1[C@H]([C@@H]([C@H](O[C@@H]1CN)OC)N)O)N)O)O	-	-	-4.84389999999999	353.179814824	11	7	5	195.9	0	0.250190891094437	4.62591738728602	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.60E-05	2.60E-05	0	0	0	0
625	Neamine mimic_5	Target_lig_371	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.10E-05	0	0	0	0	-	-	10.1002/cbic.200400105	15368574	Disaccharide mimetics of the aminoglycoside antibiotic neamine.	Venot A, Swayze EE, Griffey RH, Boons GJ	Chembiochem	5	1228-36	2004	0.75, 2.5, 7.5, 25 uM	0.5 uM	-	-	-	ESI–FT-ICR mass spectra	SMMRNA	[C@@H]1([C@H]([C@H]([C@@H](O[C@@H]1CN)O[C@@H]1[C@@H]([C@H]([C@@H](O[C@H]1CN)OC)N)O)N)O)O	-	-	-4.87749999999999	352.195799236	11	7	5	201.69	0	0.249821890170851	4.71572700267064	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.10E-05	1.10E-05	0	0	0	0
626	Neamine mimic_6	Target_lig_372	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	3.90E-05	0	0	0	0	-	-	10.1002/cbic.200400105	15368574	Disaccharide mimetics of the aminoglycoside antibiotic neamine.	Venot A, Swayze EE, Griffey RH, Boons GJ	Chembiochem	5	1228-36	2004	0.75, 2.5, 7.5, 25 uM	0.5 uM	-	-	-	ESI–FT-ICR mass spectra	SMMRNA	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CN)O[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1CN)OC)N)O)N)O)O	-	-	-4.87749999999999	352.195799236	11	7	5	201.69	0	0.249821890170851	4.71572700267064	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.90E-05	3.90E-05	0	0	0	0
627	Neamine mimic_7	Target_lig_373	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000281	0	0	0	0	-	-	10.1002/cbic.200400105	15368574	Disaccharide mimetics of the aminoglycoside antibiotic neamine.	Venot A, Swayze EE, Griffey RH, Boons GJ	Chembiochem	5	1228-36	2004	0.75, 2.5, 7.5, 25 uM	0.5 uM	-	-	-	ESI–FT-ICR mass spectra	SMMRNA	[C@H]1([C@H]([C@@H]([C@@H](O[C@@H]1CN)O[C@@H]1[C@@H]([C@H](O[C@H]([C@@H]1N)OC)CN)O[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)C)N)O)O)N)O)O	-	-	-6.05930000000001	497.269692448	15	9	7	266.4	0	0.158293412137217	5.28073183763891	34	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000281	0.000281	0	0	0	0
628	Neamine mimic_8	Target_lig_374	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	4.30E-05	0	0	0	0	-	-	10.1002/cbic.200400105	15368574	Disaccharide mimetics of the aminoglycoside antibiotic neamine.	Venot A, Swayze EE, Griffey RH, Boons GJ	Chembiochem	5	1228-36	2004	0.75, 2.5, 7.5, 25 uM	0.5 uM	-	-	-	ESI–FT-ICR mass spectra	SMMRNA	[C@H]1([C@@H]([C@@H]([C@H](O[C@H]1CN)O[C@@H]1[C@@H]([C@@H]([C@H](O[C@@H]1CN)OC)N)O[C@H]1[C@H]([C@H]([C@@H](O1)CO)O)O)N)O)O	-	-	-6.4142	484.238057972	15	9	8	260.61	0	0.155021208635906	5.082524016018	33	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	4.30E-05	4.30E-05	0	0	0	0
629	Neamine mimic_9	Target_lig_375	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.00E-06	0	0	0	0	-	-	10.1002/cbic.200400105	15368574	Disaccharide mimetics of the aminoglycoside antibiotic neamine.	Venot A, Swayze EE, Griffey RH, Boons GJ	Chembiochem	5	1228-36	2004	0.75, 2.5, 7.5, 25 uM	0.5 uM	-	-	-	ESI–FT-ICR mass spectra	SMMRNA	[C@H]1([C@H]([C@@H]([C@@H](O[C@@H]1CN)O[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1CN)OC)N)O[C@@H]1[C@H]([C@H]([C@H]([C@H](O1)C)N)O)O)N)O)O	-	-	-6.05930000000001	497.269692448	15	9	7	266.4	0	0.158293412137217	5.28073183763891	34	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
630	Paromomycin_mol derivative 1 16S A-site RNA	Target_lig_376	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.30E-07	0	0	0	0	-	-	10.1002/anie.200462092	15593140	Antibacterial aminoglycosides with a modified mode of binding to the ribosomal-RNA decoding site.	François B, Szychowski J, Adhikari SS, Pachamuthu K, Swayze EE, Griffey RH, Migawa MT, Westhof E, Hanessian S	Angew Chem Int Ed Engl	43	6735-8	2004	5 uL	5 uL	7.4	37	PBS	Coupled transcription-translation assay	SMMRNA	C1[C@@H]([C@@H]([C@H]([C@@H]([C@@H]1N)O[C@H]1O[C@H]([C@@H]([C@H]([C@@H]1N)O)O)CO)O[C@@H]1[C@H]([C@H]([C@H](O1)CO)O[C@H]1O[C@@H]([C@@H]([C@H]([C@@H]1N)O)O)CN)OCCN)O)N	-	-	-8.87870000000002	658.33850028	20	13	12	362.34	0	0.09247986042944	5.64419541216445	45	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.30E-07	2.30E-07	0	0	0	0
631	Paromomycin_mol derivative 2 16S A-site RNA	Target_lig_377	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.00E-07	0	0	0	0	-	-	10.1002/anie.200462092	15593140	Antibacterial aminoglycosides with a modified mode of binding to the ribosomal-RNA decoding site.	François B, Szychowski J, Adhikari SS, Pachamuthu K, Swayze EE, Griffey RH, Migawa MT, Westhof E, Hanessian S	Angew Chem Int Ed Engl	43	6735-8	2004	5 uL	5 uL	7.4	37	PBS	Coupled transcription-translation assay	SMMRNA	C1[C@@H]([C@@H]([C@H]([C@H]([C@@H]1N)O[C@@H]1O[C@H]([C@@H]([C@@H]([C@@H]1N)O)O)CO)O[C@@H]1[C@H]([C@H]([C@H](O1)CO)O[C@H]1O[C@H]([C@@H]([C@H]([C@@H]1N)O)O)CN)OCCCN)O)N	-	-	-8.48860000000002	672.354150344	20	13	13	362.34	0	0.080730344664713	5.64016740643203	46	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
632	Paromomycin_mol derivative 3 16S A-site RNA	Target_lig_378	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.30E-07	0	0	0	0	-	-	10.1002/anie.200462092	15593140	Antibacterial aminoglycosides with a modified mode of binding to the ribosomal-RNA decoding site.	François B, Szychowski J, Adhikari SS, Pachamuthu K, Swayze EE, Griffey RH, Migawa MT, Westhof E, Hanessian S	Angew Chem Int Ed Engl	43	6735-8	2004	5 uL	5 uL	7.4	37	PBS	Coupled transcription-translation assay	SMMRNA	C1[C@@H]([C@@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]1O[C@H]([C@@H]([C@H]([C@@H]1N)O)O)CO)O[C@@H]1[C@H]([C@@H]([C@H](O1)CO)O[C@H]1O[C@H]([C@@H]([C@H]([C@@H]1N)O)O)CN)OCc1cccnc1)O)N	-	-	-7.24220000000002	706.33850028	20	12	12	349.21	1	0.095985068577267	5.6029464187191	49	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.30E-07	1.30E-07	0	0	0	0
633	Heterocyclic paromomycin derivative 1	Target_lig_379	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0001	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	SMMRNA	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)OCN2C=NC3=C2N=CNC3=O)O)O)N	9-[[(1S,2S,3R,4S,6R)-4,6-diamino-2,3-dihydroxycyclohexyl]oxymethyl]-1H-purin-6-one	136861556	-2.7576	310.138953056	9	5	3	165.3	2	0.406465498445544	4.40067174674696	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0001	0.0001	0	0	0	0
634	Heterocyclic paromomycin derivative 2	Target_lig_380	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000275	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	SMMRNA	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)OCN2C=CN=C2)O)O)N	(1R,2S,3S,4R,6S)-4,6-diamino-3-(imidazol-1-ylmethoxy)cyclohexane-1,2-diol	102462539	-1.9941	242.137890436	7	4	3	119.55	1	0.486740638815768	4.3070769874454	17	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000275	0.000275	0	0	0	0
635	Heterocyclic paromomycin derivative 3	Target_lig_381	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000355	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	SMMRNA	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)OCN2C=CN=N2)O)O)N	(1R,2S,3S,4R,6S)-4,6-diamino-3-(triazol-1-ylmethoxy)cyclohexane-1,2-diol	102462543	-2.5991	243.133139404	8	4	3	132.44	1	0.457278924340242	4.49876078449941	17	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000355	0.000355	0	0	0	0
636	Heterocyclic paromomycin derivative 4	Target_lig_382	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000378	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	SMMRNA	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)OCN2C=NC=N2)O)O)N	(1R,2S,3S,4R,6S)-4,6-diamino-3-(1,2,4-triazol-1-ylmethoxy)cyclohexane-1,2-diol	102462542	-2.5991	243.133139404	8	4	3	132.44	1	0.457278924340242	4.38906389415572	17	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000378	0.000378	0	0	0	0
637	Quinolinyl_DOS_der	Target_lig_383	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.80E-05	0	0	0	0	-	-	10.1002/anie.200351354	12888972	Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.	Ding Y, Hofstadler SA, Swayze EE, Risen L, Griffey RH	Angew Chem Int Ed Engl	42	3409-12	2003	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	SMMRNA	C1[C@@H](N)[C@@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O	-	-	1.4685	403.11774716	7	4	4	114.62	2	0.451432479803258	4.16281397172473	27	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.80E-05	6.80E-05	0	0	0	0
638	Quinolinyl_DOS_paromomycin_der_1	Target_lig_384	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	<1e-06	0	0	0	0	-	-	10.1002/anie.200351354	12888972	Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.	Ding Y, Hofstadler SA, Swayze EE, Risen L, Griffey RH	Angew Chem Int Ed Engl	42	3409-12	2003	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	SMMRNA	C1[C@@H](N)[C@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O[C@@H]1O[C@@H]([C@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)CN)O)O)N)CO	-	-	-2.31119999999999	695.24479814	16	9	10	264.27	2	0.093372181281344	5.43483778753677	47	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
639	Quinolinyl_DOS_paromomycin_der_2	Target_lig_385	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.50E-06	0	0	0	0	-	-	10.1002/anie.200351354	12888972	Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.	Ding Y, Hofstadler SA, Swayze EE, Risen L, Griffey RH	Angew Chem Int Ed Engl	42	3409-12	2003	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	SMMRNA	C1[C@H](N)[C@@H](OCCNCCCN)[C@H]([C@H]([C@@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O	-	-	1.4312	503.217795544	9	5	11	141.67	2	0.17487360318346	4.36143569821737	34	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.50E-06	1.50E-06	0	0	0	0
640	Quinolinyl_DOS_paromomycin_der_3	Target_lig_386	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.00E-06	0	0	0	0	-	-	10.1002/anie.200351354	12888972	Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.	Ding Y, Hofstadler SA, Swayze EE, Risen L, Griffey RH	Angew Chem Int Ed Engl	42	3409-12	2003	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	SMMRNA	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)OCSC2=C3C=CC(=CC3=NC=C2)C(F)(F)F)OCCNCCCN)O)N	(1S,2R,3R,4S,6R)-4,6-diamino-2-[2-(3-aminopropylamino)ethoxy]-3-[[7-(trifluoromethyl)quinolin-4-yl]sulfanylmethoxy]cyclohexan-1-ol	11605808	1.4312	503.217795544	9	5	11	141.67	2	0.17487360318346	4.37338128526191	34	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
641	Acyclic DOS mimic 1_biphenyl substituent	Target_lig_387	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.30E-06	0	0	0	0	-	-	10.1002/anie.200351354	12888972	Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.	Ding Y, Hofstadler SA, Swayze EE, Risen L, Griffey RH	Angew Chem Int Ed Engl	42	3409-12	2003	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	SMMRNA	c1cccc(c1)c1ccc(cc1)CO[C@H](CO[C@@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1N)CN)CN	-	-	-0.053199999999998	417.226371092	8	5	9	146.21	2	0.381553593969954	3.85213702026924	30	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.30E-06	2.30E-06	0	0	0	0
642	Acyclic DOS mimic 2_naphthyl substituent	Target_lig_388	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.80E-06	0	0	0	0	-	-	10.1002/anie.200351354	12888972	Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.	Ding Y, Hofstadler SA, Swayze EE, Risen L, Griffey RH	Angew Chem Int Ed Engl	42	3409-12	2003	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	SMMRNA	C(O[C@@H](CO[C@@H]1O[C@H]([C@@H](O)[C@H](O)[C@H]1N)CN)CN)c1cc2ccccc2cc1	-	-	-0.566999999999999	391.210721028	8	5	8	146.21	2	0.402149882914539	3.97378594086546	28	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.80E-06	2.80E-06	0	0	0	0
643	Acyclic DOS mimic 3_benzyl substituent	Target_lig_389	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1002/anie.200351354	12888972	Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.	Ding Y, Hofstadler SA, Swayze EE, Risen L, Griffey RH	Angew Chem Int Ed Engl	42	3409-12	2003	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	SMMRNA	C(O[C@@H](CO[C@@H]1O[C@H]([C@H](O)[C@@H](O)[C@H]1N)CN)CN)c1ccccc1	-	-	-1.7202	341.195070964	8	5	8	146.21	1	0.375163063159204	3.93723835652411	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
644	Piperidine_aminoglycoside_16S _A_site_RNA_mimic_1	Target_lig_390	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0.00026	0	0	0	-	-	10.1002/cbic.200300689	12964164	Piperidine glycosides targeting the ribosomal decoding site.	Simonsen KB, Ayida BK, Vourloumis D, Winters GC, Takahashi M, Shandrick S, Zhao Q, Hermann T	Chembiochem	4	886-90	2003	100 nM - 1 mM	-	8.2	25	-	Coupled transcription-translation assay	SMMRNA	O1[C@@H]([C@H]([C@@H]([C@@H]([C@@H]1CN)O)O)N)OC[C@H]1[C@@H](CNCC1)CN	-	-	-3.07989999999999	304.211055376	8	6	5	149.01	0	0.313033685673475	4.50321994194356	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0.00026	0.00026	0	0
645	Piperidine_aminoglycoside_16S _A_site_RNA_mimic_2	Target_lig_391	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	>0.001	0	0	0	-	-	10.1002/cbic.200300689	12964164	Piperidine glycosides targeting the ribosomal decoding site.	Simonsen KB, Ayida BK, Vourloumis D, Winters GC, Takahashi M, Shandrick S, Zhao Q, Hermann T	Chembiochem	4	886-90	2003	100 nM - 1 mM	-	8.2	25	-	Coupled transcription-translation assay	SMMRNA	O1[C@@H]([C@@H]([C@@H]([C@@H]([C@@H]1CO)O)O)N)OC[C@H]1[C@@H](CNCC1)CO	-	-	-3.01269999999999	306.179086552	8	6	5	137.43	0	0.315770898765902	4.35690190480828	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0.001	0.001	0	0
646	Piperidine_aminoglycoside_16S _A_site_RNA_mimic_3	Target_lig_392	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	>0.001	0	0	0	-	-	10.1002/cbic.200300689	12964164	Piperidine glycosides targeting the ribosomal decoding site.	Simonsen KB, Ayida BK, Vourloumis D, Winters GC, Takahashi M, Shandrick S, Zhao Q, Hermann T	Chembiochem	4	886-90	2003	100 nM - 1 mM	-	8.2	25	-	Coupled transcription-translation assay	SMMRNA	O1[C@@H]([C@@H]([C@H]([C@@H]([C@@H]1CO)O)O)N)OC[C@H]1[C@@H](CNCC1)CN	-	-	-3.04629999999999	305.195070964	8	6	5	143.22	0	0.314408389451056	4.40411967669157	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0.001	0.001	0	0
647	Piperidine_aminoglycoside_16S _A_site_RNA_mimic_4	Target_lig_393	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	7.40E-05	0	0	0	-	-	10.1002/cbic.200300689	12964164	Piperidine glycosides targeting the ribosomal decoding site.	Simonsen KB, Ayida BK, Vourloumis D, Winters GC, Takahashi M, Shandrick S, Zhao Q, Hermann T	Chembiochem	4	886-90	2003	100 nM - 1 mM	-	8.2	25	-	Coupled transcription-translation assay	SMMRNA	O1[C@@H]([C@@H]([C@H]([C@@H]([C@@H]1CO)O)O)N)OC[C@H]1[C@@H]([C@@H](NCC1)O)CN	-	-	-3.72789999999999	321.189985584	9	7	5	163.45	0	0.26955269156205	4.77435606256428	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	7.40E-05	7.40E-05	0	0
648	Piperidine_aminoglycoside_16S _A_site_RNA_mimic_5	Target_lig_394	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	3.50E-05	0	0	0	-	-	10.1002/cbic.200300689	12964164	Piperidine glycosides targeting the ribosomal decoding site.	Simonsen KB, Ayida BK, Vourloumis D, Winters GC, Takahashi M, Shandrick S, Zhao Q, Hermann T	Chembiochem	4	886-90	2003	100 nM - 1 mM	-	8.2	25	-	Coupled transcription-translation assay	SMMRNA	O1[C@@H]([C@@H]([C@@H]([C@@H]([C@@H]1CN)O)O)N)O[C@@H]1[C@@H](CNC[C@H]1CN)CO	-	-	-4.1091	320.205969996	9	7	5	169.24	0	0.265876331280139	4.70521529333351	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	3.50E-05	3.50E-05	0	0
649	Azepane aminoglycoside mimic 1	Target_lig_395	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.1e-05±1e-06	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.028	14741274	Rational design of azepane-glycoside antibiotics targeting the bacterial ribosome.	Barluenga S, Simonsen KB, Littlefield ES, Ayida BK, Vourloumis D, Winters GC, Takahashi M, Shandrick S, Zhao Q, Han Q, Hermann T	Bioorg Med Chem Lett	14	713-8	2004	-	-	-	-	-	RNA fluorescence assay	SMMRNA	O1[C@H](O[C@@H]2C[C@@H](NCC[C@H]2N)CO)[C@H]([C@@H]([C@H]([C@@H]1CN)O)O)N	-	-	-3.82409999999999	320.205969996	9	7	4	169.24	0	0.274149391968226	4.69157683179505	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.00E-05	1.20E-05	0	0	0	0
650	Azepane aminoglycoside mimic 2	Target_lig_1114	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.20E-05	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.028	14741274	Rational design of azepane-glycoside antibiotics targeting the bacterial ribosome.	Barluenga S, Simonsen KB, Littlefield ES, Ayida BK, Vourloumis D, Winters GC, Takahashi M, Shandrick S, Zhao Q, Han Q, Hermann T	Bioorg Med Chem Lett	14	713-8	2004	-	-	-	-	-	RNA fluorescence assay	SMMRNA	O1[C@H](O[C@@H]2C[C@@H](NCC[C@H]2N)CO)[C@H]([C@@H]([C@H]([C@@H]1CN)O)O)N	-	-	0	0	0	0	0	0	0	0	0	0	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.20E-05	1.20E-05	0	0	0	0
651	Azepane aminoglycoside mimic 3	Target_lig_396	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	8.00E-05	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.028	14741274	Rational design of azepane-glycoside antibiotics targeting the bacterial ribosome.	Barluenga S, Simonsen KB, Littlefield ES, Ayida BK, Vourloumis D, Winters GC, Takahashi M, Shandrick S, Zhao Q, Han Q, Hermann T	Bioorg Med Chem Lett	14	713-8	2004	-	-	-	-	-	RNA fluorescence assay	SMMRNA	O1[C@H](O[C@@H]2C[C@H](NCC[C@H]2N)CO)[C@H]([C@@H]([C@H]([C@@H]1CN)O)O)N	-	-	-3.82409999999999	320.205969996	9	7	4	169.24	0	0.274149391968226	4.69157683179505	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	8.00E-05	8.00E-05	0	0	0	0
652	Diamino_piperidinyl_triazine_1	Target_lig_397	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	7.00E-06	0	0	0	-	-	10.1128/AAC.49.12.4942-4949.2005	16304156	Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.	Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T	Antimicrob Agents Chemother	49	4942-9	2005	25-200 uM	5 uM	6.7	25	60 mM NaCl	ITC and RNA fluorescence assays	SMMRNA	C1[C@@H](CN(C[C@@H]1N)c1nc(nc(N2C[C@H](C[C@@H](C2)N)N)n1)Nc1cc(c(cc1)NC(=O)c1ccc(cc1)Cl)O)N	-	-	0.955900000000003	567.258547008	12	7	6	210.59	3	0.207491482168277	4.01648617721064	40	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	7.00E-06	7.00E-06	0	0
653	Diamino_piperidinyl_triazine_2	Target_lig_398	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.00E-09	1.00E-05	0	0	0	-	-	10.1128/AAC.49.12.4942-4949.2005	16304156	Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.	Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T	Antimicrob Agents Chemother	49	4942-9	2005	25-200 uM	5 uM	6.7	25	60 mM NaCl	ITC and RNA fluorescence assays	SMMRNA	C1[C@H](CN(C[C@H]1N)c1nc(nc(N2C[C@H](C[C@@H](C2)N)N)n1)Nc1ccc(cc1)NC(=O)c1c(cc2c(c1)cccc2)O)N	-	-	1.4557	583.313169424	12	7	6	210.59	4	0.171939277070366	4.03391452512445	43	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.00E-09	2.00E-09	1.00E-05	1.00E-05	0	0
654	Diamino_piperidinyl_triazine_3	Target_lig_399	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	1.00E-05	0	0	0	-	-	10.1128/AAC.49.12.4942-4949.2005	16304156	Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.	Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T	Antimicrob Agents Chemother	49	4942-9	2005	25-200 uM	5 uM	6.7	25	60 mM NaCl	ITC and RNA fluorescence assays	SMMRNA	C(CN(CCN)c1nc(nc(N2C[C@@H](C[C@@H](C2)N)N)n1)Nc1ccc(cc1)NC(=O)c1c(cc2c(c1)cccc2)O)N	-	-	1.3148	571.313169424	12	7	10	210.59	4	0.143618266773241	3.69906216500848	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	1.00E-05	1.00E-05	0	0
655	Benzimidazole 16S A-site RNA	Target_lig_417	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0005	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=C(N2)C=C(C=C3)N	2-piperidin-4-yl-3H-benzimidazol-5-amine	44374805	1.6121	216.137496512	3	3	1	66.73	2	0.634390580981731	2.39877597125668	16	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0005	0.0005	0	0	0	0
656	Nitro substituted benzimidazole 16S A-site RNA	Target_lig_418	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000308	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-]	6-nitro-2-piperidin-4-yl-1H-benzimidazole	1530246	1.9381	246.111675688	4	2	2	83.85	2	0.626137452402644	2.39393524847712	18	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000308	0.000308	0	0	0	0
657	Halogen substituted benzimidazole	Target_lig_419	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000174	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2)Cl)Cl	5,6-dichloro-2-piperidin-4-yl-1H-benzimidazole	508378	3.3367	269.048652776	2	2	1	40.71	2	0.833971125011623	2.43727600099283	17	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000174	0.000174	0	0	0	0
658	benzimidazole_analog_rRNA_1	Target_lig_420	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0005	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1C[C@@H](C[C@@H]1C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-])N	(1S,3R)-3-(6-nitro-1H-benzimidazol-2-yl)cyclopentan-1-amine	44375184	2.0659	246.111675688	4	2	2	97.84	2	0.625552562764443	3.13764938049063	18	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0005	0.0005	0	0	0	0
659	benzimidazole_analog_rRNA_2	Target_lig_436	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000308	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC=CC=C3N2	2-piperidin-4-yl-1H-benzimidazole	715810	2.0299	201.12659748	2	2	1	40.71	2	0.740831778928756	2.14766234957315	15	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000308	0.000308	0	0	0	0
660	benzimidazole_analog_rRNA_3	Target_lig_446	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	COC(=O)C1=CC=C(C=C1)CN2C3=CC(=C(C=C3N=C2C4CCNCC4)Cl)Cl	methyl 4-[(5,6-dichloro-2-piperidin-4-ylbenzimidazol-1-yl)methyl]benzoate	44374772	4.645	417.101082272	5	1	4	56.15	3	0.627365418694042	2.34120600620112	28	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
661	benzimidazole_analog_rRNA_4	Target_lig_421	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CCC(CC1)C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-]	2-cyclohexyl-6-nitro-1H-benzimidazole	762907	3.5188	245.11642672	3	1	2	71.82	2	0.649520048558041	2.16388406504517	18	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
662	benzimidazole_analog_rRNA_5	Target_lig_422	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1=CC2=C(C=C1[N+](=O)[O-])NC(=N2)C3=CC=NC=C3	6-nitro-2-pyridin-4-yl-1H-benzimidazole	617535	2.5331	240.064725496	4	1	2	84.71	3	0.550568057082604	2.1180106922641	18	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
663	benzimidazole_analog_rRNA_6	Target_lig_423	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1=CC(=CN=C1)C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-]	6-nitro-2-pyridin-3-yl-1H-benzimidazole	617536	2.5331	240.064725496	4	1	2	84.71	3	0.550568057082604	2.1052083254002	18	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
664	benzimidazole_analog_rRNA_7	Target_lig_424	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1=CC(=CC=C1C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-])N	4-(6-nitro-1H-benzimidazol-2-yl)aniline	3089924	2.7203	254.08037556	4	2	2	97.84	3	0.4170184043351	2.05864637942195	19	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
665	benzimidazole_analog_rRNA_8	Target_lig_425	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000123	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1=CC(=CC(=C1)N)C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-]	3-(6-nitro-1H-benzimidazol-2-yl)aniline	44374814	2.7203	254.08037556	4	2	2	97.84	3	0.4170184043351	2.11914381531939	19	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000123	0.000123	0	0	0	0
666	benzimidazole_analog_rRNA_9	Target_lig_426	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000105	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CC(CCC1C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-])N	4-(6-nitro-1H-benzimidazol-2-yl)cyclohexan-1-amine	44375185	2.456	260.127325752	4	2	2	97.84	2	0.639678492706823	2.38690278967836	19	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000105	0.000105	0	0	0	0
667	benzimidazole_analog_rRNA_10	Target_lig_427	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000221	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	c1c(cc2c(c1)[nH]c(n2)[C@H]1C[C@H](CCC1)N)N(=O)O	-	-	0	0	0	0	0	0	0	0	0	0	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000221	0.000221	0	0	0	0
668	benzimidazole_analog_rRNA_11	Target_lig_428	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	CC(=O)N1CCC(CC1)C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-]	1-[4-(6-nitro-1H-benzimidazol-2-yl)piperidin-1-yl]ethanone	44374657	2.197	288.122240372	4	1	2	92.13	2	0.676916847489978	2.27779850961079	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
669	benzimidazole_analog_rRNA_12	Target_lig_429	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	CN1CCC(CC1)C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-]	2-(1-methylpiperidin-4-yl)-6-nitro-1H-benzimidazole	9795161	2.2803	260.127325752	4	1	2	75.06	2	0.663617551017412	2.2819361230117	19	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
670	benzimidazole_analog_rRNA_13	Target_lig_430	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000588	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	COC1=CC2=C(C=C1)N=C(N2)C3CCNCC3	6-methoxy-2-piperidin-4-yl-1H-benzimidazole	24252556	2.0385	231.137162164	3	2	2	49.94	2	0.83120471610035	2.22180288953286	17	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000588	0.000588	0	0	0	0
671	benzimidazole_analog_rRNA_14	Target_lig_431	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000439	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	CC1=CC2=C(C=C1)N=C(N2)C3CCNCC3	6-methyl-2-piperidin-4-yl-1H-benzimidazole	16876710	2.33832	215.142247544	2	2	1	40.71	2	0.766238331762808	2.25191541479187	16	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000439	0.000439	0	0	0	0
672	benzimidazole_analog_rRNA_15	Target_lig_432	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000361	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=C(N2)C=C(C=C3)Br	6-bromo-2-piperidin-4-yl-1H-benzimidazole	44374626	2.7924	279.037109548	2	2	1	40.71	2	0.842949547529492	2.3517668059539	16	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000361	0.000361	0	0	0	0
673	benzimidazole_analog_rRNA_16	Target_lig_433	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000508	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=C(N2)C=C(C=C3)Cl	6-chloro-2-piperidin-4-yl-1H-benzimidazole	16767385	2.6833	235.087625128	2	2	1	40.71	2	0.79807713130562	2.27236353263148	16	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000508	0.000508	0	0	0	0
674	benzimidazole_analog_rRNA_17	Target_lig_434	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000281	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=C(N2)C=C(C=C3)C(F)(F)F	2-piperidin-4-yl-6-(trifluoromethyl)-1H-benzimidazole	44374979	3.0487	269.113982108	2	2	1	40.71	2	0.83502975268445	2.39208484096041	19	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000281	0.000281	0	0	0	0
675	benzimidazole_analog_rRNA_18	Target_lig_435	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00038	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	CC1=CC2=C(C=C1Cl)N=C(N2)C3CCNCC3	5-chloro-6-methyl-2-piperidin-4-yl-1H-benzimidazole	44374978	2.99172	249.103275192	2	2	1	40.71	2	0.815862784302764	2.4394603024057	17	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00038	0.00038	0	0	0	0
676	benzimidazole_analog_rRNA_19	Target_lig_1115	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000174	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	c1(c(cc2c(c1)[nH]c(n2)C1CCNCC1)Cl)Cl	5,6-dichloro-2-piperidin-4-yl-1H-benzimidazole	508378	3.2	270.15	2	2	1	40.7	0	0	0	17	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000174	0.000174	0	0	0	0
677	benzimidazole_analog_rRNA_20	Target_lig_436	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00018	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC=CC=C3N2	2-piperidin-4-yl-1H-benzimidazole	715810	2.0299	201.12659748	2	2	1	40.71	2	0.740831778928756	2.14766234957315	15	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00018	0.00018	0	0	0	0
678	benzimidazole_analog_rRNA_21	Target_lig_437	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00011	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=C(N2)C=NC=C3	2-piperidin-4-yl-3H-imidazo[4,5-c]pyridine	22308651	1.4249	202.121846448	3	2	1	53.6	2	0.735077613486165	2.51058234957315	15	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00011	0.00011	0	0	0	0
679	benzimidazole_analog_rRNA_22	Target_lig_438	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000535	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=C(N2)C=CC=N3	2-piperidin-4-yl-1H-imidazo[4,5-b]pyridine	22308650	1.4249	202.121846448	3	2	1	53.6	2	0.735077613486165	2.4962285034193	15	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000535	0.000535	0	0	0	0
680	benzimidazole_analog_rRNA_23	Target_lig_439	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000914	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=NC=NC=C3N2	8-piperidin-4-yl-7H-purine	44374953	0.8199	203.117095416	4	2	1	66.49	2	0.719755254236676	2.75737004188084	15	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000914	0.000914	0	0	0	0
681	benzimidazole_analog_rRNA_24	Target_lig_440	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC=CC=C3S2	2-piperidin-4-yl-1,3-benzothiazole	1477439	2.7633	218.087769448	3	1	1	24.92	2	0.795815385675511	2.11561004188084	15	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
682	benzimidazole_analog_rRNA_25	Target_lig_441	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000214	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CC=C(C=C4)C(F)(F)F)Cl)Cl	5,6-dichloro-2-piperidin-4-yl-1-[[4-(trifluoromethyl)phenyl]methyl]benzimidazole	44375167	5.8772	427.082987596	3	1	3	29.85	3	0.565086675719375	2.43767180951174	28	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000214	0.000214	0	0	0	0
683	benzimidazole_analog_rRNA_26	Target_lig_442	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000159	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=C(C=C(C=C4)C(F)(F)F)C(F)(F)F)Cl)Cl	1-[[2,4-bis(trifluoromethyl)phenyl]methyl]-5,6-dichloro-2-piperidin-4-ylbenzimidazole	44375264	6.896	495.070372224	3	1	3	29.85	3	0.400339175010243	2.71886576337496	32	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000159	0.000159	0	0	0	0
684	benzimidazole_analog_rRNA_27	Target_lig_443	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000237	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=C(C(=C(C(=C4F)F)F)F)F)Cl)Cl	5,6-dichloro-1-[(2,3,4,5,6-pentafluorophenyl)methyl]-2-piperidin-4-ylbenzimidazole	44375263	5.5539	449.048493908	3	1	3	29.85	3	0.322172464071826	2.81585530613661	29	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000237	0.000237	0	0	0	0
685	benzimidazole_analog_rRNA_28	Target_lig_444	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000117	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=C(C(=C(C(=C4F)F)C(F)(F)F)F)F)Cl)Cl	5,6-dichloro-2-piperidin-4-yl-1-[[2,3,5,6-tetrafluoro-4-(trifluoromethyl)phenyl]methyl]benzimidazole	44375262	6.4336	499.045300348	3	1	3	29.85	3	0.331899414952922	2.98085617210416	32	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000117	0.000117	0	0	0	0
686	benzimidazole_analog_rRNA_29	Target_lig_445	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000241	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CC=C(C=C4)[N+](=O)[O-])Cl)Cl	5,6-dichloro-1-[(4-nitrophenyl)methyl]-2-piperidin-4-ylbenzimidazole	508383	4.7666	404.080681176	5	1	4	72.99	3	0.501571062074127	2.41712116663323	27	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000241	0.000241	0	0	0	0
687	benzimidazole_analog_rRNA_30	Target_lig_446	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000224	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	COC(=O)C1=CC=C(C=C1)CN2C3=CC(=C(C=C3N=C2C4CCNCC4)Cl)Cl	methyl 4-[(5,6-dichloro-2-piperidin-4-ylbenzimidazol-1-yl)methyl]benzoate	44374772	4.645	417.101082272	5	1	4	56.15	3	0.627365418694042	2.34120600620112	28	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000224	0.000224	0	0	0	0
688	benzimidazole_analog_rRNA_31	Target_lig_447	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000198	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CC=C(C=C4)I)Cl)Cl	5,6-dichloro-1-[(4-iodophenyl)methyl]-2-piperidin-4-ylbenzimidazole	44375012	5.463	484.992250936	3	1	3	29.85	3	0.498749055762974	2.45490508233049	25	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000198	0.000198	0	0	0	0
689	benzimidazole_analog_rRNA_32	Target_lig_448	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000405	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CC(=CC=C4)I)Cl)Cl	5,6-dichloro-1-[(3-iodophenyl)methyl]-2-piperidin-4-ylbenzimidazole	44374771	5.463	484.992250936	3	1	3	29.85	3	0.498749055762974	2.50508392848434	25	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000405	0.000405	0	0	0	0
690	benzimidazole_analog_rRNA_33	Target_lig_449	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000434	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CC=C(C=C4)Br)Cl)Cl	1-[(4-bromophenyl)methyl]-5,6-dichloro-2-piperidin-4-ylbenzimidazole	44375011	5.6209	437.006115036	3	1	3	29.85	3	0.57442160844208	2.35218777463818	25	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000434	0.000434	0	0	0	0
691	benzimidazole_analog_rRNA_34	Target_lig_450	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000575	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	CC(C)(C)C1=CC=C(C=C1)CN2C3=CC(=C(C=C3N=C2C4CCNCC4)Cl)Cl	1-[(4-tert-butylphenyl)methyl]-5,6-dichloro-2-piperidin-4-ylbenzimidazole	44375218	6.1559	415.158203224	3	1	3	29.85	3	0.554578497382465	2.41273996920015	28	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000575	0.000575	0	0	0	0
692	benzimidazole_analog_rRNA_35	Target_lig_451	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.00E-05	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CC=NC=C4)Cl)Cl	5,6-dichloro-2-piperidin-4-yl-1-(pyridin-4-ylmethyl)benzimidazole	508380	4.2534	360.090851936	4	1	3	42.74	3	0.758346066718613	2.4335681886054	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.00E-05	6.00E-05	0	0	0	0
693	benzimidazole_analog_rRNA_36	Target_lig_452	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.70E-05	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CN=CC=C4)Cl)Cl	5,6-dichloro-2-piperidin-4-yl-1-(pyridin-3-ylmethyl)benzimidazole	508381	4.2534	360.090851936	4	1	3	42.74	3	0.758346066718613	2.42638401278123	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.70E-05	6.70E-05	0	0	0	0
694	benzimidazole_analog_rRNA_37	Target_lig_453	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000278	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	CCCCN1C2=CC(=C(C=C2N=C1C3CCNCC3)Cl)Cl	1-butyl-5,6-dichloro-2-piperidin-4-ylbenzimidazole	44374604	4.6102	325.111253032	3	1	4	29.85	2	0.889025744529112	2.39626131273986	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000278	0.000278	0	0	0	0
695	benzimidazole_analog_rRNA_38	Target_lig_454	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000239	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	CN1C2=CC(=C(C=C2N=C1C3CCNCC3)Cl)Cl	5,6-dichloro-1-methyl-2-piperidin-4-ylbenzimidazole	44374602	3.3471	283.06430284	3	1	1	29.85	2	0.869983112758312	2.46513397802811	18	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000239	0.000239	0	0	0	0
696	benzimidazole_analog_rRNA_39	Target_lig_455	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000301	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	COC(=O)CN1C2=CC(=C(C=C2N=C1C3CCNCC3)Cl)Cl	methyl 2-(5,6-dichloro-2-piperidin-4-ylbenzimidazol-1-yl)acetate	44374756	2.9831	341.069782144	5	1	3	56.15	2	0.871641239272689	2.46953774924631	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000301	0.000301	0	0	0	0
697	benzimidazole_analog_rRNA_40	Target_lig_456	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000593	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CC=CC=C4Br)Cl)Cl	1-[(2-bromophenyl)methyl]-5,6-dichloro-2-piperidin-4-ylbenzimidazole	44374755	5.6209	437.006115036	3	1	3	29.85	3	0.57442160844208	2.43148777463818	25	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000593	0.000593	0	0	0	0
698	benzimidazole_analog_rRNA_41	Target_lig_457	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CSC5=C4C=C(C=C5)Cl)Cl)Cl	5,6-dichloro-1-[(5-chloro-1-benzothiophen-3-yl)methyl]-2-piperidin-4-ylbenzimidazole	44374832	6.7265	449.028701616	4	1	3	29.85	4	0.374971927839214	2.6687237839789	28	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
699	benzimidazole_analog_rRNA_42	Target_lig_458	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000122	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	c1(c(cc2c(c1)nc(n2Cc1ccc(cc1N(=O)O)C(F)(F)F)C1CCNCC1)Cl)Cl	-	-	0	0	0	0	0	0	0	0	0	0	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000122	0.000122	0	0	0	0
700	benzimidazole_analog_rRNA_43	Target_lig_459	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000243	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	c1(c(cc2c(c1)nc(n2Cc1ccc(cc1N(=O)O)N(=O)O)C1CCNCC1)Cl)Cl	-	-	0	0	0	0	0	0	0	0	0	0	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000243	0.000243	0	0	0	0
701	benzimidazole_analog_rRNA_44	Target_lig_460	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000672	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	c1(c(cc2c(c1)nc(n2Cc1ncccn1)C1CCNCC1)Cl)Cl	-	-	3.6484	361.086100904	5	1	3	55.63	3	0.772887681147635	2.62674379300101	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000672	0.000672	0	0	0	0
702	benzimidazole_analog_rRNA_45	Target_lig_461	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	c1(c(cc2c(c1)nc(n2CS(=O)(=O)c1ccc(cc1)C)C1CCNCC1)Cl)Cl	-	-	4.54992	437.073153272	5	1	4	63.99	3	0.649360427734814	2.61359157582138	28	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
703	benzimidazole_analog_rRNA_46	Target_lig_462	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	>0.001	0	0	0	0	-	-	10.1016/j.bmcl.2003.11.031	14741271	Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry.	He Y, Yang J, Wu B, Robinson D, Sprankle K, Kung PP, Lowery K, Mohan V, Hofstadler S, Swayze EE, Griffey R	Bioorg Med Chem Lett	14	695-9	2004	-	-	-	-	-	MS-based competition experiments	SMMRNA	c1(c(cc2c(c1)nc(n2CC(=O)Oc1ccc(cc1)C)C1CCNCC1)Cl)Cl	-	-	4.72412	417.101082272	5	1	4	56.15	3	0.492054654022806	2.44589850620113	28	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001	0.001	0	0	0	0
704	Ligand1 16S A-site RNA	Target_lig_464	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	<0.015	0	0	0	0	0	-	-	10.1002/chin.200515156	15546714	Identification of a novel non-carbohydrate molecule that binds to the ribosomal A-site RNA.	Maddaford SP, Motamed M, Turner KB, Choi MS, Ramnauth J, Rakhit S, Hudgins RR, Fabris D, Johnson PE	Bioorg Med Chem Lett	14	5987-90	2004	500 uM	30 nM	7.5	-	50 mM KCl	FRET assay	SMMRNA	c1c(cc2c(c1)Oc1c(N(C2=O)CCN2CCCC2)cccc1)NC(=N)C	-	-	3.94397	364.189926008	4	2	4	68.66	2	0.636773112057842	2.49863365414571	27	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0.015	0.015	0	0	0	0	0	0
705	Ligand2 16S A-site RNA	Target_lig_465	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	1.70E-05	0	0	0	0	0	-	-	10.1002/chin.200515156	15546714	Identification of a novel non-carbohydrate molecule that binds to the ribosomal A-site RNA.	Maddaford SP, Motamed M, Turner KB, Choi MS, Ramnauth J, Rakhit S, Hudgins RR, Fabris D, Johnson PE	Bioorg Med Chem Lett	14	5987-90	2004	500 uM	30 nM	7.5	-	50 mM KCl	FRET assay	SMMRNA	C1CCN(CC1)CCCNC(=O)C2=C(C3=C(CCCC3)NC2=O)O	4-hydroxy-2-oxo-N-(3-piperidin-1-ylpropyl)-5,6,7,8-tetrahydro-1H-quinoline-3-carboxamide	54682395	1.5651	333.205241724	4	3	5	85.43	1	0.714074719739012	2.39246357322079	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	1.70E-05	1.70E-05	0	0	0	0	0	0
706	Ligand3 16S A-site RNA	Target_lig_466	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	1.80E-05	0	0	0	0	0	-	-	10.1002/chin.200515156	15546714	Identification of a novel non-carbohydrate molecule that binds to the ribosomal A-site RNA.	Maddaford SP, Motamed M, Turner KB, Choi MS, Ramnauth J, Rakhit S, Hudgins RR, Fabris D, Johnson PE	Bioorg Med Chem Lett	14	5987-90	2004	500 uM	30 nM	7.5	-	50 mM KCl	FRET assay	SMMRNA	C1CCN(CC1)CCCNC[C@H]2C3=CC=CC=C3CCO2	N-[[(1R)-3,4-dihydro-1H-isochromen-1-yl]methyl]-3-piperidin-1-ylpropan-1-amine	1611271	2.766	288.220163516	3	1	6	24.5	1	0.81471352784568	2.66476647157131	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	1.80E-05	1.80E-05	0	0	0	0	0	0
707	Ligand4 16S A-site RNA	Target_lig_467	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	3.10E-05	0	0	0	0	0	-	-	10.1002/chin.200515156	15546714	Identification of a novel non-carbohydrate molecule that binds to the ribosomal A-site RNA.	Maddaford SP, Motamed M, Turner KB, Choi MS, Ramnauth J, Rakhit S, Hudgins RR, Fabris D, Johnson PE	Bioorg Med Chem Lett	14	5987-90	2004	500 uM	30 nM	7.5	-	50 mM KCl	FRET assay	SMMRNA	CN1CCCN(CC1)CC2=C(C=C(C=C2)OC)OC	1-[(2,4-dimethoxyphenyl)methyl]-4-methyl-1,4-diazepane	763014	1.8413	264.183778008	4	0	4	24.94	1	0.828279994043191	1.81336689224247	19	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	3.10E-05	3.10E-05	0	0	0	0	0	0
708	Ligand5 16S A-site RNA	Target_lig_468	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	5.30E-05	0	0	0	0	0	-	-	10.1002/chin.200515156	15546714	Identification of a novel non-carbohydrate molecule that binds to the ribosomal A-site RNA.	Maddaford SP, Motamed M, Turner KB, Choi MS, Ramnauth J, Rakhit S, Hudgins RR, Fabris D, Johnson PE	Bioorg Med Chem Lett	14	5987-90	2004	500 uM	30 nM	7.5	-	50 mM KCl	FRET assay	SMMRNA	C1=CC=C(C=C1)C2=CC=CC=C2OCCCC(=N)N	4-(2-phenylphenoxy)butanimidamide	1716319	3.44857	254.141913196	2	2	6	59.1	2	0.470991782942539	1.79333733513291	19	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	5.30E-05	5.30E-05	0	0	0	0	0	0
709	Ligand6 16S A-site RNA	Target_lig_469	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0.000242	0	0	0	0	0	-	-	10.1002/chin.200515156	15546714	Identification of a novel non-carbohydrate molecule that binds to the ribosomal A-site RNA.	Maddaford SP, Motamed M, Turner KB, Choi MS, Ramnauth J, Rakhit S, Hudgins RR, Fabris D, Johnson PE	Bioorg Med Chem Lett	14	5987-90	2004	500 uM	30 nM	7.5	-	50 mM KCl	FRET assay	SMMRNA	C1CCN(CC1)CCCNC(=O)C2=C(C3=CC=CC=C3NC2=O)O	4-hydroxy-2-oxo-N-(3-piperidin-1-ylpropyl)-1H-quinoline-3-carboxamide	54685835	1.8395	329.173941596	4	3	5	85.43	2	0.730804336043832	2.10287427556193	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0.000242	0.000242	0	0	0	0	0	0
710	Phenothiazine 1	Target_lig_474	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.43E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1(=O)N(C(=O)c2c([C@H]1C)ncn2C[C@H](O)N(C)C)C	-	-	-0.5212	266.137890436	6	1	3	78.67	1	0.588034730015036	4.10445775775174	19	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.43E-06	1.43E-06	0	0	0	0
711	Phenothiazine 2	Target_lig_475	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.19E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine	4917	4.5802	373.137946448	4	0	4	9.72	2	0.775124662295156	2.20663732679835	25	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.19E-05	1.19E-05	0	0	0	0
712	Phenothiazine 3	Target_lig_476	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.19E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=CC2=C(C=C1N=C=S)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O	3',6'-dihydroxy-6-isothiocyanatospiro[2-benzofuran-3,9'-xanthene]-1-one	18730	4.4001	389.035793452	7	2	1	88.35	3	0.36434159471551	3.48840311558202	28	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.19E-05	1.19E-05	0	0	0	0
713	Phenothiazine 4	Target_lig_477	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	2.55E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=CC=C2C(=C1)C(=O)OC2(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O	3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-one	4764	3.5601	318.089208928	4	2	2	66.76	3	0.709067432457466	2.29659802138132	24	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	2.55E-05	2.55E-05	0	0	0	0
714	Phenothiazine 6	Target_lig_478	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.000159	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	6077	4.4436	326.145284324	4	0	5	23.55	2	0.757792051694743	2.19866048303301	23	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.000159	0.000159	0	0	0	0
715	Phenothiazine 7	Target_lig_479	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.000365	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=CC=C2C(=C1)C(=O)C3=CC4=C(C=C3N2)C(=O)C5=CC=CC=C5N4	5,12-dihydroquinolino[2,3-b]acridine-7,14-dione	13976	3.676	312.089877624	2	2	0	65.72	5	0.428400761390138	2.1237862462939	24	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.000365	0.000365	0	0	0	0
716	Phenothiazine 8	Target_lig_480	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.000897	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	[C@H]12[C@@H](C[C@@H]3[N@@](C1)(CCc1c3[nH]c3c1cccc3)C)[C@H]([C@H](CC2)O)C(=O)OC	-	-	0	0	0	0	0	0	0	0	0	0	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.000897	0.000897	0	0	0	0
717	Phenothiazine 9	Target_lig_481	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.00392	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	[C@@H]1(C[C@H]([C@H]2[C@@H]([C@@H]1C(=O)C)O[C@H]1[C@@]2(C(=O)[C@@H](C(=O)C1)C(=O)C)C)O)O	-	-	-0.5459	338.136553044	7	2	2	117.97	0	0.6488460438237	5.03069825662029	24	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.00392	0.00392	0	0	0	0
718	Phenothiazine 10	Target_lig_482	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.00979	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl	3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine	2726	4.8944	318.095747288	3	0	4	6.48	2	0.791805341329135	2.1401928512014	21	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.00979	0.00979	0	0	0	0
719	Bis-guanidinylated ligand 1	Target_lig_483	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	1.54E-06	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.046	14757049	"Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic ""hot spots""."	Davis B, Afshar M, Varani G, Murchie AI, Karn J, Lentzen G, Drysdale M, Bower J, Potter AJ, Starkey ID, Swarbrick T, Aboul-ela F	J Mol Biol	336	343-56	2004	1 mM	0,0.4,0.8 mM	6.1	25	20 mM potassium phosphate	FRET and SPR	SMMRNA	COC1=CC(=C(C=C1)OCCN=C(N)N)CNCCCCN=C(N)N	2-[2-[2-[[4-(diaminomethylideneamino)butylamino]methyl]-4-methoxyphenoxy]ethyl]guanidine	448945	-0.509399999999997	351.238273168	5	5	12	159.29	1	0.192511066913818	2.48548442298983	25	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	1.54E-06	1.54E-06	0	0	0	0	0	0
720	Bis-guanidinylated ligand 2	Target_lig_484	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	2.41E-06	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.046	14757049	"Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic ""hot spots""."	Davis B, Afshar M, Varani G, Murchie AI, Karn J, Lentzen G, Drysdale M, Bower J, Potter AJ, Starkey ID, Swarbrick T, Aboul-ela F	J Mol Biol	336	343-56	2004	1 mM	0,0.4,0.8 mM	6.1	25	20 mM potassium phosphate	FRET and SPR	SMMRNA	c1c(cc(c(c1)OCCNC(=N)N)CNCCCCCNC(=N)N)OC	-	-	0.300040000000001	365.253923232	5	7	13	154.29	1	0.150600751881562	2.42766320916861	26	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	2.41E-06	2.41E-06	0	0	0	0	0	0
721	Bis-guanidinylated ligand 3	Target_lig_485	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	2.62E-06	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.046	14757049	"Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic ""hot spots""."	Davis B, Afshar M, Varani G, Murchie AI, Karn J, Lentzen G, Drysdale M, Bower J, Potter AJ, Starkey ID, Swarbrick T, Aboul-ela F	J Mol Biol	336	343-56	2004	1 mM	0,0.4,0.8 mM	6.1	25	20 mM potassium phosphate	FRET and SPR	SMMRNA	COC1=CC(=C(C=C1)OCCCN=C(N)N)CNCCCCN=C(N)N	2-[3-[2-[[4-(diaminomethylideneamino)butylamino]methyl]-4-methoxyphenoxy]propyl]guanidine	516505	-0.119299999999997	365.253923232	5	5	13	159.29	1	0.184979979636095	2.45898396786197	26	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	2.62E-06	2.62E-06	0	0	0	0	0	0
722	Bis-guanidinylated ligand 4	Target_lig_486	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	2.66E-06	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.046	14757049	"Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic ""hot spots""."	Davis B, Afshar M, Varani G, Murchie AI, Karn J, Lentzen G, Drysdale M, Bower J, Potter AJ, Starkey ID, Swarbrick T, Aboul-ela F	J Mol Biol	336	343-56	2004	1 mM	0,0.4,0.8 mM	6.1	25	20 mM potassium phosphate	FRET and SPR	SMMRNA	COC1=CC(=C(C=C1)OCCCN=C(N)N)CNCCCN=C(N)N	2-[3-[[2-[3-(diaminomethylideneamino)propoxy]-5-methoxyphenyl]methylamino]propyl]guanidine	142104300	-0.509399999999997	351.238273168	5	5	12	159.29	1	0.192511066913818	2.45254837903379	25	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	2.66E-06	2.66E-06	0	0	0	0	0	0
723	Bis-guanidinylated ligand 5	Target_lig_487	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	3.20E-06	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.046	14757049	"Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic ""hot spots""."	Davis B, Afshar M, Varani G, Murchie AI, Karn J, Lentzen G, Drysdale M, Bower J, Potter AJ, Starkey ID, Swarbrick T, Aboul-ela F	J Mol Biol	336	343-56	2004	1 mM	0,0.4,0.8 mM	6.1	25	20 mM potassium phosphate	FRET and SPR	SMMRNA	COC1=CC(=C(C=C1)OCCCN)CNCCCCN=C(N)N	2-[4-[[2-(3-aminopropoxy)-5-methoxyphenyl]methylamino]butyl]guanidine	516506	0.566000000000002	323.232125168	5	4	12	120.91	1	0.253374497898356	2.27492509841762	23	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	3.20E-06	3.20E-06	0	0	0	0	0	0
724	Bis-guanidinylated ligand 6	Target_lig_488	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	4.88E-06	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.046	14757049	"Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic ""hot spots""."	Davis B, Afshar M, Varani G, Murchie AI, Karn J, Lentzen G, Drysdale M, Bower J, Potter AJ, Starkey ID, Swarbrick T, Aboul-ela F	J Mol Biol	336	343-56	2004	1 mM	0,0.4,0.8 mM	6.1	25	20 mM potassium phosphate	FRET and SPR	SMMRNA	c1c(cc(c(c1)OCCCNC(=N)N)CNCCNC(=N)N)OC	-	-	-0.480159999999998	337.222623104	5	7	11	154.29	1	0.16335860219539	2.41442867080977	24	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	4.88E-06	4.88E-06	0	0	0	0	0	0
725	Biaryl ligand 1	Target_lig_489	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	1.48E-07	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	20 or 80 mM Kcl	FRET displacement assay	SMMRNA	C1=CC=C2C(=C1)C=C(S2)C3=CC(=C(C=C3)OCCN=C(N)N)CNCCCCN=C(N)N	2-[2-[4-(1-benzothiophen-2-yl)-2-[[4-(diaminomethylideneamino)butylamino]methyl]phenoxy]ethyl]guanidine	516511	2.3637	453.231079612	5	5	12	150.06	3	0.161343210788234	2.70393264540597	32	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	1.48E-07	1.48E-07	0	0	0	0	0	0
726	Biaryl ligand 2	Target_lig_490	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	1.61E-07	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	20 or 80 mM Kcl	FRET displacement assay	SMMRNA	C1=CC=C2C(=C1)C=C(O2)C3=CC(=C(C=C3)OCCN=C(N)N)CNCCCCN=C(N)N	2-[2-[4-(1-benzofuran-2-yl)-2-[[4-(diaminomethylideneamino)butylamino]methyl]phenoxy]ethyl]guanidine	516510	1.8952	437.253923232	5	5	12	163.2	3	0.163994098039968	2.66458398319861	32	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	1.61E-07	1.61E-07	0	0	0	0	0	0
727	Biaryl ligand 3	Target_lig_491	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	4.30E-07	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	20 or 80 mM Kcl	FRET displacement assay	SMMRNA	C1=CC=C2C=C(C=CC2=C1)C3=CC(=C(C=C3)OCCCN)CNCCCCN=C(N)N	2-[4-[[2-(3-aminopropoxy)-5-naphthalen-2-ylphenyl]methylamino]butyl]guanidine	516508	3.3776	419.268510676	4	4	12	111.68	3	0.204255329747366	2.35192831898701	31	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	4.30E-07	4.30E-07	0	0	0	0	0	0
728	Biaryl ligand 4	Target_lig_492	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	8.60E-07	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	20 or 80 mM Kcl	FRET displacement assay	SMMRNA	C1=CSC(=C1)C2=CC(=C(C=C2)OCCN=C(N)N)CNCCCCN=C(N)N	2-[2-[2-[[4-(diaminomethylideneamino)butylamino]methyl]-4-thiophen-2-ylphenoxy]ethyl]guanidine	516509	1.2105	403.215429548	5	5	12	150.06	2	0.20413584333602	2.64356619850882	28	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	8.60E-07	8.60E-07	0	0	0	0	0	0
729	Biaryl ligand 5	Target_lig_493	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	5.10E-08	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	20 or 80 mM Kcl	FRET displacement assay	SMMRNA	C1CN(CCN1)CCNCC2=C(C=CC(=C2)C3=CC4=C(C=C3)NC=C4)OCCCN	3-[4-(1H-indol-5-yl)-2-[(2-piperazin-1-ylethylamino)methyl]phenoxy]propan-1-amine	448939	2.5573	407.268510676	5	4	10	78.34	3	0.388678028960903	2.52288008286784	30	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	5.10E-08	5.10E-08	0	0	0	0	0	0
730	6_aminoquinolone_der_1	Target_lig_494	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	3.50E-06	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cc3c(c1C[C@@H](C2)c1[nH]nnn1)[nH]c(=O)c(=O)[nH]3)N(=O)O	-	-	0	0	0	0	0	0	0	0	0	0	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	3.50E-06	3.50E-06	0	0	0	0	0	0
731	guanidinoneomycin_B	Target_lig_495	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	<1e-08	0	0	0	0	2JUK	-	10.1002/cbic.200700251	18058789	Guanidinoneomycin B recognition of an HIV-1 RNA helix.	Staple DW, Venditti V, Niccolai N, Elson-Schwab L, Tor Y, Butcher SE	Chembiochem	9	93-102	2008	3 uM	2 uM	7	25-90	200 mM Kcl	UV spectroscopy	SMMRNA	[C@@H]1([C@H]([C@H]([C@H](O[C@@H]1CNC(=N)N)O[C@@H]1[C@@H]([C@@H]([C@H](C[C@H]1NC(=N)N)NC(=N)N)O)O[C@H]1[C@@H]([C@H]([C@@H](O1)CO)O[C@H]1O[C@H]([C@H]([C@@H]([C@@H]1NC(=N)N)O)O)CNC(=N)N)O)NC(=N)N)O)O	-	-	-11.74908	866.443073916	19	25	15	568.39	0	0.053656583710133	6.34665040088864	60	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	1.00E-08	1.00E-08	0	0	0	0
732	doxorubicin	Target_lig_496	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	2.8e-06±4e-07	0	0	0	0	-	-	10.1021/cb900167m	19673541	Selection and characterization of small molecules that bind the HIV-1 frameshift site RNA.	Marcheschi RJ, Mouzakis KD, Butcher SE	ACS Chem Biol	4	844-54	2009	109 to 103 M	1-2 uM	7	30	-	Fluorescence titration	SMMRNA	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	31703	0.0013	543.174060748	12	6	5	206.07	2	0.235262581685656	4.48608647582191	39	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	2.40E-06	3.20E-06	0	0	0	0
733	ethylquinoline_carboxamide derivative	Target_lig_497	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	3.5e-07±1.0999999999999999e-07	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	SMMRNA	c1cc(ccc1)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1cc2ccccc2nc1CC)CSSC[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCN)Cc1ccccc1)NC(=O)c1c(nc2c(c1)cccc2)CC)C(=O)NCCCN	-	-	4.55320000000001	1206.550699456	14	8	29	293.04	6	0.023629918366656	5.45074534077586	86	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	2.40E-07	4.60E-07	0	0	0	0
734	methylpiperazine derivative	Target_lig_498	SL-3 of HIV-1_SITE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.1e-05±3e-06	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	SMMRNA	CC1=NC2=NC(=NN2C(=C1)N3CCN(CC3)C)C4=CC=C(C=C4)Cl	2-(4-chlorophenyl)-5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine	318119	2.50492	342.135972288	6	0	2	49.56	3	0.715889401668116	2.33158063007697	24	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	8.00E-06	1.40E-05	0	0	0	0
735	methyl_carbamate derivative	Target_lig_499	SL-3 of HIV-1_SITE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	9.8e-05±4.2999999999999995e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	SMMRNA	CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H](C3=C2COC(=O)N)N4C)OC	[(4S,6S)-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),7,11-trien-8-yl]methyl carbamate	10246117	0.7515	331.116820644	7	1	3	103.63	1	0.819888841042068	4.26809835411276	24	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	5.50E-05	0.000141	0	0	0	0
736	dimethylamine_derivative	Target_lig_500	IRES HCV	Hepatitis C virus	Hepatitis C	Target_68	0	0	0	6.00E-07	0	0	0	-	-	10.1002/cbic.201000177	20564282	A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site.	Carnevali M, Parsons J, Wyles DL, Hermann T	Chembiochem	11	1364-7	2010	100 - 1000 uM	-	-	-	1mM Mg2+	FRET assay	SMMRNA	c12ccc3c(c1C[C@H](CO2)CN(C)C)n1c(n3)NC[C@H](C1)CN(C)C	-	-	1.7523	343.237210548	6	1	4	45.56	2	0.916400299841493	4.08059637543095	25	GAGGAACUACUGGAGACGUGCAGCCUC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	27	-	-	0	0	0	0	0	0	6.00E-07	6.00E-07	0	0
737	benzamide derivative	Target_lig_501	IRES HCV	Hepatitis C virus	Hepatitis C	Target_68	0	0	0	0	0.00027±9.999999999999999e-05	0	0	-	-	10.1002/cbic.201000177	20564282	A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site.	Carnevali M, Parsons J, Wyles DL, Hermann T	Chembiochem	11	1364-7	2010	100 - 1000 uM	-	-	-	1mM Mg2+	FRET assay	SMMRNA	c1cc(ccc1C(=O)C)C(=O)N[C@H](C(=O)N1C[C@H](C[C@H](C1)N)N)CCCNC(=N)N	-	-	-0.862229999999996	417.248837852	6	6	8	180.42	1	0.137628415609497	3.46413946163132	30	GAGGAACUACUGGAGACGUGCAGCCUC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	27	-	-	0	0	0	0	0	0	0	0	0.00017	0.00037
738	benzamide derivative_2	Target_lig_501	IRES HCV	Hepatitis C virus	Hepatitis C	Target_68	0	0	0	0	9.2e-05±2.9999999999999997e-05	0	0	-	-	10.1002/cbic.201000177	20564282	A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site.	Carnevali M, Parsons J, Wyles DL, Hermann T	Chembiochem	11	1364-7	2010	100 - 1000 uM	-	-	-	1mM Mg2+	FRET assay	SMMRNA	c1cc(ccc1C(=O)C)C(=O)N[C@H](C(=O)N1C[C@H](C[C@H](C1)N)N)CCCNC(=N)N	-	-	-0.862229999999996	417.248837852	6	6	8	180.42	1	0.137628415609497	3.46413946163132	30	GAGGAACUACUGGAGACGUGCAGCCUC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	27	-	-	0	0	0	0	0	0	0	0	6.20E-05	0.000122
739	Thiamine_Pyrophosphate(TPP)	Target_lig_318	B.subtilis tenA TPP riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_76	0	0	5.00E-08	0	0	0	0	2GDI	-	10.1016/j.chembiol.2005.10.007	16356850	Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine.	Sudarsan N, Cohen-Chalamish S, Nakamura S, Emilsson GM, Breaker RR	Chem Biol	12	1325-35	2005	0-10 uM	1nM - 100uM	8.3	25	20 mM MgCl2,100mM Kcl	In-line probing assays	SMMRNA	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)OP(=O)(O)[O-]	[2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethoxy-hydroxyphosphoryl] hydrogen phosphate	5431	0.20974	424.037143176	9	3	8	171.8	2	0.392748623002051	4.47021276522935	26	GGUAACCACUAGGGGUGUCCUUCAUAAGGGCUGAGAUAAAAGUGUGACUUUUAGACCCUCAUAACUUGAACAGGUUCAGACCUGCGUAGGGAAGUGGAGC	10.1016/j.chembiol.2005.10.007	Riboswitch	Riboswitch	100	-	-	0	0	0	0	5.00E-08	5.00E-08	0	0	0	0
740	Thiamine_mol	Target_lig_502	B.subtilis tenA TPP riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_76	0	0	5.00E-05	0	0	0	0	-	-	10.1016/j.chembiol.2005.10.007	16356850	Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine.	Sudarsan N, Cohen-Chalamish S, Nakamura S, Emilsson GM, Breaker RR	Chem Biol	12	1325-35	2005	0-10 uM	1nM - 100uM	8.3	25	20 mM MgCl2,100mM Kcl	In-line probing assays	SMMRNA	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO	2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol	1130	0.60774	265.11175858409	5	2	4	75.91	2	0.79412732636072	3.21657050291499	18	GGUAACCACUAGGGGUGUCCUUCAUAAGGGCUGAGAUAAAAGUGUGACUUUUAGACCCUCAUAACUUGAACAGGUUCAGACCUGCGUAGGGAAGUGGAGC	10.1016/j.chembiol.2005.10.007	Riboswitch	Riboswitch	100	-	-	0	0	0	0	5.00E-05	5.00E-05	0	0	0	0
741	Pyrithiamine_mol	Target_lig_503	B.subtilis tenA TPP riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_76	0	0	6.00E-06	0	0	0	0	-	-	10.1016/j.chembiol.2005.10.007	16356850	Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine.	Sudarsan N, Cohen-Chalamish S, Nakamura S, Emilsson GM, Breaker RR	Chem Biol	12	1325-35	2005	0-10 uM	1nM - 100uM	8.3	25	20 mM MgCl2,100mM Kcl	In-line probing assays	SMMRNA	CC1=C(C=CC=[N+]1CC2=CN=C(N=C2N)C)CCO.Br.[Br-]	2-[1-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-methylpyridin-1-ium-3-yl]ethanol;bromide;hydrobromide	10802	-1.87186	418.00038546	4	2	4	75.91	2	0.569000522878671	3.27600921483776	21	GGUAACCACUAGGGGUGUCCUUCAUAAGGGCUGAGAUAAAAGUGUGACUUUUAGACCCUCAUAACUUGAACAGGUUCAGACCUGCGUAGGGAAGUGGAGC	10.1016/j.chembiol.2005.10.007	Riboswitch	Riboswitch	100	-	-	0	0	0	0	6.00E-06	6.00E-06	0	0	0	0
742	Pyrithiamine _Pyrophosphate_der	Target_lig_504	B.subtilis tenA TPP riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_76	0	0	1.60E-07	0	0	0	0	-	-	10.1016/j.chembiol.2005.10.007	16356850	Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine.	Sudarsan N, Cohen-Chalamish S, Nakamura S, Emilsson GM, Breaker RR	Chem Biol	12	1325-35	2005	0-10 uM	1nM - 100uM	8.3	25	20 mM MgCl2,100mM Kcl	In-line probing assays	SMMRNA	n1c(ncc(c1N)CN1=CC=CC(=C1)CCO[P@@](=O)(O)P(=O)(O)O)C	-	-	0	0	0	0	0	0	0	0	0	0	GGUAACCACUAGGGGUGUCCUUCAUAAGGGCUGAGAUAAAAGUGUGACUUUUAGACCCUCAUAACUUGAACAGGUUCAGACCUGCGUAGGGAAGUGGAGC	10.1016/j.chembiol.2005.10.007	Riboswitch	Riboswitch	100	-	-	0	0	0	0	1.60E-07	1.60E-07	0	0	0	0
743	FMN	Target_lig_68	B.subtilis tenA FMN riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_77	0	0	5.00E-09	0	0	0	0	-	-	10.4161/rna.6.2.7727	19246992	Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression	Lee ER,  Blount KF, Breaker RR	RNA Biol	6	187-94	2009	0-50 uM	1 nM	8.3	23	20 mM MgCl2, 100 mM Kcl	In-line probing assays	SMMRNA	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)O)O)O)O	[5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate	710	-1.60656	456.104614882	10	6	7	208.09	1	0.176020349335941	4.02831596221591	31	GGAAGGACAAAUGAAUAAAGAUUGUAUCCUUCGGGGCAGGGUGGAAAUCCCGACCGGCGGUAGUAAAGCACAUUUGCUUUAGAGCCCGUGACCCGUGUGCAAUAGCACGCGGUGGAUUCAGUUUAAGCUGAAGCCGACAGUGAAAGUCUGGAUGGGAGAAGGAUG	10.1128/AAC.01282-15	Riboswitch	Riboswitch	165	-	-	0	0	0	0	5.00E-09	5.00E-09	0	0	0	0
744	riboflavin	Target_lig_70	B.subtilis tenA FMN riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_77	0	0	3.00E-06	0	0	0	0	-	-	10.4161/rna.6.2.7727	19246992	Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression	Lee ER,  Blount KF, Breaker RR	RNA Biol	6	187-94	2009	0-50 uM	1 nM	8.3	23	20 mM MgCl2, 100 mM Kcl	In-line probing assays	SMMRNA	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O	7,8-dimethyl-10-(2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4-dione	1072	-1.72356	376.13828436	9	5	5	161.56	1	0.328412159456043	3.79050028070519	27	GGAAGGACAAAUGAAUAAAGAUUGUAUCCUUCGGGGCAGGGUGGAAAUCCCGACCGGCGGUAGUAAAGCACAUUUGCUUUAGAGCCCGUGACCCGUGUGCAAUAGCACGCGGUGGAUUCAGUUUAAGCUGAAGCCGACAGUGAAAGUCUGGAUGGGAGAAGGAUG	10.1128/AAC.01282-15	Riboswitch	Riboswitch	165	-	-	0	0	0	0	3.00E-06	3.00E-06	0	0	0	0
745	Roseoflavin	Target_lig_505	B.subtilis tenA FMN riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_77	0	0	1.00E-07	0	0	0	0	-	-	10.4161/rna.6.2.7727	19246992	Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression	Lee ER,  Blount KF, Breaker RR	RNA Biol	6	187-94	2009	0-50 uM	1 nM	8.3	23	20 mM MgCl2, 100 mM Kcl	In-line probing assays	SMMRNA	CC1=CC2=C(C=C1N(C)C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O	8-(dimethylamino)-7-methyl-10-(2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4-dione	170973	-1.96598	405.164833456	10	5	6	164.8	1	0.292630701546369	3.95749650714692	29	GGAAGGACAAAUGAAUAAAGAUUGUAUCCUUCGGGGCAGGGUGGAAAUCCCGACCGGCGGUAGUAAAGCACAUUUGCUUUAGAGCCCGUGACCCGUGUGCAAUAGCACGCGGUGGAUUCAGUUUAAGCUGAAGCCGACAGUGAAAGUCUGGAUGGGAGAAGGAUG	10.1128/AAC.01282-15	Riboswitch	Riboswitch	165	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
746	L-homoarginine	Target_lig_57	B.subtilis lysine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_78	0	0	7e-06±4e-06	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	100 uM	-	-	37	5 mM MnCl 2, 0.5 mM CaCl 2, 2.5 mM MgCl	In-line probing assays	SMMRNA	C(CCN=C(N)N)C[C@@H](C(=O)O)N	(2S)-2-amino-6-(diaminomethylideneamino)hexanoic acid	9085	-1.158	188.127325752	3	4	6	127.72	0	0.237357288408479	2.74634282092818	13	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUGUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	http://www.genesdev.org/cgi/doi/10.1101/ gad.1140003	Riboswitch	Riboswitch	239	-	-	0	0	0	0	3.00E-06	1.10E-05	0	0	0	0
747	lysine	Target_lig_31	B.subtilis lysine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_78	0	0	3.60E-07	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	100 uM	-	-	37	5 mM MnCl 2, 0.5 mM CaCl 2, 2.5 mM MgCl	In-line probing assays	SMMRNA	C(CCN)C[C@@H](C(=O)O)N	(2S)-2,6-diaminohexanoic acid	5962	-0.472699999999999	146.105527688	3	3	5	89.34	0	0.457177158496557	2.47366829558304	10	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUGUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	http://www.genesdev.org/cgi/doi/10.1101/ gad.1140003	Riboswitch	Riboswitch	239	-	-	0	0	0	0	3.60E-07	3.60E-07	0	0	0	0
748	L-4 L_4_Oxalysine	Target_lig_506	B.subtilis lysine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_78	0	0	1.3e-05±2e-06	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	100 uM	-	-	37	5 mM MnCl 2, 0.5 mM CaCl 2, 2.5 mM MgCl	In-line probing assays	SMMRNA	C(COC[C@@H](C(=O)O)N)N	(2S)-2-amino-3-(2-aminoethoxy)propanoic acid	160555	-1.6264	148.084792244	4	3	5	98.57	0	0.406590195452929	2.86533338434043	10	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUGUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	http://www.genesdev.org/cgi/doi/10.1101/ gad.1140003	Riboswitch	Riboswitch	239	-	-	0	0	0	0	1.10E-05	1.50E-05	0	0	0	0
749	AEC	Target_lig_507	B.subtilis lysine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_78	0	0	3.00E-05	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	100 uM	-	-	37	5 mM MnCl 2, 0.5 mM CaCl 2, 2.5 mM MgCl	In-line probing assays	SMMRNA	CCC1CC1(C(=O)O)N	1-amino-2-ethylcyclopropane-1-carboxylic acid	133485	0.1984	129.078978592	2	2	2	63.32	0	0.55938888063224	3.74796579804141	9	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUGUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	http://www.genesdev.org/cgi/doi/10.1101/ gad.1140003	Riboswitch	Riboswitch	239	-	-	0	0	0	0	3.00E-05	3.00E-05	0	0	0	0
750	L-3-[(2-AMINOETHYL)-SULFONYL]-ALANINE	Target_lig_508	B.subtilis lysine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_78	0	0	2.4999999999999998e-06±3e-07	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	100 uM	-	-	37	5 mM MnCl 2, 0.5 mM CaCl 2, 2.5 mM MgCl	In-line probing assays	SMMRNA	C(CS(=O)(=O)C[C@@H](C(=O)[O-])[NH3+])[NH3+]	(2R)-2-azaniumyl-3-(2-azaniumylethylsulfonyl)propanoate	11948926	-4.9965	197.05905431609	4	2	5	129.55	0	0.456680622285498	5.68919847848104	12	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUGUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	http://www.genesdev.org/cgi/doi/10.1101/ gad.1140003	Riboswitch	Riboswitch	239	-	-	0	0	0	0	2.20E-06	2.80E-06	0	0	0	0
751	DL-TRANS-2,6-DIAMINO-4-HEXENOIC ACID	Target_lig_509	B.subtilis lysine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_78	0	0	9.7e-07±4e-08	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	100 uM	-	-	37	5 mM MnCl 2, 0.5 mM CaCl 2, 2.5 mM MgCl	In-line probing assays	SMMRNA	C(/C=C/C[NH3+])C(C(=O)[O-])[NH3+]	(E)-2,6-bis(azaniumyl)hex-4-enoate	11948929	-3.465	145.09715407609	2	2	4	95.41	0	0.401994716530582	6.23467243759487	10	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUGUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	http://www.genesdev.org/cgi/doi/10.1101/ gad.1140003	Riboswitch	Riboswitch	239	-	-	0	0	0	0	9.30E-07	1.01E-06	0	0	0	0
752	phenylacetate derivative	Target_lig_510	T-box riboswitch	Escherichia coli	Bacterial growth and infection	Target_79	0	0	6.60E-06	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	100 uM	-	-	37	5 mM MnCl 2, 0.5 mM CaCl 2, 2.5 mM MgCl	In-line probing assays	SMMRNA	C1CN(CCN1C[C@@H]2[C@H](OC(=O)N2)COC(=O)CC3=CC=CC=C3)C4=CC=CC=C4	[(4R,5S)-2-oxo-4-[(4-phenylpiperazin-1-yl)methyl]-1,3-oxazolidin-5-yl]methyl 2-phenylacetate	24821056	2.0715	409.200156344	6	1	7	71.11	2	0.706327613887873	3.0944377280843	30	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	Riboswitch, T-box element	Riboswitch	29	-	-	0	0	0	0	6.60E-06	6.60E-06	0	0	0	0
753	methyl N-(4-acetylphenyl)carbamate derivative	Target_lig_511	T-box riboswitch	Escherichia coli	Bacterial growth and infection	Target_79	0	0	9.00E-07	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	100 uM	-	-	37	5 mM MnCl 2, 0.5 mM CaCl 2, 2.5 mM MgCl	In-line probing assays	SMMRNA	CC(=O)C1=CC=C(C=C1)NC(=O)OC[C@@H]2[C@H](NC(=O)O2)CN3CCN(CC3)C4=CC=CC=C4	[(4R,5S)-2-oxo-4-[(4-phenylpiperazin-1-yl)methyl]-1,3-oxazolidin-5-yl]methyl N-(4-acetylphenyl)carbamate	24821057	2.7369	452.205969996	7	2	7	100.21	2	0.623290599021209	3.18499857217595	33	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	Riboswitch, T-box element	Riboswitch	29	-	-	0	0	0	0	9.00E-07	9.00E-07	0	0	0	0
754	hexanamide derivative_1	Target_lig_512	r(CUG)	Synthetic	-	Target_55	0	0	7.00E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	NCCCC[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1CCCN1C(=O)c1cc2c(OCO2)cc1)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCCCN)NC(=O)[C@H]1CCCN1C(=O)c1cc2c(OCO2)cc1)C(=O)NCCCN	-	-	-0.438000000000003	1098.499057808	18	10	31	356.22	2	0.033800532611899	5.20227633216278	76	GCGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCGC	http://www.smmrna.org/	RNA aptamer	Expanded Repeats	36	-	Internal Loop	0	0	0	0	7.00E-06	7.00E-06	0	0	0	0
755	hexanamide derivative_3	Target_lig_513	r(CUG)	Synthetic	-	Target_55	0	0	1.00E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CCC1=NC2=CC=CC=C2C=C1C(=O)N3CCC[C@H]3C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCCCN)NC(=O)[C@@H]4CCCN4C(=O)C5=CC6=CC=CC=C6N=C5CC)C(=O)N[C@@H](CCCCN)C(=O)NCCCN	(2S)-N-[(2R)-1-[[(2S)-6-amino-1-(3-aminopropylamino)-1-oxohexan-2-yl]amino]-3-[[(2R)-3-[[(2S)-6-amino-1-(3-aminopropylamino)-1-oxohexan-2-yl]amino]-2-[[(2S)-1-(2-ethylquinoline-3-carbonyl)pyrrolidine-2-carbonyl]amino]-3-oxopropyl]disulfanyl]-1-oxopropan-2-yl]-1-(2-ethylquinoline-3-carbonyl)pyrrolidine-2-carboxamide	25228085	2.3258	1168.603797648	16	10	33	345.08	4	0.024172990215334	5.47994818885521	82	GCGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCGC	http://www.smmrna.org/	RNA aptamer	Expanded Repeats	36	-	Internal Loop	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
756	butanediamide derivative_1	Target_lig_514	r(CUG)	Synthetic	-	Target_55	0	0	5.50E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CCc1nc2c(cccc2)cc1C(=O)N1CCC[C@@H]1C(=O)N[C@H](CSSC[C@@H](NC(=O)[C@H](NC(=O)c1c(CC)nc2c(cccc2)c1)CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)NCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCCCN	-	-	0.694999999999991	1185.593961236	17	12	36	396.96	4	0.022019712323712	5.57006078273347	83	GCGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCGC	http://www.smmrna.org/	RNA aptamer	Expanded Repeats	36	-	Internal Loop	0	0	0	0	5.50E-06	5.50E-06	0	0	0	0
757	hexanamide derivative_2	Target_lig_515	r(CUG)	Synthetic	-	Target_55	0	0	7.50E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CCc1nc2c(cccc2)cc1C(=O)N1CCC[C@@H]1C(=O)N[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCCCN)NC(=O)[C@@H]1CCCN1C(=O)c1cc2c(OCO2)cc1)C(=O)N[C@H](CCCCN)C(=O)NCCCN	-	-	0.943899999999997	1133.551427728	17	10	32	350.65	3	0.030721517337579	5.41074778610339	79	GCGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCGC	http://www.smmrna.org/	RNA aptamer	Expanded Repeats	36	-	Internal Loop	0	0	0	0	7.50E-06	7.50E-06	0	0	0	0
758	triazine-2,4,6-triamine derivative	Target_lig_516	r(CUG)	Synthetic	-	Target_55	0	4.20E-05	1.10E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCNC4=NC(=NC(=N4)N)N	2-N-[4-[(6-chloro-2-methoxyacridin-9-yl)amino]butyl]-1,3,5-triazine-2,4,6-triamine	71511622	3.7036	438.168335036	9	4	8	136.89	4	0.239366850651394	2.51589799919445	31	GCGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCGC	http://www.smmrna.org/	RNA aptamer	Expanded Repeats	36	-	Internal Loop	0	0	4.20E-05	4.20E-05	1.10E-05	1.10E-05	0	0	0	0
759	carboximidamide derivative	Target_lig_517	r(CUG)	Synthetic	-	Target_55	0	5.80E-05	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=N)C1=CC=C(C=C1)OCCCCCOC2=CC=C(C=C2)C(=N)N	4-[5-(4-ethanimidoylphenoxy)pentoxy]benzenecarboximidamide	58586324	3.98654	339.19467704	4	3	10	92.18	2	0.347072333822008	2.11275351136624	25	GCGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCGC	http://www.smmrna.org/	RNA aptamer	Expanded Repeats	36	-	Internal Loop	0	0	5.80E-05	5.80E-05	0	0	0	0	0	0
760	pent-4-ynamide derivative	Target_lig_518	r(CUG)	Synthetic	-	Target_55	0	0.00021	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@@H]1CNC(=O)CCC#C)O[C@H]1[C@H]([C@H]([C@@H](C[C@@H]1N)N)O[C@H]1O[C@@H]([C@H]([C@H]([C@@H]1O)N)O)CO)O)O)O)O	-	-	-6.7205	564.26427272	15	11	9	285.69	0	0.116029544752472	5.24122452122126	39	GCGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCGC	http://www.smmrna.org/	RNA aptamer	Expanded Repeats	36	-	Internal Loop	0	0	0.00021	0.00021	0	0	0	0	0	0
761	phenoxy_butanamide	Target_lig_519	r(CUG)	Synthetic	-	Target_55	0	0.00011	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1N(CCN(C1)c1ccc2c(c1)[nH]c(n2)c1ccc2c(c1)[nH]c(n2)c1cccc(c1)OCCCC(=O)NCCC/N=N/N)C	-	-	4.5162	594.317920456	8	4	12	152.91	5	0.07172048168158	3.08389786046786	44	GCGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCGC	http://www.smmrna.org/	RNA aptamer	Expanded Repeats	36	-	Internal Loop	0	0	0.00011	0.00011	0	0	0	0	0	0
762	pyrimidine-2,4,6-triamine	Target_lig_1252	DM1-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 1 (DM1)	Target_110	0	3.70E-05	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=C(N=C(N=C1N)N)N	pyrimidine-2,4,6-triamine	13863	-0.7768	125.070145224	5	3	0	103.84	1	0.421754100457696	2.59910493030248	9	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	46	-	Internal Loop	0	0	3.70E-05	3.70E-05	0	0	0	0	0	0
763	acridine-4-carboxamide-derivative	Target_lig_520	DM1-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 1 (DM1)	Target_110	0	0.000118	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c1(c(nc(nc1N)N)N)CCCCNc1c2c(nc3c1cccc3C(=O)NCCN(C)C)ccc(c2)OC	-	-	2.6594	517.29137136	10	5	11	170.33	4	0.147123318523274	2.82322813079768	38	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	46	-	Internal Loop	0	0	0.000118	0.000118	0	0	0	0	0	0
764	N-propylbutanamide derivative	Target_lig_521	DM1-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 1 (DM1)	Target_110	0	0.00011	1.30E-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CCCNC(=O)CCCOC1=CC=CC(=C1)C2=NC3=C(N2)C=C(C=C3)C4=NC5=C(N4)C=C(C=C5)N6CCN(CC6)C	4-[3-[6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazol-2-yl]phenoxy]-N-propylbutanamide	134332907	5.2102	551.300873424	6	3	10	102.17	5	0.206067840296308	2.67941541789488	41	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	46	-	Internal Loop	0	0	0.00011	0.00011	1.30E-07	1.30E-07	0	0	0	0
765	butanamide derivative_1	Target_lig_522	DM1-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 1 (DM1)	Target_110	0	1.10E-06	1.00E-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C(CNC(=O)CCCOc1cccc(c1)c1nc2c([nH]1)cc(cc2)c1nc2ccc(cc2[nH]1)N1CCN(C)CC1)n1cc(CN(CC(=O)N)C(=O)CN(CCC)C(=O)CN(CCC)C(=O)CN(C(=O)CN(C(=O)CN(Cc2nnn(c2)CCNC(=O)CCCOc2cccc(c2)c2nc3c([nH]2)cc(cc3)c2nc3ccc(cc3[nH]2)N2CCN(C)CC2)C)CCC)CCC)nn1	-	-	7.39750000000002	1773.963323008	25	7	46	413.64	12	0.018264649177062	6.07136340165495	130	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	46	-	Internal Loop	0	0	1.10E-06	1.10E-06	1.00E-07	1.00E-07	0	0	0	0
766	butanamide derivative_2	-	DM1-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 1 (DM1)	Target_110	0	9.60E-07	6.50E-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	-	-	-	0	0	0	0	0	0	0	0	0	0	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	46	-	Internal Loop	0	0	9.60E-07	9.60E-07	6.50E-08	6.50E-08	0	0	0	0
767	butanamide derivative_3	-	DM1-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 1 (DM1)	Target_110	0	3.90E-07	3.50E-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	-	-	-	0	0	0	0	0	0	0	0	0	0	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	46	-	Internal Loop	0	0	3.90E-07	3.90E-07	3.50E-08	3.50E-08	0	0	0	0
768	butanamide derivative_4	-	DM1-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 1 (DM1)	Target_110	0	2.20E-07	1.30E-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	-	-	-	0	0	0	0	0	0	0	0	0	0	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	46	-	Internal Loop	0	0	2.20E-07	2.20E-07	1.30E-08	1.30E-08	0	0	0	0
769	pentanamide derivative_1	Target_lig_523	DM1-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 1 (DM1)	Target_110	0	0.0002	1.00E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@@H]1CNC(=O)CCCC)O[C@@H]1[C@@H]([C@H]([C@H](C[C@@H]1N)N)O[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)N)O)CO)O)O)O)O	-	-	-5.9437	568.295572848	15	11	10	285.69	0	0.116912920789522	5.04302671902346	39	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	46	-	Internal Loop	0	0	0.0002	0.0002	1.00E-06	1.00E-06	0	0	0	0
770	pentanamide derivative_2	Target_lig_524	DM1-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 1 (DM1)	Target_110	0	6.00E-07	5.00E-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	[C@H]1([C@@H]([C@H]([C@H](O[C@@H]1CNC(=O)CCCCc1nnn(CCCN(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N)CCCn2nnc(c2)CCCCC(=O)NC[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)O[C@@H]2[C@@H]([C@@H]([C@H](C[C@H]2N)N)O[C@@H]2O[C@@H]([C@H]([C@H]([C@H]2O)N)O)CO)O)O)O)O)CCC)CCC)C)c1)O[C@@H]1[C@H]([C@@H]([C@H](C[C@@H]1N)N)O[C@H]1O[C@H]([C@@H]([C@@H]([C@@H]1O)N)O)CO)O)O)O)O	-	-	-13.7420999999999	1693.909794424	41	23	44	740.06	2	0.027399483710315	6.10911986347387	118	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	46	-	Internal Loop	0	0	6.00E-07	6.00E-07	5.00E-08	5.00E-08	0	0	0	0
771	pentanamide derivative_3	-	DM1-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 1 (DM1)	Target_110	0	1.20E-07	2.00E-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	-	-	-	0	0	0	0	0	0	0	0	0	0	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	46	-	Internal Loop	0	0	1.20E-07	1.20E-07	2.00E-08	2.00E-08	0	0	0	0
772	pentanamide derivative_4	-	DM1-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 1 (DM1)	Target_110	0	2.00E-08	4.00E-09	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	-	-	-	0	0	0	0	0	0	0	0	0	0	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	46	-	Internal Loop	0	0	2.00E-08	2.00E-08	4.00E-09	4.00E-09	0	0	0	0
773	pyrimidine-2,4,6-triamine	Target_lig_1252	DM2-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 2 (DM2)	Target_111	0	4.00E-05	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=C(N=C(N=C1N)N)N	pyrimidine-2,4,6-triamine	13863	-0.7768	125.070145224	5	3	0	103.84	1	0.421754100457696	2.59910493030248	9	GGGAGAGGGUUUAAUCCUGUACGAAAGUACCUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	48	-	Internal Loop	0	0	4.00E-05	4.00E-05	0	0	0	0	0	0
774	acridine-4-carboxamide-derivative	Target_lig_520	DM2-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 2 (DM2)	Target_111	0	3.50E-05	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c1(c(nc(nc1N)N)N)CCCCNc1c2c(nc3c1cccc3C(=O)NCCN(C)C)ccc(c2)OC	-	-	2.6594	517.29137136	10	5	11	170.33	4	0.147123318523274	2.82322813079768	38	GGGAGAGGGUUUAAUCCUGUACGAAAGUACCUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	48	-	Internal Loop	0	0	3.50E-05	3.50E-05	0	0	0	0	0	0
775	pentanamide derivative_1	Target_lig_523	DM2-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 2 (DM2)	Target_111	0	0.0001	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	[C@@H]1([C@@H]([C@H]([C@H](O[C@@H]1CNC(=O)CCCC)O[C@@H]1[C@@H]([C@H]([C@H](C[C@@H]1N)N)O[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)N)O)CO)O)O)O)O	-	-	-5.9437	568.295572848	15	11	10	285.69	0	0.116912920789522	5.04302671902346	39	GGGAGAGGGUUUAAUCCUGUACGAAAGUACCUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	48	-	Internal Loop	0	0	0.0001	0.0001	0	0	0	0	0	0
776	pentanamide derivative_5	Target_lig_525	DM2-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 2 (DM2)	Target_111	0	8.90E-08	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CCCN(CC(=O)N(CCC)CC(=O)N(C(=O)N(C(=O)N(CCCn1cc(CCCCC(=O)NC[C@@H]2O[C@H](O[C@H]3[C@H](N)C[C@@H](N)[C@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](N)[C@H]4O)[C@@H]3O)[C@H](O)[C@H](O)[C@H]2O)nn1)CC(=O)N)CCC)CCC)C(=O)CN(C)CCCn1cc(CCCCC(=O)NC[C@H]2O[C@H](O[C@H]3[C@H](N)C[C@@H](N)[C@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](N)[C@H]4O)[C@H]3O)[C@@H](O)[C@@H](O)[C@@H]2O)nn1	-	-	-12.0781	1864.015322112	43	23	48	780.68	2	0.027362275364589	7.64174489161813	130	GGGAGAGGGUUUAAUCCUGUACGAAAGUACCUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	48	-	Internal Loop	0	0	8.90E-08	8.90E-08	0	0	0	0	0	0
777	pentanamide derivative_6	-	DM2-RNA-MBNL1	Homo sapiens	Myotonic dystrophy 2 (DM2)	Target_111	0	1.60E-09	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	-	-	-	0	0	0	0	0	0	0	0	0	0	GGGAGAGGGUUUAAUCCUGUACGAAAGUACCUGAUUGGAUCCGCAAGG	http://www.smmrna.org/	mRNA	Expanded Repeats	48	-	Internal Loop	0	0	1.60E-09	1.60E-09	0	0	0	0	0	0
778	neocarzinostatin	Target_lig_148	RNA XIII	Synthetic	-	Target_123	0	0	1.10E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1C(C(C(C(O1)OC2C3CC#CC4C(O4)(C#CC3=CC2OC(=O)C5=C(C=CC6=C5C=C(C=C6C)OC)O)C7COC(=O)O7)NC)O)O	[11-[4,5-dihydroxy-6-methyl-3-(methylamino)oxan-2-yl]oxy-4-(2-oxo-1,3-dioxolan-4-yl)-5-oxatricyclo[8.3.0.04,6]tridec-1(13)-en-2,7-diyn-12-yl] 2-hydroxy-7-methoxy-5-methylnaphthalene-1-carboxylate	76632185	1.46732	661.21592556	13	4	7	174.77	2	0.191003180515107	6.57336699874626	48	GUCCGAUGCGUGUUUCACGCAGUUCGGAC	http://www.smmrna.org/	RNA aptamer	-	29	-	Stem-Loop with Bulge	0	0	0	0	1.10E-06	1.10E-06	0	0	0	0
779	Neocarzinostatin_chromophore_derivative_2	Target_lig_150	RNA XIII	Synthetic	-	Target_123	0	0	2.10E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cccc1)[C@]1(C(=O)C=C2)[C@@H](O[C@@H]2[C@@H]1c1c(C2=O)cc2c(c1)cccc2)O[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)CO)O)O)N	-	-	1.1614	529.173666824	9	4	3	148.54	3	0.392223613095501	5.34806308393096	39	GUCCGAUGCGUGUUUCACGCAGUUCGGAC	http://www.smmrna.org/	RNA aptamer	-	29	-	Stem-Loop with Bulge	0	0	0	0	2.10E-05	2.10E-05	0	0	0	0
780	Neocarzinostatin_chromophore_derivative_3	Target_lig_151	RNA XIII	Synthetic	-	Target_123	0	0	2.20E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cccc1)[C@]1([C@@H](C=C2)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)CO)O)O)N)C(=O)O[C@H]2[C@@H]1c1c(C2=O)cc2c(c1)cccc2	-	-	1.1614	529.173666824	9	4	3	148.54	3	0.366909642437388	5.32842898829686	39	GUCCGAUGCGUGUUUCACGCAGUUCGGAC	http://www.smmrna.org/	RNA aptamer	-	29	-	Stem-Loop with Bulge	0	0	0	0	2.20E-05	2.20E-05	0	0	0	0
781	Neocarzinostatin_chromophore_derivative_5	Target_lig_152	RNA XIII	Synthetic	-	Target_123	0	0	1.30E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cc(cc1)OC)[C@@]1(C(=O)C=C2)C=C[C@@H]2[C@@H]1c1c([C@H]2O[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)C)O)O)NC)cc2c(c1)cccc2	-	-	3.7778	539.230787776	7	3	4	97.25	3	0.434466412262569	5.39426082967241	40	GUCCGAUGCGUGUUUCACGCAGUUCGGAC	http://www.smmrna.org/	RNA aptamer	-	29	-	Stem-Loop with Bulge	0	0	0	0	1.30E-06	1.30E-06	0	0	0	0
782	Neocarzinostatin_chromophore_derivative_2	Target_lig_150	RNA XIV	Synthetic	-	Target_124	0	0	1.90E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cccc1)[C@]1(C(=O)C=C2)[C@@H](O[C@@H]2[C@@H]1c1c(C2=O)cc2c(c1)cccc2)O[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)CO)O)O)N	-	-	1.1614	529.173666824	9	4	3	148.54	3	0.392223613095501	5.34806308393096	39	GUCCGAUGCGUGUUUCACGCAGUCGGAC	http://www.smmrna.org/	RNA aptamer	-	28	-	Stem-Loop with Bulge	0	0	0	0	1.90E-05	1.90E-05	0	0	0	0
783	Neocarzinostatin_chromophore_derivative_3	Target_lig_151	RNA XIV	Synthetic	-	Target_124	0	0	6.80E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cccc1)[C@]1([C@@H](C=C2)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)CO)O)O)N)C(=O)O[C@H]2[C@@H]1c1c(C2=O)cc2c(c1)cccc2	-	-	1.1614	529.173666824	9	4	3	148.54	3	0.366909642437388	5.32842898829686	39	GUCCGAUGCGUGUUUCACGCAGUCGGAC	http://www.smmrna.org/	RNA aptamer	-	28	-	Stem-Loop with Bulge	0	0	0	0	6.80E-05	6.80E-05	0	0	0	0
784	Neocarzinostatin_chromophore_derivative_2	Target_lig_150	RNA XV	Synthetic	-	Target_125	0	0	2.00E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cccc1)[C@]1(C(=O)C=C2)[C@@H](O[C@@H]2[C@@H]1c1c(C2=O)cc2c(c1)cccc2)O[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)CO)O)O)N	-	-	1.1614	529.173666824	9	4	3	148.54	3	0.392223613095501	5.34806308393096	39	GUCCGAUGCGUGUUUCACGCAUCGGAC	http://www.smmrna.org/	RNA aptamer	-	27	-	Stem-Loop with Bulge	0	0	0	0	2.00E-05	2.00E-05	0	0	0	0
785	Neocarzinostatin_chromophore_derivative_4	Target_lig_526	RNA XV	Synthetic	-	Target_125	0	0	5.00E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cc(cc1)OC)[C@@]1(C(=O)C=C2)C=C[C@@H]2[C@@H]1c1c([C@H]2O[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)CO)O)O)N)cc2c(c1)cccc2	-	-	2.4895	541.210052332	8	4	4	131.47	3	0.370795224029278	5.35525718594772	40	GUCCGAUGCGUGUUUCACGCAUCGGAC	http://www.smmrna.org/	RNA aptamer	-	27	-	Stem-Loop with Bulge	0	0	0	0	5.00E-06	5.00E-06	0	0	0	0
786	Neocarzinostatin_chromophore_derivative_5	Target_lig_152	RNA XV	Synthetic	-	Target_125	0	0	4.90E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cc(cc1)OC)[C@@]1(C(=O)C=C2)C=C[C@@H]2[C@@H]1c1c([C@H]2O[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)C)O)O)NC)cc2c(c1)cccc2	-	-	3.7778	539.230787776	7	3	4	97.25	3	0.434466412262569	5.39426082967241	40	GUCCGAUGCGUGUUUCACGCAUCGGAC	http://www.smmrna.org/	RNA aptamer	-	27	-	Stem-Loop with Bulge	0	0	0	0	4.90E-06	4.90E-06	0	0	0	0
787	Neocarzinostatin_chromophore_derivative_6	Target_lig_153	RNA XV	Synthetic	-	Target_125	0	0	1.20E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cc(cc1)OC)[C@@]1(C(=O)C=C2)C=C[C@H]2[C@H]1c1c([C@@H]2O[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)C)O)O)NC)cc2c(c1)cccc2	-	-	3.7778	539.230787776	7	3	4	97.25	3	0.434466412262569	5.39426082967241	40	GUCCGAUGCGUGUUUCACGCAUCGGAC	http://www.smmrna.org/	RNA aptamer	-	27	-	Stem-Loop with Bulge	0	0	0	0	1.20E-05	1.20E-05	0	0	0	0
788	Neocarzinostatin_chromophore_derivative_5	Target_lig_152	RNA XVII	Synthetic	-	Target_126	0	0	1.60E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cc(cc1)OC)[C@@]1(C(=O)C=C2)C=C[C@@H]2[C@@H]1c1c([C@H]2O[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)C)O)O)NC)cc2c(c1)cccc2	-	-	3.7778	539.230787776	7	3	4	97.25	3	0.434466412262569	5.39426082967241	40	GUCCGAUGCGUGUUUUCACGCAGUUCGGAC	http://www.smmrna.org/	RNA aptamer	-	30	-	Stem-Loop with Bulge	0	0	0	0	1.60E-06	1.60E-06	0	0	0	0
789	Neocarzinostatin_chromophore_derivative_6	Target_lig_153	RNA XVII	Synthetic	-	Target_126	0	0	2.80E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(cc(cc1)OC)[C@@]1(C(=O)C=C2)C=C[C@H]2[C@H]1c1c([C@@H]2O[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)C)O)O)NC)cc2c(c1)cccc2	-	-	3.7778	539.230787776	7	3	4	97.25	3	0.434466412262569	5.39426082967241	40	GUCCGAUGCGUGUUUUCACGCAGUUCGGAC	http://www.smmrna.org/	RNA aptamer	-	30	-	Stem-Loop with Bulge	0	0	0	0	2.80E-06	2.80E-06	0	0	0	0
790	Streptomycin	Target_lig_63	T box antiterminator RNA	Escherichia coli	Bacterial growth and infection	Target_112	0	0	0.00079±0.00031	0	0	0	0	-	-	10.1016/j.bmcl.2005.02.007	15808490	Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.	Means JA, Hines JV	Bioorg Med Chem Lett	15	2169-72	2005	0-12.5 mg/mL	-	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET assay	SMMRNA	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	https://doi.org/10.1016/j.bmcl.2005.02.007	T-box element	Antiterminator region	29	-	Stem-Loop	0	0	0	0	0.00048	0.0011	0	0	0	0
791	Paromomycin_mol_mol	Target_lig_1116	T box antiterminator RNA	Escherichia coli	Bacterial growth and infection	Target_112	0	0	4.9999999999999996e-05±9.4e-06	0	0	0	0	-	-	10.1016/j.bmcl.2005.02.007	15808490	Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.	Means JA, Hines JV	Bioorg Med Chem Lett	15	2169-72	2005	0-12.5 mg/mL	-	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	https://doi.org/10.1016/j.bmcl.2005.02.007	T-box element	Antiterminator region	29	-	Stem-Loop	0	0	0	0	4.06E-05	5.94E-05	0	0	0	0
792	Tobramycin	Target_lig_540	T box antiterminator RNA	Escherichia coli	Bacterial growth and infection	Target_112	0	0	3.7999999999999995e-05±9e-06	0	0	0	0	-	-	10.1016/j.bmcl.2005.02.007	15808490	Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.	Means JA, Hines JV	Bioorg Med Chem Lett	15	2169-72	2005	0-12.5 mg/mL	-	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET assay	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	https://doi.org/10.1016/j.bmcl.2005.02.007	T-box element	Antiterminator region	29	-	Stem-Loop	0	0	0	0	2.90E-05	4.70E-05	0	0	0	0
793	Kanamycin A	Target_lig_7	T box antiterminator RNA	Escherichia coli	Bacterial growth and infection	Target_112	0	0	0.00020999999999999998±8.7e-05	0	0	0	0	-	-	10.1016/j.bmcl.2005.02.007	15808490	Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.	Means JA, Hines JV	Bioorg Med Chem Lett	15	2169-72	2005	0-12.5 mg/mL	-	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	https://doi.org/10.1016/j.bmcl.2005.02.007	T-box element	Antiterminator region	29	-	Stem-Loop	0	0	0	0	0.000123	0.000297	0	0	0	0
794	KANAMYCIN B	Target_lig_8	T box antiterminator RNA	Escherichia coli	Bacterial growth and infection	Target_112	0	0	0.00015±2.7e-05	0	0	0	0	-	-	10.1016/j.bmcl.2005.02.007	15808490	Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.	Means JA, Hines JV	Bioorg Med Chem Lett	15	2169-72	2005	0-12.5 mg/mL	-	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	https://doi.org/10.1016/j.bmcl.2005.02.007	T-box element	Antiterminator region	29	-	Stem-Loop	0	0	0	0	0.000123	0.000177	0	0	0	0
795	Neomycin_B	Target_lig_1246	T box antiterminator RNA	Escherichia coli	Bacterial growth and infection	Target_112	0	0	8.5e-06±2.1e-06	0	0	0	0	-	-	10.1016/j.bmcl.2005.02.007	15808490	Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.	Means JA, Hines JV	Bioorg Med Chem Lett	15	2169-72	2005	0-12.5 mg/mL	-	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	https://doi.org/10.1016/j.bmcl.2005.02.007	T-box element	Antiterminator region	29	-	Stem-Loop	0	0	0	0	6.40E-06	1.06E-05	0	0	0	0
796	gentamicin_mol_c	Target_lig_76	T box antiterminator RNA	Escherichia coli	Bacterial growth and infection	Target_112	0	0	0.00011999999999999999±1.8999999999999998e-05	0	0	0	0	-	-	10.1016/j.bmcl.2005.02.007	15808490	Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.	Means JA, Hines JV	Bioorg Med Chem Lett	15	2169-72	2005	0-12.5 mg/mL	-	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET assay	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	https://doi.org/10.1016/j.bmcl.2005.02.007	T-box element	Antiterminator region	29	-	Stem-Loop	0	0	0	0	0.000101	0.000139	0	0	0	0
797	Amikacin	Target_lig_175	T box antiterminator RNA	Escherichia coli	Bacterial growth and infection	Target_112	0	0	0.0007599999999999999±0.00027	0	0	0	0	-	-	10.1016/j.bmcl.2005.02.007	15808490	Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.	Means JA, Hines JV	Bioorg Med Chem Lett	15	2169-72	2005	0-12.5 mg/mL	-	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET assay	SMMRNA	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	https://doi.org/10.1016/j.bmcl.2005.02.007	T-box element	Antiterminator region	29	-	Stem-Loop	0	0	0	0	0.00049	0.00103	0	0	0	0
798	Streptomycin	Target_lig_63	Argininamide-TAR complex	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	2.40E-06	9.50E-06	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	2.40E-06	2.40E-06	9.50E-06	9.50E-06	0	0
799	Neomycin_B	Target_lig_1246	Argininamide-TAR complex	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	7.00E-07	9.20E-07	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	7.00E-07	7.00E-07	9.20E-07	9.20E-07	0	0
800	gentamicin_mol	Target_lig_76	Argininamide-TAR complex	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	4.30E-06	4.50E-05	0	0	0	-	-	10.1021/cr0681546	18361529	Targeting RNA with small molecules.	Thomas JR, Hergenrother PJ	Chem Rev	108	1171-224	2008	-	-	-	-	-	-	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	4.30E-06	4.30E-06	4.50E-05	4.50E-05	0	0
801	Spectinomycin	Target_lig_75	SLI of Rep A	Escherichia coli	Bacterial growth and infection	Target_127	0	0	>4e-06	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	SMMRNA	CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O	8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one	2021	-2.9256	332.158351108	9	5	2	129.51	0	0.360820282325169	5.12987922706813	23	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	https://pubs.acs.org/doi/pdf/10.1021/bi0473298	Stem-loop structure	Stem-loop I of RepA mRNA	34	-	Stem-Loop	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
802	Hygromycin_B	Target_lig_3	SLI of Rep A	Escherichia coli	Bacterial growth and infection	Target_127	0	0	>4e-06	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	SMMRNA	CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N	4-[3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6'-(1-amino-2-hydroxyethyl)-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol	3659	-7.2706	527.232638244	16	11	6	272.06	0	0.152994487643804	6.04885226343299	36	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	https://pubs.acs.org/doi/pdf/10.1021/bi0473298	Stem-loop structure	Stem-loop I of RepA mRNA	34	-	Stem-Loop	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
803	Neomycin	Target_lig_4	SLI of Rep A	Escherichia coli	Bacterial growth and infection	Target_127	0	0	8.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	https://pubs.acs.org/doi/pdf/10.1021/bi0473298	Stem-loop structure	Stem-loop I of RepA mRNA	34	-	Stem-Loop	0	0	0	0	8.00E-08	8.00E-08	0	0	0	0
804	Paromomycin_mol_mol	Target_lig_1116	SLI of Rep A	Escherichia coli	Bacterial growth and infection	Target_127	0	0	4.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	https://pubs.acs.org/doi/pdf/10.1021/bi0473298	Stem-loop structure	Stem-loop I of RepA mRNA	34	-	Stem-Loop	0	0	0	0	4.00E-08	4.00E-08	0	0	0	0
805	Tobramycin	Target_lig_540	SLI of Rep A	Escherichia coli	Bacterial growth and infection	Target_127	0	0	4.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	https://pubs.acs.org/doi/pdf/10.1021/bi0473298	Stem-loop structure	Stem-loop I of RepA mRNA	34	-	Stem-Loop	0	0	0	0	4.00E-08	4.00E-08	0	0	0	0
806	Kanamycin A	Target_lig_7	SLI of Rep A	Escherichia coli	Bacterial growth and infection	Target_127	0	0	1.70E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	https://pubs.acs.org/doi/pdf/10.1021/bi0473298	Stem-loop structure	Stem-loop I of RepA mRNA	34	-	Stem-Loop	0	0	0	0	1.70E-07	1.70E-07	0	0	0	0
807	KANAMYCIN B	Target_lig_8	SLI of Rep A	Escherichia coli	Bacterial growth and infection	Target_127	0	0	1.10E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	https://pubs.acs.org/doi/pdf/10.1021/bi0473298	Stem-loop structure	Stem-loop I of RepA mRNA	34	-	Stem-Loop	0	0	0	0	1.10E-07	1.10E-07	0	0	0	0
808	sisomicin	Target_lig_10	SLI of Rep A	Escherichia coli	Bacterial growth and infection	Target_127	0	0	3.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	https://pubs.acs.org/doi/pdf/10.1021/bi0473298	Stem-loop structure	Stem-loop I of RepA mRNA	34	-	Stem-Loop	0	0	0	0	3.00E-08	3.00E-08	0	0	0	0
809	Amikacin	Target_lig_175	SLI of Rep A	Escherichia coli	Bacterial growth and infection	Target_127	0	0	8.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	SMMRNA	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	https://pubs.acs.org/doi/pdf/10.1021/bi0473298	Stem-loop structure	Stem-loop I of RepA mRNA	34	-	Stem-Loop	0	0	0	0	8.00E-08	8.00E-08	0	0	0	0
810	gentamicin_mol	Target_lig_76	SLI of Rep A	Escherichia coli	Bacterial growth and infection	Target_127	0	0	8.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	https://pubs.acs.org/doi/pdf/10.1021/bi0473298	Stem-loop structure	Stem-loop I of RepA mRNA	34	-	Stem-Loop	0	0	0	0	8.00E-08	8.00E-08	0	0	0	0
811	Butirosin	Target_lig_220	SLI of Rep A	Escherichia coli	Bacterial growth and infection	Target_127	0	0	2.00E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	SMMRNA	C1C(C(C(C(C1NC(=O)C(CCN)O)O)OC2C(C(C(O2)CO)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	4-amino-N-[5-amino-4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-hydroxycyclohexyl]-2-hydroxybutanamide	2485	-7.78510000000001	555.275171752	16	12	10	311.71	0	0.118983994095138	5.19812698359593	38	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	https://pubs.acs.org/doi/pdf/10.1021/bi0473298	Stem-loop structure	Stem-loop I of RepA mRNA	34	-	Stem-Loop	0	0	0	0	2.00E-07	2.00E-07	0	0	0	0
812	Neomycin	Target_lig_4	Thymidylate synthase m-RNA	Homo sapiens	Cancer	Target_63	0	0	8.78e-07±9.6e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGUCGG	https://pubs.acs.org/doi/pdf/10.1021/bi9819428	mRNA	-	33	-	Stem-Loop	0	0	0	0	7.82E-07	9.74E-07	0	0	0	0
813	Paromomycin_mol_mol	Target_lig_1116	Thymidylate synthase m-RNA	Homo sapiens	Cancer	Target_63	0	0	2.321e-06±1.5199999999999998e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGUCGG	https://pubs.acs.org/doi/pdf/10.1021/bi9819428	mRNA	-	33	-	Stem-Loop	0	0	0	0	2.17E-06	2.47E-06	0	0	0	0
814	Tobramycin	Target_lig_540	Thymidylate synthase m-RNA	Homo sapiens	Cancer	Target_63	0	0	2.028e-06±2.3899999999999996e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGUCGG	https://pubs.acs.org/doi/pdf/10.1021/bi9819428	mRNA	-	33	-	Stem-Loop	0	0	0	0	1.79E-06	2.27E-06	0	0	0	0
815	KANAMYCIN B	Target_lig_8	Thymidylate synthase m-RNA	Homo sapiens	Cancer	Target_63	0	0	2.185e-06±2.7800000000000003e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGUCGG	https://pubs.acs.org/doi/pdf/10.1021/bi9819428	mRNA	-	33	-	Stem-Loop	0	0	0	0	1.91E-06	2.46E-06	0	0	0	0
816	gentamicin_mol	Target_lig_76	Thymidylate synthase m-RNA	Homo sapiens	Cancer	Target_63	0	0	2.7179999999999996e-06±4.879999999999999e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGUCGG	https://pubs.acs.org/doi/pdf/10.1021/bi9819428	mRNA	-	33	-	Stem-Loop	0	0	0	0	2.23E-06	3.21E-06	0	0	0	0
817	Streptomycin	Target_lig_63	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	2.00E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	2.00E-05	2.00E-05	0	0	0	0
818	Spectinomycin	Target_lig_75	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O	8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one	2021	-2.9256	332.158351108	9	5	2	129.51	0	0.360820282325169	5.12987922706813	23	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	0.0001	0.0001	0	0	0	0
819	Hygromycin_B	Target_lig_3	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N	4-[3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6'-(1-amino-2-hydroxyethyl)-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol	3659	-7.2706	527.232638244	16	11	6	272.06	0	0.152994487643804	6.04885226343299	36	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	0.0001	0.0001	0	0	0	0
820	Neomycin	Target_lig_4	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	1.50E-06	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	1.50E-06	1.50E-06	0	0	0	0
821	Paromomycin_mol_mol	Target_lig_1116	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	1.70E-06	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	1.70E-06	1.70E-06	0	0	0	0
822	apramycin	Target_lig_79	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	2.00E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O	5-amino-2-[[7-amino-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4-diol	439519	-6.94930000000001	539.280257132	16	11	6	283.64	0	0.149405525228447	5.52548579783966	37	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	2.00E-05	2.00E-05	0	0	0	0
823	Neamine	Target_lig_80	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	1.70E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol	413349	-5.11559999999999	322.185234552	10	8	3	203.46	0	0.247960739843155	4.62440978066844	22	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	1.70E-05	1.70E-05	0	0	0	0
824	Geneticin	Target_lig_140	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	2.00E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O	2-[4,6-diamino-3-[3-amino-4,5-dihydroxy-6-(1-hydroxyethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	354578	-5.613	496.27444348	14	10	6	248.39	0	0.164623849535594	5.36827337610045	34	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	2.00E-05	2.00E-05	0	0	0	0
825	Tobramycin	Target_lig_540	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	3.60E-06	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	3.60E-06	3.60E-06	0	0	0	0
826	Kanamycin A	Target_lig_7	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	1.00E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
827	KANAMYCIN B	Target_lig_8	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	2.50E-06	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	2.50E-06	2.50E-06	0	0	0	0
828	ribostamycin	Target_lig_9	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	8.00E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	5066	-6.6523	454.227493288	14	10	6	262.38	0	0.178778081939411	4.96778075738293	31	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	8.00E-05	8.00E-05	0	0	0	0
829	Amikacin	Target_lig_175	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	1.00E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
830	gentamicin_mol	Target_lig_76	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	3.00E-06	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	3.00E-06	3.00E-06	0	0	0	0
831	Butirosin	Target_lig_220	Bcr-Abl m-RNA	Homo sapiens	Cancer	Target_64	0	0	1.50E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1NC(=O)C(CCN)O)O)OC2C(C(C(O2)CO)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	4-amino-N-[5-amino-4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-hydroxycyclohexyl]-2-hydroxybutanamide	2485	-7.78510000000001	555.275171752	16	12	10	311.71	0	0.118983994095138	5.19812698359593	38	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	41	-	-	0	0	0	0	1.50E-05	1.50E-05	0	0	0	0
832	Streptomycin	Target_lig_63	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	2.50E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	2.50E-05	2.50E-05	0	0	0	0
833	Spectinomycin	Target_lig_75	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O	8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one	2021	-2.9256	332.158351108	9	5	2	129.51	0	0.360820282325169	5.12987922706813	23	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	0.0001	0.0001	0	0	0	0
834	Hygromycin_B	Target_lig_3	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N	4-[3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6'-(1-amino-2-hydroxyethyl)-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol	3659	-7.2706	527.232638244	16	11	6	272.06	0	0.152994487643804	6.04885226343299	36	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	0.0001	0.0001	0	0	0	0
835	Neomycin	Target_lig_4	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	1.50E-06	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	1.50E-06	1.50E-06	0	0	0	0
836	Paromomycin_mol_mol	Target_lig_1116	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	1.80E-06	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	1.80E-06	1.80E-06	0	0	0	0
837	apramycin	Target_lig_79	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	2.00E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O	5-amino-2-[[7-amino-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4-diol	439519	-6.94930000000001	539.280257132	16	11	6	283.64	0	0.149405525228447	5.52548579783966	37	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	2.00E-05	2.00E-05	0	0	0	0
838	Neamine	Target_lig_80	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	2.00E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol	413349	-5.11559999999999	322.185234552	10	8	3	203.46	0	0.247960739843155	4.62440978066844	22	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	2.00E-05	2.00E-05	0	0	0	0
839	Geneticin	Target_lig_140	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	3.00E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O	2-[4,6-diamino-3-[3-amino-4,5-dihydroxy-6-(1-hydroxyethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	354578	-5.613	496.27444348	14	10	6	248.39	0	0.164623849535594	5.36827337610045	34	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	3.00E-05	3.00E-05	0	0	0	0
840	Tobramycin	Target_lig_540	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	1.80E-06	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	1.80E-06	1.80E-06	0	0	0	0
841	Kanamycin A	Target_lig_7	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	2.00E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	2.00E-05	2.00E-05	0	0	0	0
842	KANAMYCIN B	Target_lig_8	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	5.00E-06	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	5.00E-06	5.00E-06	0	0	0	0
843	ribostamycin	Target_lig_9	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	9.00E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	5066	-6.6523	454.227493288	14	10	6	262.38	0	0.178778081939411	4.96778075738293	31	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	9.00E-05	9.00E-05	0	0	0	0
844	Amikacin	Target_lig_175	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	1.50E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	1.50E-05	1.50E-05	0	0	0	0
845	gentamicin_mol	Target_lig_76	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	6.00E-06	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	6.00E-06	6.00E-06	0	0	0	0
846	Butirosin	Target_lig_220	PAX3-FKHR m-RNA	Homo sapiens	Cancer	Target_65	0	0	2.50E-05	0	0	0	0	-	-	10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	10760928	Design of Small Molecules That Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents That Target Oncogenic RNA Sequences This work was supported by the NIH. We thank Professor Peter Voght for his suggestion of the oncogenic RNA sequences as targets.	Sucheck SJ, Greenberg WA, Tolbert TJ, Wong CH	Angew Chem Int Ed Engl	39	1080-1084	2000	-	-	7.4	-	150mM NaCl	SPR spectroscopy	SMMRNA	C1C(C(C(C(C1NC(=O)C(CCN)O)O)OC2C(C(C(O2)CO)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	4-amino-N-[5-amino-4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-hydroxycyclohexyl]-2-hydroxybutanamide	2485	-7.78510000000001	555.275171752	16	12	10	311.71	0	0.118983994095138	5.19812698359593	38	GGAUUUAAGCAGAGUUCAAAAGCCCUUCAGCGGCCAGUAG	https://doi.org/10.1002/(SICI)1521-3773(20000317)39:6%3C1080::AID-ANIE1080%3E3.0.CO;2-B	mRNA	-	40	-	-	0	0	0	0	2.50E-05	2.50E-05	0	0	0	0
847	Streptomycin	Target_lig_63	RRE-RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	1.00E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
848	Neamine	Target_lig_80	RRE-RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	2.10E-05	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol	413349	-5.11559999999999	322.185234552	10	8	3	203.46	0	0.247960739843155	4.62440978066844	22	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	2.10E-05	2.10E-05	0	0
849	Tobramycin	Target_lig_540	RRE-RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	3.00E-06	4.50E-05	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	3.00E-06	3.00E-06	4.50E-05	4.50E-05	0	0
850	Kanamycin A	Target_lig_7	RRE-RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0.00075	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0.00075	0.00075	0	0	0	0
851	KANAMYCIN B	Target_lig_8	RRE-RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	9.00E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	9.00E-05	9.00E-05	0	0	0	0
852	Neomycin_B	Target_lig_1246	RRE-RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	1.5e-07±4e-08	1.00E-06	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	1.10E-07	1.90E-07	1.00E-06	1.00E-06	0	0
853	Neomycin	Target_lig_4	RRE1	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_81	0	0	1.6e-07±3e-08	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCGCAGCUUCGGCUGCGGUACACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	29	-	-	0	0	0	0	1.30E-07	1.90E-07	0	0	0	0
854	Neomycin	Target_lig_4	RRE2	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_82	0	0	7.54e-06±1.6999999999999998e-06	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGUCGCAGCUUCGCCUCGCACACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	26	-	-	0	0	0	0	5.84E-06	9.24E-06	0	0	0	0
855	Neomycin	Target_lig_4	RRE3	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_83	0	0	6.4e-06±8e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCGCAGCUUCGGCUGCGCCCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	28	-	-	0	0	0	0	5.60E-06	7.20E-06	0	0	0	0
856	Neomycin	Target_lig_4	RRE4	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_84	0	0	4.8e-07±7e-08	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCGCAGCUUCGGCUGCGGACACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	28	-	-	0	0	0	0	4.10E-07	5.50E-07	0	0	0	0
857	Neomycin	Target_lig_4	RRE5	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_85	0	0	1.18e-06±3.2e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCGCAGCUUCGGCUGCGCACACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	28	-	-	0	0	0	0	8.60E-07	1.50E-06	0	0	0	0
858	Neomycin	Target_lig_4	RRE6	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_86	0	0	2.93e-06±8.499999999999999e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGCCGCAGCUUCGGCUGCGGACACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	28	-	-	0	0	0	0	2.08E-06	3.78E-06	0	0	0	0
859	Neomycin	Target_lig_4	RRE7	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_87	0	0	1.75e-06±5.699999999999999e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCGCAGCUUCGGCUGCGGCCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	28	-	-	0	0	0	0	1.18E-06	2.32E-06	0	0	0	0
860	Neomycin	Target_lig_4	RRE8	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_88	0	0	2.74e-06±8.299999999999999e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGUGCCGCAGCUUCGGCUGCGGACACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	29	-	-	0	0	0	0	1.91E-06	3.57E-06	0	0	0	0
861	Neomycin	Target_lig_4	RRE9	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_89	0	0	1.2499999999999999e-06±1.6e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGAGCGCAGCUUCGGCUGCGCCCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	29	-	-	0	0	0	0	1.09E-06	1.41E-06	0	0	0	0
862	Neomycin	Target_lig_4	RRE10	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_90	0	0	6.5e-07±7e-08	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCGCAGCUUCGGCUGCGCACCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	29	-	-	0	0	0	0	5.80E-07	7.20E-07	0	0	0	0
863	Neomycin	Target_lig_4	RRE11	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_91	0	0	5.4e-07±1.7000000000000001e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCGCAGCUUCGGCUGCGCAACCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	30	-	-	0	0	0	0	3.70E-07	7.10E-07	0	0	0	0
864	Neomycin	Target_lig_4	RRE12	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_92	0	0	6.5e-07±8e-08	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCGCAGCUUCGGCUGCGCAAACCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	31	-	-	0	0	0	0	5.70E-07	7.30E-07	0	0	0	0
865	Neomycin	Target_lig_4	RRE13	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_93	0	0	6.1e-07±9e-08	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCGCAGCUUCGGCUGCGCAAAACCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	32	-	-	0	0	0	0	5.20E-07	7.00E-07	0	0	0	0
866	Neomycin	Target_lig_4	RRE14	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_94	0	0	4.3999999999999997e-07±8e-08	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCGCAGCUUCGGCUGCGCGGCCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	30	-	-	0	0	0	0	3.60E-07	5.20E-07	0	0	0	0
867	Neomycin	Target_lig_4	RRE15	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_95	0	0	5.2e-07±1.3e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCGCAGCUUCGGCUGCGCUUCCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	30	-	-	0	0	0	0	3.90E-07	6.50E-07	0	0	0	0
868	Neomycin	Target_lig_4	hammerhead ribozyme16	Synthetic	Bacterial growth and infection	Target_115	0	1.35e-05±2.8999999999999998e-06	0	0	0	0	0	-	-	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7489494/	7489494	Inhibition of the hammerhead ribozyme by neomycin.	Stage TK, Hertel KJ, Uhlenbeck OC	RNA	1	95-101	1995	0-100 uM	20 nM	7.3	25	10mM MgCl2	Antibiotic screening assays and kinetic studies	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GCGAUGACCUGAUGAGGCCGAAAGGCCGAAACGUUCCCGGGAACGUCGUCGUCGC	http://www.smmrna.org/	Ribozyme	Group I ribozyme	55	-	-	0	0	1.06E-05	1.64E-05	0	0	0	0	0	0
869	Neomycin	Target_lig_4	Rnase P RNA	Thermotoga maritima	Bacterial growth and infection	Target_128	0	3.5e-05±1.2e-05	0	0	0	0	0	-	-	10.1073/pnas.96.11.6155	10339557	Inhibition of RNase P RNA cleavage by aminoglycosides.	Mikkelsen NE, Brännvall M, Virtanen A, Kirsebom LA	Proc Natl Acad Sci U S A	96	6155-60	1999	1mM	-	7.2	37	10mM Mg2+ and 1-100mM NH4+	Lead(II)-induced cleavage assay	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGAGAGGAGCAGGCGGUCGCGGGGGCGCACACCUGCGCUUCCCGAGGAAAGUCCGGACUCUGGAGCGGGGUGCCGGGUAACGCCCGGGAGGGGUGACCCUCGGACAGGGCCAUAGAGAAGAAGACCGCCCGGGGGGAAACUUCCGGGCAAGGGUGGAACGGUGGGGUAAGAGCCCACCAGCGUCGGGGCAACCCGGCGGCUUGGCAACCCCCACCUGGAGCAAGGCCAAGCAGGGGGUUGGGUCGCUCCCCCUAUUCCCCCGGGUUGGCCGCUUGAGGUGUGCGGUAACGCACACCCCAGAUUGAUGACCGCCCACGACAGAAUCCGGCUUAUGCUCCUCUCCCGUG	3Q1R	Ribozyme	Rnase	348	-	-	0	0	2.30E-05	4.70E-05	0	0	0	0	0	0
870	Neomycin	Target_lig_4	hdv	Homo sapiens	Hepatitis B	Target_129	0	2.8e-05±9.999999999999999e-06	0	0	0	0	0	-	-	10.1006/jmbi.1996.0369	8683594	Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics.	Rogers J, Chang AH, von Ahsen U, Schroeder R, Davies J	J Mol Biol	259	916-25	1996	25 uM	-	7.5	37	1mM MgCl2	Kinetic analysis of antibiotic cleavage	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	UGGCCGGCAUGGUCCCAGCCUCCUCGCUGGCGCCGGCUGGGCAACAUUCCGAGGGGACCGUCCCCUCGGUAAUGGCGAAUGGGAC	https://pubmed.ncbi.nlm.nih.gov/8683594/	Viral RNA	-	85	-	-	0	0	1.80E-05	3.80E-05	0	0	0	0	0	0
871	HTP 20	Target_lig_527	RNA aptamer_1	Synthetic	-	Target_56	0	0	2.10E-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(c(c3c(n1)cccc3)Nc1ccc(cc1)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](NC(=O)CCCN)CO)cccc2C(=O)N[C@@H](C(=O)N)CCCNC(=N)N	-	-	0.951570000000005	769.402378352	10	11	20	292.56	4	0.026039971891561	4.06683818434972	56	GGGCGGUUUUUCGAAGCUUGAGUCUCGUAGAGGGCUUCGGCCUGGCGAAUUAGACUGACGCUC	http://www.smmrna.org/	RNA aptamer	-	63	-	Stem-Loop	0	0	0	0	2.10E-08	2.10E-08	0	0	0	0
872	HTP 20	Target_lig_527	RNA aptamer_2	Synthetic	-	Target_57	0	0	1.45E-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(c(c3c(n1)cccc3)Nc1ccc(cc1)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](NC(=O)CCCN)CO)cccc2C(=O)N[C@@H](C(=O)N)CCCNC(=N)N	-	-	0.951570000000005	769.402378352	10	11	20	292.56	4	0.026039971891561	4.06683818434972	56	GGGCGGUUUUUCGAAGCUUGAGUCUUACGUAGAGGGCUUCGGCCUGGCGAUAGACUGACGCUC	http://www.smmrna.org/	RNA aptamer	-	63	-	Stem-Loop	0	0	0	0	1.45E-07	1.45E-07	0	0	0	0
873	HTP 20	Target_lig_527	RNA aptamer_3	Synthetic	-	Target_58	0	0	7.70E-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(c(c3c(n1)cccc3)Nc1ccc(cc1)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](NC(=O)CCCN)CO)cccc2C(=O)N[C@@H](C(=O)N)CCCNC(=N)N	-	-	0.951570000000005	769.402378352	10	11	20	292.56	4	0.026039971891561	4.06683818434972	56	GGGCGGUUUUUCGAAGCUUGAGUCUCUCGUAGAGGGCUUCGGCCUGGGCGCAAGACUGACGCUC	http://www.smmrna.org/	RNA aptamer	-	64	-	Stem-Loop	0	0	0	0	7.70E-07	7.70E-07	0	0	0	0
874	HTP 20	Target_lig_527	RNA aptamer_4	Synthetic	-	Target_59	0	0	9.00E-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(c(c3c(n1)cccc3)Nc1ccc(cc1)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](NC(=O)CCCN)CO)cccc2C(=O)N[C@@H](C(=O)N)CCCNC(=N)N	-	-	0.951570000000005	769.402378352	10	11	20	292.56	4	0.026039971891561	4.06683818434972	56	GGGCGGUUUUUCGAAGCUUGAGUCUCGUAGAGGGCUUCGGCCUGGCGUAGACUGACGCUC	http://www.smmrna.org/	RNA aptamer	-	60	-	Stem-Loop	0	0	0	0	9.00E-08	9.00E-08	0	0	0	0
875	HTP 21	Target_lig_528	Helix 22 of E.coli 16s RNA	Escherichia coli	Bacterial growth and infection	Target_98	0	0	1.60E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12c(c(c3c(n1)cccc3)Nc1ccc(cc1)CN)cccc2C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCCN)CCCCN)CN	-	-	1.9596	685.370015604	10	9	19	253.6	4	0.050931427928565	3.84610832562444	50	AAAUUGAAGAGUUUGAUCAUGGCUCAGAUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAACGGUAACAGGAAGAAGCUUGCUUCUUUGCUGACGAGUGGCGGACGGGUGAGUAAUGUCUGGGAAACUGCCUGAUGGAGGGGGAUAACUACUGGAAACGGUAGCUAAUACCGCAUAACGUCGCAAGACCAAAGAGGGGGACCUUCGGGCCUCUUGCCAUCGGAUGUGCCCAGAUGGGAUUAGCUAGUAGGUGGGGUAACGGCUCACCUAGGCGACGAUCCCUAGCUGGUCUGAGAGGAUGACCAGCCACACUGGAACUGAGACACGGUCCAGACUCCUACGGGAGGCAGCAGUGGGGAAUAUUGCACAAUGGGCGCAAGCCUGAUGCAGCCAUGCCGCGUGUAUGAAGAAGGCCUUCGGGUUGUAAAGUACUUUCAGCGGGGAGGAAGGGAGUAAAGUUAAUACCUUUGCUCAUUGACGUUACCCGCAGAAGAAGCACCGGCUAACUCCGUGCCAGCAGCCGCGGUAAUACGGAGGGUGCAAGCGUUAAUCGGAAUUACUGGGCGUAAAGCGCACGCAGGCGGUUUGUUAAGUCAGAUGUGAAAUCCCCGGGCUCAACCUGGGAACUGCAUCUGAUACUGGCAAGCUUGAGUCUCGUAGAGGGGGGUAGAAUUCCAGGUGUAGCGGUGAAAUGCGUAGAGAUCUGGAGGAAUACCGGUGGCGAAGGCGGCCCCCUGGACGAAGACUGACGCUCAGGUGCGAAAGCGUGGGGAGCAAACAGGAUUAGAUACCCUGGUAGUCCACGCCGUAAACGAUGUCGACUUGGAGGUUGUGCCCUUGAGGCGUGGCUUCCGGAGCUAACGCGUUAAGUCGACCGCCUGGGGAGUACGGCCGCAAGGUUAAAACUCAAAUGAAUUGACGGGGGCCCGCACAAGCGGUGGAGCAUGUGGUUUAAUUCGAUGCAACGCGAAGAACCUUACCUGGUCUUGACAUCCACGGAAGUUUUCAGAGAUGAGAAUGUGCCUUCGGGAACCGUGAGACAGGUGCUGCAUGGCUGUCGUCAGCUCGUGUUGUGAAAUGUUGGGUUAAGUCCCGCAACGAGCGCAACCCUUAUCCUUUGUUGCCAGCGGUCCGGCCGGGAACUCAAAGGAGACUGCCAGUGAUAAACUGGAGGAAGGUGGGGAUGACGUCAAGUCAUCAUGGCCCUUACGACCAGGGCUACACACGUGCUACAAUGGCGCAUACAAAGAGAAGCGACCUCGCGAGAGCAAGCGGACCUCAUAAAGUGCGUCGUAGUCCGGAUUGGAGUCUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGAAGUAGGUAGCUUAACCUUCGGGAGGGCGCUUACCACUUUGUGAUUCAUGACUGGGGUGAAGUCGUAACAAGGUAACCGUAGGGGAACCUGCGGUUGGAUCACCUCCUUA	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	1543	-	Stem-Loop	0	0	0	0	1.60E-05	1.60E-05	0	0	0	0
876	Proflavin	Target_lig_336	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	1.15E-06	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N	acridine-3,6-diamine	7099	2.5524	209.095297352	3	2	0	64.93	3	0.441447262692883	2.05911636832492	16	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	1.15E-06	1.15E-06	0	0
877	acridine orange	Target_lig_337	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	1.53E-06	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N(C)C	3-N,3-N,6-N,6-N-tetramethylacridine-3,6-diamine	62344	3.52	265.157897608	3	0	2	19.37	3	0.660864401147856	2.16285480638045	20	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	1.53E-06	1.53E-06	0	0
878	Neomycin	Target_lig_4	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	8.00E-07	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	8.00E-07	8.00E-07	0	0
879	Paromomycin_mol_mol	Target_lig_1116	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	1.40E-05	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	1.40E-05	1.40E-05	0	0
880	Tobramycin	Target_lig_540	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	3.00E-06	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	3.00E-06	3.00E-06	0	0
881	Kanamycin A	Target_lig_7	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	5.00E-05	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	5.00E-05	5.00E-05	0	0
882	KANAMYCIN B	Target_lig_8	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	3.00E-06	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	3.00E-06	3.00E-06	0	0
883	Diphenylfuran _analog_1	Target_lig_529	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	5.10E-06	0	0	0	-	-	10.1016/S0968-0896(97)00063-1	9222509	Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds	Zapp ML, Young DW, Kumar A, Singh R, Boykin DW, Wilson WD, Green MR	Bioorg Med Chem	5	1149-55	1997	1 uM	-	-	-	-	Gel mobility shift assay	SMMRNA	CN(C)CCCN=C(C1=CC=C(C=C1)C2=CC=C(O2)C3=CC=C(C=C3)C(=NCCCN(C)C)N)N	N'-[3-(dimethylamino)propyl]-4-[5-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide	457674	3.9276	474.310709836	5	2	12	96.38	3	0.235550990585172	2.73656021663548	35	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	5.10E-06	5.10E-06	0	0
884	Diphenylfuran _analog_2	Target_lig_530	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	0.0001	0	0	0	-	-	10.1016/S0968-0896(97)00063-1	9222509	Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds	Zapp ML, Young DW, Kumar A, Singh R, Boykin DW, Wilson WD, Green MR	Bioorg Med Chem	5	1149-55	1997	1 uM	-	-	-	-	Gel mobility shift assay	SMMRNA	CC(C)NC1=CC=C(C=C1)C2=CC=C(O2)C3=CC=C(C=C3)NC(C)C	N-propan-2-yl-4-[5-[4-(propan-2-ylamino)phenyl]furan-2-yl]aniline	473608	6.25420000000001	334.204513452	3	2	6	37.2	3	0.558877274329626	2.03945378426759	25	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	0.0001	0.0001	0	0
885	Diphenylfuran _analog_3	Target_lig_531	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	2.30E-06	0	0	0	-	-	10.1016/S0968-0896(97)00063-1	9222509	Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds	Zapp ML, Young DW, Kumar A, Singh R, Boykin DW, Wilson WD, Green MR	Bioorg Med Chem	5	1149-55	1997	1 uM	-	-	-	-	Gel mobility shift assay	SMMRNA	CN(C)CCCN=C(C1=CC=C(C=C1)C2=CN=C(O2)C3=CC=C(C=C3)C(=NCCCN(C)C)N)N	N'-[3-(dimethylamino)propyl]-4-[2-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]-1,3-oxazol-5-yl]benzenecarboximidamide	485983	3.3226	475.305958804	6	2	12	109.27	3	0.236258721041259	2.81637839845366	35	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	2.30E-06	2.30E-06	0	0
886	Diphenylfuran _analog_4	Target_lig_532	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	2.80E-06	0	0	0	-	-	10.1016/S0968-0896(97)00063-1	9222509	Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds	Zapp ML, Young DW, Kumar A, Singh R, Boykin DW, Wilson WD, Green MR	Bioorg Med Chem	5	1149-55	1997	1 uM	-	-	-	-	Gel mobility shift assay	SMMRNA	CN(C)CCCN=C(C1=CC=C(C=C1)C2=CC=C(S2)C3=CC=C(C=C3)C(=NCCCN(C)C)N)N	N'-[3-(dimethylamino)propyl]-4-[5-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]thiophen-2-yl]benzenecarboximidamide	485984	4.3961	490.287866216	5	2	12	83.24	3	0.223981855800634	2.76475741943268	35	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	2.80E-06	2.80E-06	0	0
887	Diphenylfuran _analog_5	Target_lig_533	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	5.10E-06	0	0	0	-	-	10.1016/S0968-0896(97)00063-1	9222509	Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds	Zapp ML, Young DW, Kumar A, Singh R, Boykin DW, Wilson WD, Green MR	Bioorg Med Chem	5	1149-55	1997	1 uM	-	-	-	-	Gel mobility shift assay	SMMRNA	CN(C)CCCN=C(C1=CC=C(C=C1)C2=NC(=NC=C2)C3=CC=C(C=C3)C(=NCCCN(C)C)N)N	N'-[3-(dimethylamino)propyl]-4-[2-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]pyrimidin-4-yl]benzenecarboximidamide	485982	3.1246	486.321943216	6	2	12	109.02	3	0.231281398170728	2.76452860267597	36	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	5.10E-06	5.10E-06	0	0
888	Diphenylfuran _analog_6	Target_lig_534	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	3.00E-05	0	0	0	-	-	10.1016/S0968-0896(97)00063-1	9222509	Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds	Zapp ML, Young DW, Kumar A, Singh R, Boykin DW, Wilson WD, Green MR	Bioorg Med Chem	5	1149-55	1997	1 uM	-	-	-	-	Gel mobility shift assay	SMMRNA	CN(C)CCCN=C(C1=CC=C(C=C1)C2=CC=C(N2)C3=CC=C(C=C3)C(=NCCCN(C)C)N)N	N'-[3-(dimethylamino)propyl]-4-[5-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]-1H-pyrrol-2-yl]benzenecarboximidamide	473615	3.6627	473.326694248	4	3	12	99.03	3	0.212331842443765	2.84133644041171	35	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	3.00E-05	3.00E-05	0	0
889	Diphenylfuran _analog_7	Target_lig_535	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	3.00E-07	0	0	0	-	-	10.1016/S0968-0896(97)00063-1	9222509	Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds	Zapp ML, Young DW, Kumar A, Singh R, Boykin DW, Wilson WD, Green MR	Bioorg Med Chem	5	1149-55	1997	1 uM	-	-	-	-	Gel mobility shift assay	SMMRNA	CN(C)CCCN=C(C1=CC=C(C=C1)C2=CC=C(O2)C3=NC4=C(N3)C=C(C=C4)C(=NCCCN(C)C)N)N	N'-[3-(dimethylamino)propyl]-2-[5-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]furan-2-yl]-3H-benzimidazole-5-carboximidamide	460172	3.8039	514.316857836	6	3	12	125.06	4	0.15000822757931	2.99943212073298	38	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	3.00E-07	3.00E-07	0	0
890	Neomycin-acridine conjugated aminoglycoside1	Target_lig_536	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	4.00E-08	0	0	0	-	-	10.1021/bi034766y	14516190	RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.	Luedtke NW, Liu Q, Tor Y	Biochemistry	42	11391-403	2003	-	10 nM	7.5	22	KCl (100 mM), sodium phosphate (10 mM), MgCl2 (2 mM), NaCl (20 mM)	Fluorescence intensity from solid phase assays	SMMRNA	[C@H]1([C@H]([C@@H]([C@@H](O[C@H]1CN)O[C@H]1[C@@H]([C@H]([C@@H](C[C@H]1N)N)O)O[C@H]1[C@@H]([C@H]([C@@H](O1)CSCCNc1c2c(cccc2)nc2c1cccc2)O[C@@H]1[C@H]([C@H]([C@H]([C@H](O1)CN)O)O)N)O)N)O)O	-	-	-4.3409	850.389490296	21	13	14	357.8	3	0.053842023451787	5.84909665941931	59	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	4.00E-08	4.00E-08	0	0
891	Neomycin-acridine conjugated aminoglycoside2	Target_lig_537	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	4.00E-08	0	0	0	-	-	10.1021/bi034766y	14516190	RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.	Luedtke NW, Liu Q, Tor Y	Biochemistry	42	11391-403	2003	-	10 nM	7.5	22	KCl (100 mM), sodium phosphate (10 mM), MgCl2 (2 mM), NaCl (20 mM)	Fluorescence intensity from solid phase assays	SMMRNA	[C@H]1([C@@H]([C@@H]([C@@H](O[C@H]1CN)O[C@H]1[C@@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@H]1[C@H]([C@@H]([C@H](O1)CNc1c2c(cccc2)nc2c1cccc2)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)CN)O)O)N)O)N)O)O	-	-	-5.0741	790.386119168	20	13	11	357.8	3	0.080808761172674	5.72007091224693	56	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	4.00E-08	4.00E-08	0	0
892	Neomycin-acridine conjugated aminoglycoside3	Target_lig_538	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	4.00E-08	0	0	0	-	-	10.1021/bi034766y	14516190	RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.	Luedtke NW, Liu Q, Tor Y	Biochemistry	42	11391-403	2003	-	10 nM	7.5	22	KCl (100 mM), sodium phosphate (10 mM), MgCl2 (2 mM), NaCl (20 mM)	Fluorescence intensity from solid phase assays	SMMRNA	[C@H]1([C@@H]([C@@H]([C@@H](O[C@@H]1CN)O[C@@H]1[C@@H]([C@@H]([C@H](C[C@@H]1N)N)O)O[C@@H]1[C@H]([C@H]([C@@H](O1)CSCCSCCNc1c2c(cccc2)nc2c1cccc2)O[C@@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)CN)O)O)N)O)N)O)O	-	-	-3.6077	910.392861424	22	13	17	357.8	3	0.045942114716126	5.99473046347246	62	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	4.00E-08	4.00E-08	0	0
893	Kanamycin A-acridine conjugate	Target_lig_539	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	6.10E-07	0	0	0	-	-	10.1021/bi034766y	14516190	RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.	Luedtke NW, Liu Q, Tor Y	Biochemistry	42	11391-403	2003	-	10 nM	7.5	22	KCl (100 mM), sodium phosphate (10 mM), MgCl2 (2 mM), NaCl (20 mM)	Fluorescence intensity from solid phase assays	SMMRNA	[C@@H]1([C@@H](C[C@@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H]([C@@H]([C@@H](O1)CN)O)O)O)N)N)O[C@@H]1[C@H]([C@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-3.47019999999999	660.311891608	16	11	8	287.3	3	0.104650168335254	5.15724895798458	47	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	6.10E-07	6.10E-07	0	0
894	Tobramycin-acridine conjugate	Target_lig_540	RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	2.40E-07	0	0	0	-	-	10.1021/bi034766y	14516190	RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.	Luedtke NW, Liu Q, Tor Y	Biochemistry	42	11391-403	2003	-	10 nM	7.5	22	KCl (100 mM), sodium phosphate (10 mM), MgCl2 (2 mM), NaCl (20 mM)	Fluorescence intensity from solid phase assays	SMMRNA	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	2.40E-07	2.40E-07	0	0
895	Dimeric naphthyridine derivative	Target_lig_541	RRE RNA construct D	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_455	0	0	0	3.2e-06±2.4e-07	0	0	0	-	-	10.1016/j.bmcl.2004.10.059	15664866	Specific recognition of napthyridine-based ligands toward guanine-containing bulges in RNA duplexes and RNA-DNA heteroduplexes.	Tok JB, Bi L, Saenz M	Bioorg Med Chem Lett	15	827-31	2005	-	10 nM - 10 uM	7.2	15	1mM MgCl2, 100mM NaCl	Fluorescence measurement	SMMRNA	CC1=NC2=C(C=C1)C=CC(=N2)NC(=O)CCNCCNCCC(=O)NC3=NC4=C(C=CC(=N4)C)C=C3	N-(7-methyl-1,8-naphthyridin-2-yl)-3-[2-[[3-[(7-methyl-1,8-naphthyridin-2-yl)amino]-3-oxopropyl]amino]ethylamino]propanamide	44391261	2.72644	486.2491722	8	4	11	133.82	4	0.237876554269842	2.79001983135679	36	GGCUGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	2.96E-06	3.44E-06	0	0
896	Monomeric derivative of naphthyridine	Target_lig_542	RRE RNA construct K	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_456	0	0	0	3.4899999999999995e-05±3.3999999999999996e-06	0	0	0	-	-	10.1016/j.bmcl.2004.10.059	15664866	Specific recognition of napthyridine-based ligands toward guanine-containing bulges in RNA duplexes and RNA-DNA heteroduplexes.	Tok JB, Bi L, Saenz M	Bioorg Med Chem Lett	15	827-31	2005	-	10 nM - 10 uM	7.2	15	1mM MgCl2, 100mM NaCl	Fluorescence measurement	SMMRNA	CC1=NC2=C(C=C1)C=CC(=N2)NC(=O)CCN	3-amino-N-(7-methyl-1,8-naphthyridin-2-yl)propanamide	44391394	1.22552	230.116761068	4	2	3	80.9	2	0.830445166054545	2.26698196645594	17	GGCUGGCGCAGCGCUGCGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	23	-	Stem-Loop with Bulge	0	0	0	0	0	0	3.15E-05	3.83E-05	0	0
897	Phenothiazine 5	Target_lig_1253	Acetylpromazine TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	7.43E-05	0	0	0	0	1LVJ	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c1ccc2c(c1)Sc1c(N2CCCN(C)C)cc(cc1)C(=O)C	1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	6077	4.4436	326.145284324	4	0	5	23.55	2	0.757792051694743	2.19866048303301	23	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	7.43E-05	7.43E-05	0	0	0	0
898	Acetylpromazine	Target_lig_176	A-site bindings	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.00036	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	6077	4.4436	326.145284324	4	0	5	23.55	2	0.757792051694743	2.19866048303301	23	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.00036	0.00036	0	0	0	0
899	Acetylpromazine	Target_lig_176	Coxsackie virus B3 RNA	Coxsackie virus	Hand, foot and mouth disease	Target_130	0	0	0.00033	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	6077	4.4436	326.145284324	4	0	5	23.55	2	0.757792051694743	2.19866048303301	23	GGGCUAGCACUCUGGUAUCACGGUACCUUUGUGCGCCC	http://www.smmrna.org/	Viral RNA	-	38	-	Stem-Loop	0	0	0	0	0.00033	0.00033	0	0	0	0
900	Acetylpromazine	Target_lig_176	Polio virus loop B construct	Polio virus	Polio	Target_131	0	0	0.0018	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	6077	4.4436	326.145284324	4	0	5	23.55	2	0.757792051694743	2.19866048303301	23	GGGGUUGUACCCACCCC	http://www.smmrna.org/	Viral RNA	-	17	-	Stem-Loop	0	0	0	0	0.0018	0.0018	0	0	0	0
901	Oxazolidinone 2	Target_lig_543	T-box RNA	Escherichia coli	Bacterial growth and infection	Target_113	0	0	3.40E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=CC=C(C=C1)N2[C@@H]([C@H](OC2=O)COC(=O)CC3=CC=CC=C3)CC4=CC=CC=C4	[(4R,5S)-4-benzyl-3-(4-methoxyphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl 2-phenylacetate	44413266	4.4176	431.1732729	5	0	8	65.07	3	0.494292817225733	3.02407553925343	32	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	T-box element	-	29	-	Stem-Loop	0	0	0	0	3.40E-06	3.40E-06	0	0	0	0
902	Oxazolidinone 6	Target_lig_544	T-box RNA	Escherichia coli	Bacterial growth and infection	Target_113	0	0	9.00E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=CC=C(C=C1)C[C@@H]2[C@H](OC(=O)N2)COC(=O)CC3=CC=CC=C3	[(4R,5S)-4-benzyl-2-oxo-1,3-oxazolidin-5-yl]methyl 2-phenylacetate	16007206	2.492	325.131408088	4	1	6	64.63	2	0.828909075382458	2.92581058525021	24	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	T-box element	-	29	-	Stem-Loop	0	0	0	0	9.00E-06	9.00E-06	0	0	0	0
903	Oxazolidinone 2	Target_lig_543	T-box C11U	Escherichia coli	Bacterial growth and infection	Target_114	0	0	2.50E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC1=CC=C(C=C1)N2[C@@H]([C@H](OC2=O)COC(=O)CC3=CC=CC=C3)CC4=CC=CC=C4	[(4R,5S)-4-benzyl-3-(4-methoxyphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl 2-phenylacetate	44413266	4.4176	431.1732729	5	0	8	65.07	3	0.494292817225733	3.02407553925343	32	GAGGGUGGAAUCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	T-box element	-	29	-	Stem-Loop	0	0	0	0	2.50E-05	2.50E-05	0	0	0	0
904	Oxazolidinone 6	Target_lig_544	T-box C11U	Escherichia coli	Bacterial growth and infection	Target_114	0	0	0.000125	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=CC=C(C=C1)C[C@@H]2[C@H](OC(=O)N2)COC(=O)CC3=CC=CC=C3	[(4R,5S)-4-benzyl-2-oxo-1,3-oxazolidin-5-yl]methyl 2-phenylacetate	16007206	2.492	325.131408088	4	1	6	64.63	2	0.828909075382458	2.92581058525021	24	GAGGGUGGAAUCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	T-box element	-	29	-	Stem-Loop	0	0	0	0	0.000125	0.000125	0	0	0	0
905	Yohimbine	Target_lig_193	fIIRE	Homo sapiens	Progressive neurodegenerative diseases,Anemia,Hyperferritinemia cataract syndrome	Target_132	0	0	3.90E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O	methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	2866	2.6471	354.194342692	4	2	1	65.56	2	0.772957405745492	3.87459645153332	26	UUCCUGCUUCAACAGUGCUUGGACGGAA	http://www.smmrna.org/	IRE element, mRNA	Iron response element (IRE)	28	-	Stem-Loop	0	0	0	0	3.90E-06	3.90E-06	0	0	0	0
906	Yohimbine	Target_lig_193	TfR_IRE	Homo sapiens	Progressive neurodegenerative diseases,Anemia,Hyperferritinemia cataract syndrome	Target_133	0	0	7.30E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O	methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	2866	2.6471	354.194342692	4	2	1	65.56	2	0.772957405745492	3.87459645153332	26	ACAUUACCGGGAGCAGUGUCUUCUGUAAUGU	http://www.smmrna.org/		Iron response element (IRE)	31	-	Stem-Loop	0	0	0	0	7.30E-06	7.30E-06	0	0	0	0
907	Yohimbine	Target_lig_193	TfR_IRE_C24U	Homo sapiens	Progressive neurodegenerative diseases,Anemia,Hyperferritinemia cataract syndrome	Target_134	0	0	5.90E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O	methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	2866	2.6471	354.194342692	4	2	1	65.56	2	0.772957405745492	3.87459645153332	26	ACAUUACCGGGAGCAGUGUCUUCUGUAAUGU	http://www.smmrna.org/		Iron response element (IRE)	31	-	Stem-Loop	0	0	0	0	5.90E-06	5.90E-06	0	0	0	0
908	Yohimbine	Target_lig_193	Yohimbine_TAR_RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	9.10E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O	methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	2866	2.6471	354.194342692	4	2	1	65.56	2	0.772957405745492	3.87459645153332	26	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	9.10E-06	9.10E-06	0	0	0	0
909	Yohimbine	Target_lig_193	Yohimbine_XII_RNA	Synthetic	Acquired immunodeficiency syndrome (AIDS)	Target_135	0	0	9.20E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O	methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	2866	2.6471	354.194342692	4	2	1	65.56	2	0.772957405745492	3.87459645153332	26	GGGCGAAUUGGGUACCGGGCCCCCCC	http://www.smmrna.org/	RNA aptamer	-	26	-	Stem-Loop	0	0	0	0	9.20E-06	9.20E-06	0	0	0	0
910	DOS	Target_lig_383	RNA_XIX	Synthetic	-	Target_136	0	0	>0.001	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	C1[C@@H](N)[C@@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O	-	-	1.4685	403.11774716	7	4	4	114.62	2	0.451432479803258	4.16281397172473	27	CGCGCGUGUGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	14	-	Stem-Loop	0	0	0	0	0.001	0.001	0	0	0	0
911	DOS_der_1	Target_lig_546	RNA_XIX	Synthetic	-	Target_136	0	0	3.40E-05	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@H](OCCCCCCCCCCCCO[C@H]2[C@@H](C[C@H](N)[C@@H](O)[C@H]2O)N)[C@H](O)[C@H]([C@@H](C1)N)O)N	-	-	-0.781999999999993	490.37303532	10	8	15	203.46	0	0.134415444715085	4.39479383162182	34	CGCGCGUGUGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	14	-	Stem-Loop	0	0	0	0	3.40E-05	3.40E-05	0	0	0	0
912	DOS_der_2	Target_lig_547	RNA_XIX	Synthetic	-	Target_136	0	0	1.60E-05	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@H](OCc2ccc(cc2)CCc2ccc(cc2)CO[C@H]2[C@@H](C[C@H](N)[C@@H](O)[C@@H]2O)N)[C@@H](O)[C@@H]([C@H](C1)N)O)N	-	-	-1.1976	530.310435064	10	8	9	203.46	2	0.194477158896788	4.31690246905065	38	CGCGCGUGUGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	14	-	Stem-Loop	0	0	0	0	1.60E-05	1.60E-05	0	0	0	0
913	DOS_der_3	Target_lig_548	RNA_XIX	Synthetic	-	Target_136	0	0	>0.00025	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@@H]([C@H](O)[C@H]([C@H](C1)N#N)O)OCc1ccc(cc1)c1ccc(cc1)CO[C@H]1[C@H](C[C@@H]([C@@H](O)[C@@H]1O)N#N)N#N)N#N	-	-	0	0	0	0	0	0	0	0	0	0	CGCGCGUGUGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	14	-	Stem-Loop	0	0	0	0	0.00025	0.00025	0	0	0	0
914	DOS_der_4	Target_lig_549	RNA_XIX	Synthetic	-	Target_136	0	0	>0.001	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	OCc1ccc(cc1)CCc1ccc(cc1)CO[C@H]1[C@@H](C[C@H](N)[C@@H](O)[C@@H]1O)N	-	-	0.6294	386.22055744	6	5	7	121.96	2	0.475768564219534	3.51736594587546	28	CGCGCGUGUGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	14	-	Stem-Loop	0	0	0	0	0.001	0.001	0	0	0	0
915	DOS	Target_lig_383	RNA_XX	Synthetic	-	Target_137	0	0	>0.001	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	C1[C@@H](N)[C@@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O	-	-	1.4685	403.11774716	7	4	4	114.62	2	0.451432479803258	4.16281397172473	27	CGCGCAGUGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	16	-	Stem-Loop	0	0	0	0	0.001	0.001	0	0	0	0
916	DOS_der_1	Target_lig_546	RNA_XX	Synthetic	-	Target_137	0	0	1.10E-05	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@H](OCCCCCCCCCCCCO[C@H]2[C@@H](C[C@H](N)[C@@H](O)[C@H]2O)N)[C@H](O)[C@H]([C@@H](C1)N)O)N	-	-	-0.781999999999993	490.37303532	10	8	15	203.46	0	0.134415444715085	4.39479383162182	34	CGCGCAGUGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	16	-	Stem-Loop	0	0	0	0	1.10E-05	1.10E-05	0	0	0	0
917	DOS_der_2	Target_lig_547	RNA_XX	Synthetic	-	Target_137	0	0	6.00E-06	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@H](OCc2ccc(cc2)CCc2ccc(cc2)CO[C@H]2[C@@H](C[C@H](N)[C@@H](O)[C@@H]2O)N)[C@@H](O)[C@@H]([C@H](C1)N)O)N	-	-	-1.1976	530.310435064	10	8	9	203.46	2	0.194477158896788	4.31690246905065	38	CGCGCAGUGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	16	-	Stem-Loop	0	0	0	0	6.00E-06	6.00E-06	0	0	0	0
918	DOS_der_3	Target_lig_548	RNA_XX	Synthetic	-	Target_137	0	0	>0.00025	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@@H]([C@H](O)[C@H]([C@H](C1)N#N)O)OCc1ccc(cc1)c1ccc(cc1)CO[C@H]1[C@H](C[C@@H]([C@@H](O)[C@@H]1O)N#N)N#N)N#N	-	-	0	0	0	0	0	0	0	0	0	0	CGCGCAGUGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	16	-	Stem-Loop	0	0	0	0	0.00025	0.00025	0	0	0	0
919	DOS_der_4	Target_lig_549	RNA_XX	Synthetic	-	Target_137	0	0	>0.001	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	OCc1ccc(cc1)CCc1ccc(cc1)CO[C@H]1[C@@H](C[C@H](N)[C@@H](O)[C@@H]1O)N	-	-	0.6294	386.22055744	6	5	7	121.96	2	0.475768564219534	3.51736594587546	28	CGCGCAGUGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	16	-	Stem-Loop	0	0	0	0	0.001	0.001	0	0	0	0
920	DOS	Target_lig_383	RNA_XXI	Synthetic	-	Target_138	0	0	>0.001	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	C1[C@@H](N)[C@@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O	-	-	1.4685	403.11774716	7	4	4	114.62	2	0.451432479803258	4.16281397172473	27	CGCGCAGUAGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	17	-	Stem-Loop	0	0	0	0	0.001	0.001	0	0	0	0
921	DOS_der_1	Target_lig_546	RNA_XXI	Synthetic	-	Target_138	0	0	1.10E-05	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@H](OCCCCCCCCCCCCO[C@H]2[C@@H](C[C@H](N)[C@@H](O)[C@H]2O)N)[C@H](O)[C@H]([C@@H](C1)N)O)N	-	-	-0.781999999999993	490.37303532	10	8	15	203.46	0	0.134415444715085	4.39479383162182	34	CGCGCAGUAGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	17	-	Stem-Loop	0	0	0	0	1.10E-05	1.10E-05	0	0	0	0
922	DOS_der_2	Target_lig_547	RNA_XXI	Synthetic	-	Target_138	0	0	6.00E-06	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@H](OCc2ccc(cc2)CCc2ccc(cc2)CO[C@H]2[C@@H](C[C@H](N)[C@@H](O)[C@@H]2O)N)[C@@H](O)[C@@H]([C@H](C1)N)O)N	-	-	-1.1976	530.310435064	10	8	9	203.46	2	0.194477158896788	4.31690246905065	38	CGCGCAGUAGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	17	-	Stem-Loop	0	0	0	0	6.00E-06	6.00E-06	0	0	0	0
923	DOS_der_3	Target_lig_548	RNA_XXI	Synthetic	-	Target_138	0	0	>0.00025	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@@H]([C@H](O)[C@H]([C@H](C1)N#N)O)OCc1ccc(cc1)c1ccc(cc1)CO[C@H]1[C@H](C[C@@H]([C@@H](O)[C@@H]1O)N#N)N#N)N#N	-	-	0	0	0	0	0	0	0	0	0	0	CGCGCAGUAGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	17	-	Stem-Loop	0	0	0	0	0.00025	0.00025	0	0	0	0
924	DOS_der_4	Target_lig_549	RNA_XXI	Synthetic	-	Target_138	0	0	>0.001	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	OCc1ccc(cc1)CCc1ccc(cc1)CO[C@H]1[C@@H](C[C@H](N)[C@@H](O)[C@@H]1O)N	-	-	0.6294	386.22055744	6	5	7	121.96	2	0.475768564219534	3.51736594587546	28	CGCGCAGUAGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	17	-	Stem-Loop	0	0	0	0	0.001	0.001	0	0	0	0
925	DOS	Target_lig_383	RNA_XXII	Synthetic	-	Target_139	0	0	>0.001	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	C1[C@@H](N)[C@@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O	-	-	1.4685	403.11774716	7	4	4	114.62	2	0.451432479803258	4.16281397172473	27	CGCGCAGUCAGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	0.001	0.001	0	0	0	0
926	DOS_der_1	Target_lig_546	RNA_XXII	Synthetic	-	Target_139	0	0	8.00E-06	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@H](OCCCCCCCCCCCCO[C@H]2[C@@H](C[C@H](N)[C@@H](O)[C@H]2O)N)[C@H](O)[C@H]([C@@H](C1)N)O)N	-	-	-0.781999999999993	490.37303532	10	8	15	203.46	0	0.134415444715085	4.39479383162182	34	CGCGCAGUCAGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	8.00E-06	8.00E-06	0	0	0	0
927	DOS_der_2	Target_lig_547	RNA_XXII	Synthetic	-	Target_139	0	0	6.00E-06	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@H](OCc2ccc(cc2)CCc2ccc(cc2)CO[C@H]2[C@@H](C[C@H](N)[C@@H](O)[C@@H]2O)N)[C@@H](O)[C@@H]([C@H](C1)N)O)N	-	-	-1.1976	530.310435064	10	8	9	203.46	2	0.194477158896788	4.31690246905065	38	CGCGCAGUCAGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	6.00E-06	6.00E-06	0	0	0	0
928	DOS_der_3	Target_lig_548	RNA_XXII	Synthetic	-	Target_139	0	0	>0.00025	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	[C@H]1([C@@H]([C@H](O)[C@H]([C@H](C1)N#N)O)OCc1ccc(cc1)c1ccc(cc1)CO[C@H]1[C@H](C[C@@H]([C@@H](O)[C@@H]1O)N#N)N#N)N#N	-	-	0	0	0	0	0	0	0	0	0	0	CGCGCAGUCAGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	0.00025	0.00025	0	0	0	0
929	DOS_der_4	Target_lig_549	RNA_XXII	Synthetic	-	Target_139	0	0	>0.001	0	0	0	0	-	-	10.1021/ja048936l	15281805	Deoxystreptamine dimers bind to RNA hairpin loops.	Liu X, Thomas JR, Hergenrother PJ	J Am Chem Soc	126	9196-7	2004	50 uL	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	SMMRNA	OCc1ccc(cc1)CCc1ccc(cc1)CO[C@H]1[C@@H](C[C@H](N)[C@@H](O)[C@@H]1O)N	-	-	0.6294	386.22055744	6	5	7	121.96	2	0.475768564219534	3.51736594587546	28	CGCGCAGUCAGUAGCGCG	https://pubs.acs.org/doi/pdf/10.1021/ja048936l	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	0.001	0.001	0	0	0	0
930	Neomycin_B	Target_lig_1246	GNRA tetraloop construct XVIII	Synthetic	-	Target_141	0	0	3.00E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGGGCGAAAGCCUUAU	http://www.smmrna.org/	Hairpin, Tetraloop	-	16	-	GNRA Tetraloop	0	0	0	0	3.00E-05	3.00E-05	0	0	0	0
931	Adenine	Target_lig_165	Spiegelmer L-A42d RNA (58 mer)	Synthetic	-	Target_142	0	0	0.0163±0.0010999999999999998	0	0	0	0	-	-	10.1038/nbt0996-1112	9631061	Mirror-image RNA that binds D-adenosine	Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP	Nat Biotechnol	14	1112-5	1996	10nM	0.1-50 uM	7.6	Room temp.	5mM MgCl2, 250mM NaCl	Equilibrium dialysis	SMMRNA	C1=NC2=NC=NC(=C2N1)N	7H-purin-6-amine	190	-0.0649	135.05449516	4	2	0	80.48	2	0.529675929378058	2.66020570619806	10	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	http://www.smmrna.org/	Spiegelmer, L-RNA	L-RNA ligand	58	-	Stem-Loop	0	0	0	0	0.0152	0.0174	0	0	0	0
932	D_Adenosine	Target_lig_551	Spiegelmer L-A42d RNA (58 mer)	Synthetic	-	Target_142	0	0	2.2e-06±1e-07	0	0	0	0	-	-	10.1038/nbt0996-1112	9631061	Mirror-image RNA that binds D-adenosine	Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP	Nat Biotechnol	14	1112-5	1996	10nM	0.1-50 uM	7.6	Room temp.	5mM MgCl2, 250mM NaCl	Equilibrium dialysis	SMMRNA	C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N	(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol	60961	-1.98	267.096753896	9	4	2	139.54	2	0.490519867679223	3.53130958813491	19	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	http://www.smmrna.org/	Spiegelmer, L-RNA	L-RNA ligand	58	-	Stem-Loop	0	0	0	0	2.10E-06	2.30E-06	0	0	0	0
933	3-O-methyl-D-Adenosine	Target_lig_552	Spiegelmer L-A42d RNA (58 mer)	Synthetic	-	Target_142	0	0	1.4e-06±2e-07	0	0	0	0	-	-	10.1038/nbt0996-1112	9631061	Mirror-image RNA that binds D-adenosine	Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP	Nat Biotechnol	14	1112-5	1996	10nM	0.1-50 uM	7.6	Room temp.	5mM MgCl2, 250mM NaCl	Equilibrium dialysis	SMMRNA	CO[C@@H]1[C@H](O[C@H]([C@@H]1O)N2C=NC3=C(N=CN=C32)N)CO	(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)-4-methoxyoxolan-3-ol	82530	-1.3259	281.11240396	9	3	3	128.54	2	0.631163101478061	3.65853168051604	20	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	http://www.smmrna.org/	Spiegelmer, L-RNA	L-RNA ligand	58	-	Stem-Loop	0	0	0	0	1.20E-06	1.60E-06	0	0	0	0
934	D-guanosine	Target_lig_553	Spiegelmer L-A42d RNA (58 mer)	Synthetic	-	Target_142	0	0	4.8e-06±5e-07	0	0	0	0	-	-	10.1038/nbt0996-1112	9631061	Mirror-image RNA that binds D-adenosine	Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP	Nat Biotechnol	14	1112-5	1996	10nM	0.1-50 uM	7.6	Room temp.	5mM MgCl2, 250mM NaCl	Equilibrium dialysis	SMMRNA	C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N	2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one	135398635	-2.6867	283.091668516	9	5	2	159.51	2	0.398137416114804	3.72017552167488	20	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	http://www.smmrna.org/	Spiegelmer, L-RNA	L-RNA ligand	58	-	Stem-Loop	0	0	0	0	4.30E-06	5.30E-06	0	0	0	0
935	3-deoxy-D-Adenosine	Target_lig_554	Spiegelmer L-A42d RNA (58 mer)	Synthetic	-	Target_142	0	0	8e-06±4e-07	0	0	0	0	-	-	10.1038/nbt0996-1112	9631061	Mirror-image RNA that binds D-adenosine	Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP	Nat Biotechnol	14	1112-5	1996	10nM	0.1-50 uM	7.6	Room temp.	5mM MgCl2, 250mM NaCl	Equilibrium dialysis	SMMRNA	C1[C@H](O[C@H]([C@@H]1O)N2C=NC3=C(N=CN=C32)N)CO	(2R,3R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolan-3-ol	6303	-0.9508	251.101839276	8	3	2	119.31	2	0.628993302830891	3.63227134158629	18	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	http://www.smmrna.org/	Spiegelmer, L-RNA	L-RNA ligand	58	-	Stem-Loop	0	0	0	0	7.60E-06	8.40E-06	0	0	0	0
936	2-deoxy-D-Adenosine	Target_lig_555	Spiegelmer L-A42d RNA (58 mer)	Synthetic	-	Target_142	0	0	0.0014±9.999999999999999e-05	0	0	0	0	-	-	10.1038/nbt0996-1112	9631061	Mirror-image RNA that binds D-adenosine	Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP	Nat Biotechnol	14	1112-5	1996	10nM	0.1-50 uM	7.6	Room temp.	5mM MgCl2, 250mM NaCl	Equilibrium dialysis	SMMRNA	C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)CO)O	(2R,3S,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol	13730	-0.9508	251.101839276	8	3	2	119.31	2	0.628993302830891	3.48419622846412	18	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	http://www.smmrna.org/	Spiegelmer, L-RNA	L-RNA ligand	58	-	Stem-Loop	0	0	0	0	0.0013	0.0015	0	0	0	0
937	D-uridine	Target_lig_556	Spiegelmer L-A42d RNA (58 mer)	Synthetic	-	Target_142	0	0	0.0023±9.999999999999999e-05	0	0	0	0	-	-	10.1038/nbt0996-1112	9631061	Mirror-image RNA that binds D-adenosine	Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP	Nat Biotechnol	14	1112-5	1996	10nM	0.1-50 uM	7.6	Room temp.	5mM MgCl2, 250mM NaCl	Equilibrium dialysis	SMMRNA	C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione	6029	-2.8519	244.069536104	7	4	2	124.78	1	0.443510591273159	3.4839049824931	17	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	http://www.smmrna.org/	Spiegelmer, L-RNA	L-RNA ligand	58	-	Stem-Loop	0	0	0	0	0.0022	0.0024	0	0	0	0
938	D-adenosine triphosphate	Target_lig_557	Spiegelmer L-A42d RNA (58 mer)	Synthetic	-	Target_142	0	0	0.0029±0.0015	0	0	0	0	-	-	10.1038/nbt0996-1112	9631061	Mirror-image RNA that binds D-adenosine	Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP	Nat Biotechnol	14	1112-5	1996	10nM	0.1-50 uM	7.6	Room temp.	5mM MgCl2, 250mM NaCl	Equilibrium dialysis	SMMRNA	C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N	[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate	5957	-1.629	506.995745462	14	7	8	279.13	2	0.19742203378388	4.41361201850629	31	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	http://www.smmrna.org/	Spiegelmer, L-RNA	L-RNA ligand	58	-	Stem-Loop	0	0	0	0	0.0014	0.0044	0	0	0	0
939	D-Cytidine	Target_lig_558	Spiegelmer L-A42d RNA (58 mer)	Synthetic	-	Target_142	0	0	0.0062±0.00019999999999999998	0	0	0	0	-	-	10.1038/nbt0996-1112	9631061	Mirror-image RNA that binds D-adenosine	Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP	Nat Biotechnol	14	1112-5	1996	10nM	0.1-50 uM	7.6	Room temp.	5mM MgCl2, 250mM NaCl	Equilibrium dialysis	SMMRNA	C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O	4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	6175	-2.563	243.085520516	8	4	2	130.83	1	0.448930489231489	3.54889461460013	17	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	http://www.smmrna.org/	Spiegelmer, L-RNA	L-RNA ligand	58	-	Stem-Loop	0	0	0	0	0.006	0.0064	0	0	0	0
940	2-O-methyl-D-Adenosine	Target_lig_559	Spiegelmer L-A42d RNA (58 mer)	Synthetic	-	Target_142	0	0	0.0129±0.0013	0	0	0	0	-	-	10.1038/nbt0996-1112	9631061	Mirror-image RNA that binds D-adenosine	Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP	Nat Biotechnol	14	1112-5	1996	10nM	0.1-50 uM	7.6	Room temp.	5mM MgCl2, 250mM NaCl	Equilibrium dialysis	SMMRNA	CO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)CO)O	(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol	102213	-1.3259	281.11240396	9	3	3	128.54	2	0.631163101478061	3.64221547172483	20	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	http://www.smmrna.org/	Spiegelmer, L-RNA	L-RNA ligand	58	-	Stem-Loop	0	0	0	0	0.0116	0.0142	0	0	0	0
941	L_Adenosine	Target_lig_560	Spiegelmer L-A42d RNA (58 mer)	Synthetic	-	Target_142	0	0	0.0202±0.0017	0	0	0	0	-	-	10.1038/nbt0996-1112	9631061	Mirror-image RNA that binds D-adenosine	Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP	Nat Biotechnol	14	1112-5	1996	10nM	0.1-50 uM	7.6	Room temp.	5mM MgCl2, 250mM NaCl	Equilibrium dialysis	SMMRNA	C1=NC(=C2C(=N1)N(C=N2)[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O)N	(2S,3S,4R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol	448374	-1.98	267.096753896	9	4	2	139.54	2	0.490519867679223	3.53130958813491	19	CUCGGUACCGCAAAAGCGUUUUUCGCAUACCUAUUCGUUAUAGGUCGAUUGUACCGAG	http://www.smmrna.org/	Spiegelmer, L-RNA	L-RNA ligand	58	-	Stem-Loop	0	0	0	0	0.0185	0.0219	0	0	0	0
942	Theophylline	Target_lig_154	T alpha aptamer	Synthetic	-	Target_60	0	5.50E-06	1.50E-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN1C2=C(C(=O)N(C1=O)C)NC=N2	1,3-dimethyl-7H-purine-2,6-dione	2153	-1.0397	180.064725496	5	1	0	72.68	2	0.562472235782798	2.54357777198685	13	GGUGAUACCAGCCGAAAGGCCCUUGGCAGCACC	http://www.smmrna.org/	RNA aptamer	-	33	-	Stem-Loop	0	0	5.50E-06	5.50E-06	1.50E-07	1.50E-07	0	0	0	0
943	biotin dimer	Target_lig_561	B alpha aptamer	Synthetic	-	Target_61	0	0	2.10E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	N=C1N[C@@H]2CS[C@@H]([C@H]2N1)CCCCC(=O)NCCOCCOCCNC(=O)CCCC[C@H]1[C@@H]2NC(=N)N[C@H]2CS1	-	-	0.333140000000005	598.308343952	8	8	19	172.48	0	0.096912059872243	4.99608215647208	40	GGACCGUCAGAGGACACGGUUAAAAAGUCCUCU	http://www.smmrna.org/	RNA aptamer	-	33	-	Pseudoknot	0	0	0	0	2.10E-06	2.10E-06	0	0	0	0
944	biotin PEO Amine	Target_lig_562	B alpha aptamer	Synthetic	-	Target_61	0	0	1.40E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	N=C1N[C@H]2CS[C@H]([C@@H]2N1)CCCCC(=O)NCCOCCOCCN	-	-	-0.364929999999998	373.214760852	6	5	13	121.49	0	0.279413466174429	4.07973622416921	25	GGACCGUCAGAGGACACGGUUAAAAAGUCCUCU	http://www.smmrna.org/	RNA aptamer	-	33	-	Pseudoknot	0	0	0	0	1.40E-05	1.40E-05	0	0	0	0
945	MBNL CCUG ligand 3	Target_lig_563	(CCUG)6	Synthetic	Myotonic dystrophy 2 (DM2)	Target_62	0	0	0.0003	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12cc(ccc1c(c1c(n2)ccc(c1)OC)NCCCCc1c(nc(nc1N)N)N)Cl	-	-	4.0214	437.173086068	8	4	7	137.99	4	0.250945076545639	2.60672136094506	31	CCUGCCUGCCUGCCUGCCUGCCUG	http://www.smmrna.org/	RNA aptamer	Expanded Repeats	24	-	Internal Loop	0	0	0	0	0.0003	0.0003	0	0	0	0
946	MBNL CCUG ligand 3	Target_lig_563	RNA A	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0003	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12cc(ccc1c(c1c(n2)ccc(c1)OC)NCCCCc1c(nc(nc1N)N)N)Cl	-	-	4.0214	437.173086068	8	4	7	137.99	4	0.250945076545639	2.60672136094506	31	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0003	0.0003	0	0	0	0
947	MBNL CCUG ligand 3	Target_lig_563	RNA B	Synthetic	-	Target_144	0	6.00E-06	2.60E-05	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12cc(ccc1c(c1c(n2)ccc(c1)OC)NCCCCc1c(nc(nc1N)N)N)Cl	-	-	4.0214	437.173086068	8	4	7	137.99	4	0.250945076545639	2.60672136094506	31	CUGGCCUGGCGCGCCUGCCCAG	http://www.smmrna.org/	RNA aptamer	-	22	-	Stem-Loop	0	0	6.00E-06	6.00E-06	2.60E-05	2.60E-05	0	0	0	0
948	MBNL CCUG ligand 3	Target_lig_563	RNA C	Synthetic	-	Target_145	0	7.00E-06	0.000165	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	c12cc(ccc1c(c1c(n2)ccc(c1)OC)NCCCCc1c(nc(nc1N)N)N)Cl	-	-	4.0214	437.173086068	8	4	7	137.99	4	0.250945076545639	2.60672136094506	31	CUGGCUGCGCGCGCCGCCAG	http://www.smmrna.org/	RNA aptamer	-	20	-	Stem-Loop	0	0	7.00E-06	7.00E-06	0.000165	0.000165	0	0	0	0
949	disulfide_der_0	Target_lig_564	HIV-1 FSS	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	3.5e-07±1.0999999999999999e-07	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	400-500 nM	7.2	Room temp.	1M MgCl2	Fluorescence titrations and Surface Plasmon Resonance (SPR)	SMMRNA	N([C@@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCCCCN)CSSC[C@@H](NC(=O)c1c(nc2c(cccc2)c1)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCCCCN)C(=O)c1c2c(nc(c1)CC)cccc2	-	-	6.89380000000001	1290.64459984	14	8	35	293.04	6	0.014852288966687	5.69055593779422	92	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	2.40E-07	4.60E-07	0	0	0	0
950	disulfide_der_1	Target_lig_565	HIV-1 FSS	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	3.5e-07±1.2e-07	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	400-500 nM	7.2	Room temp.	1M MgCl2	Fluorescence titrations and Surface Plasmon Resonance (SPR)	SMMRNA	N([C@@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)CSSC[C@@H](NC(=O)c1c(nc2c(cccc2)c1)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)C(=O)c1c2c(nc(c1)CC)cccc2	-	-	4.55320000000001	1206.550699456	14	8	29	293.04	6	0.023629918366656	5.50147535066158	86	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	2.30E-07	4.70E-07	0	0	0	0
951	disulfide_der_2	Target_lig_566	HIV-1 FSS	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	4.2999999999999996e-07±5e-08	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	400-500 nM	7.2	Room temp.	1M MgCl2	Fluorescence titrations and Surface Plasmon Resonance (SPR)	SMMRNA	N([C@H](C(=O)N1[C@H](CCC1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCCCN)CSSC[C@@H](NC(=O)c1c(nc2c(cccc2)c1)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)C(=O)c1c2c(nc(c1)C)cccc2	-	-	4.04524000000001	1178.519399328	14	8	27	293.04	6	0.026698259631964	5.36976614873359	84	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	3.80E-07	4.80E-07	0	0	0	0
952	disulfide_der_3	Target_lig_567	HIV-1 FSS	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	6.5e-07±4e-08	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	400-500 nM	7.2	Room temp.	1M MgCl2	Fluorescence titrations and Surface Plasmon Resonance (SPR)	SMMRNA	N([C@@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCCCN)CSSC[C@@H](NC(=O)c1cnc2c(cccc2)c1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)C(=O)c1c2c(ncc1)cccc2	-	-	3.42840000000001	1150.4880992	14	8	27	293.04	6	0.027110435527699	5.29385732558481	82	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	6.10E-07	6.90E-07	0	0	0	0
953	disulfide_der_6	Target_lig_568	HIV-1 FSS	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	1.42e-06±1.7000000000000001e-07	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	400-500 nM	7.2	Room temp.	1M MgCl2	Fluorescence titrations and Surface Plasmon Resonance (SPR)	SMMRNA	N([C@@H](C(=O)N1[C@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)CSSC[C@@H](NC(=O)c1c(nc2c(cc3c(c2)OCO3)c1)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)C(=O)c1c2c(nc(c1)CC)cc1c(c2)OCO1	-	-	4.01060000000001	1294.530357936	18	8	29	329.96	6	0.024289800175825	5.87237752356456	92	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	1.25E-06	1.59E-06	0	0	0	0
954	disulfide_der_7	Target_lig_569	HIV-1 FSS	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	2.3e-07±3e-08	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	400-500 nM	7.2	Room temp.	1M MgCl2	Fluorescence titrations and Surface Plasmon Resonance (SPR)	SMMRNA	N([C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)CSSC[C@H](NC(=O)c1c(nc2c(c1)C(=O)[C@@H]1[C@@H](C2=O)C=CC=C1)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)C(=O)c1c2c(nc(c1)CC)C(=O)[C@@H]1[C@H](C2=O)C=CC=C1	-	-	3.72160000000001	1370.561658064	18	8	29	361.32	4	0.028356784805513	6.70628475189178	98	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	2.00E-07	2.60E-07	0	0	0	0
955	carba_der	Target_lig_570	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	4.6999999999999995e-07±4e-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	N([C@H](C(=O)N1[C@H](CCC1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCCCN)CC=C)C(=O)c1c2c(nc(c1)CC)cccc2	-	-	2.6552	598.326753824	6	4	14	146.52	3	0.165804846046414	3.62353529819208	44	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	4.30E-07	5.10E-07	0	0	0	0
956	dicarba_analog_1	Target_lig_571	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	3.3e-07±2e-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	N([C@H](C(=O)N1[C@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)C/C=C/C[C@H](NC(=O)c1c(nc2c(c1)cccc2)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)C(=O)c1c2c(nc(c1)CC)cccc2	-	-	4.50820000000001	1168.62220752	12	8	28	293.04	6	0.024889689074487	5.4945905476597	86	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	3.10E-07	3.50E-07	0	0	0	0
957	dicarba_analog_2	Target_lig_572	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.27e-06±1.0999999999999999e-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	N([C@H](C(=O)N1[C@H](CCC1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCCCN)CCCC[C@H](NC(=O)c1c(nc2c(c1)cccc2)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCN)C(=O)c1c2c(nc(c1)CC)cccc2	-	-	4.73220000000001	1170.637857584	12	8	29	293.04	6	0.02959941604835	5.38798642007996	86	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	1.16E-06	1.38E-06	0	0	0	0
958	quinoline_der	Target_lig_24	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	2.9e-07±3e-08	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	CN(C)CCNC1=CC(=NC2=CC=CC=C21)C3=CC=CC=C3	N',N'-dimethyl-N-(2-phenylquinolin-4-yl)ethane-1,2-diamine	453048	3.8753	291.173547672	3	1	5	28.16	3	0.773072562413847	1.85236903026368	22	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	2.60E-07	3.20E-07	0	0	0	0
959	Ruthenium_der	Target_lig_574	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	3.5e-07±1.0999999999999999e-07	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	SMMRNA	C1=C(N(C(=C=1)c1c(cc(cc1C)C)C)[Ru](=Cc1ccccc1)(Cl)(Cl)P(C1CCCCC1)(C1CCCCC1)C1CCCCC1)c1c(cc(cc1C)C)C	-	-	14.41442	843.304042274	1	0	8	3.24	3	0.124047585393215	4.54274783863991	52	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	2.40E-07	4.60E-07	0	0	0	0
960	NSC54101	Target_lig_575	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	3.2e-05±1e-06	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25mM NaCl	Fluorescence and ITC experiments	SMMRNA	CN(C)C1=NC=NC2=C1N=CN2CCN3C=NC4=C3N=CN=C4N(C)C	9-[2-[6-(dimethylamino)purin-9-yl]ethyl]-N,N-dimethylpurin-6-amine	243877	0.7982	352.18724064	10	0	5	93.68	4	0.520529754662725	2.89970391773809	26	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	3.10E-05	3.30E-05	0	0	0	0
961	NSC18613	Target_lig_576	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.5e-06±7e-07	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25mM NaCl	Fluorescence and ITC experiments	SMMRNA	C[N+]1(CCCC2=CC=CC=C21)NCC[N+](C)(C)C.[I-]	trimethyl-[2-[(1-methyl-3,4-dihydro-2H-quinolin-1-ium-1-yl)amino]ethyl]azanium;iodide	5351688	-1.2153	376.12442228409	1	1	4	12.03	1	0.513686560172788	4.11934839453437	19	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	8.00E-07	2.20E-06	0	0	0	0
962	NSC252359	Target_lig_577	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.1e-05±3e-06	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25mM NaCl	Fluorescence and ITC experiments	SMMRNA	CC1=NC2=NC(=NN2C(=C1)N3CCN(CC3)C)C4=CC=C(C=C4)Cl	2-(4-chlorophenyl)-5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine	318119	2.50492	342.135972288	6	0	2	49.56	3	0.715889401668116	2.33158063007697	24	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	8.00E-06	1.40E-05	0	0	0	0
963	NSC11936	Target_lig_578	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.4e-06±4e-07	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25mM NaCl	Fluorescence and ITC experiments	SMMRNA	CN1C2=C(N=C1OCCN(C)C)N(C(=O)N(C2=O)C)C	8-[2-(dimethylamino)ethoxy]-1,3,7-trimethylpurine-2,6-dione	408205	-1.0889	281.148789468	8	0	4	74.29	2	0.71183201387062	2.60298923515922	20	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	1.00E-06	1.80E-06	0	0	0	0
964	NSC123111	Target_lig_579	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	9.8e-05±4.2999999999999995e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25mM NaCl	Fluorescence and ITC experiments	SMMRNA	CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H](C3=C2COC(=O)N)N4C)OC	[(4S,6S)-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),7,11-trien-8-yl]methyl carbamate	10246117	0.7515	331.116820644	7	1	3	103.63	1	0.819888841042068	4.26809835411276	24	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	5.50E-05	0.000141	0	0	0	0
965	NSC154020	Target_lig_580	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	0.000118±6.3e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25mM NaCl	Fluorescence and ITC experiments	SMMRNA	CN1C2=NC=NC3=C2C(=CN3C4C(C(C(O4)CO)O)O)C(=N1)N	2-(5-amino-7-methyl-2,6,7,9,11-pentazatricyclo[6.3.1.04,12]dodeca-1(12),3,5,8,10-pentaen-2-yl)-5-(hydroxymethyl)oxolane-3,4-diol	290486	-1.8871	320.123302992	10	4	2	142.25	2	0.503083716927052	4.20633622128524	23	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	5.50E-05	0.000181	0	0	0	0
966	NSC121848	Target_lig_581	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	0.000135±4.8e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25mM NaCl	Fluorescence and ITC experiments	SMMRNA	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)O)O)O)O)C.[Br-]	1-[(3,4-dihydroxyphenyl)methyl]-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-6,7-diol;bromide	5351989	-0.5707	395.073220284	4	4	2	80.92	2	0.405090719057756	3.54047818260169	24	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	8.70E-05	0.000183	0	0	0	0
967	NSC657704	Target_lig_582	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	0.000163±2e-06	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25mM NaCl	Fluorescence and ITC experiments	SMMRNA	C1=CC=C(C(=C1)/C=C\2/C(=O)N(C(=O)N2)/C=C\3/C(=O)C4=CC=CC=C4OC3=O)O	(5Z)-3-[(Z)-(2,4-dioxochromen-3-ylidene)methyl]-5-[(2-hydroxyphenyl)methylidene]imidazolidine-2,4-dione	5459242	1.9707	376.069536104	6	2	2	113.01	2	0.272409045745067	2.97141299743774	28	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	0.000161	0.000165	0	0	0	0
968	NSC61809	Target_lig_583	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	0.000157±1.8e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25mM NaCl	Fluorescence and ITC experiments	SMMRNA	C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C	(9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 3-hydroxy-2-phenylpropanoate	4120	1.0627	318.16998466809	4	1	4	59.06	1	0.512333158306654	4.81975898122338	23	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	0.000139	0.000175	0	0	0	0
969	acridine_new_derv	Target_lig_584	HIV-1 genomic SL3 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	6.7e-07±3e-08	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25mM NaCl	Fluorescence and ITC experiments	SMMRNA	c1c(cc2c(c1)c(c1c(n2)cc(c(c1)OC)C)Nc1ccc(c(c1)CN1CCN(CC1)C)O)Cl	-	-	5.55502000000001	476.197903848	6	2	5	60.86	4	0.290482040769229	2.48155428829931	34	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	6.40E-07	7.00E-07	0	0	0	0
970	racemic_oxazolidinones	Target_lig_585	Antiterminator model RNA AM1A	Bacillus subtilis	Bacterial growth and infection	Target_147	0	0	1.3e-05±4e-06	0	0	0	0	-	-	10.1021/jm2006904	21812425	Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.	Orac CM, Zhou S, Means JA, Boehm D, Bergmeier SC, Hines JV	J Med Chem	54	6786-95	2011	28,50,100 uM	100nM	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET-derived ligand-binding assay	SMMRNA	C1(=O)O[C@H]([C@H](N1)CN1CCN(CC1)c1ccccc1)COC(=O)Cc1ccccc1	-	-	2.0715	409.200156344	6	1	7	71.11	2	0.706327613887873	3.0944377280843	30	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	mRNA	-	29	-	Internal Loop	0	0	0	0	9.00E-06	1.70E-05	0	0	0	0
971	racemic_oxazolidinones_2	Target_lig_586	Antiterminator model RNA AM1A	Bacillus subtilis	Bacterial growth and infection	Target_147	0	0	9e-07±4e-06	0	0	0	0	-	-	10.1021/jm2006904	21812425	Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.	Orac CM, Zhou S, Means JA, Boehm D, Bergmeier SC, Hines JV	J Med Chem	54	6786-95	2011	28,50,100 uM	100nM	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET-derived ligand-binding assay	SMMRNA	C1(=O)O[C@H]([C@H](N1)CN1CCN(CC1)c1ccccc1)COC(=O)Nc1ccc(cc1)C(=O)C	-	-	2.7369	452.205969996	7	2	7	100.21	2	0.623290599021209	3.18499857217595	33	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	mRNA	-	29	-	Internal Loop	0	0	0	0	3.10E-06	4.90E-06	0	0	0	0
972	Pubchem26532231	Target_lig_587	HIV-1 genomic SL2 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_148	0	1.8000000000000002e-08±1.4000000000000001e-08	0	4.3e-08±8e-09	0	0	0	-	-	10.1021/jm201442t	22587465	Identification of HIV-1 inhibitors targeting the nucleocapsid protein	Breuer S, Chang MW, Yuan J, Torbett BE	J Med Chem	55	4968-77	2012	10nM	10uM	-	Room temp.	10nM ZnCl2	Fluorescence polarization and electrophoresis mobility shift assay with Differential scanning fluorimetry	SMMRNA	COC1=CC=CC(=C1OC)C=C2C(=O)C(C(=S)S2)N	4-amino-2-[(2,3-dimethoxyphenyl)methylidene]-5-sulfanylidenethiolan-3-one	2796938	2.0153	295.033685276	6	1	3	61.55	1	0.679757034976296	3.18183012095275	19	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	-	118	-	Apical Loop	0	0	4.00E-09	3.20E-08	0	0	3.50E-08	5.10E-08	0	0
973	Pubchem26533388	Target_lig_588	HIV-1 genomic SL2 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_148	0	2e-08±5e-09	0	3.3000000000000004e-08±1e-08	0	0	0	-	-	10.1021/jm201442t	22587465	Identification of HIV-1 inhibitors targeting the nucleocapsid protein	Breuer S, Chang MW, Yuan J, Torbett BE	J Med Chem	55	4968-77	2012	10nM	10uM	-	Room temp.	10nM ZnCl2	Fluorescence polarization and electrophoresis mobility shift assay with Differential scanning fluorimetry	SMMRNA	C1OC2=C(O1)C=C(C=C2)C=C3C(=NOC3=O)C4=CC=CC=C4	4-(1,3-benzodioxol-5-ylmethylidene)-3-phenyl-1,2-oxazol-5-one	222981	2.7598	293.068807832	5	0	2	57.12	2	0.630821260666897	2.38398418558912	22	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	-	118	-	Apical Loop	0	0	1.50E-08	2.50E-08	0	0	2.30E-08	4.30E-08	0	0
974	Pubchem26541579	Target_lig_589	HIV-1 genomic SL2 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_148	0	1.4000000000000001e-08±7.000000000000001e-09	0	5.0000000000000004e-08±1.2000000000000002e-08	0	0	0	-	-	10.1021/jm201442t	22587465	Identification of HIV-1 inhibitors targeting the nucleocapsid protein	Breuer S, Chang MW, Yuan J, Torbett BE	J Med Chem	55	4968-77	2012	10nM	10uM	-	Room temp.	10nM ZnCl2	Fluorescence polarization and electrophoresis mobility shift assay with Differential scanning fluorimetry	SMMRNA	CCOC1=C(C=C(C=C1)C=C(C)[N+](=O)[O-])OC	1-ethoxy-2-methoxy-4-(2-nitroprop-1-enyl)benzene	616962	2.7314	237.10010796	4	0	5	61.6	1	0.583160851515428	2.16206323735895	17	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	-	118	-	Apical Loop	0	0	7.00E-09	2.10E-08	0	0	3.80E-08	6.20E-08	0	0
975	Pubchem26529289	Target_lig_590	HIV-1 genomic SL2 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_148	0	2.2000000000000002e-08±9.000000000000001e-09	0	1.8000000000000002e-08±1.6e-08	0	0	0	-	-	10.1021/jm201442t	22587465	Identification of HIV-1 inhibitors targeting the nucleocapsid protein	Breuer S, Chang MW, Yuan J, Torbett BE	J Med Chem	55	4968-77	2012	10nM	10uM	-	Room temp.	10nM ZnCl2	Fluorescence polarization and electrophoresis mobility shift assay with Differential scanning fluorimetry	SMMRNA	CC(=CC1=CC2=C(C=C1)OCO2)[N+](=O)[O-]	5-(2-nitroprop-1-enyl)-1,3-benzodioxole	226317	2.0528	207.053157768	4	0	2	61.6	1	0.549626858688195	2.43456388803468	15	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	-	118	-	Apical Loop	0	0	1.30E-08	3.10E-08	0	0	2.00E-09	3.40E-08	0	0
976	Pubchem26540561	Target_lig_591	HIV-1 genomic SL2 rna	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_148	0	7.3e-08±5.0000000000000004e-08	0	0	0	0	0	-	-	10.1021/jm201442t	22587465	Identification of HIV-1 inhibitors targeting the nucleocapsid protein	Breuer S, Chang MW, Yuan J, Torbett BE	J Med Chem	55	4968-77	2012	10nM	10uM	-	Room temp.	10nM ZnCl2	Fluorescence polarization and electrophoresis mobility shift assay with Differential scanning fluorimetry	SMMRNA	C1=CC(=C(C=C1[N+](=O)[O-])C=C2C(=O)NC(=S)S2)SC3=NC=C(C=C3)C(F)(F)F	5-[[5-nitro-2-[5-(trifluoromethyl)pyridin-2-yl]sulfanylphenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one	2747659	4.6486	442.967988776	7	1	4	85.13	2	0.318675185722154	2.88970484735997	28	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	-	118	-	Apical Loop	0	0	2.30E-08	1.23E-07	0	0	0	0	0	0
977	Bis amidophenyl furans derivative 1	Target_lig_592	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	1.00E-06	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	CN(C)CCCN=C(C1=CC=CC(=C1)C2=CC=C(O2)C3=CC(=CC=C3)C(=NCCCN(C)C)N)N	N'-[3-(dimethylamino)propyl]-3-[5-[3-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide	485809	3.9276	474.310709836	5	2	12	96.38	3	0.235550990585172	2.81837000684527	35	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	1.00E-06	1.00E-06	0	0
978	Bis amidophenyl furans derivative 2	Target_lig_593	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	7.50E-07	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	c1cc(cc(c1)C(=N)NCCCN(CC)CC)c1oc(cc1)c1cccc(c1)C(=N)NCCCN(CC)CC	-	-	5.90734000000001	530.373310092	5	4	16	91.38	3	0.105034765478542	3.1178889111405	39	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	7.50E-07	7.50E-07	0	0
979	Bis amidophenyl furans derivative 3	Target_lig_594	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	1.70E-06	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	CN(C)CCCCN=C(C1=CC=CC(=C1)C2=CC=C(O2)C3=CC(=CC=C3)C(=NCCCCN(C)C)N)N	N'-[4-(dimethylamino)butyl]-3-[5-[3-[N'-[4-(dimethylamino)butyl]carbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide	485987	4.7078	502.342009964	5	2	14	96.38	3	0.189089703366654	2.84592090066365	37	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	1.70E-06	1.70E-06	0	0
980	Bis amidophenyl furans derivative 4	Target_lig_595	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	3.90E-06	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	CN(C)CCCCCCN=C(C1=CC=CC(=C1)C2=CC=C(O2)C3=CC(=CC=C3)C(=NCCCCCCN(C)C)N)N	N'-[6-(dimethylamino)hexyl]-3-[5-[3-[N'-[6-(dimethylamino)hexyl]carbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide	54250194	6.26820000000001	558.40461022	5	2	18	96.38	3	0.108995275904407	2.91725429363453	41	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	3.90E-06	3.90E-06	0	0
981	Bis amidophenyl furans derivative 5	Target_lig_596	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	4.00E-06	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	c1cc(cc(c1)C(=N)NCC)c1oc(cc1)c1cccc(c1)C(=N)NCC	-	-	4.48334	360.195011388	3	4	6	84.9	3	0.386059125459342	2.88645183596389	27	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	4.00E-06	4.00E-06	0	0
982	Bisamidophenyl thiophene derivative 2	Target_lig_597	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	2.40E-06	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	c1cc(cc(c1)C(=N)NCCN1CCCC1)c1sc(cc1)c1cccc(c1)C(=N)NN1CCOCC1	-	-	4.25504	502.251480708	6	4	8	87.47	3	0.273225589126712	3.1248976029321	36	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	2.40E-06	2.40E-06	0	0
983	Bisamidophenyl thiophene derivative 3	Target_lig_598	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	2.80E-06	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	c1cc(cc(c1)C(=N)NCCN1CCCC1)c1sc(cc1)c1cccc(c1)C(=N)NCCCN1CCCC[C@@H]1C	-	-	6.27234000000001	556.334816408	5	4	11	78.24	3	0.127497926496535	3.5455143643968	40	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	2.80E-06	2.80E-06	0	0
984	Bisamidophenyl thiophene derivative 6	Target_lig_599	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	4.00E-06	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	c1cc(cc(c1)C(=N)NCC[C@H]1CCCN1C)c1sc(cc1)c1cccc(c1)C(=N)NCC[C@H]1N(CCC1)C	-	-	5.88064000000001	542.319166344	5	4	10	78.24	3	0.190582358551828	3.95603984278534	39	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	4.00E-06	4.00E-06	0	0
985	Bisamidophenyl thiophene derivative 7	Target_lig_600	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	8.10E-07	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	CCN(CC)CCCN=C(C1=CC=CC(=C1)C2=CC=C(S2)C3=CC(=CC=C3)C(=NCCCN(CC)CC)N)N	N'-[3-(diethylamino)propyl]-3-[5-[3-[N'-[3-(diethylamino)propyl]carbamimidoyl]phenyl]thiophen-2-yl]benzenecarboximidamide	54219182	5.95650000000001	546.350466472	5	2	16	83.24	3	0.131986650963005	2.96155834980994	39	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	8.10E-07	8.10E-07	0	0
986	Bisamidophenyl thiophene derivative 8	Target_lig_601	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	1.10E-06	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	c1cc(cc(c1)C(=N)NCCCN1[C@@H](CCCC1)C)c1sc(cc1)c1cccc(c1)C(=N)NCCCN1CCCC[C@H]1C	-	-	7.44104000000001	598.3817666	5	4	12	78.24	3	0.09927412060043	3.91226985192207	43	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	1.10E-06	1.10E-06	0	0
987	Bisamidophenyl thiophene derivative 9	Target_lig_602	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	8.10E-07	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	c1cc(cc(c1)C(=N)NCc1cnccc1)c1sc(cc1)c1cccc(c1)C(=N)NCC[C@H]1N(CCC1)C	-	-	5.99154000000001	522.256566088	5	4	9	87.89	4	0.160578309056168	3.54721450558165	38	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	8.10E-07	8.10E-07	0	0
988	Bisamidophenyl thiophene derivative 10	Target_lig_603	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	6.00E-06	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	c1cc(cc(c1)C(=N)NCc1cnccc1)c1sc(cc1)c1cccc(c1)C(=N)NCCCN(CC)CC	-	-	6.23914000000001	524.272216152	5	4	12	87.89	4	0.10036620466646	3.05401498786584	38	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	6.00E-06	6.00E-06	0	0
989	Bisamidophenyl thiophene derivative 11	Target_lig_604	HIV RRE RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	1.30E-06	0	0	0	-	-	US005668165A, September 16,1997	-	Small molecule inhibition of RNA/ligand binding	Wuonola MA, Li Z	-	-	-	1997	-	-	-	-	-	Nitrocellulose filter-binding assay	SMMRNA	c1cc(cc(c1)C(=N)NCC[C@H]1CCCN1C)c1sc(cc1)c1cccc(c1)C(=N)NCCCN(CC)CC	-	-	6.12824000000001	544.334816408	5	4	13	78.24	3	0.11862681661219	3.63837909967198	39	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	1.30E-06	1.30E-06	0	0
990	SL3 RNA_ligand1	Target_lig_605	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	0.000163±2e-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CC1=CC=CN2C1=NC3=C(C2=O)C=C(C(=N)N3CCOCCO)C(=O)N[C@@H](C)C4=CC=CC=C4	7-[2-(2-hydroxyethoxy)ethyl]-6-imino-11-methyl-2-oxo-N-[(1S)-1-phenylethyl]-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide	98128260	1.93699	461.206304344	8	3	8	121.71	4	0.273476209754069	3.10101925949622	34	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	0.000161	0.000165	0	0	0	0
991	SL3 RNA_ligand3	Target_lig_606	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.1e-05±4.9999999999999996e-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C2C=C(C=CC2=C1)/C=C/3\C(=O)N=C(S3)N	(5E)-2-amino-5-(naphthalen-2-ylmethylidene)-1,3-thiazol-4-one	1224675	2.7688	254.05138394	3	1	1	55.45	2	0.796035106127064	2.16346601770789	18	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	6.00E-06	1.60E-05	0	0	0	0
992	SL3 RNA_ligand4	Target_lig_607	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.1e-06±1e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	COC1=C(C=C(C=C1)NCC2=CC=C(S2)[N+](=O)[O-])OC	3,4-dimethoxy-N-[(5-nitrothiophen-2-yl)methyl]aniline	784311	3.2856	294.067427928	6	1	6	73.63	2	0.653418866038467	2.14170727890792	20	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	1.00E-06	1.20E-06	0	0	0	0
993	SL3 RNA_ligand5	Target_lig_608	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	3.5e-06±3e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C2C=C(C=CC2=C1)/C=C/3\C(=O)NC(=S)N3	(5E)-5-(naphthalen-2-ylmethylidene)-2-sulfanylideneimidazolidin-4-one	677488	2.185	254.05138394	2	2	1	41.13	2	0.605191356463955	2.26591690528186	18	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	3.20E-06	3.80E-06	0	0	0	0
994	SL3 RNA_ligand6	Target_lig_609	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	4.9999999999999996e-06±3e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C(C=C1)C[N+]2=CC=C(C=C2)C(=O)N/N=C\C3=CC=C(C=C3)Br	1-benzyl-N-[(Z)-(4-bromophenyl)methylideneamino]pyridin-1-ium-4-carboxamide	5509111	3.5488	394.05495068409	2	1	5	45.34	3	0.400992164013645	2.25595808549171	25	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	4.70E-06	5.30E-06	0	0	0	0
995	SL3 RNA_ligand7	Target_lig_610	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	9.999999999999999e-06±4.9999999999999996e-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CC1CCN(CC1)C2=CC=C(C=C2)N	4-(4-methylpiperidin-1-yl)aniline	605442	2.5051	190.146998576	2	1	1	29.26	1	0.689352707173481	1.75017827799983	14	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	5.00E-06	1.50E-05	0	0	0	0
996	SL3 RNA_ligand8	Target_lig_611	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	6.80E-05	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C(C=C1)OCCNC2=CC=CC=C2N	2-N-(2-phenoxyethyl)benzene-1,2-diamine	2295787	2.7597	228.126263132	3	2	5	47.28	2	0.610756850955603	1.5974161203021	17	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	6.80E-05	6.80E-05	0	0	0	0
997	SL3 RNA_ligand9	Target_lig_612	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.6999999999999998e-06±2e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC2=C(C=CC(=C2N=C1)SCCO)[N+](=O)[O-]	2-(5-nitroquinolin-8-yl)sulfanylethanol	2847027	2.2274	250.04121318	5	1	4	76.26	2	0.511248477788479	2.40420600491748	17	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	1.50E-06	1.90E-06	0	0	0	0
998	SL3 RNA_ligand10	Target_lig_613	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	4.5e-06±9e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C(C(=C1)/C=C\2/C(=O)N(C(=O)N2)/C=C/3\C(=O)C4=CC=CC=C4OC3=O)O	(5Z)-3-[(E)-(2,4-dioxochromen-3-ylidene)methyl]-5-[(2-hydroxyphenyl)methylidene]imidazolidine-2,4-dione	5771709	1.9707	376.069536104	6	2	2	113.01	2	0.272409045745067	2.97141299743774	28	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	3.60E-06	5.40E-06	0	0	0	0
999	SL3 RNA_ligand11	Target_lig_614	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.1e-05±2e-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC=C(C=C4)S(=O)(=O)N)S(=O)(=O)O)N	1-amino-9,10-dioxo-4-(4-sulfamoylanilino)anthracene-2-sulfonic acid	3356666	1.6819	473.03514182	8	4	4	186.72	3	0.252497564162134	2.48521320128188	32	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	9.00E-06	1.30E-05	0	0	0	0
1000	SL3 RNA_ligand12	Target_lig_615	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.1099999999999999e-05±1e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	c12ccccc1C(=O)[C@H]1[C@H](C2=O)C(=CC=C1NCCO)NCCO	-	-	0.2432	328.14230712	6	4	6	98.66	1	0.597222196247646	3.82575997115842	24	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	1.10E-05	1.12E-05	0	0	0	0
1001	SL3 RNA_ligand13	Target_lig_616	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.3199999999999999e-05±3e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CC1=CC=CN2C1=NC3=C(C2=O)C=C(C(=N)N3CCCO)C(=O)NC	7-(3-hydroxypropyl)-6-imino-N,11-dimethyl-2-oxo-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide	2938622	0.17909	341.148789468	7	3	4	112.48	3	0.587573710482988	2.66483852714654	25	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	1.29E-05	1.35E-05	0	0	0	0
1002	SL3 RNA_ligand14	Target_lig_617	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	3.2999999999999996e-05±3e-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CC1=CC=CN2C1=NC3=C(C2=O)C=C(C(=N)N3CC4=CN=CC=C4)C(=O)NCCN5CCOCC5	6-imino-11-methyl-N-(2-morpholin-4-ylethyl)-2-oxo-7-(pyridin-3-ylmethyl)-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide	1309471	0.94239	473.217537724	9	2	6	117.61	4	0.402725681102029	2.73704384192109	35	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	3.00E-05	3.60E-05	0	0	0	0
1003	SL3 RNA_ligand15	Target_lig_618	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	4.4e-05±6e-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CC1=CC=CN2C1=NC3=C(C2=O)C=C(C(=N)N3C[C@H]4CCCO4)C(=O)N5CCN(CC5)C	6-imino-11-methyl-5-(4-methylpiperazine-1-carbonyl)-7-[[(2R)-oxolan-2-yl]methyl]-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaen-2-one	1281474	1.00369	436.222288756	8	1	3	95.93	3	0.61838132073288	3.20454832979881	32	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	3.80E-05	5.00E-05	0	0	0	0
1004	SL3 RNA_ligand16	Target_lig_619	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	5.10E-05	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C(C=C1)N2C=C(C(=N2)C3=CC4=C(C=CC5=CC=CC=C54)OC3=O)C=C6C(=O)NC(=S)NC6=O	5-[[3-(3-oxobenzo[f]chromen-2-yl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione	1341957	3.7132	492.089225992	7	2	3	106.23	5	0.130780534350925	2.72847101478875	36	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	5.10E-05	5.10E-05	0	0	0	0
1005	SL3 RNA_ligand17	Target_lig_620	SL3 RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	8.999999999999999e-05±9.999999999999999e-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F	10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine	5566	4.9456	407.164303428	4	0	4	9.72	2	0.709478258096045	2.35159927543189	28	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	8.00E-05	0.0001	0	0	0	0
1006	SL3 RNA_ligand4	Target_lig_607	Double stranded RNA seq	Synthetic	-	Target_149	0	0	3.2e-06±5e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	COC1=C(C=C(C=C1)NCC2=CC=C(S2)[N+](=O)[O-])OC	3,4-dimethoxy-N-[(5-nitrothiophen-2-yl)methyl]aniline	784311	3.2856	294.067427928	6	1	6	73.63	2	0.653418866038467	2.14170727890792	20	AUCACCUCCUUAUAAGGAGGUGAU	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	24	-	Double Stranded RNA (dsRNA)	0	0	0	0	2.70E-06	3.70E-06	0	0	0	0
1007	SL3 RNA_ligand5	Target_lig_608	Double stranded RNA seq	Synthetic	-	Target_149	0	0	8.2e-06±9e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C2C=C(C=CC2=C1)/C=C/3\C(=O)NC(=S)N3	(5E)-5-(naphthalen-2-ylmethylidene)-2-sulfanylideneimidazolidin-4-one	677488	2.185	254.05138394	2	2	1	41.13	2	0.605191356463955	2.26591690528186	18	AUCACCUCCUUAUAAGGAGGUGAU	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	24	-	Double Stranded RNA (dsRNA)	0	0	0	0	7.30E-06	9.10E-06	0	0	0	0
1008	SL3 RNA_ligand6	Target_lig_609	Double stranded RNA seq	Synthetic	-	Target_149	0	0	8.3e-06±3e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C(C=C1)C[N+]2=CC=C(C=C2)C(=O)N/N=C\C3=CC=C(C=C3)Br	1-benzyl-N-[(Z)-(4-bromophenyl)methylideneamino]pyridin-1-ium-4-carboxamide	5509111	3.5488	394.05495068409	2	1	5	45.34	3	0.400992164013645	2.25595808549171	25	AUCACCUCCUUAUAAGGAGGUGAU	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	24	-	Double Stranded RNA (dsRNA)	0	0	0	0	8.00E-06	8.60E-06	0	0	0	0
1009	SL3 RNA_ligand7	Target_lig_610	Double stranded RNA seq	Synthetic	-	Target_149	0	0	0.00018899999999999999±6e-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CC1CCN(CC1)C2=CC=C(C=C2)N	4-(4-methylpiperidin-1-yl)aniline	605442	2.5051	190.146998576	2	1	1	29.26	1	0.689352707173481	1.75017827799983	14	AUCACCUCCUUAUAAGGAGGUGAU	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	24	-	Double Stranded RNA (dsRNA)	0	0	0	0	0.000183	0.000195	0	0	0	0
1010	SL3 RNA_ligand9	Target_lig_612	Double stranded RNA seq	Synthetic	-	Target_149	0	0	2.1899999999999998e-06±1e-08	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC2=C(C=CC(=C2N=C1)SCCO)[N+](=O)[O-]	2-(5-nitroquinolin-8-yl)sulfanylethanol	2847027	2.2274	250.04121318	5	1	4	76.26	2	0.511248477788479	2.40420600491748	17	AUCACCUCCUUAUAAGGAGGUGAU	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	24	-	Double Stranded RNA (dsRNA)	0	0	0	0	2.18E-06	2.20E-06	0	0	0	0
1011	SL3 RNA_ligand10	Target_lig_613	Double stranded RNA seq	Synthetic	-	Target_149	0	0	5.0999999999999995e-06±9e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C(C(=C1)/C=C\2/C(=O)N(C(=O)N2)/C=C/3\C(=O)C4=CC=CC=C4OC3=O)O	(5Z)-3-[(E)-(2,4-dioxochromen-3-ylidene)methyl]-5-[(2-hydroxyphenyl)methylidene]imidazolidine-2,4-dione	5771709	1.9707	376.069536104	6	2	2	113.01	2	0.272409045745067	2.97141299743774	28	AUCACCUCCUUAUAAGGAGGUGAU	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	24	-	Double Stranded RNA (dsRNA)	0	0	0	0	4.20E-06	6.00E-06	0	0	0	0
1012	SL3 RNA_ligand11	Target_lig_614	Double stranded RNA seq	Synthetic	-	Target_149	0	0	1.12e-05±8e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC=C(C=C4)S(=O)(=O)N)S(=O)(=O)O)N	1-amino-9,10-dioxo-4-(4-sulfamoylanilino)anthracene-2-sulfonic acid	3356666	1.6819	473.03514182	8	4	4	186.72	3	0.252497564162134	2.48521320128188	32	AUCACCUCCUUAUAAGGAGGUGAU	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	24	-	Double Stranded RNA (dsRNA)	0	0	0	0	1.04E-05	1.20E-05	0	0	0	0
1013	SL3 RNA_ligand12	Target_lig_615	Double stranded RNA seq	Synthetic	-	Target_149	0	0	8.4e-06±8e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	c12ccccc1C(=O)[C@H]1[C@H](C2=O)C(=CC=C1NCCO)NCCO	-	-	0.2432	328.14230712	6	4	6	98.66	1	0.597222196247646	3.82575997115842	24	AUCACCUCCUUAUAAGGAGGUGAU	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	24	-	Double Stranded RNA (dsRNA)	0	0	0	0	7.60E-06	9.20E-06	0	0	0	0
1014	SL3 RNA_ligand13	Target_lig_616	Double stranded RNA seq	Synthetic	-	Target_149	0	0	1.2e-05±1e-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CC1=CC=CN2C1=NC3=C(C2=O)C=C(C(=N)N3CCCO)C(=O)NC	7-(3-hydroxypropyl)-6-imino-N,11-dimethyl-2-oxo-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide	2938622	0.17909	341.148789468	7	3	4	112.48	3	0.587573710482988	2.66483852714654	25	AUCACCUCCUUAUAAGGAGGUGAU	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	24	-	Double Stranded RNA (dsRNA)	0	0	0	0	1.10E-05	1.30E-05	0	0	0	0
1015	SL3 RNA_ligand17	Target_lig_620	Double stranded RNA seq	Synthetic	-	Target_149	0	0	>0.001109	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F	10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine	5566	4.9456	407.164303428	4	0	4	9.72	2	0.709478258096045	2.35159927543189	28	AUCACCUCCUUAUAAGGAGGUGAU	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	24	-	Double Stranded RNA (dsRNA)	0	0	0	0	0.001109	0.001109	0	0	0	0
1016	SL3 RNA_ligand4	Target_lig_607	single stranded RNA seq	Synthetic	-	Target_150	0	0	2.20E-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	COC1=C(C=C(C=C1)NCC2=CC=C(S2)[N+](=O)[O-])OC	3,4-dimethoxy-N-[(5-nitrothiophen-2-yl)methyl]aniline	784311	3.2856	294.067427928	6	1	6	73.63	2	0.653418866038467	2.14170727890792	20	AUCACCUCCUUA	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	12	-	-	0	0	0	0	2.20E-06	2.20E-06	0	0	0	0
1017	SL3 RNA_ligand5	Target_lig_608	single stranded RNA seq	Synthetic	-	Target_150	0	0	9.499999999999999e-06±1e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C2C=C(C=CC2=C1)/C=C/3\C(=O)NC(=S)N3	(5E)-5-(naphthalen-2-ylmethylidene)-2-sulfanylideneimidazolidin-4-one	677488	2.185	254.05138394	2	2	1	41.13	2	0.605191356463955	2.26591690528186	18	AUCACCUCCUUA	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	12	-	-	0	0	0	0	9.40E-06	9.60E-06	0	0	0	0
1018	SL3 RNA_ligand6	Target_lig_609	single stranded RNA seq	Synthetic	-	Target_150	0	0	1.18e-05±3e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C(C=C1)C[N+]2=CC=C(C=C2)C(=O)N/N=C\C3=CC=C(C=C3)Br	1-benzyl-N-[(Z)-(4-bromophenyl)methylideneamino]pyridin-1-ium-4-carboxamide	5509111	3.5488	394.05495068409	2	1	5	45.34	3	0.400992164013645	2.25595808549171	25	AUCACCUCCUUA	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	12	-	-	0	0	0	0	1.15E-05	1.21E-05	0	0	0	0
1019	SL3 RNA_ligand7	Target_lig_610	single stranded RNA seq	Synthetic	-	Target_150	0	0	0.00028±9.999999999999999e-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CC1CCN(CC1)C2=CC=C(C=C2)N	4-(4-methylpiperidin-1-yl)aniline	605442	2.5051	190.146998576	2	1	1	29.26	1	0.689352707173481	1.75017827799983	14	AUCACCUCCUUA	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	12	-	-	0	0	0	0	0.00027	0.00029	0	0	0	0
1020	SL3 RNA_ligand9	Target_lig_612	single stranded RNA seq	Synthetic	-	Target_150	0	0	2e-06±5e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC2=C(C=CC(=C2N=C1)SCCO)[N+](=O)[O-]	2-(5-nitroquinolin-8-yl)sulfanylethanol	2847027	2.2274	250.04121318	5	1	4	76.26	2	0.511248477788479	2.40420600491748	17	AUCACCUCCUUA	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	12	-	-	0	0	0	0	1.50E-06	2.50E-06	0	0	0	0
1021	SL3 RNA_ligand10	Target_lig_613	single stranded RNA seq	Synthetic	-	Target_150	0	0	4.10E-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C(C(=C1)/C=C\2/C(=O)N(C(=O)N2)/C=C/3\C(=O)C4=CC=CC=C4OC3=O)O	(5Z)-3-[(E)-(2,4-dioxochromen-3-ylidene)methyl]-5-[(2-hydroxyphenyl)methylidene]imidazolidine-2,4-dione	5771709	1.9707	376.069536104	6	2	2	113.01	2	0.272409045745067	2.97141299743774	28	AUCACCUCCUUA	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	12	-	-	0	0	0	0	4.10E-06	4.10E-06	0	0	0	0
1022	SL3 RNA_ligand11	Target_lig_614	single stranded RNA seq	Synthetic	-	Target_150	0	0	8.9e-06±4e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC=C(C=C4)S(=O)(=O)N)S(=O)(=O)O)N	1-amino-9,10-dioxo-4-(4-sulfamoylanilino)anthracene-2-sulfonic acid	3356666	1.6819	473.03514182	8	4	4	186.72	3	0.252497564162134	2.48521320128188	32	AUCACCUCCUUA	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	12	-	-	0	0	0	0	8.50E-06	9.30E-06	0	0	0	0
1023	SL3 RNA_ligand12	Target_lig_615	single stranded RNA seq	Synthetic	-	Target_150	0	0	1.4e-05±2e-06	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	c12ccccc1C(=O)[C@H]1[C@H](C2=O)C(=CC=C1NCCO)NCCO	-	-	0.2432	328.14230712	6	4	6	98.66	1	0.597222196247646	3.82575997115842	24	AUCACCUCCUUA	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	12	-	-	0	0	0	0	1.20E-05	1.60E-05	0	0	0	0
1024	SL3 RNA_ligand13	Target_lig_616	single stranded RNA seq	Synthetic	-	Target_150	0	0	7.499999999999999e-06±1e-07	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CC1=CC=CN2C1=NC3=C(C2=O)C=C(C(=N)N3CCCO)C(=O)NC	7-(3-hydroxypropyl)-6-imino-N,11-dimethyl-2-oxo-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide	2938622	0.17909	341.148789468	7	3	4	112.48	3	0.587573710482988	2.66483852714654	25	AUCACCUCCUUA	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	12	-	-	0	0	0	0	7.40E-06	7.60E-06	0	0	0	0
1025	SL3 RNA_ligand17	Target_lig_620	single stranded RNA seq	Synthetic	-	Target_150	0	0	>0.0006039999999999999	0	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F	10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine	5566	4.9456	407.164303428	4	0	4	9.72	2	0.709478258096045	2.35159927543189	28	AUCACCUCCUUA	https://pubs.acs.org/doi/pdf/10.1021/jm2007694	RNA aptamer	-	12	-	-	0	0	0	0	0.000604	0.000604	0	0	0	0
1026	SL3 RNA_ligand1	Target_lig_605	SL3 RNA_NCp7_Complex	-	-	-	0	0.00010999999999999999±5.9999999999999995e-05	0	0.00033999999999999997±7.999999999999999e-05	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	CC1=CC=CN2C1=NC3=C(C2=O)C=C(C(=N)N3CCOCCO)C(=O)N[C@@H](C)C4=CC=CC=C4	7-[2-(2-hydroxyethoxy)ethyl]-6-imino-11-methyl-2-oxo-N-[(1S)-1-phenylethyl]-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide	98128260	1.93699	461.206304344	8	3	8	121.71	4	0.273476209754069	3.10101925949622	34	-	-	-	-	0	-	-	0	0	5.00E-05	0.00017	0	0	0.00026	0.00042	0	0
1027	SL3 RNA_ligand3	Target_lig_606	SL3 RNA_NCp7_Complex	-	-	-	0	1.9999999999999998e-05±9.999999999999999e-06	0	7e-05±2.9999999999999997e-05	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C2C=C(C=CC2=C1)/C=C/3\C(=O)N=C(S3)N	(5E)-2-amino-5-(naphthalen-2-ylmethylidene)-1,3-thiazol-4-one	1224675	2.7688	254.05138394	3	1	1	55.45	2	0.796035106127064	2.16346601770789	18	-	-	-	-	0	-	-	0	0	1.00E-05	3.00E-05	0	0	4.00E-05	0.0001	0	0
1028	SL3 RNA_ligand4	Target_lig_607	SL3 RNA_NCp7_Complex	-	-	-	0	0.00019999999999999998±9.999999999999999e-05	0	0.0007±0.00035	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	COC1=C(C=C(C=C1)NCC2=CC=C(S2)[N+](=O)[O-])OC	3,4-dimethoxy-N-[(5-nitrothiophen-2-yl)methyl]aniline	784311	3.2856	294.067427928	6	1	6	73.63	2	0.653418866038467	2.14170727890792	20	-	-	-	-	0	-	-	0	0	0.0001	0.0003	0	0	0.00035	0.00105	0	0
1029	SL3 RNA_ligand8	Target_lig_611	SL3 RNA_NCp7_Complex	-	-	-	0	3.9999999999999996e-05±1e-06	0	0.00012299999999999998±3e-06	0	0	0	-	-	10.1021/jm2007694	22480197	Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.	Warui DM, Baranger AM	J Med Chem	55	4132-41	2012	1 mM	10 uM	7.4	25	-	Fluorescence experiments, ITC, Gel mobility shift assay	SMMRNA	C1=CC=C(C=C1)OCCNC2=CC=CC=C2N	2-N-(2-phenoxyethyl)benzene-1,2-diamine	2295787	2.7597	228.126263132	3	2	5	47.28	2	0.610756850955603	1.5974161203021	17	-	-	-	-	0	-	-	0	0	3.90E-05	4.10E-05	0	0	0.00012	0.000126	0	0
1030	ligand 3-3	Target_lig_621	RNA seq A	Synthetic	Myotonic dystrophy 1 (DM1)	Target_151	0	0	5.4e-06±6e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	-0.438000000000003	1098.499057808	18	10	31	356.22	2	0.033800532611899	5.20227633216278	76	CCGCUGCUGCUGCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	4.80E-06	6.00E-06	0	0	0	0
1031	ligand 4-4	Target_lig_622	RNA seq A	Synthetic	Myotonic dystrophy 1 (DM1)	Target_151	0	0	6.7e-06±2e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]4CCCN4C(=O)c4cc5c(nc4CC)cccc5)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC3)c1CC)cccc2	-	-	2.3258	1168.603797648	16	10	33	345.08	4	0.024172990215334	5.47994818885521	82	CCGCUGCUGCUGCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	6.50E-06	6.90E-06	0	0	0	0
1032	ligand 2-4	Target_lig_623	RNA seq A	Synthetic	Myotonic dystrophy 1 (DM1)	Target_151	0	0	4.5e-06±6e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CC(=O)N)c1CC)cccc2	-	-	0.694999999999995	1185.593961236	17	12	36	396.96	4	0.022019712323712	5.57006078273347	83	CCGCUGCUGCUGCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	3.90E-06	5.10E-06	0	0	0	0
1033	ligand 3-4	Target_lig_624	RNA seq A	Synthetic	Myotonic dystrophy 1 (DM1)	Target_151	0	0	4.1e-06±2e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	0.943899999999999	1133.551427728	17	10	32	350.65	3	0.030721517337579	5.41074778610339	79	CCGCUGCUGCUGCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	3.90E-06	4.30E-06	0	0	0	0
1034	ligand 3-3	Target_lig_621	RNA seq A (20 x t-RNA)	Synthetic	Myotonic dystrophy 1 (DM1)	Target_152	0	0	1.4e-05±4e-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	-0.438000000000003	1098.499057808	18	10	31	356.22	2	0.033800532611899	5.20227633216278	76	CCGCUGCUGCUGCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	1.00E-05	1.80E-05	0	0	0	0
1035	ligand 4-4	Target_lig_622	RNA seq A (20 x t-RNA)	Synthetic	Myotonic dystrophy 1 (DM1)	Target_152	0	0	1.8e-05±2.1e-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]4CCCN4C(=O)c4cc5c(nc4CC)cccc5)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC3)c1CC)cccc2	-	-	2.3258	1168.603797648	16	10	33	345.08	4	0.024172990215334	5.47994818885521	82	CCGCUGCUGCUGCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	1.59E-05	2.01E-05	0	0	0	0
1036	ligand 2-4	Target_lig_623	RNA seq A (20 x t-RNA)	Synthetic	Myotonic dystrophy 1 (DM1)	Target_152	0	0	9.999999999999999e-06±7e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CC(=O)N)c1CC)cccc2	-	-	0.694999999999995	1185.593961236	17	12	36	396.96	4	0.022019712323712	5.57006078273347	83	CCGCUGCUGCUGCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	9.30E-06	1.07E-05	0	0	0	0
1037	ligand 3-4	Target_lig_624	RNA seq A (20 x t-RNA)	Synthetic	Myotonic dystrophy 1 (DM1)	Target_152	0	0	9.6e-06±7e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	0.943899999999999	1133.551427728	17	10	32	350.65	3	0.030721517337579	5.41074778610339	79	CCGCUGCUGCUGCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	8.90E-06	1.03E-05	0	0	0	0
1038	ligand 3-3	Target_lig_621	RNA seq B	Synthetic	Myotonic dystrophy 1 (DM1)	Target_153	0	0	2.50E-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	-0.438000000000003	1098.499057808	18	10	31	356.22	2	0.033800532611899	5.20227633216278	76	GGGCUGCUGCUGCUGCUGGGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	21	-	Stem-Loop	0	0	0	0	2.50E-06	2.50E-06	0	0	0	0
1039	ligand 4-4	Target_lig_622	RNA seq B	Synthetic	Myotonic dystrophy 1 (DM1)	Target_153	0	0	2.10E-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]4CCCN4C(=O)c4cc5c(nc4CC)cccc5)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC3)c1CC)cccc2	-	-	2.3258	1168.603797648	16	10	33	345.08	4	0.024172990215334	5.47994818885521	82	GGGCUGCUGCUGCUGCUGGGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	21	-	Stem-Loop	0	0	0	0	2.10E-06	2.10E-06	0	0	0	0
1040	ligand 2-4	Target_lig_623	RNA seq B	Synthetic	Myotonic dystrophy 1 (DM1)	Target_153	0	0	2.10E-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CC(=O)N)c1CC)cccc2	-	-	0.694999999999995	1185.593961236	17	12	36	396.96	4	0.022019712323712	5.57006078273347	83	GGGCUGCUGCUGCUGCUGGGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	21	-	Stem-Loop	0	0	0	0	2.10E-06	2.10E-06	0	0	0	0
1041	ligand 3-4	Target_lig_624	RNA seq B	Synthetic	Myotonic dystrophy 1 (DM1)	Target_153	0	0	1.90E-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	0.943899999999999	1133.551427728	17	10	32	350.65	3	0.030721517337579	5.41074778610339	79	GGGCUGCUGCUGCUGCUGGGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	21	-	Stem-Loop	0	0	0	0	1.90E-06	1.90E-06	0	0	0	0
1042	ligand 3-3	Target_lig_621	RNA seq C	Synthetic	Myotonic dystrophy 1 (DM1)	Target_154	0	0	9.3e-06±4e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	-0.438000000000003	1098.499057808	18	10	31	356.22	2	0.033800532611899	5.20227633216278	76	CCGCUGGGCAACCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	8.90E-06	9.70E-06	0	0	0	0
1043	ligand 4-4	Target_lig_622	RNA seq C	Synthetic	Myotonic dystrophy 1 (DM1)	Target_154	0	0	7.099999999999999e-06±1.1e-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]4CCCN4C(=O)c4cc5c(nc4CC)cccc5)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC3)c1CC)cccc2	-	-	2.3258	1168.603797648	16	10	33	345.08	4	0.024172990215334	5.47994818885521	82	CCGCUGGGCAACCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	6.00E-06	8.20E-06	0	0	0	0
1044	ligand 2-4	Target_lig_623	RNA seq C	Synthetic	Myotonic dystrophy 1 (DM1)	Target_154	0	0	6.4e-06±1e-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CC(=O)N)c1CC)cccc2	-	-	0.694999999999995	1185.593961236	17	12	36	396.96	4	0.022019712323712	5.57006078273347	83	CCGCUGGGCAACCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	5.40E-06	7.40E-06	0	0	0	0
1045	ligand 3-4	Target_lig_624	RNA seq C	Synthetic	Myotonic dystrophy 1 (DM1)	Target_154	0	0	4.7e-06±1e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	0.943899999999999	1133.551427728	17	10	32	350.65	3	0.030721517337579	5.41074778610339	79	CCGCUGGGCAACCUGCGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	4.60E-06	4.80E-06	0	0	0	0
1046	ligand 3-3	Target_lig_621	RNA seq D	Synthetic	Myotonic dystrophy 1 (DM1)	Target_155	0	0	7.499999999999999e-06±9e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	-0.438000000000003	1098.499057808	18	10	31	356.22	2	0.033800532611899	5.20227633216278	76	CGCGCUGCUGCGCG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	14	-	Stem-Loop	0	0	0	0	6.60E-06	8.40E-06	0	0	0	0
1047	ligand 4-4	Target_lig_622	RNA seq D	Synthetic	Myotonic dystrophy 1 (DM1)	Target_155	0	0	8.5e-06±1e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]4CCCN4C(=O)c4cc5c(nc4CC)cccc5)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC3)c1CC)cccc2	-	-	2.3258	1168.603797648	16	10	33	345.08	4	0.024172990215334	5.47994818885521	82	CGCGCUGCUGCGCG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	14	-	Stem-Loop	0	0	0	0	8.40E-06	8.60E-06	0	0	0	0
1048	ligand 2-4	Target_lig_623	RNA seq D	Synthetic	Myotonic dystrophy 1 (DM1)	Target_155	0	0	4.599999999999999e-06±1e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CC(=O)N)c1CC)cccc2	-	-	0.694999999999995	1185.593961236	17	12	36	396.96	4	0.022019712323712	5.57006078273347	83	CGCGCUGCUGCGCG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	14	-	Stem-Loop	0	0	0	0	4.50E-06	4.70E-06	0	0	0	0
1049	ligand 3-4	Target_lig_624	RNA seq D	Synthetic	Myotonic dystrophy 1 (DM1)	Target_155	0	0	6e-06±1e-07	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	0.943899999999999	1133.551427728	17	10	32	350.65	3	0.030721517337579	5.41074778610339	79	CGCGCUGCUGCGCG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	14	-	Stem-Loop	0	0	0	0	5.90E-06	6.10E-06	0	0	0	0
1050	ligand 3-3	Target_lig_621	RNA seq E	Synthetic	Myotonic dystrophy 1 (DM1)	Target_156	0	0	2.1e-05±1.4e-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	-0.438000000000003	1098.499057808	18	10	31	356.22	2	0.033800532611899	5.20227633216278	76	CCAGCUGGCAACAGCUGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	1.96E-05	2.24E-05	0	0	0	0
1051	ligand 4-4	Target_lig_622	RNA seq E	Synthetic	Myotonic dystrophy 1 (DM1)	Target_156	0	0	>3.9999999999999996e-05	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]4CCCN4C(=O)c4cc5c(nc4CC)cccc5)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC3)c1CC)cccc2	-	-	2.3258	1168.603797648	16	10	33	345.08	4	0.024172990215334	5.47994818885521	82	CCAGCUGGCAACAGCUGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	4.00E-05	4.00E-05	0	0	0	0
1052	ligand 2-4	Target_lig_623	RNA seq E	Synthetic	Myotonic dystrophy 1 (DM1)	Target_156	0	0	1.95e-05±1e-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CC(=O)N)c1CC)cccc2	-	-	0.694999999999995	1185.593961236	17	12	36	396.96	4	0.022019712323712	5.57006078273347	83	CCAGCUGGCAACAGCUGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	1.85E-05	2.05E-05	0	0	0	0
1053	ligand 3-4	Target_lig_624	RNA seq E	Synthetic	Myotonic dystrophy 1 (DM1)	Target_156	0	0	2.1e-05±1.8e-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	0.943899999999999	1133.551427728	17	10	32	350.65	3	0.030721517337579	5.41074778610339	79	CCAGCUGGCAACAGCUGG	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	18	-	Stem-Loop	0	0	0	0	1.92E-05	2.28E-05	0	0	0	0
1054	ligand 3-3	Target_lig_621	RNA seq F	Synthetic	Myotonic dystrophy 1 (DM1)	Target_157	0	0	4.1e-05±9e-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	-0.438000000000003	1098.499057808	18	10	31	356.22	2	0.033800532611899	5.20227633216278	76	GGCCUUCCCACAAGGGAAGGCC	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	22	-	Stem-Loop	0	0	0	0	3.20E-05	5.00E-05	0	0	0	0
1055	ligand 4-4	Target_lig_622	RNA seq F	Synthetic	Myotonic dystrophy 1 (DM1)	Target_157	0	0	2.4e-05±4.9999999999999996e-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]4CCCN4C(=O)c4cc5c(nc4CC)cccc5)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC3)c1CC)cccc2	-	-	2.3258	1168.603797648	16	10	33	345.08	4	0.024172990215334	5.47994818885521	82	GGCCUUCCCACAAGGGAAGGCC	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	22	-	Stem-Loop	0	0	0	0	1.90E-05	2.90E-05	0	0	0	0
1056	ligand 2-4	Target_lig_623	RNA seq F	Synthetic	Myotonic dystrophy 1 (DM1)	Target_157	0	0	2.2e-05±2e-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	n1c2c(cc(C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CC(=O)N)c1CC)cccc2	-	-	0.694999999999995	1185.593961236	17	12	36	396.96	4	0.022019712323712	5.57006078273347	83	GGCCUUCCCACAAGGGAAGGCC	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	22	-	Stem-Loop	0	0	0	0	2.00E-05	2.40E-05	0	0	0	0
1057	ligand 3-4	Target_lig_624	RNA seq F	Synthetic	Myotonic dystrophy 1 (DM1)	Target_157	0	0	1.6e-05±4e-06	0	0	0	0	-	-	10.1021/ja804398y	18998634	Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1)	Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL	J Am Chem Soc	130	16254-61	2008	-	10 nM	7.2	22	1mM MgCl2	ITC, Densitometric analysis and Dynamic light scattering (DLS) measurements	SMMRNA	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4c(nc3CC)cccc4)C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CCC1)cc2	-	-	0.943899999999999	1133.551427728	17	10	32	350.65	3	0.030721517337579	5.41074778610339	79	GGCCUUCCCACAAGGGAAGGCC	https://pubs.acs.org/doi/10.1021/ja804398y	RNA aptamer	-	22	-	Stem-Loop	0	0	0	0	1.20E-05	2.00E-05	0	0	0	0
1058	Triptycene 1	Target_lig_625	RpoH σ32mRNA factor	Escherichia coli	Bacterial growth and infection	Target_158	0	0	2.50E-06	0	0	0	0	-	-	10.1002/anie.201601626	27240201	Modulation of the E. coli rpoH Temperature Sensor with Triptycene-Based Small Molecules.	Barros SA, Yoon I, Chenoweth DM	Angew Chem Int Ed Engl	55	8258-61	2016	-	120 nM	7.2	-	10 mM sodium phosphate	Fluorescence-based titration (Labeled RNA)	RBIND	[NH3+]CCCC[C@H]([NH3+])C(=O)NC1=CC2=C(C=C1)C1C3=CC=C(NC(=O)[C@@H]([NH3+])CCCC[NH3+])C=C3C2C2=C1C=CC(NC(=O)[C@@H]([NH3+])CCCC[NH3+])=C2	-	-	-1.4426	689.47079526854	3	9	18	253.14	3	0.049221688105192	6.1005684356821	50	AUCGAUUGAGAGGAUUUGAAUGACUGACAAAAUGCAAAGUUUAGCUUUAGCCCCAGUUGGCAACGCAGCUAACGCGUGGCCGAUGUUGUCGGCUGACGAGGAGCGGGCGCUGGCUGAAAAGCUGCAUUACCAUGGCGCACCUGCGGUUUGUUGUUCAUAUUGCUCGUAAUUAUGCGGGCUAUGGC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC93392/	mRNA	mRNA	185	-		0	0	0	0	2.50E-06	2.50E-06	0	0	0	0
1059	Triptycene 2	Target_lig_626	RpoH σ32mRNA factor	Escherichia coli	Bacterial growth and infection	Target_158	0	0	1.50E-06	0	0	0	0	-	-	10.1002/anie.201601626	27240201	Modulation of the E. coli rpoH Temperature Sensor with Triptycene-Based Small Molecules.	Barros SA, Yoon I, Chenoweth DM	Angew Chem Int Ed Engl	55	8258-61	2016	-	120 nM	7.2	-	50 mM sodium phosphate	Fluorescence-based titration (Labeled RNA)	RBIND	NC(=[NH2+])NCCC[C@H]([NH3+])C(=O)NC1=CC2=C(C=C1)C1C3=CC=C(NC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])C=C3C2C2=C1C=CC(NC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])=C2	-	-	-7.34840000000001	773.48923926854	3	15	18	361.14	3	0.02237751759392	6.18512480757182	56	AUCGAUUGAGAGGAUUUGAAUGACUGACAAAAUGCAAAGUUUAGCUUUAGCCCCAGUUGGCAACGCAGCUAACGCGUGGCCGAUGUUGUCGGCUGACGAGGAGCGGGCGCUGGCUGAAAAGCUGCAUUACCAUGGCGCACCUGCGGUUUGUUGUUCAUAUUGCUCGUAAUUAUGCGGGCUAUGGC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC93392/	mRNA	mRNA	185	-		0	0	0	0	1.50E-06	1.50E-06	0	0	0	0
1060	Targaprimir-96	Target_lig_627	Pri-miR-96 RNAC  (UU loop mutant to AU basepair)	Homo sapiens	Cancer,Breast cancer	Target_159	0	0	>4e-06	0	0	0	0	-	-	10.1073/pnas.1523975113	27170187	Design of a small molecule against an oncogenic noncoding RNA.	Velagapudi SP, Cameron MD, Haga CL, Rosenberg LH, Lafitte M, Duckett DR, Phinney DG, Disney MD	Proc Natl Acad Sci U S A	113	5898-903	2016	1-100 nM	-	7	-	8 mM Na2HPO4, 190 mM NaCl, 1 mM EDTA, and 40 µg/mL BSA	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	-	-	6.68820000000001	1392.83244050818	15	7	31	283.69	9	0.022315852067149	5.66294504191733	102	GGGAGAGGGUUUAAUUACGAAAGUAAUUGGAUCCGCAAGG	10.1073/pnas.1523975113	miRNA	pri-miRNA	40	Nuclease processing site	Internal Loop	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
1061	Targaprimir-96	Target_lig_627	Pri-miR-96 RNA1 (Drosha processing site only)	Homo sapiens	Cancer,Breast cancer	Target_160	0	0	1.2e-06±3e-07	0	0	0	0	-	-	10.1073/pnas.1523975113	27170187	Design of a small molecule against an oncogenic noncoding RNA.	Velagapudi SP, Cameron MD, Haga CL, Rosenberg LH, Lafitte M, Duckett DR, Phinney DG, Disney MD	Proc Natl Acad Sci U S A	113	5898-903	2016	1-100 nM	-	7	-	9 mM Na2HPO4, 190 mM NaCl, 1 mM EDTA, and 40 µg/mL BSA	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	-	-	6.68820000000001	1392.83244050818	15	7	31	283.69	9	0.022315852067149	5.66294504191733	102	GGGAGAGGGUUUAUUUACGAAAGUAUAUGGAUCCGCAAGG	10.1073/pnas.1523975113	miRNA	pri-miRNA	40	Drosha site	Internal Loop	0	0	0	0	9.00E-07	1.50E-06	0	0	0	0
1062	Targaprimir-96	Target_lig_627	Pri-miR-96 RNA2 (desired GG loop only)	Homo sapiens	Cancer,Breast cancer	Target_161	0	0	9e-07±2e-07	0	0	0	0	-	-	10.1073/pnas.1523975113	27170187	Design of a small molecule against an oncogenic noncoding RNA.	Velagapudi SP, Cameron MD, Haga CL, Rosenberg LH, Lafitte M, Duckett DR, Phinney DG, Disney MD	Proc Natl Acad Sci U S A	113	5898-903	2016	1-100 nM	-	7	-	10 mM Na2HPO4, 190 mM NaCl, 1 mM EDTA, and 40 µg/mL BSA	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	-	-	6.68820000000001	1392.83244050818	15	7	31	283.69	9	0.022315852067149	5.66294504191733	102	GGGAGAGGGUUUACGAACGAAAGUUGGUGGAUCCGCAAGG	10.1073/pnas.1523975113	miRNA	pri-miRNA	40	GG loop	Internal Loop	0	0	0	0	7.00E-07	1.10E-06	0	0	0	0
1063	Targaprimir-96	Target_lig_627	Pri-miR-96 RNA3 (both the Drosha target site and adjacent target site)	Homo sapiens	Cancer,Breast cancer	Target_162	0	0	1.9999999999999998e-05±7e-06	0	0	0	0	-	-	10.1073/pnas.1523975113	27170187	Design of a small molecule against an oncogenic noncoding RNA.	Velagapudi SP, Cameron MD, Haga CL, Rosenberg LH, Lafitte M, Duckett DR, Phinney DG, Disney MD	Proc Natl Acad Sci U S A	113	5898-903	2016	1-100 nM	-	7	-	11 mM Na2HPO4, 190 mM NaCl, 1 mM EDTA, and 40 µg/mL BSA	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	-	-	6.68820000000001	1392.83244050818	15	7	31	283.69	9	0.022315852067149	5.66294504191733	102	GGGAGAGGGUUUACGAUUUACGAAAGUAUAUGGUGGAUCCGCAAGG	10.1073/pnas.1523975113	miRNA	pri-miRNA	46	Drosha site	Internal Loop	0	0	0	0	1.30E-05	2.70E-05	0	0	0	0
1064	Targaprimir-96	Target_lig_627	Pri-miR-96 RNA4 (GG to GC loop mutation)	Homo sapiens	Cancer,Breast cancer	Target_163	0	0	1.2e-06±3e-07	0	0	0	0	-	-	10.1073/pnas.1523975113	27170187	Design of a small molecule against an oncogenic noncoding RNA.	Velagapudi SP, Cameron MD, Haga CL, Rosenberg LH, Lafitte M, Duckett DR, Phinney DG, Disney MD	Proc Natl Acad Sci U S A	113	5898-903	2016	1-100 nM	-	7	-	12 mM Na2HPO4, 190 mM NaCl, 1 mM EDTA, and 40 µg/mL BSA	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	-	-	6.68820000000001	1392.83244050818	15	7	31	283.69	9	0.022315852067149	5.66294504191733	102	GGGAGAGGGUUUACGAUUUACGAAAGUAUAUCGUGGAUCCGCAAGG	10.1073/pnas.1523975113	miRNA	pri-miRNA	46	Drosha site	Internal Loop	0	0	0	0	9.00E-07	1.50E-06	0	0	0	0
1065	Targaprimir-96	Target_lig_627	Pri-miR-96 RNA5 (UU loop mutant to UA loop)	Homo sapiens	Cancer,Breast cancer	Target_164	0	0	1.5e-06±2e-07	0	0	0	0	-	-	10.1073/pnas.1523975113	27170187	Design of a small molecule against an oncogenic noncoding RNA.	Velagapudi SP, Cameron MD, Haga CL, Rosenberg LH, Lafitte M, Duckett DR, Phinney DG, Disney MD	Proc Natl Acad Sci U S A	113	5898-903	2016	1-100 nM	-	7	-	13 mM Na2HPO4, 190 mM NaCl, 1 mM EDTA, and 40 µg/mL BSA	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	-	-	6.68820000000001	1392.83244050818	15	7	31	283.69	9	0.022315852067149	5.66294504191733	102	GGGAGAGGGUUUACGAUUUACGAAAGUAAAUGGUGGAUCCGCAAGG	10.1073/pnas.1523975113	miRNA	pri-miRNA	46	GG loop	Internal Loop	0	0	0	0	1.30E-06	1.70E-06	0	0	0	0
1066	Targaprimir-96	Target_lig_627	Pri-miR-96 AT-rich DNA hairpin	Homo sapiens	Cancer,Breast cancer	Target_165	0	0	>4.9999999999999996e-05	0	0	0	0	-	-	10.1073/pnas.1523975113	27170187	Design of a small molecule against an oncogenic noncoding RNA.	Velagapudi SP, Cameron MD, Haga CL, Rosenberg LH, Lafitte M, Duckett DR, Phinney DG, Disney MD	Proc Natl Acad Sci U S A	113	5898-903	2016	1-100 nM	-	7	-	14 mM Na2HPO4, 190 mM NaCl, 1 mM EDTA, and 40 µg/mL BSA	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	-	-	6.68820000000001	1392.83244050818	15	7	31	283.69	9	0.022315852067149	5.66294504191733	102	CGCGAATTCGCGTTTTCGCGAATTCGCG	10.1073/pnas.1523975113	miRNA	pri-miRNA	28	UU loop	Internal Loop	0	0	0	0	5.00E-05	5.00E-05	0	0	0	0
1067	2-AU-2	Target_lig_628	r(AUUCU)11	Synthetic	Spinocerebellar ataxia 10 (SCA10)	Target_166	0	0	1.85e-07±1e-09	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	1 uM	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 0.1 mM EDTA (+ 20% PEG 8000 for values in parenthesis)	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=[NH2+])C2=CC=C(C=C2)C2=CC=C(O2)C2=CC=C(C=C2)C(N)=[NH2+])N=N1)C(=O)CNCC1=CN(CCCNC(=[NH2+])C2=CC=C(C=C2)C2=CC=C(O2)C2=CC=C(C=C2)C(N)=[NH2+])N=N1	-	-	-1.89550000000002	1183.62822686436	13	10	32	382.21	8	0.012518273272024	5.00214453753228	87	AUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCU	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	55	Intron	Internal Loop	0	0	0	0	1.84E-07	1.86E-07	0	0	0	0
1068	2-AU-2	Target_lig_628	r(AUUCU)11	Synthetic	Spinocerebellar ataxia 10 (SCA10)	Target_166	0	0	0	0	1.4599999999999998e-07±8e-09	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	1 uM	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 0.1 mM EDTA (+ 20% PEG 8000 for values in parenthesis)	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=[NH2+])C2=CC=C(C=C2)C2=CC=C(O2)C2=CC=C(C=C2)C(N)=[NH2+])N=N1)C(=O)CNCC1=CN(CCCNC(=[NH2+])C2=CC=C(C=C2)C2=CC=C(O2)C2=CC=C(C=C2)C(N)=[NH2+])N=N1	-	-	-1.89550000000002	1183.62822686436	13	10	32	382.21	8	0.012518273272024	5.00214453753228	87	AUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCU	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	55	Intron	Internal Loop	0	0	0	0	0	0	0	0	1.38E-07	1.54E-07
1069	2-AU-2	Target_lig_628	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	4.00E-06	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	1 uM	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 0.1 mM EDTA	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=[NH2+])C2=CC=C(C=C2)C2=CC=C(O2)C2=CC=C(C=C2)C(N)=[NH2+])N=N1)C(=O)CNCC1=CN(CCCNC(=[NH2+])C2=CC=C(C=C2)C2=CC=C(O2)C2=CC=C(C=C2)C(N)=[NH2+])N=N1	-	-	-1.89550000000002	1183.62822686436	13	10	32	382.21	8	0.012518273272024	5.00214453753228	87	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
1070	Bisamidinium 6	Target_lig_629	r(CCUG)8-MBNL1 complex	Synthetic	Myotonic dystrophy 2 (DM2)	Target_168	0	8.7e-06±1.8999999999999998e-06	0	7.340000000000001e-05±6e-06	0	0	0	-	-	10.1002/cmdc.201402095	24938413	Small molecules that target the toxic RNA in myotonic dystrophy type 2.	Nguyen L, Lee J, Wong CH, Zimmerman SC	ChemMedChem	9	2455-62	2014	0.05-200 uM	-	-	-	-	Electrophoretic Mobility Shift Assay	RBIND	NC1=NC(N)=C(CCCNC(=[NH2+])C2=CC=C(C=C2)C(=[NH2+])NCCCC2=C(N)N=C(N)[NH+]=C2N)C(N)=N1	-	-	-4.3649	495.31526638027	9	10	10	284.17	3	0.072751741608839	4.25622772484792	36	GGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCC	10.1002/cmdc.201402095	RNA aptamer, mRNA	Expanded Repeats	36	Intron	Internal Loop	0	0	6.80E-06	1.06E-05	0	0	6.74E-05	7.94E-05	0	0
1071	Bisamidinium 8	Target_lig_630	r(CCUG)8-MBNL1 complex	Synthetic	Myotonic dystrophy 2 (DM2)	Target_168	0	1.5e-06±3e-07	0	1.29e-05±1e-06	0	0	0	-	-	10.1002/cmdc.201402095	24938413	Small molecules that target the toxic RNA in myotonic dystrophy type 2.	Nguyen L, Lee J, Wong CH, Zimmerman SC	ChemMedChem	9	2455-62	2014	0.05-200 uM	-	-	-	-	Electrophoretic Mobility Shift Assay	RBIND	NC1=NC(N)=C(CCCCNC(=[NH2+])C2=CC=C(C=C2)C(=[NH2+])NCCCCC2=C(N)N=C(N)[NH+]=C2N)C(N)=N1	-	-	-3.5847	523.34656650827	9	10	12	284.17	3	0.062835249122593	4.20816862291005	38	GGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCC	10.1002/cmdc.201402095	RNA aptamer, mRNA	Expanded Repeats	36	Intron	Internal Loop	0	0	1.20E-06	1.80E-06	0	0	1.19E-05	1.39E-05	0	0
1072	Bisamidinium 10	Target_lig_631	r(CCUG)8-MBNL1 complex	Synthetic	Myotonic dystrophy 2 (DM2)	Target_168	0	1.6999999999999998e-06±4e-07	0	1.4699999999999998e-05±1.2e-06	0	0	0	-	-	10.1002/cmdc.201402095	24938413	Small molecules that target the toxic RNA in myotonic dystrophy type 2.	Nguyen L, Lee J, Wong CH, Zimmerman SC	ChemMedChem	9	2455-62	2014	0.05-200 uM	-	-	-	-	Electrophoretic Mobility Shift Assay	RBIND	NC1=NC(N)=C(CCCNC(=[NH2+])C2=CC(=CC=C2)C(=[NH2+])NCCCC2=C(N)N=C(N)[NH+]=C2N)C(N)=N1	-	-	-4.3649	495.31526638027	9	10	10	284.17	3	0.072751741608839	4.29602434023253	36	GGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCC	10.1002/cmdc.201402095	RNA aptamer, mRNA	Expanded Repeats	36	Intron	Internal Loop	0	0	1.30E-06	2.10E-06	0	0	1.35E-05	1.59E-05	0	0
1073	Bisamidinium 11	Target_lig_632	r(CCUG)8-MBNL1 complex	Synthetic	Myotonic dystrophy 2 (DM2)	Target_168	0	2.8999999999999998e-06±6e-07	0	2.49e-05±2e-06	0	0	0	-	-	10.1002/cmdc.201402095	24938413	Small molecules that target the toxic RNA in myotonic dystrophy type 2.	Nguyen L, Lee J, Wong CH, Zimmerman SC	ChemMedChem	9	2455-62	2014	0.05-200 uM	-	-	-	-	Electrophoretic Mobility Shift Assay	RBIND	NC1=NC(N)=C(CCCCNC(=[NH2+])C2=CC=CC(=C2)C(=[NH2+])NCCCCC2=C(N)N=C(N)[NH+]=C2N)C(N)=N1	-	-	-3.5847	523.34656650827	9	10	12	284.17	3	0.062835249122593	4.24571259968799	38	GGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCC	10.1002/cmdc.201402095	RNA aptamer, mRNA	Expanded Repeats	36	Intron	Internal Loop	0	0	2.30E-06	3.50E-06	0	0	2.29E-05	2.69E-05	0	0
1074	2H-3	Target_lig_633	r(CGG)12-DGCR8Δ complex	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	1.8e-05±7e-07	0	0	0	-	-	10.1021/cb400875u	24506227	Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.	Tran T, Childs-Disney JL, Liu B, Guan L, Rzuczek S, Disney MD	ACS Chem Biol	9	904-12	2014	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	4.7627	1690.92511206818	22	10	44	404.52	12	0.023002023844326	6.32200142872334	124	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	1.73E-05	1.87E-05	0	0
1075	2H-3	Target_lig_633	r(CGG)12-DGCR8Δ complex; 65-fold excess tRNA	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	2.9999999999999997e-05±7e-07	0	0	0	-	-	10.1021/cb400875u	24506227	Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.	Tran T, Childs-Disney JL, Liu B, Guan L, Rzuczek S, Disney MD	ACS Chem Biol	9	904-12	2014	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	4.7627	1690.92511206818	22	10	44	404.52	12	0.023002023844326	6.32200142872334	124	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	2.93E-05	3.07E-05	0	0
1076	2H-4	Target_lig_634	r(CUG)109	Synthetic	Myotonic dystrophy 1 (DM1)	Target_170	0	0	1.00E-07	0	0	0	0	-	-	10.1021/cb200408a	22332923	Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive	Childs-Disney JL, Hoskins J, Rzuczek SG, Thornton CA, Disney MD	ACS Chem Biol	7	856-62	2012	1 uM	-	7	-	8 mM sodium phosphate, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	5.00129999999999	1789.99352597618	23	10	48	424.83	12	0.022421701174059	6.55404280770321	131			RNA aptamer, mRNA	Expanded Repeats	0	3'-UTR	Internal Loop	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
1077	2H-4	Target_lig_634	r(CUG)exp-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_171	0	0	0	1.10E-05	0	0	0	-	-	10.1021/cb200408a	22332923	Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive	Childs-Disney JL, Hoskins J, Rzuczek SG, Thornton CA, Disney MD	ACS Chem Biol	7	856-62	2012	1 uM	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	5.00129999999999	1789.99352597618	23	10	48	424.83	12	0.022421701174059	6.55404280770321	131			RNA aptamer, mRNA	Expanded Repeats	0	3'-UTR	Internal Loop	0	0	0	0	0	0	1.10E-05	1.10E-05	0	0
1078	2H-4	Target_lig_634	r(CGG)12-DGCR8Δ complex	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	1.9999999999999998e-05±2e-07	0	0	0	-	-	10.1021/cb400875u	24506227	Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.	Tran T, Childs-Disney JL, Liu B, Guan L, Rzuczek S, Disney MD	ACS Chem Biol	9	904-12	2014	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	5.00129999999999	1789.99352597618	23	10	48	424.83	12	0.022421701174059	6.55404280770321	131	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	1.98E-05	2.02E-05	0	0
1079	2H-4	Target_lig_634	r(CGG)12	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	2.12e-07±3.5e-08	0	0	0	0	-	-	10.1021/cb400875u	24506227	Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.	Tran T, Childs-Disney JL, Liu B, Guan L, Rzuczek S, Disney MD	ACS Chem Biol	9	904-12	2014	1 uM	-	7	-	8 mM sodium phosphate, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	5.00129999999999	1789.99352597618	23	10	48	424.83	12	0.022421701174059	6.55404280770321	131	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	1.77E-07	2.47E-07	0	0	0	0
1080	2H-4	Target_lig_634	r(CGG)12-DGCR8Δ complex; 65-fold excess tRNA	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	2.8e-05±1e-06	0	0	0	-	-	10.1021/cb400875u	24506227	Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.	Tran T, Childs-Disney JL, Liu B, Guan L, Rzuczek S, Disney MD	ACS Chem Biol	9	904-12	2014	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	5.00129999999999	1789.99352597618	23	10	48	424.83	12	0.022421701174059	6.55404280770321	131	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	2.70E-05	2.90E-05	0	0
1081	2H-5	Target_lig_635	r(CGG)12-DGCR8Δ complex	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	1.8e-05±8e-07	0	0	0	-	-	10.1021/cb400875u	24506227	Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.	Tran T, Childs-Disney JL, Liu B, Guan L, Rzuczek S, Disney MD	ACS Chem Biol	9	904-12	2014	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	5.23989999999999	1889.06193988418	24	10	52	445.14	12	0.021784552721255	6.79239746043313	138	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	1.72E-05	1.88E-05	0	0
1082	2H-5	Target_lig_635	r(CGG)12-DGCR8Δ complex; 65-fold excess tRNA	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	2.3e-05±3e-06	0	0	0	-	-	10.1021/cb400875u	24506227	Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.	Tran T, Childs-Disney JL, Liu B, Guan L, Rzuczek S, Disney MD	ACS Chem Biol	9	904-12	2014	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	5.23989999999999	1889.06193988418	24	10	52	445.14	12	0.021784552721255	6.79239746043313	138	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	2.00E-05	2.60E-05	0	0
1083	2H-5	Target_lig_635	r(CGG)12	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	2.8e-07±7.599999999999999e-08	0	0	0	0	-	-	10.1021/cb400875u	24506227	Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.	Tran T, Childs-Disney JL, Liu B, Guan L, Rzuczek S, Disney MD	ACS Chem Biol	9	904-12	2014	1 uM	-	7	-	8 mM sodium phosphate, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Intrinsic)	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	5.23989999999999	1889.06193988418	24	10	52	445.14	12	0.021784552721255	6.79239746043313	138	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	2.04E-07	3.56E-07	0	0	0	0
1084	2H-6	Target_lig_636	r(CGG)12-DGCR8Δ complex	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	2.3e-05±1e-06	0	0	0	-	-	10.1021/cb400875u	24506227	Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.	Tran T, Childs-Disney JL, Liu B, Guan L, Rzuczek S, Disney MD	ACS Chem Biol	9	904-12	2014	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	5.47849999999998	1988.13035379218	25	10	56	465.45	12	0.021095249483148	7.03650637425704	145	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	2.20E-05	2.40E-05	0	0
1085	2H-6	Target_lig_636	r(CGG)12-DGCR8Δ complex; 65-fold excess tRNA	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	2.4e-05±2e-06	0	0	0	-	-	10.1021/cb400875u	24506227	Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.	Tran T, Childs-Disney JL, Liu B, Guan L, Rzuczek S, Disney MD	ACS Chem Biol	9	904-12	2014	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN(CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1)C(=O)CNCC1=CN(CCCNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)N=N1	-	-	5.47849999999998	1988.13035379218	25	10	56	465.45	12	0.021095249483148	7.03650637425704	145	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	2.20E-05	2.60E-05	0	0
1086	2HE-5NMe	Target_lig_637	r(CGG)12-DGCR8Δ complex	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	4.7199999999999994e-07±8e-08	0	0	0	-	-	10.1021/acschembio.6b00147	27276216	Small Molecule Recognition and Tools to Study Modulation of r(CGG)(exp) in Fragile X-Associated Tremor Ataxia Syndrome.	Yang WY, He F, Strack RL, Oh SY, Frazer M, Jaffrey SR, Todd PK, Disney MD	ACS Chem Biol	11	2456-65	2016	1 uM	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	C[C@H](N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)C[NH2+]CCCN1C=C(C[N+]2=CC3=C(C)C4=C(NC5=C4C=C(O)C=C5)C(C)=C3C=C2)N=N1)C(=O)N(CCCN1C=C(C[N+]2=CC3=C(C)C4=C(NC5=C4C=C(O)C=C5)C(C)=C3C=C2)N=N1)CC(N)=O	-	-	3.35368000000001	1325.70434568827	15	6	26	322.78	10	0.033522764978707	6.81045637050968	97	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	3.92E-07	5.52E-07	0	0
1087	2HE-5NMe	Target_lig_637	r(CGG)12-DGCR8Δ complex; 65-fold excess tRNA	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	3.5e-06±6e-07	0	0	0	-	-	10.1021/acschembio.6b00147	27276216	Small Molecule Recognition and Tools to Study Modulation of r(CGG)(exp) in Fragile X-Associated Tremor Ataxia Syndrome.	Yang WY, He F, Strack RL, Oh SY, Frazer M, Jaffrey SR, Todd PK, Disney MD	ACS Chem Biol	11	2456-65	2016	1 uM	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	C[C@H](N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)C[NH2+]CCCN1C=C(C[N+]2=CC3=C(C)C4=C(NC5=C4C=C(O)C=C5)C(C)=C3C=C2)N=N1)C(=O)N(CCCN1C=C(C[N+]2=CC3=C(C)C4=C(NC5=C4C=C(O)C=C5)C(C)=C3C=C2)N=N1)CC(N)=O	-	-	3.35368000000001	1325.70434568827	15	6	26	322.78	10	0.033522764978707	6.81045637050968	97	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	2.90E-06	4.10E-06	0	0
1088	2HE-5NMe	Target_lig_637	r(CGG)12	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	5e-08±5.999999999999999e-10	0	0	0	0	-	-	10.1021/acschembio.6b00147	27276216	Small Molecule Recognition and Tools to Study Modulation of r(CGG)(exp) in Fragile X-Associated Tremor Ataxia Syndrome.	Yang WY, He F, Strack RL, Oh SY, Frazer M, Jaffrey SR, Todd PK, Disney MD	ACS Chem Biol	11	2456-65	2016	-	60 nM	-	-	1 X Kinetics Buffer (ForteBio)	Biolayer Interferometry	RBIND	C[C@H](N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)C[NH2+]CCCN1C=C(C[N+]2=CC3=C(C)C4=C(NC5=C4C=C(O)C=C5)C(C)=C3C=C2)N=N1)C(=O)N(CCCN1C=C(C[N+]2=CC3=C(C)C4=C(NC5=C4C=C(O)C=C5)C(C)=C3C=C2)N=N1)CC(N)=O	-	-	3.35368000000001	1325.70434568827	15	6	26	322.78	10	0.033522764978707	6.81045637050968	97	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	4.94E-08	5.06E-08	0	0	0	0
1089	2HE-5NMe	Target_lig_637	r(CGG)12	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	6.5e-08±1.4e-08	0	0	0	0	-	-	10.1021/acschembio.6b00147	27276216	Small Molecule Recognition and Tools to Study Modulation of r(CGG)(exp) in Fragile X-Associated Tremor Ataxia Syndrome.	Yang WY, He F, Strack RL, Oh SY, Frazer M, Jaffrey SR, Todd PK, Disney MD	ACS Chem Biol	11	2456-65	2016	-	60 nM	-	-	1 X Kinetics Buffer (ForteBio)	Biolayer Interferometry	RBIND	C[C@H](N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)C[NH2+]CCCN1C=C(C[N+]2=CC3=C(C)C4=C(NC5=C4C=C(O)C=C5)C(C)=C3C=C2)N=N1)C(=O)N(CCCN1C=C(C[N+]2=CC3=C(C)C4=C(NC5=C4C=C(O)C=C5)C(C)=C3C=C2)N=N1)CC(N)=O	-	-	3.35368000000001	1325.70434568827	15	6	26	322.78	10	0.033522764978707	6.81045637050968	97	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	5.10E-08	7.90E-08	0	0	0	0
1090	2H-3G	Target_lig_638	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	3.00E-06	0	0	0	-	-	10.1021/cb400265y	24032410	Features of modularly assembled compounds that impart bioactivity against an RNA target	Rzuczek SG, Gao Y, Tang Z, Thornton CA, Kodadek T, Disney MD	ACS Chem Biol	8	2312-21	2013	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	C[NH+]1CCN(CC1)C1=CC=C2NC(=NC2=C1)C1=CC=C2NC(=NC2=C1)C1=CC(OCCCC(=O)NCCNC(=O)CNC(=O)CNC(=O)CNC(=O)CCCOC2=CC=CC(=C2)C2=NC3=CC(=CC=C3N2)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)=CC=C1	-	-	3.12840000000001	1217.60244058018	13	11	25	294.04	10	0.036754952212101	4.87798495977636	90	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	3.00E-06	3.00E-06	0	0
1091	2H-3NMe	Target_lig_639	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	3.00E-05	0	0	0	-	-	10.1021/cb400265y	24032410	Features of modularly assembled compounds that impart bioactivity against an RNA target	Rzuczek SG, Gao Y, Tang Z, Thornton CA, Kodadek T, Disney MD	ACS Chem Biol	8	2312-21	2013	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	C[C@@H](N(C)C(=O)[C@@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)C(=O)NCCNC(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	-	-	5.32050000000001	1301.69634096418	13	8	25	267.67	10	0.033745048221434	6.15119094552498	96	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	3.00E-05	3.00E-05	0	0
1092	2H-3NPr	Target_lig_640	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	1.50E-05	0	0	0	-	-	10.1021/cb400265y	24032410	Features of modularly assembled compounds that impart bioactivity against an RNA target	Rzuczek SG, Gao Y, Tang Z, Thornton CA, Kodadek T, Disney MD	ACS Chem Biol	8	2312-21	2013	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN([C@H](C)C(=O)N(CCC)[C@H](C)C(=O)N(CCC)[C@H](C)C(=O)NCCNC(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	-	-	7.66110000000002	1385.79024134818	13	8	31	267.67	10	0.019429437823529	6.37388303995492	102	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	1.50E-05	1.50E-05	0	0
1093	2H-K4	Target_lig_641	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	3.00E-05	0	0	0	-	-	10.1021/cb400265y	24032410	Features of modularly assembled compounds that impart bioactivity against an RNA target	Rzuczek SG, Gao Y, Tang Z, Thornton CA, Kodadek T, Disney MD	ACS Chem Biol	8	2312-21	2013	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN(CC(=O)N[C@H](CCCCNC(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)C(N)=O)C(=O)CN(CCC)C(=O)CN(CCC)C(=O)CN(CCC)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	-	-	6.75840000000002	1527.86446890818	15	9	39	331.07	10	0.017980097196537	6.19750294998201	112	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	3.00E-05	3.00E-05	0	0
1094	2H-K4NH	Target_lig_642	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	3.50E-05	0	0	0	-	-	10.1021/cb400265y	24032410	Features of modularly assembled compounds that impart bioactivity against an RNA target	Rzuczek SG, Gao Y, Tang Z, Thornton CA, Kodadek T, Disney MD	ACS Chem Biol	8	2312-21	2013	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	C[C@@H](NC(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)N[C@H](CCCCNC(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)C(N)=O	-	-	3.82280000000001	1415.73926839618	15	13	31	366.23	10	0.027480215035854	6.50147480386487	104	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	3.50E-05	3.50E-05	0	0
1095	2H-K4NMe	Target_lig_643	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	2.00E-05	0	0	0	-	-	10.1021/cb400265y	24032410	Features of modularly assembled compounds that impart bioactivity against an RNA target	Rzuczek SG, Gao Y, Tang Z, Thornton CA, Kodadek T, Disney MD	ACS Chem Biol	8	2312-21	2013	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	C[C@@H](N(C)C(=O)[C@@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)C(=O)N[C@H](CCCCNC(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)C(N)=O	-	-	5.19160000000001	1471.80186865218	15	9	31	331.07	10	0.025255549859365	6.85181891386455	108	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	2.00E-05	2.00E-05	0	0
1096	2H-K4NMeS	Target_lig_644	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	1.00E-06	0	0	0	-	-	10.1038/nchembio.2251	27941760	Precise small-molecule recognition of a toxic CUG RNA repeat expansion.	Rzuczek SG, Colgan LA, Nakai Y, Cameron MD, Furling D, Yasuda R, Disney MD	Nat Chem Biol	13	188-193	2017	-	80 nM	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	C[C@H](N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)C(=O)N(CCCCN(C)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)CC(N)=O	-	-	5.48750000000002	1485.81751871618	15	7	31	313.49	10	0.026446014977577	6.7733078092859	109	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	1.00E-06	1.00E-06	0	0
1097	2H-K4NMeS	Target_lig_644	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	1.3199999999999999e-08±1e-09	0	0	0	0	-	-	10.1038/nchembio.2251	27941760	Precise small-molecule recognition of a toxic CUG RNA repeat expansion.	Rzuczek SG, Colgan LA, Nakai Y, Cameron MD, Furling D, Yasuda R, Disney MD	Nat Chem Biol	13	188-193	2017	4 uM	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Intrinsic)	RBIND	C[C@H](N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)C(=O)N(CCCCN(C)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)CC(N)=O	-	-	5.48750000000002	1485.81751871618	15	7	31	313.49	10	0.026446014977577	6.7733078092859	109	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	1.22E-08	1.42E-08	0	0	0	0
1098	2H-K4NMeS	Target_lig_644	r(CUG)109	Synthetic	Myotonic dystrophy 1 (DM1)	Target_170	0	0	1.2399999999999999e-08±1.4e-09	0	0	0	0	-	-	10.1038/nchembio.2251	27941760	Precise small-molecule recognition of a toxic CUG RNA repeat expansion.	Rzuczek SG, Colgan LA, Nakai Y, Cameron MD, Furling D, Yasuda R, Disney MD	Nat Chem Biol	13	188-193	2017	4 uM	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Intrinsic)	RBIND	C[C@H](N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)C(=O)N(CCCCN(C)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)CC(N)=O	-	-	5.48750000000002	1485.81751871618	15	7	31	313.49	10	0.026446014977577	6.7733078092859	109			RNA aptamer, mRNA	Expanded Repeats	0	3'-UTR	Internal Loop	0	0	0	0	1.10E-08	1.38E-08	0	0	0	0
1099	2H-K4NPr	Target_lig_645	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	3.00E-05	0	0	0	-	-	10.1021/cb400265y	24032410	Features of modularly assembled compounds that impart bioactivity against an RNA target	Rzuczek SG, Gao Y, Tang Z, Thornton CA, Kodadek T, Disney MD	ACS Chem Biol	8	2312-21	2013	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CCCN([C@H](C)C(=O)N(CCC)[C@H](C)C(=O)N(CCC)[C@H](C)C(=O)N(CCC)[C@H](C)C(=O)N[C@H](CCCCNC(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1)C(N)=O)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	-	-	8.31240000000002	1583.92706916418	15	9	39	331.07	10	0.016357960691876	7.15388329429472	116	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	3.00E-05	3.00E-05	0	0
1100	Acridine 1	Target_lig_646	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	1.4999999999999999e-05±2e-06	0	0	0	-	-	10.1021/cb400265y	24032410	Features of modularly assembled compounds that impart bioactivity against an RNA target	Rzuczek SG, Gao Y, Tang Z, Thornton CA, Kodadek T, Disney MD	ACS Chem Biol	8	2312-21	2013	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CC(=O)NCCC[NH2+]CCC[NH2+]CCCNC(=O)C1=C2[NH+]=C3C=CC=CC3=C(NCCCCNC3=NC(N)=NC(N)=[NH+]3)C2=CC=C1	-	-	-0.957199999999998	634.41577452036	8	8	20	221.58	4	0.044579370682068	4.84955861983887	46	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	1.30E-05	1.70E-05	0	0
1101	Acridine 5	Target_lig_647	r(CUG)4	Synthetic	Myotonic dystrophy 1 (DM1)	Target_172	0	0	8.60E-08	0	0	0	0	-	-	10.1021/jacs.5b09266	26473464	Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.	Nguyen L, Luu LM, Peng S, Serrano JF, Chan HY, Zimmerman SC	J Am Chem Soc	137	14180-9	2015	-	0-6 uM	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	NC1=NC(N)=[NH+]C(NCCCCNC2=C3C=CC=CC3=[NH+]C3=C(C=CC=C23)C(=O)NCCN(CC[NH3+])CC[NH3+])=N1	-	-	-1.6046	550.35825964436	8	7	15	217.78	4	0.067299552989458	4.58940668323818	40	CUGCUGCUGCUG	10.1021/cb400265y	RNA aptamer, mRNA	Expanded Repeats	12	3'-UTR	Internal Loop	0	0	0	0	8.60E-08	8.60E-08	0	0	0	0
1102	Acridine 9	Target_lig_648	r(CUG)6	Synthetic	Myotonic dystrophy 1 (DM1)	Target_173	0	0	3.2e-07±2e-08	0	0	0	0	-	-	10.1021/jm400794z	24188018	Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.	Jahromi AH, Fu Y, Miller KA, Nguyen L, Luu LM, Baranger AM, Zimmerman SC	J Med Chem	56	9471-9481	2013	-	-	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	NC1=NC(NCCCCNC2=C3C=CC=C(C(=O)NCCC[NH2+]CCC[NH2+]CCCNC(=O)C4=C5[NH+]=C6C=CC=CC6=C(NCCCCNC6=NC(N)=[NH+]C(N)=N6)C5=CC=C4)C3=[NH+]C3=CC=CC=C23)=[NH+]C(N)=N1	-	-	0.529899999999997	994.59577000054	14	12	28	351.74	8	0.023544687645011	5.61410642361615	73	CUGCUGCUGCUGCUGCUG	10.1021/cb400265y	RNA aptamer, mRNA	Expanded Repeats	18	3'-UTR	Internal Loop	0	0	0	0	3.00E-07	3.40E-07	0	0	0	0
1103	Acridine 9	Target_lig_648	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	1.1e-06±1e-07	0	0	0	-	-	10.1021/jm400794z	24188018	Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.	Jahromi AH, Fu Y, Miller KA, Nguyen L, Luu LM, Baranger AM, Zimmerman SC	J Med Chem	56	9471-9481	2013	-	-	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	NC1=NC(NCCCCNC2=C3C=CC=C(C(=O)NCCC[NH2+]CCC[NH2+]CCCNC(=O)C4=C5[NH+]=C6C=CC=CC6=C(NCCCCNC6=NC(N)=[NH+]C(N)=N6)C5=CC=C4)C3=[NH+]C3=CC=CC=C23)=[NH+]C(N)=N1	-	-	0.529899999999997	994.59577000054	14	12	28	351.74	8	0.023544687645011	5.61410642361615	73	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	1.00E-06	1.20E-06	0	0
1104	Bisamidinium 2	Target_lig_649	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	8e-06±2e-06	0.00011499999999999999±1.4e-05	0	0	0	-	-	10.1021/ja5012146	24702247	Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.	Wong CH, Nguyen L, Peh J, Luu LM, Sanchez JS, Richardson SL, Tuccinardi T, Tsoi H, Chan WY, Chan HY, Baranger AM, Hergenrother PJ, Zimmerman SC	J Am Chem Soc	136	6355-61	2014	<2.4 mM	0.22 mM	8	-	20 mM Tris-Hcl, 175 mM NaCl, 5 mM MgCl2, 1.25 mM 2-mercapto-ethanol (BME), 12.5% glycerol, 2mg/mL bovine serum albumin (BSA), 0.1 mg/mL heparin, and 0.05% Triton X	Electrophoretic Mobility Shift Assay	RBIND	NC1=NC(N)=[NH+]C(NCCCCNC(=[NH2+])C2=CC=C(C=C2)C(=[NH2+])NCCCCNC2=[NH+]C(N)=NC(N)=N2)=N1	-	-	-4.8012	526.34434089636	10	10	14	283.22	3	0.053761156855857	4.68029897531712	38	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	6.00E-06	1.00E-05	0.000101	0.000129	0	0
1105	Bisamidinium 2	Target_lig_649	r(CUG)12-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	1.4e-05±2e-06	0	0	0	0	-	-	10.1021/ja5012146	24702247	Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.	Wong CH, Nguyen L, Peh J, Luu LM, Sanchez JS, Richardson SL, Tuccinardi T, Tsoi H, Chan WY, Chan HY, Baranger AM, Hergenrother PJ, Zimmerman SC	J Am Chem Soc	136	6355-61	2014	<2.4 mM	0.22 mM	8	-	20 mM Tris-Hcl, 175 mM NaCl, 5 mM MgCl2, 1.25 mM 2-mercapto-ethanol (BME), 12.5% glycerol, 2mg/mL bovine serum albumin (BSA), 0.1 mg/mL heparin, and 0.1% Triton X	Electrophoretic Mobility Shift Assay	RBIND	NC1=NC(N)=[NH+]C(NCCCCNC(=[NH2+])C2=CC=C(C=C2)C(=[NH2+])NCCCCNC2=[NH+]C(N)=NC(N)=N2)=N1	-	-	-4.8012	526.34434089636	10	10	14	283.22	3	0.053761156855857	4.68029897531712	38	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	1.20E-05	1.60E-05	0	0	0	0
1106	Bisamidinium 2	Target_lig_649	tRNA	Saccharomyces cereviseae	-	Target_1	0	0	>0.00019999999999999998	0	0	0	0	-	-	10.1021/ja5012146	24702247	Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.	Wong CH, Nguyen L, Peh J, Luu LM, Sanchez JS, Richardson SL, Tuccinardi T, Tsoi H, Chan WY, Chan HY, Baranger AM, Hergenrother PJ, Zimmerman SC	J Am Chem Soc	136	6355-61	2014	500 uM	10 uM	7	-	21 mM MOPS and 300 mM NaCl	Isothermal Titration Calorimetry	RBIND	NC1=NC(N)=[NH+]C(NCCCCNC(=[NH2+])C2=CC=C(C=C2)C(=[NH2+])NCCCCNC2=[NH+]C(N)=NC(N)=N2)=N1	-	-	-4.8012	526.34434089636	10	10	14	283.22	3	0.053761156855857	4.68029897531712	38	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	0.0002	0.0002	0	0	0	0
1107	Bisamidinium 2	Target_lig_649	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	>0.00019999999999999998	0	0	0	0	-	-	10.1021/ja5012146	24702247	Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.	Wong CH, Nguyen L, Peh J, Luu LM, Sanchez JS, Richardson SL, Tuccinardi T, Tsoi H, Chan WY, Chan HY, Baranger AM, Hergenrother PJ, Zimmerman SC	J Am Chem Soc	136	6355-61	2014	500 uM	20 uM	7	-	21 mM MOPS and 300 mM NaCl	Isothermal Titration Calorimetry	RBIND	NC1=NC(N)=[NH+]C(NCCCCNC(=[NH2+])C2=CC=C(C=C2)C(=[NH2+])NCCCCNC2=[NH+]C(N)=NC(N)=N2)=N1	-	-	-4.8012	526.34434089636	10	10	14	283.22	3	0.053761156855857	4.68029897531712	38	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	0.0002	0.0002	0	0	0	0
1108	Bisamidinium 2	Target_lig_649	r(CCUG)8]	Synthetic	Myotonic dystrophy 2 (DM2)	Target_174	0	0	>0.00019999999999999998	0	0	0	0	-	-	10.1021/ja5012146	24702247	Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.	Wong CH, Nguyen L, Peh J, Luu LM, Sanchez JS, Richardson SL, Tuccinardi T, Tsoi H, Chan WY, Chan HY, Baranger AM, Hergenrother PJ, Zimmerman SC	J Am Chem Soc	136	6355-61	2014	500 uM	20 uM	7	-	21 mM MOPS and 300 mM NaCl	Isothermal Titration Calorimetry	RBIND	NC1=NC(N)=[NH+]C(NCCCCNC(=[NH2+])C2=CC=C(C=C2)C(=[NH2+])NCCCCNC2=[NH+]C(N)=NC(N)=N2)=N1	-	-	-4.8012	526.34434089636	10	10	14	283.22	3	0.053761156855857	4.68029897531712	38	CCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUG	SMMRNA database’	RNA aptamer, mRNA	Expanded Repeats	32	Intron	Internal Loop	0	0	0	0	0.0002	0.0002	0	0	0	0
1109	Bisamidinium 2	Target_lig_649	r(CUG)4	Synthetic	Myotonic dystrophy 1 (DM1)	Target_172	0	0	8.60E-08	0	0	0	0	-	-	10.1021/jacs.5b09266	26473464	Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.	Nguyen L, Luu LM, Peng S, Serrano JF, Chan HY, Zimmerman SC	J Am Chem Soc	137	14180-9	2015	-	0-6 uM	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	NC1=NC(N)=[NH+]C(NCCCCNC(=[NH2+])C2=CC=C(C=C2)C(=[NH2+])NCCCCNC2=[NH+]C(N)=NC(N)=N2)=N1	-	-	-4.8012	526.34434089636	10	10	14	283.22	3	0.053761156855857	4.68029897531712	38	CUGCUGCUGCUG	10.1021/cb400265y	RNA aptamer, mRNA	Expanded Repeats	12	3'-UTR	Internal Loop	0	0	0	0	8.60E-08	8.60E-08	0	0	0	0
1110	Bisamidinium 2a	Target_lig_650	r(CUG16)-MBNL1 complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_175	0	0	2.5e-08±8e-09	2.9e-07±2e-08	0	0	0	-	-	10.1002/cmdc.201600081	27245480	A Potent Inhibitor of Protein Sequestration by Expanded Triplet (CUG) Repeats that Shows Phenotypic Improvements in a Drosophila Model of Myotonic Dystrophy.	Luu LM, Nguyen L, Peng S, Lee J, Lee HY, Wong CH, Hergenrother PJ, Chan HY, Zimmerman SC	ChemMedChem	11	1428-35	2016	0.012 - 5 uM	0.22 nM	8	-	20 mM Tris-Hcl, 175 mM NaCl, 5 mM MgCl2, 1.25 mM 2-mercapto-ethanol (BME), 12.5% glycerol, 2mg/mL bovine serum albumin (BSA), 0.1 mg/mL heparin, and 0.05% or 0.1% Triton X	Electrophoretic Mobility Shift Assay	RBIND	NC1=NC(N)=[NH+]C(NCCCCNC(=[NH2+])C2=CC=C(C=C2)C(=[NH2+])NCCCCNC2=NC(NCC3=CN(CCCNC4=[NH+]C(N)=[NH+]C(NCCCCNC(=[NH2+])C5=CC=C(C=C5)C(=[NH2+])NCCCCNC5=NC(N)=[NH+]C(N)=N5)=N4)N=N3)=NC(N)=[NH+]2)=N1	-	-	-9.32849999999995	1174.75995546881	22	20	36	570.42	7	0.009850358940276	6.13285562541508	85	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1021/jacs.5b09266	RNA aptamer, mRNA	Expanded Repeats	48	3'-UTR	Internal Loop	0	0	0	0	1.70E-08	3.30E-08	2.70E-07	3.10E-07	0	0
1111	Bisamidinium 9	Target_lig_651	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	6e-06±4e-06	0	0	0	0	-	-	10.1021/jacs.5b09266	26473464	Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.	Nguyen L, Luu LM, Peng S, Serrano JF, Chan HY, Zimmerman SC	J Am Chem Soc	137	14180-9	2015	500 uM	10 uM	7	-	20 mM MOPS and 300 mM NaCl	Isothermal Titration Calorimetry	RBIND	NC1=NC(NCCN(CC[NH3+])CC[NH3+])=NC(NCCCCNC(=[NH2+])C2=CC=C(C=C2)C(=[NH2+])NCCCCNC2=NC(NCCN(CC[NH3+])CC[NH3+])=NC(N)=[NH+]2)=[NH+]1	-	-	-9.57019999999998	788.62664166472	12	14	30	372.28	3	0.016953153927605	5.58908982098988	56	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	2.00E-06	1.00E-05	0	0	0	0
1112	Bisamidinium 9	Target_lig_651	d(CTG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_176	0	0	4.9999999999999996e-06±1e-06	0	0	0	0	-	-	10.1021/jacs.5b09266	26473464	Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.	Nguyen L, Luu LM, Peng S, Serrano JF, Chan HY, Zimmerman SC	J Am Chem Soc	137	14180-9	2015	500 uM	10 uM	7	-	20 mM MOPS and 300 mM NaCl	Isothermal Titration Calorimetry	RBIND	NC1=NC(NCCN(CC[NH3+])CC[NH3+])=NC(NCCCCNC(=[NH2+])C2=CC=C(C=C2)C(=[NH2+])NCCCCNC2=NC(NCCN(CC[NH3+])CC[NH3+])=NC(N)=[NH+]2)=[NH+]1	-	-	-9.57019999999998	788.62664166472	12	14	30	372.28	3	0.016953153927605	5.58908982098988	56	CTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG	10.1021/jacs.5b09266	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	4.00E-06	6.00E-06	0	0	0	0
1113	DCC 4 (2012)	Target_lig_652	r(CUG)2	Synthetic	Myotonic dystrophy 1 (DM1)	Target_177	0	0	3.20E-08	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90	CCCGCUGCUGCGG	10.1093/nar/gks298	RNA aptamer, mRNA	Expanded Repeats	13	3'-UTR	Internal Loop	0	0	0	0	3.20E-08	3.20E-08	0	0	0	0
1114	DCC 4 (2012)	Target_lig_652	r(CUG)4	Synthetic	Myotonic dystrophy 1 (DM1)	Target_172	0	0	2.25E-08	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90	CUGCUGCUGCUG	10.1021/cb400265y	RNA aptamer, mRNA	Expanded Repeats	12	3'-UTR	Internal Loop	0	0	0	0	2.25E-08	2.25E-08	0	0	0	0
1115	DCC 4 (2012)	Target_lig_652	r(CUG)10	Synthetic	Myotonic dystrophy 1 (DM1)	Target_170	0	0	3.80E-08	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90			RNA aptamer, mRNA	Expanded Repeats	0	3'-UTR	Internal Loop	0	0	0	0	3.80E-08	3.80E-08	0	0	0	0
1116	DCC 4 (2012)	Target_lig_652	r(CCUG)10	Synthetic	Myotonic dystrophy 2 (DM2)	Target_179	0	0	3.90E-08	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90	CCCGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCGG	10.1093/nar/gks298	RNA aptamer, mRNA	Expanded Repeats	47	Intron	Internal Loop	0	0	0	0	3.90E-08	3.90E-08	0	0	0	0
1117	DCC 4 (2012)	Target_lig_652	r(CAG)10	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_180	0	0	4.90E-08	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90	CCCGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCGG	10.1093/nar/gks298	RNA aptamer, mRNA	Expanded Repeats	37	Exon 1	Internal Loop	0	0	0	0	4.90E-08	4.90E-08	0	0	0	0
1118	DCC 4 (2012)	Target_lig_652	RNA duplex	Synthetic	-	Target_2	0	0	6.70E-08	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	0	0	0	0	6.70E-08	6.70E-08	0	0	0	0
1119	DCC 4 (2012)	Target_lig_652	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	1.24E-06	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	1.24E-06	1.24E-06	0	0	0	0
1120	DCC 4 (2012)	Target_lig_652	r(CUG)10	Synthetic	Myotonic dystrophy 1 (DM1)	Target_170	0	0	6.6e-08±2e-09	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	1 uM	10 uM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90			RNA aptamer, mRNA	Expanded Repeats	0	3'-UTR	Internal Loop	0	0	0	0	6.40E-08	6.80E-08	0	0	0	0
1121	DCC 11 (2012)	Target_lig_653	r(CUG)2	Synthetic	Myotonic dystrophy 1 (DM1)	Target_177	0	0	6.68E-07	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC\C=C\CCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	3.2804	1290.79831190436	10	10	36	351.56	6	0.015547901693326	6.32281794111228	94	CCCGCUGCUGCGG	10.1093/nar/gks298	RNA aptamer, mRNA	Expanded Repeats	13	3'-UTR	Internal Loop	0	0	0	0	6.68E-07	6.68E-07	0	0	0	0
1122	DCC 11 (2012)	Target_lig_653	r(CUG)4	Synthetic	Myotonic dystrophy 1 (DM1)	Target_172	0	0	6.00E-08	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC\C=C\CCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	3.2804	1290.79831190436	10	10	36	351.56	6	0.015547901693326	6.32281794111228	94	CUGCUGCUGCUG	10.1021/cb400265y	RNA aptamer, mRNA	Expanded Repeats	12	3'-UTR	Internal Loop	0	0	0	0	6.00E-08	6.00E-08	0	0	0	0
1123	DCC 11 (2012)	Target_lig_653	r(CUG)10	Synthetic	Myotonic dystrophy 1 (DM1)	Target_170	0	0	2.25E-08	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC\C=C\CCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	3.2804	1290.79831190436	10	10	36	351.56	6	0.015547901693326	6.32281794111228	94			RNA aptamer, mRNA	Expanded Repeats	0	3'-UTR	Internal Loop	0	0	0	0	2.25E-08	2.25E-08	0	0	0	0
1124	DCC 11 (2012)	Target_lig_653	r(CCUG)10	Synthetic	Myotonic dystrophy 2 (DM2)	Target_179	0	0	2.10E-07	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC\C=C\CCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	3.2804	1290.79831190436	10	10	36	351.56	6	0.015547901693326	6.32281794111228	94	CCCGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCGG	10.1093/nar/gks298	RNA aptamer, mRNA	Expanded Repeats	47	Intron	Internal Loop	0	0	0	0	2.10E-07	2.10E-07	0	0	0	0
1125	DCC 11 (2012)	Target_lig_653	(CAG)10	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_180	0	0	8.62E-07	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC\C=C\CCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	3.2804	1290.79831190436	10	10	36	351.56	6	0.015547901693326	6.32281794111228	94	CCCGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCGG	10.1093/nar/gks298	RNA aptamer, mRNA	Expanded Repeats	37	Exon 1	Internal Loop	0	0	0	0	8.62E-07	8.62E-07	0	0	0	0
1126	DCC 11 (2012)	Target_lig_653	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	2.00E-06	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	-	200 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC\C=C\CCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	3.2804	1290.79831190436	10	10	36	351.56	6	0.015547901693326	6.32281794111228	94	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
1127	DCC 11 (2012)	Target_lig_653	r(CUG)10	Synthetic	Myotonic dystrophy 1 (DM1)	Target_170	0	0	5.7e-08±1e-09	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	1 uM	10 uM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC\C=C\CCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	3.2804	1290.79831190436	10	10	36	351.56	6	0.015547901693326	6.32281794111228	94			RNA aptamer, mRNA	Expanded Repeats	0	3'-UTR	Internal Loop	0	0	0	0	5.60E-08	5.80E-08	0	0	0	0
1128	DCC 11 (2012)	Target_lig_653	r(CCUG)10	Synthetic	Myotonic dystrophy 2 (DM2)	Target_179	0	0	7.36e-08±8e-10	0	0	0	0	-	-	10.1093/nar/gks298	22492623	From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy	Ofori LO, Hoskins J, Nakamori M, Thornton CA, Miller BL	Nucleic Acids Res	40	6380-90	2012	1 uM	10 uM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC\C=C\CCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	3.2804	1290.79831190436	10	10	36	351.56	6	0.015547901693326	6.32281794111228	94	CCCGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCCUGCGG	10.1093/nar/gks298	RNA aptamer, mRNA	Expanded Repeats	47	Intron	Internal Loop	0	0	0	0	7.28E-08	7.44E-08	0	0	0	0
1129	Compound 4E	Target_lig_654	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	5e-09±2e-09	0	0	0	0	-	-	10.1021/acschembio.5b00682	26496521	N-Methylation as a Strategy for Enhancing the Affinity and Selectivity of RNA-binding Peptides: Application to the HIV-1 Frameshift-Stimulating RNA.	Hilimire TA, Bennett RP, Stewart RA, Garcia-Miranda P, Blume A, Becker J, Sherer N, Helms ED, Butcher SE, Smith HC, Miller BL	ACS Chem Biol	11	88-94	2016	0-1 uM	0-10 uM	-	-	20 mM HEPES, 150 mM NaCl, and 5 mM MgCl2	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N(C)[C@@H](C\C=C\C[C@H](N(C)C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+])C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	6.74980000000001	1326.73066080818	10	4	28	261.12	8	0.022777967565924	6.35803538202521	98	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	3.00E-09	7.00E-09	0	0	0	0
1130	Compound 4E	Target_lig_654	HIV-1 FSS DNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	3.4e-08±1e-08	0	0	0	0	-	-	10.1021/acschembio.5b00682	26496521	N-Methylation as a Strategy for Enhancing the Affinity and Selectivity of RNA-binding Peptides: Application to the HIV-1 Frameshift-Stimulating RNA.	Hilimire TA, Bennett RP, Stewart RA, Garcia-Miranda P, Blume A, Becker J, Sherer N, Helms ED, Butcher SE, Smith HC, Miller BL	ACS Chem Biol	11	88-94	2016	0-1 uM	0-10 uM	-	-	20 mM HEPES, 150 mM NaCl, and 5 mM MgCl2	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N(C)[C@@H](C\C=C\C[C@H](N(C)C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+])C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	6.74980000000001	1326.73066080818	10	4	28	261.12	8	0.022777967565924	6.35803538202521	98	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	2.40E-08	4.40E-08	0	0	0	0
1131	Compound 4E	Target_lig_654	Yeast tRNA	Saccharomyces cereviseae	-	Target_1	0	0	9.1e-08±2e-08	0	0	0	0	-	-	10.1021/acschembio.5b00682	26496521	N-Methylation as a Strategy for Enhancing the Affinity and Selectivity of RNA-binding Peptides: Application to the HIV-1 Frameshift-Stimulating RNA.	Hilimire TA, Bennett RP, Stewart RA, Garcia-Miranda P, Blume A, Becker J, Sherer N, Helms ED, Butcher SE, Smith HC, Miller BL	ACS Chem Biol	11	88-94	2016	0-1 uM	0-10 uM	-	-	20 mM HEPES, 150 mM NaCl, and 5 mM MgCl2	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N(C)[C@@H](C\C=C\C[C@H](N(C)C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+])C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	6.74980000000001	1326.73066080818	10	4	28	261.12	8	0.022777967565924	6.35803538202521	98	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	7.10E-08	1.11E-07	0	0	0	0
1132	Compound 4E	Target_lig_654	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	1.2999999999999999e-08±5.1999999999999994e-09	0	0	0	0	-	-	10.1021/acschembio.5b00682	26496521	N-Methylation as a Strategy for Enhancing the Affinity and Selectivity of RNA-binding Peptides: Application to the HIV-1 Frameshift-Stimulating RNA.	Hilimire TA, Bennett RP, Stewart RA, Garcia-Miranda P, Blume A, Becker J, Sherer N, Helms ED, Butcher SE, Smith HC, Miller BL	ACS Chem Biol	11	88-94	2016	-	-	-	-	10 mM HEPES and 150 mM NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N(C)[C@@H](C\C=C\C[C@H](N(C)C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+])C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	6.74980000000001	1326.73066080818	10	4	28	261.12	8	0.022777967565924	6.35803538202521	98	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	7.80E-09	1.82E-08	0	0	0	0
1133	DCC 4 (2012)	Target_lig_652	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	1.02E-07	0	0	0	0	-	-	10.1021/jm401438g	24387306	High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity	Ofori LO, Hilimire TA, Bennett RP, Brown Jr NW, Smith HC, Miller BL	J Med Chem	57	723-32	2014	-	500 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	1.02E-07	1.02E-07	0	0	0	0
1134	DCC 4 (2012)	Target_lig_652	HIV-1 FSS DNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	7.10E-08	0	0	0	0	-	-	10.1021/jm401438g	24387306	High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity	Ofori LO, Hilimire TA, Bennett RP, Brown Jr NW, Smith HC, Miller BL	J Med Chem	57	723-32	2014	-	500 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	7.10E-08	7.10E-08	0	0	0	0
1135	DCC 4 (2012)	Target_lig_652	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	6.6e-08±3.4e-08	0	0	0	0	-	-	10.1021/jm401438g	24387306	High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity	Ofori LO, Hilimire TA, Bennett RP, Brown Jr NW, Smith HC, Miller BL	J Med Chem	57	723-32	2014	1 uM	10 uM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	3.20E-08	1.00E-07	0	0	0	0
1136	DCC 4 (2012)	Target_lig_652	HIV-1 FSS DNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	2.65e-07±3.7999999999999996e-08	0	0	0	0	-	-	10.1021/jm401438g	24387306	High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity	Ofori LO, Hilimire TA, Bennett RP, Brown Jr NW, Smith HC, Miller BL	J Med Chem	57	723-32	2014	1 uM	40 uM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	2.27E-07	3.03E-07	0	0	0	0
1137	DCC 4 (2012)	Target_lig_652	tRNA	Saccharomyces cereviseae	-	Target_1	0	0	3.34e-07±2.8e-08	0	0	0	0	-	-	10.1021/jm401438g	24387306	High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity	Ofori LO, Hilimire TA, Bennett RP, Brown Jr NW, Smith HC, Miller BL	J Med Chem	57	723-32	2014	1 uM	40 uM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C\C=C/C[C@H](NC(=O)[C@@H]1CCCN1C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+])C(=O)N[C@@H](CCCC[NH3+])C(=O)NCCC[NH3+]	-	-	1.71999999999999	1234.73571164836	10	10	32	351.56	6	0.016565195864557	6.27890567923335	90	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	3.06E-07	3.62E-07	0	0	0	0
1138	DCC 5 (2012)	Target_lig_655	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	8.90E-08	0	0	0	0	-	-	10.1021/jm401438g	24387306	High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity	Ofori LO, Hilimire TA, Bennett RP, Brown Jr NW, Smith HC, Miller BL	J Med Chem	57	723-32	2014	-	500 nM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N[C@@H](C\C=C\C[C@H](NC(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+])C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	5.38100000000001	1270.66806055218	10	8	28	296.28	8	0.017596297064047	5.98244396254042	94	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	8.90E-08	8.90E-08	0	0	0	0
1139	DCC 5 (2012)	Target_lig_655	HIV-1 FSS DNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	9.60E-08	0	0	0	0	-	-	10.1021/jm401438g	24387306	High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity	Ofori LO, Hilimire TA, Bennett RP, Brown Jr NW, Smith HC, Miller BL	J Med Chem	57	723-32	2014	-	500 nM	7.4	-	20 mM HEPES, 0.15 M NaCl, 5 mM MgCl2, and 0.005% Tween-20	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N[C@@H](C\C=C\C[C@H](NC(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+])C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	5.38100000000001	1270.66806055218	10	8	28	296.28	8	0.017596297064047	5.98244396254042	94	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	9.60E-08	9.60E-08	0	0	0	0
1140	DCC 5 (2012)	Target_lig_655	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	4.0899999999999997e-07±2.5e-08	0	0	0	0	-	-	10.1021/jm401438g	24387306	High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity	Ofori LO, Hilimire TA, Bennett RP, Brown Jr NW, Smith HC, Miller BL	J Med Chem	57	723-32	2014	1 uM	10 uM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N[C@@H](C\C=C\C[C@H](NC(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+])C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	5.38100000000001	1270.66806055218	10	8	28	296.28	8	0.017596297064047	5.98244396254042	94	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	3.84E-07	4.34E-07	0	0	0	0
1141	DCC 5 (2012)	Target_lig_655	HIV-1 FSS DNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	1.1799999999999998e-07±2e-08	0	0	0	0	-	-	10.1021/jm401438g	24387306	High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity	Ofori LO, Hilimire TA, Bennett RP, Brown Jr NW, Smith HC, Miller BL	J Med Chem	57	723-32	2014	1 uM	40 uM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N[C@@H](C\C=C\C[C@H](NC(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+])C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	5.38100000000001	1270.66806055218	10	8	28	296.28	8	0.017596297064047	5.98244396254042	94	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	9.80E-08	1.38E-07	0	0	0	0
1142	DCC 5 (2012)	Target_lig_655	tRNA	Saccharomyces cereviseae	-	Target_1	0	0	2.17e-07±2.8e-08	0	0	0	0	-	-	10.1021/jm401438g	24387306	High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity	Ofori LO, Hilimire TA, Bennett RP, Brown Jr NW, Smith HC, Miller BL	J Med Chem	57	723-32	2014	1 uM	40 uM	7.4	-	0.01 M HEPES and 0.15 M NaCl	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N[C@@H](C\C=C\C[C@H](NC(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+])C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	5.38100000000001	1270.66806055218	10	8	28	296.28	8	0.017596297064047	5.98244396254042	94	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	1.89E-07	2.45E-07	0	0	0	0
1143	S-Amino acid conjugate 13b	Target_lig_656	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	2.40E-07	0	0	0	0	-	-	10.1002/chem.201303664	24431237	Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents.	Joly JP, Mata G, Eldin P, Briant L, Fontaine-Vive F, Duca M, Benhida R	Chemistry	20	2071-9	2014	61 nM - 1 mM	10 nM	7.2	-	HEPES, 20 mM NaCl, 140 mM KCl, and 3 mM MgCl2	Fluorescence-based titration (Intrinsic)	RBIND	CC(=O)NC1=NC(=CS1)C1=CC(NC(=O)C(CNC(=O)[C@@H]([NH3+])CCCC[NH3+])NC(=O)[C@@H]([NH3+])CCCC[NH3+])=CC=C1	-	-	-2.6466	579.32932760036	6	8	17	239.85	2	0.093428206049583	4.93780560099663	40	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	2.40E-07	2.40E-07	0	0	0	0
1144	S-Amino acid conjugate 13b	Target_lig_656	HIV-1 TAR RNA; 100-fold excess tRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	6.90E-07	0	0	0	0	-	-	10.1002/chem.201303664	24431237	Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents.	Joly JP, Mata G, Eldin P, Briant L, Fontaine-Vive F, Duca M, Benhida R	Chemistry	20	2071-9	2014	61 nM - 1 mM	10 nM	7.2	-	HEPES, 20 mM NaCl, 140 mM KCl, and 3 mM MgCl2	Fluorescence-based titration (Intrinsic)	RBIND	CC(=O)NC1=NC(=CS1)C1=CC(NC(=O)C(CNC(=O)[C@@H]([NH3+])CCCC[NH3+])NC(=O)[C@@H]([NH3+])CCCC[NH3+])=CC=C1	-	-	-2.6466	579.32932760036	6	8	17	239.85	2	0.093428206049583	4.93780560099663	40	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	6.90E-07	6.90E-07	0	0	0	0
1145	S-Amino acid conjugate 13b	Target_lig_656	HIV-1 TAR RNA; 100-fold excess dsDNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	7.20E-07	0	0	0	0	-	-	10.1002/chem.201303664	24431237	Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents.	Joly JP, Mata G, Eldin P, Briant L, Fontaine-Vive F, Duca M, Benhida R	Chemistry	20	2071-9	2014	61 nM - 1 mM	10 nM	7.2	-	HEPES, 20 mM NaCl, 140 mM KCl, and 3 mM MgCl2	Fluorescence-based titration (Labeled RNA)	RBIND	CC(=O)NC1=NC(=CS1)C1=CC(NC(=O)C(CNC(=O)[C@@H]([NH3+])CCCC[NH3+])NC(=O)[C@@H]([NH3+])CCCC[NH3+])=CC=C1	-	-	-2.6466	579.32932760036	6	8	17	239.85	2	0.093428206049583	4.93780560099663	40	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	7.20E-07	7.20E-07	0	0	0	0
1146	S-Amino acid conjugate 14b	Target_lig_657	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.10E-07	0	0	0	0	-	-	10.1002/chem.201303664	24431237	Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents.	Joly JP, Mata G, Eldin P, Briant L, Fontaine-Vive F, Duca M, Benhida R	Chemistry	20	2071-9	2014	61 nM - 1 mM	10 nM	7.2	-	HEPES, 20 mM NaCl, 140 mM KCl, and 3 mM MgCl2	Fluorescence-based titration (Labeled RNA)	RBIND	CC(=O)NC1=NC(=CS1)C1=CC(NC(=O)C(CNC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])=CC=C1	-	-	-6.58380000000002	635.34162360036	6	12	17	311.85	2	0.044580029922446	4.97252924809673	44	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.10E-07	1.10E-07	0	0	0	0
1147	S-Amino acid conjugate 14b	Target_lig_657	HIV-1 TAR RNA; 100-fold excess tRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	3.50E-07	0	0	0	0	-	-	10.1002/chem.201303664	24431237	Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents.	Joly JP, Mata G, Eldin P, Briant L, Fontaine-Vive F, Duca M, Benhida R	Chemistry	20	2071-9	2014	61 nM - 1 mM	10 nM	7.2	-	HEPES, 20 mM NaCl, 140 mM KCl, and 3 mM MgCl2	Fluorescence-based titration (Labeled RNA)	RBIND	CC(=O)NC1=NC(=CS1)C1=CC(NC(=O)C(CNC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])=CC=C1	-	-	-6.58380000000002	635.34162360036	6	12	17	311.85	2	0.044580029922446	4.97252924809673	44	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	3.50E-07	3.50E-07	0	0	0	0
1148	S-Amino acid conjugate 14b	Target_lig_657	HIV-1 TAR RNA; 100-fold excess dsDNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	4.00E-07	0	0	0	0	-	-	10.1002/chem.201303664	24431237	Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents.	Joly JP, Mata G, Eldin P, Briant L, Fontaine-Vive F, Duca M, Benhida R	Chemistry	20	2071-9	2014	61 nM - 1 mM	10 nM	7.2	-	HEPES, 20 mM NaCl, 140 mM KCl, and 3 mM MgCl2	Fluorescence-based titration (Labeled RNA)	RBIND	CC(=O)NC1=NC(=CS1)C1=CC(NC(=O)C(CNC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])=CC=C1	-	-	-6.58380000000002	635.34162360036	6	12	17	311.85	2	0.044580029922446	4.97252924809673	44	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	4.00E-07	4.00E-07	0	0	0	0
1149	DCC 3 (2017)	Target_lig_658	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	9.7e-08±2e-08	0	0	0	0	-	-	10.1021/acschembio.7b00052	28448121	HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells.	Hilimire TA, Chamberlain JM, Anokhina V, Bennett RP, Swart O, Myers JR, Ashton JM, Stewart RA, Featherston AL, Gates K, Helms ED, Smith HC, Dewhurst S, Miller BL	ACS Chem Biol	12	1674-1682	2017	-	50 uM	7.4	-	10 mM HEPES, 150 mM NaCl, and 0.005% Tween	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N[C@@H](CCN1C=C(C[C@H](NC(=O)C2=C(CC)N=C3C=C4C=CC=CC4=CC3=C2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NCCC[NH3+])N=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	4.26890000000001	1325.68510758418	13	8	29	326.99	9	0.024086178283509	6.16966792359846	98	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	7.70E-08	1.17E-07	0	0	0	0
1150	DCC 3 (2017)	Target_lig_658	HIV-1 FSS RNA; 5-fold excess tRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	3.2e-08±6e-09	0	0	0	0	-	-	10.1021/acschembio.7b00052	28448121	HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells.	Hilimire TA, Chamberlain JM, Anokhina V, Bennett RP, Swart O, Myers JR, Ashton JM, Stewart RA, Featherston AL, Gates K, Helms ED, Smith HC, Dewhurst S, Miller BL	ACS Chem Biol	12	1674-1682	2017	-	50 uM	7.4	-	10 mM HEPES, 150 mM NaCl, and 0.005% Tween	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N[C@@H](CCN1C=C(C[C@H](NC(=O)C2=C(CC)N=C3C=C4C=CC=CC4=CC3=C2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NCCC[NH3+])N=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	4.26890000000001	1325.68510758418	13	8	29	326.99	9	0.024086178283509	6.16966792359846	98	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	2.60E-08	3.80E-08	0	0	0	0
1151	DCC 4 (2017)	Target_lig_659	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	6.8e-08±7e-09	0	0	0	0	-	-	10.1021/acschembio.7b00052	28448121	HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells.	Hilimire TA, Chamberlain JM, Anokhina V, Bennett RP, Swart O, Myers JR, Ashton JM, Stewart RA, Featherston AL, Gates K, Helms ED, Smith HC, Dewhurst S, Miller BL	ACS Chem Biol	12	1674-1682	2017	-	50 uM	7.4	-	10 mM HEPES, 150 mM NaCl, and 0.005% Tween	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N[C@@H](CC1=CN(CC[C@H](N(C)C(=O)C2=C(CC)N=C3C=C4C=CC=CC4=CC3=C2)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC2=CC=CC=C2)C(=O)NCCC[NH3+])N=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	4.95330000000001	1353.71640771218	13	6	29	309.41	9	0.026805454859374	6.41742472730644	100	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	6.10E-08	7.50E-08	0	0	0	0
1152	DCC 4 (2017)	Target_lig_659	HIV-1 FSS RNA; 5-fold excess tRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	6.2e-08±2e-08	0	0	0	0	-	-	10.1021/acschembio.7b00052	28448121	HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells.	Hilimire TA, Chamberlain JM, Anokhina V, Bennett RP, Swart O, Myers JR, Ashton JM, Stewart RA, Featherston AL, Gates K, Helms ED, Smith HC, Dewhurst S, Miller BL	ACS Chem Biol	12	1674-1682	2017	-	50 uM	7.4	-	10 mM HEPES, 150 mM NaCl, and 0.005% Tween	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N[C@@H](CC1=CN(CC[C@H](N(C)C(=O)C2=C(CC)N=C3C=C4C=CC=CC4=CC3=C2)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC2=CC=CC=C2)C(=O)NCCC[NH3+])N=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	4.95330000000001	1353.71640771218	13	6	29	309.41	9	0.026805454859374	6.41742472730644	100	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	4.20E-08	8.20E-08	0	0	0	0
1153	DCC 5 (2017)	Target_lig_660	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	5.899999999999999e-08±1e-08	0	0	0	0	-	-	10.1021/acschembio.7b00052	28448121	HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells.	Hilimire TA, Chamberlain JM, Anokhina V, Bennett RP, Swart O, Myers JR, Ashton JM, Stewart RA, Featherston AL, Gates K, Helms ED, Smith HC, Dewhurst S, Miller BL	ACS Chem Biol	12	1674-1682	2017	-	50 uM	7.4	-	10 mM HEPES, 150 mM NaCl, and 0.005% Tween	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N[C@@H](CC1=CN(CC[C@H](N(C)C(=O)C2=C(CC)N=C3C=C4C=CC=CC4=CC3=C2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NCCC[NH3+])N=N1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	4.95330000000001	1353.71640771218	13	6	29	309.41	9	0.026805454859374	6.41742472730644	100	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	4.90E-08	6.90E-08	0	0	0	0
1154	DCC 5 (2017)	Target_lig_660	HIV-1 FSS RNA; 5-fold excess tRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	3.1e-08±5e-09	0	0	0	0	-	-	10.1021/acschembio.7b00052	28448121	HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells.	Hilimire TA, Chamberlain JM, Anokhina V, Bennett RP, Swart O, Myers JR, Ashton JM, Stewart RA, Featherston AL, Gates K, Helms ED, Smith HC, Dewhurst S, Miller BL	ACS Chem Biol	12	1674-1682	2017	-	50 uM	7.4	-	10 mM HEPES, 150 mM NaCl, and 0.005% Tween	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N[C@@H](CC1=CN(CC[C@H](N(C)C(=O)C2=C(CC)N=C3C=C4C=CC=CC4=CC3=C2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NCCC[NH3+])N=N1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	4.95330000000001	1353.71640771218	13	6	29	309.41	9	0.026805454859374	6.41742472730644	100	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	2.60E-08	3.60E-08	0	0	0	0
1155	DCC 7 (2017)	Target_lig_661	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	1.6e-08±4e-09	0	0	0	0	-	-	10.1021/acschembio.7b00052	28448121	HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells.	Hilimire TA, Chamberlain JM, Anokhina V, Bennett RP, Swart O, Myers JR, Ashton JM, Stewart RA, Featherston AL, Gates K, Helms ED, Smith HC, Dewhurst S, Miller BL	ACS Chem Biol	12	1674-1682	2017	-	50 uM	7.4	-	10 mM HEPES, 150 mM NaCl, and 0.005% Tween	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N(C)[C@@H](CCN1C=C(C[C@H](N(C)C(=O)C2=C(CC)N=C3C=C4C=CC=CC4=CC3=C2)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC2=CC=CC=C2)C(=O)NCCC[NH3+])N=N1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	5.63770000000001	1381.74770784018	13	4	29	291.83	9	0.032745008708566	6.5438344857721	102	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	1.20E-08	2.00E-08	0	0	0	0
1156	DCC 7 (2017)	Target_lig_661	HIV-1 FSS RNA; 5-fold excess tRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	1.3e-07±2e-08	0	0	0	0	-	-	10.1021/acschembio.7b00052	28448121	HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human Cells.	Hilimire TA, Chamberlain JM, Anokhina V, Bennett RP, Swart O, Myers JR, Ashton JM, Stewart RA, Featherston AL, Gates K, Helms ED, Smith HC, Dewhurst S, Miller BL	ACS Chem Biol	12	1674-1682	2017	-	50 uM	7.4	-	10 mM HEPES, 150 mM NaCl, and 0.005% Tween	Surface Plasmon Resonance	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N(C)[C@@H](CCN1C=C(C[C@H](N(C)C(=O)C2=C(CC)N=C3C=C4C=CC=CC4=CC3=C2)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC2=CC=CC=C2)C(=O)NCCC[NH3+])N=N1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	5.63770000000001	1381.74770784018	13	4	29	291.83	9	0.032745008708566	6.5438344857721	102	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	1.10E-07	1.50E-07	0	0	0	0
1157	5FDQD	Target_lig_662	165 ribD FMN Riboswitch Aptamer, B. subtilis	Bacillus subtilis	Bacterial growth and infection	Target_189	0	0	7.50E-09	0	0	0	0	-	-	10.1128/AAC.01282-15	26169403	Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora	Blount KF, Megyola C, Plummer M, Osterman D, O'Connell T, Aristoff P, Quinn C, Chrusciel RA, Poel TJ, Schostarez HJ, Stewart CA, Walker DP, Wuts PGM, Breaker RR	Antimicrob Agents Chemother	59	5736-46	2015	-	-	-	-	-	In-line probing	RBIND	CC(CCN1C2=CC(C)=C(C)C=C2N=C2C(=O)[N-]C(=O)N=C12)C1=CC=C(F)C=C1	-	-	3.16344	391.15757767991	5	0	4	78.95	2	0.499465721637915	3.57306884714144	29	GGAAGGACAAAUGAAUAAAGAUUGUAUCCUUCGGGGCAGGGUGGAAAUCCCGACCGGCGGUAGUAAAGCACAUUUGCUUUAGAGCCCGUGACCCGUGUGCAAUAGCACGCGGUGGAUUCAGUUUAAGCUGAAGCCGACAGUGAAAGUCUGGAUGGGAGAAGGAUG	10.1128/AAC.01282-15	RNA aptamer, Riboswitch	Riboswitch	165	5'-UTR	-	0	0	0	0	7.50E-09	7.50E-09	0	0	0	0
1158	5FDQD	Target_lig_662	165 ribD FMN Riboswitch Aptamer, B. subtilis	Bacillus subtilis	Bacterial growth and infection	Target_189	0	0	0	0	0	5.00E-07	0	-	-	10.1128/AAC.01282-15	26169403	Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora	Blount KF, Megyola C, Plummer M, Osterman D, O'Connell T, Aristoff P, Quinn C, Chrusciel RA, Poel TJ, Schostarez HJ, Stewart CA, Walker DP, Wuts PGM, Breaker RR	Antimicrob Agents Chemother	59	5736-46	2015	6 nM - 100 uM	-	8	-	80 mM Tris-Hcl, 20 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, and 0.01 mg/ml BSA	Transcription termination	RBIND	CC(CCN1C2=CC(C)=C(C)C=C2N=C2C(=O)[N-]C(=O)N=C12)C1=CC=C(F)C=C1	-	-	3.16344	391.15757767991	5	0	4	78.95	2	0.499465721637915	3.57306884714144	29	GGAAGGACAAAUGAAUAAAGAUUGUAUCCUUCGGGGCAGGGUGGAAAUCCCGACCGGCGGUAGUAAAGCACAUUUGCUUUAGAGCCCGUGACCCGUGUGCAAUAGCACGCGGUGGAUUCAGUUUAAGCUGAAGCCGACAGUGAAAGUCUGGAUGGGAGAAGGAUG	10.1128/AAC.01282-15	RNA aptamer, Riboswitch	Riboswitch	165	5'-UTR	-	0	0	0	0	0	0	0	0	0	0
1159	Ribocil-B	Target_lig_663	FMN Riboswitch Aptamer, E. Coli	Fusobacterium nucleatum	Bacterial growth and infection	Target_190	0	0	6.5999999999999995e-09±2e-09	0	0	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	-	-	7.4	-	50 mM Tris-Hcl, 100 mM KCl and 2 mM MgCl2 with 0.2% DMSO	Competitive binding	RBIND	CNC1=NC=C(C=N1)CN2CCC[C@@H](C2)C3=NC(=CC(=O)N3)C4=CC=CS4	2-[(3S)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	135567058	2.7097	382.157580324	7	2	5	86.8	3	0.705545992044172	3.22468161308844	27	GGAUCUUCGGGGCAGGGUGAAAUUCCCGACCGGUGGUAUAGUCCACGAAAGUAUUUGCUUUGAUUUGGUGAAAUUCCAAAACCGACAGUAGAGUCUGGAUGAGAGAAGAUUC	https://www.rcsb.org/structure/3F2Q	RNA aptamer, Riboswitch	Riboswitch	112	5'-UTR	-	0	0	0	0	4.60E-09	8.60E-09	0	0	0	0
1160	Ribocil-C	Target_lig_664	FMN Riboswitch Aptamer, E. Coli	Fusobacterium nucleatum	Bacterial growth and infection	Target_190	0	0	<1e-09	0	0	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	-	-	7.4	-	50 mM Tris-Hcl, 100 mM KCl and 2 mM MgCl2 with 0.2% DMSO	Competitive binding	RBIND	C1C[C@@H](CN(C1)CC2=CN(C=N2)C3=NC=CC=N3)C4=NC(=CC(=O)N4)C5=CC=CS5	2-[(3S)-1-[(1-pyrimidin-2-ylimidazol-4-yl)methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	136981150	2.8537	419.152829292	8	1	5	92.59	4	0.534742446328506	3.42112161532566	30	GGAUCUUCGGGGCAGGGUGAAAUUCCCGACCGGUGGUAUAGUCCACGAAAGUAUUUGCUUUGAUUUGGUGAAAUUCCAAAACCGACAGUAGAGUCUGGAUGAGAGAAGAUUC	https://www.rcsb.org/structure/3F2Q	RNA aptamer, Riboswitch	Riboswitch	112	5'-UTR	-	0	0	0	0	1.00E-09	1.00E-09	0	0	0	0
1161	Ribocil-C	Target_lig_664	FMN Riboswitch Aptamer SA1, S. Aureus	Staphylococcus aureus	Bacterial growth and infection	Target_191	0	0	5.80E-08	0	0	0	0	-	-	10.1016/j.chembiol.2017.03.014	28434876	Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting.	Wang H, Mann PA, Xiao L, Gill C, Galgoci AM, Howe JA, Villafania A, Barbieri CM, Malinverni JC, Sher X, Mayhood T, McCurry MD, Murgolo N, Flattery A, Mack M, Roemer T	Cell Chem Biol	24	576-588.e6	2017	-	-	7.4	-	4 mM KH2PO4, 16 mM K2HPO4, 64 mM KCl, and 0.1 mM EDTA	Competitive binding	RBIND	C1C[C@@H](CN(C1)CC2=CN(C=N2)C3=NC=CC=N3)C4=NC(=CC(=O)N4)C5=CC=CS5	2-[(3S)-1-[(1-pyrimidin-2-ylimidazol-4-yl)methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	136981150	2.8537	419.152829292	8	1	5	92.59	4	0.534742446328506	3.42112161532566	30	UAAUUCUUUCGGGGCAGGGUGAAAUUCCCAACCGGCAGUAAAUAAAGCCUGCGACCUGCUAAUAUGUUUCAUAUUAGUGGCUGAUCUAGUGAGAUUCUAGAGCCGACAGUUAAAGUCUGGAUGGGAGAAAGAAUGUUAAUUAUCGACAAAGAUAAUGUAGCGUAUUUGUAAAAAUGUGUACAAAUAGGCUUAUUUAACGAUAAAUUUUUCUCCUUGCAUCUUAAUUCAUGAUGUGAGGAUU	10.1016/j.chembiol.2017.03.014	RNA aptamer, Riboswitch	Riboswitch	241	5'-UTR	-	0	0	0	0	5.80E-08	5.80E-08	0	0	0	0
1162	Ribocil-C	Target_lig_664	FMN Riboswitch Aptamer SA2, S. Aureus	Staphylococcus aureus	Bacterial growth and infection	Target_192	0	0	3.30E-08	0	0	0	0	-	-	10.1016/j.chembiol.2017.03.014	28434876	Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting.	Wang H, Mann PA, Xiao L, Gill C, Galgoci AM, Howe JA, Villafania A, Barbieri CM, Malinverni JC, Sher X, Mayhood T, McCurry MD, Murgolo N, Flattery A, Mack M, Roemer T	Cell Chem Biol	24	576-588.e6	2017	-	-	7.4	-	4 mM KH2PO4, 16 mM K2HPO4, 64 mM KCl, and 0.1 mM EDTA	Competitive binding	RBIND	C1C[C@@H](CN(C1)CC2=CN(C=N2)C3=NC=CC=N3)C4=NC(=CC(=O)N4)C5=CC=CS5	2-[(3S)-1-[(1-pyrimidin-2-ylimidazol-4-yl)methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	136981150	2.8537	419.152829292	8	1	5	92.59	4	0.534742446328506	3.42112161532566	30	AUUCAUCUUCGGGGUCGGGUGUAAUUCCCAACCGGCAGUAAAUAAAGCCUGCGACCUGCUAGUAUGUAUCAUAUUAGUGGCUGAUCUAGUGAGAUUCUAGAGCCGACAGUAUAGUCUGGAUGGGAGAAGAUGGAGGUUUUUUGUUGUGCAAUAAUCCUCCUAUUCUUACGAGAUGAAUGGAAGGAGAAAAUU	10.1016/j.chembiol.2017.03.014	RNA aptamer, Riboswitch	Riboswitch	192	5'-UTR	-	0	0	0	0	3.30E-08	3.30E-08	0	0	0	0
1163	Roseoflavin	Target_lig_505	FMN Riboswitch, S. Davawensis	Staphylococcus davawensis	Bacterial growth and infection	Target_193	0	0	1.00E-08	0	0	0	0	-	-	10.4161/rna.6.2.7727	19246992	Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression	Lee ER,  Blount KF, Breaker RR	RNA Biol	6	187-94	2009	-	-	8.3	-	50 mM Tris-Hcl, 20 mM MgCl2, 100 mM KCl	In-line probing	RBIND	CC1=CC2=C(C=C1N(C)C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O	8-(dimethylamino)-7-methyl-10-(2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4-dione	170973	-1.96598	405.164833456	10	5	6	164.8	1	0.292630701546369	3.95749650714692	29	GGUACCAGAAGCAGCGCACUCCGGGGUCGGUGAAAGUCCGAACCGGCGGUUACAGUCCGCGACCCGACCGCUUCCAGCGGCCGGUUGACCAGGUGAAAUUCCUGGACCGACGGUUAAAGUCCGGAUGGGAGGCAGUGCGCGCGGCGGGCGG	10.4161/rna.6.2.7727	Riboswitch	Riboswitch	151	5'-UTR	-	0	0	0	0	1.00E-08	1.00E-08	0	0	0	0
1164	2,6-Diaminopurine	Target_lig_1254	PbuE Riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_73	0	0	2.50E-08	0	0	0	0	-	-	10.1021/bi051008u	16201765	The kinetics of ligand binding by an adenine-sensing riboswitch.	Wickiser JK, Cheah MT, Breaker RR, Crothers DM	Biochemistry	44	13404-14	2005	500 nM	100 nM	-	-	-	Fluorescence-based	RBIND	NC1=NC(N)=C2NC=NC2=N1	7H-purine-2,6-diamine	30976	-0.482700000000001	150.065394192	5	3	0	106.5	2	0.469730963770893	2.7153646042873	11	GGAAUAAUUGUAUAACCUCAAUAAUAUGGUUUGAGGGUGUCUACCAGGAACCGUAAAAUCCUGAUUACAA	10.1021/bi051008u	Riboswitch	Riboswitch	70	-	-	0	0	0	0	2.50E-08	2.50E-08	0	0	0	0
1165	Pyrithiamine	Target_lig_503	TPP Riboswitch, B. Subtilis	Escherichia coli	Bacterial growth and infection	Target_194	0	0	6.00E-06	0	0	0	0	-	-	10.1016/j.chembiol.2005.10.007	16356850	Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine.	Sudarsan N, Cohen-Chalamish S, Nakamura S, Emilsson GM, Breaker RR	Chem Biol	12	1325-35	2005	-	-	8.3	-	50 mM Tris-Hcl, 20 mM MgCl2, and 100 mM KCl	In-line probing	RBIND	CC1=C(C=CC=[N+]1CC2=CN=C(N=C2N)C)CCO.Br.[Br-]	2-[1-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-methylpyridin-1-ium-3-yl]ethanol;bromide;hydrobromide	10802	-1.87186	418.00038546	4	2	4	75.91	2	0.569000522878671	3.27600921483776	21	GGUAACCACUAGGGGUGUCCUUCAUAAGGGCUGAGAUAAAAGUGUGACUUUUAGACCCUCAUAACUUGAACAGGUUCAGACCUGCGUAGGGAAGUGGAGC	10.1016/j.chembiol.2005.10.007	Riboswitch	Riboswitch	100	5'-UTR	-	0	0	0	0	6.00E-06	6.00E-06	0	0	0	0
1166	2-Amino-N6-Hydroxyadenine	Target_lig_665	xpt-pbuX Guanine Riboswitch, B. Subtilis	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	2.00E-08	0	0	0	0	-	-	10.1021/cb900146k	19739679	Design and antimicrobial action of purine analogues that bind Guanine riboswitches.	Kim JN, Blount KF, Puskarz I, Lim J, Link KH, Breaker RR	ACS Chem Biol	4	915-27	2009	-	-	-	-	-	In-line probing	RBIND	C1=NC2=C(N1)C(=NC(=N2)N)NO	N-(2-amino-7H-purin-6-yl)hydroxylamine	101513	-0.2638	166.060308812	6	4	1	112.74	2	0.433798094830407	3.03256192339879	12	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	2.00E-08	2.00E-08	0	0	0	0
1167	PC1	Target_lig_1255	Guanine Riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	1.00E-07	0	0	0	0	-	-	10.1371/journal.ppat.1000865	20421948	Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways.	Mulhbacher J, Brouillette E, Allard M, Fortier LC, Malouin F, Lafontaine DA	PLoS Pathog	6	e1000865	2010	-	-	8.5	-	50 mM Tris-Hcl, 20 mM MgCl2, and 100 mM KCl	In-line probing	RBIND	NC1=NC(=O)C(N)=C(N)N1	2,4,5-triamino-1H-pyrimidin-6-one	135406869	-1.4835	141.065059844	5	4	0	123.81	1	0.350338786569491	2.9082096033619	10	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
1168	Chelerythrine	Target_lig_666	108 nt yjdF Riboswitch Construct, B. subtilis, Mutant 1	Bacillus subtilis	Bacterial growth and infection	Target_195	0	0	2.40E-09	0	0	0	0	-	-	10.1261/rna.054890.115	26843526	The yjdF riboswitch candidate regulates gene expression by binding diverse azaaromatic compounds	Li S, Hwang XY, Stav S, Breaker RR	RNA	22	530-41	2016	-	-	8.3	-	50 mM Tris–HCl, 100 mM KCl, and 20 mM MgCl2	In-line probing	RBIND	C[N+]1=C2C(=C3C=CC(=C(C3=C1)OC)OC)C=CC4=CC5=C(C=C42)OCO5	1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium	2703	3.7166	348.12303447609	4	0	2	40.8	4	0.408940526892371	2.68676918177135	26	GUAUAUGGUAAACUAUGAAAAAACACGAUUCGGUUGGUAGUCCGGAUGCAUGAUUGAGAAUGUCAGUAACCUUCCCCUCCUCGGGAUGUCCAUCAUUCUUUAAUAUCU	10.1261/rna.054890.115	Riboswitch	Riboswitch	108	5'-UTR	-	0	0	0	0	2.40E-09	2.40E-09	0	0	0	0
1169	Dequalinium	Target_lig_667	108 nt yjdF Riboswitch Construct, B. subtilis, Mutant 1	Bacillus subtilis	Bacterial growth and infection	Target_195	0	0	1.00E-08	0	0	0	0	-	-	10.1261/rna.054890.115	26843526	The yjdF riboswitch candidate regulates gene expression by binding diverse azaaromatic compounds	Li S, Hwang XY, Stav S, Breaker RR	RNA	22	530-41	2016	-	-	8.3	-	50 mM Tris–HCl, 100 mM KCl, and 20 mM MgCl2	In-line probing	RBIND	CC1=[N+](C2=CC=CC=C2C(=C1)N)CCCCCCCCCC[N+]3=C(C=C(C4=CC=CC=C43)N)C	1-[10-(4-amino-2-methylquinolin-1-ium-1-yl)decyl]-2-methylquinolin-1-ium-4-amine	2993	6.17024000000001	456.32420012018	2	2	11	59.8	4	0.209367329507593	2.92112466221467	34	GUAUAUGGUAAACUAUGAAAAAACACGAUUCGGUUGGUAGUCCGGAUGCAUGAUUGAGAAUGUCAGUAACCUUCCCCUCCUCGGGAUGUCCAUCAUUCUUUAAUAUCU	10.1261/rna.054890.115	Riboswitch	Riboswitch	108	5'-UTR	-	0	0	0	0	1.00E-08	1.00E-08	0	0	0	0
1170	Harmane	Target_lig_668	108 nt yjdF Riboswitch Construct, B. subtilis, Mutant 1	Bacillus subtilis	Bacterial growth and infection	Target_195	0	0	1.00E-07	0	0	0	0	-	-	10.1261/rna.054890.115	26843526	The yjdF riboswitch candidate regulates gene expression by binding diverse azaaromatic compounds	Li S, Hwang XY, Stav S, Breaker RR	RNA	22	530-41	2016	-	-	8.3	-	50 mM Tris–HCl, 100 mM KCl, and 20 mM MgCl2	In-line probing	RBIND	CC1=NC=CC2=C1NC3=CC=CC=C23	1-methyl-9H-pyrido[3,4-b]indole	5281404	3.02452	182.08439832	1	1	0	28.68	3	0.568427006862461	2.01747608287788	14	GUAUAUGGUAAACUAUGAAAAAACACGAUUCGGUUGGUAGUCCGGAUGCAUGAUUGAGAAUGUCAGUAACCUUCCCCUCCUCGGGAUGUCCAUCAUUCUUUAAUAUCU	10.1261/rna.054890.115	Riboswitch	Riboswitch	108	5'-UTR	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
1171	Proflavin	Target_lig_336	108 nt yjdF Riboswitch Construct, B. subtilis, Mutant 1	Bacillus subtilis	Bacterial growth and infection	Target_195	0	0	6.10E-09	0	0	0	0	-	-	10.1261/rna.054890.115	26843526	The yjdF riboswitch candidate regulates gene expression by binding diverse azaaromatic compounds	Li S, Hwang XY, Stav S, Breaker RR	RNA	22	530-41	2016	-	-	8.3	-	50 mM Tris–HCl, 100 mM KCl, and 20 mM MgCl2	In-line probing	RBIND	C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N	acridine-3,6-diamine	7099	2.5524	209.095297352	3	2	0	64.93	3	0.441447262692883	2.05911636832492	16	GUAUAUGGUAAACUAUGAAAAAACACGAUUCGGUUGGUAGUCCGGAUGCAUGAUUGAGAAUGUCAGUAACCUUCCCCUCCUCGGGAUGUCCAUCAUUCUUUAAUAUCU	10.1261/rna.054890.115	Riboswitch	Riboswitch	108	5'-UTR	-	0	0	0	0	6.10E-09	6.10E-09	0	0	0	0
1172	Staurosporine	Target_lig_669	108 nt yjdF Riboswitch Construct, B. subtilis, Mutant 1	Bacillus subtilis	Bacterial growth and infection	Target_195	0	0	1.00E-07	0	0	0	0	-	-	10.1261/rna.054890.115	26843526	The yjdF riboswitch candidate regulates gene expression by binding diverse azaaromatic compounds	Li S, Hwang XY, Stav S, Breaker RR	RNA	22	530-41	2016	-	-	8.3	-	50 mM Tris–HCl, 100 mM KCl, and 20 mM MgCl2	In-line probing	RBIND	C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC	(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one	44259	4.354	466.200490692	6	2	2	69.45	5	0.405842479408347	4.95365565377427	35	GUAUAUGGUAAACUAUGAAAAAACACGAUUCGGUUGGUAGUCCGGAUGCAUGAUUGAGAAUGUCAGUAACCUUCCCCUCCUCGGGAUGUCCAUCAUUCUUUAAUAUCU	10.1261/rna.054890.115	Riboswitch	Riboswitch	108	5'-UTR	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
1173	Methylquinolinium 15	Target_lig_670	A10-RNA-WT QGRS in ADAM10 mRNA	Homo sapiens	Alzheimer’s disease	Target_196	0	0	3.40E-06	0	0	0	0	-	-	10.1021/acs.jmedchem.5b00139	25822852	Discovery of Small Molecules for Up-Regulating the Translation of Antiamyloidogenic Secretase, a Disintegrin and Metalloproteinase 10 (ADAM10), by Binding to the G-Quadruplex-Forming Sequence in the 5' Untranslated Region (UTR) of Its mRNA.	Dai J, Liu ZQ, Wang XQ, Lin J, Yao PF, Huang SL, Ou TM, Tan JH, Li D, Gu LQ, Huang ZS	J Med Chem	58	3875-91	2015	-	-	7.5	-	50 mM Tris-Hcl and 100 mM KCl	Surface Plasmon Resonance	RBIND	C[N+]1=C(C=CC2=CC=CC=C21)/C=C/C3=CC4=CC=CC=C4N3	2-[(E)-2-(1H-indol-2-yl)ethenyl]-1-methylquinolin-1-ium	118736721	4.316	285.13862496409	0	1	2	19.67	4	0.529326942585132	2.61722371221634	22	UGGGGGACGGGUAGGGGCGGGAGGUAGGGG	10.1021/acs.jmedchem.5b00139	mRNA	-	30	5'-UTR	G-Quadruplex	0	0	0	0	3.40E-06	3.40E-06	0	0	0	0
1174	Methylquinolinium 16	Target_lig_671	A10-RNA-WT QGRS in ADAM10 mRNA	Homo sapiens	Alzheimer’s disease	Target_196	0	0	1.92E-05	0	0	0	0	-	-	10.1021/acs.jmedchem.5b00139	25822852	Discovery of Small Molecules for Up-Regulating the Translation of Antiamyloidogenic Secretase, a Disintegrin and Metalloproteinase 10 (ADAM10), by Binding to the G-Quadruplex-Forming Sequence in the 5' Untranslated Region (UTR) of Its mRNA.	Dai J, Liu ZQ, Wang XQ, Lin J, Yao PF, Huang SL, Ou TM, Tan JH, Li D, Gu LQ, Huang ZS	J Med Chem	58	3875-91	2015	-	-	7.5	-	50 mM Tris-Hcl and 100 mM KCl	Surface Plasmon Resonance	RBIND	CCN1C2=C(C=C(C=C2)/C=C/C3=[N+](C4=CC=CC=C4C=C3)C)C5=CC=CC=C51	9-ethyl-3-[(E)-2-(1-methylquinolin-1-ium-2-yl)ethenyl]carbazole	71699739	5.96250000000001	363.18557515609	1	0	3	8.81	5	0.349620994786739	2.49138915817111	28	UGGGGGACGGGUAGGGGCGGGAGGUAGGGG	10.1021/acs.jmedchem.5b00139	mRNA	-	30	5'-UTR	G-Quadruplex	0	0	0	0	1.92E-05	1.92E-05	0	0	0	0
1175	Methylquinolinium 22	Target_lig_672	A10-RNA-WT QGRS in ADAM10 mRNA	Homo sapiens	Alzheimer’s disease	Target_196	0	0	2.60E-06	0	0	0	0	-	-	10.1021/acs.jmedchem.5b00139	25822852	Discovery of Small Molecules for Up-Regulating the Translation of Antiamyloidogenic Secretase, a Disintegrin and Metalloproteinase 10 (ADAM10), by Binding to the G-Quadruplex-Forming Sequence in the 5' Untranslated Region (UTR) of Its mRNA.	Dai J, Liu ZQ, Wang XQ, Lin J, Yao PF, Huang SL, Ou TM, Tan JH, Li D, Gu LQ, Huang ZS	J Med Chem	58	3875-91	2015	-	-	7.5	-	50 mM Tris-Hcl and 100 mM KCl	Surface Plasmon Resonance	RBIND	C[NH+]1CCN(CC1)C1=C2C=CC=CC2=[N+](C)C(C=CC2=CC=C(C=C2)N2CCOCC2)=C1	-	-	2.006	430.27216454818	3	1	4	24.03	3	0.641056396487443	3.45780724157761	32	UGGGGGACGGGUAGGGGCGGGAGGUAGGGG	10.1021/acs.jmedchem.5b00139	mRNA	-	30	5'-UTR	G-Quadruplex	0	0	0	0	2.60E-06	2.60E-06	0	0	0	0
1176	Methylquinolinium 23	Target_lig_673	A10-RNA-WT QGRS in ADAM10 mRNA	Homo sapiens	Alzheimer’s disease	Target_196	0	0	1.80E-06	0	0	0	0	-	-	10.1021/acs.jmedchem.5b00139	25822852	Discovery of Small Molecules for Up-Regulating the Translation of Antiamyloidogenic Secretase, a Disintegrin and Metalloproteinase 10 (ADAM10), by Binding to the G-Quadruplex-Forming Sequence in the 5' Untranslated Region (UTR) of Its mRNA.	Dai J, Liu ZQ, Wang XQ, Lin J, Yao PF, Huang SL, Ou TM, Tan JH, Li D, Gu LQ, Huang ZS	J Med Chem	58	3875-91	2015	-	-	7.5	-	50 mM Tris-Hcl and 100 mM KCl	Surface Plasmon Resonance	RBIND	C[NH+]1CCN(CC1)C1=C2C=CC=CC2=[N+](C)C(C=CC2=CC3=CC=CC=C3N2)=C1	-	-	2.6507	384.23029973618	1	2	3	27.35	4	0.522327790725783	3.67857677672484	29	UGGGGGACGGGUAGGGGCGGGAGGUAGGGG	10.1021/acs.jmedchem.5b00139	mRNA	-	30	5'-UTR	G-Quadruplex	0	0	0	0	1.80E-06	1.80E-06	0	0	0	0
1177	Methylquinolinium 24	Target_lig_674	A10-RNA-WT QGRS in ADAM10 mRNA	Homo sapiens	Alzheimer’s disease	Target_196	0	0	6.10E-06	0	0	0	0	-	-	10.1021/acs.jmedchem.5b00139	25822852	Discovery of Small Molecules for Up-Regulating the Translation of Antiamyloidogenic Secretase, a Disintegrin and Metalloproteinase 10 (ADAM10), by Binding to the G-Quadruplex-Forming Sequence in the 5' Untranslated Region (UTR) of Its mRNA.	Dai J, Liu ZQ, Wang XQ, Lin J, Yao PF, Huang SL, Ou TM, Tan JH, Li D, Gu LQ, Huang ZS	J Med Chem	58	3875-91	2015	-	-	7.5	-	50 mM Tris-Hcl and 100 mM KCl	Surface Plasmon Resonance	RBIND	CCN1C2=C(C=CC=C2)C2=C1C=CC(C=CC1=CC(N3CC[NH+](C)CC3)=C3C=CC=CC3=[N+]1C)=C2	-	-	4.2972	462.27724992818	2	1	4	16.49	5	0.394193215369512	3.48028284106987	35	UGGGGGACGGGUAGGGGCGGGAGGUAGGGG	10.1021/acs.jmedchem.5b00139	mRNA	-	30	5'-UTR	G-Quadruplex	0	0	0	0	6.10E-06	6.10E-06	0	0	0	0
1178	Methylquinolinium 24	Target_lig_674	A10-RNA-WT QGRS in ADAM10 mRNA Mutant	Homo sapiens	Alzheimer’s disease	Target_197	0	0	0.7	0	0	0	0	-	-	10.1021/acs.jmedchem.5b00139	25822852	Discovery of Small Molecules for Up-Regulating the Translation of Antiamyloidogenic Secretase, a Disintegrin and Metalloproteinase 10 (ADAM10), by Binding to the G-Quadruplex-Forming Sequence in the 5' Untranslated Region (UTR) of Its mRNA.	Dai J, Liu ZQ, Wang XQ, Lin J, Yao PF, Huang SL, Ou TM, Tan JH, Li D, Gu LQ, Huang ZS	J Med Chem	58	3875-91	2015	-	-	7.5	-	50 mM Tris-Hcl and 100 mM KCl	Surface Plasmon Resonance	RBIND	CCN1C2=C(C=CC=C2)C2=C1C=CC(C=CC1=CC(N3CC[NH+](C)CC3)=C3C=CC=CC3=[N+]1C)=C2	-	-	4.2972	462.27724992818	2	1	4	16.49	5	0.394193215369512	3.48028284106987	35	UGGGGGACGGGUAGGGGCGGGAGGUAGGGG	10.1021/acs.jmedchem.5b00139	mRNA	-	30	5'-UTR	G-Quadruplex	0	0	0	0	0.7	0.7	0	0	0	0
1179	Methylquinolinium 24	Target_lig_674	A10-RNA-WT QGRS in ADAM10 mRNA	Homo sapiens	Alzheimer’s disease	Target_196	0	0	4.9000000000000005e-06±3e-07	0	0	0	0	-	-	10.1021/acs.jmedchem.5b00139	25822852	Discovery of Small Molecules for Up-Regulating the Translation of Antiamyloidogenic Secretase, a Disintegrin and Metalloproteinase 10 (ADAM10), by Binding to the G-Quadruplex-Forming Sequence in the 5' Untranslated Region (UTR) of Its mRNA.	Dai J, Liu ZQ, Wang XQ, Lin J, Yao PF, Huang SL, Ou TM, Tan JH, Li D, Gu LQ, Huang ZS	J Med Chem	58	3875-91	2015	-	-	7.5	-	50 mM Tris-Hcl and 100 mM KCl	Surface Plasmon Resonance	RBIND	CCN1C2=C(C=CC=C2)C2=C1C=CC(C=CC1=CC(N3CC[NH+](C)CC3)=C3C=CC=CC3=[N+]1C)=C2	-	-	4.2972	462.27724992818	2	1	4	16.49	5	0.394193215369512	3.48028284106987	35	UGGGGGACGGGUAGGGGCGGGAGGUAGGGG	10.1021/acs.jmedchem.5b00139	mRNA	-	30	5'-UTR	G-Quadruplex	0	0	0	0	4.60E-06	5.20E-06	0	0	0	0
1180	Compound 1	Target_lig_675	DDPAC MAPT A Bulge	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	9.999999999999999e-06±1e-06	0	0	0	0	-	-	10.1002/cbic.201402069	25115866	Bottom-up design of small molecules that stimulate exon 10 skipping in mutant MAPT pre-mRNA	Luo Y, Disney MD	Chembiochem	15	2041-4	2014	-	-	7.5	-	10 mM Tris-Hcl, 100 mM KCl, and 0.1 mM EDTA	Microscale Thermophoresis	RBIND	NC1=CC=C(C=C1)C1=CC2=CC=C(C=C2N1)C1=[NH+]CCN1	-	-	0.847499999999999	277.14477296409	2	4	2	67.81	3	0.524595605869462	3.32880565517162	21	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	9.00E-06	1.10E-05	0	0	0	0
1181	Compound 2	Target_lig_676	DDPAC MAPT A Bulge	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	1.4e-05±2e-06	0	0	0	0	-	-	10.1002/cbic.201402069	25115866	Bottom-up design of small molecules that stimulate exon 10 skipping in mutant MAPT pre-mRNA	Luo Y, Disney MD	Chembiochem	15	2041-4	2014	-	-	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	1.20E-05	1.60E-05	0	0	0	0
1182	Compound 2	Target_lig_676	DDPAC + I17T Mutant	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_199	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1002/cbic.201402069	25115866	Bottom-up design of small molecules that stimulate exon 10 skipping in mutant MAPT pre-mRNA	Luo Y, Disney MD	Chembiochem	15	2041-4	2014	-	-	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	0.0001	0.0001	0	0	0	0
1183	Compound 2	Target_lig_676	MAPT A WT	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_200	0	0	1.4e-05±2e-06	0	0	0	0	-	-	10.1002/cbic.201402069	25115866	Bottom-up design of small molecules that stimulate exon 10 skipping in mutant MAPT pre-mRNA	Luo Y, Disney MD	Chembiochem	15	2041-4	2014	-	-	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	1.20E-05	1.60E-05	0	0	0	0
1184	Compound 2	Target_lig_676	r(CCG)12	Synthetic	Fragile X-E syndrome	Target_181	0	0	9.999999999999999e-06±2e-06	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	-	-	-	-	-	Biolayer Interferometry	RBIND	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	CCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCG	10.1016/j.neuron.2014.07.041	RNA aptamer, mRNA	Expanded Repeats	36	-	Internal Loop	0	0	0	0	8.00E-06	1.20E-05	0	0	0	0
1185	Compound 2	Target_lig_676	r(GGCC)4	Synthetic	-	Target_182	0	0	7.2e-06±2e-06	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	-	-	-	-	-	Biolayer Interferometry	RBIND	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GGCCGGCCGGCCGGCC	10.1016/j.neuron.2014.07.041	RNA aptamer, mRNA	Expanded Repeats	16	-	Internal Loop	0	0	0	0	5.20E-06	9.20E-06	0	0	0	0
1186	Compound 2	Target_lig_676	Hairpin	Synthetic	-	Target_183	0	0	>3.9999999999999996e-05	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	-	-	-	-	-	Biolayer Interferometry	RBIND	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.1016/j.neuron.2014.07.041	RNA aptamer	Expanded Repeats	48	-	Hairpin	0	0	0	0	4.00E-05	4.00E-05	0	0	0	0
1187	Compound 2	Target_lig_676	Hairpin Conformation of r(GGGGCC)8	Synthetic	-	Target_183	0	0	1.4999999999999999e-05±1e-06	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	-	-	-	-	-	Biolayer Interferometry	RBIND	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.1016/j.neuron.2014.07.041	RNA aptamer	Expanded Repeats	48	-	Hairpin	0	0	0	0	1.40E-05	1.60E-05	0	0	0	0
1188	Compound 2	Target_lig_676	G-Quadruplex Conformation of r(GGGGCC)8	Synthetic	-	Target_184	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	-	-	-	-	-	Biolayer Interferometry	RBIND	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.1016/j.neuron.2014.07.041	RNA aptamer	Expanded Repeats	48	-	G-Quadruplex	0	0	0	0	0.0001	0.0001	0	0	0	0
1189	Compound 4	Target_lig_654	DDPAC MAPT A Bulge	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	5.3e-05±8e-06	0	0	0	0	-	-	10.1002/cbic.201402069	25115866	Bottom-up design of small molecules that stimulate exon 10 skipping in mutant MAPT pre-mRNA	Luo Y, Disney MD	Chembiochem	15	2041-4	2014	-	-	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N(C)[C@@H](C\C=C\C[C@H](N(C)C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+])C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	6.74980000000001	1326.73066080818	10	4	28	261.12	8	0.022777967565924	6.35803538202521	98	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	4.50E-05	6.10E-05	0	0	0	0
1190	Benzimidazole 1 (2014)	Target_lig_678	5'UUU/3'AUA, miR-96 Precursor Processing Site	Homo sapiens	Cancer	Target_202	0	0	1.3e-06±1e-07	0	0	0	0	-	-	10.1038/nchembio.1452	24509821	Sequence-based design of bioactive small molecules that target precursor microRNAs.	Velagapudi SP, Gallo SM, Disney MD	Nat Chem Biol	10	291-7	2014	-	-	7	-	8 mM Na2HPO4, 190 mM NaCl, 1 mM EDTA and 40 μg/mL BSA	Fluorescence-based titration (Labeled Small molecule)	RBIND	CC(C)(C)C1=CC(=CC(=C1OCCCC(=O)NCCCN=[N+]=[N-])C(C)(C)C)C2=NC3=C(N2)C=C(C=C3)N4CCN(CC4)C	N-(3-azidopropyl)-4-[2,6-ditert-butyl-4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]phenoxy]butanamide	72699186	6.55230000000001	588.390022776	6	2	11	122.25	3	0.113792743303234	3.10760193000253	43	UGGCCGAUUUUGGCACUAGCACAUUUUUGCUUGUGUCUCUCCGCUCUGAGCAAUCAUGUGCAGUGCCAAUAUGGGAAA	10.1038/nchembio.1452	miRNA	miRNA	78	Precursor Processing site	Internal Loop	0	0	0	0	1.20E-06	1.40E-06	0	0	0	0
1191	Benzimidazole 1 (2014)	Target_lig_678	5'CGAUUU/3'GGUAUA, Expanded miR-96 Precursor Processing Site	Homo sapiens	Cancer	Target_203	0	0	3.3999999999999996e-06±1e-07	0	0	0	0	-	-	10.1038/nchembio.1452	24509821	Sequence-based design of bioactive small molecules that target precursor microRNAs.	Velagapudi SP, Gallo SM, Disney MD	Nat Chem Biol	10	291-7	2014	-	-	7	-	8 mM Na2HPO4, 190 mM NaCl, 1 mM EDTA and 40 μg/mL BSA	Fluorescence-based titration (Labeled Small molecule)	RBIND	CC(C)(C)C1=CC(=CC(=C1OCCCC(=O)NCCCN=[N+]=[N-])C(C)(C)C)C2=NC3=C(N2)C=C(C=C3)N4CCN(CC4)C	N-(3-azidopropyl)-4-[2,6-ditert-butyl-4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]phenoxy]butanamide	72699186	6.55230000000001	588.390022776	6	2	11	122.25	3	0.113792743303234	3.10760193000253	43	UGGCCGAUUUUGGCACUAGCACAUUUUUGCUUGUGUCUCUCCGCUCUGAGCAAUCAUGUGCAGUGCCAAUAUGGGAAA	10.1038/nchembio.1452	miRNA	miRNA	78	Precursor Processing site	Internal Loop	0	0	0	0	3.30E-06	3.50E-06	0	0	0	0
1192	D6	Target_lig_679	5'CAG/3'GAC	Synthetic	Cancer	Target_204	0	0	6e-08±3e-08	0	0	0	0	-	-	10.1021/cb200413a	22252896	Chemical correction of pre-mRNA splicing defects associated with sequestration of muscleblind-like 1 protein by expanded r(CAG)-containing transcripts.	Kumar A, Parkesh R, Sznajder LJ, Childs-Disney JL, Sobczak K, Disney MD	ACS Chem Biol	7	496-505	2012	50 nM	-	7.5	-	20 mM HEPES, 5 mM KCl, 150 mM NaCl, and 1 mM MgCl2	Fluorescence Displacement	RBIND	C1=CC(=CC=C1C(=O)OC2=CC=C(C=C2)[NH+]=C(N)N)[NH+]=C(N)N	diaminomethylidene-[4-[4-(diaminomethylideneazaniumyl)benzoyl]oxyphenyl]azanium	118724998	-3.1232	314.14802665618	2	6	4	158.32	2	0.151517572238115	3.92144986912768	23	GGGAGAGGGUUUAAUAUCAGUAUACGAAAGUAUACAGAUAUUGGAUCCGCAAGG	10.1021/cb200413a	RNA aptamer	Expanded Repeats	54	5’-UTR	Internal Loop	0	0	0	0	3.00E-08	9.00E-08	0	0	0	0
1193	Hydroxyellipticine 1a	Target_lig_680	r(CGG)12-DGCR8Δ Complex	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	3.7999999999999996e-06±3e-07	0	0	0	-	-	10.1021/acschembio.6b00147	27276216	Small Molecule Recognition and Tools to Study Modulation of r(CGG)(exp) in Fragile X-Associated Tremor Ataxia Syndrome.	Yang WY, He F, Strack RL, Oh SY, Frazer M, Jaffrey SR, Todd PK, Disney MD	ACS Chem Biol	11	2456-65	2016	-	-	-	-	-	TR-FRET	RBIND	CC1=C2C=C[N+](CC[NH+]3CCCCC3)=CC2=C(C)C2=C1NC1=C2C=C(O)C=C1	-	-	3.15304	375.22996538818	1	3	3	44.34	4	0.473376479540865	3.90309301474813	28	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	3.50E-06	4.10E-06	0	0
1194	Hydroxyellipticine 1a	Target_lig_680	r(CGG)12-DGCR8Δ Complex, 62-fold Excess tRNA	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	2.01e-05±1.2e-06	0	0	0	-	-	10.1021/acschembio.6b00147	27276216	Small Molecule Recognition and Tools to Study Modulation of r(CGG)(exp) in Fragile X-Associated Tremor Ataxia Syndrome.	Yang WY, He F, Strack RL, Oh SY, Frazer M, Jaffrey SR, Todd PK, Disney MD	ACS Chem Biol	11	2456-65	2016	-	-	-	-	-	TR-FRET	RBIND	CC1=C2C=C[N+](CC[NH+]3CCCCC3)=CC2=C(C)C2=C1NC1=C2C=C(O)C=C1	-	-	3.15304	375.22996538818	1	3	3	44.34	4	0.473376479540865	3.90309301474813	28	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	1.89E-05	2.13E-05	0	0
1195	Hydroxyellipticine 1a	Target_lig_680	r(CGG)12	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	8.00E-07	0	0	0	0	-	-	10.1021/acschembio.6b00147	27276216	Small Molecule Recognition and Tools to Study Modulation of r(CGG)(exp) in Fragile X-Associated Tremor Ataxia Syndrome.	Yang WY, He F, Strack RL, Oh SY, Frazer M, Jaffrey SR, Todd PK, Disney MD	ACS Chem Biol	11	2456-65	2016	-	-	-	-	1 X Kinetics Buffer (ForteBio)	Biolayer Interferometry	RBIND	CC1=C2C=C[N+](CC[NH+]3CCCCC3)=CC2=C(C)C2=C1NC1=C2C=C(O)C=C1	-	-	3.15304	375.22996538818	1	3	3	44.34	4	0.473376479540865	3.90309301474813	28	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	8.00E-07	8.00E-07	0	0	0	0
1196	Hydroxyellipticine 1a	Target_lig_680	r(CGG)12-DGCR8Δ Complex, 5 µM tRNA	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	1.2e-05±4e-07	0	0	0	-	-	10.1021/cb300135h	22948243	A small molecule that targets r(CGG)(exp) and improves defects in fragile X-associated tremor ataxia syndrome.	Disney MD, Liu B, Yang WY, Sellier C, Tran T, Charlet-Berguerand N, Childs-Disney JL	ACS Chem Biol	7	1711-8	2012	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CC1=C2C=C[N+](CC[NH+]3CCCCC3)=CC2=C(C)C2=C1NC1=C2C=C(O)C=C1	-	-	3.15304	375.22996538818	1	3	3	44.34	4	0.473376479540865	3.90309301474813	28	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	1.16E-05	1.24E-05	0	0
1197	Hydroxyellipticine 1a	Target_lig_680	5'CGG/3'GGC Loop	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_205	0	0	7.599999999999999e-08±4e-09	0	0	0	0	-	-	10.1021/cb300135h	22948243	A small molecule that targets r(CGG)(exp) and improves defects in fragile X-associated tremor ataxia syndrome.	Disney MD, Liu B, Yang WY, Sellier C, Tran T, Charlet-Berguerand N, Childs-Disney JL	ACS Chem Biol	7	1711-8	2012	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 110 mM NaCl, 0.1% (w/v) BSA, 2 mM MgCl2, 2 mM CaCl2, 0.05% (v/v) Tween-20, and 5 mM DTT	TR-FRET	RBIND	CC1=C2C=C[N+](CC[NH+]3CCCCC3)=CC2=C(C)C2=C1NC1=C2C=C(O)C=C1	-	-	3.15304	375.22996538818	1	3	3	44.34	4	0.473376479540865	3.90309301474813	28	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb300135h	RNA aptamer	Expanded Repeats	36	5’-UTR	Internal Loop	0	0	0	0	7.20E-08	8.00E-08	0	0	0	0
1198	Hydroxyellipticine 1a	Target_lig_680	r(CGG)12	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	9.699999999999999e-06±1e-06	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	-	-	-	-	-	Biolayer Interferometry	RBIND	CC1=C2C=C[N+](CC[NH+]3CCCCC3)=CC2=C(C)C2=C1NC1=C2C=C(O)C=C1	-	-	3.15304	375.22996538818	1	3	3	44.34	4	0.473376479540865	3.90309301474813	28	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	8.70E-06	1.07E-05	0	0	0	0
1199	Hydroxyellipticine 1a	Target_lig_680	r(GGCC)4	Synthetic	-	Target_182	0	0	8.4e-06±3.2e-06	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	-	-	-	-	-	Biolayer Interferometry	RBIND	CC1=C2C=C[N+](CC[NH+]3CCCCC3)=CC2=C(C)C2=C1NC1=C2C=C(O)C=C1	-	-	3.15304	375.22996538818	1	3	3	44.34	4	0.473376479540865	3.90309301474813	28	GGCCGGCCGGCCGGCC	10.1016/j.neuron.2014.07.041	RNA aptamer, mRNA	Expanded Repeats	16	-	Internal Loop	0	0	0	0	5.20E-06	1.16E-05	0	0	0	0
1200	Hydroxyellipticine 1a	Target_lig_680	Hairpin	Synthetic	-	Target_183	0	0	>4.9999999999999996e-05	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	-	-	-	-	-	Biolayer Interferometry	RBIND	CC1=C2C=C[N+](CC[NH+]3CCCCC3)=CC2=C(C)C2=C1NC1=C2C=C(O)C=C1	-	-	3.15304	375.22996538818	1	3	3	44.34	4	0.473376479540865	3.90309301474813	28	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.1016/j.neuron.2014.07.041	RNA aptamer	Expanded Repeats	48	-	Hairpin	0	0	0	0	5.00E-05	5.00E-05	0	0	0	0
1201	Hydroxyellipticine 1a	Target_lig_680	Hairpin Conformation of r(GGGGCC)8	Synthetic	-	Target_183	0	0	7.099999999999999e-05±7e-06	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	-	-	-	-	100 mM NaCl	Biolayer Interferometry	RBIND	CC1=C2C=C[N+](CC[NH+]3CCCCC3)=CC2=C(C)C2=C1NC1=C2C=C(O)C=C1	-	-	3.15304	375.22996538818	1	3	3	44.34	4	0.473376479540865	3.90309301474813	28	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.1016/j.neuron.2014.07.041	RNA aptamer	Expanded Repeats	48	-	Hairpin	0	0	0	0	6.40E-05	7.80E-05	0	0	0	0
1202	Hydroxyellipticine 1a	Target_lig_680	G-Quadruplex Conformation of r(GGGGCC)8	Synthetic	-	Target_184	0	0	8.2e-05±8e-06	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	-	-	-	-	100 mM Kcl	Biolayer Interferometry	RBIND	CC1=C2C=C[N+](CC[NH+]3CCCCC3)=CC2=C(C)C2=C1NC1=C2C=C(O)C=C1	-	-	3.15304	375.22996538818	1	3	3	44.34	4	0.473376479540865	3.90309301474813	28	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.1016/j.neuron.2014.07.041	RNA aptamer	Expanded Repeats	48	-	G-Quadruplex	0	0	0	0	7.40E-05	9.00E-05	0	0	0	0
1203	Benzimidazole 1 (2015)	Target_lig_681	r(CUG)12-MBNL1 Complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	6.379999999999999e-05±3.2e-06	0	0	0	-	-	10.1021/acschembio.5b00430	26414664	Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy.	Rzuczek SG, Southern MR, Disney MD	ACS Chem Biol	10	2706-15	2015	-	-	7.5	-	20 mM HEPES, 100 M KCl, 10 mM NaCl, 2 mM MgCl2, 2 mM CaCl2, 5 mM DTT, 0.1 % BSA, and 0.05 % Tween 20	TR-FRET	RBIND	C1=CC2=C(C=C1[N+](=O)[O-])NC(=N2)CCCC3=NC4=C(N3)C=C(C=C4)[N+](=O)[O-]	6-nitro-2-[3-(6-nitro-1H-benzimidazol-2-yl)propyl]-1H-benzimidazole	3096126	3.4309	366.107652928	6	2	6	143.64	4	0.394987174587706	2.52899808971015	27	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	6.06E-05	6.70E-05	0	0
1204	Benzimidazole 16 (2015)	Target_lig_682	r(CUG)12-MBNL1 Complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	9.2e-05±6e-06	0	0	0	-	-	10.1021/acschembio.5b00430	26414664	Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy.	Rzuczek SG, Southern MR, Disney MD	ACS Chem Biol	10	2706-15	2015	-	-	7.5	-	20 mM HEPES, 100 M KCl, 10 mM NaCl, 2 mM MgCl2, 2 mM CaCl2, 5 mM DTT, 0.1 % BSA, and 0.05 % Tween 20	TR-FRET	RBIND	C1=COC(=C1)C(=O)NC2=CC=C(C=C2)C3=NC4=C(N3)C=C(C=C4)NC(=O)C5=CC=CO5	N-[4-[6-(furan-2-carbonylamino)-1H-benzimidazol-2-yl]phenyl]furan-2-carboxamide	3149812	4.9205	412.117154992	5	3	5	113.16	5	0.379147180949031	2.22826684815016	31	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	8.60E-05	9.80E-05	0	0
1205	Benzimidazole 17 (2015)	Target_lig_683	r(CUG)12-MBNL1 Complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.00012869999999999998±1.4e-06	0	0	0	-	-	10.1021/acschembio.5b00430	26414664	Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy.	Rzuczek SG, Southern MR, Disney MD	ACS Chem Biol	10	2706-15	2015	-	-	7.5	-	20 mM HEPES, 100 M KCl, 10 mM NaCl, 2 mM MgCl2, 2 mM CaCl2, 5 mM DTT, 0.1 % BSA, and 0.05 % Tween 20	TR-FRET	RBIND	C1=CC=C2C(=C1)NC(=N2)C3=CC=C(C=C3)NC(=O)C4=CC=C(O4)C5=CC=C(C=C5)Cl	N-[4-(1H-benzimidazol-2-yl)phenyl]-5-(4-chlorophenyl)furan-2-carboxamide	1112705	6.3956	413.093104432	3	2	4	70.92	5	0.358015133307402	2.04482735441651	30	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.0001273	0.0001301	0	0
1206	H1	Target_lig_684	r(CUG)12-MBNL1 Complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	5.00E-05	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	-	-	7.5	-	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl2, 2 mM CaCl2, 5 mM DTT, 0.1% BSA, and 0.5% Tween-20	QTR-FRET	RBIND	C1=CC(=CC(=C1)N)C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)N=C(N5)C6=CC(=CC=C6)N	3-[6-[2-(3-aminophenyl)-3H-benzimidazol-5-yl]-1H-benzimidazol-2-yl]aniline	4644404	5.6046	416.17494464	4	4	3	109.4	6	0.28131179515576	2.42529087596866	32	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	5.00E-05	5.00E-05	0	0
1207	H1	Target_lig_684	5'CUG/3'GUC, DM1 Motif	Synthetic	Myotonic dystrophy 1 (DM1)	Target_206	0	0	7e-08±3.2e-08	0	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	-	-	7	-	8 mM Na2PO4, 185 mM NaCl, and 0.1 mM EDTA	Fluorescence Anisotropy	RBIND	C1=CC(=CC(=C1)N)C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)N=C(N5)C6=CC(=CC=C6)N	3-[6-[2-(3-aminophenyl)-3H-benzimidazol-5-yl]-1H-benzimidazol-2-yl]aniline	4644404	5.6046	416.17494464	4	4	3	109.4	6	0.28131179515576	2.42529087596866	32	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1021/ja210088v	RNA aptamer	Expanded Repeats	46	5’-UTR	Internal Loop	0	0	0	0	3.80E-08	1.02E-07	0	0	0	0
1208	H1	Target_lig_684	Fully Paired RNA	Synthetic	-	Target_207	0	0	1.8999999999999998e-07±6.099999999999999e-08	0	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	-	-	7	-	8 mM Na2PO4, 185 mM NaCl, and 0.1 mM EDTA	Fluorescence Anisotropy	RBIND	C1=CC(=CC(=C1)N)C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)N=C(N5)C6=CC(=CC=C6)N	3-[6-[2-(3-aminophenyl)-3H-benzimidazol-5-yl]-1H-benzimidazol-2-yl]aniline	4644404	5.6046	416.17494464	4	4	3	109.4	6	0.28131179515576	2.42529087596866	32	GGGAGAGGGUUUAAUUAAAAGUCGACGAAAGUCGUCGCUAAUUGGAUCCGCAAGG	10.1021/ja210088v	RNA aptamer	-	55	-	Double Stranded RNA (dsRNA)	0	0	0	0	1.29E-07	2.51E-07	0	0	0	0
1209	Lomofungin	Target_lig_685	r(CUG)10	Synthetic	Myotonic dystrophy 1 (DM1)	Target_170	0	0	9.98e-07±1.8e-07	0	0	0	0	-	-	10.1093/nar/gku275	24799433	Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects.	Hoskins JW, Ofori LO, Chen CZ, Kumar A, Sobczak K, Nakamori M, Southall N, Patnaik S, Marugan JJ, Zheng W, Austin CP, Disney MD, Miller BL, Thornton CA	Nucleic Acids Res	42	6591-602	2014	-	-	-	-	1 X HEPES buffered saline with 0.5% DMSO and 0.005% Tween-20	Fluorescence-based titration (Labeled RNA)	RBIND	COC(=O)C1=C2C(=NC\3=C(N2)C(=O)C=C(/C3=C\O)O)C(=O)C=C1	methyl (6Z)-7-hydroxy-6-(hydroxymethylidene)-4,9-dioxo-10H-phenazine-1-carboxylate	135426834	-0.056400000000001	314.05388604	7	3	1	129.58	3	0.423671627973552	3.25599911363317	23			RNA aptamer, mRNA	Expanded Repeats	0	3'-UTR	Internal Loop	0	0	0	0	8.18E-07	1.18E-06	0	0	0	0
1210	Lomofungin	Target_lig_685	r(CUG)12-MBNL1 Complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	7.17E-07	0	0	0	-	-	10.1093/nar/gku275	24799433	Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects.	Hoskins JW, Ofori LO, Chen CZ, Kumar A, Sobczak K, Nakamori M, Southall N, Patnaik S, Marugan JJ, Zheng W, Austin CP, Disney MD, Miller BL, Thornton CA	Nucleic Acids Res	42	6591-602	2014	-	-	-	-	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl2, 2 mM CaCl2, 5 mM DTT, 0.1 % BSA, and 0.05 % Tween 20	Alphascreen	RBIND	COC(=O)C1=C2C(=NC\3=C(N2)C(=O)C=C(/C3=C\O)O)C(=O)C=C1	methyl (6Z)-7-hydroxy-6-(hydroxymethylidene)-4,9-dioxo-10H-phenazine-1-carboxylate	135426834	-0.056400000000001	314.05388604	7	3	1	129.58	3	0.423671627973552	3.25599911363317	23	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	7.17E-07	7.17E-07	0	0
1211	Naphthyridine 2	Target_lig_686	r(CUG)12-MBNL1 Complex	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	2e-06±4e-07	0	0	0	-	-	10.1038/ncomms3044	23806903	Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.	Childs-Disney JL, Stepniak-Konieczna E, Tran T, Yildirim I, Park H, Chen CZ, Hoskins J, Southall N, Marugan JJ, Patnaik S, Zheng W, Austin CP, Schatz GC, Sobczak K, Thornton CA, Disney MD	Nat Commun	4	2044	2013	-	-	-	-	-	TR-FRET	RBIND	C1CCN(C1)C2=NC(=C3C(=C2)C(=C(N=C3N)N4CCCC4)C#N)N	1,8-diamino-3,6-dipyrrolidin-1-yl-2,7-naphthyridine-4-carbonitrile	2997948	1.86628	323.185843672	7	2	2	108.09	2	0.868036129600635	2.69927226887296	24	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	1.60E-06	2.40E-06	0	0
1212	Naphthyridine 2	Target_lig_686	r(CAG)12-MBNL1 Complex	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_186	0	0	0	3.7e-05±4.9999999999999996e-06	0	0	0	-	-	10.1038/ncomms3044	23806903	Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.	Childs-Disney JL, Stepniak-Konieczna E, Tran T, Yildirim I, Park H, Chen CZ, Hoskins J, Southall N, Marugan JJ, Patnaik S, Zheng W, Austin CP, Schatz GC, Sobczak K, Thornton CA, Disney MD	Nat Commun	4	2044	2013	-	-	-	-	-	TR-FRET	RBIND	C1CCN(C1)C2=NC(=C3C(=C2)C(=C(N=C3N)N4CCCC4)C#N)N	1,8-diamino-3,6-dipyrrolidin-1-yl-2,7-naphthyridine-4-carbonitrile	2997948	1.86628	323.185843672	7	2	2	108.09	2	0.868036129600635	2.69927226887296	24	GGGAGAGGGUUUAAUCAGCAGCAGCAGCAGCAGUACGAAAGUACAGCAGCAGCAGCAGCAGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	76	Exon 1	Internal Loop	0	0	0	0	0	0	3.20E-05	4.20E-05	0	0
1213	Naphthyridine 2	Target_lig_686	r(CGG)12-MBNL1 Complex	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0	4.4999999999999996e-05±4.9999999999999996e-06	0	0	0	-	-	10.1038/ncomms3044	23806903	Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.	Childs-Disney JL, Stepniak-Konieczna E, Tran T, Yildirim I, Park H, Chen CZ, Hoskins J, Southall N, Marugan JJ, Patnaik S, Zheng W, Austin CP, Schatz GC, Sobczak K, Thornton CA, Disney MD	Nat Commun	4	2044	2013	-	-	-	-	-	TR-FRET	RBIND	C1CCN(C1)C2=NC(=C3C(=C2)C(=C(N=C3N)N4CCCC4)C#N)N	1,8-diamino-3,6-dipyrrolidin-1-yl-2,7-naphthyridine-4-carbonitrile	2997948	1.86628	323.185843672	7	2	2	108.09	2	0.868036129600635	2.69927226887296	24	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	0	0	4.00E-05	5.00E-05	0	0
1214	Naphthyridine 2	Target_lig_686	r(CCUG)12-MBNL1 Complex	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	2.9e-05±3e-06	0	0	0	-	-	10.1038/ncomms3044	23806903	Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.	Childs-Disney JL, Stepniak-Konieczna E, Tran T, Yildirim I, Park H, Chen CZ, Hoskins J, Southall N, Marugan JJ, Patnaik S, Zheng W, Austin CP, Schatz GC, Sobczak K, Thornton CA, Disney MD	Nat Commun	4	2044	2013	-	-	-	-	-	TR-FRET	RBIND	C1CCN(C1)C2=NC(=C3C(=C2)C(=C(N=C3N)N4CCCC4)C#N)N	1,8-diamino-3,6-dipyrrolidin-1-yl-2,7-naphthyridine-4-carbonitrile	2997948	1.86628	323.185843672	7	2	2	108.09	2	0.868036129600635	2.69927226887296	24	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	2.60E-05	3.20E-05	0	0
1215	Naphthyridine 2	Target_lig_686	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	1.25E-07	0	0	0	0	-	-	10.1038/ncomms3044	23806903	Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.	Childs-Disney JL, Stepniak-Konieczna E, Tran T, Yildirim I, Park H, Chen CZ, Hoskins J, Southall N, Marugan JJ, Patnaik S, Zheng W, Austin CP, Schatz GC, Sobczak K, Thornton CA, Disney MD	Nat Commun	4	2044	2013	-	-	-	-	1xPBS	Fluorescence Anisotropy	RBIND	C1CCN(C1)C2=NC(=C3C(=C2)C(=C(N=C3N)N4CCCC4)C#N)N	1,8-diamino-3,6-dipyrrolidin-1-yl-2,7-naphthyridine-4-carbonitrile	2997948	1.86628	323.185843672	7	2	2	108.09	2	0.868036129600635	2.69927226887296	24	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	1.25E-07	1.25E-07	0	0	0	0
1216	Naphthyridine 2	Target_lig_686	r(CAG)12	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_186	0	0	1.40E-06	0	0	0	0	-	-	10.1038/ncomms3044	23806903	Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.	Childs-Disney JL, Stepniak-Konieczna E, Tran T, Yildirim I, Park H, Chen CZ, Hoskins J, Southall N, Marugan JJ, Patnaik S, Zheng W, Austin CP, Schatz GC, Sobczak K, Thornton CA, Disney MD	Nat Commun	4	2044	2013	-	-	-	-	1xPBS	Fluorescence Anisotropy	RBIND	C1CCN(C1)C2=NC(=C3C(=C2)C(=C(N=C3N)N4CCCC4)C#N)N	1,8-diamino-3,6-dipyrrolidin-1-yl-2,7-naphthyridine-4-carbonitrile	2997948	1.86628	323.185843672	7	2	2	108.09	2	0.868036129600635	2.69927226887296	24	GGGAGAGGGUUUAAUCAGCAGCAGCAGCAGCAGUACGAAAGUACAGCAGCAGCAGCAGCAGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	76	Exon 1	Internal Loop	0	0	0	0	1.40E-06	1.40E-06	0	0	0	0
1217	Naphthyridine 2	Target_lig_686	1 X 1 UU Hairpin	Synthetic	-	Target_208	0	0	5.30E-07	0	0	0	0	-	-	10.1038/ncomms3044	23806903	Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.	Childs-Disney JL, Stepniak-Konieczna E, Tran T, Yildirim I, Park H, Chen CZ, Hoskins J, Southall N, Marugan JJ, Patnaik S, Zheng W, Austin CP, Schatz GC, Sobczak K, Thornton CA, Disney MD	Nat Commun	4	2044	2013	-	-	-	-	1xPBS	Fluorescence Anisotropy	RBIND	C1CCN(C1)C2=NC(=C3C(=C2)C(=C(N=C3N)N4CCCC4)C#N)N	1,8-diamino-3,6-dipyrrolidin-1-yl-2,7-naphthyridine-4-carbonitrile	2997948	1.86628	323.185843672	7	2	2	108.09	2	0.868036129600635	2.69927226887296	24	CGCUGCGGAAACGCUGCG	10.1038/ncomms3044	Hairpin	-	18	-	Hairpin	0	0	0	0	5.30E-07	5.30E-07	0	0	0	0
1218	Naphthyridine 2	Target_lig_686	AU stem	Synthetic	-	Target_209	0	0	2.50E-05	0	0	0	0	-	-	10.1038/ncomms3044	23806903	Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.	Childs-Disney JL, Stepniak-Konieczna E, Tran T, Yildirim I, Park H, Chen CZ, Hoskins J, Southall N, Marugan JJ, Patnaik S, Zheng W, Austin CP, Schatz GC, Sobczak K, Thornton CA, Disney MD	Nat Commun	4	2044	2013	-	-	-	-	1xPBS	Fluorescence Anisotropy	RBIND	C1CCN(C1)C2=NC(=C3C(=C2)C(=C(N=C3N)N4CCCC4)C#N)N	1,8-diamino-3,6-dipyrrolidin-1-yl-2,7-naphthyridine-4-carbonitrile	2997948	1.86628	323.185843672	7	2	2	108.09	2	0.868036129600635	2.69927226887296	24	CGCAGCGGAAACGCUGCG	10.1038/ncomms3044	Stem-loop structure	-	18	-	Hairpin	0	0	0	0	2.50E-05	2.50E-05	0	0	0	0
1219	p7	Target_lig_687	5' CUG/3' GUC Internal Loop	Synthetic	Myotonic dystrophy 1 (DM1)	Target_210	0	0	4.599999999999999e-06±5e-07	0	0	0	0	-	-	10.1016/j.bmcl.2016.10.037	27839685	Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1.	Angelbello AJ, González ÀL, Rzuczek SG, Disney MD	Bioorg Med Chem Lett	26	5792-5796	2016	5 uM	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Intrinsic)	RBIND	C1=CC(=CC=C1C(=O)NC2=NC=C(C=C2)NC(=O)C3=CC=NC=C3)F	N-[6-[(4-fluorobenzoyl)amino]pyridin-3-yl]pyridine-4-carboxamide	1449504	3.1203	336.102253876	4	2	4	83.98	3	0.766572526989142	1.85235508233049	25	GGGAGAGGGUUUAAUCUGUACGAAAGUACUGAUUGGAUCCGCAAG	10.1016/j.bmcl.2016.10.037	Internal loop structure	Expanded Repeats	45	5’-UTR	Internal Loop	0	0	0	0	4.10E-06	5.10E-06	0	0	0	0
1220	p7	Target_lig_687	GC Stem Loop	Synthetic	-	Target_211	0	0	>2.9999999999999997e-05	0	0	0	0	-	-	10.1016/j.bmcl.2016.10.037	27839685	Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1.	Angelbello AJ, González ÀL, Rzuczek SG, Disney MD	Bioorg Med Chem Lett	26	5792-5796	2016	5 uM	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Intrinsic)	RBIND	C1=CC(=CC=C1C(=O)NC2=NC=C(C=C2)NC(=O)C3=CC=NC=C3)F	N-[6-[(4-fluorobenzoyl)amino]pyridin-3-yl]pyridine-4-carboxamide	1449504	3.1203	336.102253876	4	2	4	83.98	3	0.766572526989142	1.85235508233049	25	GCGCGCGCGAAAGCGCGCGC	10.1016/j.bmcl.2016.10.037	Stem-loop structure	-	20	-	Hairpin	0	0	0	0	3.00E-05	3.00E-05	0	0	0	0
1221	p7	Target_lig_687	AT Hairpin DNA	Synthetic	-	Target_212	0	0	>4.9999999999999996e-05	0	0	0	0	-	-	10.1016/j.bmcl.2016.10.037	27839685	Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1.	Angelbello AJ, González ÀL, Rzuczek SG, Disney MD	Bioorg Med Chem Lett	26	5792-5796	2016	5 uM	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Intrinsic)	RBIND	C1=CC(=CC=C1C(=O)NC2=NC=C(C=C2)NC(=O)C3=CC=NC=C3)F	N-[6-[(4-fluorobenzoyl)amino]pyridin-3-yl]pyridine-4-carboxamide	1449504	3.1203	336.102253876	4	2	4	83.98	3	0.766572526989142	1.85235508233049	25	CGCGAATTCGCGTTTTCGCGAATTCGCG	10.1016/j.bmcl.2016.10.037	Hairpin	-	28	-	Hairpin	0	0	0	0	5.00E-05	5.00E-05	0	0	0	0
1222	p7	Target_lig_687	tRNA	Saccharomyces cereviseae	-	Target_1	0	0	>4.9999999999999996e-05	0	0	0	0	-	-	10.1016/j.bmcl.2016.10.037	27839685	Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1.	Angelbello AJ, González ÀL, Rzuczek SG, Disney MD	Bioorg Med Chem Lett	26	5792-5796	2016	5 uM	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Intrinsic)	RBIND	C1=CC(=CC=C1C(=O)NC2=NC=C(C=C2)NC(=O)C3=CC=NC=C3)F	N-[6-[(4-fluorobenzoyl)amino]pyridin-3-yl]pyridine-4-carboxamide	1449504	3.1203	336.102253876	4	2	4	83.98	3	0.766572526989142	1.85235508233049	25	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	5.00E-05	5.00E-05	0	0	0	0
1223	IRAB	Target_lig_688	FMDV IRES RNA	Foot-and-mouth disease virus	Hand, foot and mouth disease	Target_213	0	0	0	5.00E-07	0	0	0	-	-	10.1080/15476286.2015.1025190	25775053	Local RNA flexibility perturbation of the IRES element induced by a novel ligand inhibits viral RNA translation.	Lozano G, Trapote A, Ramajo J, Elduque X, Grandas A, Robles J, Pedroso E, Martínez-Salas E	RNA Biol	12	555-68	2015	-	-	-	-	-	Dual luciferase	RBIND	C[NH+](C)CCCN1C(N)=[NH+]C2=CC=C3OC(C[NH+](C)C)=CC3=C12	-	-	-1.0371	318.22773977627	3	3	6	67.11	3	0.543642242713067	5.26001597489691	23	UGUUGCUUCGUAGCGGAGCAUGACGGCCGUGGGAACUCCUCCUUGGUAACAAGGACCCACGGGGCCAAAAGCCACGCCCACACGGGCCCGUCAUGUGUGCAACCCCAGCACGGCGACU	10.1080/15476286.2015.1025190	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	118	5'-UTR	-	0	0	0	0	0	0	5.00E-07	5.00E-07	0	0
1224	IRAB	Target_lig_688	HCV IRES RNA	Hepatitis C virus	Hepatitis C	Target_68	0	0	0	~5e-07	0	0	0	-	-	10.1080/15476286.2015.1025190	25775053	Local RNA flexibility perturbation of the IRES element induced by a novel ligand inhibits viral RNA translation.	Lozano G, Trapote A, Ramajo J, Elduque X, Grandas A, Robles J, Pedroso E, Martínez-Salas E	RNA Biol	12	555-68	2015	-	-	-	-	-	Dual luciferase	RBIND	C[NH+](C)CCCN1C(N)=[NH+]C2=CC=C3OC(C[NH+](C)C)=CC3=C12	-	-	-1.0371	318.22773977627	3	3	6	67.11	3	0.543642242713067	5.26001597489691	23	GAGGAACUACUGGAGACGUGCAGCCUC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	27	-	-	0	0	0	0	0	0	5.00E-07	5.00E-07	0	0
1225	IRAB	Target_lig_688	FMDV IRES RNA, SL3A	Foot-and-mouth disease virus	Hand, foot and mouth disease	Target_214	0	0	0	0	1.86E-05	0	0	-	-	10.1080/15476286.2015.1025190	25775053	Local RNA flexibility perturbation of the IRES element induced by a novel ligand inhibits viral RNA translation.	Lozano G, Trapote A, Ramajo J, Elduque X, Grandas A, Robles J, Pedroso E, Martínez-Salas E	RNA Biol	12	555-68	2015	-	-	7.5	-	10 mM sodium cacodylate buffer and 150 mM NaCl	Fluorescence-based titration (Labeled RNA)	RBIND	C[NH+](C)CCCN1C(N)=[NH+]C2=CC=C3OC(C[NH+](C)C)=CC3=C12	-	-	-1.0371	318.22773977627	3	3	6	67.11	3	0.543642242713067	5.26001597489691	23	UGUUGCUUCGUAGCGGAGCAUGACGGCCGUGGGAACUCCUCCUUGGUAACAAGGACCCACGGGGCCAAAAGCCACGCCCACACGGGCCCGUCAUGUGUGCAACCCCAGCACGGCGACU	10.1080/15476286.2015.1025190	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	118	5'-UTR	-	0	0	0	0	0	0	0	0	1.86E-05	1.86E-05
1226	Benzimidazole 3	Target_lig_1256	HCV IRES IIa 40-mer	Hepatitis C virus	Hepatitis C	Target_67	0	0	1.70E-05	0	0	0	0	-	-	10.1021/jm050815o	16279767	SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.	Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ, Swayze EE, Griffey RH	J Med Chem	48	7099-102	2005	-	-	-	-	100 mM ammonium acetate with 33% isopropyl alcohol	ESI-MS	RBIND	C[NH+](C)CCCOC1=CC=C2[NH+]=C(N)N(CCC[NH+](C)C)C2=C1			-1.5144	322.25903990427	3	3	9	63.2	2	0.491460624443891	5.02453833066614	23	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	1.70E-05	1.70E-05	0	0	0	0
1227	Benzimidazole 10	Target_lig_689	HCV IRES IIa 40-mer	Hepatitis C virus	Hepatitis C	Target_67	0	0	3.50E-06	0	0	0	0	-	-	10.1021/jm050815o	16279767	SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.	Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ, Swayze EE, Griffey RH	J Med Chem	48	7099-102	2005	-	-	-	-	100 mM ammonium acetate with 33% isopropyl alcohol	ESI-MS	RBIND	C[NH+](C)CCCOC1=CC=C2N=C3NCC(C[NH+](C)C)CN3C2=C1	-	-	-0.864099999999995	333.25176345218	4	3	7	47.96	2	0.577914602130262	4.875784969932	24	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	3.50E-06	3.50E-06	0	0	0	0
1228	Benzimidazole 11 / Isis-11	Target_lig_690	HCV IRES IIa 40-mer	Hepatitis C virus	Hepatitis C	Target_67	0	0	1.70E-06	0	0	0	0	-	-	10.1021/jm050815o	16279767	SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.	Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ, Swayze EE, Griffey RH	J Med Chem	48	7099-102	2005	-	-	-	-	100 mM ammonium acetate with 33% isopropyl alcohol	ESI-MS	RBIND	C[NH+](C)CCCN1C(N)=[NH+]C2=CC=C3OC(CC[NH+](C)C)CC3=C12	-	-	-1.5897	334.25903990427	3	3	7	63.2	2	0.57173130265172	5.70879672450754	24	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	1.70E-06	1.70E-06	0	0	0	0
1229	Benzimidazole 11 / Isis-11	Target_lig_690	HCV IRES IIa 38-mer	Hepatitis C virus	Hepatitis C	Target_67	0	0	2.60E-06	0	0	0	0	-	-	10.1073/pnas.0911896107	20360559	Inhibitor-induced structural change in the HCV IRES domain IIa RNA.	Paulsen RB, Seth PP, Swayze EE, Griffey RH, Skalicky JJ, Cheatham TE 3rd, Davis DR	Proc Natl Acad Sci U S A	107	7263-8	2010	-	-	-	-	-	Fluorescence-based titration (Labeled RNA)	RBIND	C[NH+](C)CCCN1C(N)=[NH+]C2=CC=C3OC(CC[NH+](C)C)CC3=C12	-	-	-1.5897	334.25903990427	3	3	7	63.2	2	0.57173130265172	5.70879672450754	24	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	2.60E-06	2.60E-06	0	0	0	0
1230	Benzimidazole 12	Target_lig_691	HCV IRES IIa 40-mer	Hepatitis C virus	Hepatitis C	Target_67	0	0	8.70E-07	0	0	0	0	-	-	10.1021/jm050815o	16279767	SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.	Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ, Swayze EE, Griffey RH	J Med Chem	48	7099-102	2005	-	-	-	-	100 mM ammonium acetate with 33% isopropyl alcohol	ESI-MS	RBIND	C[NH+](C)CCCN1C(N)=[NH+]C2=CC=C3OCC(C[NH+](C)C)CC3=C12	-	-	-1.7322	334.25903990427	3	3	6	63.2	2	0.587776130085208	5.66911199431236	24	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	8.70E-07	8.70E-07	0	0	0	0
1231	Benzimidazole 13 / Isis-13	Target_lig_1257	HCV IRES IIa 40-mer	Hepatitis C virus	Hepatitis C	Target_67	0	0	7.20E-07	0	0	0	0	-	-	10.1021/jm050815o	16279767	SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.	Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ, Swayze EE, Griffey RH	J Med Chem	48	7099-102	2005	-	-	-	-	100 mM ammonium acetate with 33% isopropyl alcohol	ESI-MS	RBIND	C[NH+](C)CC1CNC2=[NH+]C3=CC=C4OCC(C[NH+](C)C)CC4=C3N2C1			-1.66279999999999	346.25903990427	3	3	4	49.21	2	0.620590022602036	6.05112443610268	25	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	7.20E-07	7.20E-07	0	0	0	0
1232	Benzimidazole 13 / Isis-13	Target_lig_1257	HCV IRES IIa RNA	Hepatitis C virus	Hepatitis C	Target_67	0	0	0	0	6e-07±8e-08	0	0	-	-	10.1038/nchembio.217	19767736	Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA.	Parsons J, Castaldi MP, Dutta S, Dibrov SM, Wyles DL, Hermann T	Nat Chem Biol	5	823-5	2009	-	-	-	-	2 mM Mg2+	FRET	RBIND	C[NH+](C)CC1CNC2=[NH+]C3=CC=C4OCC(C[NH+](C)C)CC4=C3N2C1			-1.66279999999999	346.25903990427	3	3	4	49.21	2	0.620590022602036	6.05112443610268	25	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	0	0	0	0	5.20E-07	6.80E-07
1233	Isis-22	Target_lig_692	HCV IRES RNA	Hepatitis C virus	Hepatitis C	Target_68	0	0	2.20E-06	0	0	0	0	-	-	10.1016/j.antiviral.2010.11.004	21075143	Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.	Liu S, Nelson CA, Xiao L, Lu L, Seth PP, Davis DR, Hagedorn CH	Antiviral Res	89	54-63	2011	-	-	-	-	-	Fluorescence-based titration (Labeled RNA)	RBIND	C[NH+](C)CC1CC2=C3N4CC(C[NH+](C)C)CNC4=[NH+]C3=CC=C2O1	-	-	-1.91039999999999	332.24338984027	3	3	4	49.21	2	0.612027104161877	6.14368350057018	24	GAGGAACUACUGGAGACGUGCAGCCUC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	27	-	-	0	0	0	0	2.20E-06	2.20E-06	0	0	0	0
1234	DB213	Target_lig_693	HIV-1 FSS RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	0.00035999999999999997±2.6e-05	0	0	0	0	2L94	-	10.1021/cb200082d	21648432	Structure of the HIV-1 frameshift site RNA bound to a small molecule inhibitor of viral replication.	Marcheschi RJ, Tonelli M, Kumar A, Butcher SE	ACS Chem Biol	6	857-64	2011	-	-	7.3	-	10 mM Tris	Nuclear Magnetic Resonance	RBIND	C[NH+](C)CCC[NH+]=C(C1=CC=C(C=C1)C(=[NH+]CCC[NH+](C)C)N)N	3-[amino-[4-[amino-[3-(dimethylazaniumyl)propylazaniumylidene]methyl]phenyl]methylidene]azaniumylpropyl-dimethylazanium	53245673	-5.67240000000001	336.29795083236	0	6	10	88.86	1	0.146141947102826	5.5427530837103	24	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	0.000334	0.000386	0	0	0	0
1235	Clomiphene	Target_lig_694	HIV-1 RRE IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	1.24e-05±1.2e-06	0	0	0	0	-	-	10.1016/j.bcp.2016.02.007	26896646	Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.	Prado S, Beltrán M, Coiras M, Bedoya LM, Alcamí J, Gallego J	Biochem Pharmacol	107	14-28	2016	-	-	6.6	-	10 mM sodium phosphate and 0.1 mM EDTA	Fluorescence-based titration (Labeled RNA)	RBIND	CC[NH+](CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC=CC=C3	2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]ethyl-diethylazanium	1548952	5.1455	406.19321864809	1	1	9	13.67	3	0.485229093552801	2.93277371273002	29	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	1.12E-05	1.36E-05	0	0	0	0
1236	Clomiphene	Target_lig_694	HIV-1 RRE IIB, 100-fold Excess tRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	6e-06±1.1e-06	0	0	0	0	-	-	10.1016/j.bcp.2016.02.007	26896646	Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.	Prado S, Beltrán M, Coiras M, Bedoya LM, Alcamí J, Gallego J	Biochem Pharmacol	107	14-28	2016	-	-	6.6	-	10 mM sodium phosphate and 0.1 mM EDTA	Fluorescence-based titration (Labeled RNA)	RBIND	CC[NH+](CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC=CC=C3	2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]ethyl-diethylazanium	1548952	5.1455	406.19321864809	1	1	9	13.67	3	0.485229093552801	2.93277371273002	29	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	4.90E-06	7.10E-06	0	0	0	0
1237	Clomiphene	Target_lig_694	HIV-1 RRE IIB, 100-fold Excess dsDNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	1.6100000000000002e-05±1.5e-06	0	0	0	0	-	-	10.1016/j.bcp.2016.02.007	26896646	Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.	Prado S, Beltrán M, Coiras M, Bedoya LM, Alcamí J, Gallego J	Biochem Pharmacol	107	14-28	2016	-	-	6.6	-	10 mM sodium phosphate and 0.1 mM EDTA	Fluorescence-based titration (Labeled RNA)	RBIND	CC[NH+](CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC=CC=C3	2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]ethyl-diethylazanium	1548952	5.1455	406.19321864809	1	1	9	13.67	3	0.485229093552801	2.93277371273002	29	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	1.46E-05	1.76E-05	0	0	0	0
1238	Clomiphene	Target_lig_694	HIV-1 RRE IIB:Rev34-50	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	3.7e-06±1.3e-06	0	0	0	-	-	10.1016/j.bcp.2016.02.007	26896646	Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.	Prado S, Beltrán M, Coiras M, Bedoya LM, Alcamí J, Gallego J	Biochem Pharmacol	107	14-28	2016	-	-	6.8	-	30 mM HEPES, 100 mM KCl, 10 mM sodium phosphate, 10 mM ammonium acetate, 10 mM guanidinium chloride, 2 mM MgCl2, 20 mM NaCl, 0.5 mM EDTA, and 0.001% (v/v) Triton X-100	Fluorescence Anisotropy	RBIND	CC[NH+](CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC=CC=C3	2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]ethyl-diethylazanium	1548952	5.1455	406.19321864809	1	1	9	13.67	3	0.485229093552801	2.93277371273002	29	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	2.40E-06	5.00E-06	0	0
1239	Clomiphene	Target_lig_694	HIV-1 RRE:REV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	4.9999999999999996e-06±1e-06	0	0	0	-	-	10.1016/j.bcp.2016.02.007	26896646	Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.	Prado S, Beltrán M, Coiras M, Bedoya LM, Alcamí J, Gallego J	Biochem Pharmacol	107	14-28	2016	-	-	7.5	-	10 mM HEPES, 300 mM KCl, 1 mM MgCl2, and 0.5 mM EDTA	Electrophoretic Mobility Shift Assay	RBIND	CC[NH+](CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC=CC=C3	2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]ethyl-diethylazanium	1548952	5.1455	406.19321864809	1	1	9	13.67	3	0.485229093552801	2.93277371273002	29	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	4.00E-06	6.00E-06	0	0
1240	Cyproheptadine	Target_lig_695	HIV-1 RRE IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	1.8e-06±7e-07	0	0	0	0	-	-	10.1016/j.bcp.2016.02.007	26896646	Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.	Prado S, Beltrán M, Coiras M, Bedoya LM, Alcamí J, Gallego J	Biochem Pharmacol	107	14-28	2016	-	-	6.6	-	10 mM sodium phosphate and 0.1 mM EDTA	Fluorescence-based titration (Labeled RNA)	RBIND	C[NH+]1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1	1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidin-1-ium	4141783	3.2808	288.17467612409	0	1	0	4.44	2	0.647339435081433	3.39719886014534	22	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	1.10E-06	2.50E-06	0	0	0	0
1241	Cyproheptadine	Target_lig_695	HIV-1 RRE IIB, 100-fold Excess tRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	1.12e-05±4.7e-06	0	0	0	0	-	-	10.1016/j.bcp.2016.02.007	26896646	Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.	Prado S, Beltrán M, Coiras M, Bedoya LM, Alcamí J, Gallego J	Biochem Pharmacol	107	14-28	2016	-	-	6.6	-	10 mM sodium phosphate and 0.1 mM EDTA	Fluorescence-based titration (Labeled RNA)	RBIND	C[NH+]1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1	1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidin-1-ium	4141783	3.2808	288.17467612409	0	1	0	4.44	2	0.647339435081433	3.39719886014534	22	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	6.50E-06	1.59E-05	0	0	0	0
1242	Cyproheptadine	Target_lig_695	HIV-1 RRE IIB, 100-fold Excess dsDNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	9.199999999999998e-06±5.0999999999999995e-06	0	0	0	0	-	-	10.1016/j.bcp.2016.02.007	26896646	Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.	Prado S, Beltrán M, Coiras M, Bedoya LM, Alcamí J, Gallego J	Biochem Pharmacol	107	14-28	2016	-	-	6.6	-	10 mM sodium phosphate and 0.1 mM EDTA	Fluorescence-based titration (Labeled RNA)	RBIND	C[NH+]1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1	1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidin-1-ium	4141783	3.2808	288.17467612409	0	1	0	4.44	2	0.647339435081433	3.39719886014534	22	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	4.10E-06	1.43E-05	0	0	0	0
1243	Cyproheptadine	Target_lig_695	HIV-1 RRE IIB:Rev34-50	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	4.2e-06±2.2e-06	0	0	0	-	-	10.1016/j.bcp.2016.02.007	26896646	Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.	Prado S, Beltrán M, Coiras M, Bedoya LM, Alcamí J, Gallego J	Biochem Pharmacol	107	14-28	2016	-	-	6.8	-	30 mM HEPES, 100 mM KCl, 10 mM sodium phosphate, 10 mM ammonium acetate, 10 mM guanidinium chloride, 2 mM MgCl2, 20 mM NaCl, 0.5 mM EDTA, and 0.001% (v/v) Triton X-100	Fluorescence Anisotropy	RBIND	C[NH+]1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1	1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidin-1-ium	4141783	3.2808	288.17467612409	0	1	0	4.44	2	0.647339435081433	3.39719886014534	22	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	2.00E-06	6.40E-06	0	0
1244	Cyproheptadine	Target_lig_695	HIV-1 RRE:REV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	3e-06±1e-06	0	0	0	-	-	10.1016/j.bcp.2016.02.007	26896646	Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.	Prado S, Beltrán M, Coiras M, Bedoya LM, Alcamí J, Gallego J	Biochem Pharmacol	107	14-28	2016	-	-	7.5	-	10 mM HEPES, 300 mM KCl, 1 mM MgCl2, and 0.5 mM EDTA	Electrophoretic Mobility Shift Assay	RBIND	C[NH+]1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1	1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidin-1-ium	4141783	3.2808	288.17467612409	0	1	0	4.44	2	0.647339435081433	3.39719886014534	22	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	2.00E-06	4.00E-06	0	0
1245	WM5	Target_lig_1258	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.8999999999999998e-08±5.999999999999999e-10	0	0	0	0	-	-	10.1128/AAC.47.3.889–896.2003	12604517	New anti-human immunodeficiency virus type 1 6-aminoquinolones: mechanism of action.	Parolin C, Gatto B, Del Vecchio C, Pecere T, Tramontano E, Cecchetti V, Fravolini A, Masiero S, Palumbo M, Palù G	Antimicrob Agents Chemother	47	889-96	2003	-	-	7	-	10 mM Tris Hcl, 20 mM NaCl, and 1 mM Mg(ClO4)2	Fluorescence-based titration (Intrinsic)	RBIND	CN1C=C(C([O-])=O)C(=O)C2=CC(N)=C(C=C12)N1CCN(CC1)C1=CC=CC=N1			0.2058	378.15716307991	8	1	3	107.52	3	0.649081179706241	2.7649002418389	28	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.84E-08	1.96E-08	0	0	0	0
1246	DB60	Target_lig_696	HIV-1 TAR:Tat Interaction	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	1.00E-06	0	0	0	-	-	10.1016/S0968-0896(99)00041-3	10428378	Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chains.	Gelus N, Bailly C, Hamy F, Klimkait T, Wilson WD, Boykin DW	Bioorg Med Chem	7	1089-96	1999	-	-	7.4	-	50 mM Tris Hcl, 20 mM KCl, 5 mM DTT, and 0.1% Triton X-100	Electrophoretic Mobility Shift Assay	RBIND	C1C[NH+]=C(N1)C2=CC=C(C=C2)C3=CC=C(O3)C4=CC=C(C=C4)C5=[NH+]CCN5	2-[4-[5-[4-(4,5-dihydro-1H-imidazol-3-ium-2-yl)phenyl]furan-2-yl]phenyl]-4,5-dihydro-1H-imidazol-3-ium	90683503	-0.525599999999997	358.17826416418	3	4	4	65.14	3	0.50730389793346	3.91141171767896	27	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	1.00E-06	1.00E-06	0	0
1247	DB75	Target_lig_697	HIV-1 TAR:Tat Interaction	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	5.00E-06	0	0	0	-	-	10.1016/S0968-0896(99)00041-3	10428378	Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chains.	Gelus N, Bailly C, Hamy F, Klimkait T, Wilson WD, Boykin DW	Bioorg Med Chem	7	1089-96	1999	-	-	7.4	-	50 mM Tris Hcl, 20 mM KCl, 5 mM DTT, and 0.1% Triton X-100	Electrophoretic Mobility Shift Assay	RBIND	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=[NH2+])N)C(=[NH2+])N	[amino-[4-[5-[4-[amino(azaniumylidene)methyl]phenyl]furan-2-yl]phenyl]methylidene]azanium	3471142	-0.457599999999997	306.14696403618	1	4	4	116.36	3	0.385925632078986	2.97301660006976	23	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	5.00E-06	5.00E-06	0	0
1248	DB75	Target_lig_697	HTT exon1 RNA, 18 repeats	Homo sapiens	Huntington disease	Target_215	0	0	5.99e-05±8.609999999999999e-06	0	0	0	0	-	-	10.1021/acschemneuro.8b00027	29506378	Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder.	Matthes F, Massari S, Bochicchio A, Schorpp K, Schilling J, Weber S, Offermann N, Desantis J, Wanker E, Carloni P, Hadian K, Tabarrini O, Rossetti G, Krauss S	ACS Chem Neurosci	9	1399-1408	2018	-	400 nM	8	-	50 mM Tris-Hcl, 100 mM KCl, and 10 mM MgCl2	Microscale Thermophoresis	RBIND	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=[NH2+])N)C(=[NH2+])N	[amino-[4-[5-[4-[amino(azaniumylidene)methyl]phenyl]furan-2-yl]phenyl]methylidene]azanium	3471142	-0.457599999999997	306.14696403618	1	4	4	116.36	3	0.385925632078986	2.97301660006976	23	GGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCC	10.1021/acschemneuro.8b00027	mRNA	mRNA	58	Exon 1	-	0	0	0	0	5.13E-05	6.85E-05	0	0	0	0
1249	DB75	Target_lig_697	HTT exon1 RNA, 48 repeats	Homo sapiens	Huntington disease	Target_216	0	0	0.00015999999999999999±1.51e-05	0	0	0	0	-	-	10.1021/acschemneuro.8b00027	29506378	Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder.	Matthes F, Massari S, Bochicchio A, Schorpp K, Schilling J, Weber S, Offermann N, Desantis J, Wanker E, Carloni P, Hadian K, Tabarrini O, Rossetti G, Krauss S	ACS Chem Neurosci	9	1399-1408	2018	-	400 nM	8	-	50 mM Tris-Hcl, 100 mM KCl, and 10 mM MgCl2	-	RBIND	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=[NH2+])N)C(=[NH2+])N	[amino-[4-[5-[4-[amino(azaniumylidene)methyl]phenyl]furan-2-yl]phenyl]methylidene]azanium	3471142	-0.457599999999997	306.14696403618	1	4	4	116.36	3	0.385925632078986	2.97301660006976	23	GGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCC	10.1021/acschemneuro.8b00027	mRNA	mRNA	58	Exon 1	-	0	0	0	0	0.0001449	0.0001751	0	0	0	0
1250	Quinoxaline 3	Target_lig_1259	HIV-1 TAR:Tat	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	1.00E-05	0	0	0	-	-	10.1021/bi981308u	9760258	Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.	Mei HY, Cui M, Heldsinger A, Lemrow SM, Loo JA, Sannes-Lowery KA, Sharmeen L, Czarnik AW	Biochemistry	37	14204-12	1998	-	-	7.5	-	10 mM Tris-Hcl, 70 mM NaCl, 0.2 mM EDTA, 0.01% Nonidet P-40, and 5% glycerol	Electrophoretic Mobility Shift Assay	RBIND	NC1=NC2=CC=C(N)C(N)=C2C(N)=[NH+]1			-0.6223	191.10397077209	5	4	0	131.11	2	0.411853044735655	3.89184050472048	14	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	1.00E-05	1.00E-05	0	0
1251	S-Amino acid conjugate 1b	Target_lig_698	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	7.50E-06	0	0	0	0	-	-	10.1002/chem.201303664	24431237	Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents.	Joly JP, Mata G, Eldin P, Briant L, Fontaine-Vive F, Duca M, Benhida R	Chemistry	20	2071-9	2014	-	-	7.4	-	20 mM HEPES, 20 mM NaCl, 140 mM KCl, and 3mM MgCl2	Fluorescence-based titration (Labeled RNA)	RBIND	CC(=O)NC1=NC(=CS1)C1=CC(NC(=O)[C@@H]([NH3+])CCCC[NH3+])=CC=C1	-	-	0.7297	363.17179888018	4	4	8	126.37	2	0.516382118670913	3.64868002138172	25	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	7.50E-06	7.50E-06	0	0	0	0
1252	S-Amino acid conjugate 3b	Target_lig_699	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.75E-05	0	0	0	0	-	-	10.1002/chem.201303664	24431237	Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents.	Joly JP, Mata G, Eldin P, Briant L, Fontaine-Vive F, Duca M, Benhida R	Chemistry	20	2071-9	2014	-	-	7.4	-	20 mM HEPES, 20 mM NaCl, 140 mM KCl, and 3mM MgCl2	Fluorescence-based titration (Labeled RNA)	RBIND	CC(=O)NC1=NC(=CS1)C1=CC(NC(=O)[C@@H]([NH3+])CC2=CNC=N2)=CC=C1	-	-	1.2833	371.12847126809	5	4	6	127.41	3	0.520323744813573	3.42187642732689	26	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.75E-05	1.75E-05	0	0	0	0
1253	ST4133609	Target_lig_700	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	2.4e-06±1.1e-06	0	0	0	0	-	-	10.1021/ja502754f	24820959	Identification of biologically active, HIV TAR RNA-binding small molecules using small molecule microarrays	Sztuba-Solinska J, Shenoy SR, Gareiss P, Krumpe LRH, Le Grice SFJ, O'Keefe BR, Schneekloth Jr JS	J Am Chem Soc	136	8402-10	2014	-	-	7.4	-	1 X PBS	Fluorescence-based titration (Labeled RNA)	RBIND	CC1=NC2=C(C=C1)C(=C(S2)C(=O)NC3=CC=CC(=C3)C(F)(F)F)N	3-amino-6-methyl-N-[3-(trifluoromethyl)phenyl]thieno[2,3-b]pyridine-2-carboxamide	16762254	4.45802	351.065317664	4	2	2	68.01	3	0.716267232394479	2.19840343336065	24	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.30E-06	3.50E-06	0	0	0	0
1254	DPQ	Target_lig_701	Influenza RNA promoter	Influenza virus	Influenza	Target_217	0	0	6.15E-05	0	0	0	0	2LWK	-	10.1111/cbdd.12534	25676805	Targeting Influenza A Virus RNA Promoter.	Bottini A, De SK, Wu B, Tang C, Varani G, Pellecchia M	Chem Biol Drug Des	86	663-73	2015	-	-	6	-	10 mM potassium phosphate and 150 mM NaCl	Nuclear Magnetic Resonance	RBIND	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CC[NH2+]CC3)N)OC	6,7-dimethoxy-2-piperazin-4-ium-1-ylquinazolin-4-amine	5212112	-0.387399999999998	290.16115130009	6	2	3	90.11	2	0.800166130344128	3.26310669735525	21	GAGUAGAAACAAGGCUUCGGCCUGCUUUUGCU	10.1111/cbdd.12534	mRNA	mRNA	32	Promoter	-	0	0	0	0	6.15E-05	6.15E-05	0	0	0	0
1255	DPQ	Target_lig_701	Influenza RNA promoter	Influenza virus	Influenza	Target_217	0	0	5.05e-05±9e-06	0	0	0	0	2LWK	-	10.1111/cbdd.12534	25676805	Targeting Influenza A Virus RNA Promoter.	Bottini A, De SK, Wu B, Tang C, Varani G, Pellecchia M	Chem Biol Drug Des	86	663-73	2015	-	-	6.1	-	10 mM potassium phosphate, 50 mM NaCl, and 0.1 mM EDTA	Nuclear Magnetic Resonance	RBIND	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CC[NH2+]CC3)N)OC	6,7-dimethoxy-2-piperazin-4-ium-1-ylquinazolin-4-amine	5212112	-0.387399999999998	290.16115130009	6	2	3	90.11	2	0.800166130344128	3.26310669735525	21	GAGUAGAAACAAGGCUUCGGCCUGCUUUUGCU	10.1111/cbdd.12534	mRNA	mRNA	32	Promoter	-	0	0	0	0	4.15E-05	5.95E-05	0	0	0	0
1256	DPQ6	Target_lig_702	Influenza RNA promoter	Influenza virus	Influenza	Target_217	0	0	0.0001142	0	0	0	0	-	-	10.1111/cbdd.12534	25676805	Targeting Influenza A Virus RNA Promoter.	Bottini A, De SK, Wu B, Tang C, Varani G, Pellecchia M	Chem Biol Drug Des	86	663-73	2015	-	-	6	-	10 mM potassium phosphate and 150 mM NaCl	Nuclear Magnetic Resonance	RBIND	CCC(=O)N1CCN(CC1)C1=NC(N)=C2C=C(OC)C(OC)=CC2=[NH+]1	-	-	0.706900000000001	346.18736604809	6	1	4	95.06	2	0.875865852746398	3.19197651090192	25	GAGUAGAAACAAGGCUUCGGCCUGCUUUUGCU	10.1111/cbdd.12534	mRNA	mRNA	32	Promoter	-	0	0	0	0	0.0001142	0.0001142	0	0	0	0
1257	DPQ7	Target_lig_703	Influenza RNA promoter	Influenza virus	Influenza	Target_217	0	0	0.0001585	0	0	0	0	-	-	10.1111/cbdd.12534	25676805	Targeting Influenza A Virus RNA Promoter.	Bottini A, De SK, Wu B, Tang C, Varani G, Pellecchia M	Chem Biol Drug Des	86	663-73	2015	-	-	6	-	10 mM potassium phosphate and 150 mM NaCl	Nuclear Magnetic Resonance	RBIND	COC1=CC2=[NH+]C(=NC(N)=C2C=C1OC)N1CCN(CC1)C(=O)C(C)C	-	-	0.9529	360.20301611209	6	1	4	95.06	2	0.872330530856237	3.19754295100212	26	GAGUAGAAACAAGGCUUCGGCCUGCUUUUGCU	10.1111/cbdd.12534	mRNA	mRNA	32	Promoter	-	0	0	0	0	0.0001585	0.0001585	0	0	0	0
1258	DPQ8	Target_lig_704	Influenza RNA promoter	Influenza virus	Influenza	Target_217	0	0	4.44E-05	0	0	0	0	-	-	10.1111/cbdd.12534	25676805	Targeting Influenza A Virus RNA Promoter.	Bottini A, De SK, Wu B, Tang C, Varani G, Pellecchia M	Chem Biol Drug Des	86	663-73	2015	-	-	6	-	10 mM potassium phosphate and 150 mM NaCl	Nuclear Magnetic Resonance	RBIND	CCCC(=O)N1CCN(CC1)C1=NC(N)=C2C=C(OC)C(OC)=CC2=[NH+]1	-	-	1.097	360.20301611209	6	1	5	95.06	2	0.857799123571533	3.15320546417388	26	GAGUAGAAACAAGGCUUCGGCCUGCUUUUGCU	10.1111/cbdd.12534	mRNA	mRNA	32	Promoter	-	0	0	0	0	4.44E-05	4.44E-05	0	0	0	0
1259	DPQ10	Target_lig_705	Influenza RNA promoter	Influenza virus	Influenza	Target_217	0	0	0.0001272	0	0	0	0	-	-	10.1111/cbdd.12534	25676805	Targeting Influenza A Virus RNA Promoter.	Bottini A, De SK, Wu B, Tang C, Varani G, Pellecchia M	Chem Biol Drug Des	86	663-73	2015	-	-	6	-	10 mM potassium phosphate and 150 mM NaCl	Nuclear Magnetic Resonance	RBIND	COC1=CC2=[NH+]C(=NC(N)=C2C=C1OC)N1CCN(CC1)C(=O)C1CC1	-	-	0.7069	358.18736604809	6	1	4	95.06	2	0.864754339035035	3.15018776132878	26	GAGUAGAAACAAGGCUUCGGCCUGCUUUUGCU	10.1111/cbdd.12534	mRNA	mRNA	32	Promoter	-	0	0	0	0	0.0001272	0.0001272	0	0	0	0
1260	Compound 43 (MTDB)	Target_lig_706	SARS-Pseudoknot Construct	SARS-CoV	Severe Acute Respiratory Syndrome (SARS)	Target_218	0	0	0.00020999999999999998±1.9999999999999998e-05	0	0	0	0	-	-	10.1021/ja410344b	24446874	Anti-frameshifting ligand reduces the conformational plasticity of the SARS virus pseudoknot	Ritchie DB, Soong J, Sikkema WKA, Woodside MT	J Am Chem Soc	136	2196-9	2014	-	-	7.5	-	50 mM HEPES, 100 mM KCl, 10 mM MgCl2, and 4 mM TCEP	Surface Plasmon Resonance	RBIND	CCOC(=O)C1=CC=CC=C1NC(=O)N2CCCN(CC2)CC3=CSC(=N3)C	ethyl 2-[[4-[(2-methyl-1,3-thiazol-4-yl)methyl]-1,4-diazepane-1-carbonyl]amino]benzoate	23850430	3.36802	402.172561692	6	1	5	74.77	2	0.776413285412828	2.15410985235497	28	CGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGCGGAAACGCUGAUGUCGUAUACAGGGCU	https://www.rcsb.org/structure/7LYJ	Pseudoknot structure	mRNA	66	5’-UTR	Pseudoknot	0	0	0	0	0.00019	0.00023	0	0	0	0
1261	Compound 1 (2017)	Target_lig_707	HCV IRES-A	Hepatitis C virus	Hepatitis C	Target_219	0	0	9.28E-07	0	0	0	0	-	-	10.1021/acs.jmedchem.6b01444	28530833	Discovery of Small Molecules for Repressing Cap-Independent Translation of Human Vascular Endothelial Growth Factor (hVEGF) as Novel Antitumor Agents	Wang S, Wu Y, Wang X, Kuang G, Zhang Q, Lin S, Liu H, Tan J, Huang Z, Ou T	J Med Chem	60	5306-5319	2017	-	-	7.4	-	50 mM Tris, 150 mM KCl, and 0.005% Tween-20	Surface Plasmon Resonance	RBIND	CCN(CC)CCOC1=CC=C(C=C1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4NC(=O)CCN5CCN(CC5)C	N-[2-[4-[4-[2-(diethylamino)ethoxy]anilino]quinazolin-2-yl]phenyl]-3-(4-methylpiperazin-1-yl)propanamide	131704486	5.337	581.347823616	8	2	13	85.86	4	0.219036746015911	2.56972066846407	43	GGAGGAGGGGGAGGAGGA	10.1021/acs.jmedchem.6b01444	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	18	5'-UTR	Internal Loop	0	0	0	0	9.28E-07	9.28E-07	0	0	0	0
1262	Compound 1 (2017)	Target_lig_707	HCV IRES-A 1 Mutant	Hepatitis C virus	Hepatitis C	Target_220	0	0	3.71E-06	0	0	0	0	-	-	10.1021/acs.jmedchem.6b01444	28530833	Discovery of Small Molecules for Repressing Cap-Independent Translation of Human Vascular Endothelial Growth Factor (hVEGF) as Novel Antitumor Agents	Wang S, Wu Y, Wang X, Kuang G, Zhang Q, Lin S, Liu H, Tan J, Huang Z, Ou T	J Med Chem	60	5306-5319	2017	-	-	7.4	-	50 mM Tris, 150 mM KCl, and 0.005% Tween-20	Surface Plasmon Resonance	RBIND	CCN(CC)CCOC1=CC=C(C=C1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4NC(=O)CCN5CCN(CC5)C	N-[2-[4-[4-[2-(diethylamino)ethoxy]anilino]quinazolin-2-yl]phenyl]-3-(4-methylpiperazin-1-yl)propanamide	131704486	5.337	581.347823616	8	2	13	85.86	4	0.219036746015911	2.56972066846407	43	UGAUGAGUGUGAGGAGGA	10.1021/acs.jmedchem.6b01444	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	18	5'-UTR	Internal Loop	0	0	0	0	3.71E-06	3.71E-06	0	0	0	0
1263	Compound 1 (2017)	Target_lig_707	Hairpin DNA	Synthetic	-	Target_212	0	0	2.12E-05	0	0	0	0	-	-	10.1021/acs.jmedchem.6b01444	28530833	Discovery of Small Molecules for Repressing Cap-Independent Translation of Human Vascular Endothelial Growth Factor (hVEGF) as Novel Antitumor Agents	Wang S, Wu Y, Wang X, Kuang G, Zhang Q, Lin S, Liu H, Tan J, Huang Z, Ou T	J Med Chem	60	5306-5319	2017	-	-	7.4	-	50 mM Tris, 150 mM KCl, and 0.005% Tween-20	Surface Plasmon Resonance	RBIND	CCN(CC)CCOC1=CC=C(C=C1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4NC(=O)CCN5CCN(CC5)C	N-[2-[4-[4-[2-(diethylamino)ethoxy]anilino]quinazolin-2-yl]phenyl]-3-(4-methylpiperazin-1-yl)propanamide	131704486	5.337	581.347823616	8	2	13	85.86	4	0.219036746015911	2.56972066846407	43	CGCGAATTCGCGTTTTCGCGAATTCGCG	10.1016/j.bmcl.2016.10.037	Hairpin	-	28	-	Hairpin	0	0	0	0	2.12E-05	2.12E-05	0	0	0	0
1264	Compound 1 (2017)	Target_lig_707	HCV IRES-A	Hepatitis C virus	Hepatitis C	Target_219	0	0	1.29e-06±5.89e-08	0	0	0	0	-	-	10.1021/acs.jmedchem.6b01444	28530833	Discovery of Small Molecules for Repressing Cap-Independent Translation of Human Vascular Endothelial Growth Factor (hVEGF) as Novel Antitumor Agents	Wang S, Wu Y, Wang X, Kuang G, Zhang Q, Lin S, Liu H, Tan J, Huang Z, Ou T	J Med Chem	60	5306-5319	2017	-	-	7.4	-	10 mM Tris Hcl, 100 mM KCl, and 0.1 mM EDTA	Microscale Thermophoresis	RBIND	CCN(CC)CCOC1=CC=C(C=C1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4NC(=O)CCN5CCN(CC5)C	N-[2-[4-[4-[2-(diethylamino)ethoxy]anilino]quinazolin-2-yl]phenyl]-3-(4-methylpiperazin-1-yl)propanamide	131704486	5.337	581.347823616	8	2	13	85.86	4	0.219036746015911	2.56972066846407	43	GGAGGAGGGGGAGGAGGA	10.1021/acs.jmedchem.6b01444	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	18	5'-UTR	Internal Loop	0	0	0	0	1.23E-06	1.35E-06	0	0	0	0
1265	Compound 1 (2017)	Target_lig_707	HCV IRES-A 1 Mutant	Hepatitis C virus	Hepatitis C	Target_220	0	0	2.05e-05±9.95e-07	0	0	0	0	-	-	10.1021/acs.jmedchem.6b01444	28530833	Discovery of Small Molecules for Repressing Cap-Independent Translation of Human Vascular Endothelial Growth Factor (hVEGF) as Novel Antitumor Agents	Wang S, Wu Y, Wang X, Kuang G, Zhang Q, Lin S, Liu H, Tan J, Huang Z, Ou T	J Med Chem	60	5306-5319	2017	-	-	7.4	-	10 mM Tris Hcl, 100 mM KCl, and 0.1 mM EDTA	Microscale Thermophoresis	RBIND	CCN(CC)CCOC1=CC=C(C=C1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4NC(=O)CCN5CCN(CC5)C	N-[2-[4-[4-[2-(diethylamino)ethoxy]anilino]quinazolin-2-yl]phenyl]-3-(4-methylpiperazin-1-yl)propanamide	131704486	5.337	581.347823616	8	2	13	85.86	4	0.219036746015911	2.56972066846407	43	UGAUGAGUGUGAGGAGGA	10.1021/acs.jmedchem.6b01444	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	18	5'-UTR	Internal Loop	0	0	0	0	1.95E-05	2.15E-05	0	0	0	0
1266	Compound 1 (2017)	Target_lig_707	HCV IRES-A DNA	Hepatitis C virus	Hepatitis C	Target_222	0	0	1.45e-05±6.949999999999999e-07	0	0	0	0	-	-	10.1021/acs.jmedchem.6b01444	28530833	Discovery of Small Molecules for Repressing Cap-Independent Translation of Human Vascular Endothelial Growth Factor (hVEGF) as Novel Antitumor Agents	Wang S, Wu Y, Wang X, Kuang G, Zhang Q, Lin S, Liu H, Tan J, Huang Z, Ou T	J Med Chem	60	5306-5319	2017	-	-	7.4	-	10 mM Tris Hcl, 100 mM KCl, and 0.1 mM EDTA	Microscale Thermophoresis	RBIND	CCN(CC)CCOC1=CC=C(C=C1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4NC(=O)CCN5CCN(CC5)C	N-[2-[4-[4-[2-(diethylamino)ethoxy]anilino]quinazolin-2-yl]phenyl]-3-(4-methylpiperazin-1-yl)propanamide	131704486	5.337	581.347823616	8	2	13	85.86	4	0.219036746015911	2.56972066846407	43	CCUGACUAGUCUUUCAGG	10.1021/acs.jmedchem.6b01444	IRES element, Viral DNA	Internal Ribosome Entry Site (IRES)	18	5'-UTR	Internal Loop	0	0	0	0	1.38E-05	1.52E-05	0	0	0	0
1267	Targaprimir-18a	Target_lig_708	G_U/CUA Bulge in miR-18a	Homo sapiens	Cancer	Target_223	0	0	2.9999999999999997e-05±2e-06	0	0	0	0	-	-	10.1021/acscentsci.7b00009	28386598	Defining RNA-Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor of an Oncogenic Noncoding RNA.	Velagapudi SP, Luo Y, Tran T, Haniff HS, Nakai Y, Fallahi M, Martinez GJ, Childs-Disney JL, Disney MD	ACS Cent Sci	3	205-216	2017	-	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Labeled Ligand)	RBIND	C[NH+]1CCN(CC1)C1=CC=C(C=C1)C1=CC=C2NC(=NC2=C1)C1=CC(=C(OCCCC(=O)NCCCN=[N+]=[N-])C(=C1)C(C)(C)C)C(C)(C)C	-	-	6.80220000000001	665.42859935609	5	3	12	123.45	4	0.066651088020471	3.7257016086693	49	GGGAGAGGGUUUAUGACGAAAGUCUAUGGAUCCGCAAGG	10.1021/acscentsci.7b00009	RNA aptamer	miRNA	39	-	Internal Loop	0	0	0	0	2.80E-05	3.20E-05	0	0	0	0
1268	Targaprimir-18a	Target_lig_708	GAU/CUA Stem Mutant	Homo sapiens	Cancer	Target_224	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1021/acscentsci.7b00009	28386598	Defining RNA-Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor of an Oncogenic Noncoding RNA.	Velagapudi SP, Luo Y, Tran T, Haniff HS, Nakai Y, Fallahi M, Martinez GJ, Childs-Disney JL, Disney MD	ACS Cent Sci	3	205-216	2017	-	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Labeled Ligand)	RBIND	C[NH+]1CCN(CC1)C1=CC=C(C=C1)C1=CC=C2NC(=NC2=C1)C1=CC(=C(OCCCC(=O)NCCCN=[N+]=[N-])C(=C1)C(C)(C)C)C(C)(C)C	-	-	6.80220000000001	665.42859935609	5	3	12	123.45	4	0.066651088020471	3.7257016086693	49	GGGAGAGGGUUUAUAGACGAAAGUCUAUGGAUCCGCAAGG	10.1021/acscentsci.7b00009	Stem-loop structure	Expanded Repeats	40	5’-UTR	Internal Loop	0	0	0	0	0.0001	0.0001	0	0	0	0
1269	Targaprimir-18a	Target_lig_708	GAU/A_C Bulge in miR-18a	Homo sapiens	Cancer	Target_225	0	0	3.2e-05±4.9999999999999996e-06	0	0	0	0	-	-	10.1021/acscentsci.7b00009	28386598	Defining RNA-Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor of an Oncogenic Noncoding RNA.	Velagapudi SP, Luo Y, Tran T, Haniff HS, Nakai Y, Fallahi M, Martinez GJ, Childs-Disney JL, Disney MD	ACS Cent Sci	3	205-216	2017	-	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Labeled Ligand)	RBIND	C[NH+]1CCN(CC1)C1=CC=C(C=C1)C1=CC=C2NC(=NC2=C1)C1=CC(=C(OCCCC(=O)NCCCN=[N+]=[N-])C(=C1)C(C)(C)C)C(C)(C)C	-	-	6.80220000000001	665.42859935609	5	3	12	123.45	4	0.066651088020471	3.7257016086693	49	GGGAGAGGGUUUAGAUACGAAAGUACUGGAUCCGCAAGG	10.1021/acscentsci.7b00009	Bulge, RNA aptamer	miRNA	39	-	Internal Loop	0	0	0	0	2.70E-05	3.70E-05	0	0	0	0
1270	Targaprimir-18a	Target_lig_708	GGU/A_C Bulge Mutant	Homo sapiens	Cancer	Target_226	0	0	3.9999999999999996e-05±6e-06	0	0	0	0	-	-	10.1021/acscentsci.7b00009	28386598	Defining RNA-Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor of an Oncogenic Noncoding RNA.	Velagapudi SP, Luo Y, Tran T, Haniff HS, Nakai Y, Fallahi M, Martinez GJ, Childs-Disney JL, Disney MD	ACS Cent Sci	3	205-216	2017	-	-	7	-	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence-based titration (Labeled Ligand)	RBIND	C[NH+]1CCN(CC1)C1=CC=C(C=C1)C1=CC=C2NC(=NC2=C1)C1=CC(=C(OCCCC(=O)NCCCN=[N+]=[N-])C(=C1)C(C)(C)C)C(C)(C)C	-	-	6.80220000000001	665.42859935609	5	3	12	123.45	4	0.066651088020471	3.7257016086693	49	GGGAGAGGGUUUAGGUACGAAAGUACUGGAUCCGCAAGG	10.1021/acscentsci.7b00009	Bulge, RNA aptamer	Expanded Repeats	39	5’-UTR	Internal Loop	0	0	0	0	3.40E-05	4.60E-05	0	0	0	0
1271	Targaprimir-210	Target_lig_709	Pre-miR-210	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	6.62e-07±1.8e-08	0	0	0	0	-	-	10.1021/jacs.6b11273	28240549	Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit.	Costales MG, Haga CL, Velagapudi SP, Childs-Disney JL, Phinney DG, Disney MD	J Am Chem Soc	139	3446-3455	2017	-	-	-	-	8 mM Na2HPO4, 190 mM NaCl, 1 mM EDTA, and 40 µg/mL BSA	Fluorescence-based titration (Intrinsic)	RBIND	CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC(=CC=C6)OCCCC(=O)NCCCN=[N+]=[N-]	N-(3-azidopropyl)-4-[3-[6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazol-2-yl]phenoxy]butanamide	44221088	5.5006	592.302270392	7	3	12	150.93	5	0.075316848147928	2.98628569588825	44	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	6.44E-07	6.80E-07	0	0	0	0
1272	Compound 2ab	Target_lig_710	HCV IRES IIA	Hepatitis C virus	Hepatitis C	Target_67	0	0	0	0	6.3e-06±6e-07	0	0	-	-	10.1002/cbic.201000177	20564282	A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site.	Carnevali M, Parsons J, Wyles DL, Hermann T	Chembiochem	11	1364-7	2010	-	-	-	-	100 µM MgCl2	Fluorescence-based titration (Labeled RNA)	RBIND	CC(=O)C1=CC=C(C=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)N1C[C@@H]([NH3+])C[C@@H]([NH3+])C1	-	-	-2.1469	392.26451920827	3	4	8	149.4	1	0.295072153217204	4.53677712306482	28	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	0	0	0	0	5.70E-06	6.90E-06
1273	Compound 2ab	Target_lig_710	HCV IRES IIA	Hepatitis C virus	Hepatitis C	Target_67	0	0	0	0	0.00027±9.999999999999999e-05	0	0	-	-	10.1002/cbic.201000177	20564282	A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site.	Carnevali M, Parsons J, Wyles DL, Hermann T	Chembiochem	11	1364-7	2010	-	-	-	-	1 mM MgCl2	Fluorescence-based titration (Labeled RNA)	RBIND	CC(=O)C1=CC=C(C=C1)C(=O)N[C@@H](CCCC[NH3+])C(=O)N1C[C@@H]([NH3+])C[C@@H]([NH3+])C1	-	-	-2.1469	392.26451920827	3	4	8	149.4	1	0.295072153217204	4.53677712306482	28	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	0	0	0	0	0.00017	0.00037
1274	p-Terphenyl 6b	Target_lig_711	HIV-1 RRE IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	1.10E-05	0	0	0	0	-	-	10.1002/anie.201306665	24214163	Structure-based design of an RNA-binding p-terphenylene scaffold that inhibits HIV-1 Rev protein function	González-Bulnes L, Ibáñez I, Bedoya LM, Beltrán M, Catalán S, Alcamí J, Fustero S, Gallego J	Angew Chem Int Ed Engl	52	13405-9	2013	-	-	6	-	10 mM Na2HPO4 and 0.1 mM EDTA	Nuclear Magnetic Resonance	RBIND	COC1=CC(CC[NH3+])=C(C(CC[NH3+])=C1)C1=CC(C)=C(C(C)=C1)C1=CC(CC[NH3+])=C(O)C(CC[NH3+])=C1	-	-	0.489240000000004	480.34423232836	2	5	11	140.02	3	0.27253764323893	4.29731184232938	35	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	1.10E-05	1.10E-05	0	0	0	0
1275	p-Terphenyl 6b	Target_lig_711	HIV-1 RRE IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	6e-07±1e-07	0	0	0	0	-	-	10.1002/anie.201306665	24214163	Structure-based design of an RNA-binding p-terphenylene scaffold that inhibits HIV-1 Rev protein function	González-Bulnes L, Ibáñez I, Bedoya LM, Beltrán M, Catalán S, Alcamí J, Fustero S, Gallego J	Angew Chem Int Ed Engl	52	13405-9	2013	-	-	6	-	10 mM Na2HPO4 and 0.1 mM EDTA	Isothermal Titration Calorimetry	RBIND	COC1=CC(CC[NH3+])=C(C(CC[NH3+])=C1)C1=CC(C)=C(C(C)=C1)C1=CC(CC[NH3+])=C(O)C(CC[NH3+])=C1	-	-	0.489240000000004	480.34423232836	2	5	11	140.02	3	0.27253764323893	4.29731184232938	35	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	5.00E-07	7.00E-07	0	0	0	0
1276	p-Terphenyl 6b	Target_lig_711	HIV-1 RRE IIB:Rev Peptide	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	6.799999999999999e-06±5e-07	0	0	0	-	-	10.1002/anie.201306665	24214163	Structure-based design of an RNA-binding p-terphenylene scaffold that inhibits HIV-1 Rev protein function	González-Bulnes L, Ibáñez I, Bedoya LM, Beltrán M, Catalán S, Alcamí J, Fustero S, Gallego J	Angew Chem Int Ed Engl	52	13405-9	2013	-	-	6.8	-	30 mM HEPES, 100 mM KCl, 10 mM Na2HPO4, 10 mM ammonium acetate, 10 mM guanidinium chloride, 2 mM MgCl2, 20 mM NaCl, 0.5 mM EDTA, and 0.001% (v/v) Triton-X-100	Fluorescence Polarization	RBIND	COC1=CC(CC[NH3+])=C(C(CC[NH3+])=C1)C1=CC(C)=C(C(C)=C1)C1=CC(CC[NH3+])=C(O)C(CC[NH3+])=C1	-	-	0.489240000000004	480.34423232836	2	5	11	140.02	3	0.27253764323893	4.29731184232938	35	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	6.30E-06	7.30E-06	0	0
1277	Phenylquinolone 5	Target_lig_712	HIV-1 TAR:Tat Peptide	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	9.6e-07±2e-08	0	0	0	0	0	-	-	10.1002/cmdc.200800437	19283692	2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.	Gatto B, Tabarrini O, Massari S, Giaretta G, Sabatini S, Del Vecchio C, Parolin C, Fravolini A, Palumbo M, Cecchetti V	ChemMedChem	4	935-8	2009	10 uM	-	7.5	-	50 mM Tris-Hcl, 80 mM KCl, 0.1 % DMSO, 0.01 % Triton X-100, and 5 mg/mL BSA	Fluorescence Quenching	RBIND	CN1C(=CC(=O)C2=CC=CC=C12)C1=CC=C(OCCC[NH+]2CCCCC2)C(N)=C1	-	-	2.6254	392.23325362009	4	2	6	61.69	3	0.500774072413087	3.3966890973454	29	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	9.40E-07	9.80E-07	0	0	0	0	0	0
1278	Phenylquinolone 6	Target_lig_713	HIV-1 TAR:Tat Peptide	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	9.9e-07±1.6e-07	0	0	0	0	0	-	-	10.1002/cmdc.200800437	19283692	2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.	Gatto B, Tabarrini O, Massari S, Giaretta G, Sabatini S, Del Vecchio C, Parolin C, Fravolini A, Palumbo M, Cecchetti V	ChemMedChem	4	935-8	2009	10 uM	-	7.5	-	50 mM Tris-Hcl, 80 mM KCl, 0.1 % DMSO, 0.01 % Triton X-100, and 5 mg/mL BSA	Fluorescence Quenching	RBIND	CN1C(=CC(=O)C2=CC=CC=C12)C1=CC=C(OCCCN2CC[NH+](C)CC2)C(N)=C1	-	-	1.3869	407.24415265209	5	2	6	64.93	3	0.478805853862274	3.25015542808703	30	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	8.30E-07	1.15E-06	0	0	0	0	0	0
1279	Guanine Analog 25f	Target_lig_714	C. difficile guaA riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_228	0	0	6.50E-06	0	0	0	0	-	-	10.1016/j.ejmech.2017.11.079	29220796	Purine analogs targeting the guanine riboswitch as potential antibiotics against Clostridioides difficile.	Yan LH, Le Roux A, Boyapelly K, Lamontagne AM, Archambault MA, Picard-Jean F, Lalonde-Seguin D, St-Pierre E, Najmanovich RJ, Fortier LC, Lafontaine D, Marsault É	Eur J Med Chem	143	755-768	2018	-	-	8.5	-	50 mM Tris-Hcl, 20 mM MgCl2, and 100 mM KCl	In-line probing	RBIND	C1CCC(CC1)NC2=NC3=C(C(=O)N2)NC=N3	2-(cyclohexylamino)-1,7-dihydropurin-6-one	136994297	1.3908	233.1276601	4	3	2	86.46	2	0.731207322743313	2.7030924279944	17	GGAUCAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGGUC	https://www.rcsb.org/structure/1Y27	Riboswitch	Riboswitch	68	5’-UTR	-	0	0	0	0	6.50E-06	6.50E-06	0	0	0	0
1280	Lysine Analog 8	Target_lig_1260	lysC riboswitch	Escherichia coli	Bacterial growth and infection	Target_229	0	0	2.4999999999999998e-06±3e-07	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	0.001 - 6000 uM	1 nM	8.3	-	50 mM Tris-Hcl, 20 mM MgCl2, and 100 mM KCl	In-line probing	RBIND	[NH3+]CCS(=O)(=O)C[C@H]([NH3+])C([O-])=O	(2R)-2-azaniumyl-3-(2-azaniumylethylsulfonyl)propanoate	11948926	-4.9965	197.05905431609	4	2	5	129.55	0	0.456680622285498	5.68919847848104	12	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUAUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	10.1038/nchembio842	Riboswitch	Riboswitch	239	5’-UTR	-	0	0	0	0	2.20E-06	2.80E-06	0	0	0	0
1281	Lysine Analog 8	Target_lig_1260	lysC riboswitch mutant 1 (M1)	Escherichia coli	Bacterial growth and infection	Target_229	0	0	1.40E-05	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	0.001 - 6000 uM	1 nM	8.3	-	50 mM Tris-Hcl, 20 mM MgCl2, and 100 mM KCl	In-line probing	RBIND	[NH3+]CCS(=O)(=O)C[C@H]([NH3+])C([O-])=O	(2R)-2-azaniumyl-3-(2-azaniumylethylsulfonyl)propanoate	11948926	-4.9965	197.05905431609	4	2	5	129.55	0	0.456680622285498	5.68919847848104	12	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUAUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	10.1038/nchembio842	Riboswitch	Riboswitch	239	5’-UTR	-	0	0	0	0	1.40E-05	1.40E-05	0	0	0	0
1282	Lysine Analog 8	Target_lig_1260	lysC riboswitch mutant 1 (M2)	Escherichia coli	Bacterial growth and infection	Target_230	0	0	2.40E-05	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	0.001 - 6000 uM	1 nM	8.3	-	50 mM Tris-Hcl, 20 mM MgCl2, and 100 mM KCl	In-line probing	RBIND	[NH3+]CCS(=O)(=O)C[C@H]([NH3+])C([O-])=O	(2R)-2-azaniumyl-3-(2-azaniumylethylsulfonyl)propanoate	11948926	-4.9965	197.05905431609	4	2	5	129.55	0	0.456680622285498	5.68919847848104	12	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUGUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	10.1038/nchembio842	Riboswitch	Riboswitch	238	5’-UTR	-	0	0	0	0	2.40E-05	2.40E-05	0	0	0	0
1283	Lysine Analog 9	Target_lig_1261	lysC riboswitch	Escherichia coli	Bacterial growth and infection	Target_229	0	0	1.3e-05±2e-06	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	0.001 - 6000 uM	1 nM	8.3	-	50 mM Tris-Hcl, 20 mM MgCl2, and 100 mM KCl	In-line probing	RBIND	[NH3+]CCOC[C@H]([NH3+])C([O-])=O	(2S)-2-azaniumyl-3-(2-azaniumylethoxy)propanoate	11948928	-4.3947	149.09206869609	3	2	5	104.64	0	0.385447272718545	6.0145718458789	10	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUAUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	10.1038/nchembio842	Riboswitch	Riboswitch	239	5’-UTR	-	0	0	0	0	1.10E-05	1.50E-05	0	0	0	0
1284	Lysine Analog 9	Target_lig_1261	lysC riboswitch mutant 1 (M1)	Escherichia coli	Bacterial growth and infection	Target_229	0	0	2.90E-05	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	0.001 - 6000 uM	1 nM	8.3	-	50 mM Tris-Hcl, 20 mM MgCl2, and 100 mM KCl	In-line probing	RBIND	[NH3+]CCOC[C@H]([NH3+])C([O-])=O	(2S)-2-azaniumyl-3-(2-azaniumylethoxy)propanoate	11948928	-4.3947	149.09206869609	3	2	5	104.64	0	0.385447272718545	6.0145718458789	10	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUAUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	10.1038/nchembio842	Riboswitch	Riboswitch	239	5’-UTR	-	0	0	0	0	2.90E-05	2.90E-05	0	0	0	0
1285	Lysine Analog 9	Target_lig_1261	lysC riboswitch mutant 1 (M2)	Escherichia coli	Bacterial growth and infection	Target_230	0	0	7.50E-05	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	0.001 - 6000 uM	1 nM	8.3	-	50 mM Tris-Hcl, 20 mM MgCl2, and 100 mM KCl	In-line probing	RBIND	[NH3+]CCOC[C@H]([NH3+])C([O-])=O	(2S)-2-azaniumyl-3-(2-azaniumylethoxy)propanoate	11948928	-4.3947	149.09206869609	3	2	5	104.64	0	0.385447272718545	6.0145718458789	10	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUGUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	10.1038/nchembio842	Riboswitch	Riboswitch	238	5’-UTR	-	0	0	0	0	7.50E-05	7.50E-05	0	0	0	0
1286	EBAB	Target_lig_715	CUG x 50 repeat RNA	Synthetic	Myotonic dystrophy 1 (DM1)	Target_231	10.17 x 1E3	0	0	0	0	0	0	-	-	10.1007/s00216-018-1107-6	29736701	Affinity capillary electrophoresis for identification of active drug candidates in myotonic dystrophy type 1.	Neaga IO, Hambye S, Bodoki E, Palmieri C, Ansseau E, Belayew A, Oprean R, Blankert B	Anal Bioanal Chem	410	4495-4507	2018	-	5 uM	7.4	-	50 mM HEPES	Affinity Capillary Electrophoresis	RBIND	NC(=[NH2+])C1=CC=C(NCCNC2=CC=C(C=C2)C(N)=[NH2+])C=C1	-	-	-1.8606	298.18949754418	2	6	7	127.28	2	0.203453912757902	3.01593824552423	22	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1007/s00216-018-1107-6	RNA aptamer	Expanded Repeats	150	3'-UTR	Internal Loop	10170	10200	0	0	0	0	0	0	0	0
1287	DB1246	Target_lig_716	G4C2 repeat G-quadruplex RNA	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	4.0999999999999994e-07±7.899999999999999e-08	0	0	0	0	-	-	10.15252/emmm.201707850	29113975	G-quadruplex-binding small molecules ameliorate <i>C9orf72</i> FTD/ALS pathology <i>in vitro</i> and <i>in vivo</i>.	Simone R, Balendra R, Moens TG, Preza E, Wilson KM, Heslegrave A, Woodling NS, Niccoli T, Gilbert-Jaramillo J, Abdelkarim S, Clayton EL, Clarke M, Konrad MT, Nicoll AJ, Mitchell JS, Calvo A, Chio A, Houlden H, Polke JM, Ismail MA, Stephens CE, Vo T, Farahat AA, Wilson WD, Boykin DW, Zetterberg H, Partridge L, Wray S, Parkinson G, Neidle S, Patani R, Fratta P, Isaacs AM	EMBO Mol Med	10	22-31	2018	50 nM	-	7.4	-	10 mM Tris-Hcl and 50 mM KCl	Fluorescence Anisotropy	RBIND	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	-	-	-0.407599999999999	374.14802665618	4	4	5	155.28	4	0.274884040129034	3.4899140831242	28	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	3.31E-07	4.89E-07	0	0	0	0
1288	DB1247	Target_lig_717	G4C2 repeat G-quadruplex RNA	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	2.58e-07±6e-08	0	0	0	0	-	-	10.15252/emmm.201707850	29113975	G-quadruplex-binding small molecules ameliorate <i>C9orf72</i> FTD/ALS pathology <i>in vitro</i> and <i>in vivo</i>.	Simone R, Balendra R, Moens TG, Preza E, Wilson KM, Heslegrave A, Woodling NS, Niccoli T, Gilbert-Jaramillo J, Abdelkarim S, Clayton EL, Clarke M, Konrad MT, Nicoll AJ, Mitchell JS, Calvo A, Chio A, Houlden H, Polke JM, Ismail MA, Stephens CE, Vo T, Farahat AA, Wilson WD, Boykin DW, Zetterberg H, Partridge L, Wray S, Parkinson G, Neidle S, Patani R, Fratta P, Isaacs AM	EMBO Mol Med	10	22-31	2018	50 nM	-	7.4	-	10 mM Tris-Hcl and 50 mM KCl	Fluorescence Anisotropy	RBIND	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(S1)C1=CC=C(S1)C1=NC=C(C=C1)C(N)=[NH2+]	-	-	0.529400000000001	406.10233941618	4	4	5	129	4	0.284509440981767	3.43837177543189	28	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	1.98E-07	3.18E-07	0	0	0	0
1289	Myricetin	Target_lig_718	Duplex DNA	Synthetic	-	Target_233	0	0	2.29E-05	0	0	0	0	-	-	10.1021/acschembio.7b00699	29172480	Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs)	Khan E, Tawani A, Mishra SK, Verma AK, Upadhyay A, Kumar M, Sandhir R, Mishra A, Kumar A	ACS Chem Biol	13	180-188	2018	-	4 uM	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O	3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one	5281672	1.6936	318.03756728	8	6	1	151.59	3	0.370750464563465	2.73325962409046	23			RNA aptamer	-	0	-	-	0	0	0	0	2.29E-05	2.29E-05	0	0	0	0
1290	Myricetin	Target_lig_718	5'CAG/3'GUC x 6 repeat RNA	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_234	0	0	2.48E-06	0	0	0	0	-	-	10.1021/acschembio.7b00699	29172480	Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs)	Khan E, Tawani A, Mishra SK, Verma AK, Upadhyay A, Kumar M, Sandhir R, Mishra A, Kumar A	ACS Chem Biol	13	180-188	2018	-	4 uM	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O	3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one	5281672	1.6936	318.03756728	8	6	1	151.59	3	0.370750464563465	2.73325962409046	23	GGAGAGGGUUUAAUCAGUACGAAAGUAGUCAUUGGAUCCGCAAGG	10.1021/acschembio.7b00699	RNA aptamer	Expanded Repeats	45	5’-UTR	Internal Loop	0	0	0	0	2.48E-06	2.48E-06	0	0	0	0
1291	Myricetin	Target_lig_718	5′CAG/3′GAC x 2 repeat RNA	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_235	0	0	6.37E-08	0	0	0	0	-	-	10.1021/acschembio.7b00699	29172480	Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs)	Khan E, Tawani A, Mishra SK, Verma AK, Upadhyay A, Kumar M, Sandhir R, Mishra A, Kumar A	ACS Chem Biol	13	180-188	2018	-	4 uM	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O	3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one	5281672	1.6936	318.03756728	8	6	1	151.59	3	0.370750464563465	2.73325962409046	23	GGAGAGGGUUUAAUCAGUACGAAAGUAGACAUUGGAUCCGCAAGG	10.1021/acschembio.7b00699	RNA aptamer	Expanded Repeats	45	5’-UTR	Internal Loop	0	0	0	0	6.37E-08	6.37E-08	0	0	0	0
1292	Myricetin	Target_lig_718	5′CAG/3′GAC x 3 repeat RNA	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_236	0	0	5.80E-09	0	0	0	0	-	-	10.1021/acschembio.7b00699	29172480	Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs)	Khan E, Tawani A, Mishra SK, Verma AK, Upadhyay A, Kumar M, Sandhir R, Mishra A, Kumar A	ACS Chem Biol	13	180-188	2018	-	4 uM	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O	3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one	5281672	1.6936	318.03756728	8	6	1	151.59	3	0.370750464563465	2.73325962409046	23	GGAGAGGGUUUAAUCAGUACGAAAGUAGACAUUGGAUCCGCAAGG	10.1021/acschembio.7b00699	RNA aptamer	Expanded Repeats	45	5’-UTR	Internal Loop	0	0	0	0	5.80E-09	5.80E-09	0	0	0	0
1293	Myricetin	Target_lig_718	5′CAG/3′GAC x 4 repeat RNA	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_237	0	0	4.11E-08	0	0	0	0	-	-	10.1021/acschembio.7b00699	29172480	Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs)	Khan E, Tawani A, Mishra SK, Verma AK, Upadhyay A, Kumar M, Sandhir R, Mishra A, Kumar A	ACS Chem Biol	13	180-188	2018	-	4 uM	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O	3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one	5281672	1.6936	318.03756728	8	6	1	151.59	3	0.370750464563465	2.73325962409046	23	GGAGAGGGUUUAAUCAGUACGAAAGUAGACAUUGGAUCCGCAAGG	10.1021/acschembio.7b00699	RNA aptamer	Expanded Repeats	45	5’-UTR	Internal Loop	0	0	0	0	4.11E-08	4.11E-08	0	0	0	0
1294	Myricetin	Target_lig_718	5′CAG/3′GAC x 5 repeat RNA	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_238	0	0	5.70E-08	0	0	0	0	-	-	10.1021/acschembio.7b00699	29172480	Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs)	Khan E, Tawani A, Mishra SK, Verma AK, Upadhyay A, Kumar M, Sandhir R, Mishra A, Kumar A	ACS Chem Biol	13	180-188	2018	-	4 uM	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O	3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one	5281672	1.6936	318.03756728	8	6	1	151.59	3	0.370750464563465	2.73325962409046	23	GGAGAGGGUUUAAUCAGUACGAAAGUAGACAUUGGAUCCGCAAGG	10.1021/acschembio.7b00699	RNA aptamer	Expanded Repeats	45	5’-UTR	Internal Loop	0	0	0	0	5.70E-08	5.70E-08	0	0	0	0
1295	Myricetin	Target_lig_718	5'CAG/3'GUC x 6 repeat RNA	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_234	0	0	7.30E-08	0	0	0	0	-	-	10.1021/acschembio.7b00699	29172480	Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs)	Khan E, Tawani A, Mishra SK, Verma AK, Upadhyay A, Kumar M, Sandhir R, Mishra A, Kumar A	ACS Chem Biol	13	180-188	2018	-	4 uM	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O	3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one	5281672	1.6936	318.03756728	8	6	1	151.59	3	0.370750464563465	2.73325962409046	23	GGAGAGGGUUUAAUCAGUACGAAAGUAGUCAUUGGAUCCGCAAGG	10.1021/acschembio.7b00699	RNA aptamer	Expanded Repeats	45	5’-UTR	Internal Loop	0	0	0	0	7.30E-08	7.30E-08	0	0	0	0
1296	Myricetin	Target_lig_718	5′CAG/3′GAC x 33 repeat RNA	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_239	0	0	1.70E-09	0	0	0	0	-	-	10.1021/acschembio.7b00699	29172480	Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs)	Khan E, Tawani A, Mishra SK, Verma AK, Upadhyay A, Kumar M, Sandhir R, Mishra A, Kumar A	ACS Chem Biol	13	180-188	2018	-	4 uM	-	-	-	Fluorescence-based titration (Intrinsic)	RBIND	C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O	3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one	5281672	1.6936	318.03756728	8	6	1	151.59	3	0.370750464563465	2.73325962409046	23	GGAGAGGGUUUAAUCAGUACGAAAGUAGACAUUGGAUCCGCAAGG	10.1021/acschembio.7b00699	Internal loop structure	Expanded Repeats	45	5’-UTR	Internal Loop	0	0	0	0	1.70E-09	1.70E-09	0	0	0	0
1297	Myricetin	Target_lig_718	5′CAG/3′GAC internal loop	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_240	0	0	2.50E-07	0	0	0	0	-	-	10.1021/acschembio.7b00699	29172480	Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs)	Khan E, Tawani A, Mishra SK, Verma AK, Upadhyay A, Kumar M, Sandhir R, Mishra A, Kumar A	ACS Chem Biol	13	180-188	2018	50 uM	7 uM	7.2	-	10 mM sodium phosphate, 0.1 M NaCl, and 50 mM EDTA	Isothermal Titration Calorimetry	RBIND	C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O	3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one	5281672	1.6936	318.03756728	8	6	1	151.59	3	0.370750464563465	2.73325962409046	23	GGAGAGGGUUUAAUCAGUACGAAAGUAGACAUUGGAUCCGCAAGG	10.1021/acschembio.7b00699	Internal loop structure	Expanded Repeats	45	5’-UTR	Internal Loop	0	0	0	0	2.50E-07	2.50E-07	0	0	0	0
1298	Myricetin	Target_lig_718	5'CAG/3'GUC internal loop	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_241	0	0	0.000202	0	0	0	0	-	-	10.1021/acschembio.7b00699	29172480	Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs)	Khan E, Tawani A, Mishra SK, Verma AK, Upadhyay A, Kumar M, Sandhir R, Mishra A, Kumar A	ACS Chem Biol	13	180-188	2018	50 uM	7 uM	7.2	-	10 mM sodium phosphate, 0.1 M NaCl, and 50 mM EDTA	Isothermal Titration Calorimetry	RBIND	C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O	3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one	5281672	1.6936	318.03756728	8	6	1	151.59	3	0.370750464563465	2.73325962409046	23	GGAGAGGGUUUAAUCAGUACGAAAGUAGUCAUUGGAUCCGCAAGG	10.1021/acschembio.7b00699	Internal loop structure	Expanded Repeats	45	5’-UTR	Internal Loop	0	0	0	0	0.000202	0.000202	0	0	0	0
1299	Anthrafurandione 2a	Target_lig_719	KRAS RNA G-quadruplex utr-1	Homo sapiens	Cancer,Pancreatic ductal adenocarcinoma (PDAC)	Target_242	0	0	7.5e-08±6e-09	0	0	0	0	-	-	10.1021/acs.jmedchem.7b00622	29140695	RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.	Miglietta G, Cogoi S, Marinello J, Capranico G, Tikhomirov AS, Shchekotikhin A, Xodo LE	J Med Chem	60	9448-9461	2017	-	-	7.4	-	50 mM Tris-Hcl and 150 mM KCl	FRET	RBIND	[NH3+]CCNC1=C2OC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	-	-	0.515800000000001	366.16809340418	5	4	6	126.62	3	0.370027976302617	3.71065942837149	27	GCGGCGGCGGAGGCA	10.1021/acs.jmedchem.7b00622	G-quadruplex	-	15	5'-UTR	G-Quadruplex	0	0	0	0	6.90E-08	8.10E-08	0	0	0	0
1300	Anthrafurandione 2a	Target_lig_719	KRAS RNA G-quadruplex utr-z	Homo sapiens	Cancer,Pancreatic ductal adenocarcinoma (PDAC)	Target_243	0	0	2.51e-07±1.51e-07	0	0	0	0	-	-	10.1021/acs.jmedchem.7b00622	29140695	RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.	Miglietta G, Cogoi S, Marinello J, Capranico G, Tikhomirov AS, Shchekotikhin A, Xodo LE	J Med Chem	60	9448-9461	2017	-	-	7.4	-	50 mM Tris-Hcl and 150 mM KCl	FRET	RBIND	[NH3+]CCNC1=C2OC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	-	-	0.515800000000001	366.16809340418	5	4	6	126.62	3	0.370027976302617	3.71065942837149	27	GGCGGCGGCAGUGGCGGCGG	10.1021/acs.jmedchem.7b00622	G-quadruplex	-	20	5'-UTR	G-Quadruplex	0	0	0	0	1.00E-07	4.02E-07	0	0	0	0
1301	Anthrafurandione 2a	Target_lig_719	KRAS RNA G-quadruplex utr-4	Homo sapiens	Cancer,Pancreatic ductal adenocarcinoma (PDAC)	Target_244	0	0	9.6e-08±4.5e-08	0	0	0	0	-	-	10.1021/acs.jmedchem.7b00622	29140695	RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.	Miglietta G, Cogoi S, Marinello J, Capranico G, Tikhomirov AS, Shchekotikhin A, Xodo LE	J Med Chem	60	9448-9461	2017	-	-	7.4	-	50 mM Tris-Hcl and 150 mM KCl	FRET	RBIND	[NH3+]CCNC1=C2OC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	-	-	0.515800000000001	366.16809340418	5	4	6	126.62	3	0.370027976302617	3.71065942837149	27	CAGCAGCGGCGGCGGCAGUGG	10.1021/acs.jmedchem.7b00622	G-quadruplex	-	21	5'-UTR	G-Quadruplex	0	0	0	0	5.10E-08	1.41E-07	0	0	0	0
1302	Anthrafurandione 2a	Target_lig_719	RNA Hairpin	Synthetic	-	Target_245	0	0	5.14e-07±1.03e-07	0	0	0	0	-	-	10.1021/acs.jmedchem.7b00622	29140695	RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.	Miglietta G, Cogoi S, Marinello J, Capranico G, Tikhomirov AS, Shchekotikhin A, Xodo LE	J Med Chem	60	9448-9461	2017	-	-	7.4	-	50 mM Tris-Hcl and 150 mM KCl	FRET	RBIND	[NH3+]CCNC1=C2OC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	-	-	0.515800000000001	366.16809340418	5	4	6	126.62	3	0.370027976302617	3.71065942837149	27	CCGCCGCAGUGGCGGCGG	10.1021/acs.jmedchem.7b00622	Hairpin	-	18	-	Hairpin	0	0	0	0	4.11E-07	6.17E-07	0	0	0	0
1303	Anthrafurandione 2a	Target_lig_719	KRAS promoter DNA G-quadruplex	Homo sapiens	Cancer,Pancreatic ductal adenocarcinoma (PDAC)	Target_246	0	0	6.26e-07±7.099999999999999e-08	0	0	0	0	-	-	10.1021/acs.jmedchem.7b00622	29140695	RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.	Miglietta G, Cogoi S, Marinello J, Capranico G, Tikhomirov AS, Shchekotikhin A, Xodo LE	J Med Chem	60	9448-9461	2017	-	-	7.4	-	50 mM Tris-Hcl and 150 mM KCl	FRET	RBIND	[NH3+]CCNC1=C2OC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	-	-	0.515800000000001	366.16809340418	5	4	6	126.62	3	0.370027976302617	3.71065942837149	27			G-quadruplex	-	0	5'-UTR	G-Quadruplex	0	0	0	0	5.55E-07	6.97E-07	0	0	0	0
1304	Anthrathiophenedione 2b	Target_lig_720	KRAS RNA G-quadruplex utr-1	Homo sapiens	Cancer,Pancreatic ductal adenocarcinoma (PDAC)	Target_242	0	0	9.1e-08±1.5e-08	0	0	0	0	-	-	10.1021/acs.jmedchem.7b00622	29140695	RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.	Miglietta G, Cogoi S, Marinello J, Capranico G, Tikhomirov AS, Shchekotikhin A, Xodo LE	J Med Chem	60	9448-9461	2017	-	-	7.4	-	50 mM Tris-Hcl and 150 mM KCl	FRET	RBIND	[NH3+]CCNC1=C2SC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	-	-	0.984300000000001	382.14524978418	5	4	6	113.48	3	0.372365566884307	3.65941786992993	27	GCGGCGGCGGAGGCA	10.1021/acs.jmedchem.7b00622	G-quadruplex	-	15	5'-UTR	G-Quadruplex	0	0	0	0	7.60E-08	1.06E-07	0	0	0	0
1305	Anthrathiophenedione 2b	Target_lig_720	KRAS RNA G-quadruplex utr-z	Homo sapiens	Cancer,Pancreatic ductal adenocarcinoma (PDAC)	Target_243	0	0	2.9399999999999996e-07±1.3800000000000002e-07	0	0	0	0	-	-	10.1021/acs.jmedchem.7b00622	29140695	RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.	Miglietta G, Cogoi S, Marinello J, Capranico G, Tikhomirov AS, Shchekotikhin A, Xodo LE	J Med Chem	60	9448-9461	2017	-	-	7.4	-	50 mM Tris-Hcl and 150 mM KCl	FRET	RBIND	[NH3+]CCNC1=C2SC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	-	-	0.984300000000001	382.14524978418	5	4	6	113.48	3	0.372365566884307	3.65941786992993	27	GGCGGCGGCAGUGGCGGCGG	10.1021/acs.jmedchem.7b00622	G-quadruplex	-	20	5'-UTR	G-Quadruplex	0	0	0	0	1.56E-07	4.32E-07	0	0	0	0
1306	Anthrathiophenedione 2b	Target_lig_720	KRAS RNA G-quadruplex utr-4	Homo sapiens	Cancer,Pancreatic ductal adenocarcinoma (PDAC)	Target_244	0	0	8.3e-08±2.6999999999999997e-08	0	0	0	0	-	-	10.1021/acs.jmedchem.7b00622	29140695	RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.	Miglietta G, Cogoi S, Marinello J, Capranico G, Tikhomirov AS, Shchekotikhin A, Xodo LE	J Med Chem	60	9448-9461	2017	-	-	7.4	-	50 mM Tris-Hcl and 150 mM KCl	FRET	RBIND	[NH3+]CCNC1=C2SC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	-	-	0.984300000000001	382.14524978418	5	4	6	113.48	3	0.372365566884307	3.65941786992993	27	CAGCAGCGGCGGCGGCAGUGG	10.1021/acs.jmedchem.7b00622	G-quadruplex	-	21	5'-UTR	G-Quadruplex	0	0	0	0	5.60E-08	1.10E-07	0	0	0	0
1307	Anthrathiophenedione 2b	Target_lig_720	RNA Hairpin	Synthetic	-	Target_245	0	0	4.82e-07±1.09e-07	0	0	0	0	-	-	10.1021/acs.jmedchem.7b00622	29140695	RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.	Miglietta G, Cogoi S, Marinello J, Capranico G, Tikhomirov AS, Shchekotikhin A, Xodo LE	J Med Chem	60	9448-9461	2017	-	-	7.4	-	50 mM Tris-Hcl and 150 mM KCl	FRET	RBIND	[NH3+]CCNC1=C2SC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	-	-	0.984300000000001	382.14524978418	5	4	6	113.48	3	0.372365566884307	3.65941786992993	27	CCGCCGCAGUGGCGGCGG	10.1021/acs.jmedchem.7b00622	Hairpin	-	18	-	Hairpin	0	0	0	0	3.73E-07	5.91E-07	0	0	0	0
1308	Anthrathiophenedione 2b	Target_lig_720	KRAS promoter DNA G-quadruplex	Homo sapiens	Cancer,Pancreatic ductal adenocarcinoma (PDAC)	Target_246	0	0	2.7800000000000003e-07±2.1e-08	0	0	0	0	-	-	10.1021/acs.jmedchem.7b00622	29140695	RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation.	Miglietta G, Cogoi S, Marinello J, Capranico G, Tikhomirov AS, Shchekotikhin A, Xodo LE	J Med Chem	60	9448-9461	2017	-	-	7.4	-	50 mM Tris-Hcl and 150 mM KCl	FRET	RBIND	[NH3+]CCNC1=C2SC=CC2=C(NCC[NH3+])C2=C1C(=O)C1=CC=CC=C1C2=O	-	-	0.984300000000001	382.14524978418	5	4	6	113.48	3	0.372365566884307	3.65941786992993	27			G-quadruplex	-	0	5'-UTR	G-Quadruplex	0	0	0	0	2.57E-07	2.99E-07	0	0	0	0
1309	PK4C9	Target_lig_721	Synthetic TSL-2 RNA	Synthetic	Spinal muscular atrophy (SMA)	Target_247	0	0	0	0	1.61E-05	0	0	-	-	10.1038/s41467-018-04110-1	29795225	Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes.	Garcia-Lopez A, Tessaro F, Jonker HRA, Wacker A, Richter C, Comte A, Berntenis N, Schmucki R, Hatje K, Petermann O, Chiriano G, Perozzo R, Sciarra D, Konieczny P, Faustino I, Fournet G, Orozco M, Artero R, Metzger F, Ebeling M, Goekjian P, Joseph B, Schwalbe H, Scapozza L	Nat Commun	9	2032	2018	-	-	7	-	8 mM Na2HPO4, 185 mM NaCl, 0.1 mM EDTA, and 40 μg/mL BSA	Fluorescence Displacement	RBIND	C1=CC=C2C(=C1)C(=CN2)C(=O)C3=CN=C(N3)C(=O)C4=CNC5=C4C=CC(=C5)O	[2-(6-hydroxy-1H-indole-3-carbonyl)-1H-imidazol-5-yl]-(1H-indol-3-yl)methanone	11326167	3.5399	370.106590308	4	4	4	114.63	5	0.362243112580029	2.7609596814148	28	ACAUUCCUUAAAUUAAGGAGUAAGUCU	10.1038/s41467-018-04110-1	RNA aptamer	-	27	-	Hairpin	0	0	0	0	0	0	0	0	1.61E-05	1.61E-05
1310	SMN-C2	Target_lig_722	Oligo-4, an AGGAAG-containing RNA 15-mer	Synthetic	Spinal muscular atrophy (SMA)	Target_248	0	0	1.6e-05±2e-06	0	0	0	0	-	-	10.1073/pnas.1800260115	29712837	Mechanistic studies of a small-molecule modulator of SMN2 splicing.	Wang J, Schultz PG, Johnson KA	Proc Natl Acad Sci U S A	115	E4604-E4612	2018	200 nM	-	-	-	50 mM HEPES, 150 mM NaCl, and 4 mM MgCl2	Fluorescence Polarization	RBIND	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	AGAAGGAAGGUGCUC	10.1073/pnas.1800260115	RNA aptamer	-	15	-	-	0	0	0	0	1.40E-05	1.80E-05	0	0	0	0
1311	SMN-C2	Target_lig_722	Oligo-7, an AAGGAG-containing RNA 15-mer	Synthetic	Spinal muscular atrophy (SMA)	Target_249	0	0	4.6e-05±3e-06	0	0	0	0	-	-	10.1073/pnas.1800260115	29712837	Mechanistic studies of a small-molecule modulator of SMN2 splicing.	Wang J, Schultz PG, Johnson KA	Proc Natl Acad Sci U S A	115	E4604-E4612	2018	200 nM	-	-	-	50 mM HEPES, 150 mM NaCl, and 4 mM MgCl2	Fluorescence Polarization	RBIND	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	AAUUAAGGAGUAAGU	10.1073/pnas.1800260115	RNA aptamer	-	15	-	-	0	0	0	0	4.30E-05	4.90E-05	0	0	0	0
1312	SMN-C2	Target_lig_722	Oligo-1, a pyrimidine-rich RNA 15-mer	Synthetic	Spinal muscular atrophy (SMA)	Target_250	0	0	>0.00015999999999999999	0	0	0	0	-	-	10.1073/pnas.1800260115	29712837	Mechanistic studies of a small-molecule modulator of SMN2 splicing.	Wang J, Schultz PG, Johnson KA	Proc Natl Acad Sci U S A	115	E4604-E4612	2018	200 nM	-	-	-	50 mM HEPES, 150 mM NaCl, and 4 mM MgCl2	Fluorescence Polarization	RBIND	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	CUUCCUUUAUUUUCC	10.1073/pnas.1800260115	RNA aptamer	-	15	-	-	0	0	0	0	0.00016	0.00016	0	0	0	0
1313	SMN-C2	Target_lig_722	Oligo-2, an RNA 15-mer	Synthetic	Spinal muscular atrophy (SMA)	Target_251	0	0	>0.00015999999999999999	0	0	0	0	-	-	10.1073/pnas.1800260115	29712837	Mechanistic studies of a small-molecule modulator of SMN2 splicing.	Wang J, Schultz PG, Johnson KA	Proc Natl Acad Sci U S A	115	E4604-E4612	2018	200 nM	-	-	-	50 mM HEPES, 150 mM NaCl, and 4 mM MgCl2	Fluorescence Polarization	RBIND	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	GGUUUUAGACAAAAU	10.1073/pnas.1800260115	RNA aptamer	-	15	-	-	0	0	0	0	0.00016	0.00016	0	0	0	0
1314	SMN-C2	Target_lig_722	Oligo-3, a purine-rich RNA 15-mer	Synthetic	Spinal muscular atrophy (SMA)	Target_252	0	0	>0.00015999999999999999	0	0	0	0	-	-	10.1073/pnas.1800260115	29712837	Mechanistic studies of a small-molecule modulator of SMN2 splicing.	Wang J, Schultz PG, Johnson KA	Proc Natl Acad Sci U S A	115	E4604-E4612	2018	200 nM	-	-	-	50 mM HEPES, 150 mM NaCl, and 4 mM MgCl2	Fluorescence Polarization	RBIND	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	AAAAUCAAAAAGAAG	10.1073/pnas.1800260115	RNA aptamer	-	15	-	-	0	0	0	0	0.00016	0.00016	0	0	0	0
1315	SMN-C2	Target_lig_722	Oligo-5, an RNA 15-mer	Synthetic	Spinal muscular atrophy (SMA)	Target_253	0	0	>0.00015999999999999999	0	0	0	0	-	-	10.1073/pnas.1800260115	29712837	Mechanistic studies of a small-molecule modulator of SMN2 splicing.	Wang J, Schultz PG, Johnson KA	Proc Natl Acad Sci U S A	115	E4604-E4612	2018	200 nM	-	-	-	50 mM HEPES, 150 mM NaCl, and 4 mM MgCl2	Fluorescence Polarization	RBIND	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	UGCUCACAUUCCUUA	10.1073/pnas.1800260115	RNA aptamer	-	15	-	-	0	0	0	0	0.00016	0.00016	0	0	0	0
1316	SMN-C2	Target_lig_722	Oligo-6, an RNA 15-mer	Synthetic	Spinal muscular atrophy (SMA)	Target_254	0	0	>0.00015999999999999999	0	0	0	0	-	-	10.1073/pnas.1800260115	29712837	Mechanistic studies of a small-molecule modulator of SMN2 splicing.	Wang J, Schultz PG, Johnson KA	Proc Natl Acad Sci U S A	115	E4604-E4612	2018	200 nM	-	-	-	50 mM HEPES, 150 mM NaCl, and 4 mM MgCl2	Fluorescence Polarization	RBIND	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	CCUUAAAUUAAGGAG	10.1073/pnas.1800260115	RNA aptamer	-	15	-	-	0	0	0	0	0.00016	0.00016	0	0	0	0
1317	Quindoline CK1-14	Target_lig_723	TERRA G-quadruplex (TERRA22)	Homo sapiens	Cancer,Age-related diseases	Target_255	0	0	2.56e-06±4.8e-07	0	0	0	0	-	-	10.1016/j.bbagen.2017.09.015	28943299	Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2	Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou T, Tan J, Gu L, Huang Z, Li D	Biochim Biophys Acta Gen Subj	1861	3246-3256	2017	-	-	7.4	-	50 mM Tris-Hcl, 150 mM KCl, and 0.005% Tween-20	Surface Plasmon Resonance	RBIND	C(CN1C=C(CNC2=C3C=CC=CC3=[NH+]C3=C2OC2=C3C=CC=C2)N=N1)C[NH+]1CCCCC1	-	-	3.2158	442.24701242018	5	2	7	74.46	5	0.405930291675564	4.19261447197155	33	AGGGUUAGGGUUAGGGUUAGGG	10.1016/j.bbagen.2017.09.015	G-quadruplex	-	22	-	G-Quadruplex	0	0	0	0	2.08E-06	3.04E-06	0	0	0	0
1318	Quindoline CK1-14	Target_lig_723	Telomeric DNA G-quadruplex (HTG22)	Homo sapiens	Cancer,Age-related diseases	Target_256	0	0	1.66e-05±2.2e-06	0	0	0	0	-	-	10.1016/j.bbagen.2017.09.015	28943299	Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2	Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou T, Tan J, Gu L, Huang Z, Li D	Biochim Biophys Acta Gen Subj	1861	3246-3256	2017	-	-	7.4	-	50 mM Tris-Hcl, 150 mM KCl, and 0.005% Tween-20	Surface Plasmon Resonance	RBIND	C(CN1C=C(CNC2=C3C=CC=CC3=[NH+]C3=C2OC2=C3C=CC=C2)N=N1)C[NH+]1CCCCC1	-	-	3.2158	442.24701242018	5	2	7	74.46	5	0.405930291675564	4.19261447197155	33	GGGUUAGGGU	2M18	G-quadruplex	-	10	-	G-Quadruplex	0	0	0	0	1.44E-05	1.88E-05	0	0	0	0
1319	Quindoline CK1-14	Target_lig_723	Hairpin DNA	Synthetic	-	Target_212	0	0	0.34099999999999997±0.004	0	0	0	0	-	-	10.1016/j.bbagen.2017.09.015	28943299	Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2	Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou T, Tan J, Gu L, Huang Z, Li D	Biochim Biophys Acta Gen Subj	1861	3246-3256	2017	-	-	7.4	-	50 mM Tris-Hcl, 150 mM KCl, and 0.005% Tween-20	Surface Plasmon Resonance	RBIND	C(CN1C=C(CNC2=C3C=CC=CC3=[NH+]C3=C2OC2=C3C=CC=C2)N=N1)C[NH+]1CCCCC1	-	-	3.2158	442.24701242018	5	2	7	74.46	5	0.405930291675564	4.19261447197155	33	CGCGAATTCGCGTTTTCGCGAATTCGCG	10.1016/j.bmcl.2016.10.037	Hairpin	-	28	-	Hairpin	0	0	0	0	0.337	0.345	0	0	0	0
1320	Quindoline CK1-14	Target_lig_723	TERRA G-quadruplex (TERRA22)	Homo sapiens	Cancer,Age-related diseases	Target_255	0	0	2.1999999999999998e-07±1e-08	0	0	0	0	-	-	10.1016/j.bbagen.2017.09.015	28943299	Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2	Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou T, Tan J, Gu L, Huang Z, Li D	Biochim Biophys Acta Gen Subj	1861	3246-3256	2017	-	-	-	-	-	Microscale Thermophoresis	RBIND	C(CN1C=C(CNC2=C3C=CC=CC3=[NH+]C3=C2OC2=C3C=CC=C2)N=N1)C[NH+]1CCCCC1	-	-	3.2158	442.24701242018	5	2	7	74.46	5	0.405930291675564	4.19261447197155	33	AGGGUUAGGGUUAGGGUUAGGG	10.1016/j.bbagen.2017.09.015	G-quadruplex	-	22	-	G-Quadruplex	0	0	0	0	2.10E-07	2.30E-07	0	0	0	0
1321	Quindoline CK1-14	Target_lig_723	Telomeric DNA G-quadruplex (HTG22)	Homo sapiens	Cancer,Age-related diseases	Target_256	0	0	0.000234±6e-06	0	0	0	0	-	-	10.1016/j.bbagen.2017.09.015	28943299	Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2	Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou T, Tan J, Gu L, Huang Z, Li D	Biochim Biophys Acta Gen Subj	1861	3246-3256	2017	-	-	-	-	-	Microscale Thermophoresis	RBIND	C(CN1C=C(CNC2=C3C=CC=CC3=[NH+]C3=C2OC2=C3C=CC=C2)N=N1)C[NH+]1CCCCC1	-	-	3.2158	442.24701242018	5	2	7	74.46	5	0.405930291675564	4.19261447197155	33	GGGUUAGGGU	2M18	G-quadruplex	-	10	-	G-Quadruplex	0	0	0	0	0.000228	0.00024	0	0	0	0
1322	Quindoline CK1-14	Target_lig_723	IRES RNA G-quadruplex	Hepatitis C virus	Hepatitis C	Target_257	0	0	1.38e-06±6e-08	0	0	0	0	-	-	10.1016/j.bbagen.2017.09.015	28943299	Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2	Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou T, Tan J, Gu L, Huang Z, Li D	Biochim Biophys Acta Gen Subj	1861	3246-3256	2017	-	-	-	-	-	Microscale Thermophoresis	RBIND	C(CN1C=C(CNC2=C3C=CC=CC3=[NH+]C3=C2OC2=C3C=CC=C2)N=N1)C[NH+]1CCCCC1	-	-	3.2158	442.24701242018	5	2	7	74.46	5	0.405930291675564	4.19261447197155	33	GGAGGAGGGGGAGGAGGA	https://www.nature.com/articles/srep24793	G-quadruplex	Internal Ribosome Entry Site (IRES)	18	-	G-Quadruplex	0	0	0	0	1.32E-06	1.44E-06	0	0	0	0
1323	Quindoline CK1-14	Target_lig_723	BCL2 RNA G-quadruplex	Homo sapiens	Cancer,Chronic Myeloid Leukemia (CML)	Target_258	0	0	2.95e-06±1.6e-07	0	0	0	0	-	-	10.1016/j.bbagen.2017.09.015	28943299	Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2	Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou T, Tan J, Gu L, Huang Z, Li D	Biochim Biophys Acta Gen Subj	1861	3246-3256	2017	-	-	-	-	-	Microscale Thermophoresis	RBIND	C(CN1C=C(CNC2=C3C=CC=CC3=[NH+]C3=C2OC2=C3C=CC=C2)N=N1)C[NH+]1CCCCC1	-	-	3.2158	442.24701242018	5	2	7	74.46	5	0.405930291675564	4.19261447197155	33	AGGGGGCCGUGGGGUGGGAGCUGGGG	https://www.nature.com/articles/srep24793	G-quadruplex	-	26	-	G-Quadruplex	0	0	0	0	2.79E-06	3.11E-06	0	0	0	0
1324	Quindoline CK1-14	Target_lig_723	NRAS RNA G-quadruplex	Homo sapiens	Cancer	Target_259	0	0	4.3999999999999997e-07±3e-08	0	0	0	0	-	-	10.1016/j.bbagen.2017.09.015	28943299	Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2	Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou T, Tan J, Gu L, Huang Z, Li D	Biochim Biophys Acta Gen Subj	1861	3246-3256	2017	-	-	-	-	-	Microscale Thermophoresis	RBIND	C(CN1C=C(CNC2=C3C=CC=CC3=[NH+]C3=C2OC2=C3C=CC=C2)N=N1)C[NH+]1CCCCC1	-	-	3.2158	442.24701242018	5	2	7	74.46	5	0.405930291675564	4.19261447197155	33	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	4.10E-07	4.70E-07	0	0	0	0
1325	Quindoline CK1-14	Target_lig_723	Pu22 DNA G-quadruplex	Homo sapiens	Cancer	Target_260	0	0	7.099999999999999e-06±1.4e-07	0	0	0	0	-	-	10.1016/j.bbagen.2017.09.015	28943299	Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2	Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou T, Tan J, Gu L, Huang Z, Li D	Biochim Biophys Acta Gen Subj	1861	3246-3256	2017	-	-	-	-	-	Microscale Thermophoresis	RBIND	C(CN1C=C(CNC2=C3C=CC=CC3=[NH+]C3=C2OC2=C3C=CC=C2)N=N1)C[NH+]1CCCCC1	-	-	3.2158	442.24701242018	5	2	7	74.46	5	0.405930291675564	4.19261447197155	33	TGAGGGTGGGTAGGGTGGGTAA	10.1093/nar/gkz059	G-quadruplex	-	22	-	G-Quadruplex	0	0	0	0	6.96E-06	7.24E-06	0	0	0	0
1326	Quindoline CK1-14	Target_lig_723	TRF2:Telomeric duplex DNA (hTELO-dup)	Homo sapiens	Cancer	Target_261	0	0	5.865e-08±2.7599999999999996e-09	0	0	0	0	-	-	10.1016/j.bbagen.2017.09.015	28943299	Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2	Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou T, Tan J, Gu L, Huang Z, Li D	Biochim Biophys Acta Gen Subj	1861	3246-3256	2017	1 uM	0.1 uM	7.4	-	10 mM Tris-Hcl and 100 mM KCl	ELISA	RBIND	C(CN1C=C(CNC2=C3C=CC=CC3=[NH+]C3=C2OC2=C3C=CC=C2)N=N1)C[NH+]1CCCCC1	-	-	3.2158	442.24701242018	5	2	7	74.46	5	0.405930291675564	4.19261447197155	33	GGGUUAGGGU	2M18	G-quadruplex	-	10	-	G-Quadruplex	0	0	0	0	5.59E-08	6.14E-08	0	0	0	0
1327	Quindoline CK1-14	Target_lig_723	TRF2:TERRA G-quadruplex (TERRA22):Telomeric duplex DNA (hTELO-dup)	Homo sapiens	Cancer	Target_262	0	0	5.336e-07±3.3399999999999995e-08	0	0	0	0	-	-	10.1016/j.bbagen.2017.09.015	28943299	Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2	Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou T, Tan J, Gu L, Huang Z, Li D	Biochim Biophys Acta Gen Subj	1861	3246-3256	2017	1 uM	0.1 uM	7.4	-	10 mM Tris-Hcl and 100 mM KCl	ELISA	RBIND	C(CN1C=C(CNC2=C3C=CC=CC3=[NH+]C3=C2OC2=C3C=CC=C2)N=N1)C[NH+]1CCCCC1	-	-	3.2158	442.24701242018	5	2	7	74.46	5	0.405930291675564	4.19261447197155	33	GGGUUAGGGU	2M18	G-quadruplex	-	10	-	G-Quadruplex	0	0	0	0	5.00E-07	5.67E-07	0	0	0	0
1328	Topotecan	Target_lig_724	Cy5-U4 5′SL RNA:His-NHP2L1 protein	Human immunodeficiency virus (HIV-1)	Alternate splicing (AS)-related diseases	Target_263	0	0	0	2.1e-06±3e-07	0	0	0	-	-	10.1177/2472555217735035	28985478	Alteration of RNA Splicing by Small-Molecule Inhibitors of the Interaction between NHP2L1 and U4.	Diouf B, Lin W, Goktug A, Grace CRR, Waddell MB, Bao J, Shao Y, Heath RJ, Zheng JJ, Shelat AA, Relling MV, Chen T, Evans WE	SLAS Discov	23	164-173	2018	-	2 nM	7.6	-	20 mM Tris-Hcl, 150 mM NaCl, 0.1% Triton X-100, 0.5 mg/mL tRNA, 0.01% BSA, and 2 mM DTT	Protein Displacement	RBIND	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)[NH+]=C4C3=C2)O	(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-13-aza-3-azoniapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione	101379276	1.2659	422.17104728809	7	2	3	106.14	3	0.48181049043558	4.26321285681156	31	AUCGUAGCCAAUGAGGUUUAUCCGAGGCGCGAU	10.1177/2472555217735035	Stem-loop structure	mRNA	33	Splice site	Stem-Loop	0	0	0	0	0	0	1.80E-06	2.40E-06	0	0
1329	Topotecan	Target_lig_724	U4 5′SL RNA	Human immunodeficiency virus (HIV-1)	Alternate splicing (AS)-related diseases	Target_263	0	0	9.099999999999999e-05±7e-06	0	0	0	0	-	-	10.1177/2472555217735035	28985478	Alteration of RNA Splicing by Small-Molecule Inhibitors of the Interaction between NHP2L1 and U4.	Diouf B, Lin W, Goktug A, Grace CRR, Waddell MB, Bao J, Shao Y, Heath RJ, Zheng JJ, Shelat AA, Relling MV, Chen T, Evans WE	SLAS Discov	23	164-173	2018	50 uM	-	6.5	-	20 mM Bis-Tris, 200 mM NaCl, 2 mM TCEP, 0.01% Triton X-100, 10% glycerol, and 5% DMSO	Surface Plasmon Resonance	RBIND	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)[NH+]=C4C3=C2)O	(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-13-aza-3-azoniapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione	101379276	1.2659	422.17104728809	7	2	3	106.14	3	0.48181049043558	4.26321285681156	31	AUCGUAGCCAAUGAGGUUUAUCCGAGGCGCGAU	10.1177/2472555217735035	Stem-loop structure	mRNA	33	Splice site	Stem-Loop	0	0	0	0	8.40E-05	9.80E-05	0	0	0	0
1330	Aniline_analog_1	Target_lig_725	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	3.2e-06±7e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CC1=CC=CC=C1NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-(3,6-dibromocarbazol-9-yl)-3-(2-methylanilino)propan-2-ol	2836189	6.10092000000001	485.99423746	3	2	5	37.19	4	0.356464256401367	2.67723302876138	27	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.50E-06	3.90E-06	0	0	0	0
1331	Aniline_analog_2	Target_lig_726	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	7e-07±1e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	COC1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-(3,6-dibromocarbazol-9-yl)-3-(4-methoxyanilino)propan-2-ol	2836197	5.8011	501.98915208	4	2	6	46.42	4	0.349175352979985	2.66274311558202	28	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	6.00E-07	8.00E-07	0	0	0	0
1332	Aniline_analog_3	Target_lig_727	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	3e-06±6e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	COC1=CC(=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O)OC	1-(3,6-dibromocarbazol-9-yl)-3-(2,4-dimethoxyanilino)propan-2-ol	2858492	5.80970000000001	531.999716764	5	2	7	55.65	4	0.314554531006719	2.77514271451728	30	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.40E-06	3.60E-06	0	0	0	0
1333	Aniline_analog_4	Target_lig_728	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	1.4e-06±3e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	COC1=C(C=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O)OC	1-(3,6-dibromocarbazol-9-yl)-3-(3,4-dimethoxyanilino)propan-2-ol	72696479	5.80970000000001	531.999716764	5	2	7	55.65	4	0.314554531006719	2.74775665116886	30	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.10E-06	1.70E-06	0	0	0	0
1334	Aniline_analog_5	Target_lig_729	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	4.8e-06±1e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CCOc1ccc(cn1)NCC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)O	-	-	5.5862	517.000051112	5	2	7	59.31	4	0.334733048610811	2.92232851143966	29	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	3.80E-06	5.80E-06	0	0	0	0
1335	Aniline_analog_6	Target_lig_730	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2.2e-06±3e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CCCOc1ccc(cc1)NCC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)O	-	-	6.58130000000001	530.020452208	4	2	8	46.42	4	0.269676912098534	2.74294472440889	30	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.90E-06	2.50E-06	0	0	0	0
1336	Aniline_analog_7	Target_lig_731	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2.1e-06±5e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	OC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)CNc1ccc(cc1)N1CCOCC1	-	-	5.6291	557.03135124	5	2	6	49.66	4	0.321909466015381	2.85560525996542	32	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.60E-06	2.60E-06	0	0	0	0
1337	Aniline_analog_8	Target_lig_732	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	3.2999999999999997e-06±1.6e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CC1=C(C=CC=C1Cl)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-(3-chloro-2-methylanilino)-3-(3,6-dibromocarbazol-9-yl)propan-2-ol	5189252	6.75432	519.955265108	3	2	5	37.19	4	0.304115238490165	2.79276903817209	28	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.70E-06	4.90E-06	0	0	0	0
1338	Aniline_analog_9	Target_lig_733	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2.8999999999999998e-06±9e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CCOc1ccc(cc1Cl)NCC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)O	-	-	6.84460000000001	549.965829792	4	2	7	46.42	4	0.263819390491451	2.80271447922316	30	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.00E-06	3.80E-06	0	0	0	0
1339	Aniline_analog_10	Target_lig_734	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2.1e-06±9e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	C1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-anilino-3-(3,6-dibromocarbazol-9-yl)propan-2-ol	2836187	5.7925	471.978587396	3	2	5	37.19	4	0.38439023231789	2.61936886807533	26	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.20E-06	3.00E-06	0	0	0	0
1340	Aniline_analog_11	Target_lig_735	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	1.4e-06±4e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	C1=CC(=CC(=C1)Cl)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-(3-chloroanilino)-3-(3,6-dibromocarbazol-9-yl)propan-2-ol	3103960	6.4459	505.939615044	3	2	5	37.19	4	0.32530959024836	2.71861684494519	27	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.00E-06	1.80E-06	0	0	0	0
1341	Aniline_analog_12	Target_lig_736	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	1.4e-06±5e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	OC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)CNc1ccc2c(c1)cccc2	-	-	6.94570000000001	521.99423746	3	2	5	37.19	5	0.261415058896431	2.73044182514296	30	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	9.00E-07	1.90E-06	0	0	0	0
1342	Aniline_analog_13	Target_lig_737	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	1.2e-06±3e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CCOC1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-(3,6-dibromocarbazol-9-yl)-3-(4-ethoxyanilino)propan-2-ol	2836209	6.19120000000001	516.004802144	4	2	7	46.42	4	0.306922834591504	2.70214296927098	29	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	9.00E-07	1.50E-06	0	0	0	0
1343	Aniline_analog_14	Target_lig_738	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	1.13e-05±4.4e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CC1=CC(=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O)C	1-(3,6-dibromocarbazol-9-yl)-3-(2,4-dimethylanilino)propan-2-ol	3112587	6.40934000000001	500.009887524	3	2	5	37.19	4	0.331231281122156	2.74120175482253	28	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	6.90E-06	1.57E-05	0	0	0	0
1344	Carbazole_analog_17	Target_lig_739	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	9.199999999999998e-06±2.4e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	C1=CC=C(C=C1)NCC(CN2C3=CC=CC=C3C4=CC=CC=C42)O	1-anilino-3-carbazol-9-ylpropan-2-ol	2836185	4.2675	316.15756326	3	2	5	37.19	4	0.576857960993993	2.3156127979863	24	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	6.80E-06	1.16E-05	0	0	0	0
1345	Carbazole_analog_18	Target_lig_740	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2.2e-06±5e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CCOC1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=CC=CC=C42)O	1-(3-bromocarbazol-9-yl)-3-(4-ethoxyanilino)propan-2-ol	23794243	5.42870000000001	438.094290076	4	2	7	46.42	4	0.403887857516684	2.56425420532561	28	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.70E-06	2.70E-06	0	0	0	0
1346	Carbazole_analog_19	Target_lig_741	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	4.599999999999999e-06±1.3e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	OC(Cn1c2ccc(cc2c2c1cccc2)Br)CNc1ccc(cc1)N1CCOCC1	-	-	4.8666	479.120839172	5	2	6	49.66	4	0.413811357837599	2.73015233665193	31	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	3.30E-06	5.90E-06	0	0	0	0
1347	Carbazole_analog_20	Target_lig_742	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	1.4e-06±6e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CCOc1ccc(cc1)NCC(Cn1c2cc(Br)ccc2c2c1cc(Br)cc2)O	-	-	6.19120000000001	516.004802144	4	2	7	46.42	4	0.306922834591504	2.74800877093919	29	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	8.00E-07	2.00E-06	0	0	0	0
1348	Carbazole_analog_21	Target_lig_743	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	9.199999999999998e-06±2.6e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	OC(Cn1c2cc(Br)ccc2c2c1cc(Br)cc2)CNc1ccc(cc1)N1CCOCC1	-	-	5.62910000000001	557.03135124	5	2	6	49.66	4	0.321909466015381	2.89653925500264	32	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	6.60E-06	1.18E-05	0	0	0	0
1349	Carbazole_analog_22	Target_lig_744	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	3.7999999999999996e-06±5e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	OC(Cn1c2cc(Br)ccc2c2c1cc(Br)cc2)CNc1ccccc1C	-	-	6.10092000000001	485.99423746	3	2	5	37.19	4	0.356464256401367	2.72667278900114	27	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	3.30E-06	4.30E-06	0	0	0	0
1350	Carbazole_analog_23	Target_lig_745	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	3.2e-06±8e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CCOC1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Cl)C4=C2C=CC(=C4)Cl)O	1-(3,6-dichlorocarbazol-9-yl)-3-(4-ethoxyanilino)propan-2-ol	2836208	5.97300000000001	428.105833304	4	2	7	46.42	4	0.380414617402239	2.62069088400685	29	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.40E-06	4.00E-06	0	0	0	0
1351	Carbazole_analog_24	Target_lig_746	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	>9.999999999999999e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CCOc1ccc(cc1)NCC(Cn1c2ccc(cc2c(c1C)C)Br)O	-	-	4.89234000000001	416.10994014	4	2	7	46.42	3	0.575462650763049	2.67828029484034	26	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
1352	Carbazole_analog_25	Target_lig_747	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2.2999999999999996e-06±6e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	CCOc1ccc(cc1)NCC(CN(c1ccc(cc1)Br)c1ccc(cc1)Br)O	-	-	6.22140000000001	518.020452208	4	2	9	44.73	3	0.351875424588968	2.71386215370101	29	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.70E-06	2.90E-06	0	0	0	0
1353	Carbazole_analog_26	Target_lig_748	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	>9.999999999999999e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	OC(CN(c1ccc(cc1)Br)c1ccc(cc1)Br)CNc1ccc(cc1)N1CCOCC1	-	-	5.65930000000001	559.047001304	5	2	8	47.97	3	0.372137698228291	2.86606431703738	32	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
1354	Carbazole_analog_27	Target_lig_749	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	>9.999999999999999e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0 - 250 uM	100 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	Fluorescence intensity assay	Additional	OC(CN(c1ccc(cc1)Br)c1ccc(cc1)Br)CNc1ccccc1C	-	-	6.13112	488.009887524	3	2	7	35.5	3	0.418532002013727	2.68986539639374	27	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
1355	Aniline_analog_1	Target_lig_725	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2.2999999999999996e-06±5e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CC1=CC=CC=C1NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-(3,6-dibromocarbazol-9-yl)-3-(2-methylanilino)propan-2-ol	2836189	6.10092000000001	485.99423746	3	2	5	37.19	4	0.356464256401367	2.67723302876138	27	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.80E-06	2.80E-06	0	0	0	0
1356	Aniline_analog_2	Target_lig_726	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	8e-07±2e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	COC1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-(3,6-dibromocarbazol-9-yl)-3-(4-methoxyanilino)propan-2-ol	2836197	5.8011	501.98915208	4	2	6	46.42	4	0.349175352979985	2.66274311558202	28	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	6.00E-07	1.00E-06	0	0	0	0
1357	Aniline_analog_3	Target_lig_727	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	3.2e-06±5e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	COC1=CC(=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O)OC	1-(3,6-dibromocarbazol-9-yl)-3-(2,4-dimethoxyanilino)propan-2-ol	2858492	5.80970000000001	531.999716764	5	2	7	55.65	4	0.314554531006719	2.77514271451728	30	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.70E-06	3.70E-06	0	0	0	0
1358	Aniline_analog_4	Target_lig_728	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2.7e-06±3e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	COC1=C(C=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O)OC	1-(3,6-dibromocarbazol-9-yl)-3-(3,4-dimethoxyanilino)propan-2-ol	72696479	5.80970000000001	531.999716764	5	2	7	55.65	4	0.314554531006719	2.74775665116886	30	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.40E-06	3.00E-06	0	0	0	0
1359	Aniline_analog_5	Target_lig_729	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	7.4e-06±1.8999999999999998e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CCOc1ccc(cn1)NCC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)O	-	-	5.5862	517.000051112	5	2	7	59.31	4	0.334733048610811	2.92232851143966	29	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	5.50E-06	9.30E-06	0	0	0	0
1360	Aniline_analog_6	Target_lig_730	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	4.8e-06±1.4e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CCCOc1ccc(cc1)NCC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)O	-	-	6.58130000000001	530.020452208	4	2	8	46.42	4	0.269676912098534	2.74294472440889	30	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	3.40E-06	6.20E-06	0	0	0	0
1361	Aniline_analog_7	Target_lig_731	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2.8999999999999998e-06±5e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	OC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)CNc1ccc(cc1)N1CCOCC1	-	-	5.6291	557.03135124	5	2	6	49.66	4	0.321909466015381	2.85560525996542	32	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.40E-06	3.40E-06	0	0	0	0
1362	Aniline_analog_8	Target_lig_732	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	3.2e-06±7e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CC1=C(C=CC=C1Cl)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-(3-chloro-2-methylanilino)-3-(3,6-dibromocarbazol-9-yl)propan-2-ol	5189252	6.75432	519.955265108	3	2	5	37.19	4	0.304115238490165	2.79276903817209	28	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.50E-06	3.90E-06	0	0	0	0
1363	Aniline_analog_9	Target_lig_733	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	1.55e-05±5.5e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CCOc1ccc(cc1Cl)NCC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)O	-	-	6.84460000000001	549.965829792	4	2	7	46.42	4	0.263819390491451	2.80271447922316	30	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.00E-05	2.10E-05	0	0	0	0
1364	Aniline_analog_10	Target_lig_734	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	3.2e-06±7e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	C1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-anilino-3-(3,6-dibromocarbazol-9-yl)propan-2-ol	2836187	5.7925	471.978587396	3	2	5	37.19	4	0.38439023231789	2.61936886807533	26	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.50E-06	3.90E-06	0	0	0	0
1365	Aniline_analog_11	Target_lig_735	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	1.2e-06±2e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	C1=CC(=CC(=C1)Cl)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-(3-chloroanilino)-3-(3,6-dibromocarbazol-9-yl)propan-2-ol	3103960	6.4459	505.939615044	3	2	5	37.19	4	0.32530959024836	2.71861684494519	27	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.00E-06	1.40E-06	0	0	0	0
1366	Aniline_analog_12	Target_lig_736	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	8e-07±3e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	OC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)CNc1ccc2c(c1)cccc2	-	-	6.94570000000001	521.99423746	3	2	5	37.19	5	0.261415058896431	2.73044182514296	30	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	5.00E-07	1.10E-06	0	0	0	0
1367	Aniline_analog_13	Target_lig_737	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2e-06±6e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CCOC1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	1-(3,6-dibromocarbazol-9-yl)-3-(4-ethoxyanilino)propan-2-ol	2836209	6.19120000000001	516.004802144	4	2	7	46.42	4	0.306922834591504	2.70214296927098	29	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.40E-06	2.60E-06	0	0	0	0
1368	Aniline_analog_14	Target_lig_738	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	5.0999999999999995e-06±3e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CC1=CC(=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O)C	1-(3,6-dibromocarbazol-9-yl)-3-(2,4-dimethylanilino)propan-2-ol	3112587	6.40934000000001	500.009887524	3	2	5	37.19	4	0.331231281122156	2.74120175482253	28	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.10E-06	8.10E-06	0	0	0	0
1369	Carbazole_analog_17	Target_lig_739	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	8.3e-06±1e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	C1=CC=C(C=C1)NCC(CN2C3=CC=CC=C3C4=CC=CC=C42)O	1-anilino-3-carbazol-9-ylpropan-2-ol	2836185	4.2675	316.15756326	3	2	5	37.19	4	0.576857960993993	2.3156127979863	24	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	8.20E-06	8.40E-06	0	0	0	0
1370	Carbazole_analog_18	Target_lig_740	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2e-06±3e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CCOC1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=CC=CC=C42)O	1-(3-bromocarbazol-9-yl)-3-(4-ethoxyanilino)propan-2-ol	23794243	5.42870000000001	438.094290076	4	2	7	46.42	4	0.403887857516684	2.56425420532561	28	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.70E-06	2.30E-06	0	0	0	0
1371	Carbazole_analog_19	Target_lig_741	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	3.2e-06±6e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	OC(Cn1c2ccc(cc2c2c1cccc2)Br)CNc1ccc(cc1)N1CCOCC1	-	-	4.8666	479.120839172	5	2	6	49.66	4	0.413811357837599	2.73015233665193	31	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.60E-06	3.80E-06	0	0	0	0
1372	Carbazole_analog_20	Target_lig_742	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	1e-06±3e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CCOc1ccc(cc1)NCC(Cn1c2cc(Br)ccc2c2c1cc(Br)cc2)O	-	-	6.19120000000001	516.004802144	4	2	7	46.42	4	0.306922834591504	2.74800877093919	29	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	7.00E-07	1.30E-06	0	0	0	0
1373	Carbazole_analog_21	Target_lig_743	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2.1e-06±4e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	OC(Cn1c2cc(Br)ccc2c2c1cc(Br)cc2)CNc1ccc(cc1)N1CCOCC1	-	-	5.62910000000001	557.03135124	5	2	6	49.66	4	0.321909466015381	2.89653925500264	32	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.70E-06	2.50E-06	0	0	0	0
1374	Carbazole_analog_22	Target_lig_744	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	2.7e-06±1.1e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	OC(Cn1c2cc(Br)ccc2c2c1cc(Br)cc2)CNc1ccccc1C	-	-	6.10092000000001	485.99423746	3	2	5	37.19	4	0.356464256401367	2.72667278900114	27	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.60E-06	3.80E-06	0	0	0	0
1375	Carbazole_analog_23	Target_lig_745	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	3.7e-06±1.3e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CCOC1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Cl)C4=C2C=CC(=C4)Cl)O	1-(3,6-dichlorocarbazol-9-yl)-3-(4-ethoxyanilino)propan-2-ol	2836208	5.97300000000001	428.105833304	4	2	7	46.42	4	0.380414617402239	2.62069088400685	29	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	2.40E-06	5.00E-06	0	0	0	0
1376	Carbazole_analog_24	Target_lig_746	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	>9.999999999999999e-06	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CCOc1ccc(cc1)NCC(Cn1c2ccc(cc2c(c1C)C)Br)O	-	-	4.89234000000001	416.10994014	4	2	7	46.42	3	0.575462650763049	2.67828029484034	26	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
1377	Carbazole_analog_25	Target_lig_747	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	4.2e-06±8e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	CCOc1ccc(cc1)NCC(CN(c1ccc(cc1)Br)c1ccc(cc1)Br)O	-	-	6.22140000000001	518.020452208	4	2	9	44.73	3	0.351875424588968	2.71386215370101	29	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	3.40E-06	5.00E-06	0	0	0	0
1378	Carbazole_analog_26	Target_lig_748	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	3.6e-06±6e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	OC(CN(c1ccc(cc1)Br)c1ccc(cc1)Br)CNc1ccc(cc1)N1CCOCC1	-	-	5.65930000000001	559.047001304	5	2	8	47.97	3	0.372137698228291	2.86606431703738	32	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	3.00E-06	4.20E-06	0	0	0	0
1379	Carbazole_analog_27	Target_lig_749	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	4.4e-06±8e-07	0	0	0	0	-	-	10.1021/acschembio.6b00945	27959491	Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.	Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS Jr	ACS Chem Biol	12	435-443	2017	0.05 - 500 uM	2 uM	7.4	95	12 mM NaH2PO4, 137 mM NaCl, 3 mM Kcl,	2-aminopurine assay	Additional	OC(CN(c1ccc(cc1)Br)c1ccc(cc1)Br)CNc1ccccc1C	-	-	6.13112	488.009887524	3	2	7	35.5	3	0.418532002013727	2.68986539639374	27	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	3.60E-06	5.20E-06	0	0	0	0
1380	Regorafenib	Target_lig_750	miR-21 hairpin	Homo sapiens	Cancer	Target_265	0	0	7.30E-07	0	0	0	0	-	-	10.1016/j.jmgm.2017.02.004	28236743	Direct binding of microRNA-21 pre-element with Regorafenib: An alternative mechanism for anti-colorectal cancer chemotherapy?	Chen X, Xie B, Cao L, Zhu F, Chen B, Lv H, Fan X, Han L, Bie L, Cao X, Shen X, Cao F	J Mol Graph Model	73	48-53	2017	-	-	6.9	90	5 mM phosphate and 10 mM NaCl	Fluorescence-based binding assay	Additional	CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F	4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide	11167602	5.6888	482.0768809	4	3	5	92.35	3	0.40735964520342	2.39752253314115	33	GGGUUGACUGUUGAAUCUCAUGGCAACCC	https://pubs.acs.org/doi/pdf/10.1021/acschembio.6b00945	miRNA	miRNA	29	-	Hairpin	0	0	0	0	7.30E-07	7.30E-07	0	0	0	0
1381	Neomycin	Target_lig_4	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	0.0073999999999999995±0.00011999999999999999	0.000125±4.2e-06	0	0	0	-	-	10.1021/cb400668h	24359019	Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.	Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M	ACS Chem Biol	9	711-21	2014	0.030 nM - 0.5 μM	-	7.4	37	2.5 mM MgCl2, 12 mM NaCl	FRET Dicer assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	0.00728	0.00752	0.0001208	0.0001292	0	0
1382	Neomycin_nucleobase_3a	Target_lig_751	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	0.00048499999999999997±4.9999999999999996e-05	9.75e-06±1.1e-06	0	0	0	-	-	10.1021/cb400668h	24359019	Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.	Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M	ACS Chem Biol	9	711-21	2014	0.030 nM - 0.5 μM	-	7.4	37	2.5 mM MgCl2, 12 mM NaCl	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)Cn3cnc4c3ncnc4N)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-8.82570000000002	812.388913104	26	13	12	433.21	3	0.080717460895874	6.02177296220484	57	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	0.000435	0.000535	8.65E-06	1.09E-05	0	0
1383	Neomycin_nucleobase_3b	Target_lig_752	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	0.00105±2.9999999999999997e-05	0.00010499999999999999±3.3999999999999996e-06	0	0	0	-	-	10.1021/cb400668h	24359019	Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.	Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M	ACS Chem Biol	9	711-21	2014	0.030 nM - 0.5 μM	-	7.4	37	2.5 mM MgCl2, 12 mM NaCl	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)Cn3ccc(=O)[nH]c3=O)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-9.69760000000002	789.361695312	24	13	12	418.45	2	0.094895874939792	5.97385922975185	55	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	0.00102	0.00108	0.0001016	0.0001084	0	0
1384	Neomycin_nucleobase_3c	Target_lig_753	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	0.000597±9.999999999999999e-06	4.09e-05±1.1e-06	0	0	0	-	-	10.1021/cb400668h	24359019	Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.	Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M	ACS Chem Biol	9	711-21	2014	0.030 nM - 0.5 μM	-	7.4	37	2.5 mM MgCl2, 12 mM NaCl	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)Cn3ccc(nc3=O)N)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-9.40870000000002	788.377679724	25	13	12	424.5	2	0.09491209694511	5.9961854651059	55	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	0.000587	0.000607	3.98E-05	4.20E-05	0	0
1385	Neomycin_nucleobase_3d	Target_lig_754	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	0.000145±9.999999999999999e-06	1.15e-05±1.2e-06	0	0	0	-	-	10.1021/cb400668h	24359019	Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.	Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M	ACS Chem Biol	9	711-21	2014	0.030 nM - 0.5 μM	-	7.4	37	2.5 mM MgCl2, 12 mM NaCl	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)Cn3cnc4c3[nH]c(N)nc4=O)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-9.53240000000002	828.383827724	26	14	12	453.18	3	0.080565679788761	6.10867894960594	58	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	0.000135	0.000155	1.03E-05	1.27E-05	0	0
1386	Neomycin_nucleobase_3e	Target_lig_755	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	1.6e-05±8.8e-06	2.4199999999999997e-06±6e-08	0	0	0	-	-	10.1021/cb400668h	24359019	Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.	Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M	ACS Chem Biol	9	711-21	2014	0.030 nM - 0.5 μM	-	7.4	37	2.5 mM MgCl2, 12 mM NaCl	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCCC(=O)Nc3cccc(c3)c3ncc(s3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-5.55260000000001	966.422915664	25	14	17	434.68	3	0.059976510700828	6.19611483313436	67	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	7.20E-06	2.48E-05	2.36E-06	2.48E-06	0	0
1387	Neomycin_nucleobase_3f	Target_lig_756	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	1.3899999999999999e-05±7.599999999999999e-06	4.17e-06±1.1e-06	0	0	0	-	-	10.1021/cb400668h	24359019	Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.	Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M	ACS Chem Biol	9	711-21	2014	0.030 nM - 0.5 μM	-	7.4	37	2.5 mM MgCl2, 12 mM NaCl	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)Cc3nc4c(o3)ccc(c4)NC(=O)Nc3ccccc3)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-5.21990000000001	930.419544536	24	14	14	430.75	4	0.056175477213185	6.0658499916302	66	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	6.30E-06	2.15E-05	3.07E-06	5.27E-06	0	0
1388	Neomycin_nucleobase_3g	Target_lig_757	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	1.9699999999999998e-05±7.9e-06	1.63e-05±1.3e-06	0	0	0	-	-	10.1021/cb400668h	24359019	Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.	Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M	ACS Chem Biol	9	711-21	2014	0.030 nM - 0.5 μM	-	7.4	37	2.5 mM MgCl2, 12 mM NaCl	FRET Dicer assay	Additional	CCCCNC(=O)Nc1ccc2c(c1)nc(o2)Cc1nnn(c1)CC1OC(C(C1OC1OC(CN)C(C(C1N)O)O)O)OC1C(O)C(N)CC(C1OC1OC(CN)C(C(C1N)O)O)N	-	-	-5.94230000000002	910.450844664	24	14	16	430.75	3	0.059501410027446	6.10155495035503	64	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	1.18E-05	2.76E-05	1.50E-05	1.76E-05	0	0
1389	Neomycin_nucleobase_3h	Target_lig_758	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	1.89e-05±9e-07	8.3e-06±1.1e-06	0	0	0	-	-	10.1021/cb400668h	24359019	Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.	Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M	ACS Chem Biol	9	711-21	2014	0.030 nM - 0.5 μM	-	7.4	37	2.5 mM MgCl2, 12 mM NaCl	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)Cn3cnc(c3)c3cccc(c3)NC(=O)c3ccccc3)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-5.43180000000001	940.44027998	24	13	15	410.51	4	0.052881823887731	6.07333753256945	67	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	1.80E-05	1.98E-05	7.20E-06	9.40E-06	0	0
1390	Neomycin_nucleobase_3i	Target_lig_759	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	4.61e-05±1e-06	2.56e-05±1.1e-06	0	0	0	-	-	10.1021/cb400668h	24359019	Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.	Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M	ACS Chem Biol	9	711-21	2014	0.030 nM - 0.5 μM	-	7.4	37	2.5 mM MgCl2, 12 mM NaCl	FRET Dicer assay	Additional	CCCCNC(=O)Nc1cccc(c1)c1ncn(c1)Cc1nnn(c1)CC1OC(C(C1OC1OC(CN)C(C(C1N)O)O)O)OC1C(O)C(N)CC(C1OC1OC(CN)C(C(C1N)O)O)N	-	-	-5.76250000000002	935.48247914	24	14	17	422.54	3	0.056077849839371	6.14438137371463	66	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	4.51E-05	4.71E-05	2.45E-05	2.67E-05	0	0
1391	Neomycin_nucleobase_3j	Target_lig_760	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	1.48e-05±6.7e-06	1.03e-05±1e-06	0	0	0	-	-	10.1021/cb400668h	24359019	Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.	Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M	ACS Chem Biol	9	711-21	2014	0.030 nM - 0.5 μM	-	7.4	37	2.5 mM MgCl2, 12 mM NaCl	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)NCC(=O)Nc3nc4c([nH]3)cccc4)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-8.03210000000002	909.430443568	24	15	16	450.47	3	0.063445263734686	6.06282928051925	64	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	8.10E-06	2.15E-05	9.30E-06	1.13E-05	0	0
1392	Neomycin-S	Target_lig_761	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	1.60E-05	2.42E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-5.94270000000001	952.4072656	25	14	16	434.68	3	0.063552197275744	6.06659901722579	66	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	1.60E-05	1.60E-05	2.42E-06	2.42E-06	0	0
1393	Neomycin-3a	Target_lig_762	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	5.25E-05	1.32E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.34038000000001	1028.438565728	25	14	17	434.68	4	0.047529495716362	6.13254675584309	72	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	5.25E-05	5.25E-05	1.32E-06	1.32E-06	0	0
1394	Neomycin-3b	Target_lig_763	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	5.01E-05	9.85E-07	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)Cl)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-3.9954	1048.383943312	25	14	17	434.68	4	0.047921268690908	6.13740668695675	72	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	5.01E-05	5.01E-05	9.85E-07	9.85E-07	0	0
1395	Neomycin-3c	Target_lig_764	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	2.25E-05	1.32E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)F)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.50970000000001	1032.413493852	25	14	17	434.68	4	0.047380802695231	6.13918533219211	72	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	2.25E-05	2.25E-05	1.32E-06	1.32E-06	0	0
1396	Neomycin-3d	Target_lig_765	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	2.70E-05	1.08E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)N)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-5.06660000000001	1029.433814696	26	15	17	460.7	4	0.04401115602596	6.1696930244998	72	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	2.70E-05	2.70E-05	1.08E-06	1.08E-06	0	0
1397	Neomycin-4a	Target_lig_766	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	2.75E-05	7.88E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCCCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-5.16250000000001	980.438565728	25	14	18	434.68	3	0.052998285217386	6.11161031223104	68	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	2.75E-05	2.75E-05	7.88E-06	7.88E-06	0	0
1398	Neomycin-4b	Target_lig_767	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	2.59E-05	6.22E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCCCCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.77240000000001	994.454215792	25	14	19	434.68	3	0.050139083680351	6.13313429832637	69	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	2.59E-05	2.59E-05	6.22E-06	6.22E-06	0	0
1399	Neomycin-4c	Target_lig_768	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	3.38E-05	1.29E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)c3ccc(cc3)C(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.59470000000001	1000.4072656	25	14	15	434.68	4	0.053281423729661	6.09395766758627	70	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	3.38E-05	3.38E-05	1.29E-06	1.29E-06	0	0
1400	Neomycin-4d	Target_lig_769	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	4.05E-05	1.63E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)c3cccc(c3)C(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.59470000000001	1000.4072656	25	14	15	434.68	4	0.053281423729661	6.11323648415432	70	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	4.05E-05	4.05E-05	1.63E-06	1.63E-06	0	0
1401	Neomycin-4e	Target_lig_770	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	3.23E-05	1.45E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)Oc3ccc(cc3)C(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.46940000000001	1016.40218022	26	14	16	443.91	4	0.050316542917523	6.19496583338789	71	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	3.23E-05	3.23E-05	1.45E-06	1.45E-06	0	0
1402	Neomycin-4f	Target_lig_771	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	2.34E-05	1.72E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)Oc3cccc(c3)C(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.46940000000001	1016.40218022	26	14	16	443.91	4	0.050316542917523	6.21315534387741	71	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	2.34E-05	2.34E-05	1.72E-06	1.72E-06	0	0
1403	Apramycin-6a	Target_lig_772	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	0.000208	3.67E-05	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	CNC1C(OC2OC(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)C(C(C2O)O)N)OC2C(C1O)OC(C(C2)N)OC1C(N)CC(C(C1O)O)N	-	-	-3.9967	877.3752372	22	12	13	365.21	3	0.077839371712425	5.91075160447164	61	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	0.000208	0.000208	3.67E-05	3.67E-05	0	0
1404	Neamine-6b	Target_lig_773	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	0.00032	0.000105	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(N)CC(C(C2O)O)N)C(C(C1OCn1nnc(c1)CC(=O)Nc1cccc(c1)c1csc(n1)NC(=O)C)O)N	-	-	-2.57899999999999	676.27512924	17	9	11	294.26	3	0.100765489228876	5.06113576508994	47	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	0.00032	0.00032	0.000105	0.000105	0	0
1405	2-DOS-6c	Target_lig_774	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	0.000678	>0.001	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	O=C(Cc1nnn(c1)COC1C(N)CC(C(C1O)O)N)Nc1cccc(c1)c1csc(n1)NC(=O)C	-	-	-0.335999999999997	516.190336996	12	6	8	203.53	3	0.229806934969553	4.18470514693281	36	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	0.000678	0.000678	0.001	0.001	0	0
1406	Neomycin-S	Target_lig_761	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	1.12E-05	5.13E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-5.94270000000001	952.4072656	25	14	16	434.68	3	0.063552197275744	6.06659901722579	66	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	1.12E-05	1.12E-05	5.13E-06	5.13E-06	0	0
1407	Neomycin-3a	Target_lig_762	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	4.30E-05	2.16E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.34038000000001	1028.438565728	25	14	17	434.68	4	0.047529495716362	6.13254675584309	72	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	4.30E-05	4.30E-05	2.16E-06	2.16E-06	0	0
1408	Neomycin-3b	Target_lig_763	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	3.47E-05	2.19E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)Cl)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-3.9954	1048.383943312	25	14	17	434.68	4	0.047921268690908	6.13740668695675	72	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	3.47E-05	3.47E-05	2.19E-06	2.19E-06	0	0
1409	Neomycin-3c	Target_lig_764	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	3.37E-05	2.50E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)F)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.50970000000001	1032.413493852	25	14	17	434.68	4	0.047380802695231	6.13918533219211	72	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	3.37E-05	3.37E-05	2.50E-06	2.50E-06	0	0
1410	Neomycin-3d	Target_lig_765	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	4.75E-05	1.10E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)c3ccc(cc3)N)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-5.06660000000001	1029.433814696	26	15	17	460.7	4	0.04401115602596	6.1696930244998	72	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	4.75E-05	4.75E-05	1.10E-06	1.10E-06	0	0
1411	Neomycin-4a	Target_lig_766	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	2.31E-05	8.06E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCCCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-5.16250000000001	980.438565728	25	14	18	434.68	3	0.052998285217386	6.11161031223104	68	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	2.31E-05	2.31E-05	8.06E-06	8.06E-06	0	0
1412	Neomycin-4b	Target_lig_767	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	4.22E-05	6.40E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)CCCCCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.77240000000001	994.454215792	25	14	19	434.68	3	0.050139083680351	6.13313429832637	69	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	4.22E-05	4.22E-05	6.40E-06	6.40E-06	0	0
1413	Neomycin-4c	Target_lig_768	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	3.34E-05	1.92E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)c3ccc(cc3)C(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.59470000000001	1000.4072656	25	14	15	434.68	4	0.053281423729661	6.09395766758627	70	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	3.34E-05	3.34E-05	1.92E-06	1.92E-06	0	0
1414	Neomycin-4d	Target_lig_769	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	3.44E-05	1.75E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)c3cccc(c3)C(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.59470000000001	1000.4072656	25	14	15	434.68	4	0.053281423729661	6.11323648415432	70	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	3.44E-05	3.44E-05	1.75E-06	1.75E-06	0	0
1415	Neomycin-4e	Target_lig_770	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	3.76E-05	1.23E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)Oc3ccc(cc3)C(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.46940000000001	1016.40218022	26	14	16	443.91	4	0.050316542917523	6.19496583338789	71	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	3.76E-05	3.76E-05	1.23E-06	1.23E-06	0	0
1416	Neomycin-4f	Target_lig_771	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	3.36E-05	1.71E-06	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(Cn3nnc(c3)Oc3cccc(c3)C(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)OC(C2O)OC2C(O)C(N)CC(C2OC2OC(CN)C(C(C2N)O)O)N)C(C(C1O)O)N	-	-	-4.46940000000001	1016.40218022	26	14	16	443.91	4	0.050316542917523	6.21315534387741	71	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	3.36E-05	3.36E-05	1.71E-06	1.71E-06	0	0
1417	Apramycin-6a	Target_lig_772	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	0.000101	0.000118	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	CNC1C(OC2OC(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)C(C(C2O)O)N)OC2C(C1O)OC(C(C2)N)OC1C(N)CC(C(C1O)O)N	-	-	-3.9967	877.3752372	22	12	13	365.21	3	0.077839371712425	5.91075160447164	61	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	0.000101	0.000101	0.000118	0.000118	0	0
1418	Neamine-6b	Target_lig_773	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	0.000106	6.85E-05	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	NCC1OC(OC2C(N)CC(C(C2O)O)N)C(C(C1OCn1nnc(c1)CC(=O)Nc1cccc(c1)c1csc(n1)NC(=O)C)O)N	-	-	-2.57899999999999	676.27512924	17	9	11	294.26	3	0.100765489228876	5.06113576508994	47	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	0.000106	0.000106	6.85E-05	6.85E-05	0	0
1419	2-DOS-6c	Target_lig_774	Pre-miR-373	Homo sapiens	Cancer	Target_267	0	0	0.00314	0.00031	0	0	0	-	-	10.1002/chem.201505094	26928593	Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates	Vo DD, Tran TPA, Staedel CS, Benhida R, Darfeuille F, Giorgio AD, Duca M	Chemistry	22	5350-62	2016	0.244–500 uM	50 nM	7.4	Room temperature	12 mmNaCl, 3 m mMgCl2	FRET Dicer assay	Additional	O=C(Cc1nnn(c1)COC1C(N)CC(C(C1O)O)N)Nc1cccc(c1)c1csc(n1)NC(=O)C	-	-	-0.335999999999997	516.190336996	12	6	8	203.53	3	0.229806934969553	4.18470514693281	36	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	69	-	Stem-Loop with Bulge	0	0	0	0	0.00314	0.00314	0.00031	0.00031	0	0
1420	PA-1	Target_lig_775	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	1.5e-07±1e-08	1.06e-06±9e-08	0	0	0	-	-	10.1038/s41598-018-20053-5	29374231	Modulation of oncogenic miRNA biogenesis using functionalized polyamines.	Staedel C, Tran TPA, Giraud J, Darfeuille F, Di Giorgio A, Tourasse NJ, Salin F, Uriac P, Duca M	Sci Rep	8	1667	2018	0.244 μM to 500 μM	10 nM	7.4	25	12 mM NaCl, 3 mM  MgCl2	FRET Dicer assay	Additional	CC1(C(C2=CC=CC=C2NC1=NCCCNCCCCNCCCN)N(C)C3=CC=CC=C3)C	N-(3-aminopropyl)-N'-[3-[[3,3-dimethyl-4-(N-methylanilino)-1,4-dihydroquinolin-2-ylidene]amino]propyl]butane-1,4-diamine	135491824	4.4126	464.362745408	5	4	14	77.71	2	0.311576273418342	3.59358902990438	34	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	1.40E-07	1.60E-07	9.70E-07	1.15E-06	0	0
1421	PA-2	Target_lig_776	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	5.3e-07±7e-08	1.63e-05±2e-07	0	0	0	-	-	10.1038/s41598-018-20053-5	29374231	Modulation of oncogenic miRNA biogenesis using functionalized polyamines.	Staedel C, Tran TPA, Giraud J, Darfeuille F, Di Giorgio A, Tourasse NJ, Salin F, Uriac P, Duca M	Sci Rep	8	1667	2018	0.244 μM to 500 μM	10 nM	7.4	25	12 mM NaCl, 3 mM  MgCl2	FRET Dicer assay	Additional	C(CCNCCCCNCCCCN)CN	N'-[4-(4-aminobutylamino)butyl]butane-1,4-diamine	6452022	0.423600000000003	230.24704696	4	4	13	76.1	0	0.346019052992284	2.0243894502343	16	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	4.60E-07	6.00E-07	1.61E-05	1.65E-05	0	0
1422	PA-3	Target_lig_777	Pre-miR-372	Homo sapiens	Cancer,Gastric cancers	Target_266	0	0	1.1499999999999998e-06±3e-07	1.2699999999999999e-05±1e-07	0	0	0	-	-	10.1038/s41598-018-20053-5	29374231	Modulation of oncogenic miRNA biogenesis using functionalized polyamines.	Staedel C, Tran TPA, Giraud J, Darfeuille F, Di Giorgio A, Tourasse NJ, Salin F, Uriac P, Duca M	Sci Rep	8	1667	2018	0.244 μM to 500 μM	10 nM	7.4	25	12 mM NaCl, 3 mM  MgCl2	FRET Dicer assay	Additional	NCCCCN/C(=C/1\C(=O)C=C2C(C1=O)(C)c1c(O)c(C)c(c(c1O2)C(=O)C)O)/C	-	-	1.89712	414.179086552	8	4	6	138.95	1	0.239537888432416	3.92681671904216	30	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	https://pubs.acs.org/doi/pdf/10.1021/cb400668h	miRNA	pre-miRNA	67	-	Stem-Loop with Bulge	0	0	0	0	8.50E-07	1.45E-06	1.26E-05	1.28E-05	0	0
1423	Targapremir-210	Target_lig_1262	Pre-miR-210	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	1.60E-07	0	0	0	0	-	-	10.1016/j.chembiol.2019.04.008	31130520	Targeted Degradation of a Hypoxia-Associated Non-coding RNA Enhances the Selectivity of a Small Molecule Interacting with RNA.	Costales MG, Suresh B, Vishnu K, Disney MD	Cell Chem Biol	26	1180-1186.e5	2019	20 uM	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Microscale Thermophoresis	Additional	CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC(=CC=C6)OCCCC(=O)NCCCN=[N+]=[N-]	N-(3-azidopropyl)-4-[3-[6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazol-2-yl]phenoxy]butanamide	44221088	5.5006	592.302270392	7	3	12	150.93	5	0.075316848147928	2.98628569588825	44	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	1.60E-07	1.60E-07	0	0	0	0
1424	Targapremir-210-RL	Target_lig_1263	Pre-miR-210	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	1.90E-07	0	0	0	0	-	-	10.1016/j.chembiol.2019.04.008	31130520	Targeted Degradation of a Hypoxia-Associated Non-coding RNA Enhances the Selectivity of a Small Molecule Interacting with RNA.	Costales MG, Suresh B, Vishnu K, Disney MD	Cell Chem Biol	26	1180-1186.e5	2019	20 uM	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Microscale Thermophoresis	Additional	CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC(=CC=C6)OCCCC(=O)NCCCN=[N+]=[N-]	N-(3-azidopropyl)-4-[3-[6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazol-2-yl]phenoxy]butanamide	44221088	5.5006	592.302270392	7	3	12	150.93	5	0.075316848147928	2.98628569588825	44	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	1.90E-07	1.90E-07	0	0	0	0
1425	Targapremir-515/885	Target_lig_778	Pri-miR-515 drosha site (RNA 1)	Homo sapiens	Cancer	Target_268	0	0	9e-06±1e-06	0	0	0	0	-	-	10.1021/jacs.8b10558	30726072	A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.	Costales MG, Hoch DG, Abegg D, Childs-Disney JL, Velagapudi SP, Adibekian A, Disney MD	J Am Chem Soc	141	2960-2974	2019	0.5 uM	100 - 0.098 μM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1nc2c([nH]1)cc(cc2)N1CCN(CC1)C)C(C)(C)C	-	-	7.33567000000001	705.43474735609	8	4	12	152.48	5	0.060585593556878	3.48459464966244	52	GGGAGAGGGUUUAAUUCUUACGAAAGUAAUAAUUGGAUCCGCAAGG	https://pubs.acs.org/doi/10.1021/jacs.8b10558	miRNA	pre-miRNA	46	Drosha site	Internal Loop	0	0	0	0	8.00E-06	1.00E-05	0	0	0	0
1426	Targapremir-515/885	Target_lig_778	Pri-miR-885 drosha site (RNA 2)	Homo sapiens	Cancer	Target_269	0	0	1.2e-05±2.1e-06	0	0	0	0	-	-	10.1021/jacs.8b10558	30726072	A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.	Costales MG, Hoch DG, Abegg D, Childs-Disney JL, Velagapudi SP, Adibekian A, Disney MD	J Am Chem Soc	141	2960-2974	2019	0.5 uM	100 - 0.098 μM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1nc2c([nH]1)cc(cc2)N1CCN(CC1)C)C(C)(C)C	-	-	7.33567000000001	705.43474735609	8	4	12	152.48	5	0.060585593556878	3.48459464966244	52	GGGAGAGGGUUUAAUUUCUACGAAAGUAGCGAUUGGAUCCGCAAGG	https://pubs.acs.org/doi/10.1021/jacs.8b10558	miRNA	pre-miRNA	46	Drosha site	Internal Loop	0	0	0	0	9.90E-06	1.41E-05	0	0	0	0
1427	Targapremir-515/885	Target_lig_778	Pri-miR-515 (RNA 3)	Homo sapiens	Cancer	Target_270	0	0	7.499999999999999e-06±7e-07	0	0	0	0	-	-	10.1021/jacs.8b10558	30726072	A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.	Costales MG, Hoch DG, Abegg D, Childs-Disney JL, Velagapudi SP, Adibekian A, Disney MD	J Am Chem Soc	141	2960-2974	2019	0.5 uM	100 - 0.098 μM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1nc2c([nH]1)cc(cc2)N1CCN(CC1)C)C(C)(C)C	-	-	7.33567000000001	705.43474735609	8	4	12	152.48	5	0.060585593556878	3.48459464966244	52	GGGAGAGGGUUUAAUUCAUACGAAAGUAUUAAUUGGAUCCGCAAGG	https://pubs.acs.org/doi/10.1021/jacs.8b10558	miRNA	pre-miRNA	46	-	Internal Loop	0	0	0	0	6.80E-06	8.20E-06	0	0	0	0
1428	Targapremir-515/885	Target_lig_778	Pri-miR-515 and the adjacent RNA motif (RNA 4)	Homo sapiens	Cancer	Target_271	0	0	1.4999999999999999e-05±1.8999999999999998e-06	0	0	0	0	-	-	10.1021/jacs.8b10558	30726072	A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.	Costales MG, Hoch DG, Abegg D, Childs-Disney JL, Velagapudi SP, Adibekian A, Disney MD	J Am Chem Soc	141	2960-2974	2019	0.5 uM	100 - 0.098 μM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1nc2c([nH]1)cc(cc2)N1CCN(CC1)C)C(C)(C)C	-	-	7.33567000000001	705.43474735609	8	4	12	152.48	5	0.060585593556878	3.48459464966244	52	GGGAGAGGGUUUAAUUCAUUCUACGAAAGUAGCGUUAAUUGGAUCCGCAAGG	https://pubs.acs.org/doi/10.1021/jacs.8b10558	miRNA	pre-miRNA	52	-	Stem-Loop with Bulge	0	0	0	0	1.31E-05	1.69E-05	0	0	0	0
1429	Targapremir-515	Target_lig_778	Pri-miR-515 drosha site (RNA 1)	Homo sapiens	Cancer	Target_268	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1021/jacs.8b10558	30726072	A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.	Costales MG, Hoch DG, Abegg D, Childs-Disney JL, Velagapudi SP, Adibekian A, Disney MD	J Am Chem Soc	141	2960-2974	2019	0.5 uM	100 - 0.098 μM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1nc2c([nH]1)cc(cc2)N1CCN(CC1)C)C(C)(C)C	-	-	7.33567000000001	705.43474735609	8	4	12	152.48	5	0.060585593556878	3.48459464966244	52	GGGAGAGGGUUUAAUUCUUACGAAAGUAAUAAUUGGAUCCGCAAGG	https://pubs.acs.org/doi/10.1021/jacs.8b10558	miRNA	pre-miRNA	46	Drosha site	Internal Loop	0	0	0	0	0.0001	0.0001	0	0	0	0
1430	Targapremir-515	Target_lig_778	Pri-miR-885 drosha site (RNA 2)	Homo sapiens	Cancer	Target_269	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1021/jacs.8b10558	30726072	A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.	Costales MG, Hoch DG, Abegg D, Childs-Disney JL, Velagapudi SP, Adibekian A, Disney MD	J Am Chem Soc	141	2960-2974	2019	0.5 uM	100 - 0.098 μM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1nc2c([nH]1)cc(cc2)N1CCN(CC1)C)C(C)(C)C	-	-	7.33567000000001	705.43474735609	8	4	12	152.48	5	0.060585593556878	3.48459464966244	52	GGGAGAGGGUUUAAUUUCUACGAAAGUAGCGAUUGGAUCCGCAAGG	https://pubs.acs.org/doi/10.1021/jacs.8b10558	miRNA	pre-miRNA	46	Drosha site	Internal Loop	0	0	0	0	0.0001	0.0001	0	0	0	0
1431	Targapremir-515	Target_lig_778	Pri-miR-515 (RNA 3)	Homo sapiens	Cancer	Target_270	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1021/jacs.8b10558	30726072	A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.	Costales MG, Hoch DG, Abegg D, Childs-Disney JL, Velagapudi SP, Adibekian A, Disney MD	J Am Chem Soc	141	2960-2974	2019	0.5 uM	100 - 0.098 μM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1nc2c([nH]1)cc(cc2)N1CCN(CC1)C)C(C)(C)C	-	-	7.33567000000001	705.43474735609	8	4	12	152.48	5	0.060585593556878	3.48459464966244	52	GGGAGAGGGUUUAAUUCAUACGAAAGUAUUAAUUGGAUCCGCAAGG	https://pubs.acs.org/doi/10.1021/jacs.8b10558	miRNA	pre-miRNA	46	-	Internal Loop	0	0	0	0	0.0001	0.0001	0	0	0	0
1432	Targapremir-515	Target_lig_778	Pri-miR-515 and the adjacent RNA motif (RNA 4)	Homo sapiens	Cancer	Target_271	0	0	6e-08±1e-08	0	0	0	0	-	-	10.1021/jacs.8b10558	30726072	A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.	Costales MG, Hoch DG, Abegg D, Childs-Disney JL, Velagapudi SP, Adibekian A, Disney MD	J Am Chem Soc	141	2960-2974	2019	0.5 uM	100 - 0.098 μM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1nc2c([nH]1)cc(cc2)N1CCN(CC1)C)C(C)(C)C	-	-	7.33567000000001	705.43474735609	8	4	12	152.48	5	0.060585593556878	3.48459464966244	52	GGGAGAGGGUUUAAUUCAUUCUACGAAAGUAGCGUUAAUUGGAUCCGCAAGG	https://pubs.acs.org/doi/10.1021/jacs.8b10558	miRNA	pre-miRNA	52	-	Stem-Loop with Bulge	0	0	0	0	5.00E-08	7.00E-08	0	0	0	0
1433	Compound 1a	Target_lig_780	Pri-miR-515 and the adjacent RNA motif (RNA 4)	Homo sapiens	Cancer	Target_271	0	0	1.8e-05±5.6e-07	0	0	0	0	-	-	10.1021/jacs.8b10558	30726072	A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.	Costales MG, Hoch DG, Abegg D, Childs-Disney JL, Velagapudi SP, Adibekian A, Disney MD	J Am Chem Soc	141	2960-2974	2019	0.5 uM	100 - 0.098 μM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Fluorescence-based binding assay	Additional	CCCN(C(=O)CN(C(=O)CNCc1nnn(c1)N=[N+]=N)CCC)CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N)CCC)CCC)CCC	-	-	-0.64052999999999	692.43145286809	12	3	25	237.69	1	0.087127997047375	3.73743597696162	49	GGGAGAGGGUUUAAUUCAUUCUACGAAAGUAGCGUUAAUUGGAUCCGCAAGG	https://pubs.acs.org/doi/10.1021/jacs.8b10558	miRNA	pre-miRNA	52	-	Stem-Loop with Bulge	0	0	0	0	1.74E-05	1.86E-05	0	0	0	0
1434	Compound 1b	Target_lig_781	Pri-miR-515 and the adjacent RNA motif (RNA 4)	Homo sapiens	Cancer	Target_271	0	0	1.9999999999999998e-05±2.4e-06	0	0	0	0	-	-	10.1021/jacs.8b10558	30726072	A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.	Costales MG, Hoch DG, Abegg D, Childs-Disney JL, Velagapudi SP, Adibekian A, Disney MD	J Am Chem Soc	141	2960-2974	2019	0.5 uM	100 - 0.098 μM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Fluorescence-based binding assay	Additional	CCCN(C(=O)CNCc1nnn(c1)N=[N+]=Nn1nnc(c1)CO)CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N)CCC)CCC)CCC)CCC	-	-	-1.67219999999999	789.45906458409	16	3	27	277.14	2	0.067702677859193	4.1664304984266	56	GGGAGAGGGUUUAAUUCAUUCUACGAAAGUAGCGUUAAUUGGAUCCGCAAGG	https://pubs.acs.org/doi/10.1021/jacs.8b10558	miRNA	pre-miRNA	52	-	Stem-Loop with Bulge	0	0	0	0	1.76E-05	2.24E-05	0	0	0	0
1435	Furamidine	Target_lig_1264	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	5.6e-07±1e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.50E-07	5.70E-07
1436	Furamidine	Target_lig_1264	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	>1.5e-06	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.50E-06	1.50E-06
1437	DPF-p1	Target_lig_807	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	6.3e-08±7e-09	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN1CCN(CC1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCN1CCN(CC1)C	-	-	4.1934	472.3202119	5	0	8	26.1	3	0.489801619514729	2.21760733056905	35	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.60E-08	7.00E-08
1438	DPF-p1	Target_lig_807	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	4.1e-08±1e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN1CCN(CC1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCN1CCN(CC1)C	-	-	4.1934	472.3202119	5	0	8	26.1	3	0.489801619514729	2.21760733056905	35	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	3.10E-08	5.10E-08
1439	DPF-m1	Target_lig_782	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	6.9e-07±1.2e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN(C)CCCCN=C(C1=CC=CC(=C1)C2=CC=C(O2)C3=CC(=CC=C3)C(=NCCCCN(C)C)N)N	N'-[4-(dimethylamino)butyl]-3-[5-[3-[N'-[4-(dimethylamino)butyl]carbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide	485987	4.7078	502.342009964	5	2	14	96.38	3	0.189089703366654	2.84592090066365	37	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.70E-07	8.10E-07
1440	DPF-m1	Target_lig_782	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	2.0699999999999997e-06±4.5e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN(C)CCCCN=C(C1=CC=CC(=C1)C2=CC=C(O2)C3=CC(=CC=C3)C(=NCCCCN(C)C)N)N	N'-[4-(dimethylamino)butyl]-3-[5-[3-[N'-[4-(dimethylamino)butyl]carbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide	485987	4.7078	502.342009964	5	2	14	96.38	3	0.189089703366654	2.84592090066365	37	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.62E-06	2.52E-06
1441	DPF-o1	Target_lig_783	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	7.34e-07±5.1999999999999996e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN(CCCCNC(=N)c1ccccc1c1ccc(o1)c1ccccc1C(=N)NCCCCN(C)C)C	-	-	5.12714	502.342009964	5	4	14	91.38	3	0.13941328078865	3.03497496659772	37	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	6.82E-07	7.86E-07
1442	DPF-o1	Target_lig_783	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	1.3899999999999998e-06±2.1999999999999998e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN(CCCCNC(=N)c1ccccc1c1ccc(o1)c1ccccc1C(=N)NCCCCN(C)C)C	-	-	5.12714	502.342009964	5	4	14	91.38	3	0.13941328078865	3.03497496659772	37	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.17E-06	1.61E-06
1443	DPF-p2	Target_lig_784	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	2.017e-06±5.779999999999999e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCc1ccccc1	-	-	8.18400000000001	428.214015516	1	0	8	13.14	5	0.242761309919657	1.65982673978478	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	1.44E-06	2.60E-06
1444	DPF-p2	Target_lig_784	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	2.33e-06±2.8e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCc1ccccc1	-	-	8.18400000000001	428.214015516	1	0	8	13.14	5	0.242761309919657	1.65982673978478	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.05E-06	2.61E-06
1445	DPF-m2	Target_lig_785	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	6.800000000000001e-07±4e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)CCc1cccc(c1)c1ccc(o1)c1cccc(c1)CCc1ccccc1	-	-	8.18400000000001	428.214015516	1	0	8	13.14	5	0.242761309919657	1.82706243055036	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	6.40E-07	7.20E-07
1446	DPF-m2	Target_lig_785	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	1.4299999999999999e-06±2e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)CCc1cccc(c1)c1ccc(o1)c1cccc(c1)CCc1ccccc1	-	-	8.18400000000001	428.214015516	1	0	8	13.14	5	0.242761309919657	1.82706243055036	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.23E-06	1.63E-06
1447	DPF-o2	Target_lig_786	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	6.34e-07±7.599999999999999e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)CCc1ccccc1c1ccc(o1)c1ccccc1CCc1ccccc1	-	-	8.18400000000001	428.214015516	1	0	8	13.14	5	0.242761309919657	1.90775333964127	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.58E-07	7.10E-07
1448	DPF-o2	Target_lig_786	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	1.08e-06±1e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)CCc1ccccc1c1ccc(o1)c1ccccc1CCc1ccccc1	-	-	8.18400000000001	428.214015516	1	0	8	13.14	5	0.242761309919657	1.90775333964127	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	9.80E-07	1.18E-06
1449	DPF-p3	Target_lig_787	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	1.6469999999999999e-06±2.73e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	n1ccc(cc1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCc1cccnc1	-	-	6.97400000000001	430.204513452	3	0	8	38.92	5	0.266660664997843	2.19817115583163	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	1.37E-06	1.92E-06
1450	DPF-p3	Target_lig_787	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	1.4099999999999998e-06±2.3e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	n1ccc(cc1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCc1cccnc1	-	-	6.97400000000001	430.204513452	3	0	8	38.92	5	0.266660664997843	2.19817115583163	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.18E-06	1.64E-06
1451	DPF-m3	Target_lig_788	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	7.699999999999999e-07±1e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cn1)CCc1cccc(c1)c1ccc(o1)c1cccc(c1)CCc1cccnc1	-	-	6.97400000000001	430.204513452	3	0	8	38.92	5	0.266660664997843	2.25229898007538	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	6.70E-07	8.70E-07
1452	DPF-m3	Target_lig_788	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	3.33e-06±1.0099999999999999e-06	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cn1)CCc1cccc(c1)c1ccc(o1)c1cccc(c1)CCc1cccnc1	-	-	6.97400000000001	430.204513452	3	0	8	38.92	5	0.266660664997843	2.25229898007538	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.32E-06	4.34E-06
1453	DPF-o3	Target_lig_789	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	7.059999999999999e-07±1.4599999999999998e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cn1)CCc1ccccc1c1ccc(o1)c1ccccc1CCc1cccnc1	-	-	6.97400000000001	430.204513452	3	0	8	38.92	5	0.266660664997843	2.35496975723023	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.60E-07	8.52E-07
1454	DPF-o3	Target_lig_789	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	1.81e-06±1.7000000000000001e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cn1)CCc1ccccc1c1ccc(o1)c1ccccc1CCc1cccnc1	-	-	6.97400000000001	430.204513452	3	0	8	38.92	5	0.266660664997843	2.35496975723023	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.64E-06	1.98E-06
1455	DPF-p4	Target_lig_790	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	1.465e-06±2.5999999999999998e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	C1=CC=C(C=C1)CC2=CC=C(C=C2)C3=CC=C(O3)C4=CC=C(C=C4)CC5=CC=CC=C5	2,5-bis(4-benzylphenyl)furan	69008020	7.79520000000001	400.182715388	1	0	6	13.14	5	0.283354581228141	1.64812756076273	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	1.44E-06	1.49E-06
1456	DPF-p4	Target_lig_790	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	3.7999999999999996e-07±3e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	C1=CC=C(C=C1)CC2=CC=C(C=C2)C3=CC=C(O3)C4=CC=C(C=C4)CC5=CC=CC=C5	2,5-bis(4-benzylphenyl)furan	69008020	7.79520000000001	400.182715388	1	0	6	13.14	5	0.283354581228141	1.64812756076273	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	3.50E-07	4.10E-07
1457	DPF-m4	Target_lig_791	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	8.1e-07±1.2e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)Cc1cccc(c1)c1ccc(o1)c1cccc(c1)Cc1ccccc1	-	-	7.79520000000001	400.182715388	1	0	6	13.14	5	0.283354581228141	1.81960922490977	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	6.90E-07	9.30E-07
1458	DPF-m4	Target_lig_791	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	2.39e-06±2.4e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)Cc1cccc(c1)c1ccc(o1)c1cccc(c1)Cc1ccccc1	-	-	7.79520000000001	400.182715388	1	0	6	13.14	5	0.283354581228141	1.81960922490977	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.15E-06	2.63E-06
1459	DPF-o4	Target_lig_792	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	7.429999999999999e-07±4.2e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)Cc1ccccc1c1ccc(o1)c1ccccc1Cc1ccccc1	-	-	7.79520000000001	400.182715388	1	0	6	13.14	5	0.283354581228141	1.85671062324439	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	7.01E-07	7.85E-07
1460	DPF-o4	Target_lig_792	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	1.09e-06±1.8e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)Cc1ccccc1c1ccc(o1)c1ccccc1Cc1ccccc1	-	-	7.79520000000001	400.182715388	1	0	6	13.14	5	0.283354581228141	1.85671062324439	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	9.10E-07	1.27E-06
1461	DPF-p5	Target_lig_793	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	6.48e-07±8.699999999999998e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccc(cc1)Cc1ccc(cc1)c1ccc(o1)c1ccc(cc1)Cc1ccc(cc1)Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	1.77581784900312	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.61E-07	7.35E-07
1462	DPF-p5	Target_lig_793	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	2.35e-06±6e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccc(cc1)Cc1ccc(cc1)c1ccc(o1)c1ccc(cc1)Cc1ccc(cc1)Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	1.77581784900312	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.29E-06	2.41E-06
1463	DPF-m5	Target_lig_794	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	7.4e-07±1.6e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccc(cc1)Cc1cccc(c1)c1ccc(o1)c1cccc(c1)Cc1ccc(cc1)Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	2.01585560401664	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.80E-07	9.00E-07
1464	DPF-m5	Target_lig_794	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	1.82e-06±6.800000000000001e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccc(cc1)Cc1cccc(c1)c1ccc(o1)c1cccc(c1)Cc1ccc(cc1)Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	2.01585560401664	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.14E-06	2.50E-06
1465	DPF-o5	Target_lig_795	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	6.48e-07±5.1999999999999996e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccc(cc1)Cc1ccccc1c1ccc(o1)c1ccccc1Cc1ccc(cc1)Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	2.05422902019805	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.96E-07	7.00E-07
1466	DPF-o5	Target_lig_795	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	2.27e-06±1.8e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccc(cc1)Cc1ccccc1c1ccc(o1)c1ccccc1Cc1ccc(cc1)Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	2.05422902019805	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.09E-06	2.45E-06
1467	DPF-p6	Target_lig_796	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	1.212e-06±2.9e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccccc1Cc1ccc(cc1)c1ccc(o1)c1ccc(cc1)Cc1ccccc1Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	1.97609959910369	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	1.18E-06	1.24E-06
1468	DPF-p6	Target_lig_796	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	9.9e-08±2e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccccc1Cc1ccc(cc1)c1ccc(o1)c1ccc(cc1)Cc1ccccc1Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	1.97609959910369	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	7.90E-08	1.19E-07
1469	DPF-m6	Target_lig_797	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	5.9e-07±8e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccccc1Cc1cccc(c1)c1ccc(o1)c1cccc(c1)Cc1ccccc1Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	2.12612425583055	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.10E-07	6.70E-07
1470	DPF-m6	Target_lig_797	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	2.14e-06±6e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccccc1Cc1cccc(c1)c1ccc(o1)c1cccc(c1)Cc1ccccc1Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	2.12612425583055	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.08E-06	2.20E-06
1471	DPF-o6	Target_lig_798	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	7.76e-07±1.0199999999999999e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccccc1Cc1ccccc1c1ccc(o1)c1ccccc1Cc1ccccc1Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	2.08902944867529	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	6.74E-07	8.78E-07
1472	DPF-o6	Target_lig_798	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	2.74e-07±1e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	Clc1ccccc1Cc1ccccc1c1ccc(o1)c1ccccc1Cc1ccccc1Cl	-	-	9.102	468.104770684	1	0	6	13.14	5	0.241722827436578	2.08902944867529	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.74E-07	3.74E-07
1473	DPF-m7	Target_lig_799	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	6.7e-07±1.0999999999999999e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)c1ccc(cc1)Cc1cccc(c1)c1ccc(o1)c1cccc(c1)Cc1ccc(cc1)c1ccccc1	-	-	11.1292	552.245315644	1	0	8	13.14	7	0.182712386051084	1.99063010650413	43	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.60E-07	7.80E-07
1474	DPF-m7	Target_lig_799	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	2.08e-06±3e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)c1ccc(cc1)Cc1cccc(c1)c1ccc(o1)c1cccc(c1)Cc1ccc(cc1)c1ccccc1	-	-	11.1292	552.245315644	1	0	8	13.14	7	0.182712386051084	1.99063010650413	43	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.05E-06	2.11E-06
1475	DPF-o7	Target_lig_800	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	5.939999999999999e-07±7.2e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)c1ccc(cc1)Cc1ccccc1c1ccc(o1)c1ccccc1Cc1ccc(cc1)c1ccccc1	-	-	11.1292	552.245315644	1	0	8	13.14	7	0.182712386051084	2.03775211008195	43	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.22E-07	6.66E-07
1476	DPF-o7	Target_lig_800	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	3.87e-06±1.2e-06	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)c1ccc(cc1)Cc1ccccc1c1ccc(o1)c1ccccc1Cc1ccc(cc1)c1ccccc1	-	-	11.1292	552.245315644	1	0	8	13.14	7	0.182712386051084	2.03775211008195	43	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.67E-06	5.07E-06
1477	DPF-p8	Target_lig_801	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	3.5799999999999996e-08±1.5e-09	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	C1CN(CCC1c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C1CCN(CC1)Cc1ccccc1)Cc1ccccc1	-	-	9.3728	566.329713964	3	0	8	19.62	5	0.186536197056541	2.25540676904188	43	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	3.43E-08	3.73E-08
1478	DPF-m8	Target_lig_802	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	7.4e-07±1.3e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)CN1CCC(CC1)c1cccc(c1)c1ccc(o1)c1cccc(c1)C1CCN(CC1)Cc1ccccc1	-	-	9.3728	566.329713964	3	0	8	19.62	5	0.186536197056541	2.37660631111292	43	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	6.10E-07	8.70E-07
1479	DPF-m8	Target_lig_802	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	3.15e-06±2.1999999999999998e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)CN1CCC(CC1)c1cccc(c1)c1ccc(o1)c1cccc(c1)C1CCN(CC1)Cc1ccccc1	-	-	9.3728	566.329713964	3	0	8	19.62	5	0.186536197056541	2.37660631111292	43	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.93E-06	3.37E-06
1480	DPF-o8	Target_lig_803	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	6.949999999999999e-07±2.3899999999999996e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)CN1CCC(CC1)c1ccccc1c1ccc(o1)c1ccccc1C1CCN(CC1)Cc1ccccc1	-	-	9.3728	566.329713964	3	0	8	19.62	5	0.186536197056541	2.3555692019578	43	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	4.56E-07	9.34E-07
1481	DPF-o8	Target_lig_803	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	1.814e-06±4.5999999999999995e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(cc1)CN1CCC(CC1)c1ccccc1c1ccc(o1)c1ccccc1C1CCN(CC1)Cc1ccccc1	-	-	9.3728	566.329713964	3	0	8	19.62	5	0.186536197056541	2.3555692019578	43	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.77E-06	1.86E-06
1482	DPF-p9	Target_lig_804	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	7.899999999999999e-08±5e-09	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	N1CCN(CC1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCN1CCNCC1	-	-	3.509	444.288911772	5	2	8	43.68	3	0.556729603963411	2.36455632273272	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	7.40E-08	8.40E-08
1483	DPF-p9	Target_lig_804	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	2.5999999999999998e-08±3e-09	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	N1CCN(CC1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCN1CCNCC1	-	-	3.509	444.288911772	5	2	8	43.68	3	0.556729603963411	2.36455632273272	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.30E-08	2.90E-08
1484	DPF-m9	Target_lig_805	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	2.045e-06±2.1499999999999998e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	N1CCN(CC1)CCc1cccc(c1)c1ccc(o1)c1cccc(c1)CCN1CCNCC1	-	-	3.509	444.288911772	5	2	8	43.68	3	0.556729603963411	2.48657531113239	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	1.83E-06	2.26E-06
1485	DPF-m9	Target_lig_805	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	4.705e-06±1.071e-06	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	N1CCN(CC1)CCc1cccc(c1)c1ccc(o1)c1cccc(c1)CCN1CCNCC1	-	-	3.509	444.288911772	5	2	8	43.68	3	0.556729603963411	2.48657531113239	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	3.63E-06	5.78E-06
1486	DPF-o9	Target_lig_806	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	1.709e-06±1.98e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	N1CCN(CC1)CCc1ccccc1c1ccc(o1)c1ccccc1CCN1CCNCC1	-	-	3.509	444.288911772	5	2	8	43.68	3	0.556729603963411	2.58031517127224	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	1.51E-06	1.91E-06
1487	DPF-o9	Target_lig_806	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	4.105999999999999e-06±2.612e-06	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	N1CCN(CC1)CCc1ccccc1c1ccc(o1)c1ccccc1CCN1CCNCC1	-	-	3.509	444.288911772	5	2	8	43.68	3	0.556729603963411	2.58031517127224	33	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.49E-06	6.72E-06
1488	DPF-p10	Target_lig_807	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	5.6e-08±5e-09	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN1CCN(CC1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCN1CCN(CC1)C	-	-	4.1934	472.3202119	5	0	8	26.1	3	0.489801619514729	2.21760733056905	35	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.10E-08	6.10E-08
1489	DPF-p10	Target_lig_807	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	1.5e-08±2e-09	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN1CCN(CC1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCN1CCN(CC1)C	-	-	4.1934	472.3202119	5	0	8	26.1	3	0.489801619514729	2.21760733056905	35	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.30E-08	1.70E-08
1490	DPF-m10	Target_lig_808	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	1.1699999999999998e-06±6e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN1CCN(CC1)CCc1cccc(c1)c1ccc(o1)c1cccc(c1)CCN1CCN(CC1)C	-	-	4.1934	472.3202119	5	0	8	26.1	3	0.489801619514729	2.37730435405146	35	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	1.11E-06	1.23E-06
1491	DPF-m10	Target_lig_808	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	3.5e-06±1.06e-06	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN1CCN(CC1)CCc1cccc(c1)c1ccc(o1)c1cccc(c1)CCN1CCN(CC1)C	-	-	4.1934	472.3202119	5	0	8	26.1	3	0.489801619514729	2.37730435405146	35	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.44E-06	4.56E-06
1492	DPF-o10	Target_lig_809	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	5.02e-07±8.899999999999999e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN1CCN(CC1)CCc1ccccc1c1ccc(o1)c1ccccc1CCN1CCN(CC1)C	-	-	4.1934	472.3202119	5	0	8	26.1	3	0.489801619514729	2.42666810048816	35	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	4.13E-07	5.91E-07
1493	DPF-o10	Target_lig_809	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	1.561e-06±3.7999999999999996e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	CN1CCN(CC1)CCc1ccccc1c1ccc(o1)c1ccccc1CCN1CCN(CC1)C	-	-	4.1934	472.3202119	5	0	8	26.1	3	0.489801619514729	2.42666810048816	35	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.18E-06	1.94E-06
1494	DPF-p11	Target_lig_810	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	1.5529999999999998e-06±3.38e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1scc(c1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCc1cscc1	-	-	8.30700000000001	440.126857388	3	0	8	13.14	5	0.23638349061688	2.25870632286754	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	1.22E-06	1.89E-06
1495	DPF-p11	Target_lig_810	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	3.5099999999999995e-07±8e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1scc(c1)CCc1ccc(cc1)c1ccc(o1)c1ccc(cc1)CCc1cscc1	-	-	8.30700000000001	440.126857388	3	0	8	13.14	5	0.23638349061688	2.25870632286754	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.71E-07	4.31E-07
1496	DPF-m11	Target_lig_811	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	6.2e-07±4e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1cc(CCc2cscc2)cc(c1)c1ccc(o1)c1cccc(c1)CCc1cscc1	-	-	8.30700000000001	440.126857388	3	0	8	13.14	5	0.23638349061688	2.4381642495081	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	5.80E-07	6.60E-07
1497	DPF-m11	Target_lig_811	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	2.89e-06±4e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1cc(CCc2cscc2)cc(c1)c1ccc(o1)c1cccc(c1)CCc1cscc1	-	-	8.30700000000001	440.126857388	3	0	8	13.14	5	0.23638349061688	2.4381642495081	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	2.49E-06	3.29E-06
1498	DPF-o11	Target_lig_812	MALAT1 triple helix	Homo sapiens	Cancer	Target_272	0	0	0	0	5.47e-07±1.23e-07	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(c(c1)c1ccc(o1)c1ccccc1CCc1cscc1)CCc1cscc1	-	-	8.30700000000001	440.126857388	3	0	8	13.14	5	0.23638349061688	2.52406102370165	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	4.24E-07	6.70E-07
1499	DPF-o11	Target_lig_812	MALAT1 non-triplex forming stem-loop	Homo sapiens	Cancer	Target_273	0	0	0	0	2.5e-07±9e-08	0	0	-	-	10.1002/anie.201808823	30134013	Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.	Donlic A, Morgan BS, Xu JL, Liu A, Roble C Jr, Hargrove AE	Angew Chem Int Ed Engl	57	13242-13247	2018	2 uM	9.74, 7.74, 5.74, 3.74, 1.74, 0.74, 0.34, 0.14, 0.04 μM	7.3	37	10 mM NaH2PO4, 25 mM NaCl, 4 mM MgCl2	Fluorescence-screening assay	Additional	c1ccc(c(c1)c1ccc(o1)c1ccccc1CCc1cscc1)CCc1cscc1	-	-	8.30700000000001	440.126857388	3	0	8	13.14	5	0.23638349061688	2.52406102370165	31	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUUU	10.1002/anie.201808823	lncRNA	lncRNA	67	3′ terminal stability element for nuclear expression (ENE)	Stem-Loop with Bulge	0	0	0	0	0	0	0	0	1.60E-07	3.40E-07
1500	Compound 5	Target_lig_813	MALAT1 ENE	Homo sapiens	Cancer	Target_272	0	0	2.2999999999999996e-06±1.6999999999999998e-06	0	0	0	0	-	-	10.1021/acschembio.8b00807	30620551	Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1	Abulwerdi FA, Xu W, Ageeli AA, Yonkunas MJ, Arun G, Nam H, Schneekloth Jr JS, Dayie TK, Spector D, Baird N, Le Grice SFJ	ACS Chem Biol	14	223-235	2019	10-50 uM	100 nM	6.9	Room temperature	0.1 mM MgCl2 and 2.6 mM total monovalent salt	FRET assay	Additional	Cn1c(NCc2cccc(c2)C(=O)C)ncc1c1ccc(cc1)C(=O)C	-	-	4.1044	347.163376912	5	1	6	63.99	3	0.68183794801751	2.18824803530138	26	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	6.00E-07	4.00E-06	0	0	0	0
1501	Compound 16	Target_lig_814	MALAT1 ENE	Homo sapiens	Cancer	Target_272	0	0	6.099999999999999e-06±1.8e-06	0	0	0	0	-	-	10.1021/acschembio.8b00807	30620551	Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1	Abulwerdi FA, Xu W, Ageeli AA, Yonkunas MJ, Arun G, Nam H, Schneekloth Jr JS, Dayie TK, Spector D, Baird N, Le Grice SFJ	ACS Chem Biol	14	223-235	2019	10-50 uM	100 nM	6.9	Room temperature	0.1 mM [Mg2+] and 52.6 mM total monovalent salt	FRET assay	Additional	Cc1ccc2c(c1)[nH]c(n2)C1=C(N)N(CC1=O)C1CCCC1	-	-	2.32592	296.16371126	4	2	2	75.01	2	0.891591751687405	2.60974973081313	22	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	4.30E-06	7.90E-06	0	0	0	0
1502	Compound 5	Target_lig_813	MALAT1 ENE	Homo sapiens	Cancer	Target_272	0	0	2.8999999999999998e-06±1.6e-06	0	0	0	0	-	-	10.1021/acschembio.8b00807	30620551	Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1	Abulwerdi FA, Xu W, Ageeli AA, Yonkunas MJ, Arun G, Nam H, Schneekloth Jr JS, Dayie TK, Spector D, Baird N, Le Grice SFJ	ACS Chem Biol	14	223-235	2019	500 uM	75 uM	6.9	-	1 mM MgCl2, 200 mM monovalent salt	Isothermal Titration Calorimetry (ITC)	Additional	Cn1c(NCc2cccc(c2)C(=O)C)ncc1c1ccc(cc1)C(=O)C	-	-	4.1044	347.163376912	5	1	6	63.99	3	0.68183794801751	2.18824803530138	26	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	1.30E-06	4.50E-06	0	0	0	0
1503	Compound 16	Target_lig_814	MALAT1 ENE	Homo sapiens	Cancer	Target_272	0	0	6.099999999999999e-06±2.1e-06	0	0	0	0	-	-	10.1021/acschembio.8b00807	30620551	Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1	Abulwerdi FA, Xu W, Ageeli AA, Yonkunas MJ, Arun G, Nam H, Schneekloth Jr JS, Dayie TK, Spector D, Baird N, Le Grice SFJ	ACS Chem Biol	14	223-235	2019	500 uM	75 uM	6.9	-	1 mM MgCl2, 50 mM monovalent salt	Isothermal Titration Calorimetry (ITC)	Additional	Cc1ccc2c(c1)[nH]c(n2)C1=C(N)N(CC1=O)C1CCCC1	-	-	2.32592	296.16371126	4	2	2	75.01	2	0.891591751687405	2.60974973081313	22	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	4.00E-06	8.20E-06	0	0	0	0
1504	Compound 16	Target_lig_814	MALAT1 ENE	Homo sapiens	Cancer	Target_272	0	0	2.4999999999999998e-06±8e-07	0	0	0	0	-	-	10.1021/acschembio.8b00807	30620551	Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1	Abulwerdi FA, Xu W, Ageeli AA, Yonkunas MJ, Arun G, Nam H, Schneekloth Jr JS, Dayie TK, Spector D, Baird N, Le Grice SFJ	ACS Chem Biol	14	223-235	2019	10-50 uM	100 nM	6.9	Room temperature	1 mM MgCl2 and 102.5 mM monovalent (equimolar NaCl and Kcl)	FRET assay	Additional	Cc1ccc2c(c1)[nH]c(n2)C1=C(N)N(CC1=O)C1CCCC1	-	-	2.32592	296.16371126	4	2	2	75.01	2	0.891591751687405	2.60974973081313	22	GGAAGGUUUUUCUUUUCCUGAGAAAACAACACUAUUGUUUUCUCAGGUUUUGCUUU UUGGCCUUUUUCUAGCUUAAAAAAAAAAAAAGCAAAA	4PLX	lncRNA	lncRNA	94	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	1.70E-06	3.30E-06	0	0	0	0
1505	RGB-1	Target_lig_815	TERRA G-quadruplex	Homo sapiens	Cancer,Age-related diseases	Target_255	0	0	5.90E-06	0	0	0	0	-	-	10.1021/jacs.6b04506	27410677	A Small Molecule That Represses Translation of G-Quadruplex-Containing mRNA.	Katsuda Y, Sato S, Asano L, Morimura Y, Furuta T, Sugiyama H, Hagihara M, Uesugi M	J Am Chem Soc	138	9037-40	2016	-	-	7.6	-	100 mM Kcl	Size exclusion chromatography	Additional	O=c1n2Cc3nc4scc(c4c(=O)n3Cc2nc2c1c(cs2)c1ccoc1)c1ccco1	-	-	4.1594	460.029996864	10	0	2	96.06	6	0.384430681350489	3.32481346089021	32	AGGGUUAGGGUUAGGGUUAGGG	10.1016/j.bbagen.2017.09.015	G-quadruplex	-	22	-	G-Quadruplex	0	0	0	0	5.90E-06	5.90E-06	0	0	0	0
1506	Synucleozid	Target_lig_816	SNCA IRE	Homo sapiens	Parkinson’s disease	Target_274	0	0	0	0	2.7200000000000002e-06±3.7e-07	0	0	-	-	10.1073/pnas.1905057117	31900363	Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA	Zhang P, Park H, Zhang J, Junn E, Andrews RJ, Velagapudi SP, Abegg D, Vishnu K, Costales MG, Childs-Disney JL, Adibekian A, Moss WN, Mouradian MM, Disney MD	Proc Natl Acad Sci U S A	117	1457-1467	2020	2.7 uM	1 uM	-	Room temperature	-	2-aminopurine assay	Additional	C1CN=C(N1)C2=CC=C(C=C2)NC3=CC=C(C=C3)C4=CC5=C(N4)C=C(C=C5)C6=NCCN6	4-[6-(4,5-dihydro-1H-imidazol-2-yl)-1H-indol-2-yl]-N-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]aniline	435839	4.2781	420.206244768	5	4	5	76.6	4	0.38929444950941	2.76487905008825	32	ACUGGGAGUGGCCAUUCGACGACAGUGUGGUGUAAAGGAAUUCAUUAGCC	https://www.pnas.org/content/pnas/117/3/1457.full.pdf	mRNA	Internal Ribosome Entry Site (IRES)	50	5’-UTR	Stem-Loop	0	0	0	0	0	0	0	0	2.35E-06	3.09E-06
1507	Synucleozid-2	Target_lig_816	SNCA IRE	Homo sapiens	Parkinson’s disease	Target_274	0	0	0	0	2.1499999999999997e-06±5.3e-07	0	0	-	-	10.1073/pnas.1905057117	31900363	Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA	Zhang P, Park H, Zhang J, Junn E, Andrews RJ, Velagapudi SP, Abegg D, Vishnu K, Costales MG, Childs-Disney JL, Adibekian A, Moss WN, Mouradian MM, Disney MD	Proc Natl Acad Sci U S A	117	1457-1467	2020	2.7 uM	1 uM	-	Room temperature	-	2-aminopurine assay	Additional	C1CN=C(N1)C2=CC=C(C=C2)NC3=CC=C(C=C3)C4=CC5=C(N4)C=C(C=C5)C6=NCCN6	4-[6-(4,5-dihydro-1H-imidazol-2-yl)-1H-indol-2-yl]-N-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]aniline	435839	4.2781	420.206244768	5	4	5	76.6	4	0.38929444950941	2.76487905008825	32	ACUGGGAGUGGCCAUUCGACGACAGUGUGGUGUAAAGGAAUUCAUUAGCC	https://www.pnas.org/content/pnas/117/3/1457.full.pdf	mRNA	Internal Ribosome Entry Site (IRES)	50	5’-UTR	Stem-Loop	0	0	0	0	0	0	0	0	1.62E-06	2.68E-06
1508	Synucleozid-3	Target_lig_817	SNCA IRE	Homo sapiens	Parkinson’s disease	Target_274	0	0	0	0	2.54e-06±3.3e-07	0	0	-	-	10.1073/pnas.1905057117	31900363	Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA	Zhang P, Park H, Zhang J, Junn E, Andrews RJ, Velagapudi SP, Abegg D, Vishnu K, Costales MG, Childs-Disney JL, Adibekian A, Moss WN, Mouradian MM, Disney MD	Proc Natl Acad Sci U S A	117	1457-1467	2020	2.7 uM	1 uM	-	Room temperature	-	2-aminopurine assay	Additional	C1CN=C(N1)C2=CC=C(C=C2)OC3=CC=C(C=C3)C4=CC5=C(N4)C=C(C=C5)C6=NCCN6	6-(4,5-dihydro-1H-imidazol-2-yl)-2-[4-[4-(4,5-dihydro-1H-imidazol-2-yl)phenoxy]phenyl]-1H-indole	52603	4.3268	421.190260356	5	3	5	73.8	4	0.449157557460822	2.7466627039344	32	ACUGGGAGUGGCCAUUCGACGACAGUGUGGUGUAAAGGAAUUCAUUAGCC	https://www.pnas.org/content/pnas/117/3/1457.full.pdf	mRNA	Internal Ribosome Entry Site (IRES)	50	5’-UTR	Stem-Loop	0	0	0	0	0	0	0	0	2.21E-06	2.87E-06
1509	Synucleozid-4	Target_lig_818	SNCA IRE	Homo sapiens	Parkinson’s disease	Target_274	0	0	0	0	2.5699999999999995e-06±4.8e-07	0	0	-	-	10.1073/pnas.1905057117	31900363	Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA	Zhang P, Park H, Zhang J, Junn E, Andrews RJ, Velagapudi SP, Abegg D, Vishnu K, Costales MG, Childs-Disney JL, Adibekian A, Moss WN, Mouradian MM, Disney MD	Proc Natl Acad Sci U S A	117	1457-1467	2020	2.7 uM	1 uM	-	Room temperature	-	2-aminopurine assay	Additional	C1CN=C(N1)c1ccc(cc1)Nc1ccc(cc1)c1[nH]c2c(n1)ccc(c2)C1=NCCN1	-	-	3.6731	421.201493736	6	4	5	89.49	4	0.395841961996563	2.7395564539344	32	ACUGGGAGUGGCCAUUCGACGACAGUGUGGUGUAAAGGAAUUCAUUAGCC	https://www.pnas.org/content/pnas/117/3/1457.full.pdf	mRNA	Internal Ribosome Entry Site (IRES)	50	5’-UTR	Stem-Loop	0	0	0	0	0	0	0	0	2.09E-06	3.05E-06
1510	Synucleozid-5	Target_lig_819	SNCA IRE	Homo sapiens	Parkinson’s disease	Target_274	0	0	0	0	4.669999999999999e-06±3.5e-07	0	0	-	-	10.1073/pnas.1905057117	31900363	Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA	Zhang P, Park H, Zhang J, Junn E, Andrews RJ, Velagapudi SP, Abegg D, Vishnu K, Costales MG, Childs-Disney JL, Adibekian A, Moss WN, Mouradian MM, Disney MD	Proc Natl Acad Sci U S A	117	1457-1467	2020	2.7 uM	1 uM	-	Room temperature	-	2-aminopurine assay	Additional	C1CN=C(N1)C2=CC=C(C=C2)OC3=CC=C(C=C3)C4=NC5=C(N4)C=C(C=C5)C6=NCCN6	6-(4,5-dihydro-1H-imidazol-2-yl)-2-[4-[4-(4,5-dihydro-1H-imidazol-2-yl)phenoxy]phenyl]-1H-benzimidazole	23621424	3.7218	422.185509324	6	3	5	86.69	4	0.457520419931659	2.72134010778055	32	ACUGGGAGUGGCCAUUCGACGACAGUGUGGUGUAAAGGAAUUCAUUAGCC	https://www.pnas.org/content/pnas/117/3/1457.full.pdf	mRNA	Internal Ribosome Entry Site (IRES)	50	5’-UTR	Stem-Loop	0	0	0	0	0	0	0	0	4.32E-06	5.02E-06
1511	Neamine	Target_lig_80	Tau Stem-Loop RNA	Homo sapiens	Tauopathies	Target_275	0	0	0	0	0.0031	0	0	-	-	10.1021/jo502661j	25602935	Synthesis and tau RNA binding evaluation of ametantrone-containing ligands.	Artigas G, Marchán V	J Org Chem	80	2155-64	2015	0-614 nM	25 nM	6.8	-	10 mM sodium phosphate buffer, 100 mM NaCl	Fluorescence-based binding assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol	413349	-5.11559999999999	322.185234552	10	8	3	203.46	0	0.247960739843155	4.62440978066844	22	GCGGCAGUGUGAGUACCUUCACACGUCCC	https://pubs.acs.org/doi/pdf/10.1021/jo502661j	mRNA	pre-mRNA	29	5′ intron junction	Stem-Loop	0	0	0	0	0	0	0	0	0.0031	0.0031
1512	Guanidinoamine	Target_lig_820	Tau Stem-Loop RNA	Homo sapiens	Tauopathies	Target_275	0	0	0	0	8.30E-07	0	0	-	-	10.1021/jo502661j	25602935	Synthesis and tau RNA binding evaluation of ametantrone-containing ligands.	Artigas G, Marchán V	J Org Chem	80	2155-64	2015	0-614 nM	25 nM	6.8	-	10 mM sodium phosphate buffer, 100 mM NaCl	Fluorescence-based binding assay	Additional	NC(=N)NCC1OC(OC2C(NC(=N)N)CC(C(C2O)O)NC(=N)N)C(C(C1O)O)NC(=N)N	-	-	-7.01812000000001	490.272426808	10	16	7	346.98	0	0.116345837060347	5.2992048103344	34	GCGGCAGUGUGAGUACCUUCACACGUCCC	https://pubs.acs.org/doi/pdf/10.1021/jo502661j	mRNA	pre-mRNA	29	5′ intron junction	Stem-Loop	0	0	0	0	0	0	0	0	8.30E-07	8.30E-07
1513	Mitoxantrone	Target_lig_182	Tau Stem-Loop RNA	Homo sapiens	Tauopathies	Target_275	0	0	0	0	1.688e-07±6.199999999999999e-09	0	0	-	-	10.1021/jo502661j	25602935	Synthesis and tau RNA binding evaluation of ametantrone-containing ligands.	Artigas G, Marchán V	J Org Chem	80	2155-64	2015	0-614 nM	25 nM	6.8	-	10 mM sodium phosphate buffer, 100 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO	1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione	4212	-0.1392	444.200884616	10	8	12	163.18	2	0.139316778047515	2.81447110510123	32	GCGGCAGUGUGAGUACCUUCACACGUCCC	https://pubs.acs.org/doi/pdf/10.1021/jo502661j	mRNA	pre-mRNA	29	5′ intron junction	Stem-Loop	0	0	0	0	0	0	0	0	1.63E-07	1.75E-07
1514	Amatantrone	Target_lig_821	Tau Stem-Loop RNA	Homo sapiens	Tauopathies	Target_275	0	0	0	0	2.318e-07±8e-09	0	0	-	-	10.1021/jo502661j	25602935	Synthesis and tau RNA binding evaluation of ametantrone-containing ligands.	Artigas G, Marchán V	J Org Chem	80	2155-64	2015	0-614 nM	25 nM	6.8	-	10 mM sodium phosphate buffer, 100 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCNCCO)NCCNCCO	1,4-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione	2134	0.4496	412.211055376	8	6	12	122.72	2	0.237171260591097	2.56714558908882	30	GCGGCAGUGUGAGUACCUUCACACGUCCC	https://pubs.acs.org/doi/pdf/10.1021/jo502661j	mRNA	pre-mRNA	29	5′ intron junction	Stem-Loop	0	0	0	0	0	0	0	0	2.24E-07	2.40E-07
1515	Compound 1	Target_lig_675	DDPAC hairpin A-bulge	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	1.86e-05±2.8999999999999998e-06	0	0	0	0	-	-	10.1021/jacs.0c00768	32364710	Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing	Chen JL, Zhang P, Abe M, Aikawa H, Zhang L, Frank AJ, Zembryski T, Hubbs C, Park H, Withka J, Steppan C, Rogers L, Cabral S, Pettersson M, Wager TT, Fountain MA, Rumbaugh G, Childs-Disney JL, Disney MD	J Am Chem Soc	142	8706-8727	2020	0-200 uM	2 uM	6.3	Room temperature	0.185 M NaCl, 8 mM NaH2PO4	2-aminopurine assay	Additional	NC1=CC=C(C=C1)C1=CC2=CC=C(C=C2N1)C1=[NH+]CCN1	-	-	0.847499999999999	277.14477296409	2	4	2	67.81	3	0.524595605869462	3.32880565517162	21	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	1.57E-05	2.15E-05	0	0	0	0
1516	Compound 2	Target_lig_676	DDPAC hairpin A-bulge	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	2.14e-05±3.5e-06	0	0	0	0	-	-	10.1021/jacs.0c00768	32364710	Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing	Chen JL, Zhang P, Abe M, Aikawa H, Zhang L, Frank AJ, Zembryski T, Hubbs C, Park H, Withka J, Steppan C, Rogers L, Cabral S, Pettersson M, Wager TT, Fountain MA, Rumbaugh G, Childs-Disney JL, Disney MD	J Am Chem Soc	142	8706-8727	2020	0-200 uM	2 uM	6.3	Room temperature	0.185 M NaCl, 8 mM NaH2PO4	2-aminopurine assay	Additional	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	1.79E-05	2.49E-05	0	0	0	0
1517	Compound 3	Target_lig_823	DDPAC hairpin A-bulge	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	7.499999999999999e-06±1.1e-06	0	0	0	0	-	-	10.1021/jacs.0c00768	32364710	Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing	Chen JL, Zhang P, Abe M, Aikawa H, Zhang L, Frank AJ, Zembryski T, Hubbs C, Park H, Withka J, Steppan C, Rogers L, Cabral S, Pettersson M, Wager TT, Fountain MA, Rumbaugh G, Childs-Disney JL, Disney MD	J Am Chem Soc	142	8706-8727	2020	0-200 uM	2 uM	6.3	Room temperature	0.185 M NaCl, 8 mM NaH2PO4	2-aminopurine assay	Additional	C1=CC(=CC=C1/C=N/N=C(N)N)C2=CC3=C(S2)C=C(C=C3)/C=N/N=C(N)N	2-[(E)-[4-[6-[(E)-(diaminomethylidenehydrazinylidene)methyl]-1-benzothiophen-2-yl]phenyl]methylideneamino]guanidine	9567645	1.7829	378.137513576	5	4	5	153.52	3	0.303396705729103	2.89675373406579	27	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	6.40E-06	8.60E-06	0	0	0	0
1518	Compound 4	Target_lig_654	DDPAC hairpin A-bulge	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	3.6e-06±1.2e-06	0	0	0	0	-	-	10.1021/jacs.0c00768	32364710	Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing	Chen JL, Zhang P, Abe M, Aikawa H, Zhang L, Frank AJ, Zembryski T, Hubbs C, Park H, Withka J, Steppan C, Rogers L, Cabral S, Pettersson M, Wager TT, Fountain MA, Rumbaugh G, Childs-Disney JL, Disney MD	J Am Chem Soc	142	8706-8727	2020	0-200 uM	2 uM	6.3	Room temperature	0.185 M NaCl, 8 mM NaH2PO4	2-aminopurine assay	Additional	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N(C)[C@@H](C\C=C\C[C@H](N(C)C(=O)C1=C(CC)N=C2C=C3C=CC=CC3=CC2=C1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+])C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	-	-	6.74980000000001	1326.73066080818	10	4	28	261.12	8	0.022777967565924	6.35803538202521	98	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	2.40E-06	4.80E-06	0	0	0	0
1519	Compound 5	Target_lig_813	DDPAC hairpin A-bulge	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	1.64e-05±1.6e-06	0	0	0	0	-	-	10.1021/jacs.0c00768	32364710	Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing	Chen JL, Zhang P, Abe M, Aikawa H, Zhang L, Frank AJ, Zembryski T, Hubbs C, Park H, Withka J, Steppan C, Rogers L, Cabral S, Pettersson M, Wager TT, Fountain MA, Rumbaugh G, Childs-Disney JL, Disney MD	J Am Chem Soc	142	8706-8727	2020	0-200 uM	2 uM	6.3	Room temperature	0.185 M NaCl, 8 mM NaH2PO4	2-aminopurine assay	Additional	Cn1c(NCc2cccc(c2)C(=O)C)ncc1c1ccc(cc1)C(=O)C	-	-	4.1044	347.163376912	5	1	6	63.99	3	0.68183794801751	2.18824803530138	26	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	1.48E-05	1.80E-05	0	0	0	0
1520	Compound 6	Target_lig_826	DDPAC hairpin A-bulge	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	1.5199999999999998e-05±4.4e-06	0	0	0	0	-	-	10.1021/jacs.0c00768	32364710	Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing	Chen JL, Zhang P, Abe M, Aikawa H, Zhang L, Frank AJ, Zembryski T, Hubbs C, Park H, Withka J, Steppan C, Rogers L, Cabral S, Pettersson M, Wager TT, Fountain MA, Rumbaugh G, Childs-Disney JL, Disney MD	J Am Chem Soc	142	8706-8727	2020	0-200 uM	2 uM	6.3	Room temperature	0.185 M NaCl, 8 mM NaH2PO4	2-aminopurine assay	Additional	OC1CN(C1)Cc1ccc(cc1)C1CCN(CC1)C(=O)c1cn(c2c1cccc2)C	-	-	3.3746	403.225977168	4	1	4	48.71	3	0.726638317802747	2.26605453363264	30	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	1.08E-05	1.96E-05	0	0	0	0
1521	Compound 7	Target_lig_827	DDPAC hairpin A-bulge	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	1.6899999999999997e-05±4.1e-06	0	0	0	0	-	-	10.1021/jacs.0c00768	32364710	Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing	Chen JL, Zhang P, Abe M, Aikawa H, Zhang L, Frank AJ, Zembryski T, Hubbs C, Park H, Withka J, Steppan C, Rogers L, Cabral S, Pettersson M, Wager TT, Fountain MA, Rumbaugh G, Childs-Disney JL, Disney MD	J Am Chem Soc	142	8706-8727	2020	0-200 uM	2 uM	6.3	Room temperature	0.185 M NaCl, 8 mM NaH2PO4	2-aminopurine assay	Additional	OC1CN(C1)Cc1ccc(cc1)C1CCN(CC1)C(=O)c1c(C)nc2n1ccs2	-	-	2.90052	410.177647072	6	1	4	61.08	3	0.718519511650015	2.55369902717461	29	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	1.28E-05	2.10E-05	0	0	0	0
1522	Compound 8	Target_lig_1265	DDPAC hairpin A-bulge	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	4.8e-06±6e-07	0	0	0	0	-	-	10.1021/jacs.0c00768	32364710	Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing	Chen JL, Zhang P, Abe M, Aikawa H, Zhang L, Frank AJ, Zembryski T, Hubbs C, Park H, Withka J, Steppan C, Rogers L, Cabral S, Pettersson M, Wager TT, Fountain MA, Rumbaugh G, Childs-Disney JL, Disney MD	J Am Chem Soc	142	8706-8727	2020	0-200 uM	2 uM	6.3	Room temperature	0.185 M NaCl, 8 mM NaH2PO4	2-aminopurine assay	Additional	Oc1ccc2c(c1)c1c(C)c3c[n+](CCN4CCCCC4)ccc3c(c1[nH]2)C	5,11-dimethyl-2-(2-piperidin-1-ylethyl)-6H-pyrido[4,3-b]carbazol-2-ium-9-ol	432608	4.57014	374.22268893609	2	2	3	43.14	4	0.51598885165364	2.87840241645753	28	GGCAGUGUGAGUACCUUCAUACGUC	10.1002/cbic.201402069	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	4.20E-06	5.40E-06	0	0	0	0
1523	Pyridazine 2	Target_lig_828	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	6.00E-07	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)NC2=NN=C(C=C2)C3=CC4=CC=CC=C4S3)C	6-(1-benzothiophen-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine	73293105	5.0794	366.187817832	5	2	3	49.84	3	0.678593445947212	2.74091847075264	26	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	6.00E-07	6.00E-07
1524	Pyridazine 3	Target_lig_829	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	1.10E-06	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)N(C)C2=NN=C(C=C2)C3=CC4=CC=CC=C4S3)C	6-(1-benzothiophen-2-yl)-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine	89975061	5.1037	380.203467896	5	1	3	41.05	3	0.685920499512457	2.87408486872061	27	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	1.10E-06	1.10E-06
1525	Pyridazine 4	Target_lig_830	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	3.50E-07	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)NC2=NN=C(C=C2)C3=CC4=CC=CC=C4C=C3)C	6-naphthalen-2-yl-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine	73294187	5.0179	360.231396896	4	2	3	49.84	3	0.688604019629876	2.49819489290695	27	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	3.50E-07	3.50E-07
1526	Pyridazine 6	Target_lig_831	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	1.50E-07	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)N(C)C2=NN=C(C=C2)C3=C(C=C(C=C3)F)O)C	5-fluoro-2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol	136253018	3.7337	358.216889704	5	2	3	61.28	2	0.875302637407101	2.89457878523831	26	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	1.50E-07	1.50E-07
1527	Pyridazine 7	Target_lig_832	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	1.60E-08	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)N(C)C2=NN=C(C=C2)C3=CC4=CC=CC=C4C=C3O)C	3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]naphthalen-2-ol	136253058	4.7478	390.24196158	5	2	3	61.28	3	0.675852572425975	2.83090423776054	29	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	1.60E-08	1.60E-08
1528	Pyridazine 8	Target_lig_833	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	3.10E-08	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)N(C)C2=NN=C(C=C2)C3=C(C=C(C=C3)C#N)O)C	3-hydroxy-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]benzonitrile	136253042	3.46628	365.221560484	6	2	3	85.07	2	0.866280842037283	2.99848355019561	27	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	3.10E-08	3.10E-08
1529	Pyridazine 9	Target_lig_834	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	1.69E-06	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)N(C)C2=NN=C(C=C2)C3=C(C=C(C=C3)C#N)OC)C	3-methoxy-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]benzonitrile	86710662	3.76928	379.237210548	6	1	4	74.07	2	0.871608799553146	2.86885649571161	28	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	1.69E-06	1.69E-06
1530	Eastern amine 10	Target_lig_835	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	2.00E-08	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)N(C)C2=NN=C(C=C2)C3=C(C=C(C=C3)N4C=CC=N4)O)C	2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-5-pyrazol-1-ylphenol	136253041	3.7803	406.24810958	7	2	4	79.1	3	0.686470066712953	3.03153941735358	30	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	2.00E-08	2.00E-08
1531	Eastern amine 11	Target_lig_836	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	3.00E-08	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)OC2=NN=C(C=C2)C3=C(C=C(C=C3)N4C=CC=N4)O)C	5-pyrazol-1-yl-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol	136598272	3.7229	393.216475104	7	2	4	85.09	3	0.702654502785546	2.98262589713098	29	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	3.00E-08	3.00E-08
1532	Eastern amine 12	Target_lig_837	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	3.40E-07	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	C1CNCCC1OC2=NN=C(C=C2)C3=C(C=C(C=C3)N4C=CC=N4)O	2-(6-piperidin-4-yloxypyridazin-3-yl)-5-pyrazol-1-ylphenol	136253061	2.1657	337.153874848	7	2	4	85.09	3	0.758831286182685	2.69991547734088	25	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	3.40E-07	3.40E-07
1533	Eastern amine 13	Target_lig_838	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	3.30E-06	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	C1CNCC(C1OC2=NN=C(C=C2)C3=C(C=C(C=C3)N4C=CC=N4)O)(F)F	2-[6-(3,3-difluoropiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol	145982093	2.4109	373.135031224	7	2	4	85.09	3	0.730639051995757	3.59296157713608	27	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	3.30E-06	3.30E-06
1534	Eastern amine 14	Target_lig_839	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	>9.999999999999999e-06	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1CC(F)(F)F)(C)C)OC2=NN=C(C=C2)C3=C(C=C(C=C3)N4C=CC=N4)O)C	5-pyrazol-1-yl-2-[6-[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazin-3-yl]phenol	145992475	4.99760000000001	475.219509796	7	1	5	76.3	3	0.559947771666007	3.24402773726753	34	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	1.00E-05	1.00E-05
1535	Pyridazine 15	Target_lig_840	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	2.00E-08	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)N(C)C2=NN=C(C=C2)C3=C(C=C4C(=C3)C=CC=N4)O)C	6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol	136607508	4.1428	391.237210548	6	2	3	74.17	3	0.698875545614141	2.98661705827336	29	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	2.00E-08	2.00E-08
1536	Pyridazine 16	Target_lig_841	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	6.00E-09	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)N(C)C2=NN=C(C=C2)C3=C(C=C4C=CN=CC4=C3)O)C	7-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinolin-6-ol	136607554	4.1428	391.237210548	6	2	3	74.17	3	0.698875545614141	3.02690936596567	29	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	6.00E-09	6.00E-09
1537	Pyridazine 17	Target_lig_842	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	1.10E-08	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)N(C)C2=NN=C(C=C2)C3=C(C=C(C=C3)N4C=CC(=N4)N)O)C	5-(3-aminopyrazol-1-yl)-2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol	136377142	3.3625	421.259008612	8	3	4	105.12	3	0.593087401121579	3.13703143168826	31	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	1.10E-08	1.10E-08
1538	Pyridazine 18	Target_lig_843	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	2.30E-08	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)N(C)C2=NN=C(C=C2)C3=C(C=C(C=C3)N4C=C(C=N4)CO)O)C	5-[4-(hydroxymethyl)pyrazol-1-yl]-2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol	136598247	3.2726	436.258674264	8	3	5	99.33	3	0.564429985530367	3.13159112873993	32	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	2.30E-08	2.30E-08
1539	Pyridazine 19	Target_lig_844	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	4.00E-09	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)N(C)C2=NN=C(C=C2)C3=C(C=C(C=C3)C4=CNN=C4)O)C	2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol	136598218	3.9847	406.24810958	6	3	4	89.96	3	0.607090897648329	3.11169546130962	30	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	4.00E-09	4.00E-09
1540	Pyridazine 20	Target_lig_845	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	1.60E-07	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	C1CC2(CCN(C2)C3=NN=C(C=C3)C4=C(C=C(C=C4)C5=CNN=C5)O)CNC1	2-[6-(2,9-diazaspiro[4.5]decan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol	136598257	2.8192	376.201159388	6	3	3	89.96	3	0.651264910134846	3.84804871893882	28	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	1.60E-07	1.60E-07
1541	Pyridazine 21	Target_lig_846	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	5.80E-08	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	C1C2CN(CC2CN1)C3=NN=C(C=C3)C4=C(C=C(C=C4)C5=CNN=C5)O	2-[6-(2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol	137155129	1.8949	348.16985926	6	3	3	89.96	3	0.669730534293136	3.57322834964493	26	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	5.80E-08	5.80E-08
1542	Pyridazine 22	Target_lig_847	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	6.00E-08	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)CC2=NN=C(C=C2)C3=C(C=C(C=C3)C4=CNN=C4)O)C	5-(1H-pyrazol-4-yl)-2-[6-[(2,2,6,6-tetramethylpiperidin-4-yl)methyl]pyridazin-3-yl]phenol	136598251	4.3386	391.237210548	5	3	4	86.72	3	0.615845555092242	3.14292721045181	29	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	6.00E-08	6.00E-08
1543	Branaplam	Target_lig_848	SMN2 pre-mRNA	Homo sapiens	Spinal muscular atrophy (SMA)	Target_276	0	0	0	0	2.00E-08	0	0	-	-	10.1021/acs.jmedchem.8b01291	30407821	Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA).	Cheung AK, Hurley B, Kerrigan R, Shu L, Chin DN, Shen Y, O'Brien G, Sung MJ, Hou Y, Axford J, Cody E, Sun R, Fazal A, Fridrich C, Sanchez CC, Tomlinson RC, Jain M, Deng L, Hoffmaster K, Song C, Van Hoosear M, Shin Y, Servais R, Towler C, Hild M, Curtis D, Dietrich WF, Hamann LG, Briner K, Chen KS, Kobayashi D, Sivasankaran R, Dales NA	J Med Chem	61	11021-11036	2018	-	-	-	-	-	ELISA	Additional	CC1(CC(CC(N1)(C)C)OC2=NN=C(C=C2)C3=C(C=C(C=C3)C4=CNN=C4)O)C	5-(1H-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol	135565042	3.9273	393.216475104	6	3	4	95.95	3	0.621569708571728	3.06473696654937	29	AUACUUACCUG-GGAGUAAGUCU	5OR0	mRNA	pre-mRNA	23	Splice site	Bulge	0	0	0	0	0	0	0	0	2.00E-08	2.00E-08
1544	Compound_1	Target_lig_849	AAUU repeat	Synthetic	-	Target_277	0	0	0	0	1.7000000000000001e-07±1e-08	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC=C(C=C1)C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N	4-(5-phenylfuran-2-yl)benzenecarboximidamide	408998	3.89767	262.110613068	2	2	3	63.01	3	0.55514634979552	1.82581128610762	20	AAUUAAUUAAUUGAAAAAUUAAUUAAUU	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	28	-	-	0	0	0	0	0	0	0	0	1.60E-07	1.80E-07
1545	Compound_2	Target_lig_850	AAUU repeat	Synthetic	-	Target_277	0	0	0	0	1.7000000000000001e-07±4e-08	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	1 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	AAUUAAUUAAUUGAAAAAUUAAUUAAUU	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	28	-	-	0	0	0	0	0	0	0	0	1.30E-07	2.10E-07
1546	AU-azide	Target_lig_851	AAUU repeat	Synthetic	-	Target_277	0	0	0	0	4.5e-08±6e-09	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	1 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N	-	-	3.75311	388.18803474409	5	5	8	149.2	3	0.131410472242826	2.99244527369917	29	AAUUAAUUAAUUGAAAAAUUAAUUAAUU	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	28	-	-	0	0	0	0	0	0	0	0	3.90E-08	5.10E-08
1547	Compound_1	Target_lig_849	AUAU repeat	Synthetic	-	Target_278	0	0	0	0	4.5e-08±1e-09	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC=C(C=C1)C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N	4-(5-phenylfuran-2-yl)benzenecarboximidamide	408998	3.89767	262.110613068	2	2	3	63.01	3	0.55514634979552	1.82581128610762	20	AUAUAUAUAUAUGAAAAUAUAUAUAUAU	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	28	-	-	0	0	0	0	0	0	0	0	4.40E-08	4.60E-08
1548	Compound_2	Target_lig_850	AUAU repeat	Synthetic	-	Target_278	0	0	0	0	1.8999999999999998e-07±2e-08	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	1 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	AUAUAUAUAUAUGAAAAUAUAUAUAUAU	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	28	-	-	0	0	0	0	0	0	0	0	1.70E-07	2.10E-07
1549	AU-azide	Target_lig_851	AUAU repeat	Synthetic	-	Target_278	0	0	0	0	3.1e-08±4e-09	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	1 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N	-	-	3.75311	388.18803474409	5	5	8	149.2	3	0.131410472242826	2.99244527369917	29	AUAUAUAUAUAUGAAAAUAUAUAUAUAU	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	28	-	-	0	0	0	0	0	0	0	0	2.70E-08	3.50E-08
1550	Compound_1	Target_lig_849	GGCC repeat	Synthetic	-	Target_279	0	0	0	0	3.8999999999999997e-07±2e-08	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC=C(C=C1)C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N	4-(5-phenylfuran-2-yl)benzenecarboximidamide	408998	3.89767	262.110613068	2	2	3	63.01	3	0.55514634979552	1.82581128610762	20	GGCCGGCCGAAAGGCCGGCC	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	20	-	-	0	0	0	0	0	0	0	0	3.70E-07	4.10E-07
1551	Compound_2	Target_lig_850	GGCC repeat	Synthetic	-	Target_279	0	0	0	0	8.550000000000001e-06±2.5e-07	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	1 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	GGCCGGCCGAAAGGCCGGCC	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	20	-	-	0	0	0	0	0	0	0	0	8.30E-06	8.80E-06
1552	AU-azide	Target_lig_851	GGCC repeat	Synthetic	-	Target_279	0	0	0	0	>6e-06	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	1 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N	-	-	3.75311	388.18803474409	5	5	8	149.2	3	0.131410472242826	2.99244527369917	29	GGCCGGCCGAAAGGCCGGCC	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	20	-	-	0	0	0	0	0	0	0	0	6.00E-06	6.00E-06
1553	Compound_1	Target_lig_849	GCGC repeat	Synthetic	-	Target_280	0	0	0	0	2.4e-07±1e-08	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC=C(C=C1)C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N	4-(5-phenylfuran-2-yl)benzenecarboximidamide	408998	3.89767	262.110613068	2	2	3	63.01	3	0.55514634979552	1.82581128610762	20	GCGCGCGCGAAAGCGCGCGC	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	20	-	-	0	0	0	0	0	0	0	0	2.30E-07	2.50E-07
1554	Compound_2	Target_lig_850	GCGC repeat	Synthetic	-	Target_280	0	0	0	0	6.9499999999999995e-06±2.5e-07	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	1 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	GCGCGCGCGAAAGCGCGCGC	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	20	-	-	0	0	0	0	0	0	0	0	6.70E-06	7.20E-06
1555	AU-azide	Target_lig_851	GCGC repeat	Synthetic	-	Target_280	0	0	0	0	>2e-06	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	1 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N	-	-	3.75311	388.18803474409	5	5	8	149.2	3	0.131410472242826	2.99244527369917	29	GCGCGCGCGAAAGCGCGCGC	https://www.nature.com/articles/ncomms11647.pdf	RNA aptamer	-	20	-	-	0	0	0	0	0	0	0	0	2.00E-06	2.00E-06
1556	Compound_2	Target_lig_850	r(AUUCU)11	Synthetic	Spinocerebellar ataxia 10 (SCA10)	Target_166	0	0	3e-07±4.7e-08	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	AUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCU	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	55	Intron	Internal Loop	0	0	0	0	2.53E-07	3.47E-07	0	0	0	0
1557	AU-azide	Target_lig_851	r(AUUCU)11	Synthetic	Spinocerebellar ataxia 10 (SCA10)	Target_166	0	0	3.75e-07±3.4e-08	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N	-	-	3.75311	388.18803474409	5	5	8	149.2	3	0.131410472242826	2.99244527369917	29	AUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCU	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	55	Intron	Internal Loop	0	0	0	0	3.41E-07	4.09E-07	0	0	0	0
1558	2AU-2	Target_lig_1266	r(AUUCU)11	Synthetic	Spinocerebellar ataxia 10 (SCA10)	Target_166	0	0	1.85e-07±1e-09	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	CCCN(C(=O)CN(C(=O)CNCc1nnn(c1)CCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N)CCC)CC(=O)N(Cc1nnn(c1)CCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N)CC(=O)N			5.38318000000001	1179.599121056	17	10	32	375.25	8	0.014367172537763	4.64800905366131	87	AUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCUAUUCU	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	55	Intron	Internal Loop	0	0	0	0	1.84E-07	1.86E-07	0	0	0	0
1559	Compound_2	Target_lig_850	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	4.00E-06	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
1560	AU-azide	Target_lig_851	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	5.00E-06	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N	-	-	3.75311	388.18803474409	5	5	8	149.2	3	0.131410472242826	2.99244527369917	29	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	5.00E-06	5.00E-06	0	0	0	0
1561	2AU-2	Target_lig_1266	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	4.00E-06	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	CCCN(C(=O)CN(C(=O)CNCc1nnn(c1)CCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N)CCC)CC(=O)N(Cc1nnn(c1)CCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N)CC(=O)N			5.38318000000001	1179.599121056	17	10	32	375.25	8	0.014367172537763	4.64800905366131	87	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
1562	Compound_2	Target_lig_850	r(CGG)12	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	2.00E-06	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
1563	AU-azide	Target_lig_851	r(CGG)12	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	3.00E-06	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N	-	-	3.75311	388.18803474409	5	5	8	149.2	3	0.131410472242826	2.99244527369917	29	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	3.00E-06	3.00E-06	0	0	0	0
1564	2AU-2	Target_lig_1266	r(CGG)12	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	4.00E-06	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	CCCN(C(=O)CN(C(=O)CNCc1nnn(c1)CCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N)CCC)CC(=O)N(Cc1nnn(c1)CCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N)CC(=O)N			5.38318000000001	1179.599121056	17	10	32	375.25	8	0.014367172537763	4.64800905366131	87	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.1021/cb400875u	RNA aptamer, mRNA	Expanded Repeats	36	5'-UTR	Internal Loop	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
1565	Compound_2	Target_lig_850	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	4.00E-06	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
1566	AU-azide	Target_lig_851	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	5.00E-06	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	N=[N+]=NCCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N	-	-	3.75311	388.18803474409	5	5	8	149.2	3	0.131410472242826	2.99244527369917	29	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	5.00E-06	5.00E-06	0	0	0	0
1567	2AU-2	Target_lig_1266	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	4.00E-06	0	0	0	0	-	-	10.1038/ncomms11647	27248057	Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10	Yang W, Gao R, Southern M, Sarkar PS, Disney MD	Nat Commun	7	11647	2016	3 uM	1 uM	7	95	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	CCCN(C(=O)CN(C(=O)CNCc1nnn(c1)CCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N)CCC)CC(=O)N(Cc1nnn(c1)CCCNC(=N)c1ccc(cc1)c1ccc(o1)c1ccc(cc1)C(=N)N)CC(=O)N			5.38318000000001	1179.599121056	17	10	32	375.25	8	0.014367172537763	4.64800905366131	87	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
1568	Bis-3-chloropiperidine_1	Target_lig_852	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	4.749999999999999e-06±1.5e-07	0	0	0	-	-	10.3390/molecules26071874	33810333	Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein	Sosic A, Olivato G, Carraro C, Göttlich R, Fabris D, Gatto B	Molecules	26	1874	2021	10,50,100 uM	1 uM	7.5	37	NaH2PO4 0.2 mM, Na2HPO4 0.6 mM, Na2 EDTA 0.1 mM	Fluorescence quenching assay	Additional	CC1(CC(CN(C1)CCCN2CC(CC(C2)(C)C)Cl)Cl)C	5-chloro-1-[3-(5-chloro-3,3-dimethylpiperidin-1-yl)propyl]-3,3-dimethylpiperidine	118730019	4.0551	334.194254384	2	0	4	6.48	0	0.71519052345146	4.08271353587397	21	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	4.60E-06	4.90E-06	0	0
1569	Bis-3-chloropiperidine_2	Target_lig_853	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	2.75e-06±7e-07	0	0	0	-	-	10.3390/molecules26071874	33810333	Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein	Sosic A, Olivato G, Carraro C, Göttlich R, Fabris D, Gatto B	Molecules	26	1874	2021	10,50,100 uM	1 uM	7.5	37	NaH2PO4 0.2 mM, Na2HPO4 0.6 mM, Na2 EDTA 0.1 mM	Fluorescence quenching assay	Additional	CC1(CC(CN(C1)CCCCCN2CC(CC(C2)(C)C)Cl)Cl)C	5-chloro-1-[5-(5-chloro-3,3-dimethylpiperidin-1-yl)pentyl]-3,3-dimethylpiperidine	118730021	4.83530000000001	362.225554512	2	0	6	6.48	0	0.492363623544842	3.9835450267615	23	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	2.05E-06	3.45E-06	0	0
1570	Bis-3-chloropiperidine_3	Target_lig_854	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	3.5499999999999995e-06±3.7e-07	0	0	0	-	-	10.3390/molecules26071874	33810333	Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein	Sosic A, Olivato G, Carraro C, Göttlich R, Fabris D, Gatto B	Molecules	26	1874	2021	10,50,100 uM	1 uM	7.5	37	NaH2PO4 0.2 mM, Na2HPO4 0.6 mM, Na2 EDTA 0.1 mM	Fluorescence quenching assay	Additional	CC1(CC(CN(C1)CCCCCCN2CC(CC(C2)(C)C)Cl)Cl)C	5-chloro-1-[6-(5-chloro-3,3-dimethylpiperidin-1-yl)hexyl]-3,3-dimethylpiperidine	118730022	5.22540000000001	376.241204576	2	0	7	6.48	0	0.443015831978383	3.9451167790564	24	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	3.18E-06	3.92E-06	0	0
1571	Bis-3-chloropiperidine_4	Target_lig_855	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	5.0899999999999995e-06±5e-08	0	0	0	-	-	10.3390/molecules26071874	33810333	Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein	Sosic A, Olivato G, Carraro C, Göttlich R, Fabris D, Gatto B	Molecules	26	1874	2021	10,50,100 uM	1 uM	7.5	37	NaH2PO4 0.2 mM, Na2HPO4 0.6 mM, Na2 EDTA 0.1 mM	Fluorescence quenching assay	Additional	CC1(CC(CN(C1)CCCC[C@@H](C(=O)OC)N2CC(CC(C2)(C)C)Cl)Cl)C	methyl (2S)-2,6-bis(5-chloro-3,3-dimethylpiperidin-1-yl)hexanoate	118730023	4.3769	420.231033816	4	0	7	32.78	0	0.347124054680433	4.35375992243332	27	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	5.04E-06	5.14E-06	0	0
1572	Bis-3-chloropiperidine_5	Target_lig_856	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	4.78e-06±7.1e-07	0	0	0	-	-	10.3390/molecules26071874	33810333	Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein	Sosic A, Olivato G, Carraro C, Göttlich R, Fabris D, Gatto B	Molecules	26	1874	2021	10,50,100 uM	1 uM	7.5	37	NaH2PO4 0.2 mM, Na2HPO4 0.6 mM, Na2 EDTA 0.1 mM	Fluorescence quenching assay	Additional	COC(=O)[C@H](N1CC(Cl)CC(C1)(C)C)CCCCN1CC(Cl)CC(C1)(C)C	-	-	4.3769	420.231033816	4	0	7	32.78	0	0.347124054680433	4.35375992243332	27	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	4.07E-06	5.49E-06	0	0
1573	DM1_compound1	Target_lig_1267	r(CUG)16	Synthetic	Myotonic dystrophy 1 (DM1)	Target_281	0	0	3.8999999999999997e-07±8e-08	0	0	0	0	-	-	10.1002/cmdc.202100243	34114350	A Novel Minor Groove Binder as a Potential Therapeutic Agent for Myotonic Dystrophy Type 1.	Li K, Krueger SB, Zimmerman SC	ChemMedChem	16	2638-2644	2021	1.5 mM	150 uM	7.4	25	1XPBS	Isothermal Titration Calorimetry (ITC)	Additional	COc1ccc2c(c1)c(NCCCCNc1nc(N)nc(n1)N)c1c(n2)cc(cc1)Cl	2-N-[4-[(6-chloro-2-methoxyacridin-9-yl)amino]butyl]-1,3,5-triazine-2,4,6-triamine	71511622	3.7036	438.168335036	9	4	8	136.89	4	0.239366850651394	2.51589799919445	31	GGGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCCC	https://pubmed.ncbi.nlm.nih.gov/34114350/	mRNA	Expanded Repeats	54	-	Internal Loop	0	0	0	0	3.10E-07	4.70E-07	0	0	0	0
1574	DM1_compound3	Target_lig_1268	r(CUG)16	Synthetic	Myotonic dystrophy 1 (DM1)	Target_281	0	0	8e-06±2e-06	0	0	0	0	-	-	10.1002/cmdc.202100243	34114350	A Novel Minor Groove Binder as a Potential Therapeutic Agent for Myotonic Dystrophy Type 1.	Li K, Krueger SB, Zimmerman SC	ChemMedChem	16	2638-2644	2021	1.5 mM	150 uM	7.4	25	1XPBS	Isothermal Titration Calorimetry (ITC)	Additional	[NH2+]=C(c1ccc(cc1)C(=[NH2+])NCCCCNc1nc(N)nc(n1)N)NCCCCNc1nc(N)nc(n1)N			-3.6394	524.32978799218	12	10	14	280.72	3	0.055287419955898	3.46262681465555	38	GGGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCCC	https://pubmed.ncbi.nlm.nih.gov/34114350/	mRNA	Expanded Repeats	54	-	Internal Loop	0	0	0	0	6.00E-06	1.00E-05	0	0	0	0
1575	DM1_compound5	Target_lig_857	r(CUG)16	Synthetic	Myotonic dystrophy 1 (DM1)	Target_281	0	0	5.4999999999999995e-05±1e-06	0	0	0	0	-	-	10.1002/cmdc.202100243	34114350	A Novel Minor Groove Binder as a Potential Therapeutic Agent for Myotonic Dystrophy Type 1.	Li K, Krueger SB, Zimmerman SC	ChemMedChem	16	2638-2644	2021	1.5 mM	150 uM	7.4	25	1XPBS	Isothermal Titration Calorimetry (ITC)	Additional	CN(CCCNc1nc(NCCCCCCNC(=O)CC2=CCC(=N2)NC(=O)CC2=CCC(=N2)NC(=O)CCCCCCNc2nc(N)nc(n2)N)nc(n1)N)C	-	-	1.7027	790.493927716	18	9	25	306.75	2	0.064663387271789	4.05884083291666	57	GGGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCCC	https://pubmed.ncbi.nlm.nih.gov/34114350/	mRNA	Expanded Repeats	54	-	Internal Loop	0	0	0	0	5.40E-05	5.60E-05	0	0	0	0
1576	Neomycin	Target_lig_4	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	4e-06±3e-06	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	1.00E-06	7.00E-06	0	0	0	0
1577	Sisomycin	Target_lig_1269	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	4e-06±2e-06	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	2.00E-06	6.00E-06	0	0	0	0
1578	Tobramycin	Target_lig_540	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	8e-06±4e-06	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	4.00E-06	1.20E-05	0	0	0	0
1579	Amikacin	Target_lig_175	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	1.4999999999999999e-05±4e-06	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	1.10E-05	1.90E-05	0	0	0	0
1580	Gentamycin	Target_lig_1270	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	1.6e-05±1e-06	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC	2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	3467	-3.32749999999999	477.316248716	12	8	7	199.73	0	0.18159830996278	5.32260812677801	33	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	1.50E-05	1.70E-05	0	0	0	0
1581	Apramycin	Target_lig_772	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	2.2e-05±1.2e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CNC1C(OC2OC(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)C(C(C2O)O)N)OC2C(C1O)OC(C(C2)N)OC1C(N)CC(C(C1O)O)N	-	-	-3.9967	877.3752372	22	12	13	365.21	3	0.077839371712425	5.91075160447164	61	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	1.00E-05	3.40E-05	0	0	0	0
1582	Netilmicin	Target_lig_1271	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	2.8e-05±3.5e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N	2-[4-amino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	4460	-3.20069999999999	475.300598652	12	8	8	199.73	0	0.175035370530913	5.30603969377175	33	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	7.00E-06	6.30E-05	0	0	0	0
1583	Kanamycin-A	Target_lig_1272	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	4.4e-05±1.8e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	2.60E-05	6.20E-05	0	0	0	0
1584	Ribostamycin	Target_lig_1273	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	8.999999999999999e-05±7.3e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	5066	-6.6523	454.227493288	14	10	6	262.38	0	0.178778081939411	4.96778075738293	31	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	1.70E-05	0.000163	0	0	0	0
1585	Geneticin	Target_lig_140	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	0.000101±4.4e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O	2-[4,6-diamino-3-[3-amino-4,5-dihydroxy-6-(1-hydroxyethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	354578	-5.613	496.27444348	14	10	6	248.39	0	0.164623849535594	5.36827337610045	34	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	5.70E-05	0.000145	0	0	0	0
1586	Streptomycin	Target_lig_63	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	0.000134±7.599999999999999e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	5.80E-05	0.00021	0	0	0	0
1587	Hygromycin	Target_lig_3	Oligonucleotide 3	Synthetic	Cancer	Target_282	0	0	0.000261±9.099999999999999e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N	4-[3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6'-(1-amino-2-hydroxyethyl)-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol	3659	-7.2706	527.232638244	16	11	6	272.06	0	0.152994487643804	6.04885226343299	36	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	0.00017	0.000352	0	0	0	0
1588	Neomycin	Target_lig_4	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	3e-06±2e-06	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	1.00E-06	5.00E-06	0	0	0	0
1589	Sisomycin	Target_lig_1269	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	4e-06±2e-06	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	2.00E-06	6.00E-06	0	0	0	0
1590	Tobramycin	Target_lig_540	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	8e-06±4.9999999999999996e-06	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	3.00E-06	1.30E-05	0	0	0	0
1591	Amikacin	Target_lig_175	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	1.4e-05±3e-06	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	1.10E-05	1.70E-05	0	0	0	0
1592	Gentamycin	Target_lig_1270	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	1.3e-05±3e-06	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC	2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	3467	-3.32749999999999	477.316248716	12	8	7	199.73	0	0.18159830996278	5.32260812677801	33	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	1.00E-05	1.60E-05	0	0	0	0
1593	Apramycin	Target_lig_772	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	2.3e-05±1.2e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CNC1C(OC2OC(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)C(C(C2O)O)N)OC2C(C1O)OC(C(C2)N)OC1C(N)CC(C(C1O)O)N	-	-	-3.9967	877.3752372	22	12	13	365.21	3	0.077839371712425	5.91075160447164	61	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	1.10E-05	3.50E-05	0	0	0	0
1594	Netilmicin	Target_lig_1271	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	2.7e-05±3.4e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N	2-[4-amino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	4460	-3.20069999999999	475.300598652	12	8	8	199.73	0	0.175035370530913	5.30603969377175	33	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	7.00E-06	6.10E-05	0	0	0	0
1595	Kanamycin-A	Target_lig_1272	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	4.4999999999999996e-05±2.3e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	2.20E-05	6.80E-05	0	0	0	0
1596	Ribostamycin	Target_lig_1273	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	7.8e-05±6.7e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	5066	-6.6523	454.227493288	14	10	6	262.38	0	0.178778081939411	4.96778075738293	31	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	1.10E-05	0.000145	0	0	0	0
1597	Geneticin	Target_lig_140	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	9.4e-05±5.6999999999999996e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O	2-[4,6-diamino-3-[3-amino-4,5-dihydroxy-6-(1-hydroxyethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	354578	-5.613	496.27444348	14	10	6	248.39	0	0.164623849535594	5.36827337610045	34	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	3.70E-05	0.000151	0	0	0	0
1598	Streptomycin	Target_lig_63	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	0.00011499999999999999±7.999999999999999e-05	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	3.50E-05	0.000195	0	0	0	0
1599	Hygromycin	Target_lig_3	Oligonucleotide 4	Synthetic	Cancer	Target_283	0	0	0.00029099999999999997±0.00010999999999999999	0	0	0	0	-	-	10.1038/s41598-021-88922-0	33931703	Interbase-FRET binding assay for pre-microRNAs.	Bood M, Del Nogal AW, Nilsson JR, Edfeldt F, Dahlén A, Lemurell M, Wilhelmsson LM, Grøtli M	Sci Rep	11	9396	2021	915 uM	1 uM	7.2	-	20 mM sodium cacodylate, 80 mM NaCl, 100 mM	FRET assay	Additional	CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N	4-[3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6'-(1-amino-2-hydroxyethyl)-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol	3659	-7.2706	527.232638244	16	11	6	272.06	0	0.152994487643804	6.04885226343299	36	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	https://www.nature.com/articles/s41598-021-88922-0	miRNA	pre-miRNA	43	-	Stem-Loop	0	0	0	0	0.000181	0.000401	0	0	0	0
1600	SMN-C2	Target_lig_722	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	5.40E-06	0	2.6e-07±1.3e-07	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	1 mM	1 uM	-	-	40 mM HEPES, 200 mM NaCl	Surface Plasmon Resonance (SPR)	Additional	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	5.40E-06	5.40E-06	0	0	1.30E-07	3.90E-07
1601	SMN-C5	Target_lig_858	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	8.00E-06	0	5.899999999999999e-08±9e-09	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	1 mM	1 uM	-	-	40 mM HEPES, 200 mM NaCl	Surface Plasmon Resonance (SPR)	Additional	CC1=CN2C=C(C=C(C2=N1)F)C3=CC(=O)N4C=C(C=CC4=N3)N5CCN(CC5)C	2-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-7-(4-methylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one	89740936	2.20852	392.176087512	7	0	2	58.15	4	0.523577300534403	2.83249550539518	29	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	8.00E-06	8.00E-06	0	0	5.00E-08	6.80E-08
1602	SMN2_compound_1	Target_lig_859	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	1.85e-05±5.4e-06	0	1.4e-08±3e-09	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	C[C@H]1CN(CCN1)C2=CC3=C(C=C2)C=C(C(=O)O3)C4=CN5C=C(N=C(C5=N4)C)C	3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3S)-3-methylpiperazin-1-yl]chromen-2-one	89655253	2.91764	389.185174976	7	1	2	75.67	4	0.531488068059142	3.37479079132844	29	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	1.31E-05	2.39E-05	0	0	1.10E-08	1.70E-08
1603	SMN2_compound_2	Target_lig_860	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	5.1e-05±4.9000000000000005e-06	0	>8e-06	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	O=C(OC(C)(C)C)NCCN1CCN(C[C@@H]1C)c1ccc2c(c1)oc(=O)c(c2)c1cn2c(n1)c(C)nc(c2)C	-	-	4.15474	532.279803632	9	1	5	105.21	4	0.382325244476039	3.49861422166008	39	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	4.61E-05	5.59E-05	0	0	8.00E-06	8.00E-06
1604	SMN2_compound_3	Target_lig_861	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	>9.999999999999999e-05	0	>8e-06	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	CN1CCN(CC1)c1ccc2c(c1)oc(=O)c(c2)c1ccccc1Cl	-	-	3.8652	354.113505528	4	0	2	36.69	3	0.654628453633876	2.1471723900228	25	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	0.0001	0.0001	0	0	8.00E-06	8.00E-06
1605	SMN2_compound_4	Target_lig_862	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	3.59e-05±1.48e-05	0	>8e-06	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	CN1CCN(CC1)c1ccc2c(c1)oc(=O)c(c2)c1cccc(c1)Cl	-	-	3.8652	354.113505528	4	0	2	36.69	3	0.654628453633876	2.14941277463818	25	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	2.11E-05	5.07E-05	0	0	8.00E-06	8.00E-06
1606	SMN2_compound_5	Target_lig_863	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	3.06e-05±1.23e-05	0	>8e-06	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	CN1CCN(CC1)c1ccc2c(c1)oc(=O)c(c2)c1ccc(cc1)Cl	-	-	3.8652	354.113505528	4	0	2	36.69	3	0.654628453633876	2.09715892848433	25	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	1.83E-05	4.29E-05	0	0	8.00E-06	8.00E-06
1607	SMN2_compound_6	Target_lig_864	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	3.28e-05±5.6e-06	0	>8e-06	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	CN1CCN(CC1)c1cc(F)c2c(c1)oc(=O)c(c2)c1cccc(c1)Cl	-	-	4.0043	372.104083716	4	0	2	36.69	3	0.636935446917367	2.32474612148029	26	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	2.72E-05	3.84E-05	0	0	8.00E-06	8.00E-06
1608	SMN2_compound_7	Target_lig_865	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	3.09e-05±6.7e-06	0	>8e-06	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	CN1CCN(CC1)c1cc(F)c2c(c1)oc(=O)c(c2)c1ccc(cc1)Cl	-	-	4.0043	372.104083716	4	0	2	36.69	3	0.636935446917367	2.27390454143871	26	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	2.42E-05	3.76E-05	0	0	8.00E-06	8.00E-06
1609	SMN2_compound_8	Target_lig_866	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	>9.999999999999999e-05	0	>8e-06	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	CN1CCN(CC1)c1ccc2c(c1)oc(=O)c(c2C)c1cccc(c1)Cl	-	-	4.17362	368.129155592	4	0	2	36.69	3	0.635907692530771	2.23706815890233	26	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	0.0001	0.0001	0	0	8.00E-06	8.00E-06
1610	SMN2_compound_9	Target_lig_867	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	>9.999999999999999e-05	0	>8e-06	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	CN1CCN(CC1)c1ccc2c(c1)oc(=O)c(c2C)c1ccc(cc1)Cl	-	-	4.17362	368.129155592	4	0	2	36.69	3	0.635907692530771	2.18567460380877	26	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	0.0001	0.0001	0	0	8.00E-06	8.00E-06
1611	SMN2_compound_10	Target_lig_868	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	1.45e-05±2.2999999999999996e-06	0	>8e-06	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	C1CN(CCN1)C2=CC3=C(C=C2)C=C(C(=O)O3)C4=CN5C=CC=CC5=N4	3-imidazo[1,2-a]pyridin-2-yl-7-piperazin-1-ylchromen-2-one	71622408	2.5173	346.142975816	6	1	2	62.78	4	0.565239454552656	2.55506245649663	26	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	1.22E-05	1.68E-05	0	0	8.00E-06	8.00E-06
1612	SMN2_compound_11	Target_lig_869	SMN2 pre-mRNA GA-rich sequence	Homo sapiens	Spinal muscular atrophy (SMA)	Target_284	0	0	1.14e-05±7e-07	0	>8e-06	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	COc1ncc2n(c1)cc(n2)c1cc2ccc(cc2oc1=O)N1CCNCC1	-	-	1.9209	377.148789468	8	1	3	84.9	4	0.546117487063674	2.85584525573208	28	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	https://doi.org/10.1093/nar/gkab602	mRNA	pre-mRNA	46	Splice site	Bulge	0	0	0	0	1.07E-05	1.21E-05	0	0	8.00E-06	8.00E-06
1613	SMN-C2	Target_lig_722	Seq20	Synthetic	Spinal muscular atrophy (SMA)	Target_285	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	UGAAGGAAGGUUUCGACCUUCCUUCA	https://doi.org/10.1093/nar/gkab602	RNA aptamer	pre-mRNA	26	Splice site	Stem-Loop	0	0	0	0	0.0001	0.0001	0	0	0	0
1614	SMN-C2	Target_lig_722	Seq21	Synthetic	Spinal muscular atrophy (SMA)	Target_286	0	0	4.599999999999999e-06±6e-07	0	0	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	GCGCCGACUGAAGGAAGGAGUCGGCGC	https://doi.org/10.1093/nar/gkab602	RNA aptamer	pre-mRNA	27	Splice site	Bulge	0	0	0	0	4.00E-06	5.20E-06	0	0	0	0
1615	SMN-C2	Target_lig_722	Seq22	Synthetic	Spinal muscular atrophy (SMA)	Target_287	0	0	1.1e-05±8e-07	0	0	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	GTGCCAGTTCGCTGGCACTGAAGGAAGGT	https://doi.org/10.1093/nar/gkab602	RNA aptamer	pre-mRNA	29	Splice site	Bulge	0	0	0	0	1.02E-05	1.18E-05	0	0	0	0
1616	SMN-C2	Target_lig_722	Seq23	Synthetic	Spinal muscular atrophy (SMA)	Target_288	0	0	5.6e-06±1.6999999999999998e-06	0	0	0	0	-	-	10.1093/nar/gkab602	34283224	Recognition of single-stranded nucleic acids by small-molecule splicing modulators.	Tang Z, Akhter S, Ramprasad A, Wang X, Reibarkh M, Wang J, Aryal S, Thota SS, Zhao J, Douglas JT, Gao P, Holmstrom ED, Miao Y, Wang J	Nucleic Acids Res	49	7870-7883	2021	750 uM	1-128 uM	-	25	40 mM HEPES, 200 mM NaCl	Fluorescence polarization binding assay	Additional	CC[NH+]1CCN(C[C@@H]1C)C1=CC=C2C=C(C3=CN4C=C(C)N=C(C)C4=N3)C(=O)OC2=C1	-	-	2.23284	418.22375155609	6	1	3	68.08	4	0.517036985748497	4.36998453181564	31	GCCAGGCGCACUUUCGAGUGCGCGAAGGAAGGCUGGC	https://doi.org/10.1093/nar/gkab602	RNA aptamer	pre-mRNA	37	Splice site	Bulge	0	0	0	0	3.90E-06	7.30E-06	0	0	0	0
1617	CCUG_compound_1	Target_lig_870	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.03	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CCNC1=NC(=NC2=CC=CC=C21)NC3=CC=C(C=C3)NC(=O)C	N-[4-[[4-(ethylamino)quinazolin-2-yl]amino]phenyl]acetamide	52108663	3.7636	321.158960228	5	3	5	78.94	3	0.66657367417778	1.94517862338801	24	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.03	0.03	0	0
1618	CCUG_compound_2	Target_lig_871	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.035	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(=O)NC1=CC=C(C=C1)NC2=NC3=CC=CC=C3C(=N2)N4CCCC4	N-[4-[(4-pyrrolidin-1-ylquinazolin-2-yl)amino]phenyl]acetamide	50946172	3.932	347.174610292	5	2	4	70.15	3	0.748154146390701	1.9829385987754	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.035	0.035	0	0
1619	CCUG_compound_3	Target_lig_872	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.04	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	COC1=CC=C(C=C1)NC2=NC3=CC=CC=C3C(=N2)NCCCO	3-[[2-(4-methoxyanilino)quinazolin-4-yl]amino]propan-1-ol	52110137	3.1763	324.15862588	6	3	7	79.3	3	0.579369887406673	1.96856884794606	24	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.04	0.04	0	0
1620	CCUG_compound_4	Target_lig_873	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.04	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN(C)C1=CC=C(C=C1)NC2=NC3=CC=CC=C3C(=N2)NCCCO	3-[[2-[4-(dimethylamino)anilino]quinazolin-4-yl]amino]propan-1-ol	50947418	3.2337	337.190260356	6	3	7	73.31	3	0.574951771694972	2.11843008233049	25	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.04	0.04	0	0
1621	CCUG_compound_5	Target_lig_874	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.045	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(=O)NC1=CC=C(C=C1)NC2=NC3=CC=CC=C3C(=N2)NCC4CCCO4	N-[4-[[4-(oxolan-2-ylmethylamino)quinazolin-2-yl]amino]phenyl]acetamide	50947964	3.9227	377.185174976	6	3	6	88.17	3	0.603354228231811	2.59231342984093	28	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.045	0.045	0	0
1622	CCUG_compound_6	Target_lig_875	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.05	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN(C)C1=NC(=NC2=CC=CC=C21)NC3=CC=C(C=C3)C(=O)N	4-[[4-(dimethylamino)quinazolin-2-yl]amino]benzamide	50944573	2.5383	307.143310164	5	2	4	84.14	3	0.77353577780827	2.00509764279632	23	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.05	0.05	0	0
1623	CCUG_compound_7	Target_lig_876	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.05	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	C1COC2=C(O1)C=CC(=C2)NC3=NC4=CC=CC=C4C(=N3)NCCCO	3-[[2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)quinazolin-4-yl]amino]propan-1-ol	50946481	2.9389	352.1535405	7	3	6	88.53	3	0.587854266393217	2.23685806089223	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.05	0.05	0	0
1624	CCUG_compound_8	Target_lig_877	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.05	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	COC1=C(C=C(C=C1)NC2=NC3=CC=CC=C3C(=N2)NCCO)Cl	2-[[2-(3-chloro-4-methoxyanilino)quinazolin-4-yl]amino]ethanol	52110057	3.4396	344.104003464	6	3	6	79.3	3	0.635405067153137	2.06282477723417	24	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.05	0.05	0	0
1625	CCUG_compound_9	Target_lig_878	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.06	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(=O)NC1=CC=C(C=C1)NC2=NC3=CC=CC=C3C(=N2)NCCO	N-[4-[[4-(2-hydroxyethylamino)quinazolin-2-yl]amino]phenyl]acetamide	52110050	2.736	337.153874848	6	4	6	99.17	3	0.551906572067797	2.0195146977151	25	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.06	0.06	0	0
1626	CCUG_compound_10	Target_lig_879	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.06	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN(C)C1=CC=C(C=C1)NC2=NC3=CC=CC=C3C(=N2)N(C)C	2-N-[4-(dimethylamino)phenyl]-4-N,4-N-dimethylquinazoline-2,4-diamine	50947450	3.5054	307.179695672	5	1	4	44.29	3	0.798910405999698	2.06226521676082	23	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.06	0.06	0	0
1627	CCUG_compound_11	Target_lig_880	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.065	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN(C)C1=NC(=NC2=CC=CC=C21)NC3=CC=C(C=C3)OC	2-N-(4-methoxyphenyl)-4-N,4-N-dimethylquinazoline-2,4-diamine	52108425	3.448	294.148061196	5	1	4	50.28	3	0.798423144217991	1.89968819235159	22	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.065	0.065	0	0
1628	CCUG_compound_12	Target_lig_881	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.07	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	COC1=C(C=CC(=C1)C2=NC3=C(N2)C=C(C=C3)N4C=NN=N4)OCCN5CCCC5	2-[3-methoxy-4-(2-pyrrolidin-1-ylethoxy)phenyl]-6-(tetrazol-1-yl)-1H-benzimidazole	46987061	2.6888	405.191322976	8	1	7	93.98	4	0.505120569407458	2.44273418831295	30	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.07	0.07	0	0
1629	CCUG_compound_13	Target_lig_882	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.07	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN(C)C1=NC(=NC2=CC=CC=C21)NC3=CC=C(C=C3)O	4-[[4-(dimethylamino)quinazolin-2-yl]amino]phenol	50947420	3.145	280.132411132	5	2	3	61.28	3	0.721656597500424	1.99793746658602	21	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.07	0.07	0	0
1630	CCUG_compound_14	Target_lig_883	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.07	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CCN1C2=CC=CC=C2C(=N1)CNC(=O)CN(C)C3CCNCC3	N-[(1-ethylindazol-3-yl)methyl]-2-[methyl(piperidin-4-yl)amino]acetamide	118763646	1.3562	329.221560484	5	2	6	62.19	2	0.839892131117019	2.47238999462547	24	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.07	0.07	0	0
1631	CCUG_compound_15	Target_lig_884	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.07	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(=O)NC1=CC=CC(=C1)NC2=NC3=CC=CC=C3C(=N2)N4CCCC4	N-[3-[(4-pyrrolidin-1-ylquinazolin-2-yl)amino]phenyl]acetamide	50946878	3.932	347.174610292	5	2	4	70.15	3	0.748154146390701	2.03151673642722	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.07	0.07	0	0
1632	CCUG_compound_16	Target_lig_885	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.07	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(C1=CC(=CC=C1)NC2=NC3=CC=CC=C3C(=N2)N4CCCC4)O	1-[3-[(4-pyrrolidin-1-ylquinazolin-2-yl)amino]phenyl]ethanol	50946841	4.0269	334.179361324	5	2	4	61.28	3	0.754237585456836	2.54638001837103	25	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.07	0.07	0	0
1633	CCUG_compound_17	Target_lig_886	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.075	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN(C)C1=NC(=NC2=CC=CC=C21)NC3=CC(=CC=C3)O	3-[[4-(dimethylamino)quinazolin-2-yl]amino]phenol	50947035	3.145	280.132411132	5	2	3	61.28	3	0.771445406028334	2.06749592812448	21	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.075	0.075	0	0
1634	CCUG_compound_18	Target_lig_887	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.075	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(=O)C1=CC(=CC=C1)NC2=NC3=CC=CC=C3C(=N2)NCCCO	1-[3-[[4-(3-hydroxypropylamino)quinazolin-2-yl]amino]phenyl]ethanone	52110143	3.3703	336.15862588	6	3	7	87.14	3	0.452850443958489	2.08816854386895	25	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.075	0.075	0	0
1635	CCUG_compound_19	Target_lig_888	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.08	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(=O)NC1=CC=CC(=C1)NC2=NC3=CC=CC=C3C(=N2)N(C)C	N-[3-[[4-(dimethylamino)quinazolin-2-yl]amino]phenyl]acetamide	50946353	3.3978	321.158960228	5	2	4	70.15	3	0.770532394206155	2.03917760037011	24	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.08	0.08	0	0
1636	CCUG_compound_20	Target_lig_889	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.08	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN(C)C1=NC(=NC2=CC=CC=C21)NC3=CC4=C(C=C3)OCCO4	2-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-N,4-N-dimethylquinazoline-2,4-diamine	50946097	3.2106	322.142975816	6	1	3	59.51	3	0.798864914836706	2.18883346333068	24	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.08	0.08	0	0
1637	CCUG_compound_21	Target_lig_890	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.08	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC1=CC=CC=C1NC2=NC3=CC=CC=C3C(=N2)NCCCO	3-[[2-(2-methylanilino)quinazolin-4-yl]amino]propan-1-ol	44537355	3.47612	308.16371126	5	3	6	70.07	3	0.608244332855253	2.00190647791069	23	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.08	0.08	0	0
1638	CCUG_compound_22	Target_lig_891	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.085	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	C=CCNC1=NC(=NC2=CC=CC=C21)NC3=CC=C(C=C3)O	4-[[4-(prop-2-enylamino)quinazolin-2-yl]amino]phenol	52110341	3.6769	292.132411132	5	3	5	70.07	3	0.494146742121222	2.13799354949445	22	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.085	0.085	0	0
1639	CCUG_compound_23	Target_lig_892	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.085	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN(C)C1=NC(=NC2=CC=CC=C21)NC3=CC(=CC=C3)OC	2-N-(3-methoxyphenyl)-4-N,4-N-dimethylquinazoline-2,4-diamine	50945481	3.448	294.148061196	5	1	4	50.28	3	0.798423144217991	1.95675852202192	22	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.085	0.085	0	0
1640	CCUG_compound_24	Target_lig_893	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.09	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(=O)NC1=CC=CC(=C1)NC2=NC3=CC=CC=C3C(=N2)NCC4CCCO4	N-[3-[[4-(oxolan-2-ylmethylamino)quinazolin-2-yl]amino]phenyl]acetamide	50947823	3.9227	377.185174976	6	3	6	88.17	3	0.603354228231811	2.63733706961579	28	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.09	0.09	0	0
1641	CCUG_compound_25	Target_lig_894	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.095	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	C1=CC=C2C(=C1)C(=NC(=N2)NC3=CC=C(C=C3)O)NCCCO	4-[[4-(3-hydroxypropylamino)quinazolin-2-yl]amino]phenol	50945420	2.8733	310.142975816	6	4	6	90.3	3	0.413334579850277	2.05344930225053	23	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.095	0.095	0	0
1642	CCUG_compound_26	Target_lig_895	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.095	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(C1=CC(=CC=C1)NC2=NC3=CC=CC=C3C(=N2)N(C)C)O	1-[3-[[4-(dimethylamino)quinazolin-2-yl]amino]phenyl]ethanol	50947145	3.4927	308.16371126	5	2	4	61.28	3	0.772291756758396	2.57341089123047	23	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.095	0.095	0	0
1643	CCUG_compound_27	Target_lig_896	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.1	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	COC1=CC=CC(=C1)NC2=NC3=CC=CC=C3C(=N2)NCCCO	3-[[2-(3-methoxyanilino)quinazolin-4-yl]amino]propan-1-ol	52110136	3.1763	324.15862588	6	3	7	79.3	3	0.579369887406673	2.01993214464936	24	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.1	0.1	0	0
1644	CCUG_compound_28	Target_lig_897	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.1	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(=O)C1=CC(=CC=C1)NC2=NC3=CC=CC=C3C(=N2)N(C)C	1-[3-[[4-(dimethylamino)quinazolin-2-yl]amino]phenyl]ethanone	50947135	3.642	306.148061196	5	1	4	58.12	3	0.745720655958839	2.02874474338803	23	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.1	0.1	0	0
1645	CCUG_compound_29	Target_lig_898	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.1	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CCNC1=NC(=NC2=CC=CC=C21)NC3=CC=C(C=C3)O	4-[[4-(ethylamino)quinazolin-2-yl]amino]phenol	52108651	3.5108	280.132411132	5	3	4	70.07	3	0.637922615177264	1.95139645775878	21	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.1	0.1	0	0
1646	CCUG_compound_30	Target_lig_899	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.105	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CCOC1=C(C=C(C=C1)C(=O)NC2=C(C=CC(=C2)C3=NC4=CC=CC=C4N3)Cl)[N+](=O)[O-]	N-[5-(1H-benzimidazol-2-yl)-2-chlorophenyl]-4-ethoxy-3-nitrobenzamide	1338419	5.4425	436.093832704	5	2	6	110.15	4	0.308505382959085	2.1728002070989	31	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.105	0.105	0	0
1647	CCUG_compound_31	Target_lig_900	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.105	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CNC1=NC(=NC2=CC=CC=C21)NC3=CC(=CC=C3)O	3-[[4-(methylamino)quinazolin-2-yl]amino]phenol	50946621	3.1207	266.116761068	5	3	3	70.07	3	0.679155004739031	2.01408078212884	20	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.105	0.105	0	0
1648	CCUG_compound_32	Target_lig_901	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.11	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(=O)NC1=CC=CC(=C1)NC2=NC3=CC=CC=C3C(=N2)NCCCO	N-[3-[[4-(3-hydroxypropylamino)quinazolin-2-yl]amino]phenyl]acetamide	50947324	3.1261	351.169524912	6	4	7	99.17	3	0.488216746364403	2.10087748946366	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.11	0.11	0	0
1649	CCUG_compound_33	Target_lig_902	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.135	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CCNC1=NC(=NC2=CC=CC=C21)NC3=CC(=CC=C3)O	3-[[4-(ethylamino)quinazolin-2-yl]amino]phenol	52108650	3.5108	280.132411132	5	3	4	70.07	3	0.681934416708207	2.01981461664907	21	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.135	0.135	0	0
1650	CCUG_compound_34	Target_lig_903	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.135	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	C1=CC=C2C(=C1)C(=NC(=N2)NC3=CC(=CC=C3)F)NCCCO	3-[[2-(3-fluoroanilino)quinazolin-4-yl]amino]propan-1-ol	50947700	3.3068	312.138639384	5	3	6	70.07	3	0.609243122329302	2.04266996815179	23	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.135	0.135	0	0
1651	CCUG_compound_35	Target_lig_904	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.15	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC1=CC=C(C=C1)NC2=NC3=CC=CC=C3C(=N2)NCCCO	3-[[2-(4-methylanilino)quinazolin-4-yl]amino]propan-1-ol	50945757	3.47612	308.16371126	5	3	6	70.07	3	0.608244332855253	1.96521210362825	23	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.15	0.15	0	0
1652	CCUG_compound_36	Target_lig_905	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.155	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN1CCN(CC1)C2=NC(=NC3=CC=CC=C32)NC4=CC=C(C=C4)O.Cl	4-[[4-(4-methylpiperazin-1-yl)quinazolin-2-yl]amino]phenol;hydrochloride	2929712	3.2526	371.151288004	6	2	3	64.52	3	0.688902216058968	2.15519061212478	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.155	0.155	0	0
1653	CCUG_compound_37	Target_lig_906	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.165	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	C1=CC=C(C=C1)NC2=NC3=CC=CC=C3C(=N2)NCCCO	3-[(2-anilinoquinazolin-4-yl)amino]propan-1-ol	50946956	3.1677	294.148061196	5	3	6	70.07	3	0.609170569043643	1.91785874180214	22	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.165	0.165	0	0
1654	CCUG_compound_38	Target_lig_907	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.19	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(C)(C)C(CN1C=CN=C1)NC(=O)NC2=CC3=C(C=C2)NN=C3	1-(1-imidazol-1-yl-3,3-dimethylbutan-2-yl)-3-(1H-indazol-5-yl)urea	72915168	2.9958	326.185509324	4	3	4	87.63	3	0.688500211314276	3.02659039979625	24	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.19	0.19	0	0
1655	CCUG_compound_39	Target_lig_908	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	C1=CC=C2C(=C1)C(=NC(=N2)NC3=CC(=CC=C3)O)NCCCO	3-[[4-(3-hydroxypropylamino)quinazolin-2-yl]amino]phenol	50944645	2.8733	310.142975816	6	4	6	90.3	3	0.523455272783237	2.11574046183721	23	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1656	CCUG_compound_40	Target_lig_909	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	COC(=O)C1=CC(=CC=C1)NC2=NC3=CC=CC=C3C(=N2)N	methyl 3-[(4-aminoquinazolin-2-yl)amino]benzoate	50947920	2.7422	294.111675688	6	2	3	90.13	3	0.721808438253382	1.91351236817577	22	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1657	CCUG_compound_41	Target_lig_910	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN1C2=C(C=CC(=C2)NC(=O)NCC3=CN=CN3CCOC)C=N1	1-[[3-(2-methoxyethyl)imidazol-4-yl]methyl]-3-(1-methylindazol-6-yl)urea	72869941	1.7379	328.16477388	6	2	6	86	3	0.721515111613839	2.53618865683283	24	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1658	CCUG_compound_42	Target_lig_911	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CCOC1=C(C=CC(=C1)C2=NC3=C(N2)C=C(C=C3)N4C=NN=N4)O	2-ethoxy-4-[6-(tetrazol-1-yl)-1H-benzimidazol-2-yl]phenol	136030017	2.3099	322.117823688	7	2	4	101.74	4	0.597615883492786	2.41539214464936	24	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1659	CCUG_compound_43	Target_lig_912	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN(C)C1=CC=C(C=C1)NC2=NC3=CC=CC=C3C(=N2)N4CCOCC4.Cl	4-N,4-N-dimethyl-1-N-(4-morpholin-4-ylquinazolin-2-yl)benzene-1,4-diamine;hydrochloride	2972487	3.6978	385.166938068	6	1	4	53.52	3	0.738656609998685	2.21408979800186	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1660	CCUG_compound_44	Target_lig_913	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(=O)NC1=CC=C(C=C1)NC2=NC3=CC=CC=C3C(=N2)NCCCO	N-[4-[[4-(3-hydroxypropylamino)quinazolin-2-yl]amino]phenyl]acetamide	50944617	3.1261	351.169524912	6	4	7	99.17	3	0.488216746364403	2.05165164330981	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1661	CCUG_compound_45	Target_lig_914	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	C1OC2=C(O1)C=C(C=C2)NC3=NC4=CC=CC=C4C(=N3)NCCCO	3-[[2-(1,3-benzodioxol-5-ylamino)quinazolin-4-yl]amino]propan-1-ol	50944718	2.8964	338.137890436	7	3	6	88.53	3	0.595568498331736	2.20482005114546	25	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1662	CCUG_compound_46	Target_lig_915	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.17	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	OCCCNc1nc(Nc2ccc3OC(F)(F)Oc3c2)nc2ccccc12	-	-	3.4892	374.119046812	7	3	6	88.53	3	0.569329217087531	2.52015554763684	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.17	0.17	0	0
1663	CCUG_compound_47	Target_lig_916	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.135	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1c(Nc2nc(NCCCO)c3ccccc3n2)ccc2OCCOc12	-	-	3.24732	366.169190564	7	3	6	88.53	3	0.577189687828003	2.48912011957901	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.135	0.135	0	0
1664	CCUG_compound_48	Target_lig_917	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.07	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN1CCOc2cc(Nc3nc(NCCCO)c4ccccc4n3)ccc12	-	-	2.9963	365.185174976	7	3	6	82.54	3	0.57933855448893	2.40051700370755	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.07	0.07	0	0
1665	CCUG_compound_49	Target_lig_918	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.01	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1nc2ccc(Nc3nc(NCCCO)c4ccccc4n3)cc2o1	-	-	3.61732	349.153874848	7	3	6	96.1	4	0.457518814137517	2.36926268784423	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.01	0.01	0	0
1666	CCUG_compound_50	Target_lig_919	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.007	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1nc2ccc(Nc3nc(NCCCO)c4ccccc4n3)cc2s1	-	-	4.08582	365.131031228	7	3	6	82.96	4	0.446572982845228	2.30185560282398	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.007	0.007	0	0
1667	CCUG_compound_51	Target_lig_920	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.03	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cn1cnc2ccc(Nc3nc(NCCCO)c4ccccc4n3)cc12	-	-	3.0544	348.16985926	7	3	6	87.89	4	0.46427267966492	2.37348029918026	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.03	0.03	0	0
1668	CCUG_compound_52	Target_lig_921	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cn1nc(Nc2nc(NCCCO)c3ccccc3n2)c2ccccc12	-	-	3.0544	348.16985926	7	3	6	87.89	4	0.46427267966492	2.37121390241913	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1669	CCUG_compound_53	Target_lig_922	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN(c1ccc2OCCOc2c1)c1nc(NCCCO)c2ccccc2n1	-	-	2.9632	366.169190564	7	2	6	79.74	3	0.649354357739161	2.47712128803082	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1670	CCUG_compound_54	Target_lig_923	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.09	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	OCCCNc1nc(Nc2ccc3OCCOc3c2)nc2CCCCc12	-	-	2.6645	356.184840628	7	3	6	88.53	2	0.685823306203794	2.48046045849463	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.09	0.09	0	0
1671	CCUG_compound_55	Target_lig_924	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	OCCCNc1nc(Nc2ccc3OCCOc3c2)nc2COCc12	-	-	1.8159	344.14845512	8	3	6	97.76	2	0.682821027710988	2.72284957297498	25	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1672	CCUG_compound_56	Target_lig_925	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1n[nH]c2nc(Nc3ccc4OCCOc4c3)nc(NCCCO)c12	-	-	1.97042	356.1596885	8	4	6	117.21	3	0.495345996940528	2.70997280930172	26	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1673	CCUG_compound_57	Target_lig_926	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.105	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1cccc2c(NCCCO)nc(Nc3ccc4OCCOc4c3)nc12	-	-	3.24732	366.169190564	7	3	6	88.53	3	0.577189687828003	2.37268798715448	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.105	0.105	0	0
1674	CCUG_compound_58	Target_lig_927	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.015	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4OCCOc4c3)nc(NCCCO)c2c1	-	-	3.24732	366.169190564	7	3	6	88.53	3	0.577189687828003	2.31786948666762	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.015	0.015	0	0
1675	CCUG_compound_59	Target_lig_928	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.06	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	OCCCNc1nc(Nc2ccc3OCCOc3c2)nc2ccc(F)cc12	-	-	3.078	370.144118688	7	3	6	88.53	3	0.574771516108275	2.33960269017298	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.06	0.06	0	0
1676	CCUG_compound_60	Target_lig_929	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	OCCCNc1nc(Nc2ccc3OCCOc3c2)nc2cc(F)ccc12	-	-	3.078	370.144118688	7	3	6	88.53	3	0.574771516108275	2.36209129776791	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1677	CCUG_compound_61	Target_lig_930	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	OCCCNc1nc(Nc2ccc3OCCOc3c2)nc2c(F)cccc12	-	-	3.078	370.144118688	7	3	6	88.53	3	0.574771516108275	2.41337640000745	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1678	CCUG_compound_62	Target_lig_931	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.01	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1nc2ccc(Nc3nc(NCCCO)c4cc(C)ccc4n3)cc2o1	-	-	3.92574	363.169524912	7	3	6	96.1	4	0.446721151555953	2.44753424586169	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.01	0.01	0	0
1679	CCUG_compound_63	Target_lig_932	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.002	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1nc2ccc(Nc3nc(NCCCO)c4cc(C)ccc4n3)cc2s1	-	-	4.39424	379.146681292	7	3	6	82.96	4	0.430952073555473	2.38185554763684	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.002	0.002	0	0
1680	CCUG_compound_64	Target_lig_933	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.03	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4ncn(C)c4c3)nc(NCCCO)c2c1	-	-	3.36282	362.185509324	7	3	6	87.89	4	0.455955503853638	2.45164371331731	27	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.03	0.03	0	0
1681	CCUG_compound_65	Target_lig_934	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(sc4c3)-c3ccc(F)cc3)nc(NCCCO)c2c1	-	-	5.89192000000001	459.152909544	7	3	7	82.96	5	0.263249020421694	2.41635739155197	33	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1682	CCUG_compound_66	Target_lig_935	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(sc4c3)-c3cccc(F)c3)nc(NCCCO)c2c1	-	-	5.89192000000001	459.152909544	7	3	7	82.96	5	0.263249020421694	2.4577126800135	33	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1683	CCUG_compound_67	Target_lig_936	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(sc4c3)-c3ccccc3C)nc(NCCCO)c2c1	-	-	6.06124000000001	455.17798142	7	3	7	82.96	5	0.258756300847636	2.44317998770581	33	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1684	CCUG_compound_68	Target_lig_937	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.02	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(sc4c3)-c3cc[nH]n3)nc(NCCCO)c2c1	-	-	4.47592	431.152829292	8	4	7	111.64	5	0.281220248028835	2.89126177629893	31	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.02	0.02	0	0
1685	CCUG_compound_69	Target_lig_938	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(sc4c3)-c3ccc(cc3)C(N)=O)nc(NCCCO)c2c1	-	-	4.85172	484.168145008	8	4	8	126.05	5	0.231923109609937	2.4899324938632	35	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1686	CCUG_compound_70	Target_lig_939	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.2	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(sc4c3)-c3ccc4[nH]ccc4c3)nc(NCCCO)c2c1	-	-	6.23412000000001	480.173230388	7	4	7	98.75	6	0.202109315639822	2.65401906652346	35	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.2	0.2	0	0
1687	CCUG_compound_71	Target_lig_940	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.0004	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(NC5CCN(Cc6ccccc6)CC5)sc4c3)nc(NCCCO)c2c1	-	-	6.16232000000001	553.26237974	9	4	10	98.23	5	0.152676253307701	2.62695239266508	40	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.0004	0.0004	0	0
1688	CCUG_compound_72	Target_lig_941	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.0002	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(sc4c3)N3CCOCC3)nc(NCCCO)c2c1	-	-	3.92242	450.183795072	9	3	7	95.43	4	0.364781969547239	2.5338327734925	32	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.0002	0.0002	0	0
1689	CCUG_compound_73	Target_lig_942	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.0003	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CC(C)CNc1nc2ccc(Nc3nc(NCCCO)c4cc(C)ccc4n3)cc2s1	-	-	5.15372	436.204530516	8	4	9	94.99	4	0.269419908950339	2.53830387646324	31	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.0003	0.0003	0	0
1690	CCUG_compound_74	Target_lig_943	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.0003	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(NCCN5CCOCC5)sc4c3)nc(NCCCO)c2c1	-	-	3.82992	493.225994232	10	4	10	107.46	4	0.245204283861759	2.63886357735243	35	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.0003	0.0003	0	0
1691	CCUG_compound_75	Target_lig_944	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.105	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(NCc5ccc6OCOc6c5)sc4c3)nc(NCCCO)c2c1	-	-	5.42662	514.178709692	10	4	9	113.45	5	0.191322901063774	2.65537845485258	37	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.105	0.105	0	0
1692	CCUG_compound_76	Target_lig_945	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.11	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(NCCOCc5ccccc5)sc4c3)nc(NCCCO)c2c1	-	-	5.71452000000001	514.2150952	9	4	12	104.22	5	0.15690828009796	2.57392496155689	37	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.11	0.11	0	0
1693	CCUG_compound_77	Target_lig_946	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.02	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(NCCOc5ccccc5)sc4c3)nc(NCCCO)c2c1	-	-	5.57672	500.199445136	9	4	11	104.22	5	0.174396107179367	2.51328947521076	36	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.02	0.02	0	0
1694	CCUG_compound_78	Target_lig_947	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.001	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(NCC(C)(C)O)sc4c3)nc(NCCCO)c2c1	-	-	4.26862	452.199445136	9	5	9	115.22	4	0.239239731495251	2.67274601965714	32	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.001	0.001	0	0
1695	CCUG_compound_79	Target_lig_948	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.004	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN(C)CCNc1nc2ccc(Nc3nc(NCCCO)c4cc(C)ccc4n3)cc2s1	-	-	4.05932	451.215429548	9	4	10	98.23	4	0.268074514979359	2.57596257851634	32	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.004	0.004	0	0
1696	CCUG_compound_80	Target_lig_949	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.01	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(sc4c3)N(CCO)CCO)nc(NCCCO)c2c1	-	-	2.87682	468.194359756	10	5	11	126.66	4	0.211190393210879	2.70820671341431	33	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.01	0.01	0	0
1697	CCUG_compound_81	Target_lig_950	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.01	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	Cc1ccc2nc(Nc3ccc4nc(NCCc5ccc(cc5)S(N)(=O)=O)sc4c3)nc(NCCCO)c2c1	-	-	4.38782	563.177329788	10	5	11	155.15	5	0.147162960456906	2.66555006721415	39	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.01	0.01	0	0
1698	CCUG_compound_82	Target_lig_951	r(CCUG)12	Synthetic	Myotonic dystrophy 2 (DM2)	Target_185	0	0	0	0.001	0	0	0	-	-	10.1021/acs.jmedchem.1c00414	34101465	A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.	Wagner-Griffin S, Abe M, Benhamou RI, Angelbello AJ, Vishnu K, Chen JL, Childs-Disney JL, Disney MD	J Med Chem	64	8474-8485	2021	-	80 nM	7.5	Room temperature	20 mM HEPES, 110 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM CaCl 2	FRET assay	Additional	CN1CCN(CC1)c1nc2ccc(Nc3nc(NCCCO)c4cc(C)ccc4n3)cc2s1	-	-	3.83762	463.215429548	9	3	7	89.44	4	0.356414558224461	2.54207614155197	33	GGGAGAGGGUUUAAUCCUGCCUGCCUGCCUGCCUGCCUGUACGAAAGUACCUGCCUGCCUGCCUGCCUGCCUGAUUGGAUCCGCAAGG	10.1038/ncomms3044	RNA aptamer	Expanded Repeats	88	Intron	Internal Loop	0	0	0	0	0	0	0.001	0.001	0	0
1699	Thioflavin T	Target_lig_952	ADAM10	Homo sapiens	Alzheimer’s disease	Target_196	(2.60±0.12)×1E5	0	0	0	0	0	0	-	-	10.1038/srep24793	27098781	Thioflavin T as an efficient fluorescence sensor for selective recognition of RNA G-quadruplexes.	Xu S, Li Q, Xiang J, Yang Q, Sun H, Guan A, Wang L, Liu Y, Yu L, Shi Y, Chen H, Tang Y	Sci Rep	6	24793	2016	0.125-8 uM	-	7	25	20 mM Tris Hcl and 40 mM KCl.	Fluorescence spectroscopy	Additional	CC1=CC2=C(C=C1)[N+](=C(S2)C3=CC=C(C=C3)N(C)C)C	4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,N-dimethylaniline	16954	3.76722	283.12634602809	2	0	2	7.12	3	0.649445065907516	2.52565370747935	20	UGGGGGACGGGUAGGGGCGGGAGGUAGGGG	10.1021/acs.jmedchem.5b00139	mRNA	-	30	5'-UTR	G-Quadruplex	248000	272000	0	0	0	0	0	0	0	0
1700	Thioflavin T	Target_lig_952	BCL-2	Homo sapiens	Cancer,Chronic Myeloid Leukemia (CML)	Target_258	(2.93±0.27)x1E5	0	0	0	0	0	0	-	-	10.1038/srep24793	27098781	Thioflavin T as an efficient fluorescence sensor for selective recognition of RNA G-quadruplexes.	Xu S, Li Q, Xiang J, Yang Q, Sun H, Guan A, Wang L, Liu Y, Yu L, Shi Y, Chen H, Tang Y	Sci Rep	6	24793	2016	0.125-8 uM	-	7	25	20 mM Tris Hcl and 40 mM KCl.	Fluorescence spectroscopy	Additional	CC1=CC2=C(C=C1)[N+](=C(S2)C3=CC=C(C=C3)N(C)C)C	4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,N-dimethylaniline	16954	3.76722	283.12634602809	2	0	2	7.12	3	0.649445065907516	2.52565370747935	20	AGGGGGCCGUGGGGUGGGAGCUGGGG	https://www.nature.com/articles/srep24793	G-quadruplex	-	26	-	G-Quadruplex	266000	320000	0	0	0	0	0	0	0	0
1701	Thioflavin T	Target_lig_952	ERS1	Homo sapiens	Cancer	Target_289	(2.03±0.12)x1E5	0	0	0	0	0	0	-	-	10.1038/srep24793	27098781	Thioflavin T as an efficient fluorescence sensor for selective recognition of RNA G-quadruplexes.	Xu S, Li Q, Xiang J, Yang Q, Sun H, Guan A, Wang L, Liu Y, Yu L, Shi Y, Chen H, Tang Y	Sci Rep	6	24793	2016	0.125-8 uM	-	7	25	20 mM Tris Hcl and 40 mM KCl.	Fluorescence spectroscopy	Additional	CC1=CC2=C(C=C1)[N+](=C(S2)C3=CC=C(C=C3)N(C)C)C	4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,N-dimethylaniline	16954	3.76722	283.12634602809	2	0	2	7.12	3	0.649445065907516	2.52565370747935	20	GGGUAGGGGCAAAGGGGCUGGGG	https://www.nature.com/articles/srep24793	mRNA	mRNA	23	Exon C	G-Quadruplex	191000	215000	0	0	0	0	0	0	0	0
1702	Thioflavin T	Target_lig_952	TRF2	Homo sapiens	Cancer	Target_261	(0.62±0.61)x1E5	0	0	0	0	0	0	-	-	10.1038/srep24793	27098781	Thioflavin T as an efficient fluorescence sensor for selective recognition of RNA G-quadruplexes.	Xu S, Li Q, Xiang J, Yang Q, Sun H, Guan A, Wang L, Liu Y, Yu L, Shi Y, Chen H, Tang Y	Sci Rep	6	24793	2016	0.125-8 uM	-	7	25	20 mM Tris Hcl and 40 mM KCl.	Fluorescence spectroscopy	Additional	CC1=CC2=C(C=C1)[N+](=C(S2)C3=CC=C(C=C3)N(C)C)C	4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,N-dimethylaniline	16954	3.76722	283.12634602809	2	0	2	7.12	3	0.649445065907516	2.52565370747935	20	GGGUUAGGGU	2M18	G-quadruplex	-	10	-	G-Quadruplex	1000	123000	0	0	0	0	0	0	0	0
1703	Thioflavin T	Target_lig_952	VEGF	Homo sapiens	Cancer,Coronary artery disease,Inflammation	Target_290	(1.24±0.15)x1E5	0	0	0	0	0	0	-	-	10.1038/srep24793	27098781	Thioflavin T as an efficient fluorescence sensor for selective recognition of RNA G-quadruplexes.	Xu S, Li Q, Xiang J, Yang Q, Sun H, Guan A, Wang L, Liu Y, Yu L, Shi Y, Chen H, Tang Y	Sci Rep	6	24793	2016	0.125-8 uM	-	7	25	20 mM Tris Hcl and 40 mM KCl.	Fluorescence spectroscopy	Additional	CC1=CC2=C(C=C1)[N+](=C(S2)C3=CC=C(C=C3)N(C)C)C	4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,N-dimethylaniline	16954	3.76722	283.12634602809	2	0	2	7.12	3	0.649445065907516	2.52565370747935	20	GGAGGAGGGGGAGGAGGA	https://www.nature.com/articles/srep24793	mRNA	Internal Ribosome Entry Site (IRES)	18	5’-UTR	G-Quadruplex	109000	139000	0	0	0	0	0	0	0	0
1704	Thioflavin T	Target_lig_952	C9orf72	Homo sapiens	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_291	(1.92±0.05)x1E5	0	0	0	0	0	0	-	-	10.1038/srep24793	27098781	Thioflavin T as an efficient fluorescence sensor for selective recognition of RNA G-quadruplexes.	Xu S, Li Q, Xiang J, Yang Q, Sun H, Guan A, Wang L, Liu Y, Yu L, Shi Y, Chen H, Tang Y	Sci Rep	6	24793	2016	0.125-8 uM	-	7	25	20 mM Tris Hcl and 40 mM KCl.	Fluorescence spectroscopy	Additional	CC1=CC2=C(C=C1)[N+](=C(S2)C3=CC=C(C=C3)N(C)C)C	4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,N-dimethylaniline	16954	3.76722	283.12634602809	2	0	2	7.12	3	0.649445065907516	2.52565370747935	20	GGGGCCGGGGCCGGGGCCGGGGCC	https://www.nature.com/articles/srep24793	mRNA	Expanded Repeats	24	Intronic repeats	G-Quadruplex	187000	197000	0	0	0	0	0	0	0	0
1705	Thioflavin T	Target_lig_952	ZIC1	Homo sapiens	Craniosynostosis,Cerebellar hypoplasia	Target_292	(0.56±0.22)x1E5	0	0	0	0	0	0	-	-	10.1038/srep24793	27098781	Thioflavin T as an efficient fluorescence sensor for selective recognition of RNA G-quadruplexes.	Xu S, Li Q, Xiang J, Yang Q, Sun H, Guan A, Wang L, Liu Y, Yu L, Shi Y, Chen H, Tang Y	Sci Rep	6	24793	2016	0.125-8 uM	-	7	25	20 mM Tris Hcl and 40 mM KCl.	Fluorescence spectroscopy	Additional	CC1=CC2=C(C=C1)[N+](=C(S2)C3=CC=C(C=C3)N(C)C)C	4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,N-dimethylaniline	16954	3.76722	283.12634602809	2	0	2	7.12	3	0.649445065907516	2.52565370747935	20	GGGUGGGGGGGGCGGGGGAGGCCGGGG	https://www.nature.com/articles/srep24793	mRNA	mRNA	27	5'-UTR	G-Quadruplex	34000	78000	0	0	0	0	0	0	0	0
1706	Thioflavin T	Target_lig_952	ssAf20	Synthetic	-	Target_293	(9.37±1.28)x1E4	0	0	0	0	0	0	-	-	10.1038/srep24793	27098781	Thioflavin T as an efficient fluorescence sensor for selective recognition of RNA G-quadruplexes.	Xu S, Li Q, Xiang J, Yang Q, Sun H, Guan A, Wang L, Liu Y, Yu L, Shi Y, Chen H, Tang Y	Sci Rep	6	24793	2016	0.125-8 uM	-	7	25	20 mM Tris Hcl and 40 mM KCl.	Fluorescence spectroscopy	Additional	CC1=CC2=C(C=C1)[N+](=C(S2)C3=CC=C(C=C3)N(C)C)C	4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,N-dimethylaniline	16954	3.76722	283.12634602809	2	0	2	7.12	3	0.649445065907516	2.52565370747935	20	CAAUUGUAUAUAUUCG	https://www.nature.com/articles/srep24793	RNA aptamer	-	16	-	-	80900	106500	0	0	0	0	0	0	0	0
1707	Thioflavin T	Target_lig_952	ssAf22	Synthetic	-	Target_294	(5.53±1.59)x1E4	0	0	0	0	0	0	-	-	10.1038/srep24793	27098781	Thioflavin T as an efficient fluorescence sensor for selective recognition of RNA G-quadruplexes.	Xu S, Li Q, Xiang J, Yang Q, Sun H, Guan A, Wang L, Liu Y, Yu L, Shi Y, Chen H, Tang Y	Sci Rep	6	24793	2016	0.125-8 uM	-	7	25	20 mM Tris Hcl and 40 mM KCl.	Fluorescence spectroscopy	Additional	CC1=CC2=C(C=C1)[N+](=C(S2)C3=CC=C(C=C3)N(C)C)C	4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,N-dimethylaniline	16954	3.76722	283.12634602809	2	0	2	7.12	3	0.649445065907516	2.52565370747935	20	UGAGCUUAAUUGUAUAUAUUCG	https://www.nature.com/articles/srep24793	RNA aptamer	-	22	-	-	39400	71200	0	0	0	0	0	0	0	0
1708	Thioflavin T	Target_lig_952	HP18	Synthetic	-	Target_295	(5.62±1.94)x1E4	0	0	0	0	0	0	-	-	10.1038/srep24793	27098781	Thioflavin T as an efficient fluorescence sensor for selective recognition of RNA G-quadruplexes.	Xu S, Li Q, Xiang J, Yang Q, Sun H, Guan A, Wang L, Liu Y, Yu L, Shi Y, Chen H, Tang Y	Sci Rep	6	24793	2016	0.125-8 uM	-	7	25	20 mM Tris Hcl and 40 mM KCl.	Fluorescence spectroscopy	Additional	CC1=CC2=C(C=C1)[N+](=C(S2)C3=CC=C(C=C3)N(C)C)C	4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,N-dimethylaniline	16954	3.76722	283.12634602809	2	0	2	7.12	3	0.649445065907516	2.52565370747935	20	CAGUACAGAUCUGUACUG	https://www.nature.com/articles/srep24793	RNA aptamer	-	18	-	Stem-Loop	36800	75600	0	0	0	0	0	0	0	0
1709	Thioflavin T	Target_lig_952	dsAf16	Synthetic	-	Target_296	(1.43±1.01)x1E5	0	0	0	0	0	0	-	-	10.1038/srep24793	27098781	Thioflavin T as an efficient fluorescence sensor for selective recognition of RNA G-quadruplexes.	Xu S, Li Q, Xiang J, Yang Q, Sun H, Guan A, Wang L, Liu Y, Yu L, Shi Y, Chen H, Tang Y	Sci Rep	6	24793	2016	0.125-8 uM	-	7	25	20 mM Tris Hcl and 40 mM KCl.	Fluorescence spectroscopy	Additional	CC1=CC2=C(C=C1)[N+](=C(S2)C3=CC=C(C=C3)N(C)C)C	4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,N-dimethylaniline	16954	3.76722	283.12634602809	2	0	2	7.12	3	0.649445065907516	2.52565370747935	20	CUUAAUUGUAUAUAUUCGCGAAUAUAUACAAUUAAG	https://www.nature.com/articles/srep24793	RNA aptamer	-	36	-	Stem-Loop	42000	244000	0	0	0	0	0	0	0	0
1710	DPQ	Target_lig_701	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	4.2999999999999995e-05±4e-06	5.1e-05±4e-06	0	0	0	-	-	10.1261/rna.076257.120	33028652	Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.	Kelly ML, Chu CC, Shi H, Ganser LR, Bogerd HP, Huynh K, Hou Y, Cullen BR, Al-Hashimi HM	RNA	27	12-26	2021	-	60 nM	7	-	30 mM HEPES, 100 mM KCl, 10 mM sodium phosphate, 10 mM ammonium acetate, 10 mM guanidinium chloride, 2 mM MgCl 2 , 20 mM NaCl, 0.5 mM EDTA, and 0.001% (v/v) Triton-X100	Fluorescence-based binding assay	Additional	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CC[NH2+]CC3)N)OC	6,7-dimethoxy-2-piperazin-4-ium-1-ylquinazolin-4-amine	5212112	-0.387399999999998	290.16115130009	6	2	3	90.11	2	0.800166130344128	3.26310669735525	21	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	3.90E-05	4.70E-05	4.70E-05	5.50E-05	0	0
1711	DPQ	Target_lig_701	HIV-1 RRE IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	0.00014±4.9999999999999996e-06	0	0	0	-	-	10.1261/rna.076257.120	33028652	Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.	Kelly ML, Chu CC, Shi H, Ganser LR, Bogerd HP, Huynh K, Hou Y, Cullen BR, Al-Hashimi HM	RNA	27	12-26	2021	-	60 nM	7	-	30 mM HEPES, 100 mM KCl, 10 mM sodium phosphate, 10 mM ammonium acetate, 10 mM guanidinium chloride, 2 mM MgCl 2 , 20 mM NaCl, 0.5 mM EDTA, and 0.001% (v/v) Triton-X100	Fluorescence-based binding assay	Additional	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CC[NH2+]CC3)N)OC	6,7-dimethoxy-2-piperazin-4-ium-1-ylquinazolin-4-amine	5212112	-0.387399999999998	290.16115130009	6	2	3	90.11	2	0.800166130344128	3.26310669735525	21	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	0.000135	0.000145	0	0
1712	DPQ	Target_lig_701	Influenza A virus (IAV) promoter	Influenza virus	Influenza	Target_297	0	0	0	5.1e-05±9e-06	0	0	0	2LWK	-	10.1261/rna.076257.120	33028652	Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.	Kelly ML, Chu CC, Shi H, Ganser LR, Bogerd HP, Huynh K, Hou Y, Cullen BR, Al-Hashimi HM	RNA	27	12-26	2021	-	60 nM	7	-	30 mM HEPES, 100 mM KCl, 10 mM sodium phosphate, 10 mM ammonium acetate, 10 mM guanidinium chloride, 2 mM MgCl 2 , 20 mM NaCl, 0.5 mM EDTA, and 0.001% (v/v) Triton-X100	Fluorescence-based binding assay	Additional	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CC[NH2+]CC3)N)OC	6,7-dimethoxy-2-piperazin-4-ium-1-ylquinazolin-4-amine	5212112	-0.387399999999998	290.16115130009	6	2	3	90.11	2	0.800166130344128	3.26310669735525	21	GAGUAGAAACAAGGCUUCGGCCUGCUUUUGCUC	https://pubmed.ncbi.nlm.nih.gov/33028652/	mRNA, Viral RNA	Promoter	33	3’ end	Stem-Loop	0	0	0	0	0	0	4.20E-05	6.00E-05	0	0
1713	Pentamidine	Target_lig_953	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0.000332±5.9999999999999995e-05	0.000397±8.2e-05	0	0	0	-	-	10.1261/rna.076257.120	33028652	Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.	Kelly ML, Chu CC, Shi H, Ganser LR, Bogerd HP, Huynh K, Hou Y, Cullen BR, Al-Hashimi HM	RNA	27	12-26	2021	-	60 nM	7	-	30 mM HEPES, 100 mM KCl, 10 mM sodium phosphate, 10 mM ammonium acetate, 10 mM guanidinium chloride, 2 mM MgCl 2 , 20 mM NaCl, 0.5 mM EDTA, and 0.001% (v/v) Triton-X100	Fluorescence-based binding assay	Additional	C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N	4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide	4735	2.88284	340.189926008	4	4	10	118.2	2	0.301957821878379	1.9932846056241	25	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.000272	0.000392	0.000315	0.000479	0	0
1714	Pentamidine	Target_lig_953	HIV-1 RRE IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	>0.001	0	0	0	-	-	10.1261/rna.076257.120	33028652	Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.	Kelly ML, Chu CC, Shi H, Ganser LR, Bogerd HP, Huynh K, Hou Y, Cullen BR, Al-Hashimi HM	RNA	27	12-26	2021	-	60 nM	7	-	30 mM HEPES, 100 mM KCl, 10 mM sodium phosphate, 10 mM ammonium acetate, 10 mM guanidinium chloride, 2 mM MgCl 2 , 20 mM NaCl, 0.5 mM EDTA, and 0.001% (v/v) Triton-X100	Fluorescence-based binding assay	Additional	C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N	4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide	4735	2.88284	340.189926008	4	4	10	118.2	2	0.301957821878379	1.9932846056241	25	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	0.001	0.001	0	0
1715	Pentamidine	Target_lig_953	CUG repeat	Synthetic	Myotonic dystrophy 1 (DM1)	Target_298	0	0	0	5.8e-05±4.9999999999999996e-06	0	0	0	-	-	10.1261/rna.076257.120	33028652	Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.	Kelly ML, Chu CC, Shi H, Ganser LR, Bogerd HP, Huynh K, Hou Y, Cullen BR, Al-Hashimi HM	RNA	27	12-26	2021	-	60 nM	7	-	30 mM HEPES, 100 mM KCl, 10 mM sodium phosphate, 10 mM ammonium acetate, 10 mM guanidinium chloride, 2 mM MgCl 2 , 20 mM NaCl, 0.5 mM EDTA, and 0.001% (v/v) Triton-X100	Fluorescence-based binding assay	Additional	C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N	4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide	4735	2.88284	340.189926008	4	4	10	118.2	2	0.301957821878379	1.9932846056241	25	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	https://pubmed.ncbi.nlm.nih.gov/33028652/	mRNA	Expanded Repeats	36	-	-	0	0	0	0	0	0	5.30E-05	6.30E-05	0	0
1716	Yohimbine	Target_lig_193	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	>0.001	>0.001	0	0	0	-	-	10.1261/rna.076257.120	33028652	Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.	Kelly ML, Chu CC, Shi H, Ganser LR, Bogerd HP, Huynh K, Hou Y, Cullen BR, Al-Hashimi HM	RNA	27	12-26	2021	-	60 nM	7	-	30 mM HEPES, 100 mM KCl, 10 mM sodium phosphate, 10 mM ammonium acetate, 10 mM guanidinium chloride, 2 mM MgCl 2 , 20 mM NaCl, 0.5 mM EDTA, and 0.001% (v/v) Triton-X100	Fluorescence-based binding assay	Additional	COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O	methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	2866	2.6471	354.194342692	4	2	1	65.56	2	0.772957405745492	3.87459645153332	26	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0.001	0.001	0.001	0.001	0	0
1717	Yohimbine	Target_lig_193	Ferritin Iron Response Element (IRE)	Homo sapiens	Progressive neurodegenerative diseases,Anemia,Hyperferritinemia cataract syndrome	Target_299	0	0	0	0.0039±0.0012	0	0	0	-	-	10.1261/rna.076257.120	33028652	Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.	Kelly ML, Chu CC, Shi H, Ganser LR, Bogerd HP, Huynh K, Hou Y, Cullen BR, Al-Hashimi HM	RNA	27	12-26	2021	-	60 nM	7	-	30 mM HEPES, 100 mM KCl, 10 mM sodium phosphate, 10 mM ammonium acetate, 10 mM guanidinium chloride, 2 mM MgCl 2 , 20 mM NaCl, 0.5 mM EDTA, and 0.001% (v/v) Triton-X100	Fluorescence-based binding assay	Additional	COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O	methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate	2866	2.6471	354.194342692	4	2	1	65.56	2	0.772957405745492	3.87459645153332	26	GUCUUCCUGCUUCAACAGUGCUUGGACGGAAC	https://pubmed.ncbi.nlm.nih.gov/33028652/	mRNA	Iron responsive element (IRE)	32	5'-UTR	Internal Loop	0	0	0	0	0	0	0.0027	0.0051	0	0
1718	CB096	Target_lig_954	r(G4C2)8	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	0	0	3.26e-05±9.199999999999998e-06	0	0	-	-	10.1021/acschembio.0c00049	33196168	Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.	Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD	ACS Chem Biol	15	3112-3123	2020	-	10 nM	7	Room temperature	10 mM Na2HPO4, 100 mM LiCl	Microscale Thermophoresis	Additional	COC1=C(C=CC(=C1)C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-])O	2-methoxy-4-(6-nitro-1H-benzimidazol-2-yl)phenol	4460926	2.8523	285.074955832	5	2	3	101.28	3	0.568804728621141	2.12652106502148	21	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	0	0	0	0	2.34E-05	4.18E-05
1719	CB141	Target_lig_955	r(G4C2)8	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	0	0	4.5299999999999997e-05±7.499999999999999e-06	0	0	-	-	10.1021/acschembio.0c00049	33196168	Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.	Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD	ACS Chem Biol	15	3112-3123	2020	-	10 nM	7	Room temperature	10 mM Na2HPO4, 100 mM LiCl	Microscale Thermophoresis	Additional	C1=CC(=C(C=C1C2=NC3=CC(=C(C=C3N2)[N+](=O)[O-])Cl)[N+](=O)[O-])Cl	5-chloro-2-(4-chloro-3-nitrophenyl)-6-nitro-1H-benzimidazole	135458700	4.3531	351.976610032	5	1	3	114.96	3	0.55501246255729	2.42165625649032	23	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	0	0	0	0	3.78E-05	5.28E-05
1720	CB783	Target_lig_956	r(G4C2)8	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	0	0	>4.9999999999999996e-05	0	0	-	-	10.1021/acschembio.0c00049	33196168	Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.	Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD	ACS Chem Biol	15	3112-3123	2020	-	10 nM	7	Room temperature	10 mM Na2HPO4, 100 mM LiCl	Microscale Thermophoresis	Additional	CN(C)C1=CC=C(C=C1)C2=NC3=C(N2)C4=CC=CC=C4C5=C3C=C(C=C5)I	4-(5-iodo-1H-phenanthro[9,10-d]imidazol-2-yl)-N,N-dimethylaniline	2259661	6.2069	463.054545576	2	1	2	31.92	5	0.24956874931972	2.36283128728181	27	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	0	0	0	0	5.00E-05	5.00E-05
1721	CB549	Target_lig_957	r(G4C2)8	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	0	0	>4.9999999999999996e-05	0	0	-	-	10.1021/acschembio.0c00049	33196168	Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.	Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD	ACS Chem Biol	15	3112-3123	2020	-	10 nM	7	Room temperature	10 mM Na2HPO4, 100 mM LiCl	Microscale Thermophoresis	Additional	COC1=CC(=CC(=C1O)OC)C2=NC3=C(N2)C=C4C(=C3)NC(=O)N4	6-(4-hydroxy-3,5-dimethoxyphenyl)-3,5-dihydro-1H-imidazo[4,5-f]benzimidazol-2-one	136076879	2.1223	326.101504928	5	4	3	116.02	4	0.460063341965074	2.51402533792667	24	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	0	0	0	0	5.00E-05	5.00E-05
1722	CB063	Target_lig_958	r(G4C2)8	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	0	0	3.25e-05±6.5e-06	0	0	-	-	10.1021/acschembio.0c00049	33196168	Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.	Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD	ACS Chem Biol	15	3112-3123	2020	-	10 nM	7	Room temperature	10 mM Na2HPO4, 100 mM LiCl	Microscale Thermophoresis	Additional	CC1=C(C=CC(=C1)C2=NC3=C(N2)C=C4C(=C3)NC(=O)N4)O	6-(4-hydroxy-3-methylphenyl)-3,5-dihydro-1H-imidazo[4,5-f]benzimidazol-2-one	136118525	2.41352	280.096025624	3	4	1	97.56	4	0.430735106162994	2.4811428512014	21	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	0	0	0	0	2.60E-05	3.90E-05
1723	CB688	Target_lig_959	r(G4C2)8	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	0	0	1.26e-05±3.3999999999999996e-06	0	0	-	-	10.1021/acschembio.0c00049	33196168	Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.	Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD	ACS Chem Biol	15	3112-3123	2020	-	10 nM	7	Room temperature	10 mM Na2HPO4, 100 mM LiCl	Microscale Thermophoresis	Additional	CCOC1=CC(=CC(=C1O)CC=C)C2=NC3=C(N2)C=C4C(=C3)NC(=O)N4	6-(3-ethoxy-4-hydroxy-5-prop-2-enylphenyl)-3,5-dihydro-1H-imidazo[4,5-f]benzimidazol-2-one	136030051	3.2323	350.137890436	4	4	5	106.79	4	0.414528734399466	2.78731431274848	26	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	0	0	0	0	9.20E-06	1.60E-05
1724	CB505	Target_lig_960	r(G4C2)8	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	0	0	>4.9999999999999996e-05	0	0	-	-	10.1021/acschembio.0c00049	33196168	Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.	Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD	ACS Chem Biol	15	3112-3123	2020	-	10 nM	7	Room temperature	10 mM Na2HPO4, 100 mM LiCl	Microscale Thermophoresis	Additional	CN1C2=CC=CC=C2[N+](=C1C3=CC=CC(=C3O)CC=C)C	2-(1,3-dimethylbenzimidazol-3-ium-2-yl)-6-prop-2-enylphenol	869804	3.1039	279.14918964809	2	1	3	29.04	3	0.579079369193504	2.81180242095368	21	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	0	0	0	0	5.00E-05	5.00E-05
1725	CB348	Target_lig_961	r(G4C2)8	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	0	0	>9.999999999999999e-05	0	0	-	-	10.1021/acschembio.0c00049	33196168	Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.	Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD	ACS Chem Biol	15	3112-3123	2020	-	10 nM	7	Room temperature	10 mM Na2HPO4, 100 mM LiCl	Microscale Thermophoresis	Additional	CC(C)NC(=O)NC1=NN(C2=C1C(=CC=C2)OCCN(C)C)C3=CC=C(C=C3)F	1-[4-[2-(dimethylamino)ethoxy]-1-(4-fluorophenyl)indazol-3-yl]-3-propan-2-ylurea	70750470	3.6349	399.207053292	5	2	7	71.42	3	0.636424065299403	2.42948030613661	29	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	0	0	0	0	0.0001	0.0001
1726	CB047	Target_lig_962	r(G4C2)8	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	0	0	6.099999999999999e-06±1.1e-06	0	0	-	-	10.1021/acschembio.0c00049	33196168	Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.	Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD	ACS Chem Biol	15	3112-3123	2020	-	10 nM	7	Room temperature	10 mM Na2HPO4, 100 mM LiCl	Microscale Thermophoresis	Additional	CC1=C(SC(=N1)NC(=O)NC2=C(N(C(=S)S2)C)C)C(=O)NC3=CC=CC=C3	2-[(3,4-dimethyl-2-sulfanylidene-1,3-thiazol-5-yl)carbamoylamino]-4-methyl-N-phenyl-1,3-thiazole-5-carboxamide	2177109	4.78573	419.054437784	7	3	4	88.05	3	0.530869858124018	2.51554811568418	27	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	0	0	0	0	5.00E-06	7.20E-06
1727	CB174	Target_lig_963	r(G4C2)8	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	0	0	3.07e-05±5.0999999999999995e-06	0	0	-	-	10.1021/acschembio.0c00049	33196168	Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.	Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD	ACS Chem Biol	15	3112-3123	2020	-	10 nM	7	Room temperature	10 mM Na2HPO4, 100 mM LiCl	Microscale Thermophoresis	Additional	CC1=CC(=C(C=C1)O)NC2=NC3=CC=CC=C3C(=N2)NC	4-methyl-2-[[4-(methylamino)quinazolin-2-yl]amino]phenol	52108211	3.42912	280.132411132	5	3	3	70.07	3	0.641168183618272	2.08710669735525	21	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	0	0	0	0	2.56E-05	3.58E-05
1728	CB019	Target_lig_964	r(G4C2)8	Synthetic	Amyotrophic lateral sclerosis/frontotemporal dementia (C9ORF72)	Target_232	0	0	0	0	8.8e-06±1.3e-06	0	0	-	-	10.1021/acschembio.0c00049	33196168	Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.	Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD	ACS Chem Biol	15	3112-3123	2020	-	10 nM	7	Room temperature	10 mM Na2HPO4, 100 mM LiCl	Microscale Thermophoresis	Additional	C1CCN(C1)C2=NC(=NC3=CC=CC=C32)NC4=CC5=C(C=C4)OCO5	N-(1,3-benzodioxol-5-yl)-4-pyrrolidin-1-ylquinazolin-2-amine	50946474	3.7023	334.142975816	6	1	3	59.51	3	0.787954079921663	2.1327533900228	25	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.15252/emmm.201707850	RNA aptamer, G-quadruplex	Expanded Repeats	216	-	G-Quadruplex	0	0	0	0	0	0	0	0	7.50E-06	1.01E-05
1729	Compound1	Target_lig_965	Pre-miR-21	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	1.8e-05±4e-06	>4.9999999999999996e-05	0	0	0	-	-	10.1073/pnas.2012217117	33318191	A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.	Suresh BM, Li W, Zhang P, Wang KW, Yildirim I, Parker CG, Disney MD	Proc Natl Acad Sci U S A	117	33197-33203	2020	10 mM	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM  NaCl	Microscale Thermophoresis	Additional	N=[N+]=NCCCNC(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)cc(cc2)c1ccc(cc1)N1CCN(CC1)C	-	-	4.86437	553.30339884409	7	3	12	123.8	4	0.131273985418418	2.81181234097181	41	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	1.40E-05	2.20E-05	5.00E-05	5.00E-05	0	0
1730	Compound9	Target_lig_966	Pre-miR-21	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	1e-06±1e-07	1.2e-06±8e-07	0	0	0	-	-	10.1073/pnas.2012217117	33318191	A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.	Suresh BM, Li W, Zhang P, Wang KW, Yildirim I, Parker CG, Disney MD	Proc Natl Acad Sci U S A	117	33197-33203	2020	10 mM	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM  NaCl	Microscale Thermophoresis	Additional	CN1CCN(CC1)c1ccc(cc1)c1ccc2c(c1)[nH]c(n2)c1ccc(cc1)OCCCC(=O)N1CCN(CC1)c1nncc2c1ccs2	-	-	6.16120000000001	672.29949352	9	1	9	93.72	6	0.182735017629459	2.98772122578382	49	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	9.00E-07	1.10E-06	4.00E-07	2.00E-06	0	0
1731	Compound7	Target_lig_967	Pre-miR-21	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	1.28e-07±5e-08	0	0	0	0	-	-	10.1073/pnas.2012217117	33318191	A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.	Suresh BM, Li W, Zhang P, Wang KW, Yildirim I, Parker CG, Disney MD	Proc Natl Acad Sci U S A	117	33197-33203	2020	10 mM	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM  NaCl	Microscale Thermophoresis	Additional	CN1CCN(CC1)c1ccc(cc1)c1ccc2c(c1)[nH]c(n2)c1ccc(cc1)OCCCC(=O)N(Cc1ccncc1)CCNC(=O)c1ccc(c(c1)C)F	-	-	7.10902000000001	739.364616552	7	2	14	106.69	6	0.114826421055948	3.00880027816514	55	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	7.80E-08	1.78E-07	0	0	0	0
1732	Compound8	Target_lig_968	Pre-miR-21	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	2.69e-07±1.2e-07	0	0	0	0	-	-	10.1073/pnas.2012217117	33318191	A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.	Suresh BM, Li W, Zhang P, Wang KW, Yildirim I, Parker CG, Disney MD	Proc Natl Acad Sci U S A	117	33197-33203	2020	10 mM	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM  NaCl	Microscale Thermophoresis	Additional	Coc1ccc(cc1OCC1=NC2N(C1)C=CC=C2)NC(=O)CCCOc1ccc(cc1)c1[nH]c2c(n1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C	-	-	0	0	0	0	0	0	0	0	0	0	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	1.49E-07	3.89E-07	0	0	0	0
1733	Compound9	Target_lig_966	miR-21 WT	Homo sapiens	Cancer	Target_301	0	0	3.36e-07±1e-07	0	0	0	0	-	-	10.1073/pnas.2012217117	33318191	A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.	Suresh BM, Li W, Zhang P, Wang KW, Yildirim I, Parker CG, Disney MD	Proc Natl Acad Sci U S A	117	33197-33203	2020	10 mM	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM  NaCl	Microscale Thermophoresis	Additional	CN1CCN(CC1)c1ccc(cc1)c1ccc2c(c1)[nH]c(n2)c1ccc(cc1)OCCCC(=O)N1CCN(CC1)c1nncc2c1ccs2	-	-	6.16120000000001	672.29949352	9	1	9	93.72	6	0.182735017629459	2.98772122578382	49	GUUGACUGUUGAAUCUCAUGGCAAC	www.pnas.org/cgi/doi/10.1073/pnas.2012217117	miRNA	miRNA	25	-	-	0	0	0	0	2.36E-07	4.36E-07	0	0	0	0
1734	Compound9	Target_lig_966	miR-21 BP	Homo sapiens	Cancer	Target_302	0	0	>9.999999999999999e-06	0	0	0	0	-	-	10.1073/pnas.2012217117	33318191	A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.	Suresh BM, Li W, Zhang P, Wang KW, Yildirim I, Parker CG, Disney MD	Proc Natl Acad Sci U S A	117	33197-33203	2020	10 mM	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM  NaCl	Microscale Thermophoresis	Additional	CN1CCN(CC1)c1ccc(cc1)c1ccc2c(c1)[nH]c(n2)c1ccc(cc1)OCCCC(=O)N1CCN(CC1)c1nncc2c1ccs2	-	-	6.16120000000001	672.29949352	9	1	9	93.72	6	0.182735017629459	2.98772122578382	49	GUUGACUGUUGAAUCUCAAUGGUCAAC	www.pnas.org/cgi/doi/10.1073/pnas.2012217117	miRNA	miRNA	27	-	-	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
1735	Compound9	Target_lig_966	miR-21 A bulge	Homo sapiens	Cancer	Target_303	0	0	2.3e-07±1e-07	0	0	0	0	-	-	10.1073/pnas.2012217117	33318191	A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.	Suresh BM, Li W, Zhang P, Wang KW, Yildirim I, Parker CG, Disney MD	Proc Natl Acad Sci U S A	117	33197-33203	2020	10 mM	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM  NaCl	Microscale Thermophoresis	Additional	CN1CCN(CC1)c1ccc(cc1)c1ccc2c(c1)[nH]c(n2)c1ccc(cc1)OCCCC(=O)N1CCN(CC1)c1nncc2c1ccs2	-	-	6.16120000000001	672.29949352	9	1	9	93.72	6	0.182735017629459	2.98772122578382	49	GUUGACUGUUGAAUCUCAAUGGUCAAC	www.pnas.org/cgi/doi/10.1073/pnas.2012217117	miRNA	miRNA	27	-	Stem-Loop with Bulge	0	0	0	0	1.30E-07	3.30E-07	0	0	0	0
1736	Compound9	Target_lig_966	miR-21 U bulge	Homo sapiens	Cancer	Target_304	0	0	>9.999999999999999e-06	0	0	0	0	-	-	10.1073/pnas.2012217117	33318191	A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.	Suresh BM, Li W, Zhang P, Wang KW, Yildirim I, Parker CG, Disney MD	Proc Natl Acad Sci U S A	117	33197-33203	2020	10 mM	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM  NaCl	Microscale Thermophoresis	Additional	CN1CCN(CC1)c1ccc(cc1)c1ccc2c(c1)[nH]c(n2)c1ccc(cc1)OCCCC(=O)N1CCN(CC1)c1nncc2c1ccs2	-	-	6.16120000000001	672.29949352	9	1	9	93.72	6	0.182735017629459	2.98772122578382	49	GUUGACUGUUGAAUCUCAUGGUCAAC	www.pnas.org/cgi/doi/10.1073/pnas.2012217117	miRNA	miRNA	26	-	Stem-Loop with Bulge	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
1737	Compound9	Target_lig_966	miR-21 G-A	Homo sapiens	Cancer	Target_305	0	0	3.2999999999999997e-06±6e-07	0	0	0	0	-	-	10.1073/pnas.2012217117	33318191	A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.	Suresh BM, Li W, Zhang P, Wang KW, Yildirim I, Parker CG, Disney MD	Proc Natl Acad Sci U S A	117	33197-33203	2020	10 mM	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM  NaCl	Microscale Thermophoresis	Additional	CN1CCN(CC1)c1ccc(cc1)c1ccc2c(c1)[nH]c(n2)c1ccc(cc1)OCCCC(=O)N1CCN(CC1)c1nncc2c1ccs2	-	-	6.16120000000001	672.29949352	9	1	9	93.72	6	0.182735017629459	2.98772122578382	49	GUUGACUGUUGAAUCUCAUAGCAAC	www.pnas.org/cgi/doi/10.1073/pnas.2012217117	miRNA	miRNA	25	-	-	0	0	0	0	2.70E-06	3.90E-06	0	0	0	0
1738	Compound1a	Target_lig_1274	r(GGGGCC)8	Synthetic	-	Target_183	0	0	9.70E-06	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	1 uM	36 nM	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl,	Biolayer Interferometry	Additional	Oc1ccc2c(c1)c1c(C)c3c[n+](CCN4CCCCC4)ccc3c(c1[nH]2)C	5,11-dimethyl-2-(2-piperidin-1-ylethyl)-6H-pyrido[4,3-b]carbazol-2-ium-9-ol	432608	4.57014	374.22268893609	2	2	3	43.14	4	0.51598885165364	2.87840241645753	28	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.1016/j.neuron.2014.07.041	RNA aptamer	Expanded Repeats	48	-	Hairpin	0	0	0	0	9.70E-06	9.70E-06	0	0	0	0
1739	Compound2	Target_lig_1275	r(GGGGCC)8	Synthetic	-	Target_183	0	0	1.00E-05	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	1 uM	36 nM	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl,	Biolayer Interferometry	Additional	NC(=N)c1ccc(cc1)Nc1ccc(cc1)c1cc2c([nH]1)cc(cc2)C(=N)N	2-[4-(4-carbamimidoylanilino)phenyl]-1H-indole-6-carboximidamide	435840	4.14664	368.17494464	3	6	5	127.56	4	0.2338463531587	2.30218754466266	28	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.1016/j.neuron.2014.07.041	RNA aptamer	Expanded Repeats	48	-	Hairpin	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
1740	Compound3	Target_lig_969	r(GGGGCC)8	Synthetic	-	Target_183	0	0	1.60E-05	0	0	0	0	-	-	10.1016/j.neuron.2014.07.041	25132468	Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.	Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD	Neuron	83	1043-50	2014	1 uM	36 nM	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl,	Biolayer Interferometry	Additional	CCN(CC)CCNC(=O)C1=CC2=C(N1)C=CC(=C2)NC(=O)C3=CC4=C(N3)C=CC(=C4)N	5-amino-N-[2-[2-(diethylamino)ethylcarbamoyl]-1H-indol-5-yl]-1H-indole-2-carboxamide	395006	3.5553	432.227374136	4	5	8	119.04	4	0.273564377417602	2.52758963757768	32	GGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCCGGGGCC	10.1016/j.neuron.2014.07.041	RNA aptamer	Expanded Repeats	48	-	Hairpin	0	0	0	0	1.60E-05	1.60E-05	0	0	0	0
1741	Pentamidine_1	Target_lig_970	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	1.00E-05	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	C1=CC(=CC=C1C(=N)N)NC(=O)C2=CC(=C(C=C2)C(=O)NC3=CC=C(C=C3)C(=N)N)N	2-amino-1-N,4-N-bis(4-carbamimidoylphenyl)benzene-1,4-dicarboxamide	416313	2.34154	415.175672912	5	7	6	183.96	3	0.184699407134163	2.12985576084748	31	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	1.00E-05	1.00E-05	0	0
1742	Pentamidine_2	Target_lig_971	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	5.00E-05	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)C(=N)N)C(=O)NC3=CC=C(C=C3)C(=N)N	1-N,4-N-bis(4-carbamimidoylphenyl)benzene-1,4-dicarboxamide	414102	2.75934	400.16477388	4	6	6	157.94	3	0.277537101887936	1.77164607963055	30	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	5.00E-05	5.00E-05	0	0
1743	Pentamidine_3	Target_lig_972	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	6.00E-05	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)N=C(N)N)C(=O)NC3=CC=C(C=C3)N=C(N)N	1-N,4-N-bis[4-(diaminomethylideneamino)phenyl]benzene-1,4-dicarboxamide	244299	2.001	430.186571944	4	6	6	187	3	0.256118207611457	2.13099779384528	32	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	6.00E-05	6.00E-05	0	0
1744	Pentamidine_4	Target_lig_973	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.0002	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	CN=C(N)NC1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)NC(=NC)N	1-[4-[(N'-methylcarbamimidoyl)amino]phenyl]-3-[4-[[4-[(N'-methylcarbamimidoyl)amino]phenyl]carbamoylamino]phenyl]urea	415595	3.6874	488.239670136	4	8	6	183.08	3	0.193206974047792	2.13127040565991	36	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.0002	0.0002	0	0
1745	Pentamidine_5	Target_lig_974	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.00025	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	C1=CC(=CC(=C1)OCCOC2=CC=C(C=C2)C(=N)N)N	4-[2-(3-aminophenoxy)ethoxy]benzenecarboximidamide	309453	2.01067	271.132076784	4	3	6	94.35	2	0.324020178394084	1.87450041077605	20	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.00025	0.00025	0	0
1746	Pentamidine_6	Target_lig_975	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.000375	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	CN=C(C1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)C(=NC)N)N	1-N,4-N-bis[4-(N'-methylcarbamimidoyl)phenyl]benzene-1,4-dicarboxamide	413923	2.8614	428.196074008	4	4	6	134.96	3	0.354539987753434	2.11598240922989	32	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.000375	0.000375	0	0
1747	Pentamidine_7	Target_lig_976	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.000375	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	C1=CC=C(C=C1)COC2=C(C=C(C=C2Cl)C(=N)N)Cl	3,5-dichloro-4-phenylmethoxybenzenecarboximidamide	427251	3.85647	294.032668364	2	2	4	59.1	2	0.664429127014784	1.91384342828504	19	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.000375	0.000375	0	0
1748	Pentamidine_8	Target_lig_977	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.001	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	CN=C(C1=CC=C(C=C1)N=C(C2=CC(=CC=C2)C(=NC3=CC=C(C=C3)C(=NC)N)N)N)N	1-N',3-N'-bis[4-(N'-methylcarbamimidoyl)phenyl]benzene-1,3-dicarboximidamide	415086	2.4308	426.228042832	4	4	6	153.52	3	0.352911879969946	2.84210154750204	32	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.001	0.001	0	0
1749	Hoechst_33258_1	Target_lig_1276	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	5.00E-05	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	Nc1cccc(c1)c1[nH]c2c(n1)cc(cc2)c1ccc2c(c1)nc([nH]2)c1cccc(c1)N	3-[6-[2-(3-aminophenyl)-3H-benzimidazol-5-yl]-1H-benzimidazol-2-yl]aniline	4644404	5.6046	416.17494464	4	4	3	109.4	6	0.28131179515576	2.46041591688519	32	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	5.00E-05	5.00E-05	0	0
1750	Hoechst_33258_2	Target_lig_978	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	6.00E-05	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	C1CN=C(N1)N/N=C/C2=CC=C(C=C2)C3=CN4C=C(C=CC4=N3)/C=N\NC5=NCCN5	N-[(E)-[4-[6-[(Z)-(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]imidazo[1,2-a]pyridin-2-yl]phenyl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	92859009	0.7667	414.202890704	10	4	5	114.86	3	0.363653704913082	3.21228186737411	31	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	6.00E-05	6.00E-05	0	0
1751	Hoechst_33258_4	Target_lig_979	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.0002	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	C1=CC(=CC(=C1)C(=O)NC2=CC=CC(=C2)C(=N)N)C(=O)NC3=CC=CC(=C3)C(=N)N	1-N,3-N-bis(3-carbamimidoylphenyl)benzene-1,3-dicarboxamide	414105	2.75934	400.16477388	4	6	6	157.94	3	0.277537101887936	2.02259383762206	30	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.0002	0.0002	0	0
1752	Hoechst_33258_5	Target_lig_980	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.0003	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	C1=CC=C2C(=C1)NC(=N2)CNC3=CC=C(C=C3)C(F)(F)F	N-(1H-benzimidazol-2-ylmethyl)-4-(trifluoromethyl)aniline	245203	4.1938	291.098332044	2	2	3	40.71	3	0.759197515339782	1.97367208197063	21	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.0003	0.0003	0	0
1753	Hoechst_33258_6	Target_lig_981	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.000375	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	C[C@@H]1CNC(=N1)c1ccc(cc1)NC(=O)Nc1ccc(cc1)C1=N[C@H](CN1)C	-	-	2.8072	376.201159388	5	4	4	89.91	2	0.661424729449505	3.73388141871895	28	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.000375	0.000375	0	0
1754	Hoechst_33258_7	Target_lig_982	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.0005	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	C1CN=C(N1)C2=CC(=CC=C2)NC(=O)C3=CC(=CC=C3)C(=O)NC4=CC=CC(=C4)C5=NCCN5	1-N,3-N-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]benzene-1,3-dicarboxamide	413678	2.8908	452.196074008	6	4	6	106.98	3	0.461353505850476	2.55174078473071	34	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.0005	0.0005	0	0
1755	Hoechst_33258_8	Target_lig_983	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.0005	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	COC1=C(C=C(C=C1)C2=NC3=CC=CC=C3N2)OC	2-(3,4-dimethoxyphenyl)-1H-benzimidazole	345698	3.2471	254.105527688	3	1	3	47.14	3	0.780074937515339	1.73112027219585	19	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.0005	0.0005	0	0
1756	Hoechst_33258_9	Target_lig_984	r(CUG)12	Synthetic	Myotonic dystrophy 1 (DM1)	Target_167	0	0	0	0.0005	0	0	0	-	-	10.1021/ja210088v	22300544	Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.	Parkesh R, Childs-Disney JL, Nakamori M, Kumar A, Wang E, Wang T, Hoskins J, Tran T, Housman D, Thornton CA, Disney MD	J Am Chem Soc	134	4731-42	2012	1000 nM	-	7	Room temperature	8 mM Na2PO4, 185 mM NaCl,	Fluorescence binding assay	Additional	C1CN=C(N1)C2=CC=C(C=C2)NC(=O)CNC(=O)NC3=CC=C(C=C3)C4=NCCN4	N-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-2-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]carbamoylamino]acetamide	416377	1.1464	405.191322976	6	5	6	119.01	2	0.49522250709322	2.55228259917176	30	CUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUG	10.1038/ncomms11647	RNA aptamer, mRNA	Expanded Repeats	36	3'-UTR	Internal Loop	0	0	0	0	0	0	0.0005	0.0005	0	0
1757	cpd8	Target_lig_985	GC-PAN triplex	Homo sapiens	Cancer,Kaposi Sarcoma	Target_306	0	0	0.0007	0	0	0	0	-	-	10.1093/nar/gkab1170	34871450	Dynamic bulge nucleotides in the KSHV PAN ENE triple helix provide a unique binding platform for small molecule ligands.	Swain M, Ageeli AA, Kasprzak WK, Li M, Miller JT, Sztuba-Solinska J, Schneekloth JS, Koirala D, Piccirili J, Fraboni AJ, Murelli RP, Wlodawer A, Shapiro BA, Baird N, Le Grice SFJ	Nucleic Acids Res	49	13179-13193	2021	0.08 uM - 2.5 mM	25 nM	6.5	Room temperature	5 mM sodium cacodylate, 50 mM KCl, and 1 mM MgCl 2	Microscale Thermophoresis	Additional	CC1=CC2=C(C=C1)N=C(C3=NN=CN23)NCCCN4CCOCC4	8-methyl-N-(3-morpholin-4-ylpropyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine	20880246	1.72012	326.185509324	7	1	5	67.58	3	0.720238743886297	2.49192836195318	24	GGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCCGGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCC	6X5N	lncRNA	lncRNA	78	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.0007	0.0007	0	0	0	0
1758	cpd13	Target_lig_986	GC-PAN triplex	Homo sapiens	Cancer,Kaposi Sarcoma	Target_306	0	0	0.000305	0	0	0	0	-	-	10.1093/nar/gkab1170	34871450	Dynamic bulge nucleotides in the KSHV PAN ENE triple helix provide a unique binding platform for small molecule ligands.	Swain M, Ageeli AA, Kasprzak WK, Li M, Miller JT, Sztuba-Solinska J, Schneekloth JS, Koirala D, Piccirili J, Fraboni AJ, Murelli RP, Wlodawer A, Shapiro BA, Baird N, Le Grice SFJ	Nucleic Acids Res	49	13179-13193	2021	0.08 uM - 2.5 mM	25 nM	6.5	Room temperature	5 mM sodium cacodylate, 50 mM KCl, and 1 mM MgCl 2	Microscale Thermophoresis	Additional	CN1C(=CN=C1NCC2=CC=CC=C2OC)C3=CC(=CC=C3)Br	5-(3-bromophenyl)-N-[(2-methoxyphenyl)methyl]-1-methylimidazol-2-amine	3970670	4.4703	371.063324296	4	1	5	39.08	3	0.718371952621684	2.1701761366102	23	GGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCCGGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCC	6X5N	lncRNA	lncRNA	78	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000305	0.000305	0	0	0	0
1759	cpd18	Target_lig_987	GC-PAN triplex	Homo sapiens	Cancer,Kaposi Sarcoma	Target_306	0	0	0.0032	0	0	0	0	-	-	10.1093/nar/gkab1170	34871450	Dynamic bulge nucleotides in the KSHV PAN ENE triple helix provide a unique binding platform for small molecule ligands.	Swain M, Ageeli AA, Kasprzak WK, Li M, Miller JT, Sztuba-Solinska J, Schneekloth JS, Koirala D, Piccirili J, Fraboni AJ, Murelli RP, Wlodawer A, Shapiro BA, Baird N, Le Grice SFJ	Nucleic Acids Res	49	13179-13193	2021	0.08 uM - 2.5 mM	25 nM	6.5	Room temperature	5 mM sodium cacodylate, 50 mM KCl, and 1 mM MgCl 2	Microscale Thermophoresis	Additional	CC1=NC2=CC=CC=C2C(=C1)N3CCN(C(C3)CCO)CC=C(C)C	2-[1-(3-methylbut-2-enyl)-4-(2-methylquinolin-4-yl)piperazin-2-yl]ethanol	70719852	3.38242	339.231062548	4	1	5	39.6	2	0.847886668199257	2.9587579907363	25	GGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCCGGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCC	6X5N	lncRNA	lncRNA	78	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.0032	0.0032	0	0	0	0
1760	cpd19	Target_lig_988	GC-PAN triplex	Homo sapiens	Cancer,Kaposi Sarcoma	Target_306	0	0	0.0008	0	0	0	0	-	-	10.1093/nar/gkab1170	34871450	Dynamic bulge nucleotides in the KSHV PAN ENE triple helix provide a unique binding platform for small molecule ligands.	Swain M, Ageeli AA, Kasprzak WK, Li M, Miller JT, Sztuba-Solinska J, Schneekloth JS, Koirala D, Piccirili J, Fraboni AJ, Murelli RP, Wlodawer A, Shapiro BA, Baird N, Le Grice SFJ	Nucleic Acids Res	49	13179-13193	2021	0.08 uM - 2.5 mM	25 nM	6.5	Room temperature	5 mM sodium cacodylate, 50 mM KCl, and 1 mM MgCl 2	Microscale Thermophoresis	Additional	CCCN(CCC)CC1=CC=C(C=C1)C(=O)N2CCOC(C2)CCN	[2-(2-aminoethyl)morpholin-4-yl]-[4-[(dipropylamino)methyl]phenyl]methanone	50967855	2.4984	347.257277296	4	1	9	58.8	1	0.745557952658508	2.73423968087715	25	GGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCCGGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCC	6X5N	lncRNA	lncRNA	78	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.0008	0.0008	0	0	0	0
1761	cpd20	Target_lig_989	GC-PAN triplex	Homo sapiens	Cancer,Kaposi Sarcoma	Target_306	0	0	0.000128	0	0	0	0	-	-	10.1093/nar/gkab1170	34871450	Dynamic bulge nucleotides in the KSHV PAN ENE triple helix provide a unique binding platform for small molecule ligands.	Swain M, Ageeli AA, Kasprzak WK, Li M, Miller JT, Sztuba-Solinska J, Schneekloth JS, Koirala D, Piccirili J, Fraboni AJ, Murelli RP, Wlodawer A, Shapiro BA, Baird N, Le Grice SFJ	Nucleic Acids Res	49	13179-13193	2021	0.08 uM - 2.5 mM	25 nM	6.5	Room temperature	5 mM sodium cacodylate, 50 mM KCl, and 1 mM MgCl 2	Microscale Thermophoresis	Additional	CCC1=CC(=NC(=N1)N2CCCC2)N3CCC(CC3)NCCN4C=CN=C4	1-(6-ethyl-2-pyrrolidin-1-ylpyrimidin-4-yl)-N-(2-imidazol-1-ylethyl)piperidin-4-amine	72873196	2.0943	369.264093992	7	1	7	62.11	2	0.806407741374398	2.61918865414571	27	GGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCCGGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCC	6X5N	lncRNA	lncRNA	78	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000128	0.000128	0	0	0	0
1762	cpd25	Target_lig_990	GC-PAN triplex	Homo sapiens	Cancer,Kaposi Sarcoma	Target_306	0	0	0.000209	0	0	0	0	-	-	10.1093/nar/gkab1170	34871450	Dynamic bulge nucleotides in the KSHV PAN ENE triple helix provide a unique binding platform for small molecule ligands.	Swain M, Ageeli AA, Kasprzak WK, Li M, Miller JT, Sztuba-Solinska J, Schneekloth JS, Koirala D, Piccirili J, Fraboni AJ, Murelli RP, Wlodawer A, Shapiro BA, Baird N, Le Grice SFJ	Nucleic Acids Res	49	13179-13193	2021	0.08 uM - 2.5 mM	25 nM	6.5	Room temperature	5 mM sodium cacodylate, 50 mM KCl, and 1 mM MgCl 2	Microscale Thermophoresis	Additional	CC1=C(C(=O)C2=C(C1=O)N3CCC(C3=N2)OC(=O)COC)NC(=O)C	(6-acetamido-7-methyl-5,8-dioxo-2,3-dihydro-1H-pyrrolo[1,2-a]benzimidazol-3-yl) 2-methoxyacetate	374010	0.3066	347.111735264	8	1	4	116.59	1	0.778904452417402	3.61385159216387	25	GGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCCGGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCC	6X5N	lncRNA	lncRNA	78	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000209	0.000209	0	0	0	0
1763	cpd15	Target_lig_991	GC-PAN triplex	Homo sapiens	Cancer,Kaposi Sarcoma	Target_306	0	0	2.7e-05±7e-06	0	0	0	0	-	-	10.1093/nar/gkab1170	34871450	Dynamic bulge nucleotides in the KSHV PAN ENE triple helix provide a unique binding platform for small molecule ligands.	Swain M, Ageeli AA, Kasprzak WK, Li M, Miller JT, Sztuba-Solinska J, Schneekloth JS, Koirala D, Piccirili J, Fraboni AJ, Murelli RP, Wlodawer A, Shapiro BA, Baird N, Le Grice SFJ	Nucleic Acids Res	49	13179-13193	2021	0.08 uM - 2.5 mM	25 nM	6.5	Room temperature	5 mM sodium cacodylate, 50 mM KCl, and 1 mM MgCl 2	Microscale Thermophoresis	Additional	CC(C)(C)CC(C)(C)NCC(=O)NC1=C2CCCC2=NC3=CC=CC=C31	N-(2,3-dihydro-1H-cyclopenta[b]quinolin-9-yl)-2-(2,4,4-trimethylpentan-2-ylamino)acetamide	2865088	4.4664	353.246712612	3	2	5	54.02	2	0.833899902325434	2.47803910484827	26	GGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCCGGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCC	6X5N	lncRNA	lncRNA	78	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	2.00E-05	3.40E-05	0	0	0	0
1764	cpd15-A1	Target_lig_992	GC-PAN triplex	Homo sapiens	Cancer,Kaposi Sarcoma	Target_306	0	0	0.00073±1.7e-05	0	0	0	0	-	-	10.1093/nar/gkab1170	34871450	Dynamic bulge nucleotides in the KSHV PAN ENE triple helix provide a unique binding platform for small molecule ligands.	Swain M, Ageeli AA, Kasprzak WK, Li M, Miller JT, Sztuba-Solinska J, Schneekloth JS, Koirala D, Piccirili J, Fraboni AJ, Murelli RP, Wlodawer A, Shapiro BA, Baird N, Le Grice SFJ	Nucleic Acids Res	49	13179-13193	2021	0.08 uM - 2.5 mM	25 nM	6.5	Room temperature	5 mM sodium cacodylate, 50 mM KCl, and 1 mM MgCl 2	Microscale Thermophoresis	Additional	O=C(Nc1ccnc2c1cccc2)CNC(CC(C)(C)C)(C)C	-	-	3.9777	313.215412484	3	2	5	54.02	2	0.877682395509156	2.2087705422046	23	GGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCCGGGUUUUUCCUUCGAAACACGAAGGUUUUUAUCCCUGCC	6X5N	lncRNA	lncRNA	78	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000713	0.000747	0	0	0	0
1765	Tobramycin	Target_lig_540	J6f1 RNA	Synthetic	-	Target_307	0	0	5.15e-09±1.52e-09	0	0	0	0	-	-	10.1021/bi972757h	9538017	The binding site of a specific aminoglycoside binding RNA molecule.	Cho J, Hamasaki K, Rando RR	Biochemistry	37	4985-92	1998	1 nM	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2	Fluorescence anisotropy	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GGCUUAGUAUAGCGAGGUUUAGCUACACUCGUGCUGAGCC	10.1021/bi972757h	RNA aptamer	-	40	-	Stem-Loop with Bulge	0	0	0	0	3.63E-09	6.67E-09	0	0	0	0
1766	Tobramycin-CRT	Target_lig_993	J6f1 RNA	Synthetic	-	Target_307	0	0	1.926e-07±1.11e-08	0	0	0	0	-	-	10.1021/bi972757h	9538017	The binding site of a specific aminoglycoside binding RNA molecule.	Cho J, Hamasaki K, Rando RR	Biochemistry	37	4985-92	1998	1 nM	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2	Fluorescence anisotropy	Additional	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	-	-	-2.51049999999999	880.40871133609	17	11	11	327.94	2	0.054746298432302	5.81306542323516	63	GGCUUAGUAUAGCGAGGUUUAGCUACACUCGUGCUGAGCC	10.1021/bi972757h	RNA aptamer	-	40	-	Stem-Loop with Bulge	0	0	0	0	1.82E-07	2.04E-07	0	0	0	0
1767	Tobramycin	Target_lig_540	J6fd6 RNA	Synthetic	-	Target_308	0	0	1.4799999999999998e-07±8e-08	0	0	0	0	-	-	10.1021/bi972757h	9538017	The binding site of a specific aminoglycoside binding RNA molecule.	Cho J, Hamasaki K, Rando RR	Biochemistry	37	4985-92	1998	1 nM	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2	Fluorescence anisotropy	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GGCUUAGUAUAGCUAGGUUUAGCUACACUCGUGCUGAGCC	10.1021/bi972757h	RNA aptamer	-	40	-	Stem-Loop with Bulge	0	0	0	0	6.80E-08	2.28E-07	0	0	0	0
1768	Tobramycin-CRT	Target_lig_993	J6fd6 RNA	Synthetic	-	Target_308	0	0	3.4e-08±8.999999999999999e-10	0	0	0	0	-	-	10.1021/bi972757h	9538017	The binding site of a specific aminoglycoside binding RNA molecule.	Cho J, Hamasaki K, Rando RR	Biochemistry	37	4985-92	1998	1 nM	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2	Fluorescence anisotropy	Additional	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	-	-	-2.51049999999999	880.40871133609	17	11	11	327.94	2	0.054746298432302	5.81306542323516	63	GGCUUAGUAUAGCUAGGUUUAGCUACACUCGUGCUGAGCC	10.1021/bi972757h	RNA aptamer	-	40	-	Stem-Loop with Bulge	0	0	0	0	3.31E-08	3.49E-08	0	0	0	0
1769	Tobramycin	Target_lig_540	J6f15 RNA	Synthetic	-	Target_309	0	0	1.8e-08±1e-09	0	0	0	0	-	-	10.1021/bi972757h	9538017	The binding site of a specific aminoglycoside binding RNA molecule.	Cho J, Hamasaki K, Rando RR	Biochemistry	37	4985-92	1998	1 nM	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2	Fluorescence anisotropy	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GGCUUAGUAUAGCGAGGUUUGGCUACACUCGUGCUGAGCC	10.1021/bi972757h	RNA aptamer	-	40	-	Stem-Loop with Bulge	0	0	0	0	1.70E-08	1.90E-08	0	0	0	0
1770	Tobramycin-CRT	Target_lig_993	J6f15 RNA	Synthetic	-	Target_309	0	0	4.258e-07±4e-08	0	0	0	0	-	-	10.1021/bi972757h	9538017	The binding site of a specific aminoglycoside binding RNA molecule.	Cho J, Hamasaki K, Rando RR	Biochemistry	37	4985-92	1998	1 nM	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2	Fluorescence anisotropy	Additional	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	-	-	-2.51049999999999	880.40871133609	17	11	11	327.94	2	0.054746298432302	5.81306542323516	63	GGCUUAGUAUAGCGAGGUUUGGCUACACUCGUGCUGAGCC	10.1021/bi972757h	RNA aptamer	-	40	-	Stem-Loop with Bulge	0	0	0	0	3.86E-07	4.66E-07	0	0	0	0
1771	Tobramycin	Target_lig_540	J6f16 RNA	Synthetic	-	Target_310	0	0	2.55e-09±2.5e-10	0	0	0	0	-	-	10.1021/bi972757h	9538017	The binding site of a specific aminoglycoside binding RNA molecule.	Cho J, Hamasaki K, Rando RR	Biochemistry	37	4985-92	1998	1 nM	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2	Fluorescence anisotropy	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GGCUUAGUAUAGCGAGGUUUAACUACACUCGUGCUGAGCC	10.1021/bi972757h	RNA aptamer	-	40	-	Stem-Loop with Bulge	0	0	0	0	2.30E-09	2.80E-09	0	0	0	0
1772	Tobramycin-CRT	Target_lig_993	J6f16 RNA	Synthetic	-	Target_310	0	0	6e-08±2e-09	0	0	0	0	-	-	10.1021/bi972757h	9538017	The binding site of a specific aminoglycoside binding RNA molecule.	Cho J, Hamasaki K, Rando RR	Biochemistry	37	4985-92	1998	1 nM	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2	Fluorescence anisotropy	Additional	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	-	-	-2.51049999999999	880.40871133609	17	11	11	327.94	2	0.054746298432302	5.81306542323516	63	GGCUUAGUAUAGCGAGGUUUAACUACACUCGUGCUGAGCC	10.1021/bi972757h	RNA aptamer	-	40	-	Stem-Loop with Bulge	0	0	0	0	5.80E-08	6.20E-08	0	0	0	0
1773	Tobramycin	Target_lig_540	J6f17 RNA	Synthetic	-	Target_311	0	0	1.8e-08±5.9e-10	0	0	0	0	-	-	10.1021/bi972757h	9538017	The binding site of a specific aminoglycoside binding RNA molecule.	Cho J, Hamasaki K, Rando RR	Biochemistry	37	4985-92	1998	1 nM	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2	Fluorescence anisotropy	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GGCUUAGUAUAGCGAGGUUUAGUUACACUCGUGCUGAGCC	10.1021/bi972757h	RNA aptamer	-	40	-	Stem-Loop with Bulge	0	0	0	0	1.74E-08	1.86E-08	0	0	0	0
1774	Tobramycin-CRT	Target_lig_993	J6f17 RNA	Synthetic	-	Target_311	0	0	4.204e-07±6.54e-08	0	0	0	0	-	-	10.1021/bi972757h	9538017	The binding site of a specific aminoglycoside binding RNA molecule.	Cho J, Hamasaki K, Rando RR	Biochemistry	37	4985-92	1998	1 nM	-	7.4	-	140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2	Fluorescence anisotropy	Additional	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	-	-	-2.51049999999999	880.40871133609	17	11	11	327.94	2	0.054746298432302	5.81306542323516	63	GGCUUAGUAUAGCGAGGUUUAGUUACACUCGUGCUGAGCC	10.1021/bi972757h	RNA aptamer	-	40	-	Stem-Loop with Bulge	0	0	0	0	3.55E-07	4.86E-07	0	0	0	0
1775	Compound C1	Target_lig_994	Pre-miR-377 dicer processing site	Homo sapiens	Cancer,Coronary artery disease,Inflammation	Target_312	0	0	2.9e-05±3e-06	4.9999999999999996e-05±9.999999999999999e-06	0	0	0	-	-	10.1038/s41557-020-0514-4	32839603	Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions	Haniff HS, Knerr L, Liu X, Crynen G, Boström J, Abegg D,  Adibekian A, Lekah E, Wang KW, Cameron MD, Yildirim I, Lemurell M, Disney MD	Nat Chem	12	952-961	2020	100 - 500 uM	250 nM	7.4	70	8 mM sodium phosphate, 150 mM NaCl	Fluorescence-based binding assay	Additional	C1=CC(=CC(=C1)C2=NC3=C(N2)C=C(C=C3)N)C4=NC5=C(N4)C=C(C=C5)N	2-[3-(6-amino-1H-benzimidazol-2-yl)phenyl]-3H-benzimidazol-5-amine	708725	3.9376	340.143644512	4	4	2	109.4	5	0.364852646151087	2.37415074452439	26	GCAGAGGUUGCCCUUGGUGAAUUCGCUUUAUUUAUGUUGAAUCACACAAAGGCAACUUUUGU	10.1038/s41557-020-0514-4	miRNA	pre-miRNA	62	Dicer site	Internal Loop	0	0	0	0	2.60E-05	3.20E-05	4.00E-05	6.00E-05	0	0
1776	Compound C2	Target_lig_995	Pre-miR-377 5′-G_G/3′-CAC bulge	Homo sapiens	Cancer,Coronary artery disease,Inflammation	Target_313	0	0	3e-06±3e-07	0	0	0	0	-	-	10.1038/s41557-020-0514-4	32839603	Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions	Haniff HS, Knerr L, Liu X, Crynen G, Boström J, Abegg D,  Adibekian A, Lekah E, Wang KW, Cameron MD, Yildirim I, Lemurell M, Disney MD	Nat Chem	12	952-961	2020	100 - 500 uM	250 nM	7.4	70	8 mM sodium phosphate, 150 mM NaCl	Fluorescence-based binding assay	Additional	CN1CCN(CC1)c1cc(Nc2nccc(c2)Nc2ccc3c(n2)cccc3)nc(n1)C	-	-	3.96722	426.228042832	8	2	5	82.1	4	0.496172301870492	2.53606878003914	32	GCAGAGGUUGCCCUUGGUGAAUUCGCUUUAUUUAUGUUGAAUCACACAAAGGCAACUUUUGU	10.1038/s41557-020-0514-4	miRNA	pre-miRNA	62	-	Bulge	0	0	0	0	2.70E-06	3.30E-06	0	0	0	0
1777	Compound C1-COOEt	Target_lig_996	Pre-miR-377 dicer processing site	Homo sapiens	Cancer,Coronary artery disease,Inflammation	Target_312	0	0	8e-07±1e-07	0	0	0	0	-	-	10.1038/s41557-020-0514-4	32839603	Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions	Haniff HS, Knerr L, Liu X, Crynen G, Boström J, Abegg D,  Adibekian A, Lekah E, Wang KW, Cameron MD, Yildirim I, Lemurell M, Disney MD	Nat Chem	12	952-961	2020	100 - 500 uM	250 nM	7.4	70	8 mM sodium phosphate, 150 mM NaCl	Fluorescence-based binding assay	Additional	CCOC(=O)CCCOC1=CC(=CC(=C1)C2=NC3=C(N2)C=C(C=C3)N)C4=NC5=C(N4)C=C(C=C5)N	ethyl 4-[3,5-bis(6-amino-1H-benzimidazol-2-yl)phenoxy]butanoate	146170522	4.6597	470.206638692	7	4	8	144.93	5	0.146554229580266	2.67639494626229	35	GCAGAGGUUGCCCUUGGUGAAUUCGCUUUAUUUAUGUUGAAUCACACAAAGGCAACUUUUGU	10.1038/s41557-020-0514-4	miRNA	pre-miRNA	62	Dicer site	Internal Loop	0	0	0	0	7.00E-07	9.00E-07	0	0	0	0
1778	Compound C2-Ak	Target_lig_997	Pre-miR-377 5′-G_G/3′-CAC bulge	Homo sapiens	Cancer,Coronary artery disease,Inflammation	Target_313	0	0	1.6e-06±1e-07	0	0	0	0	-	-	10.1038/s41557-020-0514-4	32839603	Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions	Haniff HS, Knerr L, Liu X, Crynen G, Boström J, Abegg D,  Adibekian A, Lekah E, Wang KW, Cameron MD, Yildirim I, Lemurell M, Disney MD	Nat Chem	12	952-961	2020	100 - 500 uM	250 nM	7.4	70	8 mM sodium phosphate, 150 mM NaCl	Fluorescence-based binding assay	Additional	C#CCc1nc(Nc2nccc(c2)Nc2ccc3c(n2)cccc3)cc(n1)N1CCN(CC1)C	-	-	3.8345	450.228042832	8	2	6	82.1	4	0.429087700345163	2.86661063088455	34	GCAGAGGUUGCCCUUGGUGAAUUCGCUUUAUUUAUGUUGAAUCACACAAAGGCAACUUUUGU	10.1038/s41557-020-0514-4	miRNA	pre-miRNA	62	-	Bulge	0	0	0	0	1.50E-06	1.70E-06	0	0	0	0
1779	Targapremir-377	Target_lig_998	Pre-miR-377	Homo sapiens	Cancer,Coronary artery disease,Inflammation	Target_312	0	0	1.8999999999999998e-07±5e-08	0	0	0	0	-	-	10.1038/s41557-020-0514-4	32839603	Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions	Haniff HS, Knerr L, Liu X, Crynen G, Boström J, Abegg D,  Adibekian A, Lekah E, Wang KW, Cameron MD, Yildirim I, Lemurell M, Disney MD	Nat Chem	12	952-961	2020	100 - 500 uM	250 nM	7.4	70	8 mM sodium phosphate, 150 mM NaCl	Fluorescence-based binding assay	Additional	CCCN(C(=O)CN(C(=O)CN(C(=O)CN(C(=O)CCCOc1cc(cc(c1)c1[nH]c2c(n1)cc(cc2)N)c1[nH]c2c(n1)ccc(c2)N)CCC)CCC)CCC)CC(=O)N(CC(=O)N)CCCn1cnc(c1)CN1CCN(CC1)c1nc(CC)nc(c1)Nc1nccc(c1)Nc1ccc2c(n1)cccc2	-	-	8.75670000000001	1440.783233412	21	7	37	363.19	10	0.014118151844738	5.38852664756574	106	GCAGAGGUUGCCCUUGGUGAAUUCGCUUUAUUUAUGUUGAAUCACACAAAGGCAACUUUUGU	10.1038/s41557-020-0514-4	miRNA	pre-miRNA	62	Dicer site	Internal Loop	0	0	0	0	1.40E-07	2.40E-07	0	0	0	0
1780	Neomycin	Target_lig_4	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	2.1e-05±2e-06	0	0	0	0	-	-	10.1039/c0cc00645a	20652190	Design of novel RNA ligands that bind stem-bulge HIV-1 TAR RNA.	Duca M, Malnuit V, Barbault F, Benhida R	Chem Commun (Camb)	46	6162-4	2010	-	5 nM	7.4	20	20 mM NaCl, 140 mM KCl and 3 mM MgCl2	Fluorescence-based binding assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.90E-05	2.30E-05	0	0	0	0
1781	Compound 3ab	Target_lig_999	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	2.9999999999999997e-05±2e-06	0	0	0	0	-	-	10.1039/c0cc00645a	20652190	Design of novel RNA ligands that bind stem-bulge HIV-1 TAR RNA.	Duca M, Malnuit V, Barbault F, Benhida R	Chem Commun (Camb)	46	6162-4	2010	-	5 nM	7.4	20	20 mM NaCl, 140 mM KCl and 3 mM MgCl2	Fluorescence-based binding assay	Additional	NCCCCC(C(=O)OCOC[C@H]1O[C@H](C[C@@H]1O)C(=O)Nc1cccc(c1)c1csc(n1)NC(=O)C)N	-	-	1.199	535.210069396	11	5	13	188.12	2	0.141571576710955	3.97804816364117	37	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	2.80E-05	3.20E-05	0	0	0	0
1782	Compound 3bb	Target_lig_1000	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	8e-06±1e-06	0	0	0	0	-	-	10.1039/c0cc00645a	20652190	Design of novel RNA ligands that bind stem-bulge HIV-1 TAR RNA.	Duca M, Malnuit V, Barbault F, Benhida R	Chem Commun (Camb)	46	6162-4	2010	-	5 nM	7.4	20	20 mM NaCl, 140 mM KCl and 3 mM MgCl2	Fluorescence-based binding assay	Additional	NCCCCC(C(=O)OCO[C@H]1C[C@@H](O[C@@H]1COCOC(=O)C(CCCCN)N)C(=O)Nc1cccc(c1)c1csc(n1)NC(=O)C)N	-	-	1.18030000000001	693.315597084	15	6	21	255.46	2	0.060999124662495	4.54537624152293	48	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	7.00E-06	9.00E-06	0	0	0	0
1783	Compound 3cb	Target_lig_1001	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.3e-05±1e-06	0	0	0	0	-	-	10.1039/c0cc00645a	20652190	Design of novel RNA ligands that bind stem-bulge HIV-1 TAR RNA.	Duca M, Malnuit V, Barbault F, Benhida R	Chem Commun (Camb)	46	6162-4	2010	-	5 nM	7.4	20	20 mM NaCl, 140 mM KCl and 3 mM MgCl2	Fluorescence-based binding assay	Additional	CC(=O)Nc1scc(n1)c1cccc(c1)NC(=O)[C@H]1C[C@@H]([C@H](O1)COCOC(=O)C(CCCN=C(N)N)N)O	-	-	0.123600000000003	563.216217396	11	6	13	226.5	2	0.063046359936688	4.09552903959553	39	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.20E-05	1.40E-05	0	0	0	0
1784	Compound 3db	Target_lig_1002	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	9.999999999999999e-06±1e-06	0	0	0	0	-	-	10.1039/c0cc00645a	20652190	Design of novel RNA ligands that bind stem-bulge HIV-1 TAR RNA.	Duca M, Malnuit V, Barbault F, Benhida R	Chem Commun (Camb)	46	6162-4	2010	-	5 nM	7.4	20	20 mM NaCl, 140 mM KCl and 3 mM MgCl2	Fluorescence-based binding assay	Additional	CC(=O)Nc1scc(n1)c1cccc(c1)NC(=O)[C@H]1C[C@@H]([C@H](O1)COCOC(=O)C(CCCN=C(N)N)N)OCOC(=O)C(CCCN=C(N)N)N	-	-	-0.970499999999992	749.327893084	15	8	21	332.22	2	0.025012127080043	4.75567031914292	52	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	9.00E-06	1.10E-05	0	0	0	0
1785	Compound 3aa	Target_lig_1003	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.4e-05±1e-06	0	0	0	0	-	-	10.1039/c0cc00645a	20652190	Design of novel RNA ligands that bind stem-bulge HIV-1 TAR RNA.	Duca M, Malnuit V, Barbault F, Benhida R	Chem Commun (Camb)	46	6162-4	2010	-	5 nM	7.4	20	20 mM NaCl, 140 mM KCl and 3 mM MgCl2	Fluorescence-based binding assay	Additional	NCCCCC(C(=O)OCOC[C@H]1OC(C[C@@H]1O)C(=O)Nc1cccc(c1)c1csc(n1)NC(=O)C)N	-	-	1.199	535.210069396	11	5	13	188.12	2	0.141571576710955	3.97804816364117	37	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.30E-05	1.50E-05	0	0	0	0
1786	Compound 3ba	Target_lig_1004	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.3e-05±1e-06	0	0	0	0	-	-	10.1039/c0cc00645a	20652190	Design of novel RNA ligands that bind stem-bulge HIV-1 TAR RNA.	Duca M, Malnuit V, Barbault F, Benhida R	Chem Commun (Camb)	46	6162-4	2010	-	5 nM	7.4	20	20 mM NaCl, 140 mM KCl and 3 mM MgCl2	Fluorescence-based binding assay	Additional	NCCCCC(C(=O)OCO[C@H]1CC(O[C@@H]1COCOC(=O)C(CCCCN)N)C(=O)Nc1cccc(c1)c1csc(n1)NC(=O)C)N	-	-	1.18030000000001	693.315597084	15	6	21	255.46	2	0.060999124662495	4.54537624152293	48	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.20E-05	1.40E-05	0	0	0	0
1787	Neomycin	Target_lig_4	HIV-1 TAR ab	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	3.1e-05±4.9999999999999996e-06	0	0	0	0	-	-	10.1039/c0cc00645a	20652190	Design of novel RNA ligands that bind stem-bulge HIV-1 TAR RNA.	Duca M, Malnuit V, Barbault F, Benhida R	Chem Commun (Camb)	46	6162-4	2010	-	5 nM	7.4	20	20 mM NaCl, 140 mM KCl and 3 mM MgCl2	Fluorescence-based binding assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	2.60E-05	3.60E-05	0	0	0	0
1788	Compound 3bb	Target_lig_1000	HIV-1 TAR ab	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	4.8e-05±3e-06	0	0	0	0	-	-	10.1039/c0cc00645a	20652190	Design of novel RNA ligands that bind stem-bulge HIV-1 TAR RNA.	Duca M, Malnuit V, Barbault F, Benhida R	Chem Commun (Camb)	46	6162-4	2010	-	5 nM	7.4	20	20 mM NaCl, 140 mM KCl and 3 mM MgCl2	Fluorescence-based binding assay	Additional	NCCCCC(C(=O)OCO[C@H]1C[C@@H](O[C@@H]1COCOC(=O)C(CCCCN)N)C(=O)Nc1cccc(c1)c1csc(n1)NC(=O)C)N	-	-	1.18030000000001	693.315597084	15	6	21	255.46	2	0.060999124662495	4.54537624152293	48	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	4.50E-05	5.10E-05	0	0	0	0
1789	Compound 3ba	Target_lig_1004	HIV-1 TAR ab	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.3e-05±1e-06	0	0	0	0	-	-	10.1039/c0cc00645a	20652190	Design of novel RNA ligands that bind stem-bulge HIV-1 TAR RNA.	Duca M, Malnuit V, Barbault F, Benhida R	Chem Commun (Camb)	46	6162-4	2010	-	5 nM	7.4	20	20 mM NaCl, 140 mM KCl and 3 mM MgCl2	Fluorescence-based binding assay	Additional	NCCCCC(C(=O)OCO[C@H]1CC(O[C@@H]1COCOC(=O)C(CCCCN)N)C(=O)Nc1cccc(c1)c1csc(n1)NC(=O)C)N	-	-	1.18030000000001	693.315597084	15	6	21	255.46	2	0.060999124662495	4.54537624152293	48	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.20E-05	1.40E-05	0	0	0	0
1790	Mitoxantrone	Target_lig_182	SRE in 5’ Splice Site of MAPT Exon 10	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_315	0	0	0	0	7.20E-07	0	0	2KGP	-	10.1016/j.chembiol.2009.03.009	19477420	Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone).	Zheng S, Chen Y, Donahue CP, Wolfe MS, Varani G	Chem Biol	16	557-66	2009	400 nM	-	6.7	-	50 mM NaCl, 10 mM NaPO4	FRET assay	Additional	C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO	1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione	4212	-0.1392	444.200884616	10	8	12	163.18	2	0.139316778047515	2.81447110510123	32	GGCAGUGUGAGUACCUUCAUACGUC	10.1016/j.chembiol.2009.03.009	mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	0	0	0	0	7.20E-07	7.20E-07
1791	Mitoxantrone_analog_1	Target_lig_1005	SRE in 5’ Splice Site of MAPT Exon 10	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_315	0	0	0	0	>4.9999999999999996e-05	0	0	-	-	10.1016/j.chembiol.2009.03.009	19477420	Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone).	Zheng S, Chen Y, Donahue CP, Wolfe MS, Varani G	Chem Biol	16	557-66	2009	400 nM	-	6.7	-	50 mM NaCl, 10 mM NaPO4	FRET assay	Additional	C1=CC(=C2C(=C1NCCOCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCOCCO	1,4-dihydroxy-5,8-bis[2-(2-hydroxyethoxy)ethylamino]anthracene-9,10-dione	72750	0.7148	446.168915792	10	6	12	157.58	2	0.172906904544321	2.80978328085748	32	GGCAGUGUGAGUACCUUCAUACGUC	10.1016/j.chembiol.2009.03.009	mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	0	0	0	0	5.00E-05	5.00E-05
1792	Mitoxantrone_analog_2	Target_lig_1006	SRE in 5’ Splice Site of MAPT Exon 10	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_315	0	0	0	0	>0.005	0	0	-	-	10.1016/j.chembiol.2009.03.009	19477420	Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone).	Zheng S, Chen Y, Donahue CP, Wolfe MS, Varani G	Chem Biol	16	557-66	2009	400 nM	-	6.7	-	50 mM NaCl, 10 mM NaPO4	FRET assay	Additional	C1=CC(=C2C(=C1NCCNCCN)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCN	1,4-bis[2-(2-aminoethylamino)ethylamino]-5,8-dihydroxyanthracene-9,10-dione	438708	-0.206399999999998	442.23285344	10	8	12	174.76	2	0.138414662680293	2.88197405008825	32	GGCAGUGUGAGUACCUUCAUACGUC	10.1016/j.chembiol.2009.03.009	mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	0	0	0	0	0.005	0.005
1793	Mitoxantrone_analog_3	Target_lig_1007	SRE in 5’ Splice Site of MAPT Exon 10	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_315	0	0	0	0	4.30E-06	0	0	-	-	10.1016/j.chembiol.2009.03.009	19477420	Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone).	Zheng S, Chen Y, Donahue CP, Wolfe MS, Varani G	Chem Biol	16	557-66	2009	400 nM	-	6.7	-	50 mM NaCl, 10 mM NaPO4	FRET assay	Additional	C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCNCCO)NCCNCCO	1,4-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione	2134	0.4496	412.211055376	8	6	12	122.72	2	0.237171260591097	2.56714558908882	30	GGCAGUGUGAGUACCUUCAUACGUC	10.1016/j.chembiol.2009.03.009	mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	0	0	0	0	4.30E-06	4.30E-06
1794	miR-21 binder compound 1	Target_lig_1008	miR-21	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	2.00E-05	0	0	0	0	-	-	10.1073/pnas.1914286117	31964809	Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer.	Costales MG, Aikawa H, Li Y, Childs-Disney JL, Abegg D, Hoch DG, Pradeep Velagapudi S, Nakai Y, Khan T, Wang KW, Yildirim I, Adibekian A, Wang ET, Disney MD	Proc Natl Acad Sci U S A	117	2406-2411	2020	-	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Microscale Thermophoresis	Additional	N=[N+]=NCCCNC(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C	-	-	4.86437	553.30339884409	7	3	12	123.8	4	0.131273985418418	2.82556964866411	41	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	2.00E-05	2.00E-05	0	0	0	0
1795	miR-21 binder compound 2	Target_lig_1009	miR-21	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	9.8e-07±9.7e-08	1.00E-06	0	0	0	-	-	10.1073/pnas.1914286117	31964809	Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer.	Costales MG, Aikawa H, Li Y, Childs-Disney JL, Abegg D, Hoch DG, Pradeep Velagapudi S, Nakai Y, Khan T, Wang KW, Yildirim I, Adibekian A, Wang ET, Disney MD	Proc Natl Acad Sci U S A	117	2406-2411	2020	-	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Microscale Thermophoresis	Additional	CCCN(C(=O)CN(C(=O)NCc1nnn(c1)CCCNC(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)CCC)CC(=O)N(CC(=O)N(Cc1nnn(c1)CCCNC(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)CC(=O)N)CCC	-	-	8.43770000000001	1594.8826131	21	6	42	344.76	10	0.019536209379903	5.47480118665297	117	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	8.83E-07	1.08E-06	1.00E-06	1.00E-06	0	0
1796	miR-21 binder compound 5	Target_lig_1010	miR-21	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	0	5.00E-08	0	0	0	-	-	10.1073/pnas.1914286117	31964809	Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer.	Costales MG, Aikawa H, Li Y, Childs-Disney JL, Abegg D, Hoch DG, Pradeep Velagapudi S, Nakai Y, Khan T, Wang KW, Yildirim I, Adibekian A, Wang ET, Disney MD	Proc Natl Acad Sci U S A	117	2406-2411	2020	-	5 nM	-	Room temperature	8 mM Na2HPO4, 190 mM NaCl	Microscale Thermophoresis	Additional	CCCN(C(=O)CN(C(=O)NCc1nnn(c1)CCCNC(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)CCC)CC(=O)N(CC(=O)N(Cc1nnn(c1)CCCNC(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)CC(=O)NCC[O+](c1ccc(cc1O)/C=C/1\SC(=C(C1=O)C(=O)OCC)Nc1ccccc1)C[O+](c1ccc(cc1O)/C=C/1\SC(=C(C1=O)C(=O)OCC)Nc1ccccc1)C[O+](c1ccc(cc1O)/C=C/1\SC(=C(C1=O)C(=O)OCC)Nc1ccccc1)COc1ccc(cc1O)/C=C/1\SC(=C(C1=O)C(=O)OCC)Nc1ccccc1)CCC	-	-	24.9143000000001	3192.25106709627	46	14	75	650.62	18	0.003201047790992	8.9372482268843	230	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	0	0	5.00E-08	5.00E-08	0	0
1797	Compound 2	Target_lig_676	miR-17 Dicer site	Homo sapiens	Cancer,Polycystic kidney disease,Prostate cancer,Breast cancer	Target_316	0	0	1.2e-07±2e-08	1.00E-06	0	0	0	-	-	10.1021/jacs.9b13159	32233464	Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands.	Liu X, Haniff HS, Childs-Disney JL, Shuster A, Aikawa H, Adibekian A, Disney MD	J Am Chem Soc	142	6970-6982	2020	100 nM	100 nM	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GUGCAGGUAGUGAUAUGUGCAUCUACUGCAC	10.1021/jacs.9b13159	miRNA	miRNA	31	Dicer site	Stem-Loop with Bulge	0	0	0	0	1.00E-07	1.40E-07	1.00E-06	1.00E-06	0	0
1798	Compound 2	Target_lig_676	miR-17 G-bulge	Homo sapiens	Cancer,Polycystic kidney disease,Prostate cancer,Breast cancer	Target_317	0	0	1.4999999999999999e-05±3e-06	0	0	0	0	-	-	10.1021/jacs.9b13159	32233464	Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands.	Liu X, Haniff HS, Childs-Disney JL, Shuster A, Aikawa H, Adibekian A, Disney MD	J Am Chem Soc	142	6970-6982	2020	100 nM	100 nM	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GUGCAGGUAGUGAUAUGUGCAUCUACUGCAC	10.1021/jacs.9b13159	miRNA	miRNA	31	Dicer site	Stem-Loop with Bulge	0	0	0	0	1.20E-05	1.80E-05	0	0	0	0
1799	Compound 2	Target_lig_676	miR-17 U-bulge	Homo sapiens	Cancer,Polycystic kidney disease,Prostate cancer,Breast cancer	Target_318	0	0	1.8999999999999998e-05±4.9999999999999996e-06	0	0	0	0	-	-	10.1021/jacs.9b13159	32233464	Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands.	Liu X, Haniff HS, Childs-Disney JL, Shuster A, Aikawa H, Adibekian A, Disney MD	J Am Chem Soc	142	6970-6982	2020	100 nM	100 nM	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GUGCAGGUAGUGAUAUGUGCAUCUACCUGCAC	10.1021/jacs.9b13159	miRNA	miRNA	32	Dicer site	Stem-Loop with Bulge	0	0	0	0	1.40E-05	2.40E-05	0	0	0	0
1800	Compound 2	Target_lig_676	miR-17 Base pairing control	Homo sapiens	Cancer,Polycystic kidney disease,Prostate cancer,Breast cancer	Target_319	0	0	>9.999999999999999e-05	1.00E-05	0	0	0	-	-	10.1021/jacs.9b13159	32233464	Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands.	Liu X, Haniff HS, Childs-Disney JL, Shuster A, Aikawa H, Adibekian A, Disney MD	J Am Chem Soc	142	6970-6982	2020	100 nM	100 nM	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	GUGCAGGUAGAUGAUAUGUGCAUCUACCUGCAC	10.1021/jacs.9b13159	miRNA	miRNA	33	-	Stem-Loop	0	0	0	0	0.0001	0.0001	1.00E-05	1.00E-05	0	0
1801	Compound 2	Target_lig_676	miR-18a Dicer site	Homo sapiens	Cancer,Polycystic kidney disease,Prostate cancer,Breast cancer	Target_320	0	0	1.24e-07±2.2e-08	0	0	0	0	-	-	10.1021/jacs.9b13159	32233464	Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands.	Liu X, Haniff HS, Childs-Disney JL, Shuster A, Aikawa H, Adibekian A, Disney MD	J Am Chem Soc	142	6970-6982	2020	100 nM	100 nM	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl	Fluorescence-based binding assay	Additional	NC(=[NH2+])C1=CC=C(NC2=CC=C(C=C2)C2=CC3=CC=C(C=C3N2)C(N)=[NH2+])C=C1	-	-	0.507300000000001	370.18949754418	1	6	5	131.04	4	0.225910107543072	3.02331773697035	28	UGCAGAUAGUGAAGUAGAUAGGCAUCUACUGCA	10.1021/jacs.9b13159	miRNA	miRNA	33	Dicer site	Stem-Loop with Bulge	0	0	0	0	1.02E-07	1.46E-07	0	0	0	0
1802	ATMND-C2-NH2	Target_lig_1012	Bacterial rRNA A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	4.3999999999999997e-07±8e-08	0	0	0	0	-	-	10.1002/chem.201802320	29971862	Fluorescent Trimethylated Naphthyridine Derivative with an Aminoalkyl Side Chain as the Tightest Non-aminoglycoside Ligand for the Bacterial A-site RNA.	Sato Y, Rokugawa M, Ito S, Yajima S, Sugawara H, Teramae N, Nishizawa S	Chemistry	24	13862-13870	2018	-	-	7	5	10mM sodium cacodylate, 50 mM NaCl	Fluorescence-based binding assay	Additional	CC1=C(C2=C(N=C1C)N=C(C=C2)NCCN)C	N'-(5,6,7-trimethyl-1,8-naphthyridin-2-yl)ethane-1,2-diamine	102281241	1.92566	230.153146576	4	2	3	63.83	2	0.845282115265359	2.52097296481928	17	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	3.60E-07	5.20E-07	0	0	0	0
1803	ATMND	Target_lig_1012	Bacterial rRNA A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.9999999999999998e-05±2e-06	0	0	0	0	-	-	10.1002/chem.201802320	29971862	Fluorescent Trimethylated Naphthyridine Derivative with an Aminoalkyl Side Chain as the Tightest Non-aminoglycoside Ligand for the Bacterial A-site RNA.	Sato Y, Rokugawa M, Ito S, Yajima S, Sugawara H, Teramae N, Nishizawa S	Chemistry	24	13862-13870	2018	-	-	7	5	10mM sodium cacodylate, 50 mM NaCl	Fluorescence-based binding assay	Additional	CC1=C(C2=C(N=C1C)N=C(C=C2)NCCN)C	N'-(5,6,7-trimethyl-1,8-naphthyridin-2-yl)ethane-1,2-diamine	102281241	1.92566	230.153146576	4	2	3	63.83	2	0.845282115265359	2.52097296481928	17	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.80E-05	2.20E-05	0	0	0	0
1804	ATMND-C3-NH2	Target_lig_1014	Bacterial rRNA A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1e-06±2e-07	0	0	0	0	-	-	10.1002/chem.201802320	29971862	Fluorescent Trimethylated Naphthyridine Derivative with an Aminoalkyl Side Chain as the Tightest Non-aminoglycoside Ligand for the Bacterial A-site RNA.	Sato Y, Rokugawa M, Ito S, Yajima S, Sugawara H, Teramae N, Nishizawa S	Chemistry	24	13862-13870	2018	-	-	7	5	10mM sodium cacodylate, 50 mM NaCl	Fluorescence-based binding assay	Additional	CC1=C(C2=C(N=C1C)N=C(C=C2)NCCCN)C	N'-(5,6,7-trimethyl-1,8-naphthyridin-2-yl)propane-1,3-diamine	90734716	2.31576	244.16879664	4	2	4	63.83	2	0.810098877280395	2.48248342599191	18	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	8.00E-07	1.20E-06	0	0	0	0
1805	ATMND-C4-NH2	Target_lig_1015	Bacterial rRNA A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.6e-06±3e-07	0	0	0	0	-	-	10.1002/chem.201802320	29971862	Fluorescent Trimethylated Naphthyridine Derivative with an Aminoalkyl Side Chain as the Tightest Non-aminoglycoside Ligand for the Bacterial A-site RNA.	Sato Y, Rokugawa M, Ito S, Yajima S, Sugawara H, Teramae N, Nishizawa S	Chemistry	24	13862-13870	2018	-	-	7	5	10mM sodium cacodylate, 50 mM NaCl	Fluorescence-based binding assay	Additional	NCCCCNc1ccc2c(n1)nc(c(c2C)C)C	-	-	2.70586	258.184446704	4	2	5	63.83	2	0.809352751924101	2.45227332668852	19	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.30E-06	1.90E-06	0	0	0	0
1806	AMND-C2-NH2	Target_lig_1016	Bacterial rRNA A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.6e-05±2e-06	0	0	0	0	-	-	10.1002/chem.201802320	29971862	Fluorescent Trimethylated Naphthyridine Derivative with an Aminoalkyl Side Chain as the Tightest Non-aminoglycoside Ligand for the Bacterial A-site RNA.	Sato Y, Rokugawa M, Ito S, Yajima S, Sugawara H, Teramae N, Nishizawa S	Chemistry	24	13862-13870	2018	-	-	7	5	10mM sodium cacodylate, 50 mM NaCl	Fluorescence-based binding assay	Additional	NCCNc1ccc2c(n1)nccc2	-	-	1.0004	188.106196384	4	2	3	63.83	2	0.753867640428541	2.27014812790602	14	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.40E-05	2.80E-05	0	0	0	0
1807	ADMND-C2-NH2	Target_lig_1017	Bacterial rRNA A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.2999999999999996e-06±5e-07	0	0	0	0	-	-	10.1002/chem.201802320	29971862	Fluorescent Trimethylated Naphthyridine Derivative with an Aminoalkyl Side Chain as the Tightest Non-aminoglycoside Ligand for the Bacterial A-site RNA.	Sato Y, Rokugawa M, Ito S, Yajima S, Sugawara H, Teramae N, Nishizawa S	Chemistry	24	13862-13870	2018	-	-	7	5	10mM sodium cacodylate, 50 mM NaCl	Fluorescence-based binding assay	Additional	NCCNc1ccc2c(n1)nc(cc2C)C	-	-	1.61724	216.137496512	4	2	3	63.83	2	0.817927995430544	2.3899792445791	16	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.80E-06	2.80E-06	0	0	0	0
1808	MPED	Target_lig_1277	Bacterial rRNA A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.2e-05±1e-06	0	0	0	0	-	-	10.1002/chem.201802320	29971862	Fluorescent Trimethylated Naphthyridine Derivative with an Aminoalkyl Side Chain as the Tightest Non-aminoglycoside Ligand for the Bacterial A-site RNA.	Sato Y, Rokugawa M, Ito S, Yajima S, Sugawara H, Teramae N, Nishizawa S	Chemistry	24	13862-13870	2018	-	-	7	5	10mM sodium cacodylate, 50 mM NaCl	Fluorescence-based binding assay	Additional	Cc1cc(NCCN)ncc1	N'-(4-methylpyridin-2-yl)ethane-1,2-diamine	10034794	0.76062	151.110947416	3	2	3	50.94	1	0.670228290457975	2.11146237103668	11	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.10E-05	1.30E-05	0	0	0	0
1809	CMBL-3aL	Target_lig_1018	R-Seq1	Synthetic	-	Target_321	0	0	2.18E-07	0	0	0	0	-	-	10.1016/j.omtn.2021.11.021	34976435	HT-SELEX-based identification of binding pre-miRNA hairpin-motif for small molecules	Mukherjee S, Murata A, Ishida R, Sugai A, Dohno C, Hamada M, Krishna S, Nakatani K	Mol Ther Nucleic Acids	27	165-174	2021	200-500 uM	0.2 uM	7.4	80	0.15 M NaCl	Surface Plasmon Resonance (SPR)	Additional	NCCCC(=O)NCCCN1Cc2ccc3c(n2)nc(cc3)NC(=O)OCC/C=C/CCOC(=O)Nc2nc3nc(C1)ccc3cc2	-	-	4.2674	641.307415348	11	4	7	186.58	4	0.166763250606386	5.64179975454645	47	GCUGAUUUCUUUUGGUGUUCAGAGGGGUCGGUGGUGGUGGUGGUGGUGGUUCUAGCACCAUCUGAAAUCGGUUA	10.1016/j.omtn.2021.11.021	RNA aptamer	pre-miRNA	74	-	Stem-Loop	0	0	0	0	2.18E-07	2.18E-07	0	0	0	0
1810	CMBL-3aL	Target_lig_1018	R-Seq2	Synthetic	-	Target_322	0	0	1.31E-06	0	0	0	0	-	-	10.1016/j.omtn.2021.11.021	34976435	HT-SELEX-based identification of binding pre-miRNA hairpin-motif for small molecules	Mukherjee S, Murata A, Ishida R, Sugai A, Dohno C, Hamada M, Krishna S, Nakatani K	Mol Ther Nucleic Acids	27	165-174	2021	200-500 uM	0.2 uM	7.4	80	0.15 M NaCl	Surface Plasmon Resonance (SPR)	Additional	NCCCC(=O)NCCCN1Cc2ccc3c(n2)nc(cc3)NC(=O)OCC/C=C/CCOC(=O)Nc2nc3nc(C1)ccc3cc2	-	-	4.2674	641.307415348	11	4	7	186.58	4	0.166763250606386	5.64179975454645	47	GCUGAUUUCUUUUGGUGUUCAGAGUGGUCGGUGGUUGGUGGUGGGUGGUGGUUCUAGCACCAUCUGAAAUCGGUUA	10.1016/j.omtn.2021.11.021	RNA aptamer	pre-miRNA	76	-	Stem-Loop	0	0	0	0	1.31E-06	1.31E-06	0	0	0	0
1811	CMBL-3aL	Target_lig_1018	R-Seq3	Synthetic	-	Target_323	0	0	6.82E-07	0	0	0	0	-	-	10.1016/j.omtn.2021.11.021	34976435	HT-SELEX-based identification of binding pre-miRNA hairpin-motif for small molecules	Mukherjee S, Murata A, Ishida R, Sugai A, Dohno C, Hamada M, Krishna S, Nakatani K	Mol Ther Nucleic Acids	27	165-174	2021	200-500 uM	0.2 uM	7.4	80	0.15 M NaCl	Surface Plasmon Resonance (SPR)	Additional	NCCCC(=O)NCCCN1Cc2ccc3c(n2)nc(cc3)NC(=O)OCC/C=C/CCOC(=O)Nc2nc3nc(C1)ccc3cc2	-	-	4.2674	641.307415348	11	4	7	186.58	4	0.166763250606386	5.64179975454645	47	GCUGAUUUCUUUUGGUGUUCAGAGAGGUCGGUGGUUGGUGGUGGGUGGUGGUUCUAGCACCAUCUGAAAUCGGUUA	10.1016/j.omtn.2021.11.021	RNA aptamer	pre-miRNA	76	-	Stem-Loop	0	0	0	0	6.82E-07	6.82E-07	0	0	0	0
1812	CMBL-3aL	Target_lig_1018	R-Seq4	Synthetic	-	Target_324	0	0	1.35E-07	0	0	0	0	-	-	10.1016/j.omtn.2021.11.021	34976435	HT-SELEX-based identification of binding pre-miRNA hairpin-motif for small molecules	Mukherjee S, Murata A, Ishida R, Sugai A, Dohno C, Hamada M, Krishna S, Nakatani K	Mol Ther Nucleic Acids	27	165-174	2021	200-500 uM	0.2 uM	7.4	80	0.15 M NaCl	Surface Plasmon Resonance (SPR)	Additional	NCCCC(=O)NCCCN1Cc2ccc3c(n2)nc(cc3)NC(=O)OCC/C=C/CCOC(=O)Nc2nc3nc(C1)ccc3cc2	-	-	4.2674	641.307415348	11	4	7	186.58	4	0.166763250606386	5.64179975454645	47	GCUGAUUUCUUUUGGUGUUCAGAGUGGGGUGAGCUUUCUAGCACCAUCUGAAAUCGGUUA	10.1016/j.omtn.2021.11.021	RNA aptamer	pre-miRNA	60	-	Stem-Loop	0	0	0	0	1.35E-07	1.35E-07	0	0	0	0
1813	CMBL-3aL	Target_lig_1018	Pre-miR-33a	Homo sapiens	Cancer	Target_325	0	0	1.38E-09	0	0	0	0	-	-	10.1016/j.omtn.2021.11.021	34976435	HT-SELEX-based identification of binding pre-miRNA hairpin-motif for small molecules	Mukherjee S, Murata A, Ishida R, Sugai A, Dohno C, Hamada M, Krishna S, Nakatani K	Mol Ther Nucleic Acids	27	165-174	2021	200-500 uM	0.2 uM	7.4	80	0.15 M NaCl	Surface Plasmon Resonance (SPR)	Additional	NCCCC(=O)NCCCN1Cc2ccc3c(n2)nc(cc3)NC(=O)OCC/C=C/CCOC(=O)Nc2nc3nc(C1)ccc3cc2	-	-	4.2674	641.307415348	11	4	7	186.58	4	0.166763250606386	5.64179975454645	47	GUGCAUUGUAGUUGCAUUGCAUGUUCUGGUGGUACCCAUCGAAUGUUUCCACAGUGCAUCAC	10.1016/j.omtn.2021.11.021	miRNA	pre-miRNA	62	-	Stem-Loop	0	0	0	0	1.38E-09	1.38E-09	0	0	0	0
1814	CMBL-3aL	Target_lig_1018	Pre-miR-33a-G31A	Homo sapiens	Cancer	Target_326	0	0	2.24E-09	0	0	0	0	-	-	10.1016/j.omtn.2021.11.021	34976435	HT-SELEX-based identification of binding pre-miRNA hairpin-motif for small molecules	Mukherjee S, Murata A, Ishida R, Sugai A, Dohno C, Hamada M, Krishna S, Nakatani K	Mol Ther Nucleic Acids	27	165-174	2021	200-500 uM	0.2 uM	7.4	80	0.15 M NaCl	Surface Plasmon Resonance (SPR)	Additional	NCCCC(=O)NCCCN1Cc2ccc3c(n2)nc(cc3)NC(=O)OCC/C=C/CCOC(=O)Nc2nc3nc(C1)ccc3cc2	-	-	4.2674	641.307415348	11	4	7	186.58	4	0.166763250606386	5.64179975454645	47	GUGCAUUGUAGUUGCAUUGCAUGUUCUGGUAGUACCCAUCGAAUGUUUCCACAGUGCAUCAC	10.1016/j.omtn.2021.11.021	miRNA	pre-miRNA	62	-	Stem-Loop	0	0	0	0	2.24E-09	2.24E-09	0	0	0	0
1815	CMBL-3aL	Target_lig_1018	Pre-miR-33a-G32A	Homo sapiens	Cancer	Target_327	0	0	2.55E-09	0	0	0	0	-	-	10.1016/j.omtn.2021.11.021	34976435	HT-SELEX-based identification of binding pre-miRNA hairpin-motif for small molecules	Mukherjee S, Murata A, Ishida R, Sugai A, Dohno C, Hamada M, Krishna S, Nakatani K	Mol Ther Nucleic Acids	27	165-174	2021	200-500 uM	0.2 uM	7.4	80	0.15 M NaCl	Surface Plasmon Resonance (SPR)	Additional	NCCCC(=O)NCCCN1Cc2ccc3c(n2)nc(cc3)NC(=O)OCC/C=C/CCOC(=O)Nc2nc3nc(C1)ccc3cc2	-	-	4.2674	641.307415348	11	4	7	186.58	4	0.166763250606386	5.64179975454645	47	GUGCAUUGUAGUUGCAUUGCAUGUUCUGGUGAUACCCAUCGAAUGUUUCCACAGUGCAUCAC	10.1016/j.omtn.2021.11.021	miRNA	pre-miRNA	62	-	Stem-Loop	0	0	0	0	2.55E-09	2.55E-09	0	0	0	0
1816	CMBL-3aL	Target_lig_1018	Pre-miR-24-2	Homo sapiens	Cancer	Target_328	0	0	2.04E-09	0	0	0	0	-	-	10.1016/j.omtn.2021.11.021	34976435	HT-SELEX-based identification of binding pre-miRNA hairpin-motif for small molecules	Mukherjee S, Murata A, Ishida R, Sugai A, Dohno C, Hamada M, Krishna S, Nakatani K	Mol Ther Nucleic Acids	27	165-174	2021	200-500 uM	0.2 uM	7.4	80	0.15 M NaCl	Surface Plasmon Resonance (SPR)	Additional	NCCCC(=O)NCCCN1Cc2ccc3c(n2)nc(cc3)NC(=O)OCC/C=C/CCOC(=O)Nc2nc3nc(C1)ccc3cc2	-	-	4.2674	641.307415348	11	4	7	186.58	4	0.166763250606386	5.64179975454645	47	UGCCUACUGAGCUGAAACACAGUUGGUUUGUGUACACUGGCUCAGUUCAGCAGGAACAG	10.1016/j.omtn.2021.11.021	miRNA	pre-miRNA	59	-	Stem-Loop	0	0	0	0	2.04E-09	2.04E-09	0	0	0	0
1817	DMA-135	Target_lig_1019	EV71 SLII RNA	Enterovirus A71	Hand, foot and mouth disease	Target_329	0	0	5.2e-07±9e-08	0	0	0	0	-	-	10.1038/s41467-020-18594-3	32963221	IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex.	Davila-Calderon J, Patwardhan NN, Chiu LY, Sugarman A, Cai Z, Penutmutchu SR, Li ML, Brewer G, Hargrove AE, Tolbert BS	Nat Commun	11	4775	2020	0-50 nM	90 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	CN(C)C1=C(N=C(C(=N1)N)C(=O)[NH+]=C(N)N)C#CC2=CC=CC=C2	[3-amino-5-(dimethylamino)-6-(2-phenylethynyl)pyrazine-2-carbonyl]-(diaminomethylidene)azanium	154573938	-1.9812	324.15673461609	5	4	2	138.12	2	0.285132447560012	3.52479574105296	24	GGAUCAAUAGCAGGUGUGGCACACCAGUCAUACCUUGAUCC	6XB7	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	41	5'-UTR	Stem-Loop	0	0	0	0	4.30E-07	6.10E-07	0	0	0	0
1818	DMA-001	Target_lig_1020	EV71 SLII RNA	Enterovirus A71	Hand, foot and mouth disease	Target_329	0	0	5.8e-07±6e-08	0	0	0	0	-	-	10.1038/s41467-020-18594-3	32963221	IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex.	Davila-Calderon J, Patwardhan NN, Chiu LY, Sugarman A, Cai Z, Penutmutchu SR, Li ML, Brewer G, Hargrove AE, Tolbert BS	Nat Commun	11	4775	2020	0-50 nM	90 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(Cl)c(nc1N)N(C)C)NC(=[NH2+])N	-	-	-2.4182	258.08646213609	5	4	2	135.75	1	0.344346997493619	3.51825993848391	17	GGAUCAAUAGCAGGUGUGGCACACCAGUCAUACCUUGAUCC	6XB7	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	41	5'-UTR	Stem-Loop	0	0	0	0	5.20E-07	6.40E-07	0	0	0	0
1819	DMA-155	Target_lig_1021	EV71 SLII RNA	Enterovirus A71	Hand, foot and mouth disease	Target_329	0	0	2.7e-07±5.6e-07	0	0	0	0	-	-	10.1038/s41467-020-18594-3	32963221	IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex.	Davila-Calderon J, Patwardhan NN, Chiu LY, Sugarman A, Cai Z, Penutmutchu SR, Li ML, Brewer G, Hargrove AE, Tolbert BS	Nat Commun	11	4775	2020	0-50 nM	90 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	CN(c1nc(N)c(nc1c1ccc(cc1)c1ccccc1)C(=O)NC(=[NH2+])N)C	-	-	0.262400000000001	376.18803474409	5	4	4	135.75	3	0.380959014949487	2.79678565117154	28	GGAUCAAUAGCAGGUGUGGCACACCAGUCAUACCUUGAUCC	6XB7	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	41	5'-UTR	Stem-Loop	0	0	0	0	2.90E-07	8.30E-07	0	0	0	0
1820	SMB1	Target_lig_1278	Pre-miR-210	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	1.60E-07	5.00E-07	0	0	0	-	-	10.1002/cbic.202000287	32495978	Chemical Knockdown of MicroRNA with Small-Molecule Chimeras.	Feng Y, Li J, Zhang Y	Chembiochem	21	3180-3185	2020	-	-	-	-	-	-	Additional	N=[N+]=NCCCNC(=O)CCCOc1cccc(c1)c1nc2c([nH]1)ccc(c2)c1nc2c([nH]1)cc(cc2)N1CCN(CC1)C			4.74067	593.30954684409	8	4	12	152.48	5	0.093144618388339	3.09342379964496	44	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	1.60E-07	1.60E-07	5.00E-07	5.00E-07	0	0
1821	SMB2	Target_lig_1022	Pri-miR-96	Homo sapiens	Cancer,Breast cancer	Target_159	0	0	2.00E-08	5.00E-08	0	0	0	-	-	10.1002/cbic.202000287	32495978	Chemical Knockdown of MicroRNA with Small-Molecule Chimeras.	Feng Y, Li J, Zhang Y	Chembiochem	21	3180-3185	2020	-	-	-	-	-	-	Additional	CCCN(C(=O)NCc1nnn(c1)CCCCC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1[nH]c2c(n1)cc(cc2)N1CCN(CC1)C)C(C)(C)C)CC(=O)N(C(=O)CCCOc1ccc(cc1)c1[nH]c2c(n1)cc(cc2)N1CCN(CC1)C)CCC	-	-	10.6079	1202.748076728	15	3	27	206.28	7	0.040991319278421	4.6370831793447	88	GGGAGAGGGUUUAAUUACGAAAGUAAUUGGAUCCGCAAGG	10.1073/pnas.1523975113	miRNA	pri-miRNA	40	Nuclease processing site	Internal Loop	0	0	0	0	2.00E-08	2.00E-08	5.00E-08	5.00E-08	0	0
1822	SMB3	Target_lig_1023	Pre-miR-21	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	9.80E-07	1.00E-06	0	0	0	-	-	10.1002/cbic.202000287	32495978	Chemical Knockdown of MicroRNA with Small-Molecule Chimeras.	Feng Y, Li J, Zhang Y	Chembiochem	21	3180-3185	2020	-	-	-	-	-	-	Additional	CCCN(C(=O)CN(C(=O)NCc1nnn(c1)CCCCC(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)CCC)CC(=O)N(CC(=O)N(Cc1nnn(c1)CCCCC(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)CC(=O)N)CCC	-	-	10.9039	1592.892115164	21	4	44	320.7	10	0.025782690903878	5.50700431918372	117	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	9.80E-07	9.80E-07	1.00E-06	1.00E-06	0	0
1823	SMB4	Target_lig_1279	Pre-miR-17/18a/20a	Homo sapiens	Cancer	Target_331	0	0	1.20E-07	5.00E-07	0	0	0	-	-	10.1002/cbic.202000287	32495978	Chemical Knockdown of MicroRNA with Small-Molecule Chimeras.	Feng Y, Li J, Zhang Y	Chembiochem	21	3180-3185	2020	-	-	-	-	-	-	Additional	CCCN(C(=O)CN(C(=O)NCc1nnn(c1)CCCCC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)C(C)(C)C)CCC)CC(=O)N(CC(=O)N(Cc1nnn(c1)CCCCC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)C(C)(C)C)CC(=O)N)CCC			16.0939	1817.142516188	21	4	44	320.7	10	0.025779238524025	6.24875434205145	133	UAGCUUAUCAGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGAUGGGCUGU	10.1002/cbic.202000287	miRNA	pre-miRNA	59	Dicer site	Internal Loop	0	0	0	0	1.20E-07	1.20E-07	5.00E-07	5.00E-07	0	0
1824	SMC1	Target_lig_1024	Pre-miR-210	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	1.90E-07	2.00E-07	0	0	0	-	-	10.1002/cbic.202000287	32495978	Chemical Knockdown of MicroRNA with Small-Molecule Chimeras.	Feng Y, Li J, Zhang Y	Chembiochem	21	3180-3185	2020	-	-	-	-	-	-	Additional	OC(COP(=O)(OC1C(O)C(OC1n1cnc2c1ncnc2N)COP(=O)(OC1C(O)C(OC1n1cnc2c1ncnc2N)COP(=O)(OC1C(O)C(OC1n1cnc2c1ncnc2N)COP(=O)(OC1C(O)C(OC1n1cnc2c1ncnc2N)COP(=O)(O)O)O)O)O)O)COCCCNC(=O)CCCOc1cccc(c1)c1nc2c([nH]1)ccc(c2)c1nc2c([nH]1)cc(cc2)N1CCN(CC1)C	-	-	0.407500000000014	2037.508976934	50	18	41	817.75	13	0.018219357701012	7.80834642935	139	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	1.90E-07	1.90E-07	2.00E-07	2.00E-07	0	0
1825	SMC2	Target_lig_1025	Pri-miR-96	Homo sapiens	Cancer,Breast cancer	Target_159	0	0	8.40E-08	2.00E-08	0	0	0	-	-	10.1002/cbic.202000287	32495978	Chemical Knockdown of MicroRNA with Small-Molecule Chimeras.	Feng Y, Li J, Zhang Y	Chembiochem	21	3180-3185	2020	-	-	-	-	-	-	Additional	CCCN(C(=O)N(Cc1nnn(c1)CCCCC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)N1CCN(CC1)C)C(C)(C)C)CCOCCOCCOP(=O)(OC1C(O)C(OC1n1cnc2c1ncnc2N)COP(=O)(OC1C(O)C(OC1n1cnc2c1ncnc2N)COP(=O)(OC1C(O)C(OC1n1cnc2c1ncnc2N)COP(=O)(OC1C(O)C(OC1n1cnc2c1ncnc2N)COP(=O)(O)O)O)O)O)O)CC(=O)N(C(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)ccc(c2)N1CCN(CC1)C)CCC	-	-	7.19320000000002	2731.00313043	59	16	61	902.07	15	0.013231867921872	9.0464465885299	189	GGGAGAGGGUUUAAUUACGAAAGUAAUUGGAUCCGCAAGG	10.1073/pnas.1523975113	miRNA	pri-miRNA	40	Nuclease processing site	Internal Loop	0	0	0	0	8.40E-08	8.40E-08	2.00E-08	2.00E-08	0	0
1826	SMC2-2	Target_lig_1026	Pri-miR-96	Homo sapiens	Cancer,Breast cancer	Target_159	0	0	6.40E-08	5.00E-08	0	0	0	-	-	10.1002/cbic.202000287	32495978	Chemical Knockdown of MicroRNA with Small-Molecule Chimeras.	Feng Y, Li J, Zhang Y	Chembiochem	21	3180-3185	2020	-	-	-	-	-	-	Additional	CCCN(C(=O)N(Cc1nnn(c1)CCCCC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)N1CCN(CC1)C)C(C)(C)C)CC(=O)NCCCCNCCCNC(=O)c1csc(n1)c1csc(n1)CCNC(=O)C(C(O)C)NC(=O)C(C(C(NC(=O)C(C(c1cnc[nH]1)OC1OC(CO)C(C(C1OC1OC(CO)C(C(C1O)OC(=O)N)O)O)O)NC(=O)c1nc(nc(c1C)N)C(CC(=O)N)NCC(C(=O)N)N)C)O)C)CC(=O)N(C(=O)CCCOc1ccc(cc1)c1nc2c([nH]1)ccc(c2)N1CCN(CC1)C)CCC	-	-	2.23842000000003	2682.335174216	48	24	69	865.69	11	0.024303649235382	9.07638759026429	190	GGGAGAGGGUUUAAUUACGAAAGUAAUUGGAUCCGCAAGG	10.1073/pnas.1523975113	miRNA	pri-miRNA	40	Nuclease processing site	Internal Loop	0	0	0	0	6.40E-08	6.40E-08	5.00E-08	5.00E-08	0	0
1827	SMC3	Target_lig_1027	Pre-miR-21	Homo sapiens	Cancer,Breast cancer	Target_227	0	0	0	5.00E-08	0	0	0	-	-	10.1002/cbic.202000287	32495978	Chemical Knockdown of MicroRNA with Small-Molecule Chimeras.	Feng Y, Li J, Zhang Y	Chembiochem	21	3180-3185	2020	-	-	-	-	-	-	Additional		-	-	0	0	0	0	0	0	0	0.339423589845509	0	0	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	10.1021/jacs.6b11273	miRNA	pre-miRNA	60	-	-	0	0	0	0	0	0	5.00E-08	5.00E-08	0	0
1828	SMC4	-	Pri-miR-17-92	Homo sapiens	Cancer	Target_332	0	0	0	1.00E-08	0	0	0	-	-	10.1002/cbic.202000287	32495978	Chemical Knockdown of MicroRNA with Small-Molecule Chimeras.	Feng Y, Li J, Zhang Y	Chembiochem	21	3180-3185	2020	-	-	-	-	-	-	Additional	-	-	-	0	0	0	0	0	0	0	0	0	0			miRNA	pri-miRNA	0	Drosha site	Internal Loop	0	0	0	0	0	0	1.00E-08	1.00E-08	0	0
1829	SMC4-2	-	Pre-miR-17/18a/20a	Homo sapiens	Cancer	Target_331	0	0	0	1.00E-07	0	0	0	-	-	10.1002/cbic.202000287	32495978	Chemical Knockdown of MicroRNA with Small-Molecule Chimeras.	Feng Y, Li J, Zhang Y	Chembiochem	21	3180-3185	2020	-	-	-	-	-	-	Additional	-	-	-	0	0	0	0	0	0	0	0	0	0	UAGCUUAUCAGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGAUGGGCUGU	10.1002/cbic.202000287	miRNA	pre-miRNA	59	Dicer site	Internal Loop	0	0	0	0	0	0	1.00E-07	1.00E-07	0	0
1830	MTDB	Target_lig_706	SARS-CoV pseudoknot	SARS-CoV	Severe Acute Respiratory Syndrome (SARS)	Target_218	0	0	0.00020999999999999998±1.9999999999999998e-05	0	0	0	0	-	-	10.1021/ja410344b	24446874	Anti-frameshifting ligand reduces the conformational plasticity of the SARS virus pseudoknot	Ritchie DB, Soong J, Sikkema WKA, Woodside MT	J Am Chem Soc	136	2196-9	2014	125 μM, 250 μM, or 500 μM	40 uM	7.5	37	100 mM KCl, 10 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	CCOC(=O)C1=CC=CC=C1NC(=O)N2CCCN(CC2)CC3=CSC(=N3)C	ethyl 2-[[4-[(2-methyl-1,3-thiazol-4-yl)methyl]-1,4-diazepane-1-carbonyl]amino]benzoate	23850430	3.36802	402.172561692	6	1	5	74.77	2	0.776413285412828	2.15410985235497	28	CGGUGUAAGUGCAGCCCGUCUUACACCGUGCGGCACAGCGGAAACGCUGAUGUCGUAUACAGGGCU	https://www.rcsb.org/structure/7LYJ	Pseudoknot structure	mRNA	66	5’-UTR	Pseudoknot	0	0	0	0	0.00019	0.00023	0	0	0	0
1831	Nafamostat	Target_lig_1028	SARS-CoV-2 -1PRF	SARS-CoV-2	Severe Acute Respiratory Syndrome (SARS)	Target_333	0	0	0	5e-07±4e-07	0	0	0	-	-	10.3390/v14020177	-	Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses	Munshi S, Neupane K, Ileperuma SM, Halma MTJ, Kelly JA, Halpern CF, Dinman JD, Loerch S, Woodside MT	Viruses	14	177	2022	10 uM	-	-	30	25 mM potassium chloride, 0.5 mM mag- nesium acetate, and 65 mM potassium acetate	Dual luciferase reporter assay	Additional	C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N	(6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate	4413	0	0	0	0	0	0	0	0	0	0	GCGGTGTAAGTGCAGCCCGTCTTACACCGTGCGGCACAGGCACTAGTACTGATGTCGTATACAGGGCTT	10.3390/v14020177	mRNA, Pseudoknot, Viral RNA	Programmed −1 ribosomal frameshifting (−1 PRF) elements	69		Pseudoknot	0	0	0	0	0	0	1.00E-07	9.00E-07	0	0
1832	Abemaciclib	Target_lig_1029	SARS-CoV-2 -1PRF	SARS-CoV-2	Severe Acute Respiratory Syndrome (SARS)	Target_333	0	0	0	6e-07±2e-07	0	0	0	-	-	10.3390/v14020177	-	Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses	Munshi S, Neupane K, Ileperuma SM, Halma MTJ, Kelly JA, Halpern CF, Dinman JD, Loerch S, Woodside MT	Viruses	14	177	2022	10 uM	-	-	30	25 mM potassium chloride, 0.5 mM mag- nesium acetate, and 65 mM potassium acetate	Dual luciferase reporter assay	Additional	CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F	N-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine	46220502	2.24797	347.138224784	4	4	4	140.57	3	0.24783412617485	2.95869848308124	37	GCGGTGTAAGTGCAGCCCGTCTTACACCGTGCGGCACAGGCACTAGTACTGATGTCGTATACAGGGCTT	10.3390/v14020177	mRNA, Pseudoknot, Viral RNA	Programmed −1 ribosomal frameshifting (−1 PRF) elements	69		Pseudoknot	0	0	0	0	0	0	4.00E-07	8.00E-07	0	0
1833	Palbociclib	Target_lig_1030	SARS-CoV-2 -1PRF	SARS-CoV-2	Severe Acute Respiratory Syndrome (SARS)	Target_333	0	0	0	6e-07±3e-07	0	0	0	-	-	10.3390/v14020177	-	Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses	Munshi S, Neupane K, Ileperuma SM, Halma MTJ, Kelly JA, Halpern CF, Dinman JD, Loerch S, Woodside MT	Viruses	14	177	2022	10 uM	-	-	30	25 mM potassium chloride, 0.5 mM mag- nesium acetate, and 65 mM potassium acetate	Dual luciferase reporter assay	Additional	CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C	6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one	5330286	4.93692	506.271799464	8	1	7	75	4	0.380688307358855	2.86988898062079	33	GCGGTGTAAGTGCAGCCCGTCTTACACCGTGCGGCACAGGCACTAGTACTGATGTCGTATACAGGGCTT	10.3390/v14020177	mRNA, Pseudoknot, Viral RNA	Programmed −1 ribosomal frameshifting (−1 PRF) elements	69		Pseudoknot	0	0	0	0	0	0	3.00E-07	9.00E-07	0	0
1834	Valnemulin	Target_lig_237	SARS-CoV-2 -1PRF	SARS-CoV-2	Severe Acute Respiratory Syndrome (SARS)	Target_333	0	0	0	4e-08±3e-08	0	0	0	-	-	10.3390/v14020177	-	Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses	Munshi S, Neupane K, Ileperuma SM, Halma MTJ, Kelly JA, Halpern CF, Dinman JD, Loerch S, Woodside MT	Viruses	14	177	2022	10 uM	-	-	30	25 mM potassium chloride, 0.5 mM mag- nesium acetate, and 65 mM potassium acetate	Dual luciferase reporter assay	Additional	CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC(C)(C)CNC(=O)C(C(C)C)N)C	(4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl) 2-[1-[(2-amino-3-methylbutanoyl)amino]-2-methylpropan-2-yl]sulfanylacetate	21706784	4.5042	564.359693764	7	3	9	118.72	0	0.27860165101001	5.84151584191295	39	GCGGTGTAAGTGCAGCCCGTCTTACACCGTGCGGCACAGGCACTAGTACTGATGTCGTATACAGGGCTT	10.3390/v14020177	mRNA, Pseudoknot, Viral RNA	Programmed −1 ribosomal frameshifting (−1 PRF) elements	69		Pseudoknot	0	0	0	0	0	0	1.00E-08	7.00E-08	0	0
1835	Bisantrene	Target_lig_1031	(5'CAG/3'GGC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_334	0	0	4e-06±3.6e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CN=C(N1)NN=CC2=C3C=CC=CC3=C(C4=CC=CC=C42)C=NNC5=NCCN5	N-[[10-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	51323	2.96582	447.238273168	9	2	5	105.04	3	0.575410887441828	3.09194787889204	30	GGGAGAGGGUUUAAUUCAGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	3.64E-06	4.36E-06	0	0	0	0
1836	Bisantrene	Target_lig_1031	(5'CCG/3'GAC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_335	0	0	1.2e-06±2.8e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CN=C(N1)NN=CC2=C3C=CC=CC3=C(C4=CC=CC=C42)C=NNC5=NCCN5	N-[[10-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	51323	2.96582	447.238273168	9	2	5	105.04	3	0.575410887441828	3.09194787889204	30	GGGAGAGGGUUUAAUUCCGUACGAAAGUACAGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	9.20E-07	1.48E-06	0	0	0	0
1837	Bisantrene	Target_lig_1031	(5'CGG/3'GAC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_336	0	0	6e-06±2.9e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CN=C(N1)NN=CC2=C3C=CC=CC3=C(C4=CC=CC=C42)C=NNC5=NCCN5	N-[[10-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	51323	2.96582	447.238273168	9	2	5	105.04	3	0.575410887441828	3.09194787889204	30	GGGAGAGGGUUUAAUUCGGUACGAAAGUACAGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	5.71E-06	6.29E-06	0	0	0	0
1838	Bisantrene	Target_lig_1031	(5'CCG/3'GUC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_337	0	0	4.599999999999999e-06±1.8999999999999998e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CN=C(N1)NN=CC2=C3C=CC=CC3=C(C4=CC=CC=C42)C=NNC5=NCCN5	N-[[10-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	51323	2.96582	447.238273168	9	2	5	105.04	3	0.575410887441828	3.09194787889204	30	GGGAGAGGGUUUAAUUCCGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	4.41E-06	4.79E-06	0	0	0	0
1839	Bisantrene	Target_lig_1031	(5'CAG/3'GCC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_338	0	0	1.1e-06±1.3e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CN=C(N1)NN=CC2=C3C=CC=CC3=C(C4=CC=CC=C42)C=NNC5=NCCN5	N-[[10-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	51323	2.96582	447.238273168	9	2	5	105.04	3	0.575410887441828	3.09194787889204	30	GGGAGAGGGUUUAAUUCAGUACGAAAGUACCGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	9.70E-07	1.23E-06	0	0	0	0
1840	Bisantrene	Target_lig_1031	(5'CUG/3'GCC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_339	0	0	1.2e-06±3e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CN=C(N1)NN=CC2=C3C=CC=CC3=C(C4=CC=CC=C42)C=NNC5=NCCN5	N-[[10-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	51323	2.96582	447.238273168	9	2	5	105.04	3	0.575410887441828	3.09194787889204	30	GGGAGAGGGUUUAAUUCUGUACGAAAGUACCGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	9.00E-07	1.50E-06	0	0	0	0
1841	Bisantrene	Target_lig_1031	(5'CGG/3'GCC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_340	0	0	3.4000000000000003e-07±8e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CN=C(N1)NN=CC2=C3C=CC=CC3=C(C4=CC=CC=C42)C=NNC5=NCCN5	N-[[10-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	51323	2.96582	447.238273168	9	2	5	105.04	3	0.575410887441828	3.09194787889204	30	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	2.60E-07	4.20E-07	0	0	0	0
1842	Bisantrene	Target_lig_1031	(5'CAG/3'GAC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_341	0	0	1.6e-06±3.6e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CN=C(N1)NN=CC2=C3C=CC=CC3=C(C4=CC=CC=C42)C=NNC5=NCCN5	N-[[10-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	51323	2.96582	447.238273168	9	2	5	105.04	3	0.575410887441828	3.09194787889204	30	GGGAGAGGGUUUAAUUCAGUACGAAAGUACAGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.24E-06	1.96E-06	0	0	0	0
1843	Bisantrene	Target_lig_1031	(5'CCG/3'GGC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_342	0	0	2.8999999999999998e-06±5.1e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CN=C(N1)NN=CC2=C3C=CC=CC3=C(C4=CC=CC=C42)C=NNC5=NCCN5	N-[[10-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	51323	2.96582	447.238273168	9	2	5	105.04	3	0.575410887441828	3.09194787889204	30	GGGAGAGGGUUUAAUUCCGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	2.39E-06	3.41E-06	0	0	0	0
1844	Bisantrene	Target_lig_1031	(5'CUG/3'GUC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_343	0	0	3.7e-06±2.1999999999999998e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CN=C(N1)NN=CC2=C3C=CC=CC3=C(C4=CC=CC=C42)C=NNC5=NCCN5	N-[[10-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	51323	2.96582	447.238273168	9	2	5	105.04	3	0.575410887441828	3.09194787889204	30	GGGAGAGGGUUUAAUUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	3.48E-06	3.92E-06	0	0	0	0
1845	Bisantrene	Target_lig_1031	(5'CAG/3'CUG) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_344	0	0	2.8e-06±3.6e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CN=C(N1)NN=CC2=C3C=CC=CC3=C(C4=CC=CC=C42)C=NNC5=NCCN5	N-[[10-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine	51323	2.96582	447.238273168	9	2	5	105.04	3	0.575410887441828	3.09194787889204	30	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	2.44E-06	3.16E-06	0	0	0	0
1846	B1	Target_lig_716	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	2.4e-07±5e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	-	-	-0.407599999999999	374.14802665618	4	4	5	155.28	4	0.274884040129034	3.4899140831242	28	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.90E-07	2.90E-07	0	0	0	0
1847	B2	Target_lig_693	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	1.1e-06±1.8999999999999998e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C[NH+](C)CCC[NH+]=C(C1=CC=C(C=C1)C(=[NH+]CCC[NH+](C)C)N)N	3-[amino-[4-[amino-[3-(dimethylazaniumyl)propylazaniumylidene]methyl]phenyl]methylidene]azaniumylpropyl-dimethylazanium	53245673	-5.67240000000001	336.29795083236	0	6	10	88.86	1	0.146141947102826	5.5427530837103	24	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	9.10E-07	1.29E-06	0	0	0	0
1848	B3	Target_lig_246	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	3.5e-06±5.1e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	CN(C)CCCN=C(C1=CC=C(C=C1)C2=CC=C(O2)C3=NC4=C(N3)C=C(C=C4)C(=NCCCN(C)C)N)N	N'-[3-(dimethylamino)propyl]-2-[5-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]furan-2-yl]-3H-benzimidazole-5-carboximidamide	460172	3.8039	514.316857836	6	3	12	125.06	4	0.15000822757931	2.99943212073298	38	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	2.99E-06	4.01E-06	0	0	0	0
1849	B4	Target_lig_1035	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	3.3e-07±1.2e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	CC(C)C1=CC2=C(C=C1)N=C3C=CC(=CN3C2=O)C(=O)NCCN(C)C	N-[2-(dimethylamino)ethyl]-11-oxo-2-propan-2-ylpyrido[2,1-b]quinazoline-8-carboxamide	353136	5.6753	414.103813436	6	1	4	60.45	3	0.303015523486502	2.33269872023289	26	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	2.10E-07	4.50E-07	0	0	0	0
1850	B5	Target_lig_957	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	1.4e-06±3.3e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	COC1=CC(=CC(=C1O)OC)C2=NC3=C(N2)C=C4C(=C3)NC(=O)N4	6-(4-hydroxy-3,5-dimethoxyphenyl)-3,5-dihydro-1H-imidazo[4,5-f]benzimidazol-2-one	136076879	2.1223	326.101504928	5	4	3	116.02	4	0.460063341965074	2.51402533792667	24	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.07E-06	1.73E-06	0	0	0	0
1851	B6	Target_lig_696	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	3.8999999999999997e-07±4e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1C[NH+]=C(N1)C2=CC=C(C=C2)C3=CC=C(O3)C4=CC=C(C=C4)C5=[NH+]CCN5	2-[4-[5-[4-(4,5-dihydro-1H-imidazol-3-ium-2-yl)phenyl]furan-2-yl]phenyl]-4,5-dihydro-1H-imidazol-3-ium	90683503	-0.525599999999997	358.17826416418	3	4	4	65.14	3	0.50730389793346	3.91141171767896	27	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	3.50E-07	4.30E-07	0	0	0	0
1852	B7	Target_lig_697	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	2.7e-07±6e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=[NH2+])N)C(=[NH2+])N	[amino-[4-[5-[4-[amino(azaniumylidene)methyl]phenyl]furan-2-yl]phenyl]methylidene]azanium	3471142	-0.457599999999997	306.14696403618	1	4	4	116.36	3	0.385925632078986	2.97301660006976	23	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	2.10E-07	3.30E-07	0	0	0	0
1853	B8	Target_lig_1039	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	1.4e-06±2.0999999999999997e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1N(C2=CC=CC=C2N(C1)C(=O)/C=C/C3=CC=CC=C3)C(=O)/C=C/C4=CC=CC=C4	(E)-3-phenyl-1-[4-[(E)-3-phenylprop-2-enoyl]-2,3-dihydroquinoxalin-1-yl]prop-2-en-1-one	5794474	2.5997	395.170587532	9	3	7	117.27	4	0.433856788514248	2.2586845622682	30	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.19E-06	1.61E-06	0	0	0	0
1854	B9	Target_lig_1040	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	2.2999999999999996e-06±4.0999999999999994e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	CCN(CC)CC(=O)NC1=CC=CC2=C1C(=O)C3=C(C4=CC=CC=C4C(=C3C2=O)O)O	2-(diethylamino)-N-(6,11-dihydroxy-5,12-dioxotetracen-1-yl)acetamide	423074	4.793	394.168127944	2	0	4	40.62	3	0.596988634845509	2.45255969644676	31	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.89E-06	2.71E-06	0	0	0	0
1855	B10	Target_lig_1041	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	5.299999999999999e-06±6.6e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CC2=C(CC1C(=O)O)C(=NC(=N2)NCC3=CC=CC=C3)NCC4=CC=CC=C4	2,4-bis(benzylamino)-5,6,7,8-tetrahydroquinazoline-6-carboxylic acid	235467	3.3067	418.152871804	6	3	5	106.94	3	0.429463763130821	2.71759423678448	29	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	4.64E-06	5.96E-06	0	0	0	0
1856	B11	Target_lig_1042	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	3.6e-07±7e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	1,4-bis(2-morpholin-4-ylethylamino)anthracene-9,10-dione	72737	3.8903	388.189926008	5	3	7	87.14	3	0.569187922596182	2.52077524626917	34	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	2.90E-07	4.30E-07	0	0	0	0
1857	B12	Target_lig_716	(5'CGG/3'GGC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_345	0	0	5.2e-06±5.1e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	-	-	-0.407599999999999	374.14802665618	4	4	5	155.28	4	0.274884040129034	3.4899140831242	28	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	4.69E-06	5.71E-06	0	0	0	0
1858	B1	Target_lig_716	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	3.6e-06±3.5e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	-	-	-0.407599999999999	374.14802665618	4	4	5	155.28	4	0.274884040129034	3.4899140831242	28	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	3.25E-06	3.95E-06	0	0	0	0
1859	B2	Target_lig_693	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	3.7e-07±1.7000000000000001e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C[NH+](C)CCC[NH+]=C(C1=CC=C(C=C1)C(=[NH+]CCC[NH+](C)C)N)N	3-[amino-[4-[amino-[3-(dimethylazaniumyl)propylazaniumylidene]methyl]phenyl]methylidene]azaniumylpropyl-dimethylazanium	53245673	-5.67240000000001	336.29795083236	0	6	10	88.86	1	0.146141947102826	5.5427530837103	24	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	2.00E-07	5.40E-07	0	0	0	0
1860	B3	Target_lig_246	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	1.4e-06±1.7000000000000001e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	CN(C)CCCN=C(C1=CC=C(C=C1)C2=CC=C(O2)C3=NC4=C(N3)C=C(C=C4)C(=NCCCN(C)C)N)N	N'-[3-(dimethylamino)propyl]-2-[5-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]furan-2-yl]-3H-benzimidazole-5-carboximidamide	460172	3.8039	514.316857836	6	3	12	125.06	4	0.15000822757931	2.99943212073298	38	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.23E-06	1.57E-06	0	0	0	0
1861	B4	Target_lig_1035	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	4.9000000000000005e-06±7.5e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	CC(C)C1=CC2=C(C=C1)N=C3C=CC(=CN3C2=O)C(=O)NCCN(C)C	N-[2-(dimethylamino)ethyl]-11-oxo-2-propan-2-ylpyrido[2,1-b]quinazoline-8-carboxamide	353136	5.6753	414.103813436	6	1	4	60.45	3	0.303015523486502	2.33269872023289	26	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	4.15E-06	5.65E-06	0	0	0	0
1862	B5	Target_lig_957	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	1.5e-06±4.3999999999999997e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	COC1=CC(=CC(=C1O)OC)C2=NC3=C(N2)C=C4C(=C3)NC(=O)N4	6-(4-hydroxy-3,5-dimethoxyphenyl)-3,5-dihydro-1H-imidazo[4,5-f]benzimidazol-2-one	136076879	2.1223	326.101504928	5	4	3	116.02	4	0.460063341965074	2.51402533792667	24	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.06E-06	1.94E-06	0	0	0	0
1863	B6	Target_lig_696	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	1.3e-06±2.5e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1C[NH+]=C(N1)C2=CC=C(C=C2)C3=CC=C(O3)C4=CC=C(C=C4)C5=[NH+]CCN5	2-[4-[5-[4-(4,5-dihydro-1H-imidazol-3-ium-2-yl)phenyl]furan-2-yl]phenyl]-4,5-dihydro-1H-imidazol-3-ium	90683503	-0.525599999999997	358.17826416418	3	4	4	65.14	3	0.50730389793346	3.91141171767896	27	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.05E-06	1.55E-06	0	0	0	0
1864	B7	Target_lig_697	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	1.8999999999999998e-06±3e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=[NH2+])N)C(=[NH2+])N	[amino-[4-[5-[4-[amino(azaniumylidene)methyl]phenyl]furan-2-yl]phenyl]methylidene]azanium	3471142	-0.457599999999997	306.14696403618	1	4	4	116.36	3	0.385925632078986	2.97301660006976	23	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.60E-06	2.20E-06	0	0	0	0
1865	B8	Target_lig_1039	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	7e-07±8e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1N(C2=CC=CC=C2N(C1)C(=O)/C=C/C3=CC=CC=C3)C(=O)/C=C/C4=CC=CC=C4	(E)-3-phenyl-1-[4-[(E)-3-phenylprop-2-enoyl]-2,3-dihydroquinoxalin-1-yl]prop-2-en-1-one	5794474	2.5997	395.170587532	9	3	7	117.27	4	0.433856788514248	2.2586845622682	30	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	6.20E-07	7.80E-07	0	0	0	0
1866	B9	Target_lig_1040	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	4.8e-06±5.699999999999999e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	CCN(CC)CC(=O)NC1=CC=CC2=C1C(=O)C3=C(C4=CC=CC=C4C(=C3C2=O)O)O	2-(diethylamino)-N-(6,11-dihydroxy-5,12-dioxotetracen-1-yl)acetamide	423074	4.793	394.168127944	2	0	4	40.62	3	0.596988634845509	2.45255969644676	31	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	4.23E-06	5.37E-06	0	0	0	0
1867	B10	Target_lig_1041	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	4.1e-06±5.2e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1CC2=C(CC1C(=O)O)C(=NC(=N2)NCC3=CC=CC=C3)NCC4=CC=CC=C4	2,4-bis(benzylamino)-5,6,7,8-tetrahydroquinazoline-6-carboxylic acid	235467	3.3067	418.152871804	6	3	5	106.94	3	0.429463763130821	2.71759423678448	29	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	3.58E-06	4.62E-06	0	0	0	0
1868	B11	Target_lig_1042	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	5.4e-06±6.2e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	1,4-bis(2-morpholin-4-ylethylamino)anthracene-9,10-dione	72737	3.8903	388.189926008	5	3	7	87.14	3	0.569187922596182	2.52077524626917	34	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	4.78E-06	6.02E-06	0	0	0	0
1869	B12	Target_lig_716	(5'CAG/3'GUC) x1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_346	0	0	1.55e-05±1.6e-06	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	-	-	-0.407599999999999	374.14802665618	4	4	5	155.28	4	0.274884040129034	3.4899140831242	28	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.39E-05	1.71E-05	0	0	0	0
1870	B1	Target_lig_716	(5'CGG/3'GGC)x6	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_347	0	0	1.8999999999999998e-07±9e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	-	-	-0.407599999999999	374.14802665618	4	4	5	155.28	4	0.274884040129034	3.4899140831242	28	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	78	5’-UTR	Internal Loop	0	0	0	0	1.00E-07	2.80E-07	0	0	0	0
1871	B4	Target_lig_1035	(5'CGG/3'GGC)x6	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_347	0	0	3.1e-07±7e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	CC(C)C1=CC2=C(C=C1)N=C3C=CC(=CN3C2=O)C(=O)NCCN(C)C	N-[2-(dimethylamino)ethyl]-11-oxo-2-propan-2-ylpyrido[2,1-b]quinazoline-8-carboxamide	353136	5.6753	414.103813436	6	1	4	60.45	3	0.303015523486502	2.33269872023289	26	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	78	5’-UTR	Internal Loop	0	0	0	0	2.40E-07	3.80E-07	0	0	0	0
1872	B6	Target_lig_696	(5'CGG/3'GGC)x6	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_347	0	0	8.699999999999999e-07±2e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1C[NH+]=C(N1)C2=CC=C(C=C2)C3=CC=C(O3)C4=CC=C(C=C4)C5=[NH+]CCN5	2-[4-[5-[4-(4,5-dihydro-1H-imidazol-3-ium-2-yl)phenyl]furan-2-yl]phenyl]-4,5-dihydro-1H-imidazol-3-ium	90683503	-0.525599999999997	358.17826416418	3	4	4	65.14	3	0.50730389793346	3.91141171767896	27	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	78	5’-UTR	Internal Loop	0	0	0	0	6.70E-07	1.07E-06	0	0	0	0
1873	B7	Target_lig_697	(5'CGG/3'GGC)x6	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_347	0	0	1.16e-06±1.6e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=[NH2+])N)C(=[NH2+])N	[amino-[4-[5-[4-[amino(azaniumylidene)methyl]phenyl]furan-2-yl]phenyl]methylidene]azanium	3471142	-0.457599999999997	306.14696403618	1	4	4	116.36	3	0.385925632078986	2.97301660006976	23	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	78	5’-UTR	Internal Loop	0	0	0	0	1.00E-06	1.32E-06	0	0	0	0
1874	B11	Target_lig_1042	(5'CGG/3'GGC)x6	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_347	0	0	3.6e-07±5e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	1,4-bis(2-morpholin-4-ylethylamino)anthracene-9,10-dione	72737	3.8903	388.189926008	5	3	7	87.14	3	0.569187922596182	2.52077524626917	34	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	78	5’-UTR	Internal Loop	0	0	0	0	3.10E-07	4.10E-07	0	0	0	0
1875	B1	Target_lig_716	(5'CAG/3'GUC)x6	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_348	0	0	6.799999999999999e-06±5.699999999999999e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	-	-	-0.407599999999999	374.14802665618	4	4	5	155.28	4	0.274884040129034	3.4899140831242	28	GGGAGAGGGUUUAAUUCAGCAGCAGCAGCAGCAGUACGAAAGUACUGCUGCUGCUGCUGCUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	78	5’-UTR	Internal Loop	0	0	0	0	6.23E-06	7.37E-06	0	0	0	0
1876	B4	Target_lig_1035	(5'CAG/3'GUC)x6	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_348	0	0	4.2e-06±6.5e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	CC(C)C1=CC2=C(C=C1)N=C3C=CC(=CN3C2=O)C(=O)NCCN(C)C	N-[2-(dimethylamino)ethyl]-11-oxo-2-propan-2-ylpyrido[2,1-b]quinazoline-8-carboxamide	353136	5.6753	414.103813436	6	1	4	60.45	3	0.303015523486502	2.33269872023289	26	GGGAGAGGGUUUAAUUCAGCAGCAGCAGCAGCAGUACGAAAGUACUGCUGCUGCUGCUGCUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	78	5’-UTR	Internal Loop	0	0	0	0	3.55E-06	4.85E-06	0	0	0	0
1877	B6	Target_lig_696	(5'CAG/3'GUC)x6	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_348	0	0	2.8e-06±3.5e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1C[NH+]=C(N1)C2=CC=C(C=C2)C3=CC=C(O3)C4=CC=C(C=C4)C5=[NH+]CCN5	2-[4-[5-[4-(4,5-dihydro-1H-imidazol-3-ium-2-yl)phenyl]furan-2-yl]phenyl]-4,5-dihydro-1H-imidazol-3-ium	90683503	-0.525599999999997	358.17826416418	3	4	4	65.14	3	0.50730389793346	3.91141171767896	27	GGGAGAGGGUUUAAUUCAGCAGCAGCAGCAGCAGUACGAAAGUACUGCUGCUGCUGCUGCUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	78	5’-UTR	Internal Loop	0	0	0	0	2.45E-06	3.15E-06	0	0	0	0
1878	B7	Target_lig_697	(5'CAG/3'GUC)x6	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_348	0	0	1.3e-06±3.5e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=[NH2+])N)C(=[NH2+])N	[amino-[4-[5-[4-[amino(azaniumylidene)methyl]phenyl]furan-2-yl]phenyl]methylidene]azanium	3471142	-0.457599999999997	306.14696403618	1	4	4	116.36	3	0.385925632078986	2.97301660006976	23	GGGAGAGGGUUUAAUUCAGCAGCAGCAGCAGCAGUACGAAAGUACUGCUGCUGCUGCUGCUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	78	5’-UTR	Internal Loop	0	0	0	0	9.50E-07	1.65E-06	0	0	0	0
1879	B11	Target_lig_1042	(5'CAG/3'GUC)x6	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_348	0	0	5.2e-06±7.599999999999999e-07	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	1,4-bis(2-morpholin-4-ylethylamino)anthracene-9,10-dione	72737	3.8903	388.189926008	5	3	7	87.14	3	0.569187922596182	2.52077524626917	34	GGGAGAGGGUUUAAUUCAGCAGCAGCAGCAGCAGUACGAAAGUACUGCUGCUGCUGCUGCUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	78	5’-UTR	Internal Loop	0	0	0	0	4.44E-06	5.96E-06	0	0	0	0
1880	B1	Target_lig_716	(5'CGG/3'GGC) x20	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_349	0	0	9.6e-08±2.1e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	-	-	-0.407599999999999	374.14802665618	4	4	5	155.28	4	0.274884040129034	3.4899140831242	28	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	163	5’-UTR	Internal Loop	0	0	0	0	7.50E-08	1.17E-07	0	0	0	0
1881	B4	Target_lig_1035	(5'CGG/3'GGC) x20	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_349	0	0	1.7000000000000001e-07±3.2e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	CC(C)C1=CC2=C(C=C1)N=C3C=CC(=CN3C2=O)C(=O)NCCN(C)C	N-[2-(dimethylamino)ethyl]-11-oxo-2-propan-2-ylpyrido[2,1-b]quinazoline-8-carboxamide	353136	5.6753	414.103813436	6	1	4	60.45	3	0.303015523486502	2.33269872023289	26	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	163	5’-UTR	Internal Loop	0	0	0	0	1.38E-07	2.02E-07	0	0	0	0
1882	B11	Target_lig_1042	(5'CGG/3'GGC) x20	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_349	0	0	2.0999999999999997e-07±3.2e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	1,4-bis(2-morpholin-4-ylethylamino)anthracene-9,10-dione	72737	3.8903	388.189926008	5	3	7	87.14	3	0.569187922596182	2.52077524626917	34	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	163	5’-UTR	Internal Loop	0	0	0	0	1.78E-07	2.42E-07	0	0	0	0
1883	B1	Target_lig_716	(5'CGG/3'GGC) x40	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_350	0	0	8.8e-08±1e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	-	-	-0.407599999999999	374.14802665618	4	4	5	155.28	4	0.274884040129034	3.4899140831242	28	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	284	5’-UTR	Internal Loop	0	0	0	0	7.80E-08	9.80E-08	0	0	0	0
1884	B4	Target_lig_1035	(5'CGG/3'GGC) x40	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_350	0	0	1.0999999999999999e-07±3.6e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	CC(C)C1=CC2=C(C=C1)N=C3C=CC(=CN3C2=O)C(=O)NCCN(C)C	N-[2-(dimethylamino)ethyl]-11-oxo-2-propan-2-ylpyrido[2,1-b]quinazoline-8-carboxamide	353136	5.6753	414.103813436	6	1	4	60.45	3	0.303015523486502	2.33269872023289	26	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	284	5’-UTR	Internal Loop	0	0	0	0	7.40E-08	1.46E-07	0	0	0	0
1885	B11	Target_lig_1042	(5'CGG/3'GGC) x40	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_350	0	0	1.8999999999999998e-07±1e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	1,4-bis(2-morpholin-4-ylethylamino)anthracene-9,10-dione	72737	3.8903	388.189926008	5	3	7	87.14	3	0.569187922596182	2.52077524626917	34	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	284	5’-UTR	Internal Loop	0	0	0	0	1.80E-07	2.00E-07	0	0	0	0
1886	B1	Target_lig_716	(5'CGG/3'GGC) x60	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_351	0	0	7.099999999999999e-08±1.5e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	NC(=[NH2+])C1=CC=C(N=C1)C1=CC=C(O1)C1=CC=C(O1)C1=NC=C(C=C1)C(N)=[NH2+]	-	-	-0.407599999999999	374.14802665618	4	4	5	155.28	4	0.274884040129034	3.4899140831242	28	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	402	5’-UTR	Internal Loop	0	0	0	0	5.60E-08	8.60E-08	0	0	0	0
1887	B4	Target_lig_1035	(5'CGG/3'GGC) x60	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_351	0	0	1e-07±3.2e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	CC(C)C1=CC2=C(C=C1)N=C3C=CC(=CN3C2=O)C(=O)NCCN(C)C	N-[2-(dimethylamino)ethyl]-11-oxo-2-propan-2-ylpyrido[2,1-b]quinazoline-8-carboxamide	353136	5.6753	414.103813436	6	1	4	60.45	3	0.303015523486502	2.33269872023289	26	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	402	5’-UTR	Internal Loop	0	0	0	0	6.80E-08	1.32E-07	0	0	0	0
1888	B11	Target_lig_1042	(5'CGG/3'GGC) x60	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_351	0	0	1.4e-07±1.5e-08	0	0	0	0	-	-	10.1007/s12035-021-02697-z	35040038	Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Kumar A	Mol Neurobiol			2022	400-600 uM	10-20 uM	7	25	(10 mM (K+), pH 7.0) with 50 mM KCl.	Isothermal Titration Calorimetry (ITC)	Additional	C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=CC=CC=C5C3=O	1,4-bis(2-morpholin-4-ylethylamino)anthracene-9,10-dione	72737	3.8903	388.189926008	5	3	7	87.14	3	0.569187922596182	2.52077524626917	34	GGGAGAGGGUUUAAUUCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGUACGAAAGUACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	402	5’-UTR	Internal Loop	0	0	0	0	1.25E-07	1.55E-07	0	0	0	0
1889	AIZA analog 1	Target_lig_1044	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	3.2e-07±1.3e-07	0	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	300 uM	30 uM - 6 mM	7.4	37	150 mM KCl, 10 mM MgCl 2	Isothermal Titration Calorimetry (ITC)	Additional	C1=NC(=C(N1C2C(C(C(O2)COP(=O)(O)O)O)O)N)C(=O)N	[5-(5-amino-4-carbamoylimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate	200	5.8891	396.13615912	3	1	7	55.76	4	0.395888211559076	3.96013063109498	22	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	1.90E-07	4.50E-07	0	0	0	0
1890	AIZA analog 2	Target_lig_1045	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	4.1e-05±4e-06	0	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	300 uM	30 uM - 6 mM	7.4	37	150 mM KCl, 10 mM MgCl 2	Isothermal Titration Calorimetry (ITC)	Additional	Ccn1c2ccc(cc2c2c1cccc2)N1CCNCC1	-	-	-2.7073	338.06275007	9	6	5	203.38	1	0.306190386129745	0	0	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	3.70E-05	4.50E-05	0	0	0	0
1891	AIZA analog 5	Target_lig_1046	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	2.2999999999999996e-06±6e-07	0	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	300 uM	30 uM - 6 mM	7.4	37	150 mM KCl, 10 mM MgCl 2	Isothermal Titration Calorimetry (ITC)	Additional	C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N	5-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazole-4-carboxamide	266934	0	0	0	0	0	0	0	0	0	0	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	1.70E-06	2.90E-06	0	0	0	0
1892	AIZA analog 7	Target_lig_1047	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	1.4e-06±2e-07	0	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	300 uM	30 uM - 6 mM	7.4	37	150 mM KCl, 10 mM MgCl 2	Isothermal Titration Calorimetry (ITC)	Additional	C1=CN=CC=C1N2C=NC(=C2N)C(=O)N	5-amino-1-pyridin-4-ylimidazole-4-carboxamide	91647460	-2.8243	258.096419548	8	5	3	156.85	1	0.390849892370879	2.46221333858414	15	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	1.20E-06	1.60E-06	0	0	0	0
1893	AIZA analog 8	Target_lig_1048	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	8.7e-06±1.4e-06	0	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	300 uM	30 uM - 6 mM	7.4	37	150 mM KCl, 10 mM MgCl 2	Isothermal Titration Calorimetry (ITC)	Additional	C1CNCCC1N2C=NC(=C2N)C(=O)N	5-amino-1-piperidin-4-ylimidazole-4-carboxamide	99795472	-0.0516	203.080709908	5	2	2	99.82	2	0.714034819882525	2.70195619572699	15	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	7.30E-06	1.01E-05	0	0	0	0
1894	AIZA analog 10	Target_lig_1049	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	0.00015±2.9999999999999997e-05	0	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	300 uM	30 uM - 6 mM	7.4	37	150 mM KCl, 10 mM MgCl 2	Isothermal Titration Calorimetry (ITC)	Additional	C1=NC(=C(N1CCO)N)C(=O)N	5-amino-1-(2-hydroxyethyl)imidazole-4-carboxamide	129817592	-0.5113	209.1276601	5	3	2	98.96	1	0.610431675709317	2.63190742679245	12	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	0.00012	0.00018	0	0	0	0
1895	AIZA analog 12	Target_lig_1050	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	5.6e-06±3.2e-06	0	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	300 uM	30 uM - 6 mM	7.4	37	150 mM KCl, 10 mM MgCl 2	Isothermal Titration Calorimetry (ITC)	Additional	NC(=O)c1ncn(c1N)c1ccccn1	-	-	-1.4435	170.08037556	5	3	3	107.16	1	0.51573280239229	2.44652103089183	15	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	2.40E-06	8.80E-06	0	0	0	0
1896	AIZA analog 13	Target_lig_1051	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	6e-07±6e-08	0	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	300 uM	30 uM - 6 mM	7.4	37	150 mM KCl, 10 mM MgCl 2	Isothermal Titration Calorimetry (ITC)	Additional	C1=CC(=CN=C1)N2C=NC(=C2N)C(=O)N	5-amino-1-pyridin-3-ylimidazole-4-carboxamide	86812191	-0.051600000000001	203.080709908	5	2	2	99.82	2	0.714034819882525	2.44458586605666	15	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	5.40E-07	6.60E-07	0	0	0	0
1897	AIZA analog 1	Target_lig_1044	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	0	3.7e-05±1.2e-05	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	3 uL	9 uL	8	37	2 mM MgCl 2, 2mM NaCl	Transcription termination assay	Additional	C1=NC(=C(N1C2C(C(C(O2)COP(=O)(O)O)O)O)N)C(=O)N	[5-(5-amino-4-carbamoylimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate	200	5.8891	396.13615912	3	1	7	55.76	4	0.395888211559076	3.96013063109498	22	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	0	0	2.50E-05	4.90E-05	0	0
1898	AIZA analog 7	Target_lig_1047	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	0	5.7e-06±9e-07	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	3 uL	9 uL	8	37	2 mM MgCl 2, 2mM NaCl	Transcription termination assay	Additional	C1=CN=CC=C1N2C=NC(=C2N)C(=O)N	5-amino-1-pyridin-4-ylimidazole-4-carboxamide	91647460	-2.8243	258.096419548	8	5	3	156.85	1	0.390849892370879	2.46221333858414	15	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	0	0	4.80E-06	6.60E-06	0	0
1899	AIZA analog 8	Target_lig_1048	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	0	1.6e-05±3e-06	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	3 uL	9 uL	8	37	2 mM MgCl 2, 2mM NaCl	Transcription termination assay	Additional	C1CNCCC1N2C=NC(=C2N)C(=O)N	5-amino-1-piperidin-4-ylimidazole-4-carboxamide	99795472	-0.0516	203.080709908	5	2	2	99.82	2	0.714034819882525	2.70195619572699	15	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	0	0	1.30E-05	1.90E-05	0	0
1900	AIZA analog 12	Target_lig_1050	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	0	4.8e-06±9e-07	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	3 uL	9 uL	8	37	2 mM MgCl 2, 2mM NaCl	Transcription termination assay	Additional	NC(=O)c1ncn(c1N)c1ccccn1	-	-	-1.4435	170.08037556	5	3	3	107.16	1	0.51573280239229	2.44652103089183	15	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	0	0	3.90E-06	5.70E-06	0	0
1901	AIZA analog 13	Target_lig_1051	Fusibacterium ulcerans ZTP riboswitch	Fusobacterium ulcerans	Bacterial growth and infection	Target_352	0	0	0	5.7999999999999995e-06±1.5e-06	0	0	0	-	-	10.1016/j.chembiol.2020.07.021	32795418	Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.	Tran B, Pichling P, Tenney L, Connelly CM, Moon MH, Ferré-D'Amaré AR, Schneekloth JS Jr, Jones CP	Cell Chem Biol	27	1241-1249.e4	2020	3 uL	9 uL	8	37	2 mM MgCl 2, 2mM NaCl	Transcription termination assay	Additional	C1=CC(=CN=C1)N2C=NC(=C2N)C(=O)N	5-amino-1-pyridin-3-ylimidazole-4-carboxamide	86812191	-0.051600000000001	203.080709908	5	2	2	99.82	2	0.714034819882525	2.44458586605666	15	UAUCAGUUAUAUGACUGACGGAACGUGGAAUUAACCACAUGAAGUAUAACGAUGACAAUGCCGACCGUCUGGGCG	6WZR	mRNA, Riboswitch	Riboswitch	75	5’-UTR	Bulge	0	0	0	0	0	0	4.30E-06	7.30E-06	0	0
1902	NRAS compound 1	Target_lig_1052	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	1.2e-06±5e-07	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	C1CCN(CC1)C1CCN(CC1)CCCCNc1nc(nc2c1cccc2)c1nnc(o1)c1ccccc1	-	-	-0.0516	203.080709908	5	2	2	99.82	2	0.714034819882525	2.57535620980181	38	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	7.00E-07	1.70E-06	0	0	0	0
1903	NRAS SAR 1	Target_lig_1053	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	1.2e-06±5e-07	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	C1CCN(CC1)C2CCN(CC2)CCCNC3=NC(=NC4=CC=CC=C43)C5=NN=C(O5)C6=CC=CC=C6	2-(5-phenyl-1,3,4-oxadiazol-2-yl)-N-[3-(4-piperidin-1-ylpiperidin-1-yl)propyl]quinazolin-4-amine	53003045	5.48920000000001	511.305958804	8	1	9	83.21	4	0.295509660232651	2.5458418510646	37	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	7.00E-07	1.70E-06	0	0	0	0
1904	NRAS SAR 2	Target_lig_1054	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	2.6e-07±7e-08	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	Fc1ccc(cc1)c1nnc(o1)c1nc(NCCc2ccco2)c2c(n1)cccc2	-	-	5.0991	497.29030874	8	1	8	83.21	4	0.336821782987433	2.40344533783759	30	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	1.90E-07	3.30E-07	0	0	0	0
1905	NRAS SAR 3	Target_lig_1055	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	4.2999999999999996e-07±1.2e-07	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	C1CCC(CC1)NC2=NC(=NC3=CC=CC=C32)C4=NN=C(O4)C5=CC=C(C=C5)F	N-cyclohexyl-2-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]quinazolin-4-amine	46354948	4.7335	401.128802972	7	1	6	89.87	5	0.439673915036185	2.29998424173589	29	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	3.10E-07	5.50E-07	0	0	0	0
1906	NRAS SAR 6	Target_lig_1056	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	7.4e-07±3e-08	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	CCCSCCCNC1=NC(=NC2=CC=CC=C21)C3=NN=C(O3)C4=CC=CC=C4	2-(5-phenyl-1,3,4-oxadiazol-2-yl)-N-(3-propylsulfanylpropyl)quinazolin-4-amine	53012943	5.2305	389.16518848	6	1	4	76.73	4	0.514914662890012	2.43285418806863	29	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	7.10E-07	7.70E-07	0	0	0	0
1907	NRAS SAR 7	Target_lig_1057	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	3.6e-07±6e-08	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	C1=CC=C(C=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)NCCC5=CC=CS5	2-(5-phenyl-1,3,4-oxadiazol-2-yl)-N-(2-thiophen-2-ylethyl)quinazolin-4-amine	53090522	5.292	405.162331356	7	1	9	76.73	4	0.37901201302826	2.32268773319231	29	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	3.00E-07	4.20E-07	0	0	0	0
1908	NRAS SAR 8	Target_lig_1058	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	3e-06±1.6999999999999998e-06	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	Clc1ccc(cc1)c1nnc(o1)c1nc2ccccc2c(n1)c1ccc(cc1)N(C)C	-	-	5.0629	399.115381164	7	1	6	76.73	5	0.429866966297547	2.29730831898701	31	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	1.30E-06	4.70E-06	0	0	0	0
1909	NRAS SAR 10	Target_lig_1059	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	4.8e-07±8e-08	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	CC1=CC(=CC=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)NCCC5=CN=CN5	N-[2-(1H-imidazol-5-yl)ethyl]-2-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinazolin-4-amine	53012965	5.7332	427.119987876	6	0	4	67.94	5	0.364380811824864	2.53766901977363	30	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	4.00E-07	5.60E-07	0	0	0	0
1910	NRAS SAR 12	Target_lig_1060	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	3e-07±6e-08	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	CC1=CC(=CC=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)NCCN5CCOCC5	2-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]-N-(2-morpholin-4-ylethyl)quinazolin-4-amine	53012972	4.03292	397.165108228	7	2	6	105.41	5	0.445442043681521	2.42141624540842	31	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	2.40E-07	3.60E-07	0	0	0	0
1911	NRAS SAR 14	Target_lig_1061	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	2.8e-07±4e-08	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	CC1=CC(=CC=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)NCCC5=C(ON=C5C)C	N-[2-(3,5-dimethyl-1,2-oxazol-4-yl)ethyl]-2-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinazolin-4-amine	53012974	3.39932	416.196074008	8	1	6	89.2	4	0.511590032314606	2.54866298309073	32	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	2.40E-07	3.20E-07	0	0	0	0
1912	NRAS SAR 16	Target_lig_1062	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	3.5e-07±5e-08	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	CC1=CC=C(C=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)N5CCCCC5	2-(4-methylphenyl)-5-(4-piperidin-1-ylquinazolin-2-yl)-1,3,4-oxadiazole	53012205	4.91466	426.180423944	8	1	6	102.76	5	0.408286710464635	2.22285425457925	28	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	3.00E-07	4.00E-07	0	0	0	0
1913	NRAS SAR 17	Target_lig_1063	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	5.6e-07±1.7000000000000001e-07	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	Cc1ccc(cc1)c1nnc(o1)c1nc(NCc2cccc3c2OCO3)c2c(n1)cccc2	-	-	4.64552	371.174610292	6	0	3	67.94	4	0.522287968396121	2.50021263095542	33	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	3.90E-07	7.30E-07	0	0	0	0
1914	NRAS SAR 18	Target_lig_1064	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	2.5e-07±6e-08	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	CC1=CC=C(C=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)NCCC5=CC=C(C=C5)S(=O)(=O)N	4-[2-[[2-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinazolin-4-yl]amino]ethyl]benzenesulfonamide	53012208	4.99602	437.148789468	8	1	5	95.19	5	0.410614145322005	2.40673356012368	35	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	1.90E-07	3.10E-07	0	0	0	0
1915	NRAS SAR 24	Target_lig_1065	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	5e-07±1.4e-07	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	CC1=CC=C(C=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)NCCN5CCCC5	2-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-N-(2-pyrrolidin-1-ylethyl)quinazolin-4-amine	53013007	3.95722	486.147409564	8	2	7	136.89	5	0.352672959332422	2.31566072245297	30	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	3.60E-07	6.40E-07	0	0	0	0
1916	NRAS SAR 25	Target_lig_1066	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	9.499999999999999e-07±4.5e-07	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	-	50 nM	6.9	Room temperature	100 mM Kcl	Fluorescence titration	Additional	CC1=CC=C(C=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)NCCCN5CCC6=CC=CC=C6C5	N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-2-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinazolin-4-amine	53013009	4.16292	400.201159388	7	1	6	79.97	4	0.520354575127941	2.48668981974368	36	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	5.00E-07	1.40E-06	0	0	0	0
1917	NRAS compound 1	Target_lig_1052	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	4.5e-07±1.0999999999999999e-07	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	C1CCN(CC1)C1CCN(CC1)CCCCNc1nc(nc2c1cccc2)c1nnc(o1)c1ccccc1	-	-	-0.0516	203.080709908	5	2	2	99.82	2	0.714034819882525	2.57535620980181	38	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	3.40E-07	5.60E-07	0	0	0	0
1918	Hit S1	Target_lig_1067	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	1.09e-05±1.2e-06	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	C1COCC1C2=NOC(=N2)C3=CC(=CC(=C3)CN)NC(=O)C4=CC=CC=N4	N-[3-(aminomethyl)-5-[3-(oxolan-3-yl)-1,2,4-oxadiazol-5-yl]phenyl]pyridine-2-carboxamide	72850674	5.51552	476.232459516	7	1	7	79.97	5	0.310056430076326	2.99542961698328	27	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	9.70E-06	1.21E-05	0	0	0	0
1919	Hit S2	Target_lig_1068	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	2.5399999999999997e-05±9.3e-06	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	CC1=CN=C(C=C1)NCCCNC(=O)C2=CN(N=N2)CCN	1-(2-aminoethyl)-N-[3-[(5-methylpyridin-2-yl)amino]propyl]triazole-4-carboxamide	70709734	2.3465	365.148789468	7	2	5	116.16	3	0.712625753088056	2.43046621432961	22	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	1.61E-05	3.47E-05	0	0	0	0
1920	Hit S3	Target_lig_1069	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	1.44e-05±1.03e-05	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	C1CN2CCC1C(C2)NCC3=C(N=CC=C3)OC4=CC(=C(C=C4)F)F	N-[[2-(3,4-difluorophenoxy)pyridin-3-yl]methyl]-1-azabicyclo[2.2.2]octan-3-amine	56740857	0.172220000000001	303.180758292	7	3	8	110.75	2	0.599636556910489	3.56898205072259	25	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	4.10E-06	2.47E-05	0	0	0	0
1921	Hit S4	Target_lig_1070	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	2.7899999999999997e-05±4.8e-06	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	CN1C2=C(C(=CC=C2)Cl)C(=N1)CN3CCCCC(C3)N	1-[(4-chloro-1-methylindazol-3-yl)methyl]azepan-3-amine	70709825	3.3359	345.165268732	4	1	5	37.39	2	0.901919184627733	2.87866259100715	20	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	2.31E-05	3.27E-05	0	0	0	0
1922	Hit S5	Target_lig_1071	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	3.9e-05±1.26e-05	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	C1CN(CCC1N2CCC(CC2)O)C3=NC=NC(=C3)CCN	1-[1-[6-(2-aminoethyl)pyrimidin-4-yl]piperidin-4-yl]piperidin-4-ol	56701304	2.5399	292.145474352	4	1	2	47.08	2	0.925174323572374	2.55357503987906	22	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	2.64E-05	5.16E-05	0	0	0	0
1923	Hit S6	Target_lig_1072	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	9.3e-05±1.53e-05	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	CC1=CC(=NC(=N1)N)N2CCN(CC2)C(=O)CCC3=NN4CCNCC4=C3	1-[4-(2-amino-6-methylpyrimidin-4-yl)piperazin-1-yl]-3-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl)propan-1-one	70750248	0.403300000000001	305.221560484	6	2	4	78.51	1	0.838407223459783	2.79241531095045	27	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	7.77E-05	0.0001083	0	0	0	0
1924	Hit S7	Target_lig_1073	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	9.6e-05±9.699999999999999e-06	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	CC(CCC1=CC=CO1)NC2CCC3(CC2)CCNCC3	N-[4-(furan-2-yl)butan-2-yl]-3-azaspiro[5.5]undecan-9-amine	56701740	-0.051679999999999	370.222957452	8	2	4	105.2	2	0.777170928301521	3.63013636276716	21	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	8.63E-05	0.0001057	0	0	0	0
1925	Hit S8	Target_lig_1074	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	COC1=C(C=C(C=C1)CN2CCC(CC2)N3CCN(CC3)CCO)OCC4=CC=CC=C4	2-[4-[1-[(4-methoxy-3-phenylmethoxyphenyl)methyl]piperidin-4-yl]piperazin-1-yl]ethanol	2911987	3.5027	290.23581358	3	2	5	37.2	1	0.871242949371377	2.13594586678219	32	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	0.0001	0.0001	0	0	0	0
1926	Hit S9	Target_lig_1075	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	4.81e-05±3.5e-06	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	C1=CN=CC=C1C2=NC(=NC=C2)NCCCC3=NN=C(S3)N	5-[3-[(4-pyridin-4-ylpyrimidin-2-yl)amino]propyl]-1,3,4-thiadiazol-2-amine	74235262	2.8485	439.283492044	6	1	9	48.41	2	0.648503420585742	2.49230158203883	22	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	4.46E-05	5.16E-05	0	0	0	0
1927	Hit S11	Target_lig_1076	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	CC(C)OC(=O)C1=CC=C(C=C1)NC2=NC3=CC=CC=C3C4=NN=CN42	propan-2-yl 4-([1,2,4]triazolo[4,3-c]quinazolin-5-ylamino)benzoate	22434177	2.017	313.11096448	8	2	6	102.5	3	0.670971448571547	2.31220856638674	26	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	0.0001	0.0001	0	0	0	0
1928	Hit S12	Target_lig_1077	NRAS G4 motif	Homo sapiens	Cancer	Target_259	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1101/2022.01.05.475055	-	Investigating the NRAS 5’ UTR as a Target for Small Molecules	Balaratnam S, Torrey ZR, Calabrese DR, Banco MT, Yazdani K, Liang X, Ferré-D’Amaré AR, Incarnato D, Schneekloth Jr JS	BioRxiv	-	-	2022	50 uL	5 uM	6.9	Room temperature	100 mM Kcl	Surface Plasmon Resonance (SPR)	Additional	C1CCCN(CC1)CC2=NC(=NC(=N2)NC3=CC=C(C=C3)F)N	6-(azepan-1-ylmethyl)-2-N-(4-fluorophenyl)-1,3,5-triazine-2,4-diamine	753517	3.5863	347.138224784	7	1	4	81.41	4	0.568293257491834	2.09974918743996	23	UGUGGGAGGGGCGGGUCUGGG	10.1101/2022.01.05.475055	G-quadruplex	-	21	-	G-Quadruplex	0	0	0	0	0.0001	0.0001	0	0	0	0
1929	CD33 compound 1	Target_lig_1078	CD33 pre-mRNA (K562 allele exon 2)	Homo sapiens	Alzheimer’s disease	Target_353	0	0	0	0	7.8e-06±1.3e-06	0	0	-	-	10.1021/acsmedchemlett.1c00396	35059124	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators.	Chappie TA, Abdelmessih M, Ambroise CW, Boehm M, Cai M, Green M, Guilmette E, Steppan CM, Stevens LM, Wei L, Xi S, Hasson SA	ACS Med Chem Lett	13	55-62	2022	10-25 uM	-	-	Room temperature	-	Splicing assay with Nano-luciferase reporter	Additional	Cc1cnc2n(c1)ncc2c1ccc(cc1F)C(=O)N(c1ncccc1C)C1CCCNC1	-	-	2.7125	316.181172892	6	2	4	79.96	2	0.902577960455812	3.40900646449562	33	ATCCCTGGCACTCTAGAACCCGGCCACTCCAAAAACCTGAC	10.1128/MCB.00568-18 (NM_001177608.1)	mRNA	pre-mRNA	41	5'-UTR		0	0	0	0	0	0	0	0	6.50E-06	9.10E-06
1930	CD33 compound 2	Target_lig_1079	CD33 pre-mRNA (K562 allele exon 2)	Homo sapiens	Alzheimer’s disease	Target_353	0	0	0	0	3.7e-06±1e-07	0	0	-	-	10.1021/acsmedchemlett.1c00396	35059124	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators.	Chappie TA, Abdelmessih M, Ambroise CW, Boehm M, Cai M, Green M, Guilmette E, Steppan CM, Stevens LM, Wei L, Xi S, Hasson SA	ACS Med Chem Lett	13	55-62	2022	10-25 uM	-	-	Room temperature	-	Splicing assay with Nano-luciferase reporter	Additional	CC1=C(N=CC=C1)N(C2CCCNC2)C(=O)C3=CC=C(C=C3)C4=C5N=CC=CN5N=C4	N-(3-methylpyridin-2-yl)-N-piperidin-3-yl-4-pyrazolo[1,5-a]pyrimidin-3-ylbenzamide	123918287	3.94604	444.20738764	6	1	4	75.42	4	0.515995951062819	3.19544548965278	31	ATCCCTGGCACTCTAGAACCCGGCCACTCCAAAAACCTGAC	10.1128/MCB.00568-18 (NM_001177608.1)	mRNA	pre-mRNA	41	5'-UTR		0	0	0	0	0	0	0	0	3.60E-06	3.80E-06
1931	CD33 compound 3	Target_lig_1080	CD33 pre-mRNA (K562 allele exon 2)	Homo sapiens	Alzheimer’s disease	Target_353	0	0	0	0	3.6e-06±4e-07	0	0	-	-	10.1021/acsmedchemlett.1c00396	35059124	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators.	Chappie TA, Abdelmessih M, Ambroise CW, Boehm M, Cai M, Green M, Guilmette E, Steppan CM, Stevens LM, Wei L, Xi S, Hasson SA	ACS Med Chem Lett	13	55-62	2022	10-25 uM	-	-	Room temperature	-	Splicing assay with Nano-luciferase reporter	Additional	CC1=C(N=CC=C1)N(C2CCCNC2)C(=O)C3=CC=C(C=C3)C4=C(N(N=C4)C)C(=O)OC	methyl 2-methyl-4-[4-[(3-methylpyridin-2-yl)-piperidin-3-ylcarbamoyl]phenyl]pyrazole-3-carboxylate	123332869	3.49852	412.201159388	6	1	4	75.42	4	0.555284892800551	3.23926565862383	32	ATCCCTGGCACTCTAGAACCCGGCCACTCCAAAAACCTGAC	10.1128/MCB.00568-18 (NM_001177608.1)	mRNA	pre-mRNA	41	5'-UTR		0	0	0	0	0	0	0	0	3.20E-06	4.00E-06
1932	CD33 compound 4	Target_lig_1081	CD33 pre-mRNA (K562 allele exon 2)	Homo sapiens	Alzheimer’s disease	Target_353	0	0	0	0	5.6e-06±1e-06	0	0	-	-	10.1021/acsmedchemlett.1c00396	35059124	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators.	Chappie TA, Abdelmessih M, Ambroise CW, Boehm M, Cai M, Green M, Guilmette E, Steppan CM, Stevens LM, Wei L, Xi S, Hasson SA	ACS Med Chem Lett	13	55-62	2022	10-25 uM	-	-	Room temperature	-	Splicing assay with Nano-luciferase reporter	Additional	Cnc1cncc(n1)c1ccc(cc1)C(=O)N(c1ncccc1Cl)C1CCCNC1	-	-	2.97592	433.211389724	7	1	5	89.35	3	0.622530864394372	0	0	ATCCCTGGCACTCTAGAACCCGGCCACTCCAAAAACCTGAC	10.1128/MCB.00568-18 (NM_001177608.1)	mRNA	pre-mRNA	41	5'-UTR		0	0	0	0	0	0	0	0	4.60E-06	6.60E-06
1933	CD33 compound 5	Target_lig_1082	CD33 pre-mRNA (K562 allele exon 2)	Homo sapiens	Alzheimer’s disease	Target_353	0	0	0	0	>9.999999999999999e-06	0	0	-	-	10.1021/acsmedchemlett.1c00396	35059124	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators.	Chappie TA, Abdelmessih M, Ambroise CW, Boehm M, Cai M, Green M, Guilmette E, Steppan CM, Stevens LM, Wei L, Xi S, Hasson SA	ACS Med Chem Lett	13	55-62	2022	10-25 uM	-	-	Room temperature	-	Splicing assay with Nano-luciferase reporter	Additional	O=C(N(c1ncccc1Cl)C1CCCNC1)c1ccc(cc1)c1cncc(n1)N(C)C	-	-	0	0	0	0	0	0	0	0	3.24437012802219	31	ATCCCTGGCACTCTAGAACCCGGCCACTCCAAAAACCTGAC	10.1128/MCB.00568-18 (NM_001177608.1)	mRNA	pre-mRNA	41	5'-UTR		0	0	0	0	0	0	0	0	1.00E-05	1.00E-05
1934	CD33 compound 6	Target_lig_1083	CD33 pre-mRNA (K562 allele exon 2)	Homo sapiens	Alzheimer’s disease	Target_353	0	0	0	0	>9.999999999999999e-06	0	0	-	-	10.1021/acsmedchemlett.1c00396	35059124	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators.	Chappie TA, Abdelmessih M, Ambroise CW, Boehm M, Cai M, Green M, Guilmette E, Steppan CM, Stevens LM, Wei L, Xi S, Hasson SA	ACS Med Chem Lett	13	55-62	2022	10-25 uM	-	-	Room temperature	-	Splicing assay with Nano-luciferase reporter	Additional	Cc1cncc(n1)c1ccc(cc1)C(=O)N(c1ncccc1Cl)C1CCCNC1	-	-	3.6568	436.1778371	6	1	5	74.25	3	0.657557453160101	3.11632623419883	29	ATCCCTGGCACTCTAGAACCCGGCCACTCCAAAAACCTGAC	10.1128/MCB.00568-18 (NM_001177608.1)	mRNA	pre-mRNA	41	5'-UTR		0	0	0	0	0	0	0	0	1.00E-05	1.00E-05
1935	CD33 compound 7	Target_lig_1084	CD33 pre-mRNA (K562 allele exon 2)	Homo sapiens	Alzheimer’s disease	Target_353	0	0	0	0	4.50E-06	0	0	-	-	10.1021/acsmedchemlett.1c00396	35059124	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators.	Chappie TA, Abdelmessih M, Ambroise CW, Boehm M, Cai M, Green M, Guilmette E, Steppan CM, Stevens LM, Wei L, Xi S, Hasson SA	ACS Med Chem Lett	13	55-62	2022	10-25 uM	-	-	Room temperature	-	Splicing assay with Nano-luciferase reporter	Additional	C1CC(CNC1)N(C2=C(C=CC=N2)Cl)C(=O)C3=CC=C(C=C3)N4C5=C(C=CC=N5)N=N4	N-(3-chloropyridin-2-yl)-N-piperidin-3-yl-4-(triazolo[4,5-b]pyridin-3-yl)benzamide	123336044	3.89922	407.151288004	5	1	4	71.01	3	0.709754458614587	3.1589920661532	31	ATCCCTGGCACTCTAGAACCCGGCCACTCCAAAAACCTGAC	10.1128/MCB.00568-18 (NM_001177608.1)	mRNA	pre-mRNA	41	5'-UTR		0	0	0	0	0	0	0	0	4.50E-06	4.50E-06
1936	CD33 compound 8	Target_lig_1085	CD33 pre-mRNA (K562 allele exon 2)	Homo sapiens	Alzheimer’s disease	Target_353	0	0	0	0	4.40E-06	0	0	-	-	10.1021/acsmedchemlett.1c00396	35059124	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators.	Chappie TA, Abdelmessih M, Ambroise CW, Boehm M, Cai M, Green M, Guilmette E, Steppan CM, Stevens LM, Wei L, Xi S, Hasson SA	ACS Med Chem Lett	13	55-62	2022	10-25 uM	-	-	Room temperature	-	Splicing assay with Nano-luciferase reporter	Additional	Cc1ccc2c(n1)n(nn2)c1ccc(cc1)C(=O)N(c1ncccc1Cl)C1CCCNC1	-	-	3.2627	433.14178594	7	1	4	88.83	4	0.531042577529695	3.20494521033763	32	ATCCCTGGCACTCTAGAACCCGGCCACTCCAAAAACCTGAC	10.1128/MCB.00568-18 (NM_001177608.1)	mRNA	pre-mRNA	41	5'-UTR		0	0	0	0	0	0	0	0	4.40E-06	4.40E-06
1937	CD33 compound 9	Target_lig_1086	CD33 pre-mRNA (K562 allele exon 2)	Homo sapiens	Alzheimer’s disease	Target_353	0	0	0	0	1.40E-06	0	0	-	-	10.1021/acsmedchemlett.1c00396	35059124	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators.	Chappie TA, Abdelmessih M, Ambroise CW, Boehm M, Cai M, Green M, Guilmette E, Steppan CM, Stevens LM, Wei L, Xi S, Hasson SA	ACS Med Chem Lett	13	55-62	2022	10-25 uM	-	-	Room temperature	-	Splicing assay with Nano-luciferase reporter	Additional	Cc1cnc2c(c1)nnn2c1ccc(cc1)C(=O)N(c1ncccc1Cl)C1CCCNC1	-	-	3.57112	447.157436004	7	1	4	88.83	4	0.514118691495932	3.26461468924582	32	ATCCCTGGCACTCTAGAACCCGGCCACTCCAAAAACCTGAC	10.1128/MCB.00568-18 (NM_001177608.1)	mRNA	pre-mRNA	41	5'-UTR		0	0	0	0	0	0	0	0	1.40E-06	1.40E-06
1938	CD33 compound 10	Target_lig_1087	CD33 pre-mRNA (K562 allele exon 2)	Homo sapiens	Alzheimer’s disease	Target_353	0	0	0	0	5.8e-07±1e-07	0	0	-	-	10.1021/acsmedchemlett.1c00396	35059124	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators.	Chappie TA, Abdelmessih M, Ambroise CW, Boehm M, Cai M, Green M, Guilmette E, Steppan CM, Stevens LM, Wei L, Xi S, Hasson SA	ACS Med Chem Lett	13	55-62	2022	10-25 uM	-	-	Room temperature	-	Splicing assay with Nano-luciferase reporter	Additional	C1CC(CNC1)N(C2=NC=CC3=CC=CC=C32)C(=O)C4=CC=C(C=C4)C5=C6N=CC=CN6N=C5	N-isoquinolin-1-yl-N-piperidin-3-yl-4-pyrazolo[1,5-a]pyrimidin-3-ylbenzamide	138544611	3.57112	447.157436004	7	1	4	88.83	4	0.514118691495932	3.19208903767596	34	ATCCCTGGCACTCTAGAACCCGGCCACTCCAAAAACCTGAC	10.1128/MCB.00568-18 (NM_001177608.1)	mRNA	pre-mRNA	41	5'-UTR		0	0	0	0	0	0	0	0	4.80E-07	6.80E-07
1939	Compound 4d	Target_lig_1088	HCV IRES domain Iia	Hepatitis C virus	Hepatitis C	Target_67	0	0	0	0	6.7e-05±3.5e-06	0	0	-	-	10.1039/c9cc06531h	31690898	Quinoxaline derivatives disrupt the base stacking of hepatitis C virus-internal ribosome entry site RNA: reduce translation and replication.	Chakraborty J, Kanungo A, Mahata T, Kumar K, Sharma G, Pal R, Ahammed KS, Patra D, Majhi B, Chakrabarti S, Das S, Dutta S	Chem Commun (Camb)	55	14027-14030	2019	-	-	7	37	100 uM Mg2+	Circular Dichroism	Additional	CN1CCN(CC1)CCCNc1nc2cc(ccc2nc1NCCCc1ccc(cc1)NC(=O)/C=C/c1ccc(cc1)N(C)C)[N+](=O)O	-	-	4.3433	448.201159388	6	1	4	75.42	5	0.442616386202947	3.11422086473755	48	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	0	0	0	0	6.35E-05	7.05E-05
1940	Compound 3b	Target_lig_1000	HCV IRES domain Iia	Hepatitis C virus	Hepatitis C	Target_67	0	0	0	0	0.00025±4.9999999999999996e-06	0	0	-	-	10.1039/c9cc06531h	31690898	Quinoxaline derivatives disrupt the base stacking of hepatitis C virus-internal ribosome entry site RNA: reduce translation and replication.	Chakraborty J, Kanungo A, Mahata T, Kumar K, Sharma G, Pal R, Ahammed KS, Patra D, Majhi B, Chakrabarti S, Das S, Dutta S	Chem Commun (Camb)	55	14027-14030	2019	-	-	7	37	100 uM MgCl2	Circular Dichroism	Additional	NCCCCC(C(=O)OCO[C@H]1C[C@@H](O[C@@H]1COCOC(=O)C(CCCCN)N)C(=O)Nc1cccc(c1)c1csc(n1)NC(=O)C)N	-	-	1.18030000000001	693.315597084	15	6	21	255.46	2	0.060999124662495	4.54537624152293	48	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	0	0	0	0	0.000245	0.000255
1941	Compound 4a	Target_lig_1090	HCV IRES domain Iia	Hepatitis C virus	Hepatitis C	Target_67	0	0	0	0	8.7e-05±4e-06	0	0	-	-	10.1039/c9cc06531h	31690898	Quinoxaline derivatives disrupt the base stacking of hepatitis C virus-internal ribosome entry site RNA: reduce translation and replication.	Chakraborty J, Kanungo A, Mahata T, Kumar K, Sharma G, Pal R, Ahammed KS, Patra D, Majhi B, Chakrabarti S, Das S, Dutta S	Chem Commun (Camb)	55	14027-14030	2019	-	-	7	37	100 uM MgCl2	Circular Dichroism	Additional	CN(CCCNc1nc2cc(ccc2nc1NCCCc1ccc(cc1)NC(=O)CCCCC1SCC2C1NC(=O)N2)[N+](=O)O)C	-	-	1.8424	431.28774878009	8	3	11	99.87	2	0.363422339069738	4.21429145077796	46	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	0	0	0	0	8.30E-05	9.10E-05
1942	Compound 4c	Target_lig_1091	HCV IRES domain Iia	Hepatitis C virus	Hepatitis C	Target_67	0	0	0	0	7.4e-05±3.5e-06	0	0	-	-	10.1039/c9cc06531h	31690898	Quinoxaline derivatives disrupt the base stacking of hepatitis C virus-internal ribosome entry site RNA: reduce translation and replication.	Chakraborty J, Kanungo A, Mahata T, Kumar K, Sharma G, Pal R, Ahammed KS, Patra D, Majhi B, Chakrabarti S, Das S, Dutta S	Chem Commun (Camb)	55	14027-14030	2019	-	-	7	37	100 uM MgCl2	Circular Dichroism	Additional	CN1CCN(CC1)CCCNc1nc2cc(ccc2nc1NCCCc1ccc(cc1)NC(=O)CCCCC1SCC2C1NC(=O)N2)[N+](=O)O	-	-	4.502	650.32314830809	9	6	17	163.62	3	0.069654959070355	4.28113893006035	50	CUCCCCUGUGAGGAACUACUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCGUGCAGCCUCCAGG	https://pubs.acs.org/doi/pdf/10.1021/jm050815o	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	79	-	Stem-Loop	0	0	0	0	0	0	0	0	7.05E-05	7.75E-05
1943	Curcumin	Target_lig_1092	(5'CAG/3'GGC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_334	0	0	7.5e-07±8e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	GGGAGAGGGUUUAAUUCAGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	6.70E-07	8.30E-07	0	0	0	0
1944	Curcumin	Target_lig_1092	(5'CCG/3'GAC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_335	0	0	1.05e-06±7e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	GGGAGAGGGUUUAAUUCCGUACGAAAGUACAGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	9.80E-07	1.12E-06	0	0	0	0
1945	Curcumin	Target_lig_1092	(5'CGG/3'GAC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_336	0	0	5.699999999999999e-07±1.0999999999999999e-07	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	GGGAGAGGGUUUAAUUCGGUACGAAAGUACAGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	4.60E-07	6.80E-07	0	0	0	0
1946	Curcumin	Target_lig_1092	(5'CCG/3'GUC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_337	0	0	7.799999999999999e-07±1e-07	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	GGGAGAGGGUUUAAUUCCGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	6.80E-07	8.80E-07	0	0	0	0
1947	Curcumin	Target_lig_1092	(5'CAG/3'GCC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_338	0	0	4.3999999999999997e-07±4e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	GGGAGAGGGUUUAAUUCAGUACGAAAGUACCGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	4.00E-07	4.80E-07	0	0	0	0
1948	Curcumin	Target_lig_1092	(5'CUG/3'GCC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_339	0	0	6.6e-07±4e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	GGGAGAGGGUUUAAUUCUGUACGAAAGUACCGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	6.20E-07	7.00E-07	0	0	0	0
1949	Curcumin	Target_lig_1092	(5'CGG/3'GCC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_340	0	0	1.2e-07±2e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.00E-07	1.40E-07	0	0	0	0
1950	Curcumin	Target_lig_1092	(5'CAG/3'GAC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_341	0	0	5.6e-07±7e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	GGGAGAGGGUUUAAUUCAGUACGAAAGUACAGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	4.90E-07	6.30E-07	0	0	0	0
1951	Curcumin	Target_lig_1092	(5'CCG/3'GGC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_342	0	0	8.599999999999999e-07±1e-07	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	GGGAGAGGGUUUAAUUCCGUACGAAAGUACGGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	7.60E-07	9.60E-07	0	0	0	0
1952	Curcumin	Target_lig_1092	(5'CUG/3'GUC) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_343	0	0	7.4e-07±1e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	GGGAGAGGGUUUAAUUCUGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	7.30E-07	7.50E-07	0	0	0	0
1953	Curcumin	Target_lig_1092	(5'CAG/3'CUG) x 1	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_344	0	0	2.1e-06±1.2e-07	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	10.1007/s12035-021-02697-z	mRNA	Expanded Repeats	47	5’-UTR	Internal Loop	0	0	0	0	1.98E-06	2.22E-06	0	0	0	0
1954	Curcumin	Target_lig_1092	r(CGGx1)	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_354	0	0	1.2e-07±2e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	UUGGGCCGGGUCC	10.3389/fnins.2020.00295	mRNA	Expanded Repeats	13	-	-	0	0	0	0	1.00E-07	1.40E-07	0	0	0	0
1955	Curcumin	Target_lig_1092	r(CGGx2)	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_355	0	0	1.3e-07±1e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	UUGGGCCGGCGGGUCC	10.3389/fnins.2020.00295	mRNA	Expanded Repeats	16	-	-	0	0	0	0	1.20E-07	1.40E-07	0	0	0	0
1956	Curcumin	Target_lig_1092	r(CGGx3)	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_356	0	0	1.2e-07±2e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	UUGGGCCGGCGGCGGGUCC	3SJ2	mRNA	Expanded Repeats	19	-	-	0	0	0	0	1.00E-07	1.40E-07	0	0	0	0
1957	Curcumin	Target_lig_1092	r(CGGx4)	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_357	0	0	1.06e-07±1e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	UUGGGCCGGCGGCGGCGGGUCC	10.3389/fnins.2020.00295	mRNA	Expanded Repeats	22	-	-	0	0	0	0	9.60E-08	1.16E-07	0	0	0	0
1958	Curcumin	Target_lig_1092	r(CGGx6)	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_358	0	0	9.199999999999999e-08±4e-09	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	UUGGGCCGGCGGCGGCGGCGGCGGGUCC	10.3389/fnins.2020.00295	mRNA	Expanded Repeats	28	-	-	0	0	0	0	8.80E-08	9.60E-08	0	0	0	0
1959	Curcumin	Target_lig_1092	r(CGGx20)	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_359	0	0	3.4e-08±8e-09	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	UUGGGCCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGGUCC	10.3389/fnins.2020.00295	mRNA	Expanded Repeats	71	-	-	0	0	0	0	2.60E-08	4.20E-08	0	0	0	0
1960	Curcumin	Target_lig_1092	r(CGGx40)	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_360	0	0	2.9e-08±1e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	UUGGGCCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGGUCC	10.3389/fnins.2020.00295	mRNA	Expanded Repeats	131	-	-	0	0	0	0	1.90E-08	3.90E-08	0	0	0	0
1961	Curcumin	Target_lig_1092	r(CGGx60)	Synthetic	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_361	0	0	1.2999999999999999e-08±5e-09	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	UUGGGCCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGGUCC	10.3389/fnins.2020.00295	mRNA	Expanded Repeats	191	-	-	0	0	0	0	8.00E-09	1.80E-08	0	0	0	0
1962	Curcumin	Target_lig_1092	r(AUx6)	Synthetic	-	Target_362	0	0	2.31e-06±3.6e-07	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	AUAUAUAUAUAU	10.3389/fnins.2020.00295	mRNA	Expanded Repeats	12	-	-	0	0	0	0	1.95E-06	2.67E-06	0	0	0	0
1963	Curcumin	Target_lig_1092	r(CAGx6)	Synthetic	Huntington disease,spinal and bulbar muscular atrophy,dentatorubral-pallidoluysian atrophy,seven SCAs	Target_363	0	0	1.6e-06±1.8e-07	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	UUGGGCCAGCAGCAGCAGCAGCAGGUCC	10.3389/fnins.2020.00295	mRNA	Expanded Repeats	29	-	-	0	0	0	0	1.42E-06	1.78E-06	0	0	0	0
1964	Curcumin	Target_lig_1092	r(CCGx6)	Synthetic	Fragile X-E syndrome	Target_364	0	0	8.399999999999999e-07±5e-08	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	UUGGGCCCGCCGCCGCCGCCGCCGGUCC	10.3389/fnins.2020.00295	mRNA	Expanded Repeats	29	-	-	0	0	0	0	7.90E-07	8.90E-07	0	0	0	0
1965	Curcumin	Target_lig_1092	r(CUGx6)	Synthetic	Myotonic dystrophy 1 (DM1)	Target_173	0	0	2.2e-06±3e-07	0	0	0	0	-	-	10.3389/fnins.2020.00295	32317919	Curcumin Regulates the r(CGG)<sup>exp</sup> RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.	Verma AK, Khan E, Mishra SK, Mishra A, Charlet-Berguerand N, Kumar A	Front Neurosci	14	295	2020	-	-	7	25	50 mM Kcl	Fluorescence titration	Additional	COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O	1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione	2889	4.1878	705.36534746809	10	6	17	166.86	3	0.067763252587543	2.42567365414572	27	CUGCUGCUGCUGCUGCUG	10.1021/cb400265y	RNA aptamer, mRNA	Expanded Repeats	18	3'-UTR	Internal Loop	0	0	0	0	1.90E-06	2.50E-06	0	0	0	0
1966	DMA-169	Target_lig_1093	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	3.9e-06±7e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	3.3699	368.12598836	6	2	8	93.06	2	0.548122832062327	3.2035820095661	31	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	3.20E-06	4.60E-06	0	0
1967	DMA-176	Target_lig_1094	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	1.83e-05±1e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2ccc(cc2)c2ccccc2)c(nc1N)NCCC1=NCc2c1cccc2	-	-	0.334300000000001	415.19893377609	6	5	6	156.9	3	0.288440990368983	3.14159306252049	37	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	1.73E-05	1.93E-05	0	0
1968	DMA-177	Target_lig_1095	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	1.64e-05±5.699999999999999e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c(nc1N)NCCC1=NCc2c1cccc2)c1ccc2c(c1)cccc2	-	-	2.0013	491.23023390409	6	5	7	156.9	4	0.196556916178922	3.23070172463243	35	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	1.58E-05	1.70E-05	0	0
1969	DMA-178	Target_lig_1096	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	4.6e-05±2.17e-05	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	Cc1ccc(cc1)c1nc(C(=O)NC(=[NH2+])N)c(nc1NCCC1=NCc2c1cccc2)N	-	-	1.4875	465.21458384009	6	5	6	156.9	4	0.214431807342453	3.23250798077295	32	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	2.43E-05	6.77E-05	0	0
1970	DMA-179	Target_lig_1097	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	4.81e-05±3.9e-05	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	Fc1ccc(cc1)c1nc(C(=O)NC(=[NH2+])N)c(nc1NCCC1=NCc2c1cccc2)N	-	-	0.642720000000002	429.21458384009	6	5	6	156.9	3	0.285845474280813	3.24717120985156	32	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	9.10E-06	8.71E-05	0	0
1971	DMA-180	Target_lig_1098	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	7.73e-06±9.2e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2ccccc2)c(nc1N)NCCc1nc2c([nH]1)cccc2	-	-	0.4734	433.18951196409	6	5	6	156.9	3	0.280953636352977	2.94227708303196	31	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	6.81E-06	8.65E-06	0	0
1972	DMA-182	Target_lig_1099	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	7.47e-06±8e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)NCCCn1cncc1)NC(=[NH2+])N	-	-	0.060300000000002	416.19418274409	6	6	6	173.22	4	0.190298170053715	3.03307927543189	28	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	6.67E-06	8.27E-06	0	0
1973	DMA-187	Target_lig_1100	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	1.33e-05±8.699999999999999e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	CN1CCN(CC1)CCNc1nc(N)c(nc1c1ccccc1)C(=O)NC(=[NH2+])N	-	-	-0.771899999999998	380.19418274409	7	5	7	162.36	3	0.204030716595472	2.9187985050109	29	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	1.24E-05	1.42E-05	0	0
1974	DMA-188	Target_lig_1101	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	1.3600000000000001e-06±1.5e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)NCc1c[nH]c2c1cccc2)NC(=[NH2+])N	-	-	-1.8113	398.24113293609	7	5	6	151.02	2	0.282069559985117	2.87981106314964	30	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	1.21E-06	1.51E-06	0	0
1975	DMA-190	Target_lig_1102	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	2.42e-05±5.57e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccncc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	0.6228	401.18328371209	5	6	5	160.33	4	0.212269845988296	3.35368520749177	31	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	1.86E-05	2.98E-05	0	0
1976	DMA-191	Target_lig_1103	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	1.2499999999999999e-05±3.25e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cncnc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	-0.270699999999998	416.19418274409	7	5	6	169.79	3	0.271863427441237	3.49652150826964	31	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	9.25E-06	1.58E-05	0	0
1977	DMA-192	Target_lig_1104	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	7.21e-06±1.3e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2cnc(nc2)NCCc2c[nH]c3c2cccc3)c(nc1N)NCCC1=NCc2c1cccc2	-	-	-0.875699999999998	417.18943171209	8	5	6	182.68	3	0.252972556848497	3.53006663769484	43	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	5.91E-06	8.51E-06	0	0
1978	DMA-193	Target_lig_1105	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	6.789999999999999e-06±9.1e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cnc(nc2)NCCCn2cncc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	1.2602	575.27383003209	9	7	10	210.5	5	0.09421410551999	3.61917439284491	40	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	5.88E-06	7.70E-06	0	0
1979	DMA-194	Target_lig_1106	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	1.59e-05±2.5299999999999995e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cnc(nc2)N2CCCC2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	-0.176999999999998	540.26907900009	11	6	11	212.53	4	0.083855182462226	3.46422634023253	36	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	1.34E-05	1.84E-05	0	0
1980	DMA-195	Target_lig_1107	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	1.3099999999999998e-05±1.07e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2cnc(nc2)N2CCN(CC2)c2ccccn2)c(nc1N)NCCC1=NCc2c1cccc2	-	-	-0.275499999999997	486.24728093609	9	5	7	185.92	3	0.221174209046683	3.50519451461792	43	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	1.20E-05	1.42E-05	0	0
1981	DMA-205	Target_lig_1108	HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	0	3.36e-05±5.1e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)N1CCC(CC1)c1ccccc1)NC(=[NH2+])N	-	-	-0.154099999999996	578.28472906409	11	5	8	202.05	4	0.13737485572546	2.77967812019704	31	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	0	0	3.31E-05	3.41E-05	0	0
1982	DMA-169	Target_lig_1093	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	9.3e-06±1.3e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	3.3699	368.12598836	6	2	8	93.06	2	0.548122832062327	3.2035820095661	31	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	8.00E-06	1.06E-05	0	0
1983	DMA-176	Target_lig_1094	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	1.7199999999999998e-05±2.4e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2ccc(cc2)c2ccccc2)c(nc1N)NCCC1=NCc2c1cccc2	-	-	0.334300000000001	415.19893377609	6	5	6	156.9	3	0.288440990368983	3.14159306252049	37	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	1.70E-05	1.74E-05	0	0
1984	DMA-177	Target_lig_1095	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	1.88e-05±4e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c(nc1N)NCCC1=NCc2c1cccc2)c1ccc2c(c1)cccc2	-	-	2.0013	491.23023390409	6	5	7	156.9	4	0.196556916178922	3.23070172463243	35	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	1.84E-05	1.92E-05	0	0
1985	DMA-179	Target_lig_1097	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	2.05e-05±1.5e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	Fc1ccc(cc1)c1nc(C(=O)NC(=[NH2+])N)c(nc1NCCC1=NCc2c1cccc2)N	-	-	0.642720000000002	429.21458384009	6	5	6	156.9	3	0.285845474280813	3.24717120985156	32	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	1.90E-05	2.20E-05	0	0
1986	DMA-180	Target_lig_1098	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	1.85e-05±1.2e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2ccccc2)c(nc1N)NCCc1nc2c([nH]1)cccc2	-	-	0.4734	433.18951196409	6	5	6	156.9	3	0.280953636352977	2.94227708303196	31	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	1.73E-05	1.97E-05	0	0
1987	DMA-182	Target_lig_1099	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	2.18e-05±2.4999999999999998e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)NCCCn1cncc1)NC(=[NH2+])N	-	-	0.060300000000002	416.19418274409	6	6	6	173.22	4	0.190298170053715	3.03307927543189	28	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	1.93E-05	2.43E-05	0	0
1988	DMA-187	Target_lig_1100	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	1.23e-05±1.1e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	CN1CCN(CC1)CCNc1nc(N)c(nc1c1ccccc1)C(=O)NC(=[NH2+])N	-	-	-0.771899999999998	380.19418274409	7	5	7	162.36	3	0.204030716595472	2.9187985050109	29	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	1.12E-05	1.34E-05	0	0
1989	DMA-188	Target_lig_1101	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	6.2e-06±6e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)NCc1c[nH]c2c1cccc2)NC(=[NH2+])N	-	-	-1.8113	398.24113293609	7	5	6	151.02	2	0.282069559985117	2.87981106314964	30	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	5.60E-06	6.80E-06	0	0
1990	DMA-191	Target_lig_1103	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	3.929999999999999e-05±1.0199999999999999e-05	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cncnc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	-0.270699999999998	416.19418274409	7	5	6	169.79	3	0.271863427441237	3.49652150826964	31	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	2.91E-05	4.95E-05	0	0
1991	DMA-192	Target_lig_1104	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	9.679999999999999e-06±2.3e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2cnc(nc2)NCCc2c[nH]c3c2cccc3)c(nc1N)NCCC1=NCc2c1cccc2	-	-	-0.875699999999998	417.18943171209	8	5	6	182.68	3	0.252972556848497	3.53006663769484	43	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	9.45E-06	9.91E-06	0	0
1992	DMA-193	Target_lig_1105	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	1.2499999999999999e-05±1.1e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cnc(nc2)NCCCn2cncc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	1.2602	575.27383003209	9	7	10	210.5	5	0.09421410551999	3.61917439284491	40	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	1.14E-05	1.36E-05	0	0
1993	DMA-194	Target_lig_1106	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	2.2899999999999998e-05±2.8999999999999998e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cnc(nc2)N2CCCC2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	-0.176999999999998	540.26907900009	11	6	11	212.53	4	0.083855182462226	3.46422634023253	36	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	2.00E-05	2.58E-05	0	0
1994	DMA-195	Target_lig_1107	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	1.13e-05±9.8e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2cnc(nc2)N2CCN(CC2)c2ccccn2)c(nc1N)NCCC1=NCc2c1cccc2	-	-	-0.275499999999997	486.24728093609	9	5	7	185.92	3	0.221174209046683	3.50519451461792	43	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	1.03E-05	1.23E-05	0	0
1995	DMA-205	Target_lig_1108	HIV-2 TAR	Human immunodeficiency virus (HIV-2)	Acquired immunodeficiency syndrome (AIDS)	Target_20	0	0	0	3.01e-05±3.2799999999999995e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	40 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)N1CCC(CC1)c1ccccc1)NC(=[NH2+])N	-	-	-0.154099999999996	578.28472906409	11	5	8	202.05	4	0.13737485572546	2.77967812019704	31	GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC	http://www.smmrna.org/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	30	-	Apical Loop	0	0	0	0	0	0	2.68E-05	3.34E-05	0	0
1996	DMA-169	Target_lig_1093	RRE-IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	2.9e-05±7.099999999999999e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	75 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	3.3699	368.12598836	6	2	8	93.06	2	0.548122832062327	3.2035820095661	31	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	2.19E-05	3.61E-05	0	0
1997	DMA-176	Target_lig_1094	RRE-IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	1.6199999999999997e-05±4.5e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	75 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2ccc(cc2)c2ccccc2)c(nc1N)NCCC1=NCc2c1cccc2	-	-	0.334300000000001	415.19893377609	6	5	6	156.9	3	0.288440990368983	3.14159306252049	37	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	1.58E-05	1.67E-05	0	0
1998	DMA-177	Target_lig_1095	RRE-IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	1.8e-05±3.5e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	75 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c(nc1N)NCCC1=NCc2c1cccc2)c1ccc2c(c1)cccc2	-	-	2.0013	491.23023390409	6	5	7	156.9	4	0.196556916178922	3.23070172463243	35	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	1.77E-05	1.84E-05	0	0
1999	DMA-187	Target_lig_1100	RRE-IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	7.18e-05±3.0299999999999998e-05	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	75 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	CN1CCN(CC1)CCNc1nc(N)c(nc1c1ccccc1)C(=O)NC(=[NH2+])N	-	-	-0.771899999999998	380.19418274409	7	5	7	162.36	3	0.204030716595472	2.9187985050109	29	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	4.15E-05	0.0001021	0	0
2000	DMA-191	Target_lig_1103	RRE-IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	2.98e-05±6.799999999999999e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	75 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cncnc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	-0.270699999999998	416.19418274409	7	5	6	169.79	3	0.271863427441237	3.49652150826964	31	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	2.30E-05	3.66E-05	0	0
2001	DMA-192	Target_lig_1104	RRE-IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	8.51e-06±5.2e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	75 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2cnc(nc2)NCCc2c[nH]c3c2cccc3)c(nc1N)NCCC1=NCc2c1cccc2	-	-	-0.875699999999998	417.18943171209	8	5	6	182.68	3	0.252972556848497	3.53006663769484	43	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	7.99E-06	9.03E-06	0	0
2002	DMA-193	Target_lig_1105	RRE-IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	1.4599999999999999e-05±2.7e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	75 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cnc(nc2)NCCCn2cncc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	1.2602	575.27383003209	9	7	10	210.5	5	0.09421410551999	3.61917439284491	40	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	1.19E-05	1.73E-05	0	0
2003	DMA-194	Target_lig_1106	RRE-IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	2.5699999999999998e-05±3.9e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	75 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cnc(nc2)N2CCCC2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	-0.176999999999998	540.26907900009	11	6	11	212.53	4	0.083855182462226	3.46422634023253	36	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	2.18E-05	2.96E-05	0	0
2004	DMA-195	Target_lig_1107	RRE-IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	1.19e-05±6.6e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	75 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2cnc(nc2)N2CCN(CC2)c2ccccn2)c(nc1N)NCCC1=NCc2c1cccc2	-	-	-0.275499999999997	486.24728093609	9	5	7	185.92	3	0.221174209046683	3.50519451461792	43	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	1.12E-05	1.26E-05	0	0
2005	DMA-205	Target_lig_1108	RRE-IIB	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	0	1.8999999999999998e-05±3.9e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	75 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)N1CCC(CC1)c1ccccc1)NC(=[NH2+])N	-	-	-0.154099999999996	578.28472906409	11	5	8	202.05	4	0.13737485572546	2.77967812019704	31	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	0	0	1.51E-05	2.29E-05	0	0
2006	DMA-193	Target_lig_1105	HIV-1 FSS	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	0	2.8499999999999998e-05±7.2e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	250 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cnc(nc2)NCCCn2cncc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	1.2602	575.27383003209	9	7	10	210.5	5	0.09421410551999	3.61917439284491	40	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	0	0	2.13E-05	3.57E-05	0	0
2007	DMA-194	Target_lig_1106	HIV-1 FSS	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	0	3.53e-05±1.37e-05	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	250 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cnc(nc2)N2CCCC2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	-0.176999999999998	540.26907900009	11	6	11	212.53	4	0.083855182462226	3.46422634023253	36	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	0	0	2.16E-05	4.90E-05	0	0
2008	DMA-195	Target_lig_1107	HIV-1 FSS	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_188	0	0	0	1.82e-05±7e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	250 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2cnc(nc2)N2CCN(CC2)c2ccccn2)c(nc1N)NCCC1=NCc2c1cccc2	-	-	-0.275499999999997	486.24728093609	9	5	7	185.92	3	0.221174209046683	3.50519451461792	43	GGCCUUCCCACAAGGGAAGGCC	10.1093/nar/gks298	Viral RNA	Frameshift Site	22	5'-UTR	Stem-Loop	0	0	0	0	0	0	1.75E-05	1.89E-05	0	0
2009	DMA-155	Target_lig_1021	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	2.01e-05±3.1e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	CN(c1nc(N)c(nc1c1ccc(cc1)c1ccccc1)C(=O)NC(=[NH2+])N)C	-	-	0.262400000000001	376.18803474409	5	4	4	135.75	3	0.380959014949487	2.79678565117154	28	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	1.70E-05	2.32E-05	0	0
2010	DMA-169	Target_lig_1093	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	3.0299999999999998e-05±4.5e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	3.3699	368.12598836	6	2	8	93.06	2	0.548122832062327	3.2035820095661	31	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	2.58E-05	3.48E-05	0	0
2011	DMA-176	Target_lig_1094	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	1.13e-05±6e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2ccc(cc2)c2ccccc2)c(nc1N)NCCC1=NCc2c1cccc2	-	-	0.334300000000001	415.19893377609	6	5	6	156.9	3	0.288440990368983	3.14159306252049	37	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	1.07E-05	1.19E-05	0	0
2012	DMA-177	Target_lig_1095	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	1.19e-05±1.1e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c(nc1N)NCCC1=NCc2c1cccc2)c1ccc2c(c1)cccc2	-	-	2.0013	491.23023390409	6	5	7	156.9	4	0.196556916178922	3.23070172463243	35	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	1.08E-05	1.30E-05	0	0
2013	DMA-178	Target_lig_1096	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	1.7199999999999998e-05±1.3e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	Cc1ccc(cc1)c1nc(C(=O)NC(=[NH2+])N)c(nc1NCCC1=NCc2c1cccc2)N	-	-	1.4875	465.21458384009	6	5	6	156.9	4	0.214431807342453	3.23250798077295	32	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	1.59E-05	1.85E-05	0	0
2014	DMA-179	Target_lig_1097	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	1.5199999999999998e-05±1.1e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	Fc1ccc(cc1)c1nc(C(=O)NC(=[NH2+])N)c(nc1NCCC1=NCc2c1cccc2)N	-	-	0.642720000000002	429.21458384009	6	5	6	156.9	3	0.285845474280813	3.24717120985156	32	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	1.41E-05	1.63E-05	0	0
2015	DMA-185	Target_lig_1109	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	1.95e-05±8e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccc(cc2)c2ccccc2)c(nc1N)N1CCCC1)NC(=[NH2+])N	-	-	0.913400000000001	416.21933487209	5	4	4	135.75	3	0.368744301548858	2.71972376440188	30	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	1.87E-05	2.03E-05	0	0
2016	DMA-187	Target_lig_1100	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	4.6e-05±2.67e-05	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	CN1CCN(CC1)CCNc1nc(N)c(nc1c1ccccc1)C(=O)NC(=[NH2+])N	-	-	-0.771899999999998	380.19418274409	7	5	7	162.36	3	0.204030716595472	2.9187985050109	29	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	1.93E-05	7.27E-05	0	0
2017	DMA-188	Target_lig_1101	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	3.05e-05±1.4699999999999998e-05	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)NCc1c[nH]c2c1cccc2)NC(=[NH2+])N	-	-	-1.8113	398.24113293609	7	5	6	151.02	2	0.282069559985117	2.87981106314964	30	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	1.58E-05	4.52E-05	0	0
2018	DMA-190	Target_lig_1102	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	4.8899999999999996e-05±2.31e-05	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccncc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	0.6228	401.18328371209	5	6	5	160.33	4	0.212269845988296	3.35368520749177	31	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	2.58E-05	7.20E-05	0	0
2019	DMA-191	Target_lig_1103	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	1.26e-05±2.6e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cncnc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	-0.270699999999998	416.19418274409	7	5	6	169.79	3	0.271863427441237	3.49652150826964	31	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	1.00E-05	1.52E-05	0	0
2020	DMA-192	Target_lig_1104	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	4.9999999999999996e-06±1.1e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2cnc(nc2)NCCc2c[nH]c3c2cccc3)c(nc1N)NCCC1=NCc2c1cccc2	-	-	-0.875699999999998	417.18943171209	8	5	6	182.68	3	0.252972556848497	3.53006663769484	43	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	3.90E-06	6.10E-06	0	0
2021	DMA-193	Target_lig_1105	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	4.4e-06±6e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cnc(nc2)NCCCn2cncc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	1.2602	575.27383003209	9	7	10	210.5	5	0.09421410551999	3.61917439284491	40	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	3.80E-06	5.00E-06	0	0
2022	DMA-194	Target_lig_1106	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	8.02e-06±8.199999999999999e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2cnc(nc2)N2CCCC2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	-0.176999999999998	540.26907900009	11	6	11	212.53	4	0.083855182462226	3.46422634023253	36	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	7.20E-06	8.84E-06	0	0
2023	DMA-195	Target_lig_1107	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	1.07e-05±5e-07	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	NC(=[NH2+])NC(=O)c1nc(c2cnc(nc2)N2CCN(CC2)c2ccccn2)c(nc1N)NCCC1=NCc2c1cccc2	-	-	-0.275499999999997	486.24728093609	9	5	7	185.92	3	0.221174209046683	3.50519451461792	43	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	1.02E-05	1.12E-05	0	0
2024	DMA-205	Target_lig_1108	ESSV	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_365	0	0	0	3.48e-05±3.16e-06	0	0	0	-	-	10.1039/c9ob01702j	31612165	Driving factors in amiloride recognition of HIV RNA targets.	Patwardhan NN, Cai Z, Umuhire Juru A, Hargrove AE	Org Biomol Chem	17	9313-9320	2019	0-100 uM	70 nM	7.4	-	50 mM Kcl	Tat-peptide displacement assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)N1CCC(CC1)c1ccccc1)NC(=[NH2+])N	-	-	-0.154099999999996	578.28472906409	11	5	8	202.05	4	0.13737485572546	2.77967812019704	31	GGUCUGCUAUAAGAAAGGCCUUAUUAGGACAUAUAGUUAGCCCUAGGUGUGAAUAUCAAGCAGGCC	10.1039/c9ob01702j	mRNA, Viral RNA	Exonic splicing silencers (ESS) of Vpr	66	Splice site	Stem-Loop with Bulge	0	0	0	0	0	0	3.16E-05	3.80E-05	0	0
2025	Ethidium bromide	Target_lig_6	RNA duplex (polyApolyU)	Synthetic	-	Target_2	1e-06±2e-07	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	-	-	7.6	23	20 mM Tris, 50 mM NaCl	Fluorescence titrations, Competitive experiments	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	8.00E-07	1.20E-06	0	0	0	0	0	0	0	0
2026	Ethidium bromide	Target_lig_6	RNA duplex (polyApolyU)	Synthetic	-	Target_2	6e-07±2e-07	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	-	-	7.6	37	20 mM Tris, 100 mM NaCl	Fluorescence titrations, Competitive experiments	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N	4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol	5496	-6.2958	467.259127764	14	10	6	268.17	0	0.174006568228555	5.1440149347199	32	AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU	10.1093/nar/24.22.4577	RNA aptamer	-	68	-	Double Stranded RNA (dsRNA)	4.00E-07	8.00E-07	0	0	0	0	0	0	0	0
2027	MPE-Fe(II)	Target_lig_23	E.coli F61 RNA (G661)	Escherichia coli	Bacterial growth and infection	Target_366	2.60E-05	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	2 uM	-	7.6	37	20 mM Tris, 0.1M NaCl	Fluorescence titrations, Competitive experiments	Additional	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGCGCGAGCGUUACCCGGAUUCACUGGGCGUAAAGGGCGUGUAGGCGGCCUGGGGCGUCCCAUGUGAAAGACCACGGCUCAACCGUGGGGGAGCGUGGGAUACGCUCAGGCUAGACGGUGGGAGAGGGUGGUGGAAUUCCCGGAGUAGCGGUGAAAUGCGCAGAUACCGGGAGGAACGCCGAUGGCGAAGGCAGCCACCUGGUCCACCCGUGACGCUGAGGCGCGAAAGCGUGGGGAGCAAACCGGAUUAGAUACCCGGGUAGUCCACGCCCUAAACGAUGCGCGCUAGGUCUCUGGGUCUCCUGGGGGCCGAAGCUAACGCGUUAAGCGCGCCGCCUGGGGAG	1ML5	mRNA	mRNA	344	-	-	2.60E-05	2.60E-05	0	0	0	0	0	0	0	0
2028	MPE-Fe(II)	Target_lig_23	E.coli F61 RNA (G671)	Escherichia coli	Bacterial growth and infection	Target_367	2.00E-05	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	2 uM	-	7.6	37	20 mM Tris, 0.1M NaCl	Fluorescence titrations, Competitive experiments	Additional	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGCGCGAGCGUUACCCGGAUUCACUGGGCGUAAAGGGCGUGUAGGCGGCCUGGGGCGUCCCAUGUGAAAGACCACGGCUCAACCGUGGGGGAGCGUGGGAUACGCUCAGGCUAGACGGUGGGAGAGGGUGGUGGAAUUCCCGGAGUAGCGGUGAAAUGCGCAGAUACCGGGAGGAACGCCGAUGGCGAAGGCAGCCACCUGGUCCACCCGUGACGCUGAGGCGCGAAAGCGUGGGGAGCAAACCGGAUUAGAUACCCGGGUAGUCCACGCCCUAAACGAUGCGCGCUAGGUCUCUGGGUCUCCUGGGGGCCGAAGCUAACGCGUUAAGCGCGCCGCCUGGGGAG	1ML5	mRNA	mRNA	344	-	-	2.00E-05	2.00E-05	0	0	0	0	0	0	0	0
2029	MPE-Fe(II)	Target_lig_23	E.coli F61 RNA (G727)	Escherichia coli	Bacterial growth and infection	Target_368	5.60E-05	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	2 uM	-	7.6	37	20 mM Tris, 0.1M NaCl	Fluorescence titrations, Competitive experiments	Additional	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGCGCGAGCGUUACCCGGAUUCACUGGGCGUAAAGGGCGUGUAGGCGGCCUGGGGCGUCCCAUGUGAAAGACCACGGCUCAACCGUGGGGGAGCGUGGGAUACGCUCAGGCUAGACGGUGGGAGAGGGUGGUGGAAUUCCCGGAGUAGCGGUGAAAUGCGCAGAUACCGGGAGGAACGCCGAUGGCGAAGGCAGCCACCUGGUCCACCCGUGACGCUGAGGCGCGAAAGCGUGGGGAGCAAACCGGAUUAGAUACCCGGGUAGUCCACGCCCUAAACGAUGCGCGCUAGGUCUCUGGGUCUCCUGGGGGCCGAAGCUAACGCGUUAAGCGCGCCGCCUGGGGAG	1ML5	mRNA	mRNA	344	-	-	5.60E-05	5.60E-05	0	0	0	0	0	0	0	0
2030	MPE-Fe(II)	Target_lig_23	E.coli F61 RNA (C735)	Escherichia coli	Bacterial growth and infection	Target_369	2.60E-05	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	2 uM	-	7.6	37	20 mM Tris, 0.1M NaCl	Fluorescence titrations, Competitive experiments	Additional	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGCGCGAGCGUUACCCGGAUUCACUGGGCGUAAAGGGCGUGUAGGCGGCCUGGGGCGUCCCAUGUGAAAGACCACGGCUCAACCGUGGGGGAGCGUGGGAUACGCUCAGGCUAGACGGUGGGAGAGGGUGGUGGAAUUCCCGGAGUAGCGGUGAAAUGCGCAGAUACCGGGAGGAACGCCGAUGGCGAAGGCAGCCACCUGGUCCACCCGUGACGCUGAGGCGCGAAAGCGUGGGGAGCAAACCGGAUUAGAUACCCGGGUAGUCCACGCCCUAAACGAUGCGCGCUAGGUCUCUGGGUCUCCUGGGGGCCGAAGCUAACGCGUUAAGCGCGCCGCCUGGGGAG	1ML5	mRNA	mRNA	344	-	-	2.60E-05	2.60E-05	0	0	0	0	0	0	0	0
2031	MPE-Fe(II)	Target_lig_23	E.coli F61 RNA (A746)	Escherichia coli	Bacterial growth and infection	Target_370	1.20E-05	0	0	0	0	0	0	-	-	10.1021/bi00340a016	3935157	Detection of high-affinity intercalator sites in a ribosomal RNA fragment by the affinity cleavage intercalator methidiumpropyl-EDTA-iron(II).	Kean JM, White SA, Draper DE	Biochemistry	24	5062-70	1985	2 uM	-	7.6	37	20 mM Tris, 0.1M NaCl	Fluorescence titrations, Competitive experiments	Additional	C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)NCCCNC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)O)N)N	2-[carboxymethyl-[2-[carboxymethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]ethyl]amino]acetate	4125251	0.090200000000006	645.291096588	10	6	17	218.26	4	0.038967239745357	3.43905628675577	47	GGCGCGAGCGUUACCCGGAUUCACUGGGCGUAAAGGGCGUGUAGGCGGCCUGGGGCGUCCCAUGUGAAAGACCACGGCUCAACCGUGGGGGAGCGUGGGAUACGCUCAGGCUAGACGGUGGGAGAGGGUGGUGGAAUUCCCGGAGUAGCGGUGAAAUGCGCAGAUACCGGGAGGAACGCCGAUGGCGAAGGCAGCCACCUGGUCCACCCGUGACGCUGAGGCGCGAAAGCGUGGGGAGCAAACCGGAUUAGAUACCCGGGUAGUCCACGCCCUAAACGAUGCGCGCUAGGUCUCUGGGUCUCCUGGGGGCCGAAGCUAACGCGUUAAGCGCGCCGCCUGGGGAG	1ML5	mRNA	mRNA	344	-	-	1.20E-05	1.20E-05	0	0	0	0	0	0	0	0
2032	L_arginine	Target_lig_29	IVS of Tetrahymena (1)	Tetrahymena thermophila	Bacterial growth and infection	Target_22	0	1.7±0.1 uM - 1.85±0.05	0	0	0	0	0	-	-	10.1126/science.3381099	3381099	A specific amino acid binding site composed of RNA.	Yarus M	Science	240	1751-8	1988	0-25 mM	-	8.3	37	5mM Mg2+	Gel autoradiogram	Additional	C(C[C@@H](C(=O)O)N)CN=C(N)N	(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid	6322	-1.5481	174.111675688	3	4	5	127.72	0	0.227783103512755	2.73494438418824	12	GAAAUAGCAAUAUUUACCUUUGGAGGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGGCGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUCCAGUUCACAGACUAAAUGUCGGUCGGGAAGAUGAUAUUCUUCCCAUAAGAUUAGUCGGACCUCCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUGGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGUACUCG	http://www.smmrna.org/	Ribosomal	Intervening sequence (IVS)	411	-	-	0	0	1.60E-06	1.9	0	0	0	0	0	0
2033	Myomycin	Target_lig_1280	Tetrahymena Group I intron	Tetrahymena thermophila	Bacterial growth and infection	Target_23	0	0	0	0.01	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	0,4,10,25 uM	1,5,10 uM	7.5	30	8mM Mg2+	Gel electrophoresis and titrations	Additional	C(CC(CC(=O)NCCCC(CC(=O)NC(=NC1C(C(OC(C1O)OC2C(C(C(C(C2O)OC(=O)N)O)OC(=O)N)O)CO)O)N)N)N)CN	[3-[4-[[amino-[[3-amino-6-(3,6-diaminohexanoylamino)hexanoyl]amino]methylidene]amino]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-carbamoyloxy-2,4,6-trihydroxycyclohexyl] carbamate	3040806	-7.29570000000001	725.355547312	18	14	17	419.12	0	0.037595361874912	5.44538350358129	50	GACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGACGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGGAGACUGUUGAUAUGGAUGCAGUUCACAGACUAAAUGUCGGUCGGGGAAGAUGUAUUCUUCUCAUAAGAUAUAGUCGGACCUCUCCCGAAAGGGAGUUGGAGUACUCG	https://www.rcsb.org/structure/1GRZ	mRNA	Group I intron	247	-	-	0	0	0	0	0	0	0.01	0.01	0	0
2034	Streptomycin	Target_lig_63	Tetrahymena rRNA group IC1	Tetrahymena thermophila	Bacterial growth and infection	Target_371	0	0	0	0.002	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	0,4,10,25 uM	1,5,10 uM	7.5	30	8mM Mg2+	Gel electrophoresis and titrations	Additional	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	CUUCUAAAUAGCAAUAUUUACCUUUGGAGGGAAAAGUUAUCAGGCAUGCACCUGGUAGCUAGUCUUUAAACCAAUAGAUUGCAUCGGUUUAAAAGGCAAGACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGACGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGAUCUUCUGUUGAUAUGGAUGCAGUUCACAGACUAAAUGUCGGUCGGGGAAGAUGUAUUCUUCUCAUAAGAUAUAGUCGGACCUCUCCUUAAUGGGAGCUAGCGGAUGAAGUGAUGCAACACUGGAGCCGCUGGGAACUAAUUUGUAUGCGAAAGUAUAUUGAUUAGUUUUGGAGU	https://www.rcsb.org/structure/6WLS	rRNA	Group I intron	413	-	-	0	0	0	0	0	0	0.002	0.002	0	0
2035	Streptomycin	Target_lig_63	td-mutant U870	Tetrahymena thermophila	Bacterial growth and infection	Target_118	0	0	0	0.0004	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	0,4,10,25 uM	1,5,10 uM	7.5	30	8mM Mg2+	Gel electrophoresis and titrations	Additional	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAAUGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	10.1021/bi00227a018	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.0004	0.0004	0	0
2036	Streptomycin	Target_lig_63	td truncated at PVU-II	-	-	-	0	0	0	0.001	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	0,4,10,25 uM	1,5,10 uM	7.5	30	8mM Mg2+	Gel electrophoresis and titrations	Additional	CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O	2-[3-(diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine	5297	-8.16110000000001	581.265669688	15	12	9	336.43	0	0.068244795084906	5.67815151061474	40	-	-	-	-	0	-	-	0	0	0	0	0	0	0.001	0.001	0	0
2037	Myomycin	Target_lig_1280	td-mutant U870	Tetrahymena thermophila	Bacterial growth and infection	Target_118	0	0	0	0.01	0	0	0	-	-	10.1093/nar/19.9.2261	1710351	Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.	von Ahsen U, Schroeder R	Nucleic Acids Res	19	2261-5	1991	0,4,10,25 uM	1,5,10 uM	7.5	30	8mM Mg2+	Gel electrophoresis and titrations	Additional	C(CC(CC(=O)NCCCC(CC(=O)NC(=NC1C(C(OC(C1O)OC2C(C(C(C(C2O)OC(=O)N)O)OC(=O)N)O)CO)O)N)N)N)CN	[3-[4-[[amino-[[3-amino-6-(3,6-diaminohexanoylamino)hexanoyl]amino]methylidene]amino]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-carbamoyloxy-2,4,6-trihydroxycyclohexyl] carbamate	3040806	-7.29570000000001	725.355547312	18	14	17	419.12	0	0.037595361874912	5.44538350358129	50	UUUCUUGGGUUAAUUGAGGCCUGAGUAUAAGGUGACUUAUACUUGUAAUCUAUCUAAACGGGGAACCUCUCUAGUAGACAAUCCCGUGCUAAAUUGUAGGACUGCCCGGGUUCUACAUAAAUGCCUAAUGACUAUCCCUUUGGGGAGUAGGGUCAAGUGACUCGAAACGAUAGACAACUUGCUUUAACAAGUUGGAGAUAUAGUCUGCUCUGCAUGGUGACAUGCAGCUGGAUAUAAUUCCGGGGUAAGAUUAACGACCUUAUCUGAACAUAAUGCUAC	10.1021/bi00227a018	Viral RNA, mRNA	Group I intron	279	-	-	0	0	0	0	0	0	0.01	0.01	0	0
2038	cobinamide dicyanide	Target_lig_73	cyanocobalamin 35 nt RNA aptamer	Synthetic	-	Target_31	0	0	0.0007109999999999999±0.00021999999999999998	0	0	0	0	-	-	10.1021/bi00170a016	7508262	In vitro selection of RNA aptamers specific for cyanocobalamin.	Lorsch JR, Szostak JW	Biochemistry	33	973-82	1994	-	10 uM	7.4	-	0.5 M LiCl	Affinity column binding and purification	Additional	C/C/1=C/2\[C@@]([C@@H](C(=N2)/C=C\3/C([C@@H](C(=N3)/C(=C\4/[C@]([C@H](C([N-]4)[C@]5([C@@]([C@@H](C1=N5)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)(C)CCC(=O)NCC(C)O)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N.[C-]#N.[C-]#N.[Co]	cobalt;3-[(1R,2S,3S,5Z,7S,8S,10Z,13S,15Z,17R,18R)-2,7,18-tris(2-amino-2-oxoethyl)-3,13-bis(3-amino-3-oxopropyl)-17-[3-(2-hydroxypropylamino)-3-oxopropyl]-1,2,5,7,12,12,15,17-octamethyl-8,13,18,19-tetrahydro-3H-corrin-24-id-8-yl]propanamide;dicyanide	6450878	2.71034000000001	1041.49752200373	13	8	20	406.63	0	0.082438012108535	7.31201252608937	72	CGGGUGCGCAUAACCACCUCAGUGCGAGCAA	http://www.smmrna.org/	RNA aptamer	-	31	-	Pseudoknot	0	0	0	0	0.000491	0.000931	0	0	0	0
2039	cobinamide dicyanide	Target_lig_73	cyanocobalamin 35 nt RNA aptamer	Synthetic	-	Target_31	0	0	>0.001	0	0	0	0	-	-	10.1021/bi00170a016	7508262	In vitro selection of RNA aptamers specific for cyanocobalamin.	Lorsch JR, Szostak JW	Biochemistry	33	973-82	1994	-	10 uM	7.4	-	0.25 M LiCl	Affinity column binding and purification	Additional	C/C/1=C/2\[C@@]([C@@H](C(=N2)/C=C\3/C([C@@H](C(=N3)/C(=C\4/[C@]([C@H](C([N-]4)[C@]5([C@@]([C@@H](C1=N5)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)(C)CCC(=O)NCC(C)O)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N.[C-]#N.[C-]#N.[Co]	cobalt;3-[(1R,2S,3S,5Z,7S,8S,10Z,13S,15Z,17R,18R)-2,7,18-tris(2-amino-2-oxoethyl)-3,13-bis(3-amino-3-oxopropyl)-17-[3-(2-hydroxypropylamino)-3-oxopropyl]-1,2,5,7,12,12,15,17-octamethyl-8,13,18,19-tetrahydro-3H-corrin-24-id-8-yl]propanamide;dicyanide	6450878	2.71034000000001	1041.49752200373	13	8	20	406.63	0	0.082438012108535	7.31201252608937	72	CGGGUGCGCAUAACCACCUCAGUGCGAGCAA	http://www.smmrna.org/	RNA aptamer	-	31	-	Pseudoknot	0	0	0	0	0.001	0.001	0	0	0	0
2040	cobinamide dicyanide	Target_lig_73	cyanocobalamin 35 nt RNA aptamer	Synthetic	-	Target_31	0	0	>0.001	0	0	0	0	-	-	10.1021/bi00170a016	7508262	In vitro selection of RNA aptamers specific for cyanocobalamin.	Lorsch JR, Szostak JW	Biochemistry	33	973-82	1994	-	10 uM	7.4	-	1 M NaCl or 5 mM MgCl2	Affinity column binding and purification	Additional	C/C/1=C/2\[C@@]([C@@H](C(=N2)/C=C\3/C([C@@H](C(=N3)/C(=C\4/[C@]([C@H](C([N-]4)[C@]5([C@@]([C@@H](C1=N5)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)(C)CCC(=O)NCC(C)O)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N.[C-]#N.[C-]#N.[Co]	cobalt;3-[(1R,2S,3S,5Z,7S,8S,10Z,13S,15Z,17R,18R)-2,7,18-tris(2-amino-2-oxoethyl)-3,13-bis(3-amino-3-oxopropyl)-17-[3-(2-hydroxypropylamino)-3-oxopropyl]-1,2,5,7,12,12,15,17-octamethyl-8,13,18,19-tetrahydro-3H-corrin-24-id-8-yl]propanamide;dicyanide	6450878	2.71034000000001	1041.49752200373	13	8	20	406.63	0	0.082438012108535	7.31201252608937	72	CGGGUGCGCAUAACCACCUCAGUGCGAGCAA	http://www.smmrna.org/	RNA aptamer	-	31	-	Pseudoknot	0	0	0	0	0.001	0.001	0	0	0	0
2041	cobinamide dicyanide	Target_lig_73	Yeast tRNA Phe	Saccharomyces cereviseae	-	Target_1	0	0	>0.001	0	0	0	0	-	-	10.1021/bi00170a016	7508262	In vitro selection of RNA aptamers specific for cyanocobalamin.	Lorsch JR, Szostak JW	Biochemistry	33	973-82	1994	-	10 uM	7.4	-	1 M LiCl	Affinity column binding and purification	Additional	C/C/1=C/2\[C@@]([C@@H](C(=N2)/C=C\3/C([C@@H](C(=N3)/C(=C\4/[C@]([C@H](C([N-]4)[C@]5([C@@]([C@@H](C1=N5)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)(C)CCC(=O)NCC(C)O)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N.[C-]#N.[C-]#N.[Co]	cobalt;3-[(1R,2S,3S,5Z,7S,8S,10Z,13S,15Z,17R,18R)-2,7,18-tris(2-amino-2-oxoethyl)-3,13-bis(3-amino-3-oxopropyl)-17-[3-(2-hydroxypropylamino)-3-oxopropyl]-1,2,5,7,12,12,15,17-octamethyl-8,13,18,19-tetrahydro-3H-corrin-24-id-8-yl]propanamide;dicyanide	6450878	2.71034000000001	1041.49752200373	13	8	20	406.63	0	0.082438012108535	7.31201252608937	72	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	0.001	0.001	0	0	0	0
2042	cyanocobalamine	Target_lig_72	B12.9	Synthetic	-	Target_372	0	0	3.2e-07±9e-08	0	0	0	0	-	-	10.1021/bi00170a016	7508262	In vitro selection of RNA aptamers specific for cyanocobalamin.	Lorsch JR, Szostak JW	Biochemistry	33	973-82	1994	-	10 uM	7.4	-	1 M LiCl	Affinity column binding and purification	Additional	CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]	cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;cyanide	184933	3.40921000000001	1354.567400126	20	9	26	488.71	2	0.048125213524287	8.35176404036808	93	CCGGTGCGCATAACCACCTCAGTGCGAGCAACGATGGCC	10.1021/bi00170a016	RNA aptamer	-	39	-	Stem-Loop	0	0	0	0	2.30E-07	4.10E-07	0	0	0	0
2043	cobinamide dicyanide	Target_lig_73	B12.9	Synthetic	-	Target_372	0	0	8.8e-06±5.5e-07	0	0	0	0	-	-	10.1021/bi00170a016	7508262	In vitro selection of RNA aptamers specific for cyanocobalamin.	Lorsch JR, Szostak JW	Biochemistry	33	973-82	1994	-	10 uM	7.4	-	1 M LiCl	Affinity column binding and purification	Additional	C/C/1=C/2\[C@@]([C@@H](C(=N2)/C=C\3/C([C@@H](C(=N3)/C(=C\4/[C@]([C@H](C([N-]4)[C@]5([C@@]([C@@H](C1=N5)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)(C)CCC(=O)NCC(C)O)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N.[C-]#N.[C-]#N.[Co]	cobalt;3-[(1R,2S,3S,5Z,7S,8S,10Z,13S,15Z,17R,18R)-2,7,18-tris(2-amino-2-oxoethyl)-3,13-bis(3-amino-3-oxopropyl)-17-[3-(2-hydroxypropylamino)-3-oxopropyl]-1,2,5,7,12,12,15,17-octamethyl-8,13,18,19-tetrahydro-3H-corrin-24-id-8-yl]propanamide;dicyanide	6450878	2.71034000000001	1041.49752200373	13	8	20	406.63	0	0.082438012108535	7.31201252608937	72	CCGGTGCGCATAACCACCTCAGTGCGAGCAACGATGGCC	10.1021/bi00170a016	RNA aptamer	-	39	-	Stem-Loop	0	0	0	0	8.25E-06	9.35E-06	0	0	0	0
2044	2,4,5,6-tetraaminopyrimidine	Target_lig_1121	ADENINE RIBOSWITCH	Synthetic	Bacterial growth and infection	Target_69	0	0	1.9999999999999998e-05±1e-07	0	0	0	0	-	-	10.1021/ja063645t	17076468	Modified pyrimidines specifically bind the purine riboswitch.	Gilbert SD, Mediatore SJ, Batey RT	J Am Chem Soc	128	14214-5	2006	-	-	7.5	30	100 mM KCl, 10 mM MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	C1(=C(N=C(N=C1N)N)N)N	pyrimidine-2,4,5,6-tetramine	70487	-1.1946	140.081044256	6	4	0	129.86	1	0.358005026761141	2.64355634892403	10	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGAUUAUGUCC	https://www.rcsb.org/structure/2G9C	Riboswitch	Riboswitch	67	-	-	0	0	0	0	1.99E-05	2.01E-05	0	0	0	0
2045	2,4-diaminopyrimidine	Target_lig_1122	ADENINE RIBOSWITCH	Synthetic	Bacterial growth and infection	Target_69	0	0	>0.001	0	0	0	0	-	-	10.1021/ja063645t	17076468	Modified pyrimidines specifically bind the purine riboswitch.	Gilbert SD, Mediatore SJ, Batey RT	J Am Chem Soc	128	14214-5	2006	-	-	7.5	30	100 mM KCl, 10 mM MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	C1=CN=C(N=C1N)N	pyrimidine-2,4-diamine	67431	-0.359	110.059246192	4	2	0	77.82	1	0.477761192277615	2.44028595269254	8	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGAUUAUGUCC	https://www.rcsb.org/structure/2G9C	Riboswitch	Riboswitch	67	-	-	0	0	0	0	0.001	0.001	0	0	0	0
2046	2,4,6-triamino-1,3,5-triazine	Target_lig_1123	ADENINE RIBOSWITCH	Synthetic	Bacterial growth and infection	Target_69	0	0	1.9999999999999998e-05±1e-06	0	0	0	0	-	-	10.1021/ja063645t	17076468	Modified pyrimidines specifically bind the purine riboswitch.	Gilbert SD, Mediatore SJ, Batey RT	J Am Chem Soc	128	14214-5	2006	-	-	7.5	30	100 mM KCl, 10 mM MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	Nc1nc(N)nc(n1)N	1,3,5-triazine-2,4,6-triamine	7955	-1.3818	126.065394192	6	3	0	116.73	1	0.394014068961675	2.32521667484806	9	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGAUUAUGUCC	https://www.rcsb.org/structure/2G9C	Riboswitch	Riboswitch	67	-	-	0	0	0	0	1.90E-05	2.10E-05	0	0	0	0
2047	Acetylpromazine	Target_lig_176	CVB loop D RNA	Coxsackie virus	Hand, foot and mouth disease	Target_373	0	0	0.00033	0	0	0	0	-	-	10.1021/ja0398870	15053636	NMR-based characterization of phenothiazines as a RNA binding scaffold.	Mayer M, James TL	J Am Chem Soc	126	4453-60	2004	0.5-0.7 mM	-	-	-	-	Tat transactivation assay	Additional	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	6077	4.4436	326.145284324	4	0	5	23.55	2	0.757792051694743	2.19866048303301	23	GGGCUAGCACUCUGGUAUCACGGUACCUUUGUGCGCCC	10.1021/ja0398870	mRNA, Viral RNA	mRNA	38	-	-	0	0	0	0	0.00033	0.00033	0	0	0	0
2048	Acetylpromazine	Target_lig_176	Polio virus loop B RNA	Polio virus	Polio	Target_374	0	0	0.0018	0	0	0	0	-	-	10.1021/ja0398870	15053636	NMR-based characterization of phenothiazines as a RNA binding scaffold.	Mayer M, James TL	J Am Chem Soc	126	4453-60	2004	0.5-0.7 mM	-	-	-	-	Tat transactivation assay	Additional	CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C	1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone	6077	4.4436	326.145284324	4	0	5	23.55	2	0.757792051694743	2.19866048303301	23	GGGGUUGUACCCACCCCAC	10.1021/ja0398870	mRNA, Viral RNA	mRNA	19	-	-	0	0	0	0	0.0018	0.0018	0	0	0	0
2049	Rbt427	Target_lig_1124	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	8.60E-07	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	NCCCOc1ccc(cc1CNCCCCNC(=N)N)c1cscc1	2-[4-[[2-(3-aminopropoxy)-5-thiophen-3-ylphenyl]methylamino]butyl]guanidine	9969740	2.49557	375.209281548	5	5	12	109.18	2	0.222424175055627	2.49733164330982	26	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	8.60E-07	8.60E-07	0	0	0	0
2050	Rbt429	Target_lig_1125	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.90E-07	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	NCCCOc1ccc(cc1CNCCCCNC(=N)N)c1cc2c(o1)cccc2	2-[4-[[2-(3-aminopropoxy)-5-(1-benzofuran-2-yl)phenyl]methylamino]butyl]guanidine	516514	3.18027	409.247775232	5	5	12	122.32	3	0.177869545650925	2.47285228207506	30	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.90E-07	1.90E-07	0	0	0	0
2051	Rbt446	Target_lig_1126	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	2.19E-07	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	NCCCOc1ccc(cc1CNCCc1ccc(cc1)CNC(=N)N)c1cc2c(s1)cccc2	-	-	4.61127	487.240581676	5	5	12	109.18	4	0.11388588134988	2.54934347455403	35	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	2.19E-07	2.19E-07	0	0	0	0
2052	Rbt489	Target_lig_1127	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	5.90E-07	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	NCCCOc1ccc(cc1CNCCCCN(C)C)c1cc2c(s1)cccc2	N-[[2-(3-aminopropoxy)-5-(1-benzothiophen-2-yl)phenyl]methyl]-N',N'-dimethylbutane-1,4-diamine	516517	4.7273	411.234433676	5	2	12	50.52	3	0.423238711385786	2.38320997646628	29	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	5.90E-07	5.90E-07	0	0	0	0
2053	Rbt537	Target_lig_1128	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	4.76E-07	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	NCCCOc1ccc(cc1CNCCC1CCNCC1)c1cc2c(s1)cccc2	3-[4-(1-benzothiophen-2-yl)-2-[(2-piperidin-4-ylethylamino)methyl]phenoxy]propan-1-amine	142078131	4.7752	423.234433676	5	3	10	59.31	3	0.411017323210805	2.53744654786352	30	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	4.76E-07	4.76E-07	0	0	0	0
2054	Rbt549	Target_lig_1129	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.51E-07	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	NCCCOc1ccc(cc1CNCCC1CCNCC1)c1ccc2c(c1)[nH]cc2	-	-	4.0418	406.273261708	4	4	10	75.1	3	0.383427391294944	2.58641370430258	30	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.51E-07	1.51E-07	0	0	0	0
2055	Rbt551	Target_lig_1130	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	3.36E-06	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	NCCCOc1ccc(cc1CNCCC1CCNCC1)c1ccc2c(c1)oc(c2)C(=O)NC	-	-	3.6663	464.278741012	6	4	11	101.55	3	0.323160551536237	2.70053633717826	34	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	3.36E-06	3.36E-06	0	0	0	0
2056	Rbt552	Target_lig_1131	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	4.28E-07	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	NCCCOc1ccc(cc1CNCCC1CCNCC1)c1ccccn1	-	-	2.9555	368.257611644	5	3	10	72.2	2	0.56251177952231	2.39916634645341	27	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	4.28E-07	4.28E-07	0	0	0	0
2057	Rbt555	Target_lig_1132	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	3.04E-06	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	NCCCOc1ccc(cc1CNCCC1CCNCC1)c1ccc2c(c1)c(=O)cco2	-	-	3.6669	435.252191916	6	3	10	89.52	3	0.421228982992973	2.66662328085747	32	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	3.04E-06	3.04E-06	0	0	0	0
2058	Rbt556	Target_lig_1133	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	4.46E-07	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	NCCCOc1ccc(cc1CNCCC1CCNCC1)c1ccc2c(n1)cccc2	-	-	4.1087	418.273261708	5	3	10	72.2	3	0.432325577487334	2.43372878721444	31	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	4.46E-07	4.46E-07	0	0	0	0
2059	Rbt567	Target_lig_1134	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.19E-06	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	NCCCOc1ccc(cc1CNCCC1CCNCC1)c1ccccc1	-	-	3.5605	367.262362676	4	3	10	59.31	2	0.562106245841156	2.24709576953033	27	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.19E-06	1.19E-06	0	0	0	0
2060	Rbt603	Target_lig_1135	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	2.89E-06	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	N1CCN(CC1)CCCNCc1cc(ccc1OCc1cc2c(s1)cccc2)c1cc2c(s1)cccc2	-	-	6.74690000000001	527.206504676	6	2	10	36.53	5	0.197122433874753	2.68325432507708	37	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	2.89E-06	2.89E-06	0	0	0	0
2061	Rbt605	Target_lig_1136	HIV-1 TAR RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	0	1.13E-06	0	0	0	0	-	-	10.1016/j.jmb.2003.12.028	15095977	Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.	Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J	J Mol Biol	336	625-38	2004	1, 10, 100 uM	20 nM	0.5	-	80mM Kcl	FRET assay	Additional	CN(CCCCOc1ccc(cc1CNCCCN1CCNCC1)c1cc2c(s1)cccc2)C	-	-	4.6738	480.2922829	6	2	13	39.77	3	0.347921560880503	2.55267678473071	34	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	0	0	1.13E-06	1.13E-06	0	0	0	0
2062	B-11	Target_lig_1137	RNA hairpin loop I	Synthetic	-	Target_375	0	0	5.73E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1ccc(cc1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.00821937650098	46	CGCGCGAAAGCGCG	10.1021/bi0607296	mRNA	mRNA	14	-	Stem-Loop	0	0	0	0	5.73E-06	5.73E-06	0	0	0	0
2063	B-13	Target_lig_1138	RNA hairpin loop I	Synthetic	-	Target_375	0	0	6.30E-07	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1c(C)cc(c(c1C)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)C)O)O	-	-	-1.91273999999999	686.422779448	16	8	14	264.88	3	0.086063424928087	5.27785564037176	49	CGCGCGAAAGCGCG	10.1021/bi0607296	mRNA	mRNA	14	-	Stem-Loop	0	0	0	0	6.30E-07	6.30E-07	0	0	0	0
2064	B-14	Target_lig_1139	RNA hairpin loop I	Synthetic	-	Target_375	0	0	5.06E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1cccc(n1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-3.44299999999999	645.371078224	17	8	14	277.77	3	0.079176130343416	5.16913192087968	46	CGCGCGAAAGCGCG	10.1021/bi0607296	mRNA	mRNA	14	-	Stem-Loop	0	0	0	0	5.06E-06	5.06E-06	0	0	0	0
2065	B-11	Target_lig_1137	RNA hairpin loop Ia	Synthetic	-	Target_375	0	0	7.55E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1ccc(cc1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.00821937650098	46	CGCGCGAAAGCGCG	10.1021/bi0607296	mRNA	mRNA	14	-	Stem-Loop	0	0	0	0	7.55E-06	7.55E-06	0	0	0	0
2066	B-12	Target_lig_224	RNA hairpin loop Ia	Synthetic	-	Target_375	0	0	1.36E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	[C@@H]1([C@H]([C@H](O)[C@H]([C@@H](C1)N)O)OCCCc1cn(nn1)Cc1cccc(Cn2cc(nn2)CCCO[C@H]2[C@@H](C[C@@H]([C@@H](O)[C@H]2O)N)N)c1)N	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.0391964179211	46	CGCGCGAAAGCGCG	10.1021/bi0607296	mRNA	mRNA	14	-	Stem-Loop	0	0	0	0	1.36E-06	1.36E-06	0	0	0	0
2067	B-13	Target_lig_1138	RNA hairpin loop Ia	Synthetic	-	Target_375	0	0	7.80E-07	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1c(C)cc(c(c1C)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)C)O)O	-	-	-1.91273999999999	686.422779448	16	8	14	264.88	3	0.086063424928087	5.27785564037176	49	CGCGCGAAAGCGCG	10.1021/bi0607296	mRNA	mRNA	14	-	Stem-Loop	0	0	0	0	7.80E-07	7.80E-07	0	0	0	0
2068	B-14	Target_lig_1139	RNA hairpin loop Ia	Synthetic	-	Target_375	0	0	6.08E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1cccc(n1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-3.44299999999999	645.371078224	17	8	14	277.77	3	0.079176130343416	5.16913192087968	46	CGCGCGAAAGCGCG	10.1021/bi0607296	mRNA	mRNA	14	-	Stem-Loop	0	0	0	0	6.08E-06	6.08E-06	0	0	0	0
2069	B-11	Target_lig_1137	RNA hairpin loop Ib	Synthetic	-	Target_376	0	0	6.32E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1ccc(cc1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.00821937650098	46	CGCGCUUCGGCGCG	10.1021/bi0607296	mRNA	mRNA	14	-	Stem-Loop	0	0	0	0	6.32E-06	6.32E-06	0	0	0	0
2070	B-12	Target_lig_224	RNA hairpin loop Ib	Synthetic	-	Target_376	0	0	1.54E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	[C@@H]1([C@H]([C@H](O)[C@H]([C@@H](C1)N)O)OCCCc1cn(nn1)Cc1cccc(Cn2cc(nn2)CCCO[C@H]2[C@@H](C[C@@H]([C@@H](O)[C@H]2O)N)N)c1)N	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.0391964179211	46	CGCGCUUCGGCGCG	10.1021/bi0607296	mRNA	mRNA	14	-	Stem-Loop	0	0	0	0	1.54E-06	1.54E-06	0	0	0	0
2071	B-13	Target_lig_1138	RNA hairpin loop Ib	Synthetic	-	Target_376	0	0	8.40E-07	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1c(C)cc(c(c1C)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)C)O)O	-	-	-1.91273999999999	686.422779448	16	8	14	264.88	3	0.086063424928087	5.27785564037176	49	CGCGCUUCGGCGCG	10.1021/bi0607296	mRNA	mRNA	14	-	Stem-Loop	0	0	0	0	8.40E-07	8.40E-07	0	0	0	0
2072	B-14	Target_lig_1139	RNA hairpin loop Ib	Synthetic	-	Target_376	0	0	7.88E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1cccc(n1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-3.44299999999999	645.371078224	17	8	14	277.77	3	0.079176130343416	5.16913192087968	46	CGCGCUUCGGCGCG	10.1021/bi0607296	mRNA	mRNA	14	-	Stem-Loop	0	0	0	0	7.88E-06	7.88E-06	0	0	0	0
2073	B-11	Target_lig_1137	RNA hairpin loop II	Synthetic	-	Target_377	0	0	2.07E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1ccc(cc1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.00821937650098	46	CGCGCAGUGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	16	-	Stem-Loop	0	0	0	0	2.07E-06	2.07E-06	0	0	0	0
2074	B-12	Target_lig_224	RNA hairpin loop II	Synthetic	-	Target_377	0	0	1.00E-05	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	[C@@H]1([C@H]([C@H](O)[C@H]([C@@H](C1)N)O)OCCCc1cn(nn1)Cc1cccc(Cn2cc(nn2)CCCO[C@H]2[C@@H](C[C@@H]([C@@H](O)[C@H]2O)N)N)c1)N	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.0391964179211	46	CGCGCAGUGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	16	-	Stem-Loop	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
2075	B-13	Target_lig_1138	RNA hairpin loop II	Synthetic	-	Target_377	0	0	6.00E-07	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1c(C)cc(c(c1C)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)C)O)O	-	-	-1.91273999999999	686.422779448	16	8	14	264.88	3	0.086063424928087	5.27785564037176	49	CGCGCAGUGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	16	-	Stem-Loop	0	0	0	0	6.00E-07	6.00E-07	0	0	0	0
2076	B-14	Target_lig_1139	RNA hairpin loop II	Synthetic	-	Target_377	0	0	4.57E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1cccc(n1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-3.44299999999999	645.371078224	17	8	14	277.77	3	0.079176130343416	5.16913192087968	46	CGCGCAGUGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	16	-	Stem-Loop	0	0	0	0	4.57E-06	4.57E-06	0	0	0	0
2077	B-11	Target_lig_1137	RNA hairpin loop III	Synthetic	-	Target_378	0	0	1.43E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1ccc(cc1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.00821937650098	46	CGCGCAGUAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	1.43E-06	1.43E-06	0	0	0	0
2078	B-12	Target_lig_224	RNA hairpin loop III	Synthetic	-	Target_378	0	0	9.87E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	[C@@H]1([C@H]([C@H](O)[C@H]([C@@H](C1)N)O)OCCCc1cn(nn1)Cc1cccc(Cn2cc(nn2)CCCO[C@H]2[C@@H](C[C@@H]([C@@H](O)[C@H]2O)N)N)c1)N	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.0391964179211	46	CGCGCAGUAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	9.87E-06	9.87E-06	0	0	0	0
2079	B-13	Target_lig_1138	RNA hairpin loop III	Synthetic	-	Target_378	0	0	2.55E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1c(C)cc(c(c1C)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)C)O)O	-	-	-1.91273999999999	686.422779448	16	8	14	264.88	3	0.086063424928087	5.27785564037176	49	CGCGCAGUAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	2.55E-06	2.55E-06	0	0	0	0
2080	B-14	Target_lig_1139	RNA hairpin loop III	Synthetic	-	Target_378	0	0	1.27E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1cccc(n1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-3.44299999999999	645.371078224	17	8	14	277.77	3	0.079176130343416	5.16913192087968	46	CGCGCAGUAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	1.27E-06	1.27E-06	0	0	0	0
2081	B-11	Target_lig_1137	RNA hairpin loop IIIa	Synthetic	-	Target_379	0	0	2.73E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1ccc(cc1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.00821937650098	46	CGCGCACAAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	2.73E-06	2.73E-06	0	0	0	0
2082	B-12	Target_lig_224	RNA hairpin loop IIIa	Synthetic	-	Target_379	0	0	2.23E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	[C@@H]1([C@H]([C@H](O)[C@H]([C@@H](C1)N)O)OCCCc1cn(nn1)Cc1cccc(Cn2cc(nn2)CCCO[C@H]2[C@@H](C[C@@H]([C@@H](O)[C@H]2O)N)N)c1)N	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.0391964179211	46	CGCGCACAAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	2.23E-06	2.23E-06	0	0	0	0
2083	B-13	Target_lig_1138	RNA hairpin loop IIIa	Synthetic	-	Target_379	0	0	4.40E-07	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1c(C)cc(c(c1C)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)C)O)O	-	-	-1.91273999999999	686.422779448	16	8	14	264.88	3	0.086063424928087	5.27785564037176	49	CGCGCACAAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	4.40E-07	4.40E-07	0	0	0	0
2084	B-14	Target_lig_1139	RNA hairpin loop IIIa	Synthetic	-	Target_379	0	0	3.50E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1cccc(n1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-3.44299999999999	645.371078224	17	8	14	277.77	3	0.079176130343416	5.16913192087968	46	CGCGCACAAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	3.50E-06	3.50E-06	0	0	0	0
2085	B-11	Target_lig_1137	RNA hairpin loop IIIb	Synthetic	-	Target_380	0	0	2.03E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1ccc(cc1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.00821937650098	46	CGCGCACAACAAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	2.03E-06	2.03E-06	0	0	0	0
2086	B-12	Target_lig_224	RNA hairpin loop IIIb	Synthetic	-	Target_380	0	0	2.39E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	[C@@H]1([C@H]([C@H](O)[C@H]([C@@H](C1)N)O)OCCCc1cn(nn1)Cc1cccc(Cn2cc(nn2)CCCO[C@H]2[C@@H](C[C@@H]([C@@H](O)[C@H]2O)N)N)c1)N	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.0391964179211	46	CGCGCACAACAAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	2.39E-06	2.39E-06	0	0	0	0
2087	B-13	Target_lig_1138	RNA hairpin loop IIIb	Synthetic	-	Target_380	0	0	4.70E-07	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1c(C)cc(c(c1C)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)C)O)O	-	-	-1.91273999999999	686.422779448	16	8	14	264.88	3	0.086063424928087	5.27785564037176	49	CGCGCACAACAAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	4.70E-07	4.70E-07	0	0	0	0
2088	B-14	Target_lig_1139	RNA hairpin loop IIIb	Synthetic	-	Target_380	0	0	3.42E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1cccc(n1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-3.44299999999999	645.371078224	17	8	14	277.77	3	0.079176130343416	5.16913192087968	46	CGCGCACAACAAGCGCG	10.1021/bi0607296	mRNA	mRNA	17	-	Stem-Loop	0	0	0	0	3.42E-06	3.42E-06	0	0	0	0
2089	B-11	Target_lig_1137	RNA hairpin loop IV	Synthetic	-	Target_381	0	0	3.08E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1ccc(cc1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.00821937650098	46	CGCGCAGUCAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	18	-	Stem-Loop	0	0	0	0	3.08E-06	3.08E-06	0	0	0	0
2090	B-12	Target_lig_224	RNA hairpin loop IV	Synthetic	-	Target_381	0	0	3.20E-07	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	[C@@H]1([C@H]([C@H](O)[C@H]([C@@H](C1)N)O)OCCCc1cn(nn1)Cc1cccc(Cn2cc(nn2)CCCO[C@H]2[C@@H](C[C@@H]([C@@H](O)[C@H]2O)N)N)c1)N	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.0391964179211	46	CGCGCAGUCAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	18	-	Stem-Loop	0	0	0	0	3.20E-07	3.20E-07	0	0	0	0
2091	B-13	Target_lig_1138	RNA hairpin loop IV	Synthetic	-	Target_381	0	0	4.10E-07	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1c(C)cc(c(c1C)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)C)O)O	-	-	-1.91273999999999	686.422779448	16	8	14	264.88	3	0.086063424928087	5.27785564037176	49	CGCGCAGUCAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	18	-	Stem-Loop	0	0	0	0	4.10E-07	4.10E-07	0	0	0	0
2092	B-14	Target_lig_1139	RNA hairpin loop IV	Synthetic	-	Target_381	0	0	3.00E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1cccc(n1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-3.44299999999999	645.371078224	17	8	14	277.77	3	0.079176130343416	5.16913192087968	46	CGCGCAGUCAGUAGCGCG	10.1021/bi0607296	mRNA	mRNA	18	-	Stem-Loop	0	0	0	0	3.00E-06	3.00E-06	0	0	0	0
2093	B-11	Target_lig_1137	RNA hairpin loop Iva	Synthetic	-	Target_382	0	0	2.03E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1ccc(cc1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.00821937650098	46	CGCGCUUGCGAGUGCGCG	10.1021/bi0607296	mRNA	mRNA	18	-	Stem-Loop	0	0	0	0	2.03E-06	2.03E-06	0	0	0	0
2094	B-12	Target_lig_224	RNA hairpin loop Iva	Synthetic	-	Target_382	0	0	1.50E-07	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	[C@@H]1([C@H]([C@H](O)[C@H]([C@@H](C1)N)O)OCCCc1cn(nn1)Cc1cccc(Cn2cc(nn2)CCCO[C@H]2[C@@H](C[C@@H]([C@@H](O)[C@H]2O)N)N)c1)N	-	-	-2.83799999999999	644.375829256	16	8	14	264.88	3	0.082224533295905	5.0391964179211	46	CGCGCUUGCGAGUGCGCG	10.1021/bi0607296	mRNA	mRNA	18	-	Stem-Loop	0	0	0	0	1.50E-07	1.50E-07	0	0	0	0
2095	B-13	Target_lig_1138	RNA hairpin loop Iva	Synthetic	-	Target_382	0	0	4.80E-07	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1c(C)cc(c(c1C)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)C)O)O	-	-	-1.91273999999999	686.422779448	16	8	14	264.88	3	0.086063424928087	5.27785564037176	49	CGCGCUUGCGAGUGCGCG	10.1021/bi0607296	mRNA	mRNA	18	-	Stem-Loop	0	0	0	0	4.80E-07	4.80E-07	0	0	0	0
2096	B-14	Target_lig_1139	RNA hairpin loop Iva	Synthetic	-	Target_382	0	0	2.24E-06	0	0	0	0	-	-	10.1021/bi0607296	16953578	Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity.	Thomas JR, Liu X, Hergenrother PJ	Biochemistry	45	10928-38	2006	-	28 nM	7.5	25	1mM MgCl2	Fluorescence binding assay	Additional	N[C@@H]1C[C@H](N)[C@H]([C@H]([C@H]1OCCCc1nnn(c1)Cc1cccc(n1)Cn1nnc(c1)CCCO[C@@H]1[C@H](N)C[C@H]([C@@H]([C@H]1O)O)N)O)O	-	-	-3.44299999999999	645.371078224	17	8	14	277.77	3	0.079176130343416	5.16913192087968	46	CGCGCUUGCGAGUGCGCG	10.1021/bi0607296	mRNA	mRNA	18	-	Stem-Loop	0	0	0	0	2.24E-06	2.24E-06	0	0	0	0
2097	Benzimidazole1	Target_lig_225	HCV IRES Domain II	Hepatitis C virus	Hepatitis C	Target_66	0	0	>9.999999999999999e-05	0	0	0	0	-	-	10.1021/jm050815o	16279767	SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.	Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ, Swayze EE, Griffey RH	J Med Chem	48	7099-102	2005	0.25-25 uM	2.5, 5 uM	-	-	100 mM ammonium acetate	Mass spectrometry screening	Additional	c1c2OC[C@@H](Cc2c2c(c1)N=C1[C@H]2C[C@@H](CN1)CN(C)C)CN(C)C	-	-	2.0976	342.24196158	5	1	4	40.1	1	0.909648875567406	4.46144069329163	25	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	0.0001	0.0001	0	0	0	0
2098	Benzimidazole10	Target_lig_1141	HCV IRES Domain II	Hepatitis C virus	Hepatitis C	Target_66	0	0	3.50E-06	0	0	0	0	-	-	10.1021/jm050815o	16279767	SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.	Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ, Swayze EE, Griffey RH	J Med Chem	48	7099-102	2005	0.25-25 uM	2.5, 5 uM	-	-	100 mM ammonium acetate	Mass spectrometry screening	Additional	CN(CCCOc1ccc2c(c1)n1CC(CNc1n2)CN(C)C)C	3-[[3-[(dimethylamino)methyl]-1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazol-7-yl]oxy]-N,N-dimethylpropan-1-amine	135433929	1.9701	331.237210548	6	1	7	45.56	2	0.786131960335845	3.36001189300892	24	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	3.50E-06	3.50E-06	0	0	0	0
2099	Benzimidazole11	Target_lig_1142	HCV IRES Domain II	Hepatitis C virus	Hepatitis C	Target_66	0	0	1.70E-06	0	0	0	0	-	-	10.1021/jm050815o	16279767	SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.	Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ, Swayze EE, Griffey RH	J Med Chem	48	7099-102	2005	0.25-25 uM	2.5, 5 uM	-	-	100 mM ammonium acetate	Mass spectrometry screening	Additional	CN(CCCn1c(N)nc2c1c1CC(Oc1cc2)CN(C)C)C	7-[(dimethylamino)methyl]-1-[3-(dimethylamino)propyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine	9948877	1.4353	317.221560484	6	1	6	59.55	2	0.873374594066318	3.2957664015855	23	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	1.70E-06	1.70E-06	0	0	0	0
2100	Benzimidazole12	Target_lig_1143	HCV IRES Domain II	Hepatitis C virus	Hepatitis C	Target_66	0	0	8.60E-07	0	0	0	0	-	-	10.1021/jm050815o	16279767	SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.	Seth PP, Miyaji A, Jefferson EA, Sannes-Lowery KA, Osgood SA, Propp SS, Ranken R, Massire C, Sampath R, Ecker DJ, Swayze EE, Griffey RH	J Med Chem	48	7099-102	2005	0.25-25 uM	2.5, 5 uM	-	-	100 mM ammonium acetate	Mass spectrometry screening	Additional	CN(CCCn1c(N)nc2c1c1CC(COc1cc2)CN(C)C)C	8-[(dimethylamino)methyl]-1-[3-(dimethylamino)propyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine	9996819	1.6829	331.237210548	6	1	6	59.55	2	0.872659061330155	3.32351153507011	24	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	8.60E-07	8.60E-07	0	0	0	0
2101	Azithromycin	Target_lig_223	50S subunit	Escherichia coli	Bacterial growth and infection	Target_100	0	0	2 nM - 5.6	0	0	0	0	-	-	10.1128/AAC.49.8.3367–3372.2005	16048949	Fluorescence polarization method to characterize macrolide-ribosome interactions.	Yan K, Hunt E, Berge J, May E, Copeland RA, Gontarek RR	Antimicrob Agents Chemother	49	3367-72	2005	-	3 nM	7.5	37	20 mM HEPES, 50 mM NH 4 Cl, 10 mM MgCl 2 , 0.05% Tween 20	Filter binding assay	Additional	CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O	11-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one	2269	1.90070000000001	748.508525744	14	5	7	180.08	0	0.238475441191226	6.13284897579343	52	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	2.00E-09	5.60E-09	0	0	0	0
2102	Telithromycin	Target_lig_317	50S subunit	Escherichia coli	Bacterial growth and infection	Target_100	0	0	6.4 nM - 11.0	0	0	0	0	-	-	10.1128/AAC.49.8.3367–3372.2005	16048949	Fluorescence polarization method to characterize macrolide-ribosome interactions.	Yan K, Hunt E, Berge J, May E, Copeland RA, Gontarek RR	Antimicrob Agents Chemother	49	3367-72	2005	-	3 nM	7.5	37	20 mM HEPES, 50 mM NH 4 Cl, 10 mM MgCl 2 , 0.05% Tween 20	Filter binding assay	Additional	CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C	8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone	21881641	4.92920000000001	811.47314328	14	1	11	171.85	2	0.184283434829262	6.03700146103189	58	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	6.40E-09	1.10E-08	0	0	0	0
2103	Tylosin	Target_lig_320	50S subunit	Escherichia coli	Bacterial growth and infection	Target_100	0	0	3.9 nM - 6.2	0	0	0	0	-	-	10.1128/AAC.49.8.3367–3372.2005	16048949	Fluorescence polarization method to characterize macrolide-ribosome interactions.	Yan K, Hunt E, Berge J, May E, Copeland RA, Gontarek RR	Antimicrob Agents Chemother	49	3367-72	2005	-	3 nM	7.5	37	20 mM HEPES, 50 mM NH 4 Cl, 10 mM MgCl 2 , 0.05% Tween 20	Filter binding assay	Additional	CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC	2-[6-[5-(4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde	5062352	1.83350000000001	915.519150004	18	5	13	238.67	0	0.130887261974031	6.85125631597821	64	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	3.90E-09	6.20E-09	0	0	0	0
2104	Kitasamycin	Target_lig_1144	50S subunit	Escherichia coli	Bacterial growth and infection	Target_100	0	0	4.6 nM - 8.9	0	0	0	0	-	-	10.1128/AAC.49.8.3367–3372.2005	16048949	Fluorescence polarization method to characterize macrolide-ribosome interactions.	Yan K, Hunt E, Berge J, May E, Copeland RA, Gontarek RR	Antimicrob Agents Chemother	49	3367-72	2005	-	3 nM	7.5	37	20 mM HEPES, 50 mM NH 4 Cl, 10 mM MgCl 2 , 0.05% Tween 20	Filter binding assay	Additional	CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)C)N(C)C)O)CC=O)C)O	-	-	2.1208	699.419376392	13	4	8	173.68	0	0.214621079175555	6.20768800309583	49	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	4.60E-09	8.90E-09	0	0	0	0
2105	Josamycin	Target_lig_1145	50S subunit	Escherichia coli	Bacterial growth and infection	Target_100	0	0	7.0 nM - 9.3	0	0	0	0	-	-	10.1128/AAC.49.8.3367–3372.2005	16048949	Fluorescence polarization method to characterize macrolide-ribosome interactions.	Yan K, Hunt E, Berge J, May E, Copeland RA, Gontarek RR	Antimicrob Agents Chemother	49	3367-72	2005	-	3 nM	7.5	37	20 mM HEPES, 50 mM NH 4 Cl, 10 mM MgCl 2 , 0.05% Tween 20	Filter binding assay	Additional	CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)OC(=O)C)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O	[6-[6-[[4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate	3804	3.01340000000001	827.466720508	16	3	12	206.05	0	0.146936618067381	6.42250270760899	58	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	7.00E-09	9.30E-09	0	0	0	0
2106	Rokitamycin	Target_lig_1146	50S subunit	Escherichia coli	Bacterial growth and infection	Target_100	0	0	16.8 nM - 21.9	0	0	0	0	-	-	10.1128/AAC.49.8.3367–3372.2005	16048949	Fluorescence polarization method to characterize macrolide-ribosome interactions.	Yan K, Hunt E, Berge J, May E, Copeland RA, Gontarek RR	Antimicrob Agents Chemother	49	3367-72	2005	-	3 nM	7.5	37	20 mM HEPES, 50 mM NH 4 Cl, 10 mM MgCl 2 , 0.05% Tween 20	Filter binding assay	Additional	CCCC(=O)OC1C(OC(CC1(C)OC(=O)CC)OC2C(OC(C(C2N(C)C)O)OC3C(CC(C(C=CC=CCC(OC(=O)CC(C3OC)O)C)O)C)CC=O)C)C	[6-[6-[[4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-2,4-dimethyl-4-propanoyloxyoxan-3-yl] butanoate	5091	3.15750000000001	827.466720508	16	3	13	206.05	0	0.138567539965326	6.4398140350126	58	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	1.68E-08	2.19E-08	0	0	0	0
2107	Eryrthromycin	Target_lig_233	50S subunit	Escherichia coli	Bacterial growth and infection	Target_100	0	0	7.6 nM - 7.8	0	0	0	0	-	-	10.1128/AAC.49.8.3367–3372.2005	16048949	Fluorescence polarization method to characterize macrolide-ribosome interactions.	Yan K, Hunt E, Berge J, May E, Copeland RA, Gontarek RR	Antimicrob Agents Chemother	49	3367-72	2005	-	3 nM	7.5	37	20 mM HEPES, 50 mM NH 4 Cl, 10 mM MgCl 2 , 0.05% Tween 20	Filter binding assay	Additional	CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O	6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione	3255	1.7856	733.461241204	14	5	7	193.91	0	0.237872505983735	6.08831082805574	51	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	7.60E-09	7.80E-09	0	0	0	0
2108	Quercetin	Target_lig_1147	tRNA	Saccharomyces cereviseae	-	Target_1	(4.8±0.5)x1E4	0	0	0	0	0	0	-	-	10.1007/s12013-007-0037-2	17873337	An overview of DNA and RNA bindings to antioxidant flavonoids.	Kanakis CD, Tarantilis PA, Polissiou MG, Diamantoglou S, Tajmir-Riahi HA	Cell Biochem Biophys	49	29-36	2007	0.005 - 0.3 mM	0.25 mM	7.3	5	Tris/Hcl buffer	FTIR spectroscopy	Additional	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O	2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one	5280343	1.988	302.04265266	7	5	1	131.36	3	0.434190440299098	2.54470874180214	22	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	43000	53000	0	0	0	0	0	0	0	0
2109	Kaempferol	Target_lig_1148	tRNA	Saccharomyces cereviseae	-	Target_1	(4.65±0.45)x1E4	0	0	0	0	0	0	-	-	10.1007/s12013-007-0037-2	17873337	An overview of DNA and RNA bindings to antioxidant flavonoids.	Kanakis CD, Tarantilis PA, Polissiou MG, Diamantoglou S, Tajmir-Riahi HA	Cell Biochem Biophys	49	29-36	2007	0.005 - 0.3 mM	0.25 mM	7.3	5	Tris/Hcl buffer	FTIR spectroscopy	Additional	C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O	3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one	5280863	2.2824	286.04773804	6	4	1	111.13	3	0.545851399414342	2.37454759921201	21	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	42000	51000	0	0	0	0	0	0	0	0
2110	T4MPyP	Target_lig_1149	tRNA	Saccharomyces cereviseae	-	Target_1	0	0	1.209e-06±1.28e-07	0	0	0	0	-	-	10.1016/j.bbaexp.2005.06.003	16005529	Porphyrins and porphines bind strongly and specifically to tRNA, precursor tRNA and to M1 RNA and inhibit the ribonuclease P ribozyme reaction.	Hori Y, Rogert MC, Tanaka T, Kikuchi Y, Bichenkova EV, Wilton AN, Gbaj A, Douglas KT	Biochim Biophys Acta	1730	47-55	2005	10 nM	-	7.6	20	100mM NH4Cl, 60 mM MgCl2	Fluorescence emission spectrum	Additional	C[n+]1ccc(cc1)-c1c2ccc(n2)c(-c2cc[n+](C)cc2)c2ccc([nH]2)c(-c2cc[n+](C)cc2)c2ccc(n2)c(-c2cc[n+](C)cc2)c2ccc1[nH]2	5,10,15,20-tetrakis(1-methylpyridin-1-ium-4-yl)-21,22,23,24-tetrahydroporphyrin	53633502	6.62160000000001	678.31974889636	2	2	4	72.88	7	0.205578379353376	5.61003207536561	52	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	1.08E-06	1.34E-06	0	0	0	0
2111	TMAP	Target_lig_1150	tRNA	Saccharomyces cereviseae	-	Target_1	0	0	1.0699999999999999e-07±2.1e-08	0	0	0	0	-	-	10.1016/j.bbaexp.2005.06.003	16005529	Porphyrins and porphines bind strongly and specifically to tRNA, precursor tRNA and to M1 RNA and inhibit the ribonuclease P ribozyme reaction.	Hori Y, Rogert MC, Tanaka T, Kikuchi Y, Bichenkova EV, Wilton AN, Gbaj A, Douglas KT	Biochim Biophys Acta	1730	47-55	2005	10 nM	-	7.6	20	100mM NH4Cl, 60 mM MgCl2	Fluorescence emission spectrum	Additional	C[N+](c1ccc(cc1)/C/1=c/2\cc/c(=C(/c3ccc([nH]3)/C(=c/3\[nH]/c(=C(\c4[nH]c1cc4)/c1ccc(cc1)[N+](C)(C)C)/cc3)/c1ccc(cc1)[N+](C)(C)C)\c1ccc(cc1)[N+](C)(C)C)/[nH]2)(C)C	trimethyl-[4-[(5Z,9Z,15Z,19Z)-10,15,20-tris[4-(trimethylazaniumyl)phenyl]-21,22,23,24-tetrahydroporphyrin-5-yl]phenyl]azanium	101957940	7.08840000000001	848.52319972836	0	4	8	63.16	8	0.11829061655461	5.67078115373093	64	GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA	https://www.rcsb.org/structure/1EHZ	tRNA	-	76	-	Cloverleaf	0	0	0	0	8.60E-08	1.28E-07	0	0	0	0
2112	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer	Synthetic	-	Target_6	0	0	5.00E-08	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGGAAGGGAAGAAACUGCGGCUUCGGCCGGCUUCCC	http://www.smmrna.org/	RNA aptamer	-	36	-	UUCG Tetraloop	0	0	0	0	5.00E-08	5.00E-08	0	0	0	0
2113	Pyronin Y	Target_lig_1152	Aptamer	Synthetic	-	Target_6	0	0	2.25E-07	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C=C3C=CC(=[N+](C)C)C=C3O2.[Cl-]	[6-(dimethylamino)xanthen-3-ylidene]-dimethylazanium;chloride	7085	-0.360599999999999	302.118590908	2	0	1	19.39	1	0.45171121088765	2.7656160900678	21	GGGAAGGGAAGAAACUGCGGCUUCGGCCGGCUUCCC	http://www.smmrna.org/	RNA aptamer	-	36	-	UUCG Tetraloop	0	0	0	0	2.25E-07	2.25E-07	0	0	0	0
2114	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant C25	Synthetic	-	Target_383	0	0	3.68E-07	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGCAACGAAUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	3.68E-07	3.68E-07	0	0	0	0
2115	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant G25	Synthetic	-	Target_384	0	0	1.90E-06	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGGAACGAAUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	1.90E-06	1.90E-06	0	0	0	0
2116	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant A25	Synthetic	-	Target_385	0	0	5 uM - 6	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGAAACGAAUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	5.00E-06	6.00E-06	0	0	0	0
2117	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant C9	Synthetic	-	Target_386	0	0	2.90E-06	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGCCUGGCGAGAGCCAGGUAACGAAUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	2.90E-06	2.90E-06	0	0	0	0
2118	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant G9	Synthetic	-	Target_387	0	0	6.40E-08	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGGCUGGCGAGAGCCAGGUAACGAAUGGUACC	1F1T	RNA aptamer	-	40	-	-	0	0	0	0	6.40E-08	6.40E-08	0	0	0	0
2119	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant U9	Synthetic	-	Target_388	0	0	1.40E-07	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGUCUGGCGAGAGCCAGGUAACGAAUGGUACC	1F1T	RNA aptamer	-	40	-	-	0	0	0	0	1.40E-07	1.40E-07	0	0	0	0
2120	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant G30	Synthetic	-	Target_389	0	0	1.60E-06	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUAACGGAUGGUACC	1F1T	RNA aptamer	-	38	-	-	0	0	0	0	1.60E-06	1.60E-06	0	0	0	0
2121	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant C30	Synthetic	-	Target_390	0	0	5.00E-07	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUAACGCAUGGUACC	1F1T	RNA aptamer	-	38	-	-	0	0	0	0	5.00E-07	5.00E-07	0	0	0	0
2122	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant U30	Synthetic	-	Target_391	0	0	4.60E-06	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUAACGUAUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	4.60E-06	4.60E-06	0	0	0	0
2123	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant C27	Synthetic	-	Target_392	0	0	4.01E-06	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUACCGAAUGGUACC	1F1T	RNA aptamer	-	38	-	-	0	0	0	0	4.01E-06	4.01E-06	0	0	0	0
2124	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant G27	Synthetic	-	Target_393	0	0	6 uM - 7	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUAGCGAAUGGUACC	1F1T	RNA aptamer	-	38	-	-	0	0	0	0	6.00E-09	7.00E-06	0	0	0	0
2125	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant U27	Synthetic	-	Target_394	0	0	7 uM - 8	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUAUCGAAUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	7.00E-06	8.00E-06	0	0	0	0
2126	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant G10C23	Synthetic	-	Target_395	0	0	3.38E-07	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGAGUGGCGAGAGCCACGUAACGAAUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	3.38E-07	3.38E-07	0	0	0	0
2127	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant G26	Synthetic	-	Target_396	0	0	8 uM - 9	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUGACGAAUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	8.00E-06	9.00E-06	0	0	0	0
2128	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant U26	Synthetic	-	Target_397	0	0	4 uM - 5	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUUACGAAUGGUACC	1F1T	RNA aptamer	-	38	-	-	0	0	0	0	4.00E-06	5.00E-06	0	0	0	0
2129	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant C26	Synthetic	-	Target_398	0	0	6.00E-06	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUCACGAAUGGUACC	1F1T	RNA aptamer	-	38	-	-	0	0	0	0	6.00E-06	6.00E-06	0	0	0	0
2130	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant A11U22	Synthetic	-	Target_399	0	0	4.80E-08	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACAGGCGAGAGCCUGGUAACGAAUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	4.80E-08	4.80E-08	0	0	0	0
2131	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant C24	Synthetic	-	Target_400	0	0	5.12E-07	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGCUAACGAAUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	5.12E-07	5.12E-07	0	0	0	0
2132	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant G31	Synthetic	-	Target_401	0	0	7.20E-06	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUAACGAGUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	7.20E-06	7.20E-06	0	0	0	0
2133	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant C31	Synthetic	-	Target_402	0	0	1.20E-06	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUAACGACUGGUACC	1F1T	RNA aptamer	-	38	-	-	0	0	0	0	1.20E-06	1.20E-06	0	0	0	0
2134	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant U31	Synthetic	-	Target_403	0	0	1.95E-06	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCGACUGGCGAGAGCCAGGUAACGAUUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	1.95E-06	1.95E-06	0	0	0	0
2135	Tetramethylrosamine (TMR)	Target_lig_1151	Aptamer mutant C8G28	Synthetic	-	Target_404	0	0	5 uM - 6	0	0	0	0	-	-	10.1002/cbic.200300701	14695514	Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex.	Flinders J, DeFina SC, Brackett DM, Baugh C, Wilson C, Dieckmann T	Chembiochem	5	62-72	2004	-	-	-	-	-	Fluorescence anisotropy and intensity measurements	Additional	CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4	[6-(dimethylamino)-9-phenylxanthen-3-ylidene]-dimethylazanium	2762681	4.3024	343.18048977609	2	0	2	19.39	2	0.399184105950119	2.5483147285489	26	GGUACCCCACUGGCGAGAGCCAGGUAAGGAAUGGUACC	1F1T	RNA aptamer	-	39	-	-	0	0	0	0	5.00E-06	6.00E-06	0	0	0	0
2136	S-adenosyl methionine	Target_lig_314	B.subtilis cysH	Bacillus subtilis	Bacterial growth and infection	Target_405	0	0	1x1E-6	0	0	0	0	-	-	10.1038/nsb967	12910260	An mRNA structure that controls gene expression by binding S-adenosylmethionine.	Winkler WC, Nahvi A, Sudarsan N, Barrick JE, Breaker RR	Nat Struct Biol	10	701-7	2003	100nM	1nM	8.3	25	20 mM MgCl2, 100  mM  KCl	In-line probing assays	Additional	C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O	2-amino-4-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylsulfonio]butanoate	5136	-3.2569	398.137238804	11	4	7	185.46	2	0.344969936201303	4.7565494434378	27	GGUACAAUCUAAAAACUUAUCAAGAGCGGCUGAGGGACUGGACCUAUGAAGCCCGGCAACCUGCAUAGUUUGUAAGGUGCUACUUCCAGCAAAAUGAAUUCCAUUUUGAAAGAUAAGGGCUGCAUGCUGUUCCUGUCUUUCUUUCCGCCGAUUGAAAGUUUUUU	10.1038/nsb967	mRNA, Riboswitch	Riboswitch	164	5'-UTR	-	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
2137	SAH	Target_lig_1153	B.subtilis cysH	Bacillus subtilis	Bacterial growth and infection	Target_405	0	0	8x1E-4	0	0	0	0	-	-	10.1038/nsb967	12910260	An mRNA structure that controls gene expression by binding S-adenosylmethionine.	Winkler WC, Nahvi A, Sudarsan N, Barrick JE, Breaker RR	Nat Struct Biol	10	701-7	2003	100nM	1nM	8.3	25	20 mM MgCl2, 100  mM  KCl	In-line probing assays	Additional	C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CSCCC(C(=O)O)N)O)O)N	2-amino-4-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]butanoic acid	193	-1.4371	384.12158874	11	5	7	182.63	2	0.35241047665031	3.98785622076409	26	GGUACAAUCUAAAAACUUAUCAAGAGCGGCUGAGGGACUGGACCUAUGAAGCCCGGCAACCUGCAUAGUUUGUAAGGUGCUACUUCCAGCAAAAUGAAUUCCAUUUUGAAAGAUAAGGGCUGCAUGCUGUUCCUGUCUUUCUUUCCGCCGAUUGAAAGUUUUUU	10.1038/nsb967	mRNA, Riboswitch	Riboswitch	164	5'-UTR	-	0	0	0	0	0.0008	0.0008	0	0	0	0
2138	SAC	Target_lig_1154	B.subtilis cysH	Bacillus subtilis	Bacterial growth and infection	Target_405	0	0	>1x1E-3	0	0	0	0	-	-	10.1038/nsb967	12910260	An mRNA structure that controls gene expression by binding S-adenosylmethionine.	Winkler WC, Nahvi A, Sudarsan N, Barrick JE, Breaker RR	Nat Struct Biol	10	701-7	2003	100nM	1nM	8.3	25	20 mM MgCl2, 100  mM  KCl	In-line probing assays	Additional	C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CSCC(C(=O)O)N)O)O)N	2-amino-3-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]propanoic acid	3573837	-1.8272	370.105938676	11	5	6	182.63	2	0.385390137965272	3.9919951079453	25	GGUACAAUCUAAAAACUUAUCAAGAGCGGCUGAGGGACUGGACCUAUGAAGCCCGGCAACCUGCAUAGUUUGUAAGGUGCUACUUCCAGCAAAAUGAAUUCCAUUUUGAAAGAUAAGGGCUGCAUGCUGUUCCUGUCUUUCUUUCCGCCGAUUGAAAGUUUUUU	10.1038/nsb967	mRNA, Riboswitch	Riboswitch	164	5'-UTR	-	0	0	0	0	0.001	0.001	0	0	0	0
2139	S-adenosyl methionine	Target_lig_314	B.anthracis cysH	Bacillus anthracis	Bacterial growth and infection	Target_406	0	0	1x1E-8	0	0	0	0	-	-	10.1038/nsb967	12910260	An mRNA structure that controls gene expression by binding S-adenosylmethionine.	Winkler WC, Nahvi A, Sudarsan N, Barrick JE, Breaker RR	Nat Struct Biol	10	701-7	2003	100nM	1nM	8.3	25	20 mM MgCl2, 100  mM  KCl	In-line probing assays	Additional	C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O	2-amino-4-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylsulfonio]butanoate	5136	-3.2569	398.137238804	11	4	7	185.46	2	0.344969936201303	4.7565494434378	27	GGAGCUUAUCAAGAGAAGCGGAGGGAACUGGCCCGGCGAAGCUCGGCAACCUGCUUAUAGAAAGCAAGGUGCUAAAUCCAGCAAAAUGGAUUCCAUUUUGAAAGAUAAGGUAAAAUAUAUUACCGAACAGUCUUUUCGAAAUGGGAAAGAUUUUUUUUAU	10.1038/nsb967	mRNA, Riboswitch	Riboswitch	160	5'-UTR	-	0	0	0	0	1.00E-08	1.00E-08	0	0	0	0
2140	SAH	Target_lig_1153	B.anthracis cysH	Bacillus anthracis	Bacterial growth and infection	Target_406	0	0	3x1E-6	0	0	0	0	-	-	10.1038/nsb967	12910260	An mRNA structure that controls gene expression by binding S-adenosylmethionine.	Winkler WC, Nahvi A, Sudarsan N, Barrick JE, Breaker RR	Nat Struct Biol	10	701-7	2003	100nM	1nM	8.3	25	20 mM MgCl2, 100  mM  KCl	In-line probing assays	Additional	C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CSCCC(C(=O)O)N)O)O)N	2-amino-4-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]butanoic acid	193	-1.4371	384.12158874	11	5	7	182.63	2	0.35241047665031	3.98785622076409	26	GGAGCUUAUCAAGAGAAGCGGAGGGAACUGGCCCGGCGAAGCUCGGCAACCUGCUUAUAGAAAGCAAGGUGCUAAAUCCAGCAAAAUGGAUUCCAUUUUGAAAGAUAAGGUAAAAUAUAUUACCGAACAGUCUUUUCGAAAUGGGAAAGAUUUUUUUUAU	10.1038/nsb967	mRNA, Riboswitch	Riboswitch	160	5'-UTR	-	0	0	0	0	3.00E-06	3.00E-06	0	0	0	0
2141	SAC	Target_lig_1154	B.anthracis cysH	Bacillus anthracis	Bacterial growth and infection	Target_406	0	0	>1x1E-3	0	0	0	0	-	-	10.1038/nsb967	12910260	An mRNA structure that controls gene expression by binding S-adenosylmethionine.	Winkler WC, Nahvi A, Sudarsan N, Barrick JE, Breaker RR	Nat Struct Biol	10	701-7	2003	100nM	1nM	8.3	25	20 mM MgCl2, 100  mM  KCl	In-line probing assays	Additional	C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CSCC(C(=O)O)N)O)O)N	2-amino-3-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]propanoic acid	3573837	-1.8272	370.105938676	11	5	6	182.63	2	0.385390137965272	3.9919951079453	25	GGAGCUUAUCAAGAGAAGCGGAGGGAACUGGCCCGGCGAAGCUCGGCAACCUGCUUAUAGAAAGCAAGGUGCUAAAUCCAGCAAAAUGGAUUCCAUUUUGAAAGAUAAGGUAAAAUAUAUUACCGAACAGUCUUUUCGAAAUGGGAAAGAUUUUUUUUAU	10.1038/nsb967	mRNA, Riboswitch	Riboswitch	160	5'-UTR	-	0	0	0	0	0.001	0.001	0	0	0	0
2142	Tobramycin	Target_lig_540	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	2.20E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	2.20E-06	2.20E-06	0	0	0	0
2143	Neomycin B	Target_lig_1251	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	2.90E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	2.90E-06	2.90E-06	0	0	0	0
2144	Compd 32	Target_lig_1155	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	6.80E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)O)N)N)C(CC1O)N	-	-	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.22057933543547	32	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	6.80E-06	6.80E-06	0	0	0	0
2145	Compd 33	Target_lig_1156	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	7.00E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)O)N)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.74369571710226	43	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	7.00E-07	7.00E-07	0	0	0	0
2146	Compd 34	Target_lig_1157	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	2.50E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.70511030596168	43	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	2.50E-07	2.50E-07	0	0	0	0
2147	Compd 35	Target_lig_1158	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	2.70E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)N)O)N)C(CC1O)N	4-amino-2-(aminomethyl)-6-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,5-diol	60000851	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.21084999733171	32	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	2.70E-06	2.70E-06	0	0	0	0
2148	Compd 37	Target_lig_1159	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	2.30E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1O)O)N)O	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.64426839614736	43	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	2.30E-06	2.30E-06	0	0	0	0
2149	Compd 38	Target_lig_1160	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	2.30E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	2.30E-06	2.30E-06	0	0	0	0
2150	Compd 39	Target_lig_1161	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	4.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
2151	Compd 40	Target_lig_1281	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	3.30E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	3.30E-06	3.30E-06	0	0	0	0
2152	Compd 41	Target_lig_1162	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	5.30E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	5.30E-07	5.30E-07	0	0	0	0
2153	Compd 42	Target_lig_1282	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	2.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
2154	Compd 43	Target_lig_1283	HCV IRES Domain IIId	Hepatitis C virus	Hepatitis C	Target_66	0	0	1.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	http://www.smmrna.org/	IRES element, Viral RNA	Internal Ribosome Entry Site (IRES)	29	-	Stem-Loop	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
2155	sisomicin	Target_lig_10	Bacterial 16S A-site	-	-	-	0	0	1.30E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	-	-	-	-	0	-	-	0	0	0	0	1.30E-06	1.30E-06	0	0	0	0
2156	Tobramycin	Target_lig_540	Bacterial 16S A-site	-	-	-	0	0	2.10E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	-	-	-	-	0	-	-	0	0	0	0	2.10E-06	2.10E-06	0	0	0	0
2157	Neomycin B	Target_lig_1251	Bacterial 16S A-site	-	-	-	0	0	2.00E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	-	-	-	-	0	-	-	0	0	0	0	2.00E-07	2.00E-07	0	0	0	0
2158	Compd 32	Target_lig_1155	Bacterial 16S A-site	-	-	-	0	0	5.90E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)O)N)N)C(CC1O)N	-	-	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.22057933543547	32	-	-	-	-	0	-	-	0	0	0	0	5.90E-06	5.90E-06	0	0	0	0
2159	Compd 33	Target_lig_1156	Bacterial 16S A-site	-	-	-	0	0	1.70E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)O)N)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.74369571710226	43	-	-	-	-	0	-	-	0	0	0	0	1.70E-06	1.70E-06	0	0	0	0
2160	Compd 34	Target_lig_1157	Bacterial 16S A-site	-	-	-	0	0	4.30E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.70511030596168	43	-	-	-	-	0	-	-	0	0	0	0	4.30E-06	4.30E-06	0	0	0	0
2161	Compd 35	Target_lig_1158	Bacterial 16S A-site	-	-	-	0	0	3.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)N)O)N)C(CC1O)N	4-amino-2-(aminomethyl)-6-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,5-diol	60000851	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.21084999733171	32	-	-	-	-	0	-	-	0	0	0	0	3.00E-06	3.00E-06	0	0	0	0
2162	Compd 36	Target_lig_1163	Bacterial 16S A-site	-	-	-	0	0	1.80E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CO)C(C(C3N)O)O)C(C(C2N)O)O)N)C(CC1O)N	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.63852701683701	43	-	-	-	-	0	-	-	0	0	0	0	1.80E-06	1.80E-06	0	0	0	0
2163	Compd 37	Target_lig_1159	Bacterial 16S A-site	-	-	-	0	0	3.80E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1O)O)N)O	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.64426839614736	43	-	-	-	-	0	-	-	0	0	0	0	3.80E-06	3.80E-06	0	0	0	0
2164	Compd 38	Target_lig_1160	Bacterial 16S A-site	-	-	-	0	0	6.60E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	-	-	-	-	0	-	-	0	0	0	0	6.60E-06	6.60E-06	0	0	0	0
2165	Compd 39	Target_lig_1161	Bacterial 16S A-site	-	-	-	0	0	2.60E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	-	-	-	-	0	-	-	0	0	0	0	2.60E-06	2.60E-06	0	0	0	0
2166	Compd 40	Target_lig_1281	Bacterial 16S A-site	-	-	-	0	0	4.60E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	-	-	-	-	0	-	-	0	0	0	0	4.60E-06	4.60E-06	0	0	0	0
2167	Compd 41	Target_lig_1162	Bacterial 16S A-site	-	-	-	0	0	3.60E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	-	-	-	-	0	-	-	0	0	0	0	3.60E-06	3.60E-06	0	0	0	0
2168	Compd 42	Target_lig_1282	Bacterial 16S A-site	-	-	-	0	0	2.30E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	-	-	-	-	0	-	-	0	0	0	0	2.30E-06	2.30E-06	0	0	0	0
2169	Compd 43	Target_lig_1283	Bacterial 16S A-site	-	-	-	0	0	3.70E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	-	-	-	-	0	-	-	0	0	0	0	3.70E-06	3.70E-06	0	0	0	0
2170	sisomicin	Target_lig_10	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	1.20E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	1.20E-05	1.20E-05	0	0	0	0
2171	Tobramycin	Target_lig_540	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	1.90E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	1.90E-05	1.90E-05	0	0	0	0
2172	Neomycin B	Target_lig_1251	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	2.80E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	2.80E-06	2.80E-06	0	0	0	0
2173	Compd 32	Target_lig_1155	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	1.10E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)O)N)N)C(CC1O)N	-	-	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.22057933543547	32	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	1.10E-05	1.10E-05	0	0	0	0
2174	Compd 33	Target_lig_1156	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	1.80E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)O)N)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.74369571710226	43	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	1.80E-06	1.80E-06	0	0	0	0
2175	Compd 34	Target_lig_1157	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	6.20E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.70511030596168	43	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	6.20E-07	6.20E-07	0	0	0	0
2176	Compd 35	Target_lig_1158	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	4.90E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)N)O)N)C(CC1O)N	4-amino-2-(aminomethyl)-6-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,5-diol	60000851	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.21084999733171	32	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	4.90E-06	4.90E-06	0	0	0	0
2177	Compd 36	Target_lig_1163	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	5.30E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CO)C(C(C3N)O)O)C(C(C2N)O)O)N)C(CC1O)N	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.63852701683701	43	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	5.30E-06	5.30E-06	0	0	0	0
2178	Compd 37	Target_lig_1159	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	1.40E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1O)O)N)O	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.64426839614736	43	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	1.40E-05	1.40E-05	0	0	0	0
2179	Compd 38	Target_lig_1160	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	1.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
2180	Compd 39	Target_lig_1161	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	4.20E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	4.20E-07	4.20E-07	0	0	0	0
2181	Compd 40	Target_lig_1281	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	8.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	8.00E-06	8.00E-06	0	0	0	0
2182	Compd 41	Target_lig_1162	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	6.70E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	6.70E-07	6.70E-07	0	0	0	0
2183	Compd 42	Target_lig_1282	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	2.50E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	2.50E-06	2.50E-06	0	0	0	0
2184	Compd 43	Target_lig_1283	E. coli transglycosidase mRNA	Escherichia coli	Bacterial growth and infection	Target_407	0	0	1.70E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	GAAGACAGCCGCUUCUACGAGCAU	http://www.smmrna.org/	mRNA	mRNA	24	-	-	0	0	0	0	1.70E-06	1.70E-06	0	0	0	0
2185	sisomicin	Target_lig_10	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	4.30E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	4.30E-06	4.30E-06	0	0	0	0
2186	Tobramycin	Target_lig_540	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	2.70E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	2.70E-06	2.70E-06	0	0	0	0
2187	Neomycin B	Target_lig_1251	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	2.90E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	2.90E-06	2.90E-06	0	0	0	0
2188	Compd 32	Target_lig_1155	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	1.20E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)O)N)N)C(CC1O)N	-	-	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.22057933543547	32	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	1.20E-05	1.20E-05	0	0	0	0
2189	Compd 33	Target_lig_1156	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	3.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)O)N)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.74369571710226	43	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	3.00E-06	3.00E-06	0	0	0	0
2190	Compd 34	Target_lig_1157	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	4.20E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.70511030596168	43	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	4.20E-07	4.20E-07	0	0	0	0
2191	Compd 35	Target_lig_1158	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	1.80E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)N)O)N)C(CC1O)N	4-amino-2-(aminomethyl)-6-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,5-diol	60000851	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.21084999733171	32	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	1.80E-06	1.80E-06	0	0	0	0
2192	Compd 36	Target_lig_1163	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	9.40E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CO)C(C(C3N)O)O)C(C(C2N)O)O)N)C(CC1O)N	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.63852701683701	43	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	9.40E-06	9.40E-06	0	0	0	0
2193	Compd 37	Target_lig_1159	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	2.80E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1O)O)N)O	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.64426839614736	43	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	2.80E-07	2.80E-07	0	0	0	0
2194	Compd 38	Target_lig_1160	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	1.20E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	1.20E-05	1.20E-05	0	0	0	0
2195	Compd 39	Target_lig_1161	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	2.60E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	2.60E-06	2.60E-06	0	0	0	0
2196	Compd 40	Target_lig_1281	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	3.80E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	3.80E-06	3.80E-06	0	0	0	0
2197	Compd 41	Target_lig_1162	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	3.50E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	3.50E-06	3.50E-06	0	0	0	0
2198	Compd 42	Target_lig_1282	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	3.10E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	3.10E-06	3.10E-06	0	0	0	0
2199	Compd 43	Target_lig_1283	HCV IRES Domain Iib	Hepatitis C virus	Hepatitis C	Target_408	0	0	9.50E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	http://www.smmrna.org/	mRNA, Viral RNA	Internal Ribosome Entry Site (IRES)	48	-	-	0	0	0	0	9.50E-06	9.50E-06	0	0	0	0
2200	sisomicin	Target_lig_10	HIV-FSS	-	-	-	0	0	2.70E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	-	-	-	-	0	-	-	0	0	0	0	2.70E-06	2.70E-06	0	0	0	0
2201	Tobramycin	Target_lig_540	HIV-FSS	-	-	-	0	0	6.40E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	-	-	-	-	0	-	-	0	0	0	0	6.40E-07	6.40E-07	0	0	0	0
2202	Neomycin B	Target_lig_1251	HIV-FSS	-	-	-	0	0	1.60E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	-	-	-	-	0	-	-	0	0	0	0	1.60E-06	1.60E-06	0	0	0	0
2203	Compd 32	Target_lig_1155	HIV-FSS	-	-	-	0	0	4.70E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)O)N)N)C(CC1O)N	-	-	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.22057933543547	32	-	-	-	-	0	-	-	0	0	0	0	4.70E-06	4.70E-06	0	0	0	0
2204	Compd 33	Target_lig_1156	HIV-FSS	-	-	-	0	0	1.20E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)O)N)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.74369571710226	43	-	-	-	-	0	-	-	0	0	0	0	1.20E-06	1.20E-06	0	0	0	0
2205	Compd 34	Target_lig_1157	HIV-FSS	-	-	-	0	0	3.40E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.70511030596168	43	-	-	-	-	0	-	-	0	0	0	0	3.40E-06	3.40E-06	0	0	0	0
2206	Compd 35	Target_lig_1158	HIV-FSS	-	-	-	0	0	3.20E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)N)O)N)C(CC1O)N	4-amino-2-(aminomethyl)-6-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,5-diol	60000851	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.21084999733171	32	-	-	-	-	0	-	-	0	0	0	0	3.20E-07	3.20E-07	0	0	0	0
2207	Compd 36	Target_lig_1163	HIV-FSS	-	-	-	0	0	1.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CO)C(C(C3N)O)O)C(C(C2N)O)O)N)C(CC1O)N	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.63852701683701	43	-	-	-	-	0	-	-	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
2208	Compd 37	Target_lig_1159	HIV-FSS	-	-	-	0	0	7.10E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1O)O)N)O	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.64426839614736	43	-	-	-	-	0	-	-	0	0	0	0	7.10E-07	7.10E-07	0	0	0	0
2209	Compd 38	Target_lig_1160	HIV-FSS	-	-	-	0	0	4.60E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	-	-	-	-	0	-	-	0	0	0	0	4.60E-06	4.60E-06	0	0	0	0
2210	Compd 39	Target_lig_1161	HIV-FSS	-	-	-	0	0	1.70E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	-	-	-	-	0	-	-	0	0	0	0	1.70E-06	1.70E-06	0	0	0	0
2211	Compd 40	Target_lig_1281	HIV-FSS	-	-	-	0	0	2.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	-	-	-	-	0	-	-	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
2212	Compd 41	Target_lig_1162	HIV-FSS	-	-	-	0	0	7.60E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	-	-	-	-	0	-	-	0	0	0	0	7.60E-06	7.60E-06	0	0	0	0
2213	Compd 42	Target_lig_1282	HIV-FSS	-	-	-	0	0	1.60E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	-	-	-	-	0	-	-	0	0	0	0	1.60E-06	1.60E-06	0	0	0	0
2214	Compd 43	Target_lig_1283	HIV-FSS	-	-	-	0	0	4.50E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	-	-	-	-	0	-	-	0	0	0	0	4.50E-06	4.50E-06	0	0	0	0
2215	sisomicin	Target_lig_10	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	1.50E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	1.50E-05	1.50E-05	0	0	0	0
2216	Tobramycin	Target_lig_540	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	1.40E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	1.40E-05	1.40E-05	0	0	0	0
2217	Neomycin B	Target_lig_1251	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	2.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
2218	Compd 32	Target_lig_1155	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	1.90E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)O)N)N)C(CC1O)N	-	-	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.22057933543547	32	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	1.90E-05	1.90E-05	0	0	0	0
2219	Compd 33	Target_lig_1156	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	1.10E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)O)N)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.74369571710226	43	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	1.10E-06	1.10E-06	0	0	0	0
2220	Compd 34	Target_lig_1157	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	8.30E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.70511030596168	43	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	8.30E-07	8.30E-07	0	0	0	0
2221	Compd 35	Target_lig_1158	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	6.80E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)N)O)N)C(CC1O)N	4-amino-2-(aminomethyl)-6-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,5-diol	60000851	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.21084999733171	32	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	6.80E-06	6.80E-06	0	0	0	0
2222	Compd 36	Target_lig_1163	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	5.10E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CO)C(C(C3N)O)O)C(C(C2N)O)O)N)C(CC1O)N	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.63852701683701	43	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	5.10E-06	5.10E-06	0	0	0	0
2223	Compd 37	Target_lig_1159	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	3.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1O)O)N)O	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.64426839614736	43	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	3.00E-06	3.00E-06	0	0	0	0
2224	Compd 38	Target_lig_1160	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	5.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	5.00E-06	5.00E-06	0	0	0	0
2225	Compd 39	Target_lig_1161	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	4.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
2226	Compd 40	Target_lig_1281	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	1.40E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	1.40E-05	1.40E-05	0	0	0	0
2227	Compd 41	Target_lig_1162	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	1.20E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	1.20E-06	1.20E-06	0	0	0	0
2228	Compd 42	Target_lig_1282	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	7.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	7.00E-06	7.00E-06	0	0	0	0
2229	Compd 43	Target_lig_1283	HIV protease active site (PAS) mRNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_409	0	0	6.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	http://www.smmrna.org/	mRNA, Viral RNA	mRNA	41	-	-	0	0	0	0	6.00E-06	6.00E-06	0	0	0	0
2230	sisomicin	Target_lig_10	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	1.00E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	-	-	-	-	0	-	-	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
2231	Tobramycin	Target_lig_540	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	1.30E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	-	-	-	-	0	-	-	0	0	0	0	1.30E-06	1.30E-06	0	0	0	0
2232	Neomycin B	Target_lig_1251	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	2.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	-	-	-	-	0	-	-	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
2233	Compd 32	Target_lig_1155	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	3.20E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)O)N)N)C(CC1O)N	-	-	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.22057933543547	32	-	-	-	-	0	-	-	0	0	0	0	3.20E-06	3.20E-06	0	0	0	0
2234	Compd 33	Target_lig_1156	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	3.50E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)O)N)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.74369571710226	43	-	-	-	-	0	-	-	0	0	0	0	3.50E-06	3.50E-06	0	0	0	0
2235	Compd 34	Target_lig_1157	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	7.50E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.70511030596168	43	-	-	-	-	0	-	-	0	0	0	0	7.50E-07	7.50E-07	0	0	0	0
2236	Compd 35	Target_lig_1158	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	3.80E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)N)O)N)C(CC1O)N	4-amino-2-(aminomethyl)-6-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,5-diol	60000851	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.21084999733171	32	-	-	-	-	0	-	-	0	0	0	0	3.80E-06	3.80E-06	0	0	0	0
2237	Compd 36	Target_lig_1163	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	3.20E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CO)C(C(C3N)O)O)C(C(C2N)O)O)N)C(CC1O)N	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.63852701683701	43	-	-	-	-	0	-	-	0	0	0	0	3.20E-06	3.20E-06	0	0	0	0
2238	Compd 37	Target_lig_1159	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	7.00E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1O)O)N)O	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.64426839614736	43	-	-	-	-	0	-	-	0	0	0	0	7.00E-07	7.00E-07	0	0	0	0
2239	Compd 38	Target_lig_1160	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	5.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	-	-	-	-	0	-	-	0	0	0	0	5.00E-06	5.00E-06	0	0	0	0
2240	Compd 39	Target_lig_1161	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	4.00E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	-	-	-	-	0	-	-	0	0	0	0	4.00E-06	4.00E-06	0	0	0	0
2241	Compd 40	Target_lig_1281	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	8.50E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	-	-	-	-	0	-	-	0	0	0	0	8.50E-06	8.50E-06	0	0	0	0
2242	Compd 41	Target_lig_1162	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	6.40E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	-	-	-	-	0	-	-	0	0	0	0	6.40E-06	6.40E-06	0	0	0	0
2243	Compd 42	Target_lig_1282	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	3.50E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	-	-	-	-	0	-	-	0	0	0	0	3.50E-06	3.50E-06	0	0	0	0
2244	Compd 43	Target_lig_1283	human oncogenic Bcr-Abl mRNA	-	-	-	0	0	1.40E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	-	-	-	-	0	-	-	0	0	0	0	1.40E-05	1.40E-05	0	0	0	0
2245	sisomicin	Target_lig_10	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	3.70E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	3.70E-05	3.70E-05	0	0	0	0
2246	Tobramycin	Target_lig_540	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	6.50E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	6.50E-05	6.50E-05	0	0	0	0
2247	Neomycin B	Target_lig_1251	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	3.00E-07	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	3.00E-07	3.00E-07	0	0	0	0
2248	Compd 32	Target_lig_1155	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	2.50E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)O)N)N)C(CC1O)N	-	-	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.22057933543547	32	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	2.50E-05	2.50E-05	0	0	0	0
2249	Compd 33	Target_lig_1156	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	1.60E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)O)N)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.74369571710226	43	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	1.60E-06	1.60E-06	0	0	0	0
2250	Compd 34	Target_lig_1157	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	9.40E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1O)N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.70511030596168	43	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	9.40E-06	9.40E-06	0	0	0	0
2251	Compd 35	Target_lig_1158	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	8.10E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(C(C2O)N)O)N)C(CC1O)N	4-amino-2-(aminomethyl)-6-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,5-diol	60000851	-6.32940000000001	466.275112176	14	10	6	273.96	0	0.174257225849881	5.21084999733171	32	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	8.10E-06	8.10E-06	0	0	0	0
2252	Compd 37	Target_lig_1159	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	5.20E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1O)O)N)O	-	-	-8.50520000000002	628.327935596	19	13	9	353.11	0	0.112599181907171	5.64426839614736	43	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	5.20E-05	5.20E-05	0	0	0	0
2253	Compd 38	Target_lig_1160	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	1.40E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	1.40E-05	1.40E-05	0	0	0	0
2254	Compd 39	Target_lig_1161	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	9.60E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	9.60E-06	9.60E-06	0	0	0	0
2255	Compd 40	Target_lig_1281	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	1.30E-05	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(COC3OC(CN)C(C(C3O)O)O)C(C(C2N)O)N)N)C(CC1O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.72110858182375	43	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	1.30E-05	1.30E-05	0	0	0	0
2256	Compd 41	Target_lig_1162	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	9.40E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N	-	-	-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	9.40E-06	9.40E-06	0	0	0	0
2257	Compd 42	Target_lig_1282	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	3.90E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1O)OC1OC(CO)C(C(C1N)O)O)N			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.69338285238078	43	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	3.90E-06	3.90E-06	0	0	0	0
2258	Compd 43	Target_lig_1283	human tyrosine sulfotransferase mRNA	Homo sapiens	Cancer	Target_410	0	0	5.10E-06	0	0	0	0	-	-	10.1002/anie.200460558	15578772	Targeting RNAs with tobramycin analogues.	Liang FS, Wang SK, Nakatani T, Wong CH	Angew Chem Int Ed Engl	43	6496-500	2004	1 uM	-	-	-	-	Surface Plasmon Resonance (SPR)	Additional	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O			-8.53880000000002	627.343920008	19	13	9	358.9	0	0.112721606869411	5.71370566405187	43	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	http://www.smmrna.org/	mRNA	mRNA	33	-	-	0	0	0	0	5.10E-06	5.10E-06	0	0	0	0
2259	tetracyclin	Target_lig_74	Tetracycline riboswitch A08G mutant	Synthetic	-	Target_412	0	0	1.05e-09±1.2e-10	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54685734	-0.370999999999999	444.153265728	9	6	2	181.62	1	0.33151896393022	4.2536794077623	32	GGGCCUAGAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	9.30E-10	1.17E-09	0	0	0	0
2260	tetracyclin	Target_lig_74	Tetracycline riboswitch A09G mutant	Synthetic	-	Target_413	0	0	1.6200000000000002e-07±1.6e-08	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54685734	-0.370999999999999	444.153265728	9	6	2	181.62	1	0.33151896393022	4.2536794077623	32	GGGCCUAAGACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	1.46E-07	1.78E-07	0	0	0	0
2261	tetracyclin	Target_lig_74	Tetracycline riboswitch A13U mutant	Synthetic	-	Target_414	0	0	2.22e-07±2.2000000000000002e-08	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54685734	-0.370999999999999	444.153265728	9	6	2	181.62	1	0.33151896393022	4.2536794077623	32	GGGCCUAAAACAUUCCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	2.00E-07	2.44E-07	0	0	0	0
2262	tetracyclin	Target_lig_74	Tetracycline riboswitch A50U mutant	Synthetic	-	Target_415	0	0	1.96e-07±2.4000000000000003e-08	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54685734	-0.370999999999999	444.153265728	9	6	2	181.62	1	0.33151896393022	4.2536794077623	32	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAUGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	1.72E-07	2.20E-07	0	0	0	0
2263	tetracyclin	Target_lig_74	Tetracycline riboswitch G51U mutant	Synthetic	-	Target_416	0	0	2.9300000000000004e-09±1.9000000000000002e-10	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54685734	-0.370999999999999	444.153265728	9	6	2	181.62	1	0.33151896393022	4.2536794077623	32	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAUAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	2.74E-09	3.12E-09	0	0	0	0
2264	tetracyclin	Target_lig_74	Tetracycline riboswitch U54G mutant	Synthetic	-	Target_417	0	0	2.6300000000000002e-09±2.3000000000000003e-10	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54685734	-0.370999999999999	444.153265728	9	6	2	181.62	1	0.33151896393022	4.2536794077623	32	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAGACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	2.40E-09	2.86E-09	0	0	0	0
2265	tetracyclin	Target_lig_74	Tetracycline riboswitch A55G mutant	Synthetic	-	Target_418	0	0	1.69e-09±3.5e-10	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54685734	-0.370999999999999	444.153265728	9	6	2	181.62	1	0.33151896393022	4.2536794077623	32	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUGCGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	1.34E-09	2.04E-09	0	0	0	0
2266	cltc	Target_lig_1164	Tetracycline riboswitch	Synthetic	-	Target_411	0	0	5.73e-10±9.2e-11	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CN(C1C(=O)C(=C(C2(C1CC1C(=C(O)c3c(C1(C)O)c(Cl)ccc3O)C2=O)O)O)C(=O)N)C	7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54677440	0.2824	478.114293376	9	6	2	181.62	1	0.325054597175159	4.35304098778978	33	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	71	5'-UTR	-	0	0	0	0	4.81E-10	6.65E-10	0	0	0	0
2267	cmt1	Target_lig_1165	Tetracycline riboswitch	Synthetic	-	Target_411	0	0	1.97e-09±8.9e-10	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	NC(=O)C1=C(O)C2(C(CC1=O)CC1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O	1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54684440	0.0889	401.111066568	8	6	1	178.38	1	0.358312298381941	4.09457104141106	29	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	71	5'-UTR	-	0	0	0	0	1.08E-09	2.86E-09	0	0	0	0
2268	cmt6	Target_lig_1166	Tetracycline riboswitch	Synthetic	-	Target_411	0	0	2.77e-09±4.4000000000000003e-10	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	NC(=O)C1=C(O)C2(C(C(C1=O)O)CC1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O	-	-	-0.9403	417.105981188	9	7	1	198.61	1	0.281746795487632	4.35435609509996	30	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	71	5'-UTR	-	0	0	0	0	2.33E-09	3.21E-09	0	0	0	0
2269	cmt5	Target_lig_1167	Tetracycline riboswitch	Synthetic	-	Target_411	0	0	4.6000000000000007e-10±9.9e-10	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	NNC1=C2C(=O)C3(O)C(CC2C(c2c1c(O)ccc2)(C)O)CC(=O)C(=C3O)C(=O)N	-	-	-1.0058	415.137950012	9	7	2	196.2	1	0.179798495787775	4.37646019258806	30	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	71	5'-UTR	-	0	0	0	0	5.30E-10	1.45E-09	0	0	0	0
2270	cmt2	Target_lig_1168	Tetracycline riboswitch	Synthetic	-	Target_411	0	0	9.800000000000002e-09±1.1000000000000001e-09	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	N#CC1=C(O)C2(C(C(C1=O)N(C)C)CC1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O	-	-	0.66728	426.142701044	9	5	1	162.32	1	0.434210741549864	4.4168467107002	31	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	71	5'-UTR	-	0	0	0	0	8.70E-09	1.09E-08	0	0	0	0
2271	otc	Target_lig_1169	Tetracycline riboswitch	Synthetic	-	Target_411	0	0	1.78e-09±3.2000000000000003e-10	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CN(C1C(=O)C(=C(C2(C1C(O)C1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O)O)C(=O)N)C	4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54686003	-1.4002	460.148180348	10	7	2	201.85	1	0.257273539291624	4.48062241028369	33	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	71	5'-UTR	-	0	0	0	0	1.46E-09	2.10E-09	0	0	0	0
2272	dox	Target_lig_496	Tetracycline riboswitch	Synthetic	-	Target_411	0	0	1.1800000000000001e-07±1.2000000000000002e-08	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	31703	0.0013	543.174060748	12	6	5	206.07	2	0.235262581685656	4.48608647582191	39	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	71	5'-UTR	-	0	0	0	0	1.06E-07	1.30E-07	0	0	0	0
2273	cmt8	Target_lig_1171	Tetracycline riboswitch	Synthetic	-	Target_411	0	0	5.47e-07±4.7000000000000004e-08	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	NC(=O)C1=C(O)C2(C(CC1=O)C(O)C1C(=C(O)c3c(C1C)cccc3O)C2=O)O	1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	54685050	-0.0443	401.111066568	8	6	1	178.38	1	0.354668589140271	4.13738903044403	29	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	71	5'-UTR	-	0	0	0	0	5.00E-07	5.94E-07	0	0	0	0
2274	san	Target_lig_18	Tetracycline riboswitch	Synthetic	-	Target_411	0	0	2.22e-08±4.8e-09	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	C[N+]1=C2C(=C3C=CC4=C(C3=C1)OCO4)C=CC5=CC6=C(C=C52)OCO6	24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene	5154	3.4281	332.09173434809	4	0	0	40.8	4	0.365369910827105	2.89850674553215	25	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	71	5'-UTR	-	0	0	0	0	1.74E-08	2.70E-08	0	0	0	0
2275	atc	Target_lig_1173	Tetracycline riboswitch	Synthetic	-	Target_411	0	0	3.5000000000000003e-09±2.6e-09	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CN(C1C(=O)C(=C(C2(C1CC1C(C)c3cccc(c3C(=C1C2=O)O)O)O)O)C(=O)N)C	4-(dimethylamino)-1,10,11,12a-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide	76169468	0.524999999999999	428.158351108	8	5	2	161.39	1	0.426127664420957	4.22428892458388	31	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	71	5'-UTR	-	0	0	0	0	9.00E-10	6.10E-09	0	0	0	0
2276	otc	Target_lig_1169	Tetracycline riboswitch A09G mutant	Synthetic	-	Target_413	0	0	4.4500000000000003e-07±2.8000000000000003e-08	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CN(C1C(=O)C(=C(C2(C1C(O)C1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O)O)C(=O)N)C	4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54686003	-1.4002	460.148180348	10	7	2	201.85	1	0.257273539291624	4.48062241028369	33	GGGCCUAAGACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	4.17E-07	4.73E-07	0	0	0	0
2277	cmt2	Target_lig_1168	Tetracycline riboswitch A09G mutant	Synthetic	-	Target_413	0	0	2.64e-06±1.9e-07	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	N#CC1=C(O)C2(C(C(C1=O)N(C)C)CC1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O	-	-	0.66728	426.142701044	9	5	1	162.32	1	0.434210741549864	4.4168467107002	31	GGGCCUAAGACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	2.45E-06	2.83E-06	0	0	0	0
2278	dox	Target_lig_496	Tetracycline riboswitch A09G mutant	Synthetic	-	Target_413	0	0	1.77e-05±4.4e-06	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	31703	0.0013	543.174060748	12	6	5	206.07	2	0.235262581685656	4.48608647582191	39	GGGCCUAAGACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	1.33E-05	2.21E-05	0	0	0	0
2279	otc	Target_lig_1169	Tetracycline riboswitch A13U mutant	Synthetic	-	Target_414	0	0	5.32e-07±9.400000000000001e-08	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CN(C1C(=O)C(=C(C2(C1C(O)C1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O)O)C(=O)N)C	4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54686003	-1.4002	460.148180348	10	7	2	201.85	1	0.257273539291624	4.48062241028369	33	GGGCCUAAAACAUUCCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	4.38E-07	6.26E-07	0	0	0	0
2280	cmt2	Target_lig_1168	Tetracycline riboswitch A13U mutant	Synthetic	-	Target_414	0	0	1.7e-06±1.6e-07	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	N#CC1=C(O)C2(C(C(C1=O)N(C)C)CC1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O	-	-	0.66728	426.142701044	9	5	1	162.32	1	0.434210741549864	4.4168467107002	31	GGGCCUAAAACAUUCCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	1.54E-06	1.86E-06	0	0	0	0
2281	dox	Target_lig_496	Tetracycline riboswitch A13U mutant	Synthetic	-	Target_414	0	0	2.42e-06±1.9e-07	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	31703	0.0013	543.174060748	12	6	5	206.07	2	0.235262581685656	4.48608647582191	39	GGGCCUAAAACAUUCCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	2.23E-06	2.61E-06	0	0	0	0
2282	otc	Target_lig_1169	Tetracycline riboswitch A50U mutant	Synthetic	-	Target_415	0	0	6.000000000000001e-07±4e-08	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	CN(C1C(=O)C(=C(C2(C1C(O)C1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O)O)C(=O)N)C	4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide	54686003	-1.4002	460.148180348	10	7	2	201.85	1	0.257273539291624	4.48062241028369	33	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAUGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	5.60E-07	6.40E-07	0	0	0	0
2283	cmt2	Target_lig_1168	Tetracycline riboswitch A50U mutant	Synthetic	-	Target_415	0	0	2.57e-06±1.7000000000000001e-07	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	N#CC1=C(O)C2(C(C(C1=O)N(C)C)CC1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O	-	-	0.66728	426.142701044	9	5	1	162.32	1	0.434210741549864	4.4168467107002	31	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAUGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	2.40E-06	2.74E-06	0	0	0	0
2284	dox	Target_lig_496	Tetracycline riboswitch A50U mutant	Synthetic	-	Target_415	0	0	1.0500000000000001e-05±2.6e-06	0	0	0	0	-	-	10.1093/nar/gkl347	16707663	Thermodynamic characterization of an engineered tetracycline-binding riboswitch.	Müller M, Weigand JE, Weichenrieder O, Suess B	Nucleic Acids Res	34	2607-17	2006	-	-	7.5	25	20 mM potassium phosphate buffer, 100 mM NaCl, 10 mM MgCl2	Fluorescence titration spectroscopy (FTS)	Additional	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	31703	0.0013	543.174060748	12	6	5	206.07	2	0.235262581685656	4.48608647582191	39	GGGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAUGAAUACGACCACCUAGGCUC	10.1093/nar/gkl347	mRNA, Riboswitch	Riboswitch	72	5'-UTR	-	0	0	0	0	7.90E-06	1.31E-05	0	0	0	0
2285	Siomycin	Target_lig_1174	L11 BD RNA	Thermotoga maritima	Bacterial growth and infection	Target_122	0	0	0	2.5e-07±4e-08	0	0	0	-	-	10.1016/S1074-5521(03)00173-X	12954336	Structural basis for contrasting activities of ribosome binding thiazole antibiotics.	Lentzen G, Klinck R, Matassova N, Aboul-ela F, Murchie AI	Chem Biol	10	769-78	2003	1-2 uM	1 mM	7.5	37	70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2	Coupled transcription-translation assay	Additional	CC=C1C2=NC(CS2)C(=O)NC(C3=NC(=CS3)C(=O)NC4C(OC(=O)C5=NC6=C(C=CC(C6O)NC(C(=O)NC(=C)C(=O)NC(=C)C(=O)NC(C(=O)NC7(CCC(=NC7C8=CSC4=N8)C9=NC(=CS9)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)C2=NC(=CS2)C(=O)NC(C(=O)N1)C(C)O)C)C(C)C)C(=C5)C(C)O)C)C(C)(C(C)O)O	N-[3-[(3-amino-3-oxoprop-1-en-2-yl)amino]-3-oxoprop-1-en-2-yl]-2-[18-(2,3-dihydroxybutan-2-yl)-11-ethylidene-59-hydroxy-8,31-bis(1-hydroxyethyl)-26,46-dimethyl-40,43-dimethylidene-6,9,16,23,28,38,41,44,47-nonaoxo-37-propan-2-yl-27-oxa-3,13,20,56-tetrathia-7,10,17,24,36,39,42,45,48,52,58,61,62,63,64-pentadecazanonacyclo[23.23.9.329,35.12,5.112,15.119,22.154,57.01,53.032,60]tetrahexaconta-2(64),4,12(63),19(62),21,29(61),30,32(60),33,51,54,57-dodecaen-51-yl]-1,3-thiazole-4-carboxamide	16130049	0.509000000000005	1647.461051752	31	17	11	562.74	5	0.063257531881354	8.91353067883276	113	GCUGGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAGUGCGUAACAGCUCACCAGC	https://www.rcsb.org/structure/1MMS	Ribosomal, RNA aptamer	-	58	-	Four-way junction	0	0	0	0	0	0	2.10E-07	2.90E-07	0	0
2286	Tylosin	Target_lig_320	U2609_Ecoli_ribosome	Escherichia coli	Bacterial growth and infection	Target_99	0	0	7.581e-08±9.87e-09	0	0	0	0	-	-	10.1074/jbc.M708371200	18079110	Stepwise binding of tylosin and erythromycin to Escherichia coli ribosomes, characterized by kinetic and footprinting analysis.	Petropoulos AD, Kouvela EC, Dinos GP, Kalpaxis DL	J Biol Chem	283	4756-65	2008	4 uM	100 nM	7.2	25	4.5 mM Mg(CH3COO)2, 150 mM NH4Cl	Footprinting assay	Additional	CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC	2-[6-[5-(4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde	5062352	1.83350000000001	915.519150004	18	5	13	238.67	0	0.130887261974031	6.85125631597821	64	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	https://www.rcsb.org/structure/1K73	Ribosomal	Peptidyl Transferase Centre (PTC)	2922	-	-	0	0	0	0	6.59E-08	8.57E-08	0	0	0	0
2287	Tylosin	Target_lig_320	U754A_Ecoli_ribosome	Escherichia coli	Bacterial growth and infection	Target_419	0	0	4.0430000000000005e-08±4.290000000000001e-09	0	0	0	0	-	-	10.1074/jbc.M708371200	18079110	Stepwise binding of tylosin and erythromycin to Escherichia coli ribosomes, characterized by kinetic and footprinting analysis.	Petropoulos AD, Kouvela EC, Dinos GP, Kalpaxis DL	J Biol Chem	283	4756-65	2008	4 uM	100 nM	7.2	25	4.5 mM Mg(CH3COO)2, 150 mM NH4Cl	Footprinting assay	Additional	CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC	2-[6-[5-(4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde	5062352	1.83350000000001	915.519150004	18	5	13	238.67	0	0.130887261974031	6.85125631597821	64			mRNA	-	0	-	-	0	0	0	0	3.61E-08	4.47E-08	0	0	0	0
2288	Lincomycin	Target_lig_1175	50S ribosome (CLINDAMYCIN)	Escherichia coli	Bacterial growth and infection	Target_100	0	0	5.00E-06	0	0	0	0	-	-	10.1093/nar/20.18.4717	1383931	Interaction of the antibiotics clindamycin and lincomycin with Escherichia coli 23S ribosomal RNA.	Douthwaite S	Nucleic Acids Res	20	4717-20	1992	0.1-1000 uM	6 pmol	7.2	37	20 mM-MgCl2, 100mM-NH4Cl	Footprinting assay	Additional	CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O	N-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide	3928	-0.856999999999997	406.213757808	8	5	7	122.49	0	0.37034350763057	4.69871442337648	27	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	5.00E-06	5.00E-06	0	0	0	0
2289	Sordarin	Target_lig_321	EF2 (SORDARIN)	-	-	-	0	0	3.11E-06	0	0	0	0	-	-	10.1128/aac.42.9.2274	9736548	Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts	Domínguez JM, Kelly VA, Kinsman OS, Marriott MS, Gómez de las Heras F, Martín JJ	Antimicrob Agents Chemother	42	2274-8	1998	-	-	7.4	-	150 mM potassium acetate, 10 mM magnesium acetate	In vitro translation assay	Additional	CC1CCC2C1CC3(C4CC2(C3(C(=C4)C(C)C)C(=O)O)C=O)COC5C(C(C(C(O5)C)OC)O)O	2-[(3,4-dihydroxy-5-methoxy-6-methyloxan-2-yl)oxymethyl]-9-formyl-5-methyl-13-propan-2-yltetracyclo[7.4.0.02,11.04,8]tridec-12-ene-1-carboxylic acid	22219016	2.4092	492.27231824	7	3	7	122.52	0	0.36584256814943	6.25754842704786	35	-	-	-	-	0	-	-	0	0	0	0	3.11E-06	3.11E-06	0	0	0	0
2290	Pulvomycin	Target_lig_322	EF-Tu (PULVOMYCIN)	-	-	-	0	0	1.00E-06	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Additional	CC1C(C(C(C(O1)OC(C)C(C=CC=CC=CC(=O)C(C)C(C(C)C2CC=CC=CC=CC(C(=O)C(=CC=CC(=CC(C(=CCC(=O)O2)C)O)C)C)O)O)O)OC)O)OC	22-[3,12-dihydroxy-13-(4-hydroxy-3,5-dimethoxy-6-methyloxan-2-yl)oxy-4-methyl-5-oxotetradeca-6,8,10-trien-2-yl]-6,14-dihydroxy-5,8,12-trimethyl-1-oxacyclodocosa-4,7,9,11,15,17,19-heptaene-2,13-dione	159327	4.81910000000001	838.450342172	13	5	13	198.51	0	0.073359397262317	6.76834289407344	60	-	-	-	-	0	-	-	0	0	0	0	1.00E-06	1.00E-06	0	0	0	0
2291	Enacyloxin IIa	Target_lig_323	EF_Tu_tRNA_ENACYLOXIN	-	-	-	0	0	7.00E-08	0	0	0	0	-	-	10.1002/j.1460-2075.1996.tb00618.x	8665868	Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome	Cetin R, Krab IM, Anborgh PH, Cool RH, Watanabe T, Sugiyama T, Izaki K, Parmeggiani A	EMBO J	15	2604-11	1996	50 uM	100 pmol	7.6	30	86 mM NH4C1, 6.7 mM MgCl2	Poly(U)-directed poly(Phe) synthesis	Additional	CC/C=C/[C@H]([C@H]([C@@H](CC(=O)[C@H]([C@@H]([C@H](C)/C(=C/C=C/C=C(\C)/C=C/C=C/C(=O)O[C@@H]1C[C@H](CC[C@@H]1O)C(=O)O)/Cl)O)O)O)Cl)OC(=O)N	(1S,3R,4S)-3-[(2E,4E,6E,8E,10Z,12S,13R,14S,17R,18S,19R,20E)-19-carbamoyloxy-11,18-dichloro-13,14,17-trihydroxy-6,12-dimethyl-15-oxotricosa-2,4,6,8,10,20-hexaenoyl]oxy-4-hydroxycyclohexane-1-carboxylic acid	5288163	3.5969	701.23696662	10	6	18	213.91	0	0.039917064724689	5.73943808358489	47	-	-	-	-	0	-	-	0	0	0	0	7.00E-08	7.00E-08	0	0	0	0
2292	Virginiamycin S	Target_lig_1176	50S ribosome (Virginiamycin M)	Escherichia coli	Bacterial growth and infection	Target_100	0	0	4×1E-7	0	0	0	0	-	-	10.1016/j.cell.2005.02.005	15851032	Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.	Tu D, Blaha G, Moore PB, Steitz TA	Cell	121	257-70	2005	-	-	-	-	-	-	Additional	CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CCC(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CC6=CC=CC=C6)C	N-(3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl)-3-hydroxypyridine-2-carboxamide	122731	1.20400000000001	823.354090768	11	4	6	224.72	3	0.258717158217449	5.39415905102624	60	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	6XZ7	Ribosomal	-	2898	-	-	0	0	0	0	4.00E-07	4.00E-07	0	0	0	0
2293	Linezolid	Target_lig_307	23SrRNA A2058G mutant	Escherichia coli	Bacterial growth and infection	Target_420	0	4.37e-05±4.2e-06	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F	N-[[3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	3929	1.1236	337.14378434	5	1	4	71.11	1	0.891597388751196	2.75916822785055	24			rRNA	-	0	-	-	0	0	3.95E-05	4.79E-05	0	0	0	0	0	0
2294	Linezolid	Target_lig_307	23SrRNA G2032A mutant	Escherichia coli	Bacterial growth and infection	Target_421	0	0.0001418±2.8499999999999998e-05	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F	N-[[3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	3929	1.1236	337.14378434	5	1	4	71.11	1	0.891597388751196	2.75916822785055	24			rRNA	-	0	-	-	0	0	0.0001133	0.0001703	0	0	0	0	0	0
2295	Linezolid	Target_lig_307	23SrRNA G2447A mutant	Escherichia coli	Bacterial growth and infection	Target_422	0	0.0007942±0.0001846	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F	N-[[3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	3929	1.1236	337.14378434	5	1	4	71.11	1	0.891597388751196	2.75916822785055	24			rRNA	-	0	-	-	0	0	0.0006096	0.0009788	0	0	0	0	0	0
2296	XA043	Target_lig_1177	23SrRNA	Escherichia coli	Bacterial growth and infection	Target_104	0	3.25e-06±1.8999999999999998e-07	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)c1ccncc1	N-[[(5S)-2-oxo-3-(4-pyridin-4-ylphenyl)-1,3-oxazolidin-5-yl]methyl]acetamide	130982	2.2099	311.126991404	4	1	4	71.53	2	0.939466485323562	2.57164284389319	23	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCAUCCCGACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACUGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACUAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGCAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCUU	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	2904	-	-	0	0	3.06E-06	3.44E-06	0	0	0	0	0	0
2297	XA043	Target_lig_1177	23SrRNA A2058G mutant	Escherichia coli	Bacterial growth and infection	Target_420	0	1.1789999999999999e-05±9.3e-07	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)c1ccncc1	N-[[(5S)-2-oxo-3-(4-pyridin-4-ylphenyl)-1,3-oxazolidin-5-yl]methyl]acetamide	130982	2.2099	311.126991404	4	1	4	71.53	2	0.939466485323562	2.57164284389319	23			rRNA	-	0	-	-	0	0	1.09E-05	1.27E-05	0	0	0	0	0	0
2298	XA043	Target_lig_1177	23SrRNA G2032A mutant	Escherichia coli	Bacterial growth and infection	Target_421	0	2.71e-05±5.7e-06	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)c1ccncc1	N-[[(5S)-2-oxo-3-(4-pyridin-4-ylphenyl)-1,3-oxazolidin-5-yl]methyl]acetamide	130982	2.2099	311.126991404	4	1	4	71.53	2	0.939466485323562	2.57164284389319	23			rRNA	-	0	-	-	0	0	2.14E-05	3.28E-05	0	0	0	0	0	0
2299	XA043	Target_lig_1177	23SrRNA G2447A mutant	Escherichia coli	Bacterial growth and infection	Target_422	0	0.0003858±9.47e-05	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)c1ccncc1	N-[[(5S)-2-oxo-3-(4-pyridin-4-ylphenyl)-1,3-oxazolidin-5-yl]methyl]acetamide	130982	2.2099	311.126991404	4	1	4	71.53	2	0.939466485323562	2.57164284389319	23			rRNA	-	0	-	-	0	0	0.0002911	0.0004805	0	0	0	0	0	0
2300	Chloramphenicol	Target_lig_228	23SrRNA	Escherichia coli	Bacterial growth and infection	Target_104	0	2.5e-07±3e-08	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide	298	0.909	322.012326844	5	3	6	112.7	1	0.409070928047897	3.12962708276815	20	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCAUCCCGACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACUGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACUAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGCAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCUU	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	2904	-	-	0	0	2.20E-07	2.80E-07	0	0	0	0	0	0
2301	Chloramphenicol	Target_lig_228	23SrRNA A2058G mutant	Escherichia coli	Bacterial growth and infection	Target_420	0	7.4e-07±4e-08	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide	298	0.909	322.012326844	5	3	6	112.7	1	0.409070928047897	3.12962708276815	20			rRNA	-	0	-	-	0	0	7.00E-07	7.80E-07	0	0	0	0	0	0
2302	Chloramphenicol	Target_lig_228	23SrRNA G2032A mutant	Escherichia coli	Bacterial growth and infection	Target_421	0	9e-07±1e-07	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide	298	0.909	322.012326844	5	3	6	112.7	1	0.409070928047897	3.12962708276815	20			rRNA	-	0	-	-	0	0	8.00E-07	1.00E-06	0	0	0	0	0	0
2303	Sparsomycin	Target_lig_306	23SrRNA	Escherichia coli	Bacterial growth and infection	Target_104	0	4.3999999999999997e-07±5e-08	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	CC1=C(C(=O)NC(=O)N1)C=CC(=O)NC(CO)CS(=O)CSC	N-[1-hydroxy-3-(methylsulfanylmethylsulfinyl)propan-2-yl]-3-(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)prop-2-enamide	14967	-1.06888	361.076612708	6	4	8	132.12	1	0.436064068045395	4.13107838372711	23	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCAUCCCGACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACUGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACUAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGCAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCUU	https://www.rcsb.org/structure/3J9Z	Ribosomal	-	2904	-	-	0	0	3.90E-07	4.90E-07	0	0	0	0	0	0
2304	Sparsomycin	Target_lig_306	23SrRNA A2058G mutant	Escherichia coli	Bacterial growth and infection	Target_420	0	1.2e-07±1e-08	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	CC1=C(C(=O)NC(=O)N1)C=CC(=O)NC(CO)CS(=O)CSC	N-[1-hydroxy-3-(methylsulfanylmethylsulfinyl)propan-2-yl]-3-(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)prop-2-enamide	14967	-1.06888	361.076612708	6	4	8	132.12	1	0.436064068045395	4.13107838372711	23			rRNA	-	0	-	-	0	0	1.10E-07	1.30E-07	0	0	0	0	0	0
2305	Sparsomycin	Target_lig_306	23SrRNA G2032A mutant	Escherichia coli	Bacterial growth and infection	Target_421	0	8.699999999999999e-07±8e-08	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	CC1=C(C(=O)NC(=O)N1)C=CC(=O)NC(CO)CS(=O)CSC	N-[1-hydroxy-3-(methylsulfanylmethylsulfinyl)propan-2-yl]-3-(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)prop-2-enamide	14967	-1.06888	361.076612708	6	4	8	132.12	1	0.436064068045395	4.13107838372711	23			rRNA	-	0	-	-	0	0	7.90E-07	9.50E-07	0	0	0	0	0	0
2306	Sparsomycin	Target_lig_306	23SrRNA G2447A mutant	Escherichia coli	Bacterial growth and infection	Target_422	0	1.2e-07±2e-08	0	0	0	0	0	-	-	10.1074/jbc.M209249200	12645571	Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.	Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL	J Biol Chem	278	9802-7	2003	-	0.24 uM	-	-	-	Competitive binding experiments	Additional	CC1=C(C(=O)NC(=O)N1)C=CC(=O)NC(CO)CS(=O)CSC	N-[1-hydroxy-3-(methylsulfanylmethylsulfinyl)propan-2-yl]-3-(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)prop-2-enamide	14967	-1.06888	361.076612708	6	4	8	132.12	1	0.436064068045395	4.13107838372711	23			rRNA	-	0	-	-	0	0	1.00E-07	1.40E-07	0	0	0	0	0	0
2307	Rx-01_002	Target_lig_1178	Ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	9.00E-08	0	0	0	-	-	10.1128/AAC.01193-07	18663023	R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.	Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F	Antimicrob Agents Chemother	52	3550-7	2008	0.1 - 1 mM	50-200 nM	7.8	37	10 mM MgOAc, 60 mM NH4Cl	Competitive binding experiments	Additional	CC(=O)NC[C@@H]1OC(=O)N(C1)c1ccc(c(c1)F)c1ccc(cc1)CNC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O	(E)-N-[[4-[4-[(5S)-5-(acetamidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl]phenyl]methyl]-3-(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)prop-2-enamide	23404107	1.96862	535.186711772	6	4	8	153.46	3	0.323648398545238	3.29128140585203	39	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	9.00E-08	9.00E-08	0	0
2308	Rx-01_007	Target_lig_1179	Ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	2.00E-08	0	0	0	-	-	10.1128/AAC.01193-07	18663023	R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.	Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F	Antimicrob Agents Chemother	52	3550-7	2008	0.1 - 1 mM	50-200 nM	7.8	37	10 mM MgOAc, 60 mM NH4Cl	Competitive binding experiments	Additional	Ncc1ccc(cc1)c1ccc(cc1F)N1C[C@@H](OC1=O)CNC(=O)C	N-[[(5S)-3-[4-[4-(aminomethyl)phenyl]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	25023632	0	0	0	0	0	0	0	0	0	0	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	2.00E-08	2.00E-08	0	0
2309	Rx-01_133	Target_lig_1180	Ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	2.00E-08	0	0	0	-	-	10.1128/AAC.01193-07	18663023	R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.	Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F	Antimicrob Agents Chemother	52	3550-7	2008	0.1 - 1 mM	50-200 nM	7.8	37	10 mM MgOAc, 60 mM NH4Cl	Competitive binding experiments	Additional	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(c(c1)F)c1ccc(cc1)CNCC(=O)N	2-[[4-[4-[(5S)-5-(acetamidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl]phenyl]methylamino]acetamide	11361985	1.5289	414.170333436	5	3	8	113.76	2	0.606251204454106	2.8501798509103	30	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	2.00E-08	2.00E-08	0	0
2310	Rx-01_149	Target_lig_1181	Ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	2.00E-08	0	0	0	-	-	10.1128/AAC.01193-07	18663023	R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.	Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F	Antimicrob Agents Chemother	52	3550-7	2008	0.1 - 1 mM	50-200 nM	7.8	37	10 mM MgOAc, 60 mM NH4Cl	Competitive binding experiments	Additional	NC(=N)NCc1ccc(cc1)c1ccc(cc1F)N1C[C@@H](OC1=O)CNC(=O)C	N-[[(5S)-3-[4-[4-[(diaminomethylideneamino)methyl]phenyl]-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	52943501	1.93707	399.170667784	4	4	6	120.54	2	0.437005234487455	2.89061072748332	29	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	2.00E-08	2.00E-08	0	0
2311	Rx-01_413	Target_lig_1182	Ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	1.30E-07	0	0	0	-	-	10.1128/AAC.01193-07	18663023	R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.	Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F	Antimicrob Agents Chemother	52	3550-7	2008	0.1 - 1 mM	50-200 nM	7.8	37	10 mM MgOAc, 60 mM NH4Cl	Competitive binding experiments	Additional	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(c(c1)F)c1ccc(cc1)n1ccnn1	-	-	2.5347	395.139367656	6	1	5	89.35	3	0.717164004288521	2.98882341412733	29	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	1.30E-07	1.30E-07	0	0
2312	Rx-01_423	Target_lig_1183	Ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	2.00E-08	0	0	0	-	-	10.1128/AAC.01193-07	18663023	R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.	Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F	Antimicrob Agents Chemother	52	3550-7	2008	0.1 - 1 mM	50-200 nM	7.8	37	10 mM MgOAc, 60 mM NH4Cl	Competitive binding experiments	Additional	FCCCNCc1ccc(cc1)c1ccc(cc1F)N1C[C@@H](OC1=O)CNC(=O)C	N-[[(5S)-3-[3-fluoro-4-[4-[(3-fluoropropylamino)methyl]phenyl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide	11293965	3.4032	417.1863981	4	2	9	70.67	2	0.613826128321548	2.91654452447203	30	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	2.00E-08	2.00E-08	0	0
2313	Rx-01_445	Target_lig_1184	Ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	6.00E-08	0	0	0	-	-	10.1128/AAC.01193-07	18663023	R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.	Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F	Antimicrob Agents Chemother	52	3550-7	2008	0.1 - 1 mM	50-200 nM	7.8	37	10 mM MgOAc, 60 mM NH4Cl	Competitive binding experiments	Additional	CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(c(c1)F)c1ccc(cc1)n1ncnn1	-	-	1.9297	396.134616624	7	1	5	102.24	3	0.707072588751961	3.12284083766765	29	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	6.00E-08	6.00E-08	0	0
2314	Chloramphenicol	Target_lig_228	Ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	7.80E-06	0	0	0	-	-	10.1128/AAC.01193-07	18663023	R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.	Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F	Antimicrob Agents Chemother	52	3550-7	2008	0.1 - 1 mM	50-200 nM	7.8	37	10 mM MgOAc, 60 mM NH4Cl	Competitive binding experiments	Additional	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	2,2-dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide	298	0.909	322.012326844	5	3	6	112.7	1	0.409070928047897	3.12962708276815	20	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	7.80E-06	7.80E-06	0	0
2315	Florfenicol	Target_lig_1185	Ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	7.00E-07	0	0	0	-	-	10.1128/AAC.01193-07	18663023	R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.	Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F	Antimicrob Agents Chemother	52	3550-7	2008	0.1 - 1 mM	50-200 nM	7.8	37	10 mM MgOAc, 60 mM NH4Cl	Competitive binding experiments	Additional	CS(=O)(=O)C1=CC=C(C=C1)C(C(CF)NC(=O)C(Cl)Cl)O	2,2-dichloro-N-[3-fluoro-1-hydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide	5201447	1.3815	357.000462508	4	2	6	83.47	1	0.753022368524909	3.24172535773632	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	7.00E-07	7.00E-07	0	0
2316	Sparsomycin	Target_lig_306	Ribosomal A-site	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	2.00E-08	0	0	0	-	-	10.1128/AAC.01193-07	18663023	R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.	Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F	Antimicrob Agents Chemother	52	3550-7	2008	0.1 - 1 mM	50-200 nM	7.8	37	10 mM MgOAc, 60 mM NH4Cl	Competitive binding experiments	Additional	CC1=C(C(=O)NC(=O)N1)C=CC(=O)NC(CO)CS(=O)CSC	N-[1-hydroxy-3-(methylsulfanylmethylsulfinyl)propan-2-yl]-3-(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)prop-2-enamide	14967	-1.06888	361.076612708	6	4	8	132.12	1	0.436064068045395	4.13107838372711	23	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	2.00E-08	2.00E-08	0	0
2317	Hypoxanthine	Target_lig_162	B.subtilis xpt-pbuX guanine binding domain of guanine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	7.319999999999999e-07±3.4e-08	0	0	0	0	-	-	10.1038/nature03037	15549109	Structure of a natural guanine-responsive riboswitch complexed with the metabolite hypoxanthine.	Batey RT, Gilbert SD, Montange RK	Nature	432	411-5	2004	-	-	-	-	20mM MgCl2 and 2 mM Na2-EDTA	Isothermal Titration Calorimetry (ITC)	Additional	C1=NC2=C(N1)C(=O)N=CN2	3,7-dihydropurin-6-one	790	-0.3538	136.038510748	3	2	0	74.43	2	0.519236856563892	2.99952241707339	10	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	6.98E-07	7.66E-07	0	0	0	0
2318	Hypoxanthine	Target_lig_162	B.subtilis xpt-pbuX guanine binding domain of guanine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	1.34e-06±9.4e-08	0	0	0	0	-	-	10.1038/nature03037	15549109	Structure of a natural guanine-responsive riboswitch complexed with the metabolite hypoxanthine.	Batey RT, Gilbert SD, Montange RK	Nature	432	411-5	2004	-	-	-	-	5mM MgCl2 and 2 mM Na2-EDTA	Isothermal Titration Calorimetry (ITC)	Additional	C1=NC2=C(N1)C(=O)N=CN2	3,7-dihydropurin-6-one	790	-0.3538	136.038510748	3	2	0	74.43	2	0.519236856563892	2.99952241707339	10	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	1.25E-06	1.43E-06	0	0	0	0
2319	Hypoxanthine	Target_lig_162	B.subtilis xpt-pbuX guanine binding domain of guanine riboswitch	Bacillus subtilis	Bacterial growth and infection	Target_74	0	0	4e-06±1.8999999999999998e-07	0	0	0	0	-	-	10.1038/nature03037	15549109	Structure of a natural guanine-responsive riboswitch complexed with the metabolite hypoxanthine.	Batey RT, Gilbert SD, Montange RK	Nature	432	411-5	2004	-	-	-	-	0.25mM MgCl2 and 2 mM Na2-EDTA	Isothermal Titration Calorimetry (ITC)	Additional	C1=NC2=C(N1)C(=O)N=CN2	3,7-dihydropurin-6-one	790	-0.3538	136.038510748	3	2	0	74.43	2	0.519236856563892	2.99952241707339	10	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGACUAUGUCC	https://www.rcsb.org/structure/4FE5	Riboswitch	Riboswitch	67	-	-	0	0	0	0	3.81E-06	4.19E-06	0	0	0	0
2320	Ribocil	Target_lig_663	FMN RIBOSWITCH APTAMER	Synthetic	Bacterial growth and infection	Target_36	0	0	1.6e-08±3.0000000000000004e-09	0	2.00E-07	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	CNC1=NC=C(C=N1)CN2CCC[C@@H](C2)C3=NC(=CC(=O)N3)C4=CC=CS4	2-[(3S)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	135567058	2.7097	382.157580324	7	2	5	86.8	3	0.705545992044172	3.22468161308844	27	GGCGUGUAGGAUAUGCUUCGGCAGAAGGACACGCC	https://www.rcsb.org/structure/1FMN	RNA aptamer, Riboswitch	Riboswitch	35	-	-	0	0	0	0	1.30E-08	1.90E-08	0	0	2.00E-07	2.00E-07
2321	Ribocil-A	Target_lig_1187	FMN RIBOSWITCH APTAMER	Synthetic	Bacterial growth and infection	Target_36	0	0	>1e-05	0	0	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	CNc1ncc(cn1)CN1CCC[C@H](C1)c1nc(O)cc(n1)c1cccs1	2-[(3R)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	136869448	3.122	382.157580324	8	2	5	87.06	3	0.700881824177965	3.24751374551298	27	GGCGUGUAGGAUAUGCUUCGGCAGAAGGACACGCC	https://www.rcsb.org/structure/1FMN	RNA aptamer, Riboswitch	Riboswitch	35	-	-	0	0	0	0	1.00E-05	1.00E-05	0	0	0	0
2322	Ribocil-B	Target_lig_663	FMN RIBOSWITCH APTAMER	Synthetic	Bacterial growth and infection	Target_36	0	0	6.6e-09±2e-09	0	0	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	CNC1=NC=C(C=N1)CN2CCC[C@@H](C2)C3=NC(=CC(=O)N3)C4=CC=CS4	2-[(3S)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	135567058	2.7097	382.157580324	7	2	5	86.8	3	0.705545992044172	3.22468161308844	27	GGCGUGUAGGAUAUGCUUCGGCAGAAGGACACGCC	https://www.rcsb.org/structure/1FMN	RNA aptamer, Riboswitch	Riboswitch	35	-	-	0	0	0	0	4.60E-09	8.60E-09	0	0	0	0
2323	Ribocil-C	Target_lig_664	FMN RIBOSWITCH APTAMER	Synthetic	Bacterial growth and infection	Target_36	0	0	<1e-09	0	0	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	C1C[C@@H](CN(C1)CC2=CN(C=N2)C3=NC=CC=N3)C4=NC(=CC(=O)N4)C5=CC=CS5	2-[(3S)-1-[(1-pyrimidin-2-ylimidazol-4-yl)methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	136981150	2.8537	419.152829292	8	1	5	92.59	4	0.534742446328506	3.42112161532566	30	GGCGUGUAGGAUAUGCUUCGGCAGAAGGACACGCC	https://www.rcsb.org/structure/1FMN	RNA aptamer, Riboswitch	Riboswitch	35	-	-	0	0	0	0	1.00E-09	1.00E-09	0	0	0	0
2324	Ribocil	Target_lig_663	FMN riboswitch C111U mutant	Synthetic	Bacterial growth and infection	Target_423	0	0	0	0	0.0002	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	CNC1=NC=C(C=N1)CN2CCC[C@@H](C2)C3=NC(=CC(=O)N3)C4=CC=CS4	2-[(3S)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	135567058	2.7097	382.157580324	7	2	5	86.8	3	0.705545992044172	3.22468161308844	27			mRNA, Riboswitch	Riboswitch	0	5'-UTR	-	0	0	0	0	0	0	0	0	0.0002	0.0002
2325	Ribocil	Target_lig_663	FMN riboswitch C100U mutant	Synthetic	Bacterial growth and infection	Target_424	0	0	0	0	2.40E-07	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	CNC1=NC=C(C=N1)CN2CCC[C@@H](C2)C3=NC(=CC(=O)N3)C4=CC=CS4	2-[(3S)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	135567058	2.7097	382.157580324	7	2	5	86.8	3	0.705545992044172	3.22468161308844	27			mRNA, Riboswitch	Riboswitch	0	5'-UTR	-	0	0	0	0	0	0	0	0	2.40E-07	2.40E-07
2326	Ribocil	Target_lig_663	FMN riboswitch C33U mutant	Synthetic	Bacterial growth and infection	Target_425	0	0	0	0	0.0002	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	CNC1=NC=C(C=N1)CN2CCC[C@@H](C2)C3=NC(=CC(=O)N3)C4=CC=CS4	2-[(3S)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	135567058	2.7097	382.157580324	7	2	5	86.8	3	0.705545992044172	3.22468161308844	27			mRNA, Riboswitch	Riboswitch	0	5'-UTR	-	0	0	0	0	0	0	0	0	0.0002	0.0002
2327	Ribocil	Target_lig_663	FMN riboswitch G37U mutant	Synthetic	Bacterial growth and infection	Target_426	0	0	0	0	>0.00019999999999999998	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	CNC1=NC=C(C=N1)CN2CCC[C@@H](C2)C3=NC(=CC(=O)N3)C4=CC=CS4	2-[(3S)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	135567058	2.7097	382.157580324	7	2	5	86.8	3	0.705545992044172	3.22468161308844	27			mRNA, Riboswitch	Riboswitch	0	5'-UTR	-	0	0	0	0	0	0	0	0	0.0002	0.0002
2328	Ribocil	Target_lig_663	FMN riboswitch U218C mutant	Synthetic	Bacterial growth and infection	Target_427	0	0	0	0	2.10E-06	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	CNC1=NC=C(C=N1)CN2CCC[C@@H](C2)C3=NC(=CC(=O)N3)C4=CC=CS4	2-[(3S)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	135567058	2.7097	382.157580324	7	2	5	86.8	3	0.705545992044172	3.22468161308844	27			mRNA, Riboswitch	Riboswitch	0	5'-UTR	-	0	0	0	0	0	0	0	0	2.10E-06	2.10E-06
2329	Ribocil	Target_lig_663	FMN riboswitch del94-102 mutant	Synthetic	Bacterial growth and infection	Target_428	0	0	0	0	>0.00019999999999999998	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	CNC1=NC=C(C=N1)CN2CCC[C@@H](C2)C3=NC(=CC(=O)N3)C4=CC=CS4	2-[(3S)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	135567058	2.7097	382.157580324	7	2	5	86.8	3	0.705545992044172	3.22468161308844	27			mRNA, Riboswitch	Riboswitch	0	5'-UTR	-	0	0	0	0	0	0	0	0	0.0002	0.0002
2330	Ribocil	Target_lig_663	FMN riboswitch C219U mutant	Synthetic	Bacterial growth and infection	Target_429	0	0	0	0	2.00E-07	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	CNC1=NC=C(C=N1)CN2CCC[C@@H](C2)C3=NC(=CC(=O)N3)C4=CC=CS4	2-[(3S)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	135567058	2.7097	382.157580324	7	2	5	86.8	3	0.705545992044172	3.22468161308844	27			mRNA, Riboswitch	Riboswitch	0	5'-UTR	-	0	0	0	0	0	0	0	0	2.00E-07	2.00E-07
2331	Ribocil	Target_lig_663	FMN riboswitch G93U mutant	Synthetic	Bacterial growth and infection	Target_430	0	0	0	0	0.0002	0	0	-	-	10.1038/nature15542	26416753	Selective small-molecule inhibition of an RNA structural element.	Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T	Nature	526	672-7	2015	30-240 nM	6.6-150 nM	7.4	Room temp.	100 mM KCl and 2 mM MgCl2	Fluorescence-based binding and displacement assays	Additional	CNC1=NC=C(C=N1)CN2CCC[C@@H](C2)C3=NC(=CC(=O)N3)C4=CC=CS4	2-[(3S)-1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one	135567058	2.7097	382.157580324	7	2	5	86.8	3	0.705545992044172	3.22468161308844	27			mRNA, Riboswitch	Riboswitch	0	5'-UTR	-	0	0	0	0	0	0	0	0	0.0002	0.0002
2332	Neomycin B	Target_lig_1251	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	7.00E-09	0	0	-	-	10.1016/j.bmcl.2010.10.001	29137205	Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.	Ayeleso TB, Matumba MG, Mukwevho E	Molecules	22		2017	500 nM - 1 mM	1nM - 1mM	6.8	37	30 mM Sodium cacodylate buffer	RNA fluorescence and coupled in-vitro transcription-translation assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	7.00E-09	7.00E-09
2333	Neamine	Target_lig_80	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	9.50E-06	0	0	-	-	10.1016/j.bmcl.2010.10.001	29137205	Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.	Ayeleso TB, Matumba MG, Mukwevho E	Molecules	22		2017	500 nM - 1 mM	1nM - 1mM	6.8	37	30 mM Sodium cacodylate buffer	RNA fluorescence and coupled in-vitro transcription-translation assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol	413349	-5.11559999999999	322.185234552	10	8	3	203.46	0	0.247960739843155	4.62440978066844	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	9.50E-06	9.50E-06
2334	Spiro-compound_4	Target_lig_1190	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	6.50E-06	0	0	-	-	10.1016/j.bmcl.2010.10.001	29137205	Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.	Ayeleso TB, Matumba MG, Mukwevho E	Molecules	22		2017	500 nM - 1 mM	1nM - 1mM	6.8	37	30 mM Sodium cacodylate buffer	RNA fluorescence and coupled in-vitro transcription-translation assay	Additional	OC1C[C@]2(OCC1O)[C@@H](N)C[C@H](C([C@H]2O)O)N	-	-	-3.3526	248.13722174	7	6	0	142.19	0	0.262769002831054	5.47735578859491	17	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	6.50E-06	6.50E-06
2335	Spiro-compound_5	Target_lig_1191	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	0.000141	0	0	-	-	10.1016/j.bmcl.2010.10.001	29137205	Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.	Ayeleso TB, Matumba MG, Mukwevho E	Molecules	22		2017	500 nM - 1 mM	1nM - 1mM	6.8	37	30 mM Sodium cacodylate buffer	RNA fluorescence and coupled in-vitro transcription-translation assay	Additional	O[C@H]1CO[C@@]2(CC[C@H]1O)[C@@H](N)C[C@H](C([C@H]2O)O)N	-	-	-2.9625	262.152871804	7	6	0	142.19	0	0.273634853319626	5.32419117120781	18	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	0.000141	0.000141
2336	Spiro-compound_6	Target_lig_1192	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	8.40E-06	0	0	-	-	10.1016/j.bmcl.2010.10.001	29137205	Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.	Ayeleso TB, Matumba MG, Mukwevho E	Molecules	22		2017	500 nM - 1 mM	1nM - 1mM	6.8	37	30 mM Sodium cacodylate buffer	RNA fluorescence and coupled in-vitro transcription-translation assay	Additional	N[C@@H]1C[C@H](N)[C@]2([C@@H](C1O)O)CCC=CCO2	-	-	-1.1281	228.1473925	5	4	0	101.73	0	0.393037132742927	5.38463404679889	16	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	8.40E-06	8.40E-06
2337	Spiro-compound_7	Target_lig_1193	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	6.30E-05	0	0	-	-	10.1016/j.bmcl.2010.10.001	29137205	Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.	Ayeleso TB, Matumba MG, Mukwevho E	Molecules	22		2017	500 nM - 1 mM	1nM - 1mM	6.8	37	30 mM Sodium cacodylate buffer	RNA fluorescence and coupled in-vitro transcription-translation assay	Additional	C=CCC(CN[C@@H]1C[C@H](N)[C@]2([C@@H](C1O)O)CCC=CCO2)(C)C	-	-	1.1051	324.241292884	5	4	5	87.74	0	0.569057935745507	5.48440171805077	23	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	6.30E-05	6.30E-05
2338	Spiro-ether_compound_3	Target_lig_1194	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	0.6688±0.0179	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	Additional	OCc1nnn(c1)C[C@@H]1CC[C@@]2(O1)[C@@H](N)C[C@H](C([C@H]2O)O)N	-	-	-2.5317	313.175004216	9	5	3	152.67	1	0.409283543854222	5.21395814050921	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	0.6509	0.6867
2339	Spiro-ether_compound_4	Target_lig_1195	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	3.7500000000000005e-08±6.200000000000001e-09	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	Additional	OCCc1nnn(c1)C[C@@H]1CC[C@]2(O1)[C@@H](N)C[C@H](C([C@H]2O)O)N	-	-	-2.4892	327.19065428	9	5	4	152.67	1	0.407056916691279	5.17585287045139	23	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	3.13E-08	4.37E-08
2340	Spiro-ether_compound_5	Target_lig_1196	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	2.066e-07±4.08e-08	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	Additional	OCCNCc1nnn(c1)C[C@@H]1CC[C@]2(O1)[C@@H](N)C[C@H](C([C@H]2O)O)N	-	-	-2.94209999999999	356.217203376	10	6	6	164.7	1	0.292404021879538	5.13918214272014	25	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	1.66E-07	2.47E-07
2341	Spiro-ether_compound_6	Target_lig_1197	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	1.9290000000000001e-07±5.5000000000000004e-09	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	Additional	OC[C@H](Cc1nnn(c1)C[C@@H]1CC[C@]2(O1)[C@@H](N)C[C@H](C([C@H]2O)O)N)O	-	-	-3.1283	357.201218964	10	6	5	172.9	1	0.318371219549113	5.3356929512922	25	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	1.87E-07	1.98E-07
2342	Spiro-ether_compound_7	Target_lig_1198	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	0.9502±0.0466	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	Additional	OCc1c(CO)nnn1C[C@@H]1CC[C@]2(O1)[C@@H](N)C[C@H](C([C@H]2O)O)N	-	-	-3.0394	343.1855689	10	6	4	172.9	1	0.332031544155166	5.42312546877527	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	0.9036	0.9968
2343	Spiro-ether_compound_8	Target_lig_1199	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	4.5280000000000003e-07±1.0900000000000002e-08	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	Additional	NC(=O)NCc1nnn(c1)C[C@@H]1CC[C@]2(O1)[C@@H](N)C[C@H](C([C@H]2O)O)N	-	-	-2.8557	355.19680228	9	6	4	187.56	1	0.332485227973718	5.14449072370437	25	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	4.42E-07	4.64E-07
2344	Spiro-ether_compound_9	Target_lig_1284	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	2.22e-08±5.4e-09	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	Additional	OCc1c(CO)nnn1C[C@@H]1CC[C@]2(O1)[C@@H](N)C[C@H](C([C@H]2O)O)N			-3.0394	343.1855689	10	6	4	172.9	1	0.332031544155166	5.42312546877527	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	1.68E-08	2.76E-08
2345	Spiro-ether_compound_10	Target_lig_1200	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	4.32e-08±6e-10	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	Additional	CCCCNC(=O)OCc1c(COC(=O)NCCCC)nnn1C[C@@H]1CC[C@]2(O1)[C@@H](N)C[C@H](C([C@H]2O)O)N	-	-	0.028600000000004	541.322396716	12	6	12	209.1	1	0.19437965553907	5.17803255039486	38	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	4.26E-08	4.38E-08
2346	Neomycin	Target_lig_4	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	7.000000000000001e-09±6e-10	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	6.40E-09	7.60E-09
2347	Neamine	Target_lig_80	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	0	0.0095±0.0012	0	0	-	-	10.1002/cbic.201100076	21557427	Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.	Katsoulis IA, Kythreoti G, Papakyriakou A, Koltsida K, Anastasopoulou P, Stathakis CI, Mavridis I, Cottin T, Saridakis E, Vourloumis D	Chembiochem	12	1188-92	2011	10 pM - 1 mM	20 nM, 100 nM, 500 nM and 1 uM	6.8	25	Sodium cacodylate buffer	Indicative fluorescence binding studies	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol	413349	-5.11559999999999	322.185234552	10	8	3	203.46	0	0.247960739843155	4.62440978066844	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	0	0	0.0083	0.0107
2348	Neamine mimic_10	Target_lig_1285	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	6.90E-05	0	0	0	0	-	-	10.1002/cbic.200400105	15368574	Disaccharide mimetics of the aminoglycoside antibiotic neamine.	Venot A, Swayze EE, Griffey RH, Boons GJ	Chembiochem	5	1228-36	2004	0.75, 2.5, 7.5, 25 uM	0.5 uM	-	-	-	ESI–FT-ICR mass spectra	Additional	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CO)O[C@H]1[C@@H]([C@H](O[C@H]([C@@H]1N)OC)CN)O)N)O)O			-4.84389999999999	353.179814824	11	7	5	195.9	0	0.250190891094437	4.63278205074756	24	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	6.90E-05	6.90E-05	0	0	0	0
2349	Neamine_derivative_14	Target_lig_1201	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000667	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OCn1cnc2c1cccc2)O)O	(1R,2S,3S,4R,6S)-4,6-diamino-3-(benzimidazol-1-ylmethoxy)cyclohexane-1,2-diol	102462540	-0.840899999999998	292.1535405	7	4	3	119.55	2	0.585352941511914	3.93567181848618	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000667	0.000667	0	0	0	0
2350	Neamine_derivative_15	Target_lig_1202	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000439	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OCn1c2ccccc2nc1C(F)(F)F)O)O	(1R,2S,3S,4R,6S)-4,6-diamino-3-[[2-(trifluoromethyl)benzimidazol-1-yl]methoxy]cyclohexane-1,2-diol	102462541	0.177900000000001	360.140925128	7	4	3	119.55	2	0.61984571338615	4.06768464168522	25	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000439	0.000439	0	0	0	0
2351	Neamine_derivative_18	Target_lig_1203	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000682	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OCn1ccc(n1)I)O)O	-	-	-1.3895	368.034538404	7	4	3	119.55	1	0.488084334082899	4.64462955917618	18	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000682	0.000682	0	0	0	0
2352	Neamine_derivative_19	Target_lig_1204	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000488	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OSc1cncnc1)O)O	-	-	-1.351	272.094311372	8	4	3	127.51	1	0.49722771719461	4.58198300344619	18	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000488	0.000488	0	0	0	0
2353	Neamine_derivative_20	Target_lig_1205	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.001079	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OSc1cnc(nc1)C(F)(F)F)O)O	-	-	-0.332199999999999	340.081696	8	4	3	127.51	1	0.550816066007128	4.56697163346763	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.001079	0.001079	0	0	0	0
2354	Neamine_derivative_26	Target_lig_1206	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000554	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OC[N+]1N=Nc2c1nccc2)O)O	-	-	-1.0117	294.14348985609	9	4	3	145.24	1	0.52532876566456	5.0748676463871	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000554	0.000554	0	0	0	0
2355	Neamine_derivative_27	Target_lig_1207	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000554	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OC[N+]1N=Nc2c1cccn2)O)O	-	-	-1.0117	294.14348985609	9	4	3	145.24	1	0.52532876566456	5.07916699449662	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000554	0.000554	0	0	0	0
2356	Neamine_derivative_28	Target_lig_1208	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000554	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OCn1nc2c(n1)cccn2)O)O	(1R,2S,3S,4R,6S)-4,6-diamino-3-(triazolo[4,5-b]pyridin-2-ylmethoxy)cyclohexane-1,2-diol	102462550	-2.0509	294.144038436	9	4	3	145.33	2	0.505769639198105	4.49426321353182	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000554	0.000554	0	0	0	0
2357	Neamine_derivative_29	Target_lig_1209	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000441	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OCn1ccc(n1)C(F)(F)F)O)O	(1R,2S,3S,4R,6S)-4,6-diamino-3-[[3-(trifluoromethyl)pyrazol-1-yl]methoxy]cyclohexane-1,2-diol	102462551	-0.975299999999999	310.125275064	7	4	3	119.55	1	0.56982915803505	4.26840331876557	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000441	0.000441	0	0	0	0
2358	Neamine_derivative_30	Target_lig_1210	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.000441	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OCn1nccc1C(F)(F)F)O)O	(1R,2S,3S,4R,6S)-4,6-diamino-3-[[5-(trifluoromethyl)pyrazol-1-yl]methoxy]cyclohexane-1,2-diol	102462552	-0.975299999999999	310.125275064	7	4	3	119.55	1	0.56982915803505	4.42391540667765	21	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.000441	0.000441	0	0	0	0
2359	Neamine_derivative_33	Target_lig_1211	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0.0001	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	N[C@@H]1C[C@H](N)[C@H]([C@@H]([C@H]1OCn1cnc2c1nc[nH]c2=O)O)O	9-[[(1S,2S,3R,4S,6R)-4,6-diamino-2,3-dihydroxycyclohexyl]oxymethyl]-1H-purin-6-one	136861556	-2.7576	310.138953056	9	5	3	165.3	2	0.406465498445544	4.40067174674696	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0.0001	0.0001	0	0	0	0
2360	Neamine	Target_lig_80	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.40E-05	0	0	0	0	-	-	10.1021/ol015794g	11405670	An efficient synthesis of mimetics of neamine for RNA recognition.	Ding Y, Hofstadler SA, Swayze EE, Griffey RH	Org Lett	3	1621-3	2001	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol	413349	-5.11559999999999	322.185234552	10	8	3	203.46	0	0.247960739843155	4.62440978066844	22	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.40E-05	2.40E-05	0	0	0	0
2361	Apramycin	Target_lig_772	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.00E-06	0	0	0	0	-	-	10.1002/anie.200351354	12888972	Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.	Ding Y, Hofstadler SA, Swayze EE, Risen L, Griffey RH	Angew Chem Int Ed Engl	42	3409-12	2003	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	CNC1C(OC2OC(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)C(C(C2O)O)N)OC2C(C1O)OC(C(C2)N)OC1C(N)CC(C(C1O)O)N	-	-	-3.9967	877.3752372	22	12	13	365.21	3	0.077839371712425	5.91075160447164	61	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
2362	Bekanamycin	Target_lig_1286	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.00E-06	0	0	0	0	-	-	10.1002/anie.200351354	12888972	Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.	Ding Y, Hofstadler SA, Swayze EE, Risen L, Griffey RH	Angew Chem Int Ed Engl	42	3409-12	2003	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
2363	Tobramycin	Target_lig_540	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	2.00E-06	0	0	0	0	-	-	10.1002/anie.200351354	12888972	Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.	Ding Y, Hofstadler SA, Swayze EE, Risen L, Griffey RH	Angew Chem Int Ed Engl	42	3409-12	2003	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	2.00E-06	2.00E-06	0	0	0	0
2364	Paromomycin	Target_lig_5	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	1.10E-07	0	0	0	0	-	-	10.1002/anie.200351354	12888972	Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.	Ding Y, Hofstadler SA, Swayze EE, Risen L, Griffey RH	Angew Chem Int Ed Engl	42	3409-12	2003	10 mM	1 - 7 uM	7 - 8.5	225	50 mM NH4-Oac	ESI-MS	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	1.10E-07	1.10E-07	0	0	0	0
2365	Diamino_piperidinyl_triazine_4	Target_lig_1212	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	9.20E-05	0	0	0	-	-	10.1128/AAC.49.12.4942-4949.2005	16304156	Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.	Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T	Antimicrob Agents Chemother	49	4942-9	2005	25-200 uM	5 uM	6.7	25	60 mM NaCl	ITC and RNA fluorescence assays	Additional	N[C@@H]1C[C@H](N)CN(C1)c1nc(nc(n1)N)N1C[C@H](N)C[C@H](C1)N	-	-	-2.8168	322.234190832	10	5	2	175.25	1	0.381602502856047	4.11288333666986	23	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	9.20E-05	9.20E-05	0	0
2366	Diamino_piperidinyl_triazine_5	Target_lig_1213	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	3.60E-05	0	0	0	-	-	10.1128/AAC.49.12.4942-4949.2005	16304156	Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.	Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T	Antimicrob Agents Chemother	49	4942-9	2005	25-200 uM	5 uM	6.7	25	60 mM NaCl	ITC and RNA fluorescence assays	Additional	N[C@@H]1C[C@H](N)CN(C1)c1nc(NC2CCNC2)nc(n1)N1C[C@H](N)C[C@H](C1)N	-	-	-2.6252	391.292040056	11	6	4	173.29	1	0.316849879068104	4.33011254519386	28	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	3.60E-05	3.60E-05	0	0
2367	Diamino_piperidinyl_triazine_6	Target_lig_1214	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	2.10E-05	0	0	0	-	-	10.1128/AAC.49.12.4942-4949.2005	16304156	Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.	Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T	Antimicrob Agents Chemother	49	4942-9	2005	25-200 uM	5 uM	6.7	25	60 mM NaCl	ITC and RNA fluorescence assays	Additional	COc1ccc(cc1)Nc1nc(nc(n1)N1C[C@H](N)C[C@H](C1)N)N1C[C@H](N)C[C@@H](C1)N	-	-	-0.646799999999996	428.276055644	11	5	5	170.49	2	0.40984373838417	3.8636682900257	31	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	2.10E-05	2.10E-05	0	0
2368	Diamino_piperidinyl_triazine_7	Target_lig_1215	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	1.10E-05	0	0	0	-	-	10.1128/AAC.49.12.4942-4949.2005	16304156	Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.	Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T	Antimicrob Agents Chemother	49	4942-9	2005	25-200 uM	5 uM	6.7	25	60 mM NaCl	ITC and RNA fluorescence assays	Additional	N[C@@H]1C[C@H](N)CN(C1)c1nc(Nc2ccc(cc2)NC(=O)C)nc(n1)N1C[C@H](N)C[C@H](C1)N	-	-	-0.696999999999998	455.286954676	11	6	5	190.36	2	0.334118796355636	3.90707792485097	33	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	1.10E-05	1.10E-05	0	0
2369	Diamino_piperidinyl_triazine_8	Target_lig_1216	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	1.20E-05	0	0	0	-	-	10.1128/AAC.49.12.4942-4949.2005	16304156	Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.	Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T	Antimicrob Agents Chemother	49	4942-9	2005	25-200 uM	5 uM	6.7	25	60 mM NaCl	ITC and RNA fluorescence assays	Additional	CC(CC(=O)Nc1ccc(cc1O)Nc1nc(nc(n1)N1C[C@H](N)C[C@H](C1)N)N1C[C@H](N)C[C@@H](C1)N)C	-	-	0.034800000000004	513.328819488	12	7	7	210.59	2	0.244514217703066	4.12641889237099	37	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	1.20E-05	1.20E-05	0	0
2370	Diamino_piperidinyl_triazine_9	Target_lig_1217	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	7.00E-06	0	0	0	-	-	10.1128/AAC.49.12.4942-4949.2005	16304156	Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.	Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T	Antimicrob Agents Chemother	49	4942-9	2005	25-200 uM	5 uM	6.7	25	60 mM NaCl	ITC and RNA fluorescence assays	Additional	N[C@@H]1C[C@H](N)CN(C1)c1nc(Nc2ccc(c(c2)O)NC(=O)c2ccc(cc2)C)nc(n1)N1C[C@H](N)C[C@H](C1)N	-	-	0.610920000000001	547.313169424	12	7	6	210.59	3	0.211632013452106	4.00784152098192	40	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	7.00E-06	7.00E-06	0	0
2371	Paromomycin	Target_lig_5	16s_rRNA A SITE	Escherichia coli	Bacterial growth and infection	Target_3	0	0	0	2.30E-07	0	0	0	-	-	10.1128/AAC.49.12.4942-4949.2005	16304156	Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.	Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T	Antimicrob Agents Chemother	49	4942-9	2005	25-200 uM	5 uM	6.7	25	60 mM NaCl	ITC and RNA fluorescence assays	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GAGCGUCACACCUUCGGGUGAAGUCGCUC	http://www.smmrna.org/	Ribosomal	A-site for tRNA	29	-	-	0	0	0	0	0	0	2.30E-07	2.30E-07	0	0
2372	rbt202	Target_lig_1218	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	3.40E-06	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.046	14757049	"Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic ""hot spots""."	Davis B, Afshar M, Varani G, Murchie AI, Karn J, Lentzen G, Drysdale M, Bower J, Potter AJ, Starkey ID, Swarbrick T, Aboul-ela F	J Mol Biol	336	343-56	2004	1 mM	0,0.4,0.8 mM	6.1	25	20 mM potassium phosphate	FRET and SPR	Additional	Coc1ccc(c(c1)CNCCCNC(=N)N)OCCNC(=N)N	-	-	0	0	0	0	0	0	0	0	0	0	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	3.40E-06	3.40E-06	0	0	0	0	0	0
2373	rbt394	Target_lig_1219	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	1.45E-05	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.046	14757049	"Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic ""hot spots""."	Davis B, Afshar M, Varani G, Murchie AI, Karn J, Lentzen G, Drysdale M, Bower J, Potter AJ, Starkey ID, Swarbrick T, Aboul-ela F	J Mol Biol	336	343-56	2004	1 mM	0,0.4,0.8 mM	6.1	25	20 mM potassium phosphate	FRET and SPR	Additional	NCCOc1ccc(cc1CNCCCCNC(=N)N)OC	2-[4-[[2-(2-aminoethoxy)-5-methoxyphenyl]methylamino]butyl]guanidine	142104296	0.385570000000002	309.216475104	5	5	11	118.41	1	0.229103994568269	2.26268067728601	22	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	1.45E-05	1.45E-05	0	0	0	0	0	0
2374	rbt442	Target_lig_1220	RNA_Str_HIV-1 TAR	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_19	0	3.20E-05	0	0	0	0	0	-	-	10.1016/j.jmb.2003.12.046	14757049	"Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic ""hot spots""."	Davis B, Afshar M, Varani G, Murchie AI, Karn J, Lentzen G, Drysdale M, Bower J, Potter AJ, Starkey ID, Swarbrick T, Aboul-ela F	J Mol Biol	336	343-56	2004	1 mM	0,0.4,0.8 mM	6.1	25	20 mM potassium phosphate	FRET and SPR	Additional	NCCCOc1ccc(cc1CNC(=O)CCCNC(=N)N)OC	-	-	0.302270000000002	337.211389724	5	5	11	135.48	1	0.223834323282481	2.22301489354226	24	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319144/	TAR element, Viral RNA	Trans-Activation Response Element (TAR)	29	-	Apical Loop	0	0	3.20E-05	3.20E-05	0	0	0	0	0	0
2375	Cinchonidine	Target_lig_1221	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	0.00019319999999999998±2.13e-05	0	0	0	0	-	-	10.1021/cb900167m	19673541	Selection and characterization of small molecules that bind the HIV-1 frameshift site RNA.	Marcheschi RJ, Mouzakis KD, Butcher SE	ACS Chem Biol	4	844-54	2009	109 to 103 M	1-2 uM	7	30	-	Fluorescence titration	Additional	C=CC1CN2CCC1CC2C(C3=CC=NC4=CC=CC=C34)O	(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-quinolin-4-ylmethanol	2757	3.1646	294.173213324	3	1	3	36.36	2	0.883423550325557	4.37440788895616	22	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	0.0001719	0.0002145	0	0	0	0
2376	Butamben	Target_lig_1222	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	3.9399999999999995e-05±7e-06	0	0	0	0	-	-	10.1021/cb900167m	19673541	Selection and characterization of small molecules that bind the HIV-1 frameshift site RNA.	Marcheschi RJ, Mouzakis KD, Butcher SE	ACS Chem Biol	4	844-54	2009	109 to 103 M	1-2 uM	7	30	-	Fluorescence titration	Additional	CCCCOC(=O)C1=CC=C(C=C1)N	butyl 4-aminobenzoate	2482	2.2257	193.11027872	3	1	4	52.32	1	0.452921348025126	1.58905928391699	14	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	3.24E-05	4.64E-05	0	0	0	0
2377	Idarubicin	Target_lig_1223	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	9.1e-06±1.3e-06	0	0	0	0	-	-	10.1021/cb900167m	19673541	Selection and characterization of small molecules that bind the HIV-1 frameshift site RNA.	Marcheschi RJ, Mouzakis KD, Butcher SE	ACS Chem Biol	4	844-54	2009	109 to 103 M	1-2 uM	7	30	-	Fluorescence titration	Additional	CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O	9-acetyl-7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione	3685	1.0203	497.168581444	10	5	3	176.61	2	0.328346506104878	4.33736632656311	36	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	7.80E-06	1.04E-05	0	0	0	0
2378	ethylquinoline_carboxamide derivative	Target_lig_497	FSS_mutant_1	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_431	0	0	4.5e-07±4e-08	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	c1cc(ccc1)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1cc2ccccc2nc1CC)CSSC[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCN)Cc1ccccc1)NC(=O)c1c(nc2c(c1)cccc2)CC)C(=O)NCCCN	-	-	4.55320000000001	1206.550699456	14	8	29	293.04	6	0.023629918366656	5.45074534077586	86	GGCCUUCCUACAAGGGAAGGCC	10.1021/jm100231t	mRNA, Viral RNA	Frameshift Site	22	-	-	0	0	0	0	4.10E-07	4.90E-07	0	0	0	0
2379	ethylquinoline_carboxamide derivative	Target_lig_497	FSS_mutant_2	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_432	0	0	3.3e-07±1.2e-07	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	c1cc(ccc1)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1cc2ccccc2nc1CC)CSSC[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCN)Cc1ccccc1)NC(=O)c1c(nc2c(c1)cccc2)CC)C(=O)NCCCN	-	-	4.55320000000001	1206.550699456	14	8	29	293.04	6	0.023629918366656	5.45074534077586	86	CCGGAAGGGACAACCCUUCCGG	10.1021/jm100231t	mRNA, Viral RNA	Frameshift Site	22	-	-	0	0	0	0	2.10E-07	4.50E-07	0	0	0	0
2380	ethylquinoline_carboxamide derivative	Target_lig_497	FSS_mutant_3	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_433	0	0	7.599999999999999e-07±6e-08	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	c1cc(ccc1)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1cc2ccccc2nc1CC)CSSC[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCN)Cc1ccccc1)NC(=O)c1c(nc2c(c1)cccc2)CC)C(=O)NCCCN	-	-	4.55320000000001	1206.550699456	14	8	29	293.04	6	0.023629918366656	5.45074534077586	86	GGCCUUCCCGCAAGGGAAGGCC	10.1021/jm100231t	mRNA, Viral RNA	Frameshift Site	23	-	-	0	0	0	0	7.00E-07	8.20E-07	0	0	0	0
2381	ethylquinoline_carboxamide derivative	Target_lig_497	FSS_mutant_4	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_434	0	0	1.1e-06±1e-07	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	c1cc(ccc1)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1cc2ccccc2nc1CC)CSSC[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCN)Cc1ccccc1)NC(=O)c1c(nc2c(c1)cccc2)CC)C(=O)NCCCN	-	-	4.55320000000001	1206.550699456	14	8	29	293.04	6	0.023629918366656	5.45074534077586	86	GGCCUUCCCCACCGGGAAGGCC	10.1021/jm100231t	mRNA, Viral RNA	Frameshift Site	23	-	-	0	0	0	0	1.00E-06	1.20E-06	0	0	0	0
2382	ethylquinoline_carboxamide derivative	Target_lig_497	FSS_mutant_5	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_435	0	0	>3.9999999999999996e-05	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	c1cc(ccc1)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1cc2ccccc2nc1CC)CSSC[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCN)Cc1ccccc1)NC(=O)c1c(nc2c(c1)cccc2)CC)C(=O)NCCCN	-	-	4.55320000000001	1206.550699456	14	8	29	293.04	6	0.023629918366656	5.45074534077586	86	CCGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCGG	10.1021/jm100231t	mRNA, Viral RNA	Frameshift Site	36	-	-	0	0	0	0	4.00E-05	4.00E-05	0	0	0	0
2383	ethylquinoline_carboxamide derivative 2	Target_lig_1224	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	4.2999999999999996e-07±5e-08	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	NCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](NC(=O)c1cc2ccccc2nc1C)CSSC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCN)Cc1ccccc1)NC(=O)c1cc2ccccc2nc1C	-	-	4.04524000000001	1178.519399328	14	8	27	293.04	6	0.026698259631964	5.31173625434799	84	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	3.80E-07	4.80E-07	0	0	0	0
2384	ethylquinoline_carboxamide derivative 3	Target_lig_1225	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	6.5e-07±4e-08	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	NCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](NC(=O)c1cnc2c(c1)cccc2)CSSC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCN)Cc1ccccc1)NC(=O)c1cnc2c(c1)cccc2	-	-	3.42840000000001	1150.4880992	14	8	27	293.04	6	0.027110435527699	5.22668476260449	82	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	6.10E-07	6.90E-07	0	0	0	0
2385	ethylquinoline_carboxamide derivative 4	Target_lig_1226	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	1.42e-06±1.7000000000000001e-07	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	NCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](NC(=O)c1cc2cc3OCOc3cc2nc1CC)CSSC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCN)Cc1ccccc1)NC(=O)c1cc2cc3OCOc3cc2nc1CC	-	-	4.01060000000001	1294.530357936	18	8	29	329.96	6	0.024289800175825	5.83041986807285	92	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	1.25E-06	1.59E-06	0	0	0	0
2386	ethylquinoline_carboxamide derivative 5	Target_lig_1227	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	2.3e-07±3e-08	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	NCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Nc1ccc2c(c1)C(=O)c1c(C2=O)cccc1)CSSC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCN)Cc1ccccc1)Nc1ccc2c(c1)C(=O)c1c(C2=O)cccc1	-	-	5.24700000000001	1252.487430504	16	8	27	301.4	6	0.024099190534998	5.49115980786951	90	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	2.00E-07	2.60E-07	0	0	0	0
2387	2-ethylquinoline-3-carboxylic acid	Target_lig_1228	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	2.9e-07±3e-08	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	Ccc1nc2ccccc2cc1C(=O)O	2-ethylquinoline-3-carboxylic acid	17933414	0	0	0	0	0	0	0	0	0	0	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	2.60E-07	3.20E-07	0	0	0	0
2388	Dicarba_derivative_8	Target_lig_1229	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	4.6999999999999995e-07±4e-08	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	C=CC[C@@H](C(=O)N1CCCC1C(=O)NC(C(=O)NCCCN)Cc1ccccc1)NC(=O)c1cc2ccccc2nc1CC	-	-	2.6552	598.326753824	6	4	14	146.52	3	0.165804846046414	3.65672729819208	44	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	4.30E-07	5.10E-07	0	0	0	0
2389	Dicarba_derivative_9	Target_lig_1230	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_109	0	0	3.3e-07±2e-08	0	0	0	0	-	-	10.1021/jm100231t	20672840	Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.	Palde PB, Ofori LO, Gareiss PC, Lerea J, Miller BL	J Med Chem	53	6018-27	2010	100 nM - 10 uM	8-16 uM	7.2	Room temp.	4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM Kcl	Fluorescence titration	Additional	NCCCNC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(NC(=O)c1cc2ccccc2nc1CC)C/C=C/C[C@@H](C(=O)N1CCCC1C(=O)NC(C(=O)NCCCN)Cc1ccccc1)NC(=O)c1cc2ccccc2nc1CC	-	-	4.50820000000001	1168.62220752	12	8	28	293.04	6	0.024889689074487	5.44386053777399	86	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	http://www.smmrna.org/	Viral RNA, FSS element, Stem-loop structure	Frameshift Site	52	-	Stem-Loop	0	0	0	0	3.10E-07	3.50E-07	0	0	0	0
2390	Acridine_derivative_2 (AD2)	Target_lig_1231	SL-3 of HIV-1_SITE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	6.7e-07±3e-08	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	Coc1ccc2c(c1)c(Nc1ccc(c(c1)CN1CCN(CC1)C)O)c1c(n2)cc(cc1)Cl	4-[(6-chloro-2-methoxyacridin-9-yl)amino]-2-[(4-methylpiperazin-1-yl)methyl]phenol	421105	0	0	0	0	0	0	0	0	0	0	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	6.40E-07	7.00E-07	0	0	0	0
2391	NSC119236	Target_lig_1232	SL-3 of HIV-1_SITE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.4e-06±4e-07	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CCOC(=O)C1=C2C=CC=CN2C3=C1C(=O)C4=CC=CC=C4C3=O	ethyl 6,11-dioxonaphtho[2,3-b]indolizine-12-carboxylate	273769	2.8914	319.084457896	5	0	2	64.85	3	0.532935430081578	2.29155226100359	24	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	1.00E-06	1.80E-06	0	0	0	0
2392	SL3_compound_6	Target_lig_1233	SL-3 of HIV-1_SITE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	1.5e-06±7e-07	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	C[N+](CCN[N+]1(C)CCCc2c1cccc2)(C)C	trimethyl-[2-[(1-methyl-3,4-dihydro-2H-quinolin-1-ium-1-yl)amino]ethyl]azanium	409129	1.7807	249.21940070418	1	1	4	12.03	1	0.802216841684785	3.96591603537281	18	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	8.00E-07	2.20E-06	0	0	0	0
2393	SL3_compound_2	Target_lig_1234	SL-3 of HIV-1_SITE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	3.2e-05±1e-06	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CN(c1ncnc2c1n(CCn1cnc3c1ncnc3N(C)C)cn2)C	7-[2-[6-(dimethylamino)purin-9-yl]ethyl]-N,N-dimethylpurin-6-amine	46883068	0.7982	352.18724064	10	0	5	93.68	4	0.520529754662725	3.06338229611647	26	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	3.10E-05	3.30E-05	0	0	0	0
2394	NSC154020	Target_lig_580	SL-3 of HIV-1_SITE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	0.000118±6.3e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CN1C2=NC=NC3=C2C(=CN3C4C(C(C(O4)CO)O)O)C(=N1)N	2-(5-amino-7-methyl-2,6,7,9,11-pentazatricyclo[6.3.1.04,12]dodeca-1(12),3,5,8,10-pentaen-2-yl)-5-(hydroxymethyl)oxolane-3,4-diol	290486	-1.8871	320.123302992	10	4	2	142.25	2	0.503083716927052	4.20633622128524	23	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	5.50E-05	0.000181	0	0	0	0
2395	NSC121848	Target_lig_581	SL-3 of HIV-1_SITE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	0.000135±4.8e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)O)O)O)O)C.[Br-]	1-[(3,4-dihydroxyphenyl)methyl]-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-6,7-diol;bromide	5351989	-0.5707	395.073220284	4	4	2	80.92	2	0.405090719057756	3.54047818260169	24	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	8.70E-05	0.000183	0	0	0	0
2396	NSC61809	Target_lig_583	SL-3 of HIV-1_SITE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	0.000157±1.8e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C	(9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 3-hydroxy-2-phenylpropanoate	4120	1.0627	318.16998466809	4	1	4	59.06	1	0.512333158306654	4.81975898122338	23	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	0.000139	0.000175	0	0	0	0
2397	NSC657704	Target_lig_582	SL-3 of HIV-1_SITE	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_146	0	0	0.000163±2e-06	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	C1=CC=C(C(=C1)/C=C\2/C(=O)N(C(=O)N2)/C=C\3/C(=O)C4=CC=CC=C4OC3=O)O	(5Z)-3-[(Z)-(2,4-dioxochromen-3-ylidene)methyl]-5-[(2-hydroxyphenyl)methylidene]imidazolidine-2,4-dione	5459242	1.9707	376.069536104	6	2	2	113.01	2	0.272409045745067	2.97141299743774	28	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	http://www.smmrna.org/	Viral RNA, Stem-loop structure	Psi Packing Domain	118	-	Apical Loop	0	0	0	0	0.000161	0.000165	0	0	0	0
2398	Acridine_derivative_2 (AD2)	Target_lig_1231	Duplex RNA	Synthetic	-	Target_436	0	0	8.699999999999999e-07±5e-08	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	Coc1ccc2c(c1)c(Nc1ccc(c(c1)CN1CCN(CC1)C)O)c1c(n2)cc(cc1)Cl	4-[(6-chloro-2-methoxyacridin-9-yl)amino]-2-[(4-methylpiperazin-1-yl)methyl]phenol	421105	0	0	0	0	0	0	0	0	0	0	AUCACCUCCUUA	10.1021/jm900599v	RNA aptamer	-	12	-	Stem-Loop	0	0	0	0	8.20E-07	9.20E-07	0	0	0	0
2399	NSC119236	Target_lig_1232	Duplex RNA	Synthetic	-	Target_436	0	0	3e-06±1e-06	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CCOC(=O)C1=C2C=CC=CN2C3=C1C(=O)C4=CC=CC=C4C3=O	ethyl 6,11-dioxonaphtho[2,3-b]indolizine-12-carboxylate	273769	2.8914	319.084457896	5	0	2	64.85	3	0.532935430081578	2.29155226100359	24	AUCACCUCCUUA	10.1021/jm900599v	RNA aptamer	-	12	-	Stem-Loop	0	0	0	0	2.00E-06	4.00E-06	0	0	0	0
2400	SL3_compound_6	Target_lig_1233	Duplex RNA	Synthetic	-	Target_436	0	0	6.099999999999999e-06±9e-07	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	C[N+](CCN[N+]1(C)CCCc2c1cccc2)(C)C	trimethyl-[2-[(1-methyl-3,4-dihydro-2H-quinolin-1-ium-1-yl)amino]ethyl]azanium	409129	1.7807	249.21940070418	1	1	4	12.03	1	0.802216841684785	3.96591603537281	18	AUCACCUCCUUA	10.1021/jm900599v	RNA aptamer	-	12	-	Stem-Loop	0	0	0	0	5.20E-06	7.00E-06	0	0	0	0
2401	methylpiperazine derivative	Target_lig_498	Duplex RNA	Synthetic	-	Target_436	0	0	6.9e-05±1.2e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CC1=NC2=NC(=NN2C(=C1)N3CCN(CC3)C)C4=CC=C(C=C4)Cl	2-(4-chlorophenyl)-5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine	318119	2.50492	342.135972288	6	0	2	49.56	3	0.715889401668116	2.33158063007697	24	AUCACCUCCUUA	10.1021/jm900599v	RNA aptamer	-	12	-	Stem-Loop	0	0	0	0	5.70E-05	8.10E-05	0	0	0	0
2402	methyl_carbamate derivative	Target_lig_499	Duplex RNA	Synthetic	-	Target_436	0	0	0.000345±3.9e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H](C3=C2COC(=O)N)N4C)OC	[(4S,6S)-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),7,11-trien-8-yl]methyl carbamate	10246117	0.7515	331.116820644	7	1	3	103.63	1	0.819888841042068	4.26809835411276	24	AUCACCUCCUUA	10.1021/jm900599v	RNA aptamer	-	12	-	Stem-Loop	0	0	0	0	0.000306	0.000384	0	0	0	0
2403	Acridine_derivative_2 (AD2)	Target_lig_1231	Single_stranded_RNA	Synthetic	-	Target_437	0	0	3e-06±3e-07	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	Coc1ccc2c(c1)c(Nc1ccc(c(c1)CN1CCN(CC1)C)O)c1c(n2)cc(cc1)Cl	4-[(6-chloro-2-methoxyacridin-9-yl)amino]-2-[(4-methylpiperazin-1-yl)methyl]phenol	421105	0	0	0	0	0	0	0	0	0	0	AUCACCUCCUUA	10.1021/jm900599v	RNA aptamer	-	12	-	-	0	0	0	0	2.70E-06	3.30E-06	0	0	0	0
2404	NSC119236	Target_lig_1232	Single_stranded_RNA	Synthetic	-	Target_437	0	0	2.2999999999999996e-06±1e-07	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CCOC(=O)C1=C2C=CC=CN2C3=C1C(=O)C4=CC=CC=C4C3=O	ethyl 6,11-dioxonaphtho[2,3-b]indolizine-12-carboxylate	273769	2.8914	319.084457896	5	0	2	64.85	3	0.532935430081578	2.29155226100359	24	AUCACCUCCUUA	10.1021/jm900599v	RNA aptamer	-	12	-	-	0	0	0	0	2.20E-06	2.40E-06	0	0	0	0
2405	SL3_compound_6	Target_lig_1233	Single_stranded_RNA	Synthetic	-	Target_437	0	0	7.8e-06±3e-07	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	C[N+](CCN[N+]1(C)CCCc2c1cccc2)(C)C	trimethyl-[2-[(1-methyl-3,4-dihydro-2H-quinolin-1-ium-1-yl)amino]ethyl]azanium	409129	1.7807	249.21940070418	1	1	4	12.03	1	0.802216841684785	3.96591603537281	18	AUCACCUCCUUA	10.1021/jm900599v	RNA aptamer	-	12	-	-	0	0	0	0	7.50E-06	8.10E-06	0	0	0	0
2406	methylpiperazine derivative	Target_lig_498	Single_stranded_RNA	Synthetic	-	Target_437	0	0	0.000276±4.9999999999999996e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CC1=NC2=NC(=NN2C(=C1)N3CCN(CC3)C)C4=CC=C(C=C4)Cl	2-(4-chlorophenyl)-5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine	318119	2.50492	342.135972288	6	0	2	49.56	3	0.715889401668116	2.33158063007697	24	AUCACCUCCUUA	10.1021/jm900599v	RNA aptamer	-	12	-	-	0	0	0	0	0.000226	0.000326	0	0	0	0
2407	methyl_carbamate derivative	Target_lig_499	Single_stranded_RNA	Synthetic	-	Target_437	0	0	>0.0049	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H](C3=C2COC(=O)N)N4C)OC	[(4S,6S)-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),7,11-trien-8-yl]methyl carbamate	10246117	0.7515	331.116820644	7	1	3	103.63	1	0.819888841042068	4.26809835411276	24	AUCACCUCCUUA	10.1021/jm900599v	RNA aptamer	-	12	-	-	0	0	0	0	0.0049	0.0049	0	0	0	0
2408	SL3_compound_6	Target_lig_1233	SL3_duplex_RNA	Escherichia coli	Bacterial growth and infection	Target_438	0	0	1.4e-05±4.9999999999999996e-06	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	C[N+](CCN[N+]1(C)CCCc2c1cccc2)(C)C	trimethyl-[2-[(1-methyl-3,4-dihydro-2H-quinolin-1-ium-1-yl)amino]ethyl]azanium	409129	1.7807	249.21940070418	1	1	4	12.03	1	0.802216841684785	3.96591603537281	18	GGACUAGCGCUAGUCC	10.1021/jm900599v	mRNA	mRNA	16	-	Stem-Loop	0	0	0	0	9.00E-06	1.90E-05	0	0	0	0
2409	methylpiperazine derivative	Target_lig_498	SL3_duplex_RNA	Escherichia coli	Bacterial growth and infection	Target_438	0	0	5.8e-05±1e-06	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CC1=NC2=NC(=NN2C(=C1)N3CCN(CC3)C)C4=CC=C(C=C4)Cl	2-(4-chlorophenyl)-5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine	318119	2.50492	342.135972288	6	0	2	49.56	3	0.715889401668116	2.33158063007697	24	GGACUAGCGCUAGUCC	10.1021/jm900599v	mRNA	mRNA	16	-	Stem-Loop	0	0	0	0	5.70E-05	5.90E-05	0	0	0	0
2410	methyl_carbamate derivative	Target_lig_499	SL4 RNA	Escherichia coli	Bacterial growth and infection	Target_439	0	0	7.9e-05±1.3e-05	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H](C3=C2COC(=O)N)N4C)OC	[(4S,6S)-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),7,11-trien-8-yl]methyl carbamate	10246117	0.7515	331.116820644	7	1	3	103.63	1	0.819888841042068	4.26809835411276	24	GGUGCGAGAGCGUC	10.1021/jm900599v	mRNA	mRNA	14	-	-	0	0	0	0	6.60E-05	9.20E-05	0	0	0	0
2411	methylpiperazine derivative	Target_lig_498	SL2 RNA	Escherichia coli	Bacterial growth and infection	Target_440	0	0	4.6e-05±9e-06	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CC1=NC2=NC(=NN2C(=C1)N3CCN(CC3)C)C4=CC=C(C=C4)Cl	2-(4-chlorophenyl)-5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine	318119	2.50492	342.135972288	6	0	2	49.56	3	0.715889401668116	2.33158063007697	24	GGCGACUGGUGAGUACGCC	10.1021/jm900599v	mRNA	mRNA	19	-	-	0	0	0	0	3.70E-05	5.50E-05	0	0	0	0
2412	methylpiperazine derivative	Target_lig_498	SL4 RNA	Escherichia coli	Bacterial growth and infection	Target_439	0	0	7e-05±4e-06	0	0	0	0	-	-	10.1021/jm900599v	19691339	Identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal Psi of human immunodeficiency virus-1.	Warui DM, Baranger AM	J Med Chem	52	5462-73	2009	500 uM	20 uM	7.4	25	25 mM NaCl	Isothermal Titration Calorimetry (ITC)	Additional	CC1=NC2=NC(=NN2C(=C1)N3CCN(CC3)C)C4=CC=C(C=C4)Cl	2-(4-chlorophenyl)-5-methyl-7-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine	318119	2.50492	342.135972288	6	0	2	49.56	3	0.715889401668116	2.33158063007697	24	GGUGCGAGAGCGUC	10.1021/jm900599v	mRNA	mRNA	14	-	-	0	0	0	0	6.60E-05	7.40E-05	0	0	0	0
2413	N6-1-Iminoethyl-L-lysine	Target_lig_1235	T-box riboswitch	Escherichia coli	Bacterial growth and infection	Target_79	0	0	1.1e-05±3e-06	0	0	0	0	-	-	10.1038/nchembio842	17143270	Antibacterial lysine analogs that target lysine riboswitches.	Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR	Nat Chem Biol	3	44-9	2007	100 uM	-	-	37	5 mM MnCl 2, 0.5 mM CaCl 2, 2.5 mM MgCl	In-line probing assays	Additional	CC(=[NH+]CCCC[C@@H](C(=O)[O-])[NH3+])N	(2S)-6-(1-aminoethylideneazaniumyl)-2-azaniumylhexanoate	7048552	-4.0252	188.13935323609	2	3	6	107.76	0	0.224286176527732	5.71779666708203	13	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	Riboswitch, T-box element	Riboswitch	29	-	-	0	0	0	0	8.00E-06	1.40E-05	0	0	0	0
2414	Butirosin	Target_lig_220	U15C,U16C SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_441	0	0	2.00E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1NC(=O)C(CCN)O)O)OC2C(C(C(O2)CO)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	4-amino-N-[5-amino-4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-hydroxycyclohexyl]-2-hydroxybutanamide	2485	-7.78510000000001	555.275171752	16	12	10	311.71	0	0.118983994095138	5.19812698359593	38	AUUUUUCCUCGAACCCGGCGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	2.00E-07	2.00E-07	0	0	0	0
2415	Amikacin	Target_lig_175	U15C,U16C SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_441	0	0	7.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	AUUUUUCCUCGAACCCGGCGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	7.00E-08	7.00E-08	0	0	0	0
2416	Neomycin	Target_lig_4	U15C,U16C SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_441	0	0	7.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	AUUUUUCCUCGAACCCGGCGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	7.00E-08	7.00E-08	0	0	0	0
2417	KANAMYCIN B	Target_lig_8	U15C,U16C SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_441	0	0	1.10E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	AUUUUUCCUCGAACCCGGCGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	1.10E-07	1.10E-07	0	0	0	0
2418	Kanamycin A	Target_lig_7	U15C,U16C SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_441	0	0	2.90E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	AUUUUUCCUCGAACCCGGCGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	2.90E-07	2.90E-07	0	0	0	0
2419	gentamicin_mol	Target_lig_76	U15C,U16C SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_441	0	0	6.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	AUUUUUCCUCGAACCCGGCGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	6.00E-08	6.00E-08	0	0	0	0
2420	Tobramycin	Target_lig_540	U15C,U16C SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_441	0	0	9.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	AUUUUUCCUCGAACCCGGCGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	9.00E-08	9.00E-08	0	0	0	0
2421	sisomicin	Target_lig_10	U15C,U16C SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_441	0	0	4.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	AUUUUUCCUCGAACCCGGCGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	4.00E-08	4.00E-08	0	0	0	0
2422	Paromomycin_mol_mol	Target_lig_1116	U15C,U16C SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_441	0	0	4.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	AUUUUUCCUCGAACCCGGCGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	4.00E-08	4.00E-08	0	0	0	0
2423	Butirosin	Target_lig_220	G17A,G18A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_442	0	0	2.00E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1NC(=O)C(CCN)O)O)OC2C(C(C(O2)CO)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	4-amino-N-[5-amino-4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-hydroxycyclohexyl]-2-hydroxybutanamide	2485	-7.78510000000001	555.275171752	16	12	10	311.71	0	0.118983994095138	5.19812698359593	38	AUUUUUCCUCGAACUUAACGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	35	-	-	0	0	0	0	2.00E-07	2.00E-07	0	0	0	0
2424	Amikacin	Target_lig_175	G17A,G18A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_442	0	0	1.30E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	AUUUUUCCUCGAACUUAACGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	35	-	-	0	0	0	0	1.30E-07	1.30E-07	0	0	0	0
2425	Neomycin	Target_lig_4	G17A,G18A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_442	0	0	5.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	AUUUUUCCUCGAACUUAACGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	35	-	-	0	0	0	0	5.00E-08	5.00E-08	0	0	0	0
2426	KANAMYCIN B	Target_lig_8	G17A,G18A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_442	0	0	1.00E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	AUUUUUCCUCGAACUUAACGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	35	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
2427	Kanamycin A	Target_lig_7	G17A,G18A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_442	0	0	1.20E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	AUUUUUCCUCGAACUUAACGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	35	-	-	0	0	0	0	1.20E-07	1.20E-07	0	0	0	0
2428	gentamicin_mol	Target_lig_76	G17A,G18A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_442	0	0	1.00E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	AUUUUUCCUCGAACUUAACGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	35	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
2429	Tobramycin	Target_lig_540	G17A,G18A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_442	0	0	3.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	AUUUUUCCUCGAACUUAACGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	35	-	-	0	0	0	0	3.00E-08	3.00E-08	0	0	0	0
2430	sisomicin	Target_lig_10	G17A,G18A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_442	0	0	4.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	AUUUUUCCUCGAACUUAACGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	35	-	-	0	0	0	0	4.00E-08	4.00E-08	0	0	0	0
2431	Paromomycin_mol_mol	Target_lig_1116	G17A,G18A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_442	0	0	5.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	AUUUUUCCUCGAACUUAACGGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	35	-	-	0	0	0	0	5.00E-08	5.00E-08	0	0	0	0
2432	Butirosin	Target_lig_220	C19U,G20A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_443	0	0	1.50E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1NC(=O)C(CCN)O)O)OC2C(C(C(O2)CO)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	4-amino-N-[5-amino-4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-hydroxycyclohexyl]-2-hydroxybutanamide	2485	-7.78510000000001	555.275171752	16	12	10	311.71	0	0.118983994095138	5.19812698359593	38	AUUUUUCCUCGAACUUGGUAGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	1.50E-07	1.50E-07	0	0	0	0
2433	Amikacin	Target_lig_175	C19U,G20A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_443	0	0	7.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	AUUUUUCCUCGAACUUGGUAGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	7.00E-08	7.00E-08	0	0	0	0
2434	Neomycin	Target_lig_4	C19U,G20A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_443	0	0	5.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	AUUUUUCCUCGAACUUGGUAGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	5.00E-08	5.00E-08	0	0	0	0
2435	KANAMYCIN B	Target_lig_8	C19U,G20A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_443	0	0	1.00E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	AUUUUUCCUCGAACUUGGUAGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	1.00E-07	1.00E-07	0	0	0	0
2436	Kanamycin A	Target_lig_7	C19U,G20A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_443	0	0	3.00E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	AUUUUUCCUCGAACUUGGUAGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	3.00E-07	3.00E-07	0	0	0	0
2437	gentamicin_mol	Target_lig_76	C19U,G20A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_443	0	0	7.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	AUUUUUCCUCGAACUUGGUAGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	7.00E-08	7.00E-08	0	0	0	0
2438	Tobramycin	Target_lig_540	C19U,G20A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_443	0	0	6.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	AUUUUUCCUCGAACUUGGUAGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	6.00E-08	6.00E-08	0	0	0	0
2439	sisomicin	Target_lig_10	C19U,G20A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_443	0	0	3.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	AUUUUUCCUCGAACUUGGUAGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	3.00E-08	3.00E-08	0	0	0	0
2440	Paromomycin_mol_mol	Target_lig_1116	C19U,G20A SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_443	0	0	5.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	AUUUUUCCUCGAACUUGGUAGAACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	5.00E-08	5.00E-08	0	0	0	0
2441	Butirosin	Target_lig_220	G21A,A22G SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_444	0	0	2.60E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1NC(=O)C(CCN)O)O)OC2C(C(C(O2)CO)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	4-amino-N-[5-amino-4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-hydroxycyclohexyl]-2-hydroxybutanamide	2485	-7.78510000000001	555.275171752	16	12	10	311.71	0	0.118983994095138	5.19812698359593	38	AUUUUUCCUCGAACUUGGCGAGACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	2.60E-07	2.60E-07	0	0	0	0
2442	Amikacin	Target_lig_175	G21A,A22G SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_444	0	0	1.20E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N	4-amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide	2142	-8.42420000000002	585.285736436	17	13	10	331.94	0	0.113063794044575	5.28776755590454	40	AUUUUUCCUCGAACUUGGCGAGACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	1.20E-07	1.20E-07	0	0	0	0
2443	Neomycin	Target_lig_4	G21A,A22G SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_444	0	0	3.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	AUUUUUCCUCGAACUUGGCGAGACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	3.00E-08	3.00E-08	0	0	0	0
2444	KANAMYCIN B	Target_lig_8	G21A,A22G SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_444	0	0	1.30E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	AUUUUUCCUCGAACUUGGCGAGACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	1.30E-07	1.30E-07	0	0	0	0
2445	Kanamycin A	Target_lig_7	G21A,A22G SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_444	0	0	2.40E-07	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol	815	-7.2914	484.238057972	15	11	6	282.61	0	0.166853651933486	5.0520043780266	33	AUUUUUCCUCGAACUUGGCGAGACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	2.40E-07	2.40E-07	0	0	0	0
2446	gentamicin_mol	Target_lig_76	G21A,A22G SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_444	0	0	9.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	AUUUUUCCUCGAACUUGGCGAGACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	9.00E-08	9.00E-08	0	0	0	0
2447	Tobramycin	Target_lig_540	G21A,A22G SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_444	0	0	7.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	AUUUUUCCUCGAACUUGGCGAGACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	7.00E-08	7.00E-08	0	0	0	0
2448	sisomicin	Target_lig_10	G21A,A22G SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_444	0	0	6.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	5224	-3.85149999999999	447.269298524	12	8	6	213.72	0	0.196401857262319	5.29073268164636	31	AUUUUUCCUCGAACUUGGCGAGACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	6.00E-08	6.00E-08	0	0	0	0
2449	Paromomycin_mol_mol	Target_lig_1116	G21A,A22G SLI_mutant	Escherichia coli	Bacterial growth and infection	Target_444	0	0	5.00E-08	0	0	0	0	-	-	10.1021/bi0473298	15865425	The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid.	Thomas JR, DeNap JC, Wong ML, Hergenrother PJ	Biochemistry	44	6800-8	2005	25 uL	37.5 nM	7.5	37	1mM MgCl2	Fluorescence titration	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	AUUUUUCCUCGAACUUGGCGAGACGCAGAAAAAU	10.1021/bi0473298	mRNA	mRNA	34	-	-	0	0	0	0	5.00E-08	5.00E-08	0	0	0	0
2450	CRP	Target_lig_147	Thymidylate synthase m-RNA	Homo sapiens	Cancer	Target_63	0	0	7.329999999999999e-07±4.1e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC3C(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C4CCCN4C(=O)C(CCCCN)N	1-[2-[[2-[[5-amino-2-[[1-(2,6-diaminohexanoyl)pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid	22146496	-0.000699999999992	767.433009784	9	8	20	276.14	2	0.083550176470666	4.39770138518893	55	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGUCGG	https://pubs.acs.org/doi/pdf/10.1021/bi9819428	mRNA	-	33	-	Stem-Loop	0	0	0	0	6.92E-07	7.74E-07	0	0	0	0
2451	CRG	Target_lig_1236	Thymidylate synthase m-RNA	Homo sapiens	Cancer	Target_63	0	0	8.489999999999999e-07±5e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	CNC1C(O)C(OCC1(C)O)OC1C(N)CC(C(C1O)OC1OC(CCC1N)C(CCNC(=O)c1ccc(c(c1)C(=O)O)c1c2ccc(=[N+](C)C)cc2oc2c1ccc(c2)N(C)C)C)N	-	-	0.834800000000011	904.48148235209	15	9	13	273.49	2	0.066441643296219	5.9404803633512	65	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGUCGG	https://pubs.acs.org/doi/pdf/10.1021/bi9819428	mRNA	-	33	-	Stem-Loop	0	0	0	0	7.99E-07	8.99E-07	0	0	0	0
2452	CRT	Target_lig_993	Thymidylate synthase m-RNA	Homo sapiens	Cancer	Target_63	0	0	8.149999999999999e-07±6.3e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	-	-	-2.51049999999999	880.40871133609	17	11	11	327.94	2	0.054746298432302	5.81306542323516	63	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGUCGG	https://pubs.acs.org/doi/pdf/10.1021/bi9819428	mRNA	-	33	-	Stem-Loop	0	0	0	0	7.52E-07	8.78E-07	0	0	0	0
2453	CRK	Target_lig_1238	Thymidylate synthase m-RNA	Homo sapiens	Cancer	Target_63	0	0	9.469999999999999e-07±8.699999999999998e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(C(C2N)O)O)N)C(C(C1O)N)O	-	-	-3.5397	896.40362595609	18	12	11	348.17	2	0.051237784361364	5.86078957711484	64	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGUCGG	https://pubs.acs.org/doi/pdf/10.1021/bi9819428	mRNA	-	33	-	Stem-Loop	0	0	0	0	8.60E-07	1.03E-06	0	0	0	0
2454	Neomycin	Target_lig_4	TS mRNA Construct_4	Homo sapiens	Cancer	Target_445	0	0	9.77e-07±5.3999999999999994e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGGGGG	10.1021/bi9819428	mRNA	mRNA	34	-	-	0	0	0	0	9.23E-07	1.03E-06	0	0	0	0
2455	Paromomycin_mol_mol	Target_lig_1116	TS mRNA Construct_4	Homo sapiens	Cancer	Target_445	0	0	1.863e-06±1.1299999999999999e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGGGGG	10.1021/bi9819428	mRNA	mRNA	34	-	-	0	0	0	0	1.75E-06	1.98E-06	0	0	0	0
2456	gentamicin_mol	Target_lig_76	TS mRNA Construct_4	Homo sapiens	Cancer	Target_445	0	0	2.544e-06±1.82e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGGGGG	10.1021/bi9819428	mRNA	mRNA	34	-	-	0	0	0	0	2.36E-06	2.73E-06	0	0	0	0
2457	Tobramycin	Target_lig_540	TS mRNA Construct_4	Homo sapiens	Cancer	Target_445	0	0	2.292e-06±2.8e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGGGGG	10.1021/bi9819428	mRNA	mRNA	34	-	-	0	0	0	0	2.01E-06	2.57E-06	0	0	0	0
2458	KANAMYCIN B	Target_lig_8	TS mRNA Construct_4	Homo sapiens	Cancer	Target_445	0	0	2.428e-06±3.08e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGGGGG	10.1021/bi9819428	mRNA	mRNA	34	-	-	0	0	0	0	2.12E-06	2.74E-06	0	0	0	0
2459	CRP	Target_lig_147	TS mRNA Construct_4	Homo sapiens	Cancer	Target_445	0	0	7.14e-07±6.6e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC3C(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C4CCCN4C(=O)C(CCCCN)N	1-[2-[[2-[[5-amino-2-[[1-(2,6-diaminohexanoyl)pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid	22146496	-0.000699999999992	767.433009784	9	8	20	276.14	2	0.083550176470666	4.39770138518893	55	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGGGGG	10.1021/bi9819428	mRNA	mRNA	34	-	-	0	0	0	0	6.48E-07	7.80E-07	0	0	0	0
2460	CRG	Target_lig_1236	TS mRNA Construct_4	Homo sapiens	Cancer	Target_445	0	0	9.19e-07±8e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	CNC1C(O)C(OCC1(C)O)OC1C(N)CC(C(C1O)OC1OC(CCC1N)C(CCNC(=O)c1ccc(c(c1)C(=O)O)c1c2ccc(=[N+](C)C)cc2oc2c1ccc(c2)N(C)C)C)N	-	-	0.834800000000011	904.48148235209	15	9	13	273.49	2	0.066441643296219	5.9404803633512	65	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGGGGG	10.1021/bi9819428	mRNA	mRNA	34	-	-	0	0	0	0	8.39E-07	9.99E-07	0	0	0	0
2461	CRT	Target_lig_993	TS mRNA Construct_4	Homo sapiens	Cancer	Target_445	0	0	8.769999999999999e-07±7.899999999999999e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	-	-	-2.51049999999999	880.40871133609	17	11	11	327.94	2	0.054746298432302	5.81306542323516	63	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGGGGG	10.1021/bi9819428	mRNA	mRNA	34	-	-	0	0	0	0	7.98E-07	9.56E-07	0	0	0	0
2462	CRK	Target_lig_1238	TS mRNA Construct_4	Homo sapiens	Cancer	Target_445	0	0	1.107e-06±9.1e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(C(C2N)O)O)N)C(C(C1O)N)O	-	-	-3.5397	896.40362595609	18	12	11	348.17	2	0.051237784361364	5.86078957711484	64	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGGGGG	10.1021/bi9819428	mRNA	mRNA	34	-	-	0	0	0	0	1.02E-06	1.20E-06	0	0	0	0
2463	Neomycin	Target_lig_4	TS mRNA Construct_5	Homo sapiens	Cancer	Target_446	0	0	1.448e-06±1.01e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	CCCCCGCCACCUUCGGGUGGCCGGGG	10.1021/bi9819428	mRNA	mRNA	26	-	-	0	0	0	0	1.35E-06	1.55E-06	0	0	0	0
2464	Paromomycin_mol_mol	Target_lig_1116	TS mRNA Construct_5	Homo sapiens	Cancer	Target_446	0	0	2.241e-06±2.0999999999999997e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	CCCCCGCCACCUUCGGGUGGCCGGGG	10.1021/bi9819428	mRNA	mRNA	26	-	-	0	0	0	0	2.03E-06	2.45E-06	0	0	0	0
2465	gentamicin_mol	Target_lig_76	TS mRNA Construct_5	Homo sapiens	Cancer	Target_446	0	0	2.8330000000000002e-06±2.41e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O	2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	582362	-3.9767	449.284948588	12	8	6	213.72	0	0.194844191411331	5.16899065295033	31	CCCCCGCCACCUUCGGGUGGCCGGGG	10.1021/bi9819428	mRNA	mRNA	26	-	-	0	0	0	0	2.59E-06	3.07E-06	0	0	0	0
2466	Tobramycin	Target_lig_540	TS mRNA Construct_5	Homo sapiens	Cancer	Target_446	0	0	3.3279999999999997e-06±2.93e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	[C@H]1([C@H](C[C@H]([C@H]([C@H]1O)O[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CN)O)N)N)N)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CNc1c2ccccc2nc2c1cccc2)O)N)O	-	-	-2.47459999999999	643.3329614	15	10	8	272.86	3	0.113888067874624	5.18717668633395	46	CCCCCGCCACCUUCGGGUGGCCGGGG	10.1021/bi9819428	mRNA	mRNA	26	-	-	0	0	0	0	3.04E-06	3.62E-06	0	0	0	0
2467	KANAMYCIN B	Target_lig_8	TS mRNA Construct_5	Homo sapiens	Cancer	Target_446	0	0	3.4919999999999998e-06±3.22e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	CCCCCGCCACCUUCGGGUGGCCGGGG	10.1021/bi9819428	mRNA	mRNA	26	-	-	0	0	0	0	3.17E-06	3.81E-06	0	0	0	0
2468	CRP	Target_lig_147	TS mRNA Construct_5	Homo sapiens	Cancer	Target_446	0	0	1.1169999999999999e-06±9.4e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC3C(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C4CCCN4C(=O)C(CCCCN)N	1-[2-[[2-[[5-amino-2-[[1-(2,6-diaminohexanoyl)pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid	22146496	-0.000699999999992	767.433009784	9	8	20	276.14	2	0.083550176470666	4.39770138518893	55	CCCCCGCCACCUUCGGGUGGCCGGGG	10.1021/bi9819428	mRNA	mRNA	26	-	-	0	0	0	0	1.02E-06	1.21E-06	0	0	0	0
2469	CRG	Target_lig_1236	TS mRNA Construct_5	Homo sapiens	Cancer	Target_446	0	0	1.2450000000000002e-06±9.7e-08	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	CNC1C(O)C(OCC1(C)O)OC1C(N)CC(C(C1O)OC1OC(CCC1N)C(CCNC(=O)c1ccc(c(c1)C(=O)O)c1c2ccc(=[N+](C)C)cc2oc2c1ccc(c2)N(C)C)C)N	-	-	0.834800000000011	904.48148235209	15	9	13	273.49	2	0.066441643296219	5.9404803633512	65	CCCCCGCCACCUUCGGGUGGCCGGGG	10.1021/bi9819428	mRNA	mRNA	26	-	-	0	0	0	0	1.15E-06	1.34E-06	0	0	0	0
2470	CRT	Target_lig_993	TS mRNA Construct_5	Homo sapiens	Cancer	Target_446	0	0	1.3089999999999999e-06±1.28e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	-	-	-2.51049999999999	880.40871133609	17	11	11	327.94	2	0.054746298432302	5.81306542323516	63	CCCCCGCCACCUUCGGGUGGCCGGGG	10.1021/bi9819428	mRNA	mRNA	26	-	-	0	0	0	0	1.18E-06	1.44E-06	0	0	0	0
2471	CRK	Target_lig_1238	TS mRNA Construct_5	Homo sapiens	Cancer	Target_446	0	0	1.482e-06±1.3900000000000001e-07	0	0	0	0	-	-	10.1021/bi9819428	9890899	Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.	Tok JB, Cho J, Rando RR	Biochemistry	38	199-206	1999	1 uM	-	7.4	20	150 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(C(C2N)O)O)N)C(C(C1O)N)O	-	-	-3.5397	896.40362595609	18	12	11	348.17	2	0.051237784361364	5.86078957711484	64	CCCCCGCCACCUUCGGGUGGCCGGGG	10.1021/bi9819428	mRNA	mRNA	26	-	-	0	0	0	0	1.34E-06	1.62E-06	0	0	0	0
2472	Neomycin	Target_lig_4	RRE16	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_447	0	0	5.699999999999999e-07±7e-08	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUCGGCGCAGCUUCGGCUGCGGUAGACC	10.1021/bi990273a	mRNA, Viral RNA	Rev Response Element (RRE)	29	-	Stem-Loop with Bulge	0	0	0	0	5.00E-07	6.40E-07	0	0	0	0
2473	Neomycin	Target_lig_4	RRE17	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_448	0	0	6.3e-07±1.2e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGUGCGCAGCUUCGGCUGCGGUACACC	10.1021/bi990273a	mRNA, Viral RNA	Rev Response Element (RRE)	29	-	Stem-Loop with Bulge	0	0	0	0	5.10E-07	7.50E-07	0	0	0	0
2474	Neomycin	Target_lig_4	RRE18	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_449	0	0	5.1e-07±9e-08	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGCGCGCAGCUUCGGCUGCGGUACACC	10.1021/bi990273a	mRNA, Viral RNA	Rev Response Element (RRE)	29	-	Stem-Loop with Bulge	0	0	0	0	4.20E-07	6.00E-07	0	0	0	0
2475	Neomycin	Target_lig_4	RRE19	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_450	0	0	8.399999999999999e-07±1.7000000000000001e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGACGCAGCUUCGGCUGACUGUACACC	10.1021/bi990273a	mRNA, Viral RNA	Rev Response Element (RRE)	30	-	Stem-Loop with Bulge	0	0	0	0	6.70E-07	1.01E-06	0	0	0	0
2476	Neomycin	Target_lig_4	RRE20	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_451	0	0	3.3999999999999996e-06±8.299999999999999e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGCCGCAGCUUCGGCUGACGGUACACC	10.1021/bi990273a	mRNA, Viral RNA	Rev Response Element (RRE)	30	-	Stem-Loop with Bulge	0	0	0	0	2.57E-06	4.23E-06	0	0	0	0
2477	Neomycin	Target_lig_4	RRE21	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_452	0	0	6e-07±9e-08	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGAGCAGCUUCGGCUGAUGGUACACC	10.1021/bi990273a	mRNA, Viral RNA	Rev Response Element (RRE)	30	-	Stem-Loop with Bulge	0	0	0	0	5.10E-07	6.90E-07	0	0	0	0
2478	Neomycin	Target_lig_4	RRE22	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_453	0	0	4.9e-07±1e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GGUGGGCUCAGCUUCGGCUGACGGUACACC	10.1021/bi990273a	mRNA, Viral RNA	Rev Response Element (RRE)	30	-	Stem-Loop with Bulge	0	0	0	0	3.90E-07	5.90E-07	0	0	0	0
2479	Paromomycin	Target_lig_5	RRE-RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	8.3e-06±1.1e-06	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	7.20E-06	9.40E-06	0	0	0	0
2480	Kanamycin B	Target_lig_1287	RRE-RNA	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_80	0	0	5.6e-06±8.299999999999999e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GCACUAUGGGCGCCAGCGUCAAUGACGCUGACGGUACAGCCAGACAAUUAUUGUCUGGUAUAGUGC	http://www.smmrna.org/	RRE element, Viral RNA	Rev Response Element (RRE)	66	-	-	0	0	0	0	4.77E-06	6.43E-06	0	0	0	0
2481	Paromomycin	Target_lig_5	RRE3	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_83	0	0	2.4999999999999998e-05±2.4999999999999998e-06	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GGUGGGCGCAGCUUCGGCUGCGCCCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	28	-	-	0	0	0	0	2.25E-05	2.75E-05	0	0	0	0
2482	Paromomycin	Target_lig_5	RRE4	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_84	0	0	1.55e-05±3.6e-06	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GGUGGGCGCAGCUUCGGCUGCGGACACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	28	-	-	0	0	0	0	1.19E-05	1.91E-05	0	0	0	0
2483	Paromomycin	Target_lig_5	RRE11	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_91	0	0	1.8699999999999997e-05±3.3999999999999996e-06	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GGUGGGCGCAGCUUCGGCUGCGCAACCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	30	-	-	0	0	0	0	1.53E-05	2.21E-05	0	0	0	0
2484	Kanamycin B	Target_lig_1287	RRE3	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_83	0	0	1.2499999999999999e-05±1.28e-06	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GGUGGGCGCAGCUUCGGCUGCGCCCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	28	-	-	0	0	0	0	1.12E-05	1.38E-05	0	0	0	0
2485	Kanamycin B	Target_lig_1287	RRE4	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_84	0	0	6.3e-06±7.2e-07	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GGUGGGCGCAGCUUCGGCUGCGGACACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	28	-	-	0	0	0	0	5.58E-06	7.02E-06	0	0	0	0
2486	Kanamycin B	Target_lig_1287	RRE11	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_91	0	0	1.33e-05±2.4999999999999998e-06	0	0	0	0	-	-	10.1021/bi990273a	10387102	Specificity in the binding of aminoglycosides to HIV-RRE RNA.	Cho J, Rando RR	Biochemistry	38	8548-54	1999	Varies for each RRE in uM	0-1000 uM	7.5	25	150 mM NaCl, 2 mM MgCl2	Fluorescence anisotropy and intensity measurements	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GGUGGGCGCAGCUUCGGCUGCGCAACCACC	https://pubs.acs.org/doi/pdf/10.1021/bi990273a	RRE element, Viral RNA	Rev Response Element (RRE)	30	-	-	0	0	0	0	1.08E-05	1.58E-05	0	0	0	0
2487	Paromomycin	Target_lig_5	Rnase P RNA	Thermotoga maritima	Bacterial growth and infection	Target_128	0	0.00018999999999999998±1.2e-05	0	0	0	0	0	-	-	10.1073/pnas.96.11.6155	10339557	Inhibition of RNase P RNA cleavage by aminoglycosides.	Mikkelsen NE, Brännvall M, Virtanen A, Kirsebom LA	Proc Natl Acad Sci U S A	96	6155-60	1999	1mM	-	7.2	37	10mM Mg2+ and 1-100mM NH4+	Lead(II)-induced cleavage assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol	4689	-8.86170000000002	615.29630112	19	13	9	347.32	0	0.114375084550252	5.51024454014854	42	GGAGAGGAGCAGGCGGUCGCGGGGGCGCACACCUGCGCUUCCCGAGGAAAGUCCGGACUCUGGAGCGGGGUGCCGGGUAACGCCCGGGAGGGGUGACCCUCGGACAGGGCCAUAGAGAAGAAGACCGCCCGGGGGGAAACUUCCGGGCAAGGGUGGAACGGUGGGGUAAGAGCCCACCAGCGUCGGGGCAACCCGGCGGCUUGGCAACCCCCACCUGGAGCAAGGCCAAGCAGGGGGUUGGGUCGCUCCCCCUAUUCCCCCGGGUUGGCCGCUUGAGGUGUGCGGUAACGCACACCCCAGAUUGAUGACCGCCCACGACAGAAUCCGGCUUAUGCUCCUCUCCCGUG	3Q1R	Ribozyme	Rnase	348	-	-	0	0	0.000178	0.000202	0	0	0	0	0	0
2488	Kanamycin B	Target_lig_1287	Rnase P RNA	Thermotoga maritima	Bacterial growth and infection	Target_128	0	0.00027499999999999996±7.5e-05	0	0	0	0	0	-	-	10.1073/pnas.96.11.6155	10339557	Inhibition of RNase P RNA cleavage by aminoglycosides.	Mikkelsen NE, Brännvall M, Virtanen A, Kirsebom LA	Proc Natl Acad Sci U S A	96	6155-60	1999	1mM	-	7.2	37	10mM Mg2+ and 1-100mM NH4+	Lead(II)-induced cleavage assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol	816	-7.32500000000001	483.254042384	15	11	6	288.4	0	0.167133517937075	5.14878741998465	33	GGAGAGGAGCAGGCGGUCGCGGGGGCGCACACCUGCGCUUCCCGAGGAAAGUCCGGACUCUGGAGCGGGGUGCCGGGUAACGCCCGGGAGGGGUGACCCUCGGACAGGGCCAUAGAGAAGAAGACCGCCCGGGGGGAAACUUCCGGGCAAGGGUGGAACGGUGGGGUAAGAGCCCACCAGCGUCGGGGCAACCCGGCGGCUUGGCAACCCCCACCUGGAGCAAGGCCAAGCAGGGGGUUGGGUCGCUCCCCCUAUUCCCCCGGGUUGGCCGCUUGAGGUGUGCGGUAACGCACACCCCAGAUUGAUGACCGCCCACGACAGAAUCCGGCUUAUGCUCCUCUCCCGUG	3Q1R	Ribozyme	Rnase	348	-	-	0	0	0.0002	0.00035	0	0	0	0	0	0
2489	Neomycin	Target_lig_4	hammerhead ribozyme16	Synthetic	Bacterial growth and infection	Target_115	0	1.35E-05	0	0	0	0	0	-	-	10.1073/pnas.96.11.6155	10339557	Inhibition of RNase P RNA cleavage by aminoglycosides.	Mikkelsen NE, Brännvall M, Virtanen A, Kirsebom LA	Proc Natl Acad Sci U S A	96	6155-60	1999	1mM	-	7.2	37	10mM Mg2+ and 1-100mM NH4+	Lead(II)-induced cleavage assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GCGAUGACCUGAUGAGGCCGAAAGGCCGAAACGUUCCCGGGAACGUCGUCGUCGC	http://www.smmrna.org/	Ribozyme	Group I ribozyme	55	-	-	0	0	1.35E-05	1.35E-05	0	0	0	0	0	0
2490	Neomycin	Target_lig_4	Group I intron	Tetrahymena thermophila	Bacterial growth and infection	Target_23	0	5.00E-07	0	0	0	0	0	-	-	10.1073/pnas.96.11.6155	10339557	Inhibition of RNase P RNA cleavage by aminoglycosides.	Mikkelsen NE, Brännvall M, Virtanen A, Kirsebom LA	Proc Natl Acad Sci U S A	96	6155-60	1999	1mM	-	7.2	37	10mM Mg2+ and 1-100mM NH4+	Lead(II)-induced cleavage assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42	GACCGUCAAAUUGCGGGAAAGGGGUCAACAGCCGUUCAGUACCAAGUCUCAGGGGAAACUUUGAGAUGGCCUUGCAAAGGGUAUGGUAAUAAGCUGACGGACAUGGUCCUAACCACGCAGCCAAGUCCUAAGUCAACAGGAGACUGUUGAUAUGGAUGCAGUUCACAGACUAAAUGUCGGUCGGGGAAGAUGUAUUCUUCUCAUAAGAUAUAGUCGGACCUCUCCCGAAAGGGAGUUGGAGUACUCG	https://www.rcsb.org/structure/1GRZ	mRNA	Group I intron	247	-	-	0	0	5.00E-07	5.00E-07	0	0	0	0	0	0
2491	Neomycin	Target_lig_4	HDV self-cleavage RNA	Homo sapiens	Bacterial growth and infection	Target_454	0	2.80E-05	0	0	0	0	0	-	-	10.1073/pnas.96.11.6155	10339557	Inhibition of RNase P RNA cleavage by aminoglycosides.	Mikkelsen NE, Brännvall M, Virtanen A, Kirsebom LA	Proc Natl Acad Sci U S A	96	6155-60	1999	1mM	-	7.2	37	10mM Mg2+ and 1-100mM NH4+	Lead(II)-induced cleavage assay	Additional	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N	5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol	4454	-8.89530000000002	614.312285532	19	13	9	353.11	0	0.114512756987258	5.54442724269727	42			mRNA, Viral RNA	-	0	-	-	0	0	2.80E-05	2.80E-05	0	0	0	0	0	0
2492	Dimeric naphthyridine derivative	Target_lig_541	RRE RNA construct A	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_457	0	0	0	1.4e-06±9e-08	0	0	0	-	-	10.1016/j.bmcl.2004.10.059	15664866	Specific recognition of napthyridine-based ligands toward guanine-containing bulges in RNA duplexes and RNA-DNA heteroduplexes.	Tok JB, Bi L, Saenz M	Bioorg Med Chem Lett	15	827-31	2005	-	10 nM - 10 uM	7.2	15	1mM MgCl2, 100mM NaCl	Fluorescence measurement	Additional	CC1=NC2=C(C=C1)C=CC(=N2)NC(=O)CCNCCNCCC(=O)NC3=NC4=C(C=CC(=N4)C)C=C3	N-(7-methyl-1,8-naphthyridin-2-yl)-3-[2-[[3-[(7-methyl-1,8-naphthyridin-2-yl)amino]-3-oxopropyl]amino]ethylamino]propanamide	44391261	2.72644	486.2491722	8	4	11	133.82	4	0.237876554269842	2.79001983135679	36	GGCTGGCGCAGCGCTGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	1.31E-06	1.49E-06	0	0
2493	Dimeric naphthyridine derivative	Target_lig_541	RRE RNA construct B	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_458	0	0	0	2.4e-06±1.4e-07	0	0	0	-	-	10.1016/j.bmcl.2004.10.059	15664866	Specific recognition of napthyridine-based ligands toward guanine-containing bulges in RNA duplexes and RNA-DNA heteroduplexes.	Tok JB, Bi L, Saenz M	Bioorg Med Chem Lett	15	827-31	2005	-	10 nM - 10 uM	7.2	15	1mM MgCl2, 100mM NaCl	Fluorescence measurement	Additional	CC1=NC2=C(C=C1)C=CC(=N2)NC(=O)CCNCCNCCC(=O)NC3=NC4=C(C=CC(=N4)C)C=C3	N-(7-methyl-1,8-naphthyridin-2-yl)-3-[2-[[3-[(7-methyl-1,8-naphthyridin-2-yl)amino]-3-oxopropyl]amino]ethylamino]propanamide	44391261	2.72644	486.2491722	8	4	11	133.82	4	0.237876554269842	2.79001983135679	36	GGCTGGCGCAGCGCUGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	2.26E-06	2.54E-06	0	0
2494	Dimeric naphthyridine derivative	Target_lig_541	RRE RNA construct C	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_459	0	0	0	2.8999999999999998e-06±1.8999999999999998e-07	0	0	0	-	-	10.1016/j.bmcl.2004.10.059	15664866	Specific recognition of napthyridine-based ligands toward guanine-containing bulges in RNA duplexes and RNA-DNA heteroduplexes.	Tok JB, Bi L, Saenz M	Bioorg Med Chem Lett	15	827-31	2005	-	10 nM - 10 uM	7.2	15	1mM MgCl2, 100mM NaCl	Fluorescence measurement	Additional	CC1=NC2=C(C=C1)C=CC(=N2)NC(=O)CCNCCNCCC(=O)NC3=NC4=C(C=CC(=N4)C)C=C3	N-(7-methyl-1,8-naphthyridin-2-yl)-3-[2-[[3-[(7-methyl-1,8-naphthyridin-2-yl)amino]-3-oxopropyl]amino]ethylamino]propanamide	44391261	2.72644	486.2491722	8	4	11	133.82	4	0.237876554269842	2.79001983135679	36	GGCUGGCGCAGCGCUGCGGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	24	-	Stem-Loop with Bulge	0	0	0	0	0	0	2.71E-06	3.09E-06	0	0
2495	Dimeric naphthyridine derivative	Target_lig_541	RRE RNA construct I	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_460	0	0	0	3.51e-05±4e-06	0	0	0	-	-	10.1016/j.bmcl.2004.10.059	15664866	Specific recognition of napthyridine-based ligands toward guanine-containing bulges in RNA duplexes and RNA-DNA heteroduplexes.	Tok JB, Bi L, Saenz M	Bioorg Med Chem Lett	15	827-31	2005	-	10 nM - 10 uM	7.2	15	1mM MgCl2, 100mM NaCl	Fluorescence measurement	Additional	CC1=NC2=C(C=C1)C=CC(=N2)NC(=O)CCNCCNCCC(=O)NC3=NC4=C(C=CC(=N4)C)C=C3	N-(7-methyl-1,8-naphthyridin-2-yl)-3-[2-[[3-[(7-methyl-1,8-naphthyridin-2-yl)amino]-3-oxopropyl]amino]ethylamino]propanamide	44391261	2.72644	486.2491722	8	4	11	133.82	4	0.237876554269842	2.79001983135679	36	GGCTGGCGCAGCGCTGCGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	23	-	Stem-Loop with Bulge	0	0	0	0	0	0	3.11E-05	3.91E-05	0	0
2496	Dimeric naphthyridine derivative	Target_lig_541	RRE RNA construct J	Human immunodeficiency virus (HIV-1)	Acquired immunodeficiency syndrome (AIDS)	Target_461	0	0	0	3.23e-05±3.9e-06	0	0	0	-	-	10.1016/j.bmcl.2004.10.059	15664866	Specific recognition of napthyridine-based ligands toward guanine-containing bulges in RNA duplexes and RNA-DNA heteroduplexes.	Tok JB, Bi L, Saenz M	Bioorg Med Chem Lett	15	827-31	2005	-	10 nM - 10 uM	7.2	15	1mM MgCl2, 100mM NaCl	Fluorescence measurement	Additional	CC1=NC2=C(C=C1)C=CC(=N2)NC(=O)CCNCCNCCC(=O)NC3=NC4=C(C=CC(=N4)C)C=C3	N-(7-methyl-1,8-naphthyridin-2-yl)-3-[2-[[3-[(7-methyl-1,8-naphthyridin-2-yl)amino]-3-oxopropyl]amino]ethylamino]propanamide	44391261	2.72644	486.2491722	8	4	11	133.82	4	0.237876554269842	2.79001983135679	36	GGCTGGCGCAGCGCUGCGCAGCC	10.1016/j.bmcl.2004.10.059	mRNA, Viral RNA	Rev Response Element (RRE)	23	-	Stem-Loop with Bulge	0	0	0	0	0	0	2.84E-05	3.62E-05	0	0
2497	Compound (4R,5S)-1	Target_lig_1239	Antiterminator model RNA AM1A	Bacillus subtilis	Bacterial growth and infection	Target_147	0	0	1.2e-05±4.9999999999999996e-06	0	0	0	0	-	-	10.1021/jm2006904	21812425	Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.	Orac CM, Zhou S, Means JA, Boehm D, Bergmeier SC, Hines JV	J Med Chem	54	6786-95	2011	28,50,100 uM	100nM	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET-derived ligand-binding assay	Additional	O=C(Cc1ccccc1)OC[C@H]1OC(=O)NC1CN1CCN(CC1)c1ccccc1	-	-	2.0715	409.200156344	6	1	7	71.11	2	0.706327613887873	3.0944377280843	30	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	mRNA	-	29	-	Internal Loop	0	0	0	0	7.00E-06	1.70E-05	0	0	0	0
2498	Compound (4S,5R)-1	Target_lig_1240	Antiterminator model RNA AM1A	Bacillus subtilis	Bacterial growth and infection	Target_147	0	0	1.6e-05±4.9999999999999996e-06	0	0	0	0	-	-	10.1021/jm2006904	21812425	Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.	Orac CM, Zhou S, Means JA, Boehm D, Bergmeier SC, Hines JV	J Med Chem	54	6786-95	2011	28,50,100 uM	100nM	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET-derived ligand-binding assay	Additional	O=C(Cc1ccccc1)OCC1OC(=O)N[C@H]1CN1CCN(CC1)c1ccccc1	-	-	2.0715	409.200156344	6	1	7	71.11	2	0.706327613887873	3.0944377280843	30	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	mRNA	-	29	-	Internal Loop	0	0	0	0	1.10E-05	2.10E-05	0	0	0	0
2499	Compound (4R,5S)-2	Target_lig_1241	Antiterminator model RNA AM1A	Bacillus subtilis	Bacterial growth and infection	Target_147	0	0	3e-06±1e-06	0	0	0	0	-	-	10.1021/jm2006904	21812425	Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.	Orac CM, Zhou S, Means JA, Boehm D, Bergmeier SC, Hines JV	J Med Chem	54	6786-95	2011	28,50,100 uM	100nM	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET-derived ligand-binding assay	Additional	O=C(Nc1ccc(cc1)C(=O)C)OC[C@H]1OC(=O)NC1CN1CCN(CC1)c1ccccc1	-	-	2.7369	452.205969996	7	2	7	100.21	2	0.623290599021209	3.18499857217595	33	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	mRNA	-	29	-	Internal Loop	0	0	0	0	2.00E-06	4.00E-06	0	0	0	0
2500	Compound (4S,5R)-2	Target_lig_1242	Antiterminator model RNA AM1A	Bacillus subtilis	Bacterial growth and infection	Target_147	0	0	1.6e-06±5e-07	0	0	0	0	-	-	10.1021/jm2006904	21812425	Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.	Orac CM, Zhou S, Means JA, Boehm D, Bergmeier SC, Hines JV	J Med Chem	54	6786-95	2011	28,50,100 uM	100nM	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET-derived ligand-binding assay	Additional	O=C(Nc1ccc(cc1)C(=O)C)OCC1OC(=O)N[C@H]1CN1CCN(CC1)c1ccccc1	-	-	2.7369	452.205969996	7	2	7	100.21	2	0.623290599021209	3.18499857217595	33	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	mRNA	-	29	-	Internal Loop	0	0	0	0	1.10E-06	2.10E-06	0	0	0	0
2501	Compound cis-2	Target_lig_1243	Antiterminator model RNA AM1A	Bacillus subtilis	Bacterial growth and infection	Target_147	0	0	1.8e-06±7e-07	0	0	0	0	-	-	10.1021/jm2006904	21812425	Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.	Orac CM, Zhou S, Means JA, Boehm D, Bergmeier SC, Hines JV	J Med Chem	54	6786-95	2011	28,50,100 uM	100nM	6.5	25	50 mM NaCl, 5 mM MgCl2	FRET-derived ligand-binding assay	Additional	O=C(Nc1ccc(cc1)C(=O)C)OC[C@H]1OC(=O)N[C@H]1CN1CCN(CC1)c1ccccc1	[(4S,5S)-2-oxo-4-[(4-phenylpiperazin-1-yl)methyl]-1,3-oxazolidin-5-yl]methyl N-(4-acetylphenyl)carbamate	54758037	2.7369	452.205969996	7	2	7	100.21	2	0.623290599021209	3.18499857217595	33	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	http://www.smmrna.org/	mRNA	-	29	-	Internal Loop	0	0	0	0	1.10E-06	2.50E-06	0	0	0	0
2502	IRE-03	Target_lig_1288	EV71 SLII RNA	Enterovirus 71	Hand, foot and mouth disease	Target_329	0	0	0	0	0.00004679	0	0	-	-	10.1021/acs.jcim.4c01903	40022654	Identification of Small-Molecule Inhibitors for Enterovirus A71 IRES by Structure-Based Virtual Screening	Wang K, Lee SXY, Jaladanki CK, Ho WS, Chu JJH, Fan H, Chai CLL	J Chem Inf Model	65(6)	3010-3021	2025	100 uL	100 uL	7.5	25	-	Viral plaque reduction assay	Additional	Oc1ccc(c(c1)O)c1n[nH]c(c1c1cnn(c1)c1ccccc1)C	4-[5-methyl-4-(1-phenylpyrazol-4-yl)-1H-pyrazol-3-yl]benzene-1,3-diol	4547259	3.64902	332.127325752	5	3	3	86.96	4	0.534303203870612	2.52031662079203	25	GGAUCAAUAGCAGGUGUGGCACACCAGUCAUACCUUGAUCC	6XB7	Viral RNA	Internal Ribosomal Entry Site (IRES)	41	5’-UTR	Stem-Loop	0	0	0	0	0	0	0	0	0.00004679	0.00004679
2503	IRE-03-3	Target_lig_1289	EV71 SLII RNA	Enterovirus 71	Hand, foot and mouth disease	Target_329	0	0	0	0	0.00001196	0	0	-	-	10.1021/acs.jcim.4c01903	40022654	Identification of Small-Molecule Inhibitors for Enterovirus A71 IRES by Structure-Based Virtual Screening	Wang K, Lee SXY, Jaladanki CK, Ho WS, Chu JJH, Fan H, Chai CLL	J Chem Inf Model	65(6)	3010-3021	2025	100 uL	100 uL	7.5	25	-	Viral plaque reduction assay	Additional	COc1c(OC)ccc(c1O)c1n[nH]c(c1c1cnn(c1)c1ccccc1)C(F)(F)F	2,3-dimethoxy-6-[4-(1-phenylpyrazol-4-yl)-5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol	2210931	4.671	430.125275064	6	2	5	85.19	4	0.480685744660171	2.77539176726287	31	GGAUCAAUAGCAGGUGUGGCACACCAGUCAUACCUUGAUCC	6XB7	Viral RNA	Internal Ribosomal Entry Site (IRES)	41	5’-UTR	Stem-Loop	0	0	0	0	0	0	0	0	0.00001196	0.00001196
2504	CGG Compound 1a	Target_lig_1274	r(CGG)12	Homo sapiens	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0.00000005	0	0	0	0	-	-	10.3390/genes16030278	40149430	Sustained Epigenetic Reactivation in Fragile X Neurons with an RNA-Binding Small Molecule	Kam CW, Dumelie JG, Ciceri G, Yang WY, Disney MD, Studer L, Jaffrey SR	Genes (Basel)	16(3)	278	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Biolayer Interferometry	Additional	Oc1ccc2c(c1)c1c(C)c3c[n+](CCN4CCCCC4)ccc3c(c1[nH]2)C	5,11-dimethyl-2-(2-piperidin-1-ylethyl)-6H-pyrido[4,3-b]carbazol-2-ium-9-ol	432608	4.57014	374.22268893609	2	2	3	43.14	4	0.51598885165364	2.87840241645753	28	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.3390/genes16030278	mRNA	Expanded repeats	36	5’-UTR	Internal loop	0	0	0	0	0.00000005	0.00000005	0	0	0	0
2505	2HE-5Nme	Target_lig_1291	r(CGG)12	Homo sapiens	Fragile X-associated tremor/ataxia syndrome (FXTAS)	Target_169	0	0	0.000000065	0	0	0	0	-	-	10.3390/genes16030278	40149430	Sustained Epigenetic Reactivation in Fragile X Neurons with an RNA-Binding Small Molecule	Kam CW, Dumelie JG, Ciceri G, Yang WY, Disney MD, Studer L, Jaffrey SR	Genes (Basel)	16(3)	278	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Biolayer Interferometry	Additional	NC(=O)CN(C(=O)C(N(C(=O)C(N(C(=O)C(N(C(=O)C(N(C(=O)C(N(C(=O)CNCCCn1nnc(c1)C[n+]1ccc2c(c1)c(C)c1c(c2C)[nH]c2c1cc(O)cc2)C)C)C)C)C)C)C)C)C)C)CCCn1nnc(c1)C[n+]1ccc2c(c1)c(C)c1c(c2C)[nH]c2c1cc(O)cc2	-	-	4.37988000000001	1324.69706923618	16	6	26	318.2	10	0.0323993683865336	6.59903389859957	97	CGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGG	10.3390/genes16030278	mRNA	Expanded repeats	36	5’-UTR	Internal loop	0	0	0	0	0.000000065	0.000000065	0	0	0	0
2506	BI compound 8	Target_lig_1292	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.00000216	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc(c(n1)N)CCN1CCCC(C1)(O)c1nnn(c1)c1ccc2c(c1)nccn2	-	-	1.41722	431.21820642	10	2	5	131.76	4	0.481256195727503	3.56478441629296	32	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.00000216	0.00000216	0	0	0	0
2507	BI compound 1	Target_lig_1293	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.000003677	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	CNCc1cnc(nc1N)C	2-methyl-5-(methylaminomethyl)pyrimidin-4-amine	20607204	0.08662	152.106196384	4	2	2	63.83	1	0.629910781758922	2.51696187475877	11	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000003677	0.000003677	0	0	0	0
2508	BI compound 9	Target_lig_1294	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.0000037	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc(c(n1)N)CN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)cccc2	-	-	2.50342	407.243358548	7	2	5	96.19	3	0.670716498661908	3.22481766309811	30	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.0000037	0.0000037	0	0	0	0
2509	BI compound 2	Target_lig_1295	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.000004525	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	CNCc1ccc2c(c1)nccn2	N-methyl-1-quinoxalin-6-ylmethanamine	26188712	1.3492	173.095297352	3	1	2	37.81	2	0.744503893975691	2.00808266498858	13	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000004525	0.000004525	0	0	0	0
2510	BI compound 10	Target_lig_1296	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.00000289	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	c1cnc2c(n1)cc(cc2)CN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)cccc2	-	-	3.766	428.232459516	6	1	5	70.17	4	0.521905781451381	3.08236673639222	32	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.00000289	0.00000289	0	0	0	0
2511	BI compound 3	Target_lig_1297	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.000018033	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	C1CCN(C1)Cc1ccc2c(c1)nccn2	-	-	2.2256	213.12659748	3	0	2	29.02	2	0.765642623203284	1.88668020611756	16	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000018033	0.000018033	0	0	0	0
2512	BI compound 11	Target_lig_1298	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.0000000164	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)cccc2	-	-	3.44502	445.259008612	6	2	6	85.96	4	0.472870924567554	3.39118493264401	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.0000000164	0.0000000164	0	0	0	0
2513	BI compound 4	Target_lig_1299	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.0000333	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	FC1CCN(C1)Cc1ccc2c(c1)nccn2	-	-	2.1736	231.117175668	3	0	2	29.02	2	0.79284688066562	2.68785334506761	17	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.0000333	0.0000333	0	0	0	0
2514	BI compound 12	Target_lig_1300	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.0000001625	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CC[C@@H](C1)OC1CCN(CC1)c1nc2c([nH]1)cccc2	-	-	3.44502	445.259008612	6	2	6	85.96	4	0.472870924567554	3.39118493264401	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.0000001625	0.0000001625	0	0	0	0
2515	BI compound 5	Target_lig_1301	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.000115933	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	FC1(F)CCN(C1)Cc1ccc2c(c1)nccn2	-	-	2.4708	249.107753856	3	0	2	29.02	2	0.818351276526219	2.43018021889132	18	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000115933	0.000115933	0	0	0	0
2516	BI compound 13	Target_lig_1302	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.0000000088	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)ccnc2	-	-	2.84002	446.25425758	7	2	6	98.85	4	0.469842513435692	3.58223642400979	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.0000000088	0.0000000088	0	0	0	0
2517	BI compound 6	Target_lig_1303	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.00002356	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2	2-methyl-7H-pyrrolo[2,3-d]pyrimidine	11665416	1.26632	133.063997224	2	1	0	41.57	2	0.587513388171808	2.66585398206013	10	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.00002356	0.00002356	0	0	0	0
2518	BI-5232	Target_lig_1304	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.000000001	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)cccn2	5-[2-[3-[1-(1H-imidazo[4,5-b]pyridin-2-yl)piperidin-4-yl]oxypyrrolidin-1-yl]ethyl]-2-methyl-7H-pyrrolo[2,3-d]pyrimidine	172873205	2.84002	446.25425758	7	2	6	98.85	4	0.469842513435692	3.55807064692972	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000000001	0.000000001	0	0	0	0
2519	BI compound 7	Target_lig_1305	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.00000054	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	NCCc1c[nH]c2c1cnc(n2)C	2-(2-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethanamine	82410753	0.76752	176.106196384	3	2	2	67.59	2	0.709702417659778	2.69324806601714	13	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.00000054	0.00000054	0	0	0	0
2520	Thiamine pyrophosphate	Target_lig_1306	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	7.00E-10	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	625 pM, 1,25 nM, 2,5 nM, 5 nM and 10 nM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc2ncc(C[n+]1csc(CCOP(=O)(O)OP(=O)(O)O)c1C)c(N)n2	2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl phosphono hydrogen phosphate	1132	0.84174	425.04441962809	8	4	8	168.97	2	0.351106713608964	3.92226926367972	26	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	7E-10	7E-10	0	0	0	0
2521	BI compound 11	Target_lig_1298	thiM aptamer mutant 1	Escherichia coli	Bacterial growth and infection	Target_462	0	0	0.000000041	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)cccc2	-	-	3.44502	445.259008612	6	2	6	85.96	4	0.472870924567554	3.39118493264401	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGGUCUGGAUAAUGCCAGCGUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000000041	0.000000041	0	0	0	0
2522	BI compound 13	Target_lig_1302	thiM aptamer mutant 1	Escherichia coli	Bacterial growth and infection	Target_462	0	0	0.000000108	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)ccnc2	-	-	2.84002	446.25425758	7	2	6	98.85	4	0.469842513435692	3.58223642400979	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGGUCUGGAUAAUGCCAGCGUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000000108	0.000000108	0	0	0	0
2523	BI-5232	Target_lig_1304	thiM aptamer mutant 1	Escherichia coli	Bacterial growth and infection	Target_462	0	0	0.0000000098	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)cccn2	5-[2-[3-[1-(1H-imidazo[4,5-b]pyridin-2-yl)piperidin-4-yl]oxypyrrolidin-1-yl]ethyl]-2-methyl-7H-pyrrolo[2,3-d]pyrimidine	172873205	2.84002	446.25425758	7	2	6	98.85	4	0.469842513435692	3.55807064692972	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGGUCUGGAUAAUGCCAGCGUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.0000000098	0.0000000098	0	0	0	0
2524	Thiamine pyrophosphate	Target_lig_1306	thiM aptamer mutant 1	Escherichia coli	Bacterial growth and infection	Target_462	0	0	0.000000233	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	625 pM, 1,25 nM, 2,5 nM, 5 nM and 10 nM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc2ncc(C[n+]1csc(CCOP(=O)(O)OP(=O)(O)O)c1C)c(N)n2	2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl phosphono hydrogen phosphate	1132	0.84174	425.04441962809	8	4	8	168.97	2	0.351106713608964	3.92226926367972	26	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGGUCUGGAUAAUGCCAGCGUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000000233	0.000000233	0	0	0	0
2525	BI compound 11	Target_lig_1298	thiM aptamer mutant 2	Escherichia coli	Bacterial growth and infection	Target_463	0	0	6.00E-10	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)cccc2	-	-	3.44502	445.259008612	6	2	6	85.96	4	0.472870924567554	3.39118493264401	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGUUUUGGAUAAUGCCAGCUUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	6E-10	6E-10	0	0	0	0
2526	BI compound 13	Target_lig_1302	thiM aptamer mutant 2	Escherichia coli	Bacterial growth and infection	Target_463	0	0	0.0000000018	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)ccnc2	-	-	2.84002	446.25425758	7	2	6	98.85	4	0.469842513435692	3.58223642400979	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGUUUUGGAUAAUGCCAGCUUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.0000000018	0.0000000018	0	0	0	0
2527	BI-5232	Target_lig_1304	thiM aptamer mutant 2	Escherichia coli	Bacterial growth and infection	Target_463	0	0	0.000000002	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)cccn2	5-[2-[3-[1-(1H-imidazo[4,5-b]pyridin-2-yl)piperidin-4-yl]oxypyrrolidin-1-yl]ethyl]-2-methyl-7H-pyrrolo[2,3-d]pyrimidine	172873205	2.84002	446.25425758	7	2	6	98.85	4	0.469842513435692	3.55807064692972	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGUUUUGGAUAAUGCCAGCUUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000000002	0.000000002	0	0	0	0
2528	Thiamine pyrophosphate	Target_lig_1306	thiM aptamer mutant 2	Escherichia coli	Bacterial growth and infection	Target_463	0	0	0.000000687	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	625 pM, 1,25 nM, 2,5 nM, 5 nM and 10 nM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc2ncc(C[n+]1csc(CCOP(=O)(O)OP(=O)(O)O)c1C)c(N)n2	2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl phosphono hydrogen phosphate	1132	0.84174	425.04441962809	8	4	8	168.97	2	0.351106713608964	3.92226926367972	26	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGUUUUGGAUAAUGCCAGCUUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000000687	0.000000687	0	0	0	0
2529	BI compound 11	Target_lig_1298	thiM aptamer mutant 3	Escherichia coli	Bacterial growth and infection	Target_464	0	0	0.0000000497	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)cccc2	-	-	3.44502	445.259008612	6	2	6	85.96	4	0.472870924567554	3.39118493264401	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGUUCUGGAUAAUGCCAGCGUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.0000000497	0.0000000497	0	0	0	0
2530	BI compound 13	Target_lig_1302	thiM aptamer mutant 3	Escherichia coli	Bacterial growth and infection	Target_464	0	0	0.0000000341	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)ccnc2	-	-	2.84002	446.25425758	7	2	6	98.85	4	0.469842513435692	3.58223642400979	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGUUCUGGAUAAUGCCAGCGUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.0000000341	0.0000000341	0	0	0	0
2531	BI-5232	Target_lig_1304	thiM aptamer mutant 3	Escherichia coli	Bacterial growth and infection	Target_464	0	0	0.0000000025	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	320 nM, 1.6 μM, 8 μM, 40 μM, 200 μM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc2c(n1)[nH]cc2CCN1CCC(C1)OC1CCN(CC1)c1nc2c([nH]1)cccn2	5-[2-[3-[1-(1H-imidazo[4,5-b]pyridin-2-yl)piperidin-4-yl]oxypyrrolidin-1-yl]ethyl]-2-methyl-7H-pyrrolo[2,3-d]pyrimidine	172873205	2.84002	446.25425758	7	2	6	98.85	4	0.469842513435692	3.55807064692972	33	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGUUCUGGAUAAUGCCAGCGUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.0000000025	0.0000000025	0	0	0	0
2532	Thiamine pyrophosphate	Target_lig_1306	thiM aptamer mutant 3	Escherichia coli	Bacterial growth and infection	Target_464	0	0	0.0000022	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	625 pM, 1,25 nM, 2,5 nM, 5 nM and 10 nM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc2ncc(C[n+]1csc(CCOP(=O)(O)OP(=O)(O)O)c1C)c(N)n2	2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl phosphono hydrogen phosphate	1132	0.84174	425.04441962809	8	4	8	168.97	2	0.351106713608964	3.92226926367972	26	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGUUCUGGAUAAUGCCAGCGUAGGGAAGUUC	10.1101/2025.01.21.634073	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.0000022	0.0000022	0	0	0	0
2533	TPP analogue S2	Target_lig_1319	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.000000118	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	625 pM, 1,25 nM, 2,5 nM, 5 nM and 10 nM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	Cc1ncc(c(n1)N)C[n+]1csc(c1C)CCOP(=O)(O)O	2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl dihydrogen phosphate	1131	0.72474	345.07808910609	6	3	6	122.44	2	0.520727898405653	3.38092874180214	22	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000000118	0.000000118	0	0	0	0
2534	TPP analogue S3	Target_lig_1393	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.000002794	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	625 pM, 1,25 nM, 2,5 nM, 5 nM and 10 nM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)O	3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]thiazolium	1131	0.72473	345.34	8	3	6	151	2	0.52072	3.38092	22	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.000002794	0.000002794	0	0	0	0
2535	TPP analogue S5	Target_lig_1321	thiM aptamer	Escherichia coli	Bacterial growth and infection	Target_72	0	0	0.00005996	0	0	0	0	-	-	10.1101/2025.01.21.634073	-	Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch	Hedwig V, Spöring M, Aspnes G, Gottschling D, Klein H, Klugmann M, Kreuz S, Ries B, Schnapp G, Scharsich S, Hartig JS, Hucke O	BioRxiv	-	-	2025	625 pM, 1,25 nM, 2,5 nM, 5 nM and 10 nM	1 uM	7.4	25	10 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	OCCC1=C(C)[NH+](N=N1)Cc1cnc(nc1N)C	-	-	-0.25318	249.14583558409	6	3	4	101.19	1	0.684310226929548	4.68793203537281	18	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	2GDI	RNA aptamer, Riboswitch	Riboswitch	80	5’-UTR	-	0	0	0	0	0.00005996	0.00005996	0	0	0	0
2536	Brc3-preQ1	Target_lig_1322	Tt preQ1 aptamer mutant U22Ap	Thermoanaerobacter tengcongensis	Bacterial growth and infection	Target_465	0	0	0.000000221	0	0	0	0	-	-	10.1038/s41589-024-01801-3	39762536	Engineering covalent small molecule-RNA complexes in living cells	Bereiter R, Flemmich L, Nykiel K, Heel S, Geley S, Hanisch M, Eichler C, Breuker K, Lusser A, Micura R	Nat Chem Biol	21(6)	843-854	2025	100, 200, 500 and 1,000 µM	0	7.5	25	100 mM KCl, 50 mM MOPS, 2mM MgCl2	Fluorescence intensity assay	Additional	BrCCCNCc1c[nH]c2c1c(=O)[nH]c(n2)N	-	-	0.708	299.038172168	4	4	5	99.59	2	0.482444692789491	3.0050656203021	17	CUGGGUCGCAGUAACCCCAGUUAACAAAACAAG	10.1038/s41589-024-01801-3	RNA aptamer, Riboswitch	Riboswitch	33	5’-UTR	-	0	0	0	0	0.000000221	0.000000221	0	0	0	0
2537	PreQ1	Target_lig_331	Fpr-preQ1-III riboswitch	Faecalibacterium prausnitzii	Bacterial growth and infection	Target_466	0	0	1.7399999999999997e-08±5.7e-09	0	0	0	0	-	-	10.1093/nar/gkae886	39413212	Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations	Srivastava Y, Akinyemi O, Rohe TC, Pritchett EM, Baker CD, Sharma A, Jenkins JL, Mathews DH, Wedekind JE	Nucleic Acids Res	52(21)	13152-13173	2024	0.020 M	0	7	25	0.050 M Na-HEPES, 0.10 M NaCl and 0.006 M MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	NCc1c[nH]c2N=C(N)NC(=O)c12	2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one	135398563	-0.7079	179.080709908	4	4	1	113.58	2	0.462740545711741	2.99718975000883	13	GAGCAACUUAGGAUUUUAGGCUCCCCGGCGUGUCUCGAACCAUGCCGGGCCAAACCCAUAGGGCUGGCGGUCCCUGUGCGGUCAAAAUUCAUCCGCCGGAG	4RZD	RNA aptamer, Riboswitch	Riboswitch	101	5’-UTR	-	0	0	0	0	1.7399999999999997e-08±5.7e-09	1.7399999999999997e-08±5.7e-09	0	0	0	0
2538	PreQ1	Target_lig_331	A52G mutant of Fpr-preQ1-III riboswitch	Faecalibacterium prausnitzii	Bacterial growth and infection	Target_467	0	0	9.799999999999998e-09±2e-09	0	0	0	0	-	-	10.1093/nar/gkae886	39413212	Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations	Srivastava Y, Akinyemi O, Rohe TC, Pritchett EM, Baker CD, Sharma A, Jenkins JL, Mathews DH, Wedekind JE	Nucleic Acids Res	52(21)	13152-13173	2024	0.020 M	0	7	25	0.050 M Na-HEPES, 0.10 M NaCl and 0.006 M MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	NCc1c[nH]c2N=C(N)NC(=O)c12	2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one	135398563	-0.7079	179.080709908	4	4	1	113.58	2	0.462740545711741	2.99718975000883	13	GAGCAACUUAGGAUUUUAGGCUCCCCGGCGUGUCUCGAACCAUGCCGGGCCGAACCCAUAGGGCUGGCGGUCCCUGUGCGGUCAAAAUUCAUCCGCCGGAG	4RZD	RNA aptamer, Riboswitch	Riboswitch	101	5’-UTR	-	0	0	0	0	9.799999999999998e-09±2e-09	9.799999999999998e-09±2e-09	0	0	0	0
2539	PreQ1	Target_lig_331	A84G mutant of Fpr-preQ1-III riboswitch	Faecalibacterium prausnitzii	Bacterial growth and infection	Target_468	0	0	2.74e-08±7.4e-09	0	0	0	0	-	-	10.1093/nar/gkae886	39413212	Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations	Srivastava Y, Akinyemi O, Rohe TC, Pritchett EM, Baker CD, Sharma A, Jenkins JL, Mathews DH, Wedekind JE	Nucleic Acids Res	52(21)	13152-13173	2024	0.020 M	0	7	25	0.050 M Na-HEPES, 0.10 M NaCl and 0.006 M MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	NCc1c[nH]c2N=C(N)NC(=O)c12	2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one	135398563	-0.7079	179.080709908	4	4	1	113.58	2	0.462740545711741	2.99718975000883	13	GAGCAACUUAGGAUUUUAGGCUCCCCGGCGUGUCUCGAACCAUGCCGGGCCAAACCCAUAGGGCUGGCGGUCCCUGUGCGGUCGAAAUUCAUCCGCCGGAG	4RZD	RNA aptamer, Riboswitch	Riboswitch	101	5’-UTR	-	0	0	0	0	0.00000002	0.0000000348	0	0	0	0
2540	PreQ1	Target_lig_331	Del84 mutant of Fpr-preQ1-III riboswitch	Faecalibacterium prausnitzii	Bacterial growth and infection	Target_469	0	0	3.82e-08±2.8e-09	0	0	0	0	-	-	10.1093/nar/gkae886	39413212	Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations	Srivastava Y, Akinyemi O, Rohe TC, Pritchett EM, Baker CD, Sharma A, Jenkins JL, Mathews DH, Wedekind JE	Nucleic Acids Res	52(21)	13152-13173	2024	0.020 M	0	7	25	0.050 M Na-HEPES, 0.10 M NaCl and 0.006 M MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	NCc1c[nH]c2N=C(N)NC(=O)c12	2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one	135398563	-0.7079	179.080709908	4	4	1	113.58	2	0.462740545711741	2.99718975000883	13	GAGCAACUUAGGAUUUUAGGCUCCCCGGCGUGUCUCGAACCAUGCCGGGCCAAACCCAUAGGGCUGGCGGUCCCUGUGCGGUCAAAUUCAUCCGCCGGAG	4RZD	RNA aptamer, Riboswitch	Riboswitch	100	5’-UTR	-	0	0	0	0	0.0000000354	0.000000041	0	0	0	0
2541	PreQ1	Target_lig_331	U8C/A85G mutant of Fpr-preQ1-III riboswitch	Faecalibacterium prausnitzii	Bacterial growth and infection	Target_470	0	0	2.31e-08±1.2999999999999999e-08	0	0	0	0	-	-	10.1093/nar/gkae886	39413212	Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations	Srivastava Y, Akinyemi O, Rohe TC, Pritchett EM, Baker CD, Sharma A, Jenkins JL, Mathews DH, Wedekind JE	Nucleic Acids Res	52(21)	13152-13173	2024	0.020 M	0	7	25	0.050 M Na-HEPES, 0.10 M NaCl and 0.006 M MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	NCc1c[nH]c2N=C(N)NC(=O)c12	2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one	135398563	-0.7079	179.080709908	4	4	1	113.58	2	0.462740545711741	2.99718975000883	13	GAGCAACCUAGGAUUUUAGGCUCCCCGGCGUGUCUCGAACCAUGCCGGGCCAAACCCAUAGGGCUGGCGGUCCCUGUGCGGUCAGAAUUCAUCCGCCGGAG	4RZD	RNA aptamer, Riboswitch	Riboswitch	101	5’-UTR	-	0	0	0	0	0.0000000101	0.0000000361	0	0	0	0
2542	PreQ1	Target_lig_331	Sva-preQ1-III riboswitch	Subdoligranulum variabile	Bacterial growth and infection	Target_471	0	0	0	0	2.25e-08±4.5e-09	0	0	-	-	10.1093/nar/gkae886	39413212	Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations	Srivastava Y, Akinyemi O, Rohe TC, Pritchett EM, Baker CD, Sharma A, Jenkins JL, Mathews DH, Wedekind JE	Nucleic Acids Res	52(21)	13152-13173	2024	0.020 M	0	7	25	0.050 M Na-HEPES, 0.10 M NaCl and 0.006 M MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	NCc1c[nH]c2N=C(N)NC(=O)c12	2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one	135398563	-0.7079	179.080709908	4	4	1	113.58	2	0.462740545711741	2.99718975000883	13	AAGGCUCGUAUAAUCAUUUUAUUGAGCAACUUAGGAUUUUAGGCUCCGCCGCGAAAGCGGCGCAAACCGGUGUCAGUCUUCGGUCUGGCAUGCGGUCAAAAUCUAUCCGAAGGAGGUAAUAUUAUAUGCUGAUGAUUACGCC	10.1093/nar/gkae886	RNA aptamer, Riboswitch	Riboswitch	142	5’-UTR	-	0	0	0	0	0	0	0	0	0.000000018	0.000000027
2543	PreQ1	Target_lig_331	A52G mutant of Sva-preQ1-III riboswitch	Subdoligranulum variabile	Bacterial growth and infection	Target_472	0	0	0	0	4.001e-07±2.521e-07	0	0	-	-	10.1093/nar/gkae886	39413212	Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations	Srivastava Y, Akinyemi O, Rohe TC, Pritchett EM, Baker CD, Sharma A, Jenkins JL, Mathews DH, Wedekind JE	Nucleic Acids Res	52(21)	13152-13173	2024	0.020 M	0	7	25	0.050 M Na-HEPES, 0.10 M NaCl and 0.006 M MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	NCc1c[nH]c2N=C(N)NC(=O)c12	2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one	135398563	-0.7079	179.080709908	4	4	1	113.58	2	0.462740545711741	2.99718975000883	13	AAGGCUCGUAUAAUCAUUUUAUUGAGCAACUUAGGAUUUUAGGCUCCGCCGCGAAAGCGGCGCAGACCGGUGUCAGUCUUCGGUCUGGCAUGCGGUCAAAAUCUAUCCGAAGGAGGUAAUAUUAUAUGCUGAUGAUUACGCC	10.1093/nar/gkae886	RNA aptamer, Riboswitch	Riboswitch	142	5’-UTR	-	0	0	0	0	0	0	0	0	0.000000148	0.0000006522
2544	PreQ1	Target_lig_331	A84G mutant of Sva-preQ1-III riboswitch	Subdoligranulum variabile	Bacterial growth and infection	Target_473	0	0	0	0	8.847e-07±5.064999999999999e-07	0	0	-	-	10.1093/nar/gkae886	39413212	Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations	Srivastava Y, Akinyemi O, Rohe TC, Pritchett EM, Baker CD, Sharma A, Jenkins JL, Mathews DH, Wedekind JE	Nucleic Acids Res	52(21)	13152-13173	2024	0.020 M	0	7	25	0.050 M Na-HEPES, 0.10 M NaCl and 0.006 M MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	NCc1c[nH]c2N=C(N)NC(=O)c12	2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one	135398563	-0.7079	179.080709908	4	4	1	113.58	2	0.462740545711741	2.99718975000883	13	AAGGCUCGUAUAAUCAUUUUAUUGAGCAACUUAGGAUUUUAGGCUCCGCCGCGAAAGCGGCGCAAACCGGUGUCAGUCUUCGGUCUGGCAUGCGGUCGAAAUCUAUCCGAAGGAGGUAAUAUUAUAUGCUGAUGAUUACGCC	10.1093/nar/gkae886	RNA aptamer, Riboswitch	Riboswitch	142	5’-UTR	-	0	0	0	0	0	0	0	0	0.0000003782	0.0000013912
2545	PreQ1	Target_lig_331	Del84 mutant of Sva-preQ1-III riboswitch	Subdoligranulum variabile	Bacterial growth and infection	Target_474	0	0	0	0	1.9459999999999997e-06±6.624999999999999e-07	0	0	-	-	10.1093/nar/gkae886	39413212	Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations	Srivastava Y, Akinyemi O, Rohe TC, Pritchett EM, Baker CD, Sharma A, Jenkins JL, Mathews DH, Wedekind JE	Nucleic Acids Res	52(21)	13152-13173	2024	0.020 M	0	7	25	0.050 M Na-HEPES, 0.10 M NaCl and 0.006 M MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	NCc1c[nH]c2N=C(N)NC(=O)c12	2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one	135398563	-0.7079	179.080709908	4	4	1	113.58	2	0.462740545711741	2.99718975000883	13	AAGGCUCGUAUAAUCAUUUUAUUGAGCAACUUAGGAUUUUAGGCUCCGCCGCGAAAGCGGCGCAAACCGGUGUCAGUCUUCGGUCUGGCAUGCGGUCAAAUCUAUCCGAAGGAGGUAAUAUUAUAUGCUGAUGAUUACGCC	10.1093/nar/gkae886	RNA aptamer, Riboswitch	Riboswitch	141	5’-UTR	-	0	0	0	0	0	0	0	0	0.0000012835	0.0000026085
2546	PreQ1	Target_lig_331	U8C/A85G mutant of Sva-preQ1-III riboswitch	Subdoligranulum variabile	Bacterial growth and infection	Target_475	0	0	0	0	8.03e-08±4.55e-08	0	0	-	-	10.1093/nar/gkae886	39413212	Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations	Srivastava Y, Akinyemi O, Rohe TC, Pritchett EM, Baker CD, Sharma A, Jenkins JL, Mathews DH, Wedekind JE	Nucleic Acids Res	52(21)	13152-13173	2024	0.020 M	0	7	25	0.050 M Na-HEPES, 0.10 M NaCl and 0.006 M MgCl2	Isothermal Titration Calorimetry (ITC)	Additional	NCc1c[nH]c2N=C(N)NC(=O)c12	2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one	135398563	-0.7079	179.080709908	4	4	1	113.58	2	0.462740545711741	2.99718975000883	13	AAGGCUCGUAUAAUCAUUUUAUUGAGCAACCUAGGAUUUUAGGCUCCGCCGCGAAAGCGGCGCAAACCGGUGUCAGUCUUCGGUCUGGCAUGCGGUCAGAAUCUAUCCGAAGGAGGUAAUAUUAUAUGCUGAUGAUUACGCC	10.1093/nar/gkae886	RNA aptamer, Riboswitch	Riboswitch	142	5’-UTR	-	0	0	0	0	0	0	0	0	0.0000000348	0.0000001258
2547	Synthetic M1 (M1syn)	Target_lig_1333	Rnase P RNA	Methanobrevibacter smithii	Bacterial growth and infection	Target_476	0	1.7e-05±1e-06	0	0	0	0	0	-	-	10.1093/nar/gkae1190	39676671	Use of a small molecule microarray screen to identify inhibitors of the catalytic RNA subunit of Methanobrevibacter smithii RNase P	Sidharthan V, Sibley CD, Dunne-Dombrink K, Yang M, Zahurancik WJ, Balaratnam S, Wilburn DB, Schneekloth JS Jr, Gopalan V	Nucleic Acids Res	53(1)	gkae1190	2025	5-100 uM	1 uM	7.5	22	50 mM Tris-HCl, 2 M ammonium acetate, 400 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	COc1ccccc1[C@@]1(O)C[C@H](N[C@H](C1C)c1ccc(cc1)C)c1ccc(cc1)C	-	-	5.61164000000001	401.235479232	3	2	4	41.49	3	0.5968329582781	3.50350254552924	30	GCAAGUUAAAGACAGCUGUUGGUUUUUUUAACUAAGGAAACUCCGCCCAUCAUUACAGACUAUGGCGUUGAAAAACGUAUACUGAGAAGUAUGACUCUGGAGCAGAAACGACACGUCUUUUAAUGGUUGACUAUGAUAUUUAAUUGAGGACAUUAAAAGAAUCGGUGAAACGGCCAUUCCAUAGGAUGCAAGAACAAAGAAUGCUGAUGAUUACUGUAUGAGGCAAAAGUAGUUCGCUAAGAUGAAUGCUGUUAAACAGAAGGUGGGUUACUCUUAACAUGC	URS00006629AA	Ribozyme	-	282	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0.000016	0.000018	0	0	0	0	0	0
2548	M1-ethyl	Target_lig_1334	Rnase P RNA	Methanobrevibacter smithii	Bacterial growth and infection	Target_476	0	0.000206±1.7e-05	0	0	0	0	0	-	-	10.1093/nar/gkae1190	39676671	Use of a small molecule microarray screen to identify inhibitors of the catalytic RNA subunit of Methanobrevibacter smithii RNase P	Sidharthan V, Sibley CD, Dunne-Dombrink K, Yang M, Zahurancik WJ, Balaratnam S, Wilburn DB, Schneekloth JS Jr, Gopalan V	Nucleic Acids Res	53(1)	gkae1190	2025	5-100 uM	1 uM	7.5	22	50 mM Tris-HCl, 2 M ammonium acetate, 400 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	COc1ccccc1C1(O)CC(NC(C1CC)c1ccc(cc1)C)c1ccc(cc1)C	-	-	6.00174000000001	415.251129296	3	2	5	41.49	3	0.536774604481385	3.54023315016556	31	GCAAGUUAAAGACAGCUGUUGGUUUUUUUAACUAAGGAAACUCCGCCCAUCAUUACAGACUAUGGCGUUGAAAAACGUAUACUGAGAAGUAUGACUCUGGAGCAGAAACGACACGUCUUUUAAUGGUUGACUAUGAUAUUUAAUUGAGGACAUUAAAAGAAUCGGUGAAACGGCCAUUCCAUAGGAUGCAAGAACAAAGAAUGCUGAUGAUUACUGUAUGAGGCAAAAGUAGUUCGCUAAGAUGAAUGCUGUUAAACAGAAGGUGGGUUACUCUUAACAUGC	URS00006629AA	Ribozyme	-	282	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0.000189	0.000223	0	0	0	0	0	0
2549	M1-desMe	Target_lig_1335	Rnase P RNA	Methanobrevibacter smithii	Bacterial growth and infection	Target_476	0	0.000102±2.2e-05	0	0	0	0	0	-	-	10.1093/nar/gkae1190	39676671	Use of a small molecule microarray screen to identify inhibitors of the catalytic RNA subunit of Methanobrevibacter smithii RNase P	Sidharthan V, Sibley CD, Dunne-Dombrink K, Yang M, Zahurancik WJ, Balaratnam S, Wilburn DB, Schneekloth JS Jr, Gopalan V	Nucleic Acids Res	53(1)	gkae1190	2025	5-100 uM	1 uM	7.5	22	50 mM Tris-HCl, 2 M ammonium acetate, 400 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	COc1ccccc1[C@]1(O)C[C@@H](N[C@@H](C1)c1ccc(cc1)C)c1ccc(cc1)C	-	-	5.36564	387.219829168	3	2	4	41.49	3	0.632664327611797	3.33324214769729	29	GCAAGUUAAAGACAGCUGUUGGUUUUUUUAACUAAGGAAACUCCGCCCAUCAUUACAGACUAUGGCGUUGAAAAACGUAUACUGAGAAGUAUGACUCUGGAGCAGAAACGACACGUCUUUUAAUGGUUGACUAUGAUAUUUAAUUGAGGACAUUAAAAGAAUCGGUGAAACGGCCAUUCCAUAGGAUGCAAGAACAAAGAAUGCUGAUGAUUACUGUAUGAGGCAAAAGUAGUUCGCUAAGAUGAAUGCUGUUAAACAGAAGGUGGGUUACUCUUAACAUGC	URS00006629AA	Ribozyme	-	282	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0.00008	0.000124	0	0	0	0	0	0
2550	M1comm	Target_lig_1336	Rnase P RNA	Methanobrevibacter smithii	Bacterial growth and infection	Target_476	0	4.9e-05±1.3e-05	0	0	0	0	0	-	-	10.1093/nar/gkae1190	39676671	Use of a small molecule microarray screen to identify inhibitors of the catalytic RNA subunit of Methanobrevibacter smithii RNase P	Sidharthan V, Sibley CD, Dunne-Dombrink K, Yang M, Zahurancik WJ, Balaratnam S, Wilburn DB, Schneekloth JS Jr, Gopalan V	Nucleic Acids Res	53(1)	gkae1190	2025	5-100 uM	1 uM	7.5	22	50 mM Tris-HCl, 2 M ammonium acetate, 400 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	COc1ccccc1C1(O)CC(NC(C1C)c1ccc(cc1)C)c1ccc(cc1)C	4-(2-methoxyphenyl)-3-methyl-2,6-bis(4-methylphenyl)piperidin-4-ol	2888898	5.61164000000001	401.235479232	3	2	4	41.49	3	0.5968329582781	3.50350254552924	30	GCAAGUUAAAGACAGCUGUUGGUUUUUUUAACUAAGGAAACUCCGCCCAUCAUUACAGACUAUGGCGUUGAAAAACGUAUACUGAGAAGUAUGACUCUGGAGCAGAAACGACACGUCUUUUAAUGGUUGACUAUGAUAUUUAAUUGAGGACAUUAAAAGAAUCGGUGAAACGGCCAUUCCAUAGGAUGCAAGAACAAAGAAUGCUGAUGAUUACUGUAUGAGGCAAAAGUAGUUCGCUAAGAUGAAUGCUGUUAAACAGAAGGUGGGUUACUCUUAACAUGC	URS00006629AA	Ribozyme	-	282	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0.000036	0.000062	0	0	0	0	0	0
2551	M1-desMe-N-allyl	Target_lig_1337	Rnase P RNA	Methanobrevibacter smithii	Bacterial growth and infection	Target_476	0	0.000329±5.9e-05	0	0	0	0	0	-	-	10.1093/nar/gkae1190	39676671	Use of a small molecule microarray screen to identify inhibitors of the catalytic RNA subunit of Methanobrevibacter smithii RNase P	Sidharthan V, Sibley CD, Dunne-Dombrink K, Yang M, Zahurancik WJ, Balaratnam S, Wilburn DB, Schneekloth JS Jr, Gopalan V	Nucleic Acids Res	53(1)	gkae1190	2025	5-100 uM	1 uM	7.5	22	50 mM Tris-HCl, 2 M ammonium acetate, 400 mM MgCl2	Surface Plasmon Resonance (SPR)	Additional	C=CCN1[C@H](C[C@@](C[C@H]1c1ccc(cc1)C)(O)c1ccccc1OC)c1ccc(cc1)C	-	-	6.26404000000001	427.251129296	3	1	6	32.7	3	0.471089226472843	3.53590854357531	32	GCAAGUUAAAGACAGCUGUUGGUUUUUUUAACUAAGGAAACUCCGCCCAUCAUUACAGACUAUGGCGUUGAAAAACGUAUACUGAGAAGUAUGACUCUGGAGCAGAAACGACACGUCUUUUAAUGGUUGACUAUGAUAUUUAAUUGAGGACAUUAAAAGAAUCGGUGAAACGGCCAUUCCAUAGGAUGCAAGAACAAAGAAUGCUGAUGAUUACUGUAUGAGGCAAAAGUAGUUCGCUAAGAUGAAUGCUGUUAAACAGAAGGUGGGUUACUCUUAACAUGC	URS00006629AA	Ribozyme	-	282	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0.00027	0.000388	0	0	0	0	0	0
2552	DMZ-P5	Target_lig_1338	MALAT1 G-quadruplex G1	Homo sapiens	Cancer	Target_477	0	0	0	0	0	0	0.0000172	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	Clc1ccc(cc1)CNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCc1ccc(cc1)Cl	N'-[(4-chlorophenyl)methyl]-4-[2-[4-[N'-[(4-chlorophenyl)methyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	169205691	7.33454000000001	529.15484916	4	5	9	108.51	4	0.0676404254236566	2.90009025878217	37	GGCGGUGCUUGAAGGGGAGGGAAAGGGGGAAAGCGGGCAACCACUUUUC	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2553	DMZ-P8	Target_lig_1339	MALAT1 G-quadruplex G1	Homo sapiens	Cancer	Target_477	0	0	0	0	0	0	0.0000069	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NC1CCN(CC1)Cc1ccccc1)NC1CCN(CC1)Cc1ccccc1	N'-(1-benzylpiperidin-4-yl)-4-[2-[4-[N'-(1-benzylpiperidin-4-yl)carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271104	6.95654000000001	627.37979244	6	5	11	114.99	4	0.0534114269747732	3.09720222304256	47	GGCGGUGCUUGAAGGGGAGGGAAAGGGGGAAAGCGGGCAACCACUUUUC	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2554	DMZ-P8Cl	Target_lig_1340	MALAT1 G-quadruplex G1	Homo sapiens	Cancer	Target_477	0	0	0	0	0	0	0.0000233	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	Clc1ccc(cc1)CN1CCC(CC1)NC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NC1CCN(CC1)Cc1ccc(cc1)Cl	-	-	8.26334000000001	695.301847736	6	5	11	114.99	4	0.0469072335067548	3.19884932951034	49	GGCGGUGCUUGAAGGGGAGGGAAAGGGGGAAAGCGGGCAACCACUUUUC	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2555	DMZ-P9	Target_lig_1341	MALAT1 G-quadruplex G1	Homo sapiens	Cancer	Target_477	0	0	0	0	0	0	0.0000049	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCN1CCNCC1)NCCN1CCNCC1	N'-(2-piperazin-1-ylethyl)-4-[2-[4-[N'-(2-piperazin-1-ylethyl)carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271108	1.43774	505.338990248	8	7	11	139.05	2	0.106134940284456	3.31170520150043	37	GGCGGUGCUUGAAGGGGAGGGAAAGGGGGAAAGCGGGCAACCACUUUUC	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2556	DMZ-P13	Target_lig_1342	MALAT1 G-quadruplex G1	Homo sapiens	Cancer	Target_477	0	0	0	0	0	0	0.0000016	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCC1CCN(CC1)Cc1ccccc1)NCCC1CCN(CC1)Cc1ccccc1	N'-[2-(1-benzylpiperidin-4-yl)ethyl]-4-[2-[4-[N'-[2-(1-benzylpiperidin-4-yl)ethyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271115	8.23194000000001	683.442392696	6	5	15	114.99	4	0.0374956929145835	3.2691072143013	51	GGCGGUGCUUGAAGGGGAGGGAAAGGGGGAAAGCGGGCAACCACUUUUC	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2557	DMZ-P14	Target_lig_1343	MALAT1 G-quadruplex G1	Homo sapiens	Cancer	Target_477	0	0	0	0	0	0	0.0000724	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CCN(Cc1ccccc1)CCCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCCN(Cc1ccccc1)CC	-	-	7.45174000000001	631.411092568	6	5	19	114.99	4	0.0242463538137001	3.21603404091224	47	GGCGGUGCUUGAAGGGGAGGGAAAGGGGGAAAGCGGGCAACCACUUUUC	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2558	DMZ-M1	Target_lig_1344	MALAT1 G-quadruplex G1	Homo sapiens	Cancer	Target_477	0	0	0	0	0	0	0.0000019	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CN(CCCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCCN(C)C)C	N'-[3-(dimethylamino)propyl]-4-[2-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	169205715	3.53074	451.317192184	6	5	13	114.99	2	0.105059958363125	3.16767082207306	33	GGCGGUGCUUGAAGGGGAGGGAAAGGGGGAAAGCGGGCAACCACUUUUC	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2559	DMZ-M10	Target_lig_1345	MALAT1 G-quadruplex G1	Homo sapiens	Cancer	Target_477	0	0	0	0	0	0	0.0000121	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CN1CCN(CC1)CCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCN1CCN(CC1)C	-	-	2.12214	533.370290376	8	5	11	121.47	2	0.129844068859688	3.19459203332327	39	GGCGGUGCUUGAAGGGGAGGGAAAGGGGGAAAGCGGGCAACCACUUUUC	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2560	DMZ-P5	Target_lig_1338	MALAT1 G-quadruplex G2	Homo sapiens	Cancer	Target_478	0	0	0	0	0	0	0.0000051	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	Clc1ccc(cc1)CNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCc1ccc(cc1)Cl	N'-[(4-chlorophenyl)methyl]-4-[2-[4-[N'-[(4-chlorophenyl)methyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	169205691	7.33454000000001	529.15484916	4	5	9	108.51	4	0.0676404254236566	2.90009025878217	37	GCUGGAAUUUGGAGGGAUGGGAGGAGGGGGUGGGGCUUACUUGUUGU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	47	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2561	DMZ-P8	Target_lig_1339	MALAT1 G-quadruplex G2	Homo sapiens	Cancer	Target_478	0	0	0	0	0	0	0.0000089	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NC1CCN(CC1)Cc1ccccc1)NC1CCN(CC1)Cc1ccccc1	N'-(1-benzylpiperidin-4-yl)-4-[2-[4-[N'-(1-benzylpiperidin-4-yl)carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271104	6.95654000000001	627.37979244	6	5	11	114.99	4	0.0534114269747732	3.09720222304256	47	GCUGGAAUUUGGAGGGAUGGGAGGAGGGGGUGGGGCUUACUUGUUGU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	47	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2562	DMZ-P8Cl	Target_lig_1340	MALAT1 G-quadruplex G2	Homo sapiens	Cancer	Target_478	0	0	0	0	0	0	0.0000335	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	Clc1ccc(cc1)CN1CCC(CC1)NC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NC1CCN(CC1)Cc1ccc(cc1)Cl	-	-	8.26334000000001	695.301847736	6	5	11	114.99	4	0.0469072335067548	3.19884932951034	49	GCUGGAAUUUGGAGGGAUGGGAGGAGGGGGUGGGGCUUACUUGUUGU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	47	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2563	DMZ-P9	Target_lig_1341	MALAT1 G-quadruplex G2	Homo sapiens	Cancer	Target_478	0	0	0	0	0	0	0.0000258	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCN1CCNCC1)NCCN1CCNCC1	N'-(2-piperazin-1-ylethyl)-4-[2-[4-[N'-(2-piperazin-1-ylethyl)carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271108	1.43774	505.338990248	8	7	11	139.05	2	0.106134940284456	3.31170520150043	37	GCUGGAAUUUGGAGGGAUGGGAGGAGGGGGUGGGGCUUACUUGUUGU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	47	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2564	DMZ-P13	Target_lig_1342	MALAT1 G-quadruplex G2	Homo sapiens	Cancer	Target_478	0	0	0	0	0	0	0.0000019	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCC1CCN(CC1)Cc1ccccc1)NCCC1CCN(CC1)Cc1ccccc1	N'-[2-(1-benzylpiperidin-4-yl)ethyl]-4-[2-[4-[N'-[2-(1-benzylpiperidin-4-yl)ethyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271115	8.23194000000001	683.442392696	6	5	15	114.99	4	0.0374956929145835	3.2691072143013	51	GCUGGAAUUUGGAGGGAUGGGAGGAGGGGGUGGGGCUUACUUGUUGU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	47	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2565	DMZ-P14	Target_lig_1343	MALAT1 G-quadruplex G2	Homo sapiens	Cancer	Target_478	0	0	0	0	0	0	0.0000305	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CCN(Cc1ccccc1)CCCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCCN(Cc1ccccc1)CC	-	-	7.45174000000001	631.411092568	6	5	19	114.99	4	0.0242463538137001	3.21603404091224	47	GCUGGAAUUUGGAGGGAUGGGAGGAGGGGGUGGGGCUUACUUGUUGU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	47	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2566	DMZ-M1	Target_lig_1344	MALAT1 G-quadruplex G2	Homo sapiens	Cancer	Target_478	0	0	0	0	0	0	0.0000035	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CN(CCCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCCN(C)C)C	N'-[3-(dimethylamino)propyl]-4-[2-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	169205715	3.53074	451.317192184	6	5	13	114.99	2	0.105059958363125	3.16767082207306	33	GCUGGAAUUUGGAGGGAUGGGAGGAGGGGGUGGGGCUUACUUGUUGU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	47	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2567	DMZ-M10	Target_lig_1345	MALAT1 G-quadruplex G2	Homo sapiens	Cancer	Target_478	0	0	0	0	0	0	0.0000145	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CN1CCN(CC1)CCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCN1CCN(CC1)C	-	-	2.12214	533.370290376	8	5	11	121.47	2	0.129844068859688	3.19459203332327	39	GCUGGAAUUUGGAGGGAUGGGAGGAGGGGGUGGGGCUUACUUGUUGU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	47	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2568	DMZ-P5	Target_lig_1338	MALAT1 G-quadruplex G3	Homo sapiens	Cancer	Target_479	0	0	0	0	0	0	0.0000009	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	Clc1ccc(cc1)CNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCc1ccc(cc1)Cl	N'-[(4-chlorophenyl)methyl]-4-[2-[4-[N'-[(4-chlorophenyl)methyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	169205691	7.33454000000001	529.15484916	4	5	9	108.51	4	0.0676404254236566	2.90009025878217	37	GUGACCUUAUAUAGGGAAGGGAGGGGGUGCCUGUGGGGUUUUAAAGAAU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2569	DMZ-P8	Target_lig_1339	MALAT1 G-quadruplex G3	Homo sapiens	Cancer	Target_479	0	0	0	0	0	0	0.0000019	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NC1CCN(CC1)Cc1ccccc1)NC1CCN(CC1)Cc1ccccc1	N'-(1-benzylpiperidin-4-yl)-4-[2-[4-[N'-(1-benzylpiperidin-4-yl)carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271104	6.95654000000001	627.37979244	6	5	11	114.99	4	0.0534114269747732	3.09720222304256	47	GUGACCUUAUAUAGGGAAGGGAGGGGGUGCCUGUGGGGUUUUAAAGAAU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2570	DMZ-P8Cl	Target_lig_1340	MALAT1 G-quadruplex G3	Homo sapiens	Cancer	Target_479	0	0	0	0	0	0	0.0000062	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	Clc1ccc(cc1)CN1CCC(CC1)NC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NC1CCN(CC1)Cc1ccc(cc1)Cl	-	-	8.26334000000001	695.301847736	6	5	11	114.99	4	0.0469072335067548	3.19884932951034	49	GUGACCUUAUAUAGGGAAGGGAGGGGGUGCCUGUGGGGUUUUAAAGAAU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2571	DMZ-P9	Target_lig_1341	MALAT1 G-quadruplex G3	Homo sapiens	Cancer	Target_479	0	0	0	0	0	0	0.0000011	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCN1CCNCC1)NCCN1CCNCC1	N'-(2-piperazin-1-ylethyl)-4-[2-[4-[N'-(2-piperazin-1-ylethyl)carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271108	1.43774	505.338990248	8	7	11	139.05	2	0.106134940284456	3.31170520150043	37	GUGACCUUAUAUAGGGAAGGGAGGGGGUGCCUGUGGGGUUUUAAAGAAU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2572	DMZ-P13	Target_lig_1342	MALAT1 G-quadruplex G3	Homo sapiens	Cancer	Target_479	0	0	0	0	0	0	0.0000004	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCC1CCN(CC1)Cc1ccccc1)NCCC1CCN(CC1)Cc1ccccc1	N'-[2-(1-benzylpiperidin-4-yl)ethyl]-4-[2-[4-[N'-[2-(1-benzylpiperidin-4-yl)ethyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271115	8.23194000000001	683.442392696	6	5	15	114.99	4	0.0374956929145835	3.2691072143013	51	GUGACCUUAUAUAGGGAAGGGAGGGGGUGCCUGUGGGGUUUUAAAGAAU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2573	DMZ-P14	Target_lig_1343	MALAT1 G-quadruplex G3	Homo sapiens	Cancer	Target_479	0	0	0	0	0	0	0.0000025	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CCN(Cc1ccccc1)CCCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCCN(Cc1ccccc1)CC	-	-	7.45174000000001	631.411092568	6	5	19	114.99	4	0.0242463538137001	3.21603404091224	47	GUGACCUUAUAUAGGGAAGGGAGGGGGUGCCUGUGGGGUUUUAAAGAAU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2574	DMZ-M1	Target_lig_1344	MALAT1 G-quadruplex G3	Homo sapiens	Cancer	Target_479	0	0	0	0	0	0	0.0000011	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CN(CCCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCCN(C)C)C	N'-[3-(dimethylamino)propyl]-4-[2-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	169205715	3.53074	451.317192184	6	5	13	114.99	2	0.105059958363125	3.16767082207306	33	GUGACCUUAUAUAGGGAAGGGAGGGGGUGCCUGUGGGGUUUUAAAGAAU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2575	DMZ-M10	Target_lig_1345	MALAT1 G-quadruplex G3	Homo sapiens	Cancer	Target_479	0	0	0	0	0	0	0.0000033	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CN1CCN(CC1)CCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCN1CCN(CC1)C	-	-	2.12214	533.370290376	8	5	11	121.47	2	0.129844068859688	3.19459203332327	39	GUGACCUUAUAUAGGGAAGGGAGGGGGUGCCUGUGGGGUUUUAAAGAAU	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	49	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2576	DMZ-P5	Target_lig_1338	NEAT1 G-quadruplex N1	Homo sapiens	Cancer	Target_480	0	0	0	0	0	0	0.0000076	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	Clc1ccc(cc1)CNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCc1ccc(cc1)Cl	N'-[(4-chlorophenyl)methyl]-4-[2-[4-[N'-[(4-chlorophenyl)methyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	169205691	7.33454000000001	529.15484916	4	5	9	108.51	4	0.0676404254236566	2.90009025878217	37	GGAGGUGACCUGGGAGGGAGGGAGGGAGGCGCGGAGCCG	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	39	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2577	DMZ-P8	Target_lig_1339	NEAT1 G-quadruplex N1	Homo sapiens	Cancer	Target_480	0	0	0	0	0	0	0.0000155	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NC1CCN(CC1)Cc1ccccc1)NC1CCN(CC1)Cc1ccccc1	N'-(1-benzylpiperidin-4-yl)-4-[2-[4-[N'-(1-benzylpiperidin-4-yl)carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271104	6.95654000000001	627.37979244	6	5	11	114.99	4	0.0534114269747732	3.09720222304256	47	GGAGGUGACCUGGGAGGGAGGGAGGGAGGCGCGGAGCCG	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	39	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2578	DMZ-P8Cl	Target_lig_1340	NEAT1 G-quadruplex N1	Homo sapiens	Cancer	Target_480	0	0	0	0	0	0	0.0000103	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	Clc1ccc(cc1)CN1CCC(CC1)NC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NC1CCN(CC1)Cc1ccc(cc1)Cl	-	-	8.26334000000001	695.301847736	6	5	11	114.99	4	0.0469072335067548	3.19884932951034	49	GGAGGUGACCUGGGAGGGAGGGAGGGAGGCGCGGAGCCG	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	39	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2579	DMZ-P9	Target_lig_1341	NEAT1 G-quadruplex N1	Homo sapiens	Cancer	Target_480	0	0	0	0	0	0	0.0000097	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCN1CCNCC1)NCCN1CCNCC1	N'-(2-piperazin-1-ylethyl)-4-[2-[4-[N'-(2-piperazin-1-ylethyl)carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271108	1.43774	505.338990248	8	7	11	139.05	2	0.106134940284456	3.31170520150043	37	GGAGGUGACCUGGGAGGGAGGGAGGGAGGCGCGGAGCCG	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	39	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2580	DMZ-P13	Target_lig_1342	NEAT1 G-quadruplex N1	Homo sapiens	Cancer	Target_480	0	0	0	0	0	0	0.000004	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	N=C(c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCC1CCN(CC1)Cc1ccccc1)NCCC1CCN(CC1)Cc1ccccc1	N'-[2-(1-benzylpiperidin-4-yl)ethyl]-4-[2-[4-[N'-[2-(1-benzylpiperidin-4-yl)ethyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	170271115	8.23194000000001	683.442392696	6	5	15	114.99	4	0.0374956929145835	3.2691072143013	51	GGAGGUGACCUGGGAGGGAGGGAGGGAGGCGCGGAGCCG	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	39	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2581	DMZ-P14	Target_lig_1343	NEAT1 G-quadruplex N1	Homo sapiens	Cancer	Target_480	0	0	0	0	0	0	0.0000132	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CCN(Cc1ccccc1)CCCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCCN(Cc1ccccc1)CC	-	-	7.45174000000001	631.411092568	6	5	19	114.99	4	0.0242463538137001	3.21603404091224	47	GGAGGUGACCUGGGAGGGAGGGAGGGAGGCGCGGAGCCG	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	39	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2582	DMZ-M1	Target_lig_1344	NEAT1 G-quadruplex N1	Homo sapiens	Cancer	Target_480	0	0	0	0	0	0	0.0000053	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CN(CCCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCCN(C)C)C	N'-[3-(dimethylamino)propyl]-4-[2-[4-[N'-[3-(dimethylamino)propyl]carbamimidoyl]phenyl]iminohydrazinyl]benzenecarboximidamide	169205715	3.53074	451.317192184	6	5	13	114.99	2	0.105059958363125	3.16767082207306	33	GGAGGUGACCUGGGAGGGAGGGAGGGAGGCGCGGAGCCG	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	39	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2583	DMZ-M10	Target_lig_1345	NEAT1 G-quadruplex N1	Homo sapiens	Cancer	Target_480	0	0	0	0	0	0	0.0000486	-	-	10.1101/2025.02.10.637408	39990451	Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA	Martyr JG, Zafferani M, Bailey MA, Zorawski MD, Montalvan NI, Muralidharan D, Fitzgerald MC, Hargrove AE	BioRxiv	-	-	2025	1, 5, 10, 25, 50 µM	8 uM	6.7	-	50 mM d11-Tris-HCl, 50 mM KCl, 5% DMSO, 90:10 RNase-free water:D2O	Fluorescence Indicator Displacement (FID)	Additional	CN1CCN(CC1)CCNC(=N)c1ccc(cc1)N/N=N/c1ccc(cc1)C(=N)NCCN1CCN(CC1)C	-	-	2.12214	533.370290376	8	5	11	121.47	2	0.129844068859688	3.19459203332327	39	GGAGGUGACCUGGGAGGGAGGGAGGGAGGCGCGGAGCCG	10.1101/2025.02.10.637408	lncRNA	G-quadruplex	39	3′ terminal stability element for nuclear expression (ENE)	G-quadruplex	0	0	0	0	0	0	0	0	0	0
2584	DMA-135	Target_lig_1019	EV71 IRES SL II	Enterovirus 71	Hand, foot and mouth disease	Target_329	0	0	0	0	0	0	1.18e-05±3.1e-06	-	-	10.1021/acs.jcim.4c01903	40022654	Identification of Small-Molecule Inhibitors for Enterovirus A71 IRES by Structure-Based Virtual Screening	Wang K, Lee SXY, Jaladanki CK, Ho WS, Chu JJH, Fan H, Chai CLL	J Chem Inf Model	65(6)	3010-3021	2025	10 uL	100 nM	7.5	-	1% DMSO and Resveratrol	Firefly Luciferase Inhibition Assay	Additional	CN(C)C1=C(N=C(C(=N1)N)C(=O)[NH+]=C(N)N)C#CC2=CC=CC=C2	[3-amino-5-(dimethylamino)-6-(2-phenylethynyl)pyrazine-2-carbonyl]-(diaminomethylidene)azanium	154573938	-1.9812	324.15673461609	5	4	2	138.12	2	0.285132447560012	3.52479574105296	24	GGAUCAAUAGCAGGUGUGGCACACCAGUCAUACCUUGAUCC	6XB7	Viral RNA	Internal Ribosomal Entry Site (IRES)	41	5’-UTR	Stem-Loop	0	0	0	0	0	0	0	0	0	0
2585	DMA-155	Target_lig_1021	EV71 IRES SL II	Enterovirus 71	Hand, foot and mouth disease	Target_329	0	0	0	0	0	0	1.67e-05±3.7e-06	-	-	10.1021/acs.jcim.4c01903	40022654	Identification of Small-Molecule Inhibitors for Enterovirus A71 IRES by Structure-Based Virtual Screening	Wang K, Lee SXY, Jaladanki CK, Ho WS, Chu JJH, Fan H, Chai CLL	J Chem Inf Model	65(6)	3010-3021	2025	10 uL	100 nM	7.5	-	1% DMSO and Resveratrol	Firefly Luciferase Inhibition Assay	Additional	CN(c1nc(N)c(nc1c1ccc(cc1)c1ccccc1)C(=O)NC(=[NH2+])N)C	-	-	0.262400000000001	376.18803474409	5	4	4	135.75	3	0.380959014949487	2.79678565117154	28	GGAUCAAUAGCAGGUGUGGCACACCAGUCAUACCUUGAUCC	6XB7	Viral RNA	Internal Ribosomal Entry Site (IRES)	41	5’-UTR	Stem-Loop	0	0	0	0	0	0	0	0	0	0
2586	DMA-169	Target_lig_1093	EV71 IRES SL II	Enterovirus 71	Hand, foot and mouth disease	Target_329	0	0	0	0	0	0	2.23e-05±7.499999999999999e-06	-	-	10.1021/acs.jcim.4c01903	40022654	Identification of Small-Molecule Inhibitors for Enterovirus A71 IRES by Structure-Based Virtual Screening	Wang K, Lee SXY, Jaladanki CK, Ho WS, Chu JJH, Fan H, Chai CLL	J Chem Inf Model	65(6)	3010-3021	2025	10 uL	100 nM	7.5	-	1% DMSO and Resveratrol	Firefly Luciferase Inhibition Assay	Additional	O=C(c1nc(c2ccccc2)c(nc1N)NCCC1=NCc2c1cccc2)NC(=[NH2+])N	-	-	0.334300000000001	415.19893377609	6	5	6	156.9	3	0.288440990368983	3.2035820095661	31	GGAUCAAUAGCAGGUGUGGCACACCAGUCAUACCUUGAUCC	6XB7	Viral RNA	Internal Ribosomal Entry Site (IRES)	41	5’-UTR	Stem-Loop	0	0	0	0	0	0	0	0	0	0
2587	DMA-179	Target_lig_1097	EV71 IRES SL II	Enterovirus 71	Hand, foot and mouth disease	Target_329	0	0	0	0	0	0	1.76e-05±5.6e-06	-	-	10.1021/acs.jcim.4c01903	40022654	Identification of Small-Molecule Inhibitors for Enterovirus A71 IRES by Structure-Based Virtual Screening	Wang K, Lee SXY, Jaladanki CK, Ho WS, Chu JJH, Fan H, Chai CLL	J Chem Inf Model	65(6)	3010-3021	2025	10 uL	100 nM	7.5	-	1% DMSO and Resveratrol	Firefly Luciferase Inhibition Assay	Additional	Fc1ccc(cc1)c1nc(C(=O)NC(=[NH2+])N)c(nc1NCCC1=NCc2c1cccc2)N	-	-	0.4734	433.18951196409	6	5	6	156.9	3	0.280953636352977	3.24717120985156	32	GGAUCAAUAGCAGGUGUGGCACACCAGUCAUACCUUGAUCC	6XB7	Viral RNA	Internal Ribosomal Entry Site (IRES)	41	5’-UTR	Stem-Loop	0	0	0	0	0	0	0	0	0	0
2588	BRACO-19	Target_lig_1374	CMV 3’-UTR G-quadruplex (PQS)	Cucumber Mosaic Virus	Plant necrosis and shunted growth	Target_481	0	0	7.14e-08±2.07e-08	0.00022634±4.4479999999999994e-05	0	0	0	-	-	10.1002/ps.8769	40068969	BRACO-19 targeted the G-quadruplex in the 3'UTR of the Cucumber mosaic virus 1a, 2b, and CP genes to inhibit viral proliferation	Gao C, Wei S, Xu Y, Mohamed HI, Liu W, Wang Z, Wu W, Wang M, He Y	Pest Manag Sci.	81(7)	4027-4034	2025	70 uL	10 uM	0	25	-	Isothermal Titration Calorimetry (ITC)	Additional	CN(C)C1=CC=C(C=C1)NC2=C3C=CC(=CC3=NC4=C2C=CC(=C4)NC(=O)CCN5CCCC5)NC(=O)CCN6CCCC6	N-[9-[4-(dimethylamino)anilino]-6-(3-pyrrolidin-1-ylpropanoylamino)acridin-3-yl]-3-pyrrolidin-1-ylpropanamide	9808666	6.04640000000001	593.347823616	7	3	11	92.84	4	0.182518307926582	2.63544762846875	44	GGUUUCUUCGGAAGGACUUCGG	10.1002/ps.8769	Viral RNA	G-quadruplex	22	3’-UTR	G-quadruplex	0	0	0	0	0.0000000507	0.0000000921	0.00018186	0.00027082	0	0
2589	BMPQ-1	Target_lig_1375	CMV 3’-UTR G-quadruplex (PQS)	Cucumber Mosaic Virus	Plant necrosis and shunted growth	Target_481	0	0	4.5199999999999997e-07±2.33e-07	0	0	0	0	-	-	10.1002/ps.8769	40068969	BRACO-19 targeted the G-quadruplex in the 3'UTR of the Cucumber mosaic virus 1a, 2b, and CP genes to inhibit viral proliferation	Gao C, Wei S, Xu Y, Mohamed HI, Liu W, Wang Z, Wu W, Wang M, He Y	Pest Manag Sci.	81(7)	4027-4034	2025	70 uL	10 uM	0	25	-	Isothermal Titration Calorimetry (ITC)	Additional	Cc1ccc(cc1)Cn1cc2-c(c3c1cc1OCOc1c3)nnc2c1ccc2c(c1)OCO2	5-(1,3-benzodioxol-5-yl)-8-[(4-methylphenyl)methyl]-12,14-dioxa-3,4,8-triazatetracyclo[7.7.0.02,6.011,15]hexadeca-1(16),2,4,6,9,11(15)-hexaene	2135496	5.01722	437.137556088	7	0	3	67.63	3	0.394993456981825	2.60694952263517	33	GGUUUCUUCGGAAGGACUUCGG	10.1002/ps.8769	Viral RNA	G-quadruplex	22	3’-UTR	G-quadruplex	0	0	0	0	0.000000219	0.000000685	0	0	0	0
2590	N-methyl mesoporphyrin IX (NMM)	Target_lig_1376	CMV 3’-UTR G-quadruplex (PQS)	Cucumber Mosaic Virus	Plant necrosis and shunted growth	Target_481	0	0	8.53e-08±6.769999999999999e-08	0	0	0	0	-	-	10.1002/ps.8769	40068969	BRACO-19 targeted the G-quadruplex in the 3'UTR of the Cucumber mosaic virus 1a, 2b, and CP genes to inhibit viral proliferation	Gao C, Wei S, Xu Y, Mohamed HI, Liu W, Wang Z, Wu W, Wang M, He Y	Pest Manag Sci.	81(7)	4027-4034	2025	70 uL	10 uM	0	25	-	Isothermal Titration Calorimetry (ITC)	Additional	CCC1=C(C)c2cc3[nH]c(cc4nc(cc5c(CC)c(C)c(cc1n2)n5C)C(C)=C4CCC(=O)O)c(CCC(=O)O)c3C	3-[18-(2-carboxyethyl)-7,12-diethyl-3,8,13,17,22-pentamethyl-23H-porphyrin-2-yl]propanoic acid	656404	7.65784000000001	580.30495576	5	3	8	121.1	3	0.251523768714341	5.4684463242916	43	GGUUUCUUCGGAAGGACUUCGG	10.1002/ps.8769	Viral RNA	G-quadruplex	22	3’-UTR	G-quadruplex	0	0	0	0	0.0000000176	0.000000153	0	0	0	0
2591	5,10,15,20-tetra(1-methyl-4-pyridyl)-porphyrin (TMPyP4)	Target_lig_1377	CMV 3’-UTR G-quadruplex (PQS)	Cucumber Mosaic Virus	Plant necrosis and shunted growth	Target_481	0	0	1.76e-07±1.64e-07	0	0	0	0	-	-	10.1002/ps.8769	40068969	BRACO-19 targeted the G-quadruplex in the 3'UTR of the Cucumber mosaic virus 1a, 2b, and CP genes to inhibit viral proliferation	Gao C, Wei S, Xu Y, Mohamed HI, Liu W, Wang Z, Wu W, Wang M, He Y	Pest Manag Sci.	81(7)	4027-4034	2025	70 uL	10 uM	0	25	-	Isothermal Titration Calorimetry (ITC)	Additional	C[n+]1ccc(-c2c3nc(c(-c4cc[n+](C)cc4)c4ccc([nH]4)c(-c4cc[n+](C)cc4)c4nc(c(-c5cc[n+](C)cc5)c5ccc2[nH]5)C=C4)C=C3)cc1.[Cl-].[Cl-].[Cl-].[Cl-]	5,10,15,20-tetrakis(1-methylpyridin-1-ium-4-yl)-21,23-dihydroporphyrin;tetrachloride	135509775	-5.36240000000001	818.197353936	2	2	4	72.88	7	0.174559769784483	5.89595145367419	56	GGUUUCUUCGGAAGGACUUCGG	10.1002/ps.8769	Viral RNA	G-quadruplex	22	3’-UTR	G-quadruplex	0	0	0	0	0.000000012	0.00000034	0	0	0	0
2592	CNV	Target_lig_1378	Tte-PreQ1 riboswitch	Thermoanaerobacter tengcongensis	Bacterial growth and infection	Target_482	0	0	4e-07±2e-07	0	0	0	0	-	-	10.1002/anie.202503078	40163345	Harnessing Molecular Recognition for Small-Molecule-Mediated Reversible Photochemical Control Over mRNA Translation	Parmar S, Tenney L, Liang X, Routzahn JT 4th, Sibley CD, Schneekloth JS Jr	Angew Chem Int Ed Engl	64(22)	e202503078	2025	100 uM	100 nM	7.5	75	50 mM Tris, 100 mM KCl, 1 mM MgCl2	Microscale thermophoresis (MST)	Additional	N#CC/C=C/c1ccc2c(c1)c1ccccc1[nH]2	-	-	4.24798	232.100048384	1	1	2	39.58	3	0.704537788714501	2.39414721118785	18	CUGGGUCGCAGUAACCCCAGUUAACAAAACAAG	6E1V	RNA aptamer, Riboswitch	Riboswitch	33	5’-UTR	-	0	0	0	0	0.0000002	0.0000006	0	0	0	0
2593	Compound 1	Target_lig_1379	WT MAPT SRE	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_315	0	0	3.2999999999999997e-06±7e-07	5.9e-06±1.6999999999999998e-06	0	0	0	-	-	10.1021/acschembio.5c00260	40545738	Design of an Orally Bioavailable Small Molecule That Modulates the Microtubule-Associated Protein Tau's Pre-mRNA Splicing	Zhang P, Taghavi A, Abe M, Aikawa H, Akahori Y, Chen JL, Tong Y, Baisden JT, Cameron MD, Childs-Disney JL, Disney MD	ACS Chem Biol	20(7)	1715-1727	2025	0	0	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence intensity assay	Additional	COc1ccc2c(c1)c1ncn(c(=O)c1[nH]2)CCCN(C1CCCCC1)C	3-[3-[cyclohexyl(methyl)amino]propyl]-8-methoxy-5H-pyrimido[5,4-b]indol-4-one	23604625	3.541	368.221226136	5	1	6	63.15	3	0.722783848086336	2.46632418669009	27	GGCAGUGUGAGUACCUUCACACGUC	10.1021/acschembio.5c00260	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	0.0000026	0.000004	0.0000042	0.0000076	0	0
2594	Compound 2	Target_lig_1380	WT MAPT SRE	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_315	0	0	5.5e-07±1.0999999999999999e-07	9e-07±2e-07	0	0	0	-	-	10.1021/acschembio.5c00260	40545738	Design of an Orally Bioavailable Small Molecule That Modulates the Microtubule-Associated Protein Tau's Pre-mRNA Splicing	Zhang P, Taghavi A, Abe M, Aikawa H, Akahori Y, Chen JL, Tong Y, Baisden JT, Cameron MD, Childs-Disney JL, Disney MD	ACS Chem Biol	20(7)	1715-1727	2025	0	0	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence intensity assay	Additional	COc1cc(N)ncc1CCCN(CCCn1cnc2c(c1=O)n(C)c1c2cccc1)C	3-[3-[3-(6-amino-4-methoxypyridin-3-yl)propyl-methylamino]propyl]-5-methylpyrimido[5,4-b]indol-4-one	176125115	2.8287	434.2430242	8	1	9	91.2	4	0.435598185899826	2.76330138736635	32	GGCAGUGUGAGUACCUUCACACGUC	10.1021/acschembio.5c00260	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	0.00000044	0.00000066	0.0000007	0.0000011	0	0
2595	Compound 2	Target_lig_1380	7-deaza-guanosine modified MAPT SRE	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_483	0	0	3.3999999999999996e-06±9e-07	0	0	0	0	-	-	10.1021/acschembio.5c00260	40545738	Design of an Orally Bioavailable Small Molecule That Modulates the Microtubule-Associated Protein Tau's Pre-mRNA Splicing	Zhang P, Taghavi A, Abe M, Aikawa H, Akahori Y, Chen JL, Tong Y, Baisden JT, Cameron MD, Childs-Disney JL, Disney MD	ACS Chem Biol	20(7)	1715-1727	2025	0	0	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence intensity assay	Additional	COc1cc(N)ncc1CCCN(CCCn1cnc2c(c1=O)n(C)c1c2cccc1)C	3-[3-[3-(6-amino-4-methoxypyridin-3-yl)propyl-methylamino]propyl]-5-methylpyrimido[5,4-b]indol-4-one	176125115	2.8287	434.2430242	8	1	9	91.2	4	0.435598185899826	2.76330138736635	32	GGCA{c7G}UGUGAGUACCUUCACACGUC	10.1021/acschembio.5c00260	Bulge, mRNA	pre-mRNA	29	Splice site	Bulge	0	0	0	0	0.0000025	0.0000043	0	0	0	0
2596	Compound 1	Target_lig_1379	DDPAC MAPT SRE	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	3.6e-06±7e-07	0	0	0	0	-	-	10.1021/acschembio.5c00260	40545738	Design of an Orally Bioavailable Small Molecule That Modulates the Microtubule-Associated Protein Tau's Pre-mRNA Splicing	Zhang P, Taghavi A, Abe M, Aikawa H, Akahori Y, Chen JL, Tong Y, Baisden JT, Cameron MD, Childs-Disney JL, Disney MD	ACS Chem Biol	20(7)	1715-1727	2025	0	0	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence intensity assay	Additional	COc1ccc2c(c1)c1ncn(c(=O)c1[nH]2)CCCN(C1CCCCC1)C	3-[3-[cyclohexyl(methyl)amino]propyl]-8-methoxy-5H-pyrimido[5,4-b]indol-4-one	23604625	3.541	368.221226136	5	1	6	63.15	3	0.722783848086336	2.46632418669009	27	GGCAGUGUGAGUACCUUCAUACGUC	10.1021/acschembio.5c00260	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	0.0000029	0.0000043	0	0	0	0
2597	Compound 2	Target_lig_1380	DDPAC MAPT SRE	Homo sapiens	Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)	Target_198	0	0	5.8e-07±1e-07	0	0	0	0	-	-	10.1021/acschembio.5c00260	40545738	Design of an Orally Bioavailable Small Molecule That Modulates the Microtubule-Associated Protein Tau's Pre-mRNA Splicing	Zhang P, Taghavi A, Abe M, Aikawa H, Akahori Y, Chen JL, Tong Y, Baisden JT, Cameron MD, Childs-Disney JL, Disney MD	ACS Chem Biol	20(7)	1715-1727	2025	0	0	7	Room temperature	8 mM Na2HPO4, 185 mM NaCl, and 1 mM EDTA	Fluorescence intensity assay	Additional	COc1cc(N)ncc1CCCN(CCCn1cnc2c(c1=O)n(C)c1c2cccc1)C	3-[3-[3-(6-amino-4-methoxypyridin-3-yl)propyl-methylamino]propyl]-5-methylpyrimido[5,4-b]indol-4-one	176125115	2.8287	434.2430242	8	1	9	91.2	4	0.435598185899826	2.76330138736635	32	GGCAGUGUGAGUACCUUCAUACGUC	10.1021/acschembio.5c00260	Bulge, mRNA	pre-mRNA	25	Splice site	Bulge	0	0	0	0	0.00000048	0.00000068	0	0	0	0
2598	Compound 3	Target_lig_1384	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	2.7e-09±8.000000000000001e-11	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 mM	0.5 nM	6.9	-	20 mM HEPES, 1 mM MgCl2 and 2.5 mM equimolar NaCl/KCl	TR-FRET assay	Additional	CC1=CC=C(C=C1)C(=O)NC1=NC(=CC1)C1=CC(NC(=O)C(CC2=CN(CC[C@H]3O[C@@H](O[C@@H]4[C@@H](O)[C@H](N)C[C@H](N)[C@H]4O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)[C@H](O)[C@@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)N=N2)NC(=O)C(N)CCCCN)=CC=C1	-	-	-6.20198000000003	1167.603656892	27	17	23	515.29	3	0.0392888187338987	6.75676964920278	83	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.00000000262	0.00000000278
2599	Compound 6	Target_lig_1385	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	6.5e-07±9e-08	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 mM	0.5 nM	6.9	-	20 mM HEPES, 1 mM MgCl2 and 2.5 mM equimolar NaCl/KCl	TR-FRET assay	Additional	O=C(c1ccc(s1)c1ccccn1)Cn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+]	-	-	0.184500000000002	400.16704784818	7	2	7	125.18	3	0.547577063085363	4.69063248992018	28	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.00000056	0.00000074
2600	Compound 7	Target_lig_1386	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	2.9e-07±3e-09	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 mM	0.5 nM	6.9	-	20 mM HEPES, 1 mM MgCl2 and 2.5 mM equimolar NaCl/KCl	TR-FRET assay	Additional	O=C(c1ccc2c(c1)scc2)Cn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+]	-	-	0.275700000000001	373.15614881618	6	2	6	112.29	3	0.604200811254922	4.77501470822546	26	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.000000287	0.000000293
2601	Compound 9	Target_lig_1387	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	4e-07±3e-09	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 mM	0.5 nM	6.9	-	20 mM HEPES, 1 mM MgCl2 and 2.5 mM equimolar NaCl/KCl	TR-FRET assay	Additional	[NH3+][C@H]1CC([C@H](C1)[NH3+])OCc1nnn(c1)CC[NH+](CCn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+])CCCc1ccccc1	-	-	-4.11250000000001	586.42780200445	8	5	16	194.88	3	0.113080038644719	6.38318344878523	42	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.000000397	0.000000403
2602	Compound 10	Target_lig_1388	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	5.7e-08±1e-09	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 mM	0.5 nM	6.9	-	20 mM HEPES, 1 mM MgCl2 and 2.5 mM equimolar NaCl/KCl	TR-FRET assay	Additional	[NH3+][C@@H]1CC([C@@H](C1)[NH3+])OCc1cnnn1CC[NH+](CCn1nnc(c1)COC1C[C@@H](C[C@@H]1[NH3+])[NH3+])CCCc1ccc(cc1)c1ccccc1	-	-	-2.44550000000001	662.45910213245	8	5	17	194.88	4	0.0832938775687968	6.19251899770585	48	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.000000056	0.000000058
2603	Compound 15	Target_lig_1389	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	3e-07±4e-08	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 mM	0.5 nM	6.9	-	20 mM HEPES, 1 mM MgCl2 and 2.5 mM equimolar NaCl/KCl	TR-FRET assay	Additional	N[C@H]1C[C@H](C(C1)OCc1cnnn1CC(=O)c1ccc2c(c1)cccc2)N	-	-	1.6478	365.185174976	7	2	6	109.05	3	0.642986716393659	3.80133092024479	27	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.00000026	0.00000034
2604	Compound 46	Target_lig_1390	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	1.8999999999999998e-06±3.5e-08	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 mM	0.5 nM	6.9	-	20 mM HEPES, 1 mM MgCl2 and 2.5 mM equimolar NaCl/KCl	TR-FRET assay	Additional	O=C(c1cccs1)Cn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+]	-	-	-0.877499999999997	323.14049875218	6	2	6	112.29	2	0.672347873361084	4.91852510342108	22	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.000001865	0.000001935
2605	Compound 47	Target_lig_1391	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	1.82e-06±4e-08	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 mM	0.5 nM	6.9	-	20 mM HEPES, 1 mM MgCl2 and 2.5 mM equimolar NaCl/KCl	TR-FRET assay	Additional	O=C(c1ccccc1)Cn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+]	-	-	-0.938999999999997	317.18407781618	5	2	6	112.29	2	0.669584940077601	4.57484731341395	23	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.00000178	0.00000186
2606	Compound 50	Target_lig_1392	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	5.899999999999999e-08±4e-09	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 mM	0.5 nM	6.9	-	20 mM HEPES, 1 mM MgCl2 and 2.5 mM equimolar NaCl/KCl	TR-FRET assay	Additional	[NH3+][C@H]1C[C@H](CC1OCc1nnn(c1)CC[NH+](Cc1ccccc1)CCn1nnc(c1)COC1C[C@@H](C[C@@H]1[NH3+])[NH3+])[NH3+]	-	-	-4.54510000000001	558.39650187645	8	5	14	194.88	3	0.132102485614583	6.24359793896545	40	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.000000055	0.000000063
2607	Furamidine	Target_lig_1264	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	1.01e-08±3e-09	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 mM	0.5 nM	6.9	-	20 mM HEPES, 1 mM MgCl2 and 2.5 mM equimolar NaCl/KCl	TR-FRET assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.0000000071	0.0000000131
2608	Compound 3	Target_lig_1384	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	1.28e-08±8.000000000000001e-11	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	7.2	37	Tris-HCl 20 mM, 2.5 mM MgCl2, 12 mM NaCl	Fluorescence intensity assay	Additional	CC1=CC=C(C=C1)C(=O)NC1=NC(=CC1)C1=CC(NC(=O)C(CC2=CN(CC[C@H]3O[C@@H](O[C@@H]4[C@@H](O)[C@H](N)C[C@H](N)[C@H]4O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)[C@H](O)[C@@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)N=N2)NC(=O)C(N)CCCCN)=CC=C1	-	-	-6.20198000000003	1167.603656892	27	17	23	515.29	3	0.0392888187338987	6.75676964920278	83	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.00000001272	0.00000001288	0	0	0	0
2609	Compound 6	Target_lig_1385	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	3.71e-07±3.7999999999999996e-08	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	7.2	37	Tris-HCl 20 mM, 2.5 mM MgCl2, 12 mM NaCl	Fluorescence intensity assay	Additional	O=C(c1ccc(s1)c1ccccn1)Cn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+]	-	-	0.184500000000002	400.16704784818	7	2	7	125.18	3	0.547577063085363	4.69063248992018	28	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000000333	0.000000409	0	0	0	0
2610	Compound 7	Target_lig_1386	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	6.55e-07±9.6e-08	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	7.2	37	Tris-HCl 20 mM, 2.5 mM MgCl2, 12 mM NaCl	Fluorescence intensity assay	Additional	O=C(c1ccc2c(c1)scc2)Cn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+]	-	-	0.275700000000001	373.15614881618	6	2	6	112.29	3	0.604200811254922	4.77501470822546	26	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000000559	0.000000751	0	0	0	0
2611	Compound 9	Target_lig_1387	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	3.57e-07±2.5e-08	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	7.2	37	Tris-HCl 20 mM, 2.5 mM MgCl2, 12 mM NaCl	Fluorescence intensity assay	Additional	[NH3+][C@H]1CC([C@H](C1)[NH3+])OCc1nnn(c1)CC[NH+](CCn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+])CCCc1ccccc1	-	-	-4.11250000000001	586.42780200445	8	5	16	194.88	3	0.113080038644719	6.38318344878523	42	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000000332	0.000000382	0	0	0	0
2612	Compound 10	Target_lig_1388	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	1.0199999999999999e-07±2.8e-08	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	7.2	37	Tris-HCl 20 mM, 2.5 mM MgCl2, 12 mM NaCl	Fluorescence intensity assay	Additional	[NH3+][C@@H]1CC([C@@H](C1)[NH3+])OCc1cnnn1CC[NH+](CCn1nnc(c1)COC1C[C@@H](C[C@@H]1[NH3+])[NH3+])CCCc1ccc(cc1)c1ccccc1	-	-	-2.44550000000001	662.45910213245	8	5	17	194.88	4	0.0832938775687968	6.19251899770585	48	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000000074	0.00000013	0	0	0	0
2613	Compound 15	Target_lig_1389	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	5.37e-07±5e-08	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	7.2	37	Tris-HCl 20 mM, 2.5 mM MgCl2, 12 mM NaCl	Fluorescence intensity assay	Additional	N[C@H]1C[C@H](C(C1)OCc1cnnn1CC(=O)c1ccc2c(c1)cccc2)N	-	-	1.6478	365.185174976	7	2	6	109.05	3	0.642986716393659	3.80133092024479	27	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000000487	0.000000587	0	0	0	0
2614	Compound 46	Target_lig_1390	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	3.5499999999999995e-06±3.2e-08	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	7.2	37	Tris-HCl 20 mM, 2.5 mM MgCl2, 12 mM NaCl	Fluorescence intensity assay	Additional	O=C(c1cccs1)Cn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+]	-	-	-0.877499999999997	323.14049875218	6	2	6	112.29	2	0.672347873361084	4.91852510342108	22	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000003518	0.000003582	0	0	0	0
2615	Compound 47	Target_lig_1391	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	1.1399999999999999e-06±1.12e-07	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	7.2	37	Tris-HCl 20 mM, 2.5 mM MgCl2, 12 mM NaCl	Fluorescence intensity assay	Additional	O=C(c1ccccc1)Cn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+]	-	-	-0.938999999999997	317.18407781618	5	2	6	112.29	2	0.669584940077601	4.57484731341395	23	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000001028	0.000001252	0	0	0	0
2616	Compound 50	Target_lig_1392	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	7e-08±9e-09	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	7.2	37	Tris-HCl 20 mM, 2.5 mM MgCl2, 12 mM NaCl	Fluorescence intensity assay	Additional	[NH3+][C@H]1C[C@H](CC1OCc1nnn(c1)CC[NH+](Cc1ccccc1)CCn1nnc(c1)COC1C[C@@H](C[C@@H]1[NH3+])[NH3+])[NH3+]	-	-	-4.54510000000001	558.39650187645	8	5	14	194.88	3	0.132102485614583	6.24359793896545	40	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000000061	0.000000079	0	0	0	0
2617	Furamidine	Target_lig_1264	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	1.33e-07±3.5e-08	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	7.2	37	Tris-HCl 20 mM, 2.5 mM MgCl2, 12 mM NaCl	Fluorescence intensity assay	Additional	C1=CC(=CC=C1C2=CC=C(O2)C3=CC=C(C=C3)C(=N)N)C(=N)N	4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide	126437	3.18174	304.132411132	3	4	4	112.88	3	0.438232345121004	2.08255127462598	23	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000000098	0.000000168	0	0	0	0
2618	Compound 3	Target_lig_1384	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	4.95e-08±5e-09	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	1 uM – 0.03 nM	5 nM	0	Room temperature	-	Microscale thermophoresis (MST)	Additional	CC1=CC=C(C=C1)C(=O)NC1=NC(=CC1)C1=CC(NC(=O)C(CC2=CN(CC[C@H]3O[C@@H](O[C@@H]4[C@@H](O)[C@H](N)C[C@H](N)[C@H]4O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)[C@H](O)[C@@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)N=N2)NC(=O)C(N)CCCCN)=CC=C1	-	-	-6.20198000000003	1167.603656892	27	17	23	515.29	3	0.0392888187338987	6.75676964920278	83	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.0000000445	0.0000000545	0	0	0	0
2619	Compound 7	Target_lig_1386	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	1.5399999999999999e-06±1.5e-08	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	0	Room temperature	-	Microscale thermophoresis (MST)	Additional	O=C(c1ccc2c(c1)scc2)Cn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+]	-	-	0.275700000000001	373.15614881618	6	2	6	112.29	3	0.604200811254922	4.77501470822546	26	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.000001525	0.000001555	0	0	0	0
2620	Compound 10	Target_lig_1388	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	2.25e-07±2.5e-09	0	0	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM – 0.3 nM	5 nM	0	Room temperature	-	Microscale thermophoresis (MST)	Additional	[NH3+][C@@H]1CC([C@@H](C1)[NH3+])OCc1cnnn1CC[NH+](CCn1nnc(c1)COC1C[C@@H](C[C@@H]1[NH3+])[NH3+])CCCc1ccc(cc1)c1ccccc1	-	-	-2.44550000000001	662.45910213245	8	5	17	194.88	4	0.0832938775687968	6.19251899770585	48	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0.0000002225	0.0000002275	0	0	0	0
2621	Compound 3	Target_lig_1384	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	2.3e-07±9.999999999999999e-06	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM	50 nM	6.5	-	5 mM sodium cacodylate, 50 mM KCl, 1 mM MgCl2, 0.1 mM EDTA, 0.01% Triton X-100	Fluorescence Indicator Displacement (FID)	Additional	CC1=CC=C(C=C1)C(=O)NC1=NC(=CC1)C1=CC(NC(=O)C(CC2=CN(CC[C@H]3O[C@@H](O[C@@H]4[C@@H](O)[C@H](N)C[C@H](N)[C@H]4O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)[C@H](O)[C@@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)N=N2)NC(=O)C(N)CCCCN)=CC=C1	-	-	-6.20198000000003	1167.603656892	27	17	23	515.29	3	0.0392888187338987	6.75676964920278	83	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	-0.00000977	0.00001023
2622	Compound 7	Target_lig_1386	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	6.14e-06±2.6e-06	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM	50 nM	6.5	-	5 mM sodium cacodylate, 50 mM KCl, 1 mM MgCl2, 0.1 mM EDTA, 0.01% Triton X-100	Fluorescence Indicator Displacement (FID)	Additional	O=C(c1ccc2c(c1)scc2)Cn1nncc1COC1C[C@H](C[C@H]1[NH3+])[NH3+]	-	-	0.275700000000001	373.15614881618	6	2	6	112.29	3	0.604200811254922	4.77501470822546	26	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.00000354	0.00000874
2623	Compound 10	Target_lig_1388	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	5.78e-06±3.6e-06	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM	50 nM	6.5	-	5 mM sodium cacodylate, 50 mM KCl, 1 mM MgCl2, 0.1 mM EDTA, 0.01% Triton X-100	Fluorescence Indicator Displacement (FID)	Additional	[NH3+][C@@H]1CC([C@@H](C1)[NH3+])OCc1cnnn1CC[NH+](CCn1nnc(c1)COC1C[C@@H](C[C@@H]1[NH3+])[NH3+])CCCc1ccc(cc1)c1ccccc1	-	-	-2.44550000000001	662.45910213245	8	5	17	194.88	4	0.0832938775687968	6.19251899770585	48	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.00000218	0.00000938
2624	Compound 15	Target_lig_1389	MALAT1 triplex	Homo sapiens	Cancer	Target_272	0	0	0	0	7.92e-06±4.2999999999999995e-06	0	0	-	-	10.1021/acschembio.5c00061	-	Development of Comprehensive Screening and Assessment Assays for Small-Molecule Ligands of MALAT1 lncRNA	Pernak M, Fleurisson C, Delorme C, Moumné R, Benedetti E, Micouin L, Azoulay S, Foricher Y, Duca M	ACS Chem Biol	20(5)	1068-1076	2025	10 uM	50 nM	6.5	-	5 mM sodium cacodylate, 50 mM KCl, 1 mM MgCl2, 0.1 mM EDTA, 0.01% Triton X-100	Fluorescence Indicator Displacement (FID)	Additional	N[C@H]1C[C@H](C(C1)OCc1cnnn1CC(=O)c1ccc2c(c1)cccc2)N	-	-	1.6478	365.185174976	7	2	6	109.05	3	0.642986716393659	3.80133092024479	27	GAAGGUUUUUCUUUUCCUGAGAAAACAACACGUAUUGUUUUCUCAGGUUUUGCUUUUUGGCCUUU	10.1021/acschembio.5c00061	lncRNA	3′ terminal stability element for nuclear expression (ENE)	65	3′ terminal stability element for nuclear expression (ENE)	Triple helix	0	0	0	0	0	0	0	0	0.00000362	0.00001222
